<SEC-DOCUMENT>0000849146-22-000076.txt : 20221102
<SEC-HEADER>0000849146-22-000076.hdr.sgml : 20221102
<ACCEPTANCE-DATETIME>20221102160611
ACCESSION NUMBER:		0000849146-22-000076
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		50
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221102
DATE AS OF CHANGE:		20221102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		221354018

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lfvn-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381,d:45b6e518c14a4052bf67665f6ff68340--><html xmlns:lfvn="http://www.lifevantage.com/20220930" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lfvn-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV8yLTEtMS0xLTI3MTE2_48885d52-4bb0-402e-89a3-4e9078032041">false</ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV8zLTEtMS0xLTI3MTE2_f40b3e46-a7e6-4149-9129-6693c69b2846">2023</ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV80LTEtMS0xLTI3MTE2_efa7011c-aa5a-473d-803b-ab9b743d9651">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV81LTEtMS0xLTI3MTE2_e4266568-bf8c-4500-9ef1-db1da86250e5">0000849146</ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV82LTEtMS0xLTI3MTE2_eb287945-3a08-44ee-bf84-73cde8759f39">--06-30</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="INF" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80My9mcmFnOjQ3M2Y0YmFlZTk5OTRmYzRhOGU1YmQ3ZGE0ZTc5ODNhL3RhYmxlOmY5ODQ4NWNmZTBhZjRkYzliZDI4ZmUwNzBkODI0YmM0L3RhYmxlcmFuZ2U6Zjk4NDg1Y2ZlMGFmNGRjOWJkMjhmZTA3MGQ4MjRiYzRfMi0xLTEtMS0yNzExNg_642023d8-7dac-4854-801f-68152f06ac0d">1</ix:nonFraction><ix:nonNumeric contextRef="i977658914054449698f6d6c732ed2032_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTU4_994c7e14-50db-4ced-ba65-b8b872893dc3">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i26ba0558720045eea67b29115b0a3986_D20100927-20100927" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE5OQ_d0bf6ea3-3477-49ad-9fc2-afc2a24fddbb">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lfvn-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6856ea53c1704440948a893bb1e74c15_I20221101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i880f6ec9d0804b6fb4548530f81b7956_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="id131ac0747904e089c449612a8c5c709_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i134c0b1b046448648f3d5b336aadf135_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772c3990679040deb003807e322e476d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd874c225db84fa692c8f0221e9780f7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300ef21b8a32406f85a8fce070f62833_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65ee8ebabf91481da59551eb50755285_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d47334a25b4d05bf35eb2fc4cac648_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142357a5c6e948f8921ab76bcc4e3980_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a4a8394481341fcb8c2b42fce932721_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic912ea6c452d4756ad15fcde7ddd86a5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib49d1d736bed499fbe9fe5f9d1dc89f7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e24f72d093b44669e0b2c6422958fd3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b9681a3c672475a84d9bba889cdf521_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d4ba4946fe945eb89d86d3343e4c4c1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26d3269d23ed46ada597b50493898abc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ee4c90e2c44881aeb0c71eb0112c0e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7514593bd74a78a67f8118af0c54be_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905940febcac4f6fb8131e1282d2be84_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ecb61b96c094f12ae3c415be0611510_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa677e07c6d457c8eece153824244a4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d3fcefe8f444849b3d928b4112c0a6_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff5c682417d44fc6afa71d4889a5fe31_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ed018d6d084503a906e48fc59af41e_D20220930-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-30</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8404347bcfbe4f78be26db732735d417_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03174868560f44ff80cf933d2f69ab68_D20220630-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="region"><xbrli:measure>lfvn:region</xbrli:measure></xbrli:unit><xbrli:context id="ib732a4247f1c4b9f9cef9f2ced8879ce_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402d171eca914ca896c2460efa80a95d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe7711d279984593aa89a86b806404b8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i939ab82e679a4c00953b5bcdb1aa7115_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i429b06262ff74cbc894e05c074db49f0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46736b895fa9494fb40c592102713ba8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia36a6256f3744258b47971555a767ab1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e7f9e3862de4c17a2b53bbc46589c1d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfdce7f7d47e4eb1b5e54bb8f86005b4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7afcea9cb8e4e9c88e904f1a007bcb5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b8444b610764ffab7c655e6f33040ba_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dca30b124b04669a1465dfa6dd2bbc0_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lfvn:segment</xbrli:measure></xbrli:unit><xbrli:context id="ie2be38077dec479a8c4f830a7cc40030_I20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie46dcc75834340edbbb0d6971d255894_D20190531-20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-31</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-16</xbrli:startDate><xbrli:endDate>2019-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i977658914054449698f6d6c732ed2032_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6f19746429c4cdca994057d70e98d3a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica5344233c204858b6afe60475269d38_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6036eac111f84de4a9039a3e7d031527_I20160330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14dbc7cf32884923b5dc54345b785092_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b346e2c97643deb010bf416bf02431_I20180503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1f3dc19a5f44f8b47022c121a77785_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie05a0f91cf5441fca02cab96f9dd1693_D20180504-20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-04</xbrli:startDate><xbrli:endDate>2018-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93efb3d8dea497aa299e88710676864_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69d6cfdbf8c46398d7508667051f58b_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1887e1c461be424086a7149e6dcee766_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc83d833f5664c16b3b8e21685061d73_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec815bc3224c4b2eb6f03e0428ec3199_I20180504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i454d5b7910c542ef883eed9a307e6da4_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6026a96d5b4fe780ee9d2e9d5aafe2_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eae71368a024d6ba653f381ffe0db1c_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11854662ecd64eb0ae73d899d84d814f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88116b05befd4416b9cb7a08d858f271_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7191113c25f247479215258c91e7ce5a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i071a21c613194e0ab1b99e7ce4356c02_I20171127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if01d6b23161a4099ae7e64005f8ac196_I20200827"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fbeb3758f03482b8e51a3ca187c8244_I20220217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6a6dc1ee6443578385523d83f7da3c_D20220915-20220915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-15</xbrli:startDate><xbrli:endDate>2022-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c951d2923244147b9f226b2ae6d9238_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c717bd0b67741c8b344ee3df55eb9dc_I20061121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2006-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f9cb90e49c84d6a98d875ed5d38d73b_I20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2010-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26ba0558720045eea67b29115b0a3986_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaadfa48ed71d4f0fa49a9f9c6323fd8a_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f8f7854e7764dc285105b899092b475_D20100927-20100927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-09-27</xbrli:startDate><xbrli:endDate>2010-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9e2ea205a3d43158e970a0c0f8f359f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if899b129124943fe800d819b6de66ec3_D20180202-20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-02</xbrli:startDate><xbrli:endDate>2018-02-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a45671ea82d4f1a932759250eb31f16_D20181115-20181115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-15</xbrli:startDate><xbrli:endDate>2018-11-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdc4810b41d540409fbcb3fe43b196b2_D20201112-20201112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-12</xbrli:startDate><xbrli:endDate>2020-11-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4cb4a2f4cdf4160909164d620456770_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44c9e56976144431bc767f09ba938466_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcad4b991602480e8c333048b37bc386_I20180202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4218dd95179b44ee93fbc3f2fa44e6e1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-05</xbrli:startDate><xbrli:endDate>2019-12-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>lfvn:claim</xbrli:measure></xbrli:unit><xbrli:context id="idccc1f3bca2347cc8ac18f61b4fb2b0d_I20191205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000849146</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i45b6e518c14a4052bf67665f6ff68340_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xNjQ_fdd8889c-894e-4a59-9be1-cb9f23806af9">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MWJmNjU2OWIzMzVjNDlhNzgxOGFiOTc1MjVmM2YzOTQvdGFibGVyYW5nZToxYmY2NTY5YjMzNWM0OWE3ODE4YWI5NzUyNWYzZjM5NF8wLTAtMS0xLTI3MTE2_c2128c90-668d-45be-86ee-ef5d12d83ba9">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE QUARTERLY PERIOD ENDED <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yODE_89a3aee6-0c40-48d1-970a-7087e2fd2d6d">SEPTEMBER 30, 2022</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6ZTJhMDMxYjMwOTUzNGQ1ZWEzZDZlMTVmY2I1NDAyZmEvdGFibGVyYW5nZTplMmEwMzFiMzA5NTM0ZDVlYTNkNmUxNWZjYjU0MDJmYV8wLTAtMS0xLTI3MTE2_eab7ae1f-86aa-4fee-918b-85b8d1b97808">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE TRANSITION PERIOD FROM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> TO </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18zNjY_9b92f888-c43c-4f31-ac45-f0cc035e168c">001-35647</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM180NTE_4a8b62c9-2ff1-40ca-b904-b3c82a7066f7">LIFEVANTAGE CORP</ix:nonNumeric>ORATION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY2Y2YyMTljYjgwNGFkODk0OWE3YTU2MzNlMDIyM2MvdGFibGVyYW5nZToxNjZjZjIxOWNiODA0YWQ4OTQ5YTdhNTYzM2UwMjIzY18wLTAtMS0xLTI3MTE2_c5b3d712-6649-401f-b92d-c8750387b80f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY2Y2YyMTljYjgwNGFkODk0OWE3YTU2MzNlMDIyM2MvdGFibGVyYW5nZToxNjZjZjIxOWNiODA0YWQ4OTQ5YTdhNTYzM2UwMjIzY18wLTItMS0xLTI3MTE2_03bfb1f8-14de-4788-9a34-df42d284342b">90-0224471</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEy_d16cc90b-37a8-4231-9484-a4e3d70be5e0">3300 Triumph Blvd</ix:nonNumeric>, <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEz_f7234e84-eae9-48cf-9316-03847944215a">Suite 700</ix:nonNumeric>, <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDE0_f41d794e-451a-45c0-abd6-3a772c9be852">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182MzU_ca413316-5837-4c91-b57a-a84db50358ff">UT</ix:nonNumeric> <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182Mzg_f35cee5e-816d-486c-8ac0-639ece1c864d">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM183MDM_f2f9ce82-d8fe-42ac-ab93-d426b8f82734">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM183MDc_42d56037-19e9-4591-862e-158d93090b51">432-9000</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTAtMS0xLTI3MTE2_317395b3-b0c3-42c8-beb4-65fa8c2072bf">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTItMS0xLTI3MTE2_93de9b6f-991b-4693-a8fe-6cc833a90a21">LFVN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTQtMS0xLTI3MTE2_90023ad7-df75-43c5-8b8a-fe30c0d35e60">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15 (d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xMjM0_bdbfc997-39ba-4081-9a45-d7119c348187">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xNTU5_ee581d06-fae9-4057-96db-9c2067db1091">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8wLTItMS0xLTI3MTE2_6a4947d8-1170-456b-a4ef-e86d68a06572">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8xLTMtMS0xLTI3MTE2_c7240fcb-957a-4cd8-a1ad-aa9ec26ef7a2">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8yLTEtMS0xLTI3MTE2_32916bb4-dbf6-469b-b5ef-07ccb76b7fe2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes&#160;&#160;&#9744;&#160;&#160;No&#160;&#160;<ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182MDQ3MzEzOTU1MjA5_e52f81cd-3018-4b8f-b413-51073a795fd2">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The number of shares outstanding of the issuer&#8217;s common stock, par value $0.0001 per share, as of November&#160;1, 2022 was <ix:nonFraction unitRef="shares" contextRef="i6856ea53c1704440948a893bb1e74c15_I20221101" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEw_d13b1e59-2018-4362-80b9-1b3808234a9d">12,569,302</ix:nonFraction>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q, in particular &#8220;Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and the information incorporated by reference herein contains &#8220;forward-looking statements&#8221; (as such term is defined in Section&#160;27A of the Securities Act of 1933, as amended and Section&#160;21E of the Securities Exchange Act of 1934, as amended). These statements, which involve risks and uncertainties, reflect our current expectations, intentions, or strategies regarding our possible future results of operations, performance, and achievements. Forward-looking statements include, without limitation: statements regarding future products or product development; statements regarding future selling, general and administrative costs and research and development spending; statements regarding the future performance of our network marketing efforts; statements regarding our expectations regarding ongoing litigation; statements regarding international growth; and statements regarding future financial performance, results of operations, capital expenditures and sufficiency of capital resources to fund our operating requirements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and applicable rules of the Securities and Exchange Commission and common law.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements may be identified in this report and the information incorporated by reference by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should&#8221; and similar terms and expressions, including references to assumptions and strategies. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following factors are among those that may cause actual results to differ materially from our forward-looking statements:</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to properly manage, motivate and retain our independent distributors or to attract new customers and independent distributors on an ongoing basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic or the widespread outbreak of any other illness or communicable disease or any other public health crisis, could adversely affect our business, results of operations and financial condition;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to protect against cyber security risks and to maintain the integrity of data;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to manage existing markets, open new international markets or expand our operations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Non-compliance by our independent distributors with applicable legal requirements or our policies and procedures, including making improper and/or illegal claims about our products or earnings opportunity;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability of new products and technological innovations to gain customer or independent distributor or market acceptance;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business and stock price may be adversely affected if our internal controls over financial reporting is not effective;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to execute our product launch process due to increased pressure on our supply chain, information systems and management;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to appropriately manage our inventory;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions in our information technology systems;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International trade or foreign exchange restrictions, increased tariffs, foreign currency exchange fluctuations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to raise additional capital or complete desired acquisitions;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inability to comply with financial covenants imposed by our credit facility and the impact of debt service obligations and restrictive debt covenants;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence upon a few products for revenue;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to retain our existing distributor force or customer base or attract additional customers and/or independent distributors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">High quality materials for our products may become difficult to obtain or expensive;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Improper actions by our independent distributors that violate laws or regulations could harm our business;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Dependence on third parties to manufacture our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to the transportation channels used to distribute our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to a product recall;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Unfavorable publicity on our business or products; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks related to Global Not For Resale programs;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our direct selling program could be found to not be in compliance with current or newly adopted laws or regulations in various markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Legal proceedings may be expensive and time consuming;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strict government regulations on our business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Cannabidiol (&#8220;CBD&#8221;) products are subject to varying and changing federal, state or local laws which could adversely affect our results of operations and financial condition;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulations governing the production or marketing of our products;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Risk of investigatory and enforcement action;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Government authorities may question our tax positions or transfer pricing policies or change their laws in a manner that could increase our effective tax rate or otherwise harm our business;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to comply with anti-corruption laws;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of, or inability to attract, key personnel;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be held responsible for certain taxes or assessments and other obligations relating to the activity of our independent distributors;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the dietary supplement and personal care markets;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our inability to protect our intellectual property rights;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Third party claims that we infringe on their intellectual property;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability claims against us;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consumer discretionary spending habits factor into our economic success;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Economic, political, foreign exchange and other risks associated with international operations;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential delisting of our common stock due to non-compliance with Nasdaq's continued listing requirements;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volatility of the market price of our common stock; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Substantial sales of shares may negatively impact the market price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. Except as required by law, we have no obligation and do not undertake to update or revise any such forward-looking statements to reflect events or circumstances after the date of this report.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.686%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_13">PART I. Financial Information</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_16">Financial Statements:</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_19">Condensed Consolidated Balance Sheets (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_22">Condensed Consolidated Statements of Operations and Comprehensive Income (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_25">Condensed Consolidated Statement of Stockholders&#8217; Equity (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_31">Condensed Consolidated Statements of Cash Flows (unaudited) </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_34">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_67">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_67">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_91">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_94">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_94">27</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_97">PART II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_97">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_100">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_100">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_103">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_103">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_106">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_106">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_109">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_109">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_112">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_112">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_115">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_115">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_118">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_118">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_121">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i45b6e518c14a4052bf67665f6ff68340_121">30</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. Financial Information</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_16"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNC0xLTEtMS0yNzExNg_86769409-eae5-4611-8fea-d0ff265c9d02">17,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNC0zLTEtMS0yNzExNg_9161877f-1851-4822-acda-5b3ca927aaa9">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNS0xLTEtMS0yNzExNg_b7b2fa86-6a65-44a0-ac40-e0a35cb060aa">1,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNS0zLTEtMS0yNzExNg_062d2dbd-a487-476d-bcc3-7449108b0182">3,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNi0xLTEtMS0yNzExNg_1fed2a51-5282-429f-b38f-92730b6b2230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNi0zLTEtMS0yNzExNg_eccb1ff3-ee72-4c71-b847-1430d0fa8e1a">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNy0xLTEtMS0yNzExNg_d371181f-f5c5-490c-a79c-0e2a9bc7ebc2">18,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNy0zLTEtMS0yNzExNg_79e77ea0-1f65-4e28-9423-1ad72d663d70">16,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfOS0xLTEtMS0yNzExNg_547211c6-4a3f-436e-869c-59b2b5f78804">4,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfOS0zLTEtMS0yNzExNg_d1e8c90c-a90a-4a4b-b925-c0418fc32730">5,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTAtMS0xLTEtMjcxMTY_d74a4f37-83ac-4892-adea-823b1a90d7ab">42,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTAtMy0xLTEtMjcxMTY_b4ad59d3-15aa-4d96-9088-bb5364df3550">46,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTItMS0xLTEtMjcxMTY_372788b1-cc25-48b4-8de2-240b78f0e53f">9,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTItMy0xLTEtMjcxMTY_558e89fb-bb63-4923-a7d9-c134a799e0e0">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTMtMS0xLTEtMjcxMTY_27b9568e-cbed-4216-bfe0-d78f2cee6496">10,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTMtMy0xLTEtMjcxMTY_1d3f09f5-6a63-4947-8dd8-22be5f026d09">11,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTQtMS0xLTEtMjcxMTY_f55c4578-ffe1-414d-8c2c-4be20d18ee08">554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTQtMy0xLTEtMjcxMTY_2bbc41c4-8bf9-4d2f-858c-3a6969cd5f03">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income tax asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTUtMS0xLTEtMjcxMTY_04208465-d98d-4a68-b56e-c2c43c9a878b">3,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTUtMy0xLTEtMjcxMTY_1ec7a2e1-bc2a-471e-b419-1e7785176c67">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTctMS0xLTEtMjcxMTY_e983cd8c-8c18-4041-af9b-f30bf8d78ae1">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTctMy0xLTEtMjcxMTY_47fb04a4-f3db-44d6-81b2-c5f0d705c3f4">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTgtMS0xLTEtMjcxMTY_fb79b02d-554f-403e-bb78-27ac4a83c41d">67,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTgtMy0xLTEtMjcxMTY_853d9fb2-9bf0-447c-9235-0f8eaa48178c">70,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjItMS0xLTEtMjcxMTY_7da4e8e3-1b92-48a7-ac2b-b37c2be10231">7,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjItMy0xLTEtMjcxMTY_d7a3acf6-2d59-4b97-b882-35f40f22de5b">7,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commissions payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjMtMS0xLTEtMjcxMTY_277798ca-feca-4fc0-947c-09e2acb029f6">7,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjMtMy0xLTEtMjcxMTY_f757f13f-96db-4b98-a419-6743d89122e7">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjYtMS0xLTEtMjcxMTY_424df2ea-8340-40b2-afbf-a7e8ad7b9396">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:TaxesPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjYtMy0xLTEtMjcxMTY_cea0b0cc-c556-4564-9822-9d31de6c6470">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjctMS0xLTEtMjcxMTY_7fdf40d9-4f60-4dff-9bc8-92cd09598691">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjctMy0xLTEtMjcxMTY_3b00feb7-c686-44a3-9360-952e0ec674ca">2,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjgtMS0xLTEtMjcxMTY_79c96a53-38d3-440f-bc8f-55333206d2ac">5,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjgtMy0xLTEtMjcxMTY_c80eb12a-7130-4d93-9fe0-436d04498bee">7,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzAtMS0xLTEtMjcxMTY_34be9451-42d1-4f56-9075-64c0e2bd0157">22,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzAtMy0xLTEtMjcxMTY_c434a2e2-04eb-44e7-ac96-be85225eee10">25,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzYtMS0xLTEtMjcxMTY_df4cdd6d-a402-4902-bb5c-2814003110d5">12,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzYtMy0xLTEtMjcxMTY_10f20c11-20a6-4d14-97ae-e6ea814b0ff8">13,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzctMS0xLTEtMjcxMTY_0e556217-8a1f-4bc3-bee1-4c7be0156164">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzctMy0xLTEtMjcxMTY_fb60d476-7124-475e-b956-b3ee65114aa8">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzgtMS0xLTEtMjcxMTY_3ea1a446-5a5c-4104-bdd3-6c8f1fcfe024">35,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzgtMy0xLTEtMjcxMTY_d9391a8c-6344-4d48-b411-d6e55be653be">39,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies - Note 8</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzktMS0xLTEtMjcxMTY_ed123740-6c69-4862-80ac-ae8648c41819"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzktMy0xLTEtMjcxMTY_2ba03464-db45-43d2-9180-83655129cdf1"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Preferred stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF8zMg_4120d28f-012a-44ee-a480-2d38a5717ffd"><ix:nonFraction unitRef="usdPerShare" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF8zMg_dfbf9300-fd31-4586-8dbb-a62fb2e55168">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF80Ng_b38420c2-70fb-48a6-beb1-6b892c49c09f"><ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF80Ng_ce0b5d0b-e096-4b2b-8ca7-27f2fd461e43">5,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_2d16c40e-33f3-46c7-9429-a1756cea7d74"><ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_7b2caa0c-3e4b-4f3e-8361-aacfed7ae4c7"><ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_8bc151e7-a1e9-4b3a-953a-f3434574bec9"><ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_8bca26c6-79e1-47ae-8c7f-63e3f636f536">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMS0xLTEtMjcxMTY_4e3bf21c-f670-4000-8cc1-9b325019fae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMy0xLTEtMjcxMTY_4c7e7397-ad45-449a-bec6-20c85a810a42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl8zMA_d705b8cb-a752-458d-b365-99bc61ed09ed"><ix:nonFraction unitRef="usdPerShare" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl8zMA_dcce3950-0ba7-46ce-b3db-71aa3ed0a45b">0.0001</ix:nonFraction></ix:nonFraction> per share, <ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl80NA_415fc9ec-f0fd-46b4-a221-3726dded9ea5"><ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl80NA_d319044b-0d40-432f-9541-624d7aa60448">40,000</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl82OQ_27fe81d9-c063-4d76-9e9e-e292333eecb1"><ix:nonFraction unitRef="shares" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl82OQ_fff3b630-a53b-4687-89e7-b2abe6a355c5">12,560</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl83Ng_a101fbfb-a5cd-4d1b-aeb0-43b106736f19"><ix:nonFraction unitRef="shares" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl83Ng_aeca09cd-06a0-4c80-94bb-7c46f740b2d2">12,493</ix:nonFraction></ix:nonFraction> issued and outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMS0xLTEtMjcxMTY_d1991dd8-79eb-4c66-8b93-850ed66240a0">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMy0xLTEtMjcxMTY_3382f7e9-1a68-40c5-8b22-71cc1a7dc733">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDMtMS0xLTEtMjcxMTY_12193280-87bc-4d39-8bf8-a0c4e110d11a">131,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDMtMy0xLTEtMjcxMTY_88d4e8d9-0c33-4e3f-84e9-359b46f0c899">131,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDQtMS0xLTEtMjcxMTY_37dec837-696a-4ad5-9850-e995bd2c5534">98,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDQtMy0xLTEtMjcxMTY_ef5ce950-cf2c-4093-876d-7cc258c88598">98,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDUtMS0xLTEtMjcxMTY_b87f78e2-bdfc-4af9-bad2-fd7913668629">1,633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDUtMy0xLTEtMjcxMTY_e078f161-879e-493b-8b2b-621a81aa2ce2">1,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDYtMS0xLTEtMjcxMTY_b47e3b36-37e4-4ac1-a2c6-2e0851786803">31,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDYtMy0xLTEtMjcxMTY_eb01c39a-de47-4e8e-8b96-d4b9f00c843f">31,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDctMS0xLTEtMjcxMTY_b07f9e6c-e609-49f6-b45e-bc9aacd813a5">67,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDctMy0xLTEtMjcxMTY_25dec42d-7100-43e5-a62d-70487f327e7e">70,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div id="i45b6e518c14a4052bf67665f6ff68340_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMy0xLTEtMS0yNzExNg_d7dbfcb5-5638-4283-b925-9d0221cad667">51,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMy0zLTEtMS0yNzExNg_e78d1e93-99c2-4940-9381-644147462087">53,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNC0xLTEtMS0yNzExNg_27b9414d-5478-434e-bdd2-cdb2dfdb0431">9,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNC0zLTEtMS0yNzExNg_48e1fdfc-0301-4758-8719-adfc23904c30">9,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNS0xLTEtMS0yNzExNg_bc946b85-9c8a-46a8-9f5e-a82b99ecb16b">41,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNS0zLTEtMS0yNzExNg_a09fabbe-aa54-4bd4-b276-231b0f911af2">43,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions and incentives</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNy0xLTEtMS0yNzExNg_a32568fd-44ef-488d-92e9-299a5e32ff00">23,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="lfvn:CommissionAndIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNy0zLTEtMS0yNzExNg_1a1fe274-bdbe-4eb1-b4bb-2a786137f801">24,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfOC0xLTEtMS0yNzExNg_31b8b5fa-0191-46c2-b3ba-d94b0232526d">16,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfOC0zLTEtMS0yNzExNg_128201d2-b099-4682-8323-a5b3f30e9711">15,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTEtMS0xLTEtMjcxMTY_1d3e8494-9fce-4531-adb7-032977971445">40,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTEtMy0xLTEtMjcxMTY_ba3e61c8-1885-4076-86c5-bf868ee26e62">39,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTItMS0xLTEtMjcxMTY_db911ec1-1815-4864-80a3-ee642cccf1b0">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTItMy0xLTEtMjcxMTY_b4893db6-e7a5-42d8-bfc9-5aedb2d1d756">4,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTQtMS0xLTEtMjcxMTY_dac20eb8-c2db-4e6a-b567-d1710657b201">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTQtMy0xLTEtMjcxMTY_7929363c-6369-4280-8051-9f41719ca5fe">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTUtMS0xLTEtMjcxMTY_b35b346a-cf8f-4b75-ad78-1983ccfaa59b">438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTUtMy0xLTEtMjcxMTY_53e2eea8-92ee-4c89-b243-5b288ea2270e">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTctMS0xLTEtMjcxMTY_e56d60f1-2929-40af-9028-77b4c4386704">438</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTctMy0xLTEtMjcxMTY_6fbf0689-a7c5-4a6b-822f-2ab74ea90f9c">180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTgtMS0xLTEtMjcxMTY_0f7a971e-c72f-4788-bdfc-49abd71c5cb0">852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTgtMy0xLTEtMjcxMTY_c1a3b099-2d96-489b-99fa-437c1b8ab17c">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTktMS0xLTEtMjcxMTY_fb3fe919-dddd-438c-9874-d6265e69ab88">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTktMy0xLTEtMjcxMTY_8f8f6a88-8f63-4402-bc51-c06629cf96b1">1,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjAtMS0xLTEtMjcxMTY_92d783d5-07e6-4f84-a7e0-7f01fd0510e6">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjAtMy0xLTEtMjcxMTY_a004ab79-9739-4527-862c-cb3d4fec9d64">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjItMS0xLTEtMjcxMTY_9ddc0000-b66c-44de-9286-f38f78e5028a">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjItMy0xLTEtMjcxMTY_03eec91e-d0ba-4a55-a4aa-c15a53d43701">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjMtMS0xLTEtMjcxMTY_fdac9da9-88ff-4f1f-808d-7ae033de475d">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjMtMy0xLTEtMjcxMTY_ea25990c-503e-40ff-888f-eed6300666cb">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjUtMS0xLTEtMjcxMTY_2a054f67-1bd3-4962-8aca-4d524fa0db87">12,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjUtMy0xLTEtMjcxMTY_1dea4fdc-c577-4c5f-a5f5-7a091dbefb68">13,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjYtMS0xLTEtMjcxMTY_51f9463c-2a1c-4a2d-b078-ee2e60042b04">12,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjYtMy0xLTEtMjcxMTY_193cf361-6f50-478a-bd8d-62ee72d6ff11">13,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjgtMS0xLTEtMjcxMTY_94ae3a48-180a-48c5-b648-8603574e0a47">510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjgtMy0xLTEtMjcxMTY_b6581aff-7623-424d-bae1-532c207c763b">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzAtMS0xLTEtMjcxMTY_268fc34d-394d-46c1-8431-f3363d0c9448">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzAtMy0xLTEtMjcxMTY_23ff2fbf-ed0d-4993-bf0a-0275d83d9a9b">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzEtMS0xLTEtMjcxMTY_903cb5c7-0419-435a-9a10-3f4e18ce01d9">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzEtMy0xLTEtMjcxMTY_7b77caff-651a-4f24-81f1-42387677bf9f">3,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i134c0b1b046448648f3d5b336aadf135_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0xLTEtMS0yNzExNg_0b1da986-78e4-4ce1-a7e9-3981e9f3f513">12,493</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c0b1b046448648f3d5b336aadf135_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0zLTEtMS0yNzExNg_265aec8e-a561-4ff8-964f-f98fc6d8609a">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i772c3990679040deb003807e322e476d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy01LTEtMS0yNzExNg_c661e986-1051-4d4a-89cc-14ce8cd17ef8">131,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd874c225db84fa692c8f0221e9780f7_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy03LTEtMS0yNzExNg_b1da8713-66f9-4f43-bbfc-af1be07fe9e3">98,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i300ef21b8a32406f85a8fce070f62833_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy05LTEtMS0yNzExNg_01c00e2d-10b2-4f08-8ce3-6b4a7f198942">1,123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0xMS0xLTEtMjcxMTY_2d9064c7-0580-4d5a-a74c-dad91262e744">31,516</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNS01LTEtMS0yNzExNg_5a4f27a0-2924-4915-8fc2-d1958068fe10">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNS0xMS0xLTEtMjcxMTY_3b478346-0ef5-42b6-a153-a0b8953743a0">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNy0xLTEtMS0yNzExNg_76df20fa-4910-476a-a5f6-3980f59e872e">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNy0xMS0xLTEtMjcxMTY_24856160-d315-49dd-a4d0-7afd33e13ad6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC0xLTEtMS0yNzExNg_3a1f0550-f985-411a-9276-e24fbf0b14c1">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC01LTEtMS0yNzExNg_5cd480ae-a3dc-4a57-9326-b8d9acd81668">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC0xMS0xLTEtMjcxMTY_f831abdf-28c5-4ec9-a353-78be90a053da">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtMS0xLTEtMjcxMTY_db89dc26-dc81-4df0-8f53-a8d68f18589d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtNS0xLTEtMjcxMTY_bb7274cd-225f-4013-bcfa-3d136e778dcd">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtMTEtMS0xLTI3MTE2_8a34e639-0ec9-4466-85f5-115c9065e91f">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtNy0xLTEtMjkzODY_f0ff1e9b-e67d-4984-9a53-d9c22c44e393">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:DividendsCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtMTEtMS0xLTI5Mzg2_c8d6971f-8aad-4654-aab2-0110d1afee16">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d47334a25b4d05bf35eb2fc4cac648_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtOS0xLTEtMjcxMTY_0eebdb51-a8da-4b5d-bb99-45f7c62342e6">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtMTEtMS0xLTI3MTE2_848874c1-f122-48d0-a653-48f9b1bee9c0">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTItNy0xLTEtMjcxMTY_aabf17fc-0771-4226-bc64-bca94dcec609">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTItMTEtMS0xLTI3MTE2_4051e58a-d016-4919-957c-5dd126133e54">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i142357a5c6e948f8921ab76bcc4e3980_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMS0xLTEtMjcxMTY_b765f7e4-6bdb-4b7d-926c-d809ce89a38b">12,560</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142357a5c6e948f8921ab76bcc4e3980_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMy0xLTEtMjcxMTY_e8d4d45c-0543-4484-ba0e-f27fd09e633b">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a4a8394481341fcb8c2b42fce932721_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtNS0xLTEtMjcxMTY_181af417-a5ae-4b90-9534-dcea07ca7d37">131,726</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic912ea6c452d4756ad15fcde7ddd86a5_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtNy0xLTEtMjcxMTY_09f28d5e-ebf7-4600-80b8-47399b71f3b7">98,204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib49d1d736bed499fbe9fe5f9d1dc89f7_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtOS0xLTEtMjcxMTY_4881c98f-04aa-483a-8653-ec58b08ce448">1,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMTEtMS0xLTI3MTE2_f1a681f5-4fb1-4df6-9044-2c19ab751712">31,890</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (CONTINUED)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:29.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive (Loss) Income</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e24f72d093b44669e0b2c6422958fd3_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0xLTEtMS0yNzExNg_d6c431da-d4e0-4676-856a-08443dce2f1e">13,609</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e24f72d093b44669e0b2c6422958fd3_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0zLTEtMS0yNzExNg_80888c92-2fbe-482b-97c7-ca00a0a9cf58">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9681a3c672475a84d9bba889cdf521_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy01LTEtMS0yNzExNg_22f13ea4-f9a3-4358-823f-318f83de9744">129,048</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d4ba4946fe945eb89d86d3343e4c4c1_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy03LTEtMS0yNzExNg_cb6b1679-8622-4163-89bb-9553f62f42ad">92,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26d3269d23ed46ada597b50493898abc_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy05LTEtMS0yNzExNg_a3f06e50-d492-4252-97d1-cd73c95777ad">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0xMS0xLTEtMjcxMTY_1c5968e7-0e1e-487e-9de0-8779c31a7dd4">36,807</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNS01LTEtMS0yNzExNg_7e1243b7-7519-47be-b3fe-84e24aaef3fc">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNS0xMS0xLTEtMjcxMTY_17231ca4-0c1d-42b7-bc7f-e754164014ff">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi0xLTEtMS0yNzExNg_3b07f92c-4332-457b-b997-edadb5cd0b45">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi01LTEtMS0yNzExNg_ae1cd60a-9966-44ff-9ee7-be3d4ac2efdd">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi0xMS0xLTEtMjcxMTY_d61cb496-c0f8-450e-97bb-2e8cebbb956f">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under equity award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNy0xLTEtMS0yNzExNg_bc5c4fd3-b337-472f-8bd2-faad67fc27d7">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNy0xMS0xLTEtMjcxMTY_693d3bfc-37fc-4e79-abe8-742f4d10bd8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC0xLTEtMS0yNzExNg_eb239767-1b16-4746-8419-227a9757e74c">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC01LTEtMS0yNzExNg_f91a4c62-d442-450e-801f-a340b6eb3120">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC0xMS0xLTEtMjcxMTY_b16124c7-52b9-4f78-ab25-bba20d4f2e1b">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS0xLTEtMS0yNzExNg_703f092c-4978-4181-a646-2b8f8f166ebf">460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS03LTEtMS0yNzExNg_2b1e11f5-74c9-4fb2-87a8-d1adf197ae43">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS0xMS0xLTEtMjcxMTY_a2eafbf5-d471-4151-b59f-54027526ab8f">3,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtMS0xLTEtMjcxMTY_4a3d7b65-cba6-4c4f-a6a6-419672f7b0ba">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtNS0xLTEtMjcxMTY_13486b52-983b-485e-a719-0df368605581">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtMTEtMS0xLTI3MTE2_5907e282-0232-49df-9438-739546120852">175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91ee4c90e2c44881aeb0c71eb0112c0e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTEtOS0xLTEtMjcxMTY_33ec03cd-5eb9-46cb-8812-1b58b9f7a151">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTEtMTEtMS0xLTI3MTE2_5c46676d-1da8-408e-b921-050806f6eca7">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTItNy0xLTEtMjcxMTY_f659f442-85b4-4b29-8e84-288a3dee533d">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTItMTEtMS0xLTI3MTE2_1a6554b1-2a21-4347-bce2-95f426b01914">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balances, September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b7514593bd74a78a67f8118af0c54be_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMS0xLTEtMjcxMTY_0f2c9849-0916-46d7-8eae-546533685494">13,236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7514593bd74a78a67f8118af0c54be_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMy0xLTEtMjcxMTY_cb7b1e07-33ca-4372-91b0-f3bd523e6d93">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i905940febcac4f6fb8131e1282d2be84_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtNS0xLTEtMjcxMTY_182042e8-e856-4d7d-9f5b-da7f96f4b6be">129,862</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ecb61b96c094f12ae3c415be0611510_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtNy0xLTEtMjcxMTY_b468bfe6-9d67-41f8-a8e7-e0681e2424ee">92,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idaa677e07c6d457c8eece153824244a4_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtOS0xLTEtMjcxMTY_00614be3-d9be-4ff2-a032-cddf5a4064dc">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d3fcefe8f444849b3d928b4112c0a6_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMTEtMS0xLTI3MTE2_159028fb-60b6-45ce-a89e-c795c388bf4c">37,310</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNC0xLTEtMS0yNzExNg_684886ec-cb02-4045-aea9-19d6a86205c4">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNC0zLTEtMS0yNzExNg_4092cfc5-62c5-4a76-8a72-c16de5d04002">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNi0xLTEtMS0yNzExNg_3dfcc5ff-9394-493e-9772-d087db3a701b">841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNi0zLTEtMS0yNzExNg_f46db732-f257-4e5e-b787-82f24c4621ff">793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOC0xLTEtMS0yNzExNg_98367160-1ba6-4818-968e-9652ac29b4ab">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOC0zLTEtMS0yNzExNg_369713c0-5c9b-40c7-8eca-ba6ae713b400">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOS0xLTEtMS0yNzExNg_e693478a-d4ef-4e80-a50c-322908f032b2">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOS0zLTEtMS0yNzExNg_d19339cc-7e60-4251-b41f-14e1d51a49ee">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTQtMS0xLTEtMjcxMTY_583ecf67-29dd-49ca-9013-529b818662a4">1,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTQtMy0xLTEtMjcxMTY_dae187aa-5b8e-42fb-8e20-318698e405c8">1,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTYtMS0xLTEtMjcxMTY_35e0324b-f015-468e-9d52-69bd851e7281">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTYtMy0xLTEtMjcxMTY_db721b08-8fd1-4830-aff1-a25a1ed21f74">366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTctMS0xLTEtMjcxMTY_96936c82-49f6-45e0-a62d-a87dddd44b9e">1,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTctMy0xLTEtMjcxMTY_2323ad2b-0e13-47b9-8ecf-314fee7958ac">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTgtMS0xLTEtMjcxMTY_0db25544-d386-4bc1-b79b-c06eaf0c2b23">2,568</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTgtMy0xLTEtMjcxMTY_3425f8dd-36cb-46d9-a0fd-b8b94c8120d8">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTktMS0xLTEtMjcxMTY_287ba4c7-4255-4d8e-91b1-e38856ed24e2">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTktMy0xLTEtMjcxMTY_ec31e857-93ba-4e9f-b265-5ace9863881d">877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjAtMS0xLTEtMjcxMTY_66792572-279f-4326-9855-4a8da5968939">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjAtMy0xLTEtMjcxMTY_b3fb1eec-838e-4d99-ad23-bd55806dc93d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjEtMS0xLTEtMjcxMTY_9415d7fb-1301-4b3b-a2ea-5fca25956c9d">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjEtMy0xLTEtMjcxMTY_cbf89e93-cea8-4268-8544-cfec5b411ec8">1,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjItMS0xLTEtMjcxMTY_7a8cc2d6-a376-40fd-9b9e-82f7fefcb28e">346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjItMy0xLTEtMjcxMTY_eb4dc34e-6c6f-41ff-9f62-4cd6f05bc929">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjMtMS0xLTEtMjcxMTY_56de4c10-9a44-4947-a1b5-f81dc5db9026">2,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjMtMy0xLTEtMjcxMTY_9b117288-fe98-4fcd-a063-486f32f769e6">1,873</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjQtMS0xLTEtMjcxMTY_44df752a-3067-424a-906a-d4f26b006dbf">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="lfvn:IncreaseDecreaseInLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjQtMy0xLTEtMjcxMTY_d39a6ce1-fe72-4624-80a3-d004ff9fc41a">384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjUtMS0xLTEtMjcxMTY_decd8fec-a65d-4b6c-b12c-a950970dfe3e">311</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjUtMy0xLTEtMjcxMTY_3f11a48b-507f-4cb2-8759-bfdd81743ff8">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash (Used in) Provided by Operating Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjYtMS0xLTEtMjcxMTY_2b080ef5-07f7-4c76-bf0e-663d41dba7e9">1,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjYtMy0xLTEtMjcxMTY_2650040f-055c-4083-b5f1-92d58388f0b1">465</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzEtMS0xLTEtMjcxMTY_45d13cce-bfc7-4ccf-8af8-ac951dd634cb">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzEtMy0xLTEtMjcxMTY_07977590-51e7-4a9a-be1b-3a1b31c6d012">378</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Investing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzItMS0xLTEtMjcxMTY_5927cb79-bd5e-4c50-871a-8be6c0589a55">727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzItMy0xLTEtMjcxMTY_ee7888d6-2c9c-4b49-b123-45f9eec3921e">378</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of company stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzctMS0xLTEtMjcxMTY_7bd80ffe-8224-4e71-9de2-5bce3c40d978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzctMy0xLTEtMjcxMTY_e34b850e-3a38-42e6-b921-c3bfb8795de1">3,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of cash dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsOfDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzgtMS0xLTEtMjcxMTY_a7cd42af-c5ef-4b5b-a1c8-d1190111824e">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzgtMy0xLTEtMjcxMTY_67f876f3-572a-4628-b7bb-58979bab29b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares canceled or surrendered as payment of tax withholding and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzktMS0xLTEtMjcxMTY_e534abba-051d-4e91-8ca0-1cff98b74f49">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzktMy0xLTEtMjcxMTY_6ebf2ec0-ac5e-4c18-b99e-a6350155afa7">139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDAtMS0xLTEtMjcxMTY_cb8e6dd3-5063-4e35-8111-c3b4dc548d4a">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDAtMy0xLTEtMjcxMTY_dc45e9af-1d23-42b0-9b01-0f9307bf95f8">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDEtMS0xLTEtMjcxMTY_827f822b-ad12-46fe-b65b-27a42d18a474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDEtMy0xLTEtMjcxMTY_0d867dd4-f055-48bb-917a-dd531972079c">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDItMS0xLTEtMjcxMTY_e8ec8f7d-4bbb-4546-82fc-635b7e655676">328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDItMy0xLTEtMjcxMTY_dd7e425f-898e-4016-8085-efcfea699727">3,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Effect on Cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDMtMS0xLTEtMjcxMTY_5e5254e9-7447-47d7-aab0-95ac2f3dd804">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDMtMy0xLTEtMjcxMTY_725c6592-17a1-494e-9a6e-ce2cc1f32f61">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Decrease in Cash and Cash Equivalents:</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDQtMS0xLTEtMjcxMTY_77ed841c-d495-441e-b69c-80eaafc78bf9">2,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDQtMy0xLTEtMjcxMTY_d5853080-6590-4b0a-a545-a6be22d67163">3,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and Cash Equivalents &#8212; beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDUtMS0xLTEtMjcxMTY_fad3ba77-e9a7-4727-97b6-7a7187930fbd">20,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDUtMy0xLTEtMjcxMTY_d2496131-bbee-4fa9-9470-1d68db7c621a">23,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents &#8212; end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDYtMS0xLTEtMjcxMTY_eff411cf-7135-4599-a649-3225a3e0183d">17,619</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d3fcefe8f444849b3d928b4112c0a6_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDYtMy0xLTEtMjcxMTY_36379386-3e01-43f5-ad40-973f69cdd78a">19,929</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTEtMS0xLTEtMjcxMTY_103917c7-7468-4db2-bb6b-c9c2060d87f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTEtMy0xLTEtMjcxMTY_87487573-a6df-4778-8337-f3f7c31fb765">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTItMS0xLTEtMjcxMTY_5d8510c2-b14b-472b-a1c1-3f57a23575d3">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTItMy0xLTEtMjcxMTY_7b5ec53b-1912-4720-9d10-e9b32cc18cbe">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and notes should be read in conjunction with the audited financial statements and notes of LifeVantage Corporation (the &#8220;Company&#8221;) as of and for the year ended June&#160;30, 2022 included in the annual report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on August 23, 2022.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_37"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zNy9mcmFnOjA2NTkzNWYxYjY1MTRjMmI5ZWU3YjdmMDI0ZWFhZGQ4L3RleHRyZWdpb246MDY1OTM1ZjFiNjUxNGMyYjllZTdiN2YwMjRlYWFkZDhfMjgwNQ_498eeb34-9004-47a7-95db-e18348d2b314" continuedAt="i2f4f87d3dca0402dbcd92e3ee53b7e7a" escape="true">Organization and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i2f4f87d3dca0402dbcd92e3ee53b7e7a"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of September&#160;30, 2022, and the results of operations for the three months ended September&#160;30, 2022 and 2021, and the cash flows for the three months ended September&#160;30, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.</span></div></ix:continuation><div id="i45b6e518c14a4052bf67665f6ff68340_40"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5Njc_5ce12bf6-1800-480c-8c0f-35adbe70d803" continuedAt="ib0d2c0af8b55451fa5c91bbbe364ead8" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ib0d2c0af8b55451fa5c91bbbe364ead8" continuedAt="i1c86bf32eb334e4b9566e46714a3d716"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzc_435c3417-dbc3-4676-95af-564c60a83cec" continuedAt="i7b8d3292649c4c18b6fed65eef8d6bd3" escape="true">Consolidation</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7b8d3292649c4c18b6fed65eef8d6bd3">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5OTg_c7b848b4-b924-4f9f-a77e-8f07546ce268" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5OTQ_0239da5d-6530-49e9-b11a-891df2318ce4" continuedAt="i04a9907847074670be03e4aad214adda" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1c86bf32eb334e4b9566e46714a3d716" continuedAt="i632252e70b4a458db67a769ef997c920"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i04a9907847074670be03e4aad214adda" continuedAt="i9d3d44b181dc4db98f7138abbef5b15e">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9d3d44b181dc4db98f7138abbef5b15e">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</ix:continuation> For the three months ended September 30, 2022 and 2021, net foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjA1Ng_e05fef9e-887f-4259-b957-c58db4c86f92">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjA2Mw_e94a2b8a-00c6-4b06-9249-55b7d89ac7ee">0.2</ix:nonFraction> million, respectively, are recorded in other expense, net. </span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NjU_c40bb934-d774-4cce-b026-bd4d428257fd" continuedAt="i2e6c5ea565454061972cd4f633d7fee4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2e6c5ea565454061972cd4f633d7fee4">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTY0OTI2NzQ2MTEwMQ_d3906bf7-95e1-44bd-bbd9-5897376e1ff1">no</ix:nonFraction> realized gains or losses for three months ended September 30, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> realized losses of $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjk2NQ_356464d4-0523-4c49-aef4-7a7497684127">30,000</ix:nonFraction> related to forward contracts, are recorded in other expense, net.  The Company did not hold any derivative instruments at September&#160;30, 2022.</span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDU_186606ec-e586-417b-801b-daa497c1e772" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDY_70c91c1d-dd7b-4770-9efd-1eee1d1b8f4a" continuedAt="iba059975cf084b8ebd718af33f754135" escape="true">Concentration of Credit Risk</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba059975cf084b8ebd718af33f754135" continuedAt="i552c3c4bc918461dbbbff5486394f307">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i552c3c4bc918461dbbbff5486394f307">such risk. Financial instruments with significant credit risk include cash and investments.</ix:continuation> At September&#160;30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="iff5c682417d44fc6afa71d4889a5fe31_D20220930-20220930" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzY2NA_3225d68a-4aee-4a3d-9978-9e116c5db055">12.2</ix:nonFraction> million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="i21ed018d6d084503a906e48fc59af41e_D20220930-20220930" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzcxNw_764b742c-f9e5-4a65-b9e9-e6be5ad44b7e">5.4</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $<ix:nonFraction unitRef="usd" contextRef="i8404347bcfbe4f78be26db732735d417_D20220630-20220630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzc4OQ_0abc13ef-e34a-4da9-becb-36e5d6676ad2">15.4</ix:nonFraction>&#160;million in cash accounts at one financial institution and $<ix:nonFraction unitRef="usd" contextRef="i03174868560f44ff80cf933d2f69ab68_D20220630-20220630" decimals="-5" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzg0Mg_626ff802-ed96-4ff7-9484-0f0fcfee118e">4.8</ix:nonFraction> million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of September&#160;30, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzE_8f072ed6-24d3-433a-a74f-47b0cdd392fe" continuedAt="i7ec506435d854266857a03b554cf12a1" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ec506435d854266857a03b554cf12a1">The Company&#8217;s accounts receivable as of September&#160;30, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of September&#160;30, 2022 and June&#160;30, 2022 is not necessary.</ix:continuation> <ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDM4MA_d8c687bd-b3a0-45b9-9e89-5cfb219e6843"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="INF" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDM4MA_eada0fa0-0550-4cdf-81f1-6491fd52e15d">No</ix:nonFraction></ix:nonFraction> bad debt expense was recorded during the three months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NTc_cc90147d-b3f2-435c-9e35-df7b7be7cd02" continuedAt="ie733e248578a49aaa1b85a1152ab8f38" escape="true">As of September&#160;30, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):</ix:nonNumeric></span><ix:continuation id="ie733e248578a49aaa1b85a1152ab8f38"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:31.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS0xLTEtMS0yNzExNg_ffee517f-c9de-4b56-ad0a-b5209f9b3a42">14,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS0zLTEtMS0yNzExNg_f4315188-59a2-4c75-8e4c-1492c3de7246">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS01LTEtMS0yNzExNg_542feb4e-a491-41f8-92b1-f520b4fd5fc5">12,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="3" name="lfvn:InventoryFinishedGoodsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS03LTEtMS0yNzExNg_f202fced-a356-489a-800c-15dfc9da32a9">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi0xLTEtMS0yNzExNg_47377617-45b9-4e75-b1d4-89c03e88e600">4,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi0zLTEtMS0yNzExNg_e913cd21-a976-4dc2-ae4f-6a7001c873ea">21.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi01LTEtMS0yNzExNg_c004a9a9-6e18-462b-b5e3-347f4bf81a6d">3,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="3" name="lfvn:RawMaterialsPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi03LTEtMS0yNzExNg_ba0d3c52-00db-496e-b41a-90b2e386af19">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy0xLTEtMS0yNzExNg_2eb69dae-4981-4b11-b6f5-df2da39b6bea">18,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy0zLTEtMS0yNzExNg_9a065fcc-ebf7-47e8-b1b6-62b27b1518a8">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy01LTEtMS0yNzExNg_cfe58721-aaa7-4665-a1b2-84e466cc1c66">16,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="INF" name="lfvn:InventoryPercentOfTotalInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy03LTEtMS0yNzExNg_1458695f-b37c-4f44-b7ce-8b4479259a94">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzI_f03ce45e-4db4-4b0f-9e2d-83cb63f69426" escape="true">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</ix:nonNumeric>, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDY2NA_cad10847-d12e-4496-a4ad-1f2be6cfbd32">1.2</ix:nonFraction> million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDY3MQ_ad706daf-0a76-4009-8437-b182b93c1c2a">1.3</ix:nonFraction> million at September 30, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.</span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NzM_d01fb7be-ff04-40b1-9692-3d9b62d8fc31" continuedAt="i30ea4a4c442c4f24be5fd623346a4b1f" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i632252e70b4a458db67a769ef997c920" continuedAt="ib57e239fac944055959863ac328e80c7"><ix:continuation id="i30ea4a4c442c4f24be5fd623346a4b1f"><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div></ix:continuation><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5ODg_c5ae4e61-33eb-4b7a-bbff-8e39ed9c253c" continuedAt="i246d1b050e5843389262d8a43d549584" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i246d1b050e5843389262d8a43d549584" continuedAt="i4f82b7e2964244b09e89ac9016a1c588">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODM3Nw_882bdfdf-e4be-42b8-9c68-db78a2239999">30</ix:nonNumeric> days. After <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="lfvn:MoneyBackGuaranteePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTA5OTUxMTY0NzQzNw_882bdfdf-e4be-42b8-9c68-db78a2239999">30</ix:nonNumeric> days of purchase, only unopened product that is in a resalable and restockable condition may be returned within <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTA5OTUxMTY0NzQ0OQ_5c64d98e-85d0-4b3c-8091-36d6cf0cd983">twelve months</ix:nonNumeric> of purchase and shall receive a <ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="3" name="lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODU0OA_30bad79f-a425-4a59-82c7-aec46f247940">100</ix:nonFraction>% refund, less a <ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="INF" name="lfvn:HandlingAndRestockingFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODU2Ng_24dd4e28-28b6-47af-bf13-a50a5bcd8246">10</ix:nonFraction>% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.</ix:continuation> As of&#160;September&#160;30, 2022 and June&#160;30, 2022, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODkyMg_e51d3303-d43d-47fb-90d8-20e8a5ae3528">0.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-5" name="lfvn:ReturnLiabilityReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODkyOQ_ea07b8a8-2bf8-41f0-a23a-f7ced58f75a7">0.1</ix:nonFraction> million, respectively.</span></div><ix:continuation id="i4f82b7e2964244b09e89ac9016a1c588"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzM_e13ab7a5-6024-497a-9bba-f1d1fff54524" continuedAt="idf21f4af5b2e4af08ba806bea2955024" escape="true">Research and Development Costs</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idf21f4af5b2e4af08ba806bea2955024">The Company expenses all costs related to research and development activities, as incurred.</ix:continuation> Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended September 30, 2022 and 2021 were $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfOTQwMA_308e5d18-9cd9-4310-a007-f26eb4e2b8cd">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfOTQwNw_871a9d49-e315-493a-816e-41ba4850acb8">0.2</ix:nonFraction> million, respectively. </span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMjQ_0119196d-0d5c-48ce-80e3-7588c8f40466" continuedAt="i4bb169356b3e4aca803d7850a5fa0753" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib57e239fac944055959863ac328e80c7" continuedAt="icd7be1fc3a26481188233b6385a17e84"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4bb169356b3e4aca803d7850a5fa0753">made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</ix:continuation></span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDI_e5c51d20-6bf7-44b7-8c0c-9b307669d5a4" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5Nzg_74cd6124-2d7d-48d9-aa3e-b9cf0039b5f9" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized income tax expense of $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTU2MDE_1ad522ff-883f-48ed-9d3d-d536cb6fcb29">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTU2MDg_6e1ce81a-3f07-4da6-9473-243594f72f07">1.1</ix:nonFraction> million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzQ_28ca4736-ec4a-43bc-bc2b-36a9095f8375" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the effects of approximately <ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTYzMTQ_fb11036b-49ec-4784-a786-95df28a802dd">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTYzMjE_18e4c482-eee4-4980-af9d-f9a49a6808ca">0.2</ix:nonFraction> million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icd7be1fc3a26481188233b6385a17e84"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMDc_ec7433da-a427-47b6-98c2-641473c8cdd2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMy0xLTEtMS0yNzExNg_92d783d5-07e6-4f84-a7e0-7f01fd0510e6">610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMy0zLTEtMS0yNzExNg_c44635c7-3d91-4e61-8b0c-3a382493feb6">3,316</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNS0xLTEtMS0yNzExNg_c7b7890e-a8af-4021-9960-d57c91e15f27">12,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNS0zLTEtMS0yNzExNg_7c9945da-d082-4741-a441-4770304c7673">13,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNy0xLTEtMS0yNzExNg_2b1435d7-824f-4a8a-96c2-6263edc85e65">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNy0zLTEtMS0yNzExNg_eda8cb33-fa20-4c4c-8aab-866b9734924c">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfOS0xLTEtMS0yNzExNg_70312b35-461c-40c6-9413-4a1d835ac3d0">12,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfOS0zLTEtMS0yNzExNg_68702e31-f698-4cc1-824f-9199311f8c5b">13,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTAtMS0xLTEtMjcxMTY_9991a633-ce33-47c8-b962-75cd61c5fa2c">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTAtMy0xLTEtMjcxMTY_591bc499-94e0-4079-90d1-0933c4b41aec">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTEtMS0xLTEtMjcxMTY_da7a0841-da41-4df0-8e6f-ca9e11ff8543">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTEtMy0xLTEtMjcxMTY_783a8522-4b3e-48ba-ab64-342e8359e911">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NzY_d88f5dbc-9f57-4622-9e5b-a55a659952ce" escape="true"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in <ix:nonFraction unitRef="region" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc0Njg_33e2f189-e9df-4a02-967b-84b98b16b030">two</ix:nonFraction>&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMjA_43318fd4-9988-4d0f-9f62-455ac80e206b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these <ix:nonFraction unitRef="region" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="INF" name="lfvn:NumberOfGeographicSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc2MjM_33e2f189-e9df-4a02-967b-84b98b16b030">two</ix:nonFraction> geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib732a4247f1c4b9f9cef9f2ced8879ce_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMi0xLTEtMS0yNzExNg_39318671-5383-4bc7-bf52-ef91d2e33945">36,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402d171eca914ca896c2460efa80a95d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMi0zLTEtMS0yNzExNg_6fa07be3-5579-418b-adea-7cc23730f450">36,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe7711d279984593aa89a86b806404b8_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMy0xLTEtMS0yNzExNg_4896aafa-ef42-4372-99a5-2f512d03b54a">15,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i939ab82e679a4c00953b5bcdb1aa7115_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMy0zLTEtMS0yNzExNg_a4579139-2acf-4964-9213-c0e621af7940">16,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfNC0xLTEtMS0yNzExNg_e56ee4c0-6aac-4874-9c35-6494fbccec22">51,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfNC0zLTEtMS0yNzExNg_f8f89a88-be1e-46ba-ac69-91539c0f1268">53,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i429b06262ff74cbc894e05c074db49f0_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMi0xLTEtMS0yNzExNg_9304cc46-800a-4e0c-b368-8973a1602681">34,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46736b895fa9494fb40c592102713ba8_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMi0zLTEtMS0yNzExNg_5f9c57ce-a332-475b-860b-981e33f7862b">34,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia36a6256f3744258b47971555a767ab1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMy0xLTEtMS0yNzExNg_a1b597fa-e5e0-474e-b9ec-0981d3ca81e0">8,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e7f9e3862de4c17a2b53bbc46589c1d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMy0zLTEtMS0yNzExNg_8c2a3dc3-fcd3-4268-add5-40438b02efd5">9,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDM_d8be7990-fd43-4e0c-b273-f48c2787d841" escape="true"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzY_2b782ba5-e66c-479c-82c5-6e9b328876cf" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfdce7f7d47e4eb1b5e54bb8f86005b4_I20220930" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMS0xLTEtMS0yNzExNg_95b4f5f7-873a-499f-bc66-b85b77c07021">21,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7afcea9cb8e4e9c88e904f1a007bcb5_I20220630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMS0zLTEtMS0yNzExNg_51f70e2b-ec7e-4713-a8f6-e67c605f1cba">19,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b8444b610764ffab7c655e6f33040ba_I20220930" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMi0xLTEtMS0yNzExNg_ddda3d93-283a-4330-9819-fb6c26d5e888">1,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dca30b124b04669a1465dfa6dd2bbc0_I20220630" decimals="-3" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMi0zLTEtMS0yNzExNg_a5515204-dea7-4d49-872c-1c758325e3fa">1,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div></ix:continuation><div id="i45b6e518c14a4052bf67665f6ff68340_46"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfMjk1OA_048b32b5-46cf-4a92-9486-28d73ef6d1bc" continuedAt="i8328329296294c78b56af378a45e78fe" escape="true">Gig Economy Group Investment</ix:nonNumeric></span></div><ix:continuation id="i8328329296294c78b56af378a45e78fe" continuedAt="ibf45f173216c4855ab778f2927dba566"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $<ix:nonFraction unitRef="usd" contextRef="ie2be38077dec479a8c4f830a7cc40030_I20190531" decimals="INF" name="lfvn:NotesReceivableRelatedPartyMaximumCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfMjQ3_0498526a-d90b-4dac-b668-52ced3843942">2.0</ix:nonFraction>&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of <ix:nonFraction unitRef="number" contextRef="ie46dcc75834340edbbb0d6971d255894_D20190531-20190531" decimals="INF" name="us-gaap:DebtConversionOriginalDebtInterestRateOfDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfNDI5_c2a521e8-b849-41e4-9ec7-a5eed72b088f">8</ix:nonFraction>% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company <ix:nonFraction unitRef="shares" contextRef="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfODAy_0effb2b4-6bb6-41ab-8b6b-52062d6452ba">1,000,000</ix:nonFraction> shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $<ix:nonFraction unitRef="usd" contextRef="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfOTcz_b373f9bc-a3b6-4f47-bc0e-b73644f244d2">0.0&#160;million</ix:nonFraction> in aggregate consideration).</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibf45f173216c4855ab778f2927dba566"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $<ix:nonFraction unitRef="usd" contextRef="id131ac0747904e089c449612a8c5c709_I20220630" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfNTQ5NzU1ODE3MzE5_ebd0254c-6d43-493d-8542-af6f00706a25">2.2</ix:nonFraction>&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at September&#160;30, 2022 and June&#160;30, 2022.  During the three months ended September&#160;30, 2022 and 2021, there were no impairments recognized.</span></div></ix:continuation><div id="i45b6e518c14a4052bf67665f6ff68340_49"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjEz_e2e5be27-e319-48ee-91b8-470e12daf6de" continuedAt="i6968ce88adc8466fb76406d24faa8669" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i6968ce88adc8466fb76406d24faa8669"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTU4_994c7e14-50db-4ced-ba65-b8b872893dc3">one</span> to <ix:nonNumeric contextRef="ia6f19746429c4cdca994057d70e98d3a_I20220930" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTY0_4c7fc92b-f147-4158-8c8e-23258d07c9b5">nine years</ix:nonNumeric>. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was <ix:nonNumeric contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMjgw_69c8a51c-fe2c-47ed-a944-0aa319744f16">8.46</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMjg3_c0a29d30-680d-426d-9952-fb44f63b8c26">3.27</ix:nonFraction>%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMzUz_37f1d3a2-ba9a-4842-acef-b98922a644be">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMzYw_e9a9f3f5-331c-4770-945a-d2dcab9a2484">0.8</ix:nonFraction> million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjE1_08030a3a-6fc9-4603-8a49-0abbc02031f8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmE4ODI1OTc3ZGJiZTQ1MmU4MmFhYzc4OGUxZTc3OGMyL3RhYmxlcmFuZ2U6YTg4MjU5NzdkYmJlNDUyZTgyYWFjNzg4ZTFlNzc4YzJfMi0xLTEtMS0yNzExNg_61a4d1c7-5308-4bec-9c1e-28a5646bf561">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmE4ODI1OTc3ZGJiZTQ1MmU4MmFhYzc4OGUxZTc3OGMyL3RhYmxlcmFuZ2U6YTg4MjU5NzdkYmJlNDUyZTgyYWFjNzg4ZTFlNzc4YzJfMi0zLTEtMS0yNzExNg_7ee56ccd-b7df-45e2-b8f8-a3ee06a6bdcb">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjEy_93310192-c7d6-4f24-a8cb-f1b0072e2294" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at September&#160;30, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:82.501%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining nine months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMS0yLTEtMS0yNzExNg_08cc70d4-1233-4c85-9f36-c3f4c02badc3">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMi0yLTEtMS0yNzExNg_767d64d9-70e7-4f56-b669-fc92222893e0">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMy0yLTEtMS0yNzExNg_26839f2e-4744-4e8f-afba-424432842fc0">1,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNC0yLTEtMS0yNzExNg_79430858-5cc6-48fe-b33d-ab26c3c006cc">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNS0yLTEtMS0yNzExNg_157c370a-5ebe-4559-a7db-58c041581bb1">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNi0yLTEtMS0yNzExNg_1098c7a5-4138-4410-a5fe-3a1e18bc76c5">8,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNy0yLTEtMS0yNzExNg_b7afeeea-cd6f-42c1-9ddd-c8b5f71958db">17,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfOC0yLTEtMS0yNzExNg_f394b656-3db1-4cf1-8b1f-314a2dcfb6ea">2,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfOS0yLTEtMS0yNzExNg_209d1152-e0bf-4db2-87b0-7af9ba521f4a">15,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i45b6e518c14a4052bf67665f6ff68340_52"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMwNw_5f797dee-f8e2-4def-88a7-42f8fe4fd32c" continuedAt="i1b13257480ff4ac5abe1a06dee5c9a56" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b13257480ff4ac5abe1a06dee5c9a56" continuedAt="i2baac6c03546440fba53ec1b1dd8dbac">On March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of </ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2baac6c03546440fba53ec1b1dd8dbac"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ica5344233c204858b6afe60475269d38_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzY1_453fea04-422a-4f81-b29c-a9de7e31aa1a">10.0</ix:nonFraction> million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNDY4_4ae496d9-e92f-4fb6-9d2c-6c0ff6a1c43e">2.0</ix:nonFraction> million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $<ix:nonFraction unitRef="usd" contextRef="i14dbc7cf32884923b5dc54345b785092_D20220701-20220930" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNzI1_f8796b66-663b-4b58-9d01-1e9bee50d040">0.5</ix:nonFraction> million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from <ix:nonFraction unitRef="number" contextRef="i75b346e2c97643deb010bf416bf02431_I20180503" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTE3NA_eff93a7b-418a-4afb-8bf1-fd149bd15501">4.93</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504" decimals="INF" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTE4MA_9c6346a5-4a90-4bff-a485-48646601bab7">5.68</ix:nonFraction>%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="i75b346e2c97643deb010bf416bf02431_I20180503" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTM0NA_f5e455e1-5091-40cf-9b07-66ef2e590b78">1.50</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTM1Ng_695c0833-d892-4952-910c-663070864009">1.25</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="ie05a0f91cf5441fca02cab96f9dd1693_D20180504-20180504" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMxNA_502589fc-8560-4a43-8732-87c4641463cf">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was increased from $<ix:nonFraction unitRef="usd" contextRef="i75b346e2c97643deb010bf416bf02431_I20180503" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTQ4Nw_71ed97b3-873f-4e12-a955-63d91736380a">5.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTQ5Mw_641ffa4a-ca9b-4046-b8a0-49b34c1757f1">8.0</ix:nonFraction> million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than <ix:nonFraction unitRef="number" contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTY0OQ_1296a5e5-c3e1-4809-ac83-990c2671569e">3.00</ix:nonFraction> to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $<ix:nonFraction unitRef="usd" contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjE2Ng_65f5f6d7-2c99-4c58-9ae0-865495473d66">2.0</ix:nonFraction> million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $<ix:nonFraction unitRef="usd" contextRef="ic93efb3d8dea497aa299e88710676864_D20190201-20190201" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjUxNA_a824aead-10e8-4c59-8e64-c2bc1523fb65">2.0</ix:nonFraction> million and increased the revolving loan facility from $<ix:nonFraction unitRef="usd" contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjU2NA_65f5f6d7-2c99-4c58-9ae0-865495473d66">2.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ie69d6cfdbf8c46398d7508667051f58b_I20190201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjU3MA_87f9ab3d-9831-4141-97b0-fe9f15834065">5.0</ix:nonFraction> million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of <ix:nonFraction unitRef="number" contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjczNA_695c0833-d892-4952-910c-663070864009">1.25</ix:nonFraction> to 1.00 to <ix:nonFraction unitRef="number" contextRef="i1887e1c461be424086a7149e6dcee766_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjc0Ng_f694be9c-95e1-47fe-b528-3a3e512b7df2">1.10</ix:nonFraction> to 1.00, measured on a trailing <ix:nonNumeric contextRef="ifc83d833f5664c16b3b8e21685061d73_D20190201-20190201" name="lfvn:DebtInstrumentTrailingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMxNQ_ce12b7f0-7636-436f-bfa5-76826eb52d8f">twelve-month</ix:nonNumeric> basis, at the end of each fiscal quarter. The minimum working capital was decreased from $<ix:nonFraction unitRef="usd" contextRef="iec815bc3224c4b2eb6f03e0428ec3199_I20180504" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjg3Nw_2df67bfd-fae6-4f99-b169-05177ccca6b1">8.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i1887e1c461be424086a7149e6dcee766_I20190201" decimals="INF" name="lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjg4Mw_d9b4925d-2840-453c-a222-3c1131d6576d">6.0</ix:nonFraction> million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of <ix:nonFraction unitRef="number" contextRef="i454d5b7910c542ef883eed9a307e6da4_D20210401-20210401" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzE5OA_1fc84a49-d10d-4609-a846-0d3746cd8613">3.00</ix:nonFraction>%, with an interest rate floor of <ix:nonFraction unitRef="number" contextRef="iac6026a96d5b4fe780ee9d2e9d5aafe2_D20210401-20210401" decimals="INF" name="lfvn:DebtInstrumentFloorInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzIzMw_86e0171b-3f50-43f0-8c4e-197c7e8cd614">4.00</ix:nonFraction>%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of <ix:nonFraction unitRef="number" contextRef="i7eae71368a024d6ba653f381ffe0db1c_I20210401" decimals="INF" name="lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzQyOQ_df25003e-d133-4544-874f-3d63158e71f5">2.00</ix:nonFraction> to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $<ix:nonFraction unitRef="usd" contextRef="i11854662ecd64eb0ae73d899d84d814f_I20220930" decimals="-3" name="lfvn:DebtInstrumentCovenantMaximumAllowedDividends" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTQ5NzU1ODE0NTQ3Mg_02e0a1a7-37dc-4eba-9026-dc275bf68ab2">500,000</ix:nonFraction> per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of September&#160;30, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjYzOA_a70b2a67-58c7-46b1-a354-4e15b0a22735" continuedAt="i742ac0e389ee4ad094e06d3170edee39" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i742ac0e389ee4ad094e06d3170edee39"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> September&#160;30, 2022, the company issued no shares of common stock upon the exercise of stock options and <ix:nonFraction unitRef="shares" contextRef="i88116b05befd4416b9cb7a08d858f271_D20220701-20220930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3NTU4_f6d244fc-30f1-4921-9c96-bcdde7b133e0">17,000</ix:nonFraction> shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.  During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> September&#160;30, 2021 the company issued <ix:nonFraction unitRef="shares" contextRef="i7191113c25f247479215258c91e7ce5a_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTkw_ab71dfb4-babc-4c2f-a8f9-421591cc507b">30,000</ix:nonFraction> shares of common stock upon the exercise of stock options and approximately <ix:nonFraction unitRef="shares" contextRef="i7191113c25f247479215258c91e7ce5a_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNDgy_e39f56f6-c11d-49b7-82a3-c93f52712fb4">19,000</ix:nonFraction> shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i071a21c613194e0ab1b99e7ce4356c02_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNzA2_114a1837-0e91-46d5-bae0-7e9bdfc51a84">5</ix:nonFraction> million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="i071a21c613194e0ab1b99e7ce4356c02_I20171127" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTU5Ng_b489dfd2-0774-40a6-9703-bcb7d75e8c0c">5</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTYwMg_7c5937f3-4057-409e-aab6-f556314f42df">15</ix:nonFraction> million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTc1OQ_e164aeaa-cde0-4659-b526-8d113ec00859">15</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="if01d6b23161a4099ae7e64005f8ac196_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTc2NQ_38f69f2e-c098-468d-b0c8-db680d550674">35</ix:nonFraction> million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $<ix:nonFraction unitRef="usd" contextRef="if01d6b23161a4099ae7e64005f8ac196_I20200827" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTk5Ng_38f69f2e-c098-468d-b0c8-db680d550674">35</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i0fbeb3758f03482b8e51a3ca187c8244_I20220217" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjAwMg_c568341e-b8dc-4d5d-a963-50800abbefd9">60</ix:nonFraction> million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased no shares of common stock under this repurchase program. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased <ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3MzI2_295f9283-8a54-418e-9ab0-2ae6607556b0">0.5</ix:nonFraction> million shares of common stock at an aggregate price of $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3NDAx_e82b23d2-effc-43ea-a3f3-bb11cd5333c9">3.5</ix:nonFraction> million under this repurchase program. At&#160;September&#160;30, 2022, there is $<ix:nonFraction unitRef="usd" contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjM1NQ_1c7ccd13-32ed-475c-8cbe-057849a4f3d7">27.7</ix:nonFraction> million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of September&#160;30, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the board of directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa6a6dc1ee6443578385523d83f7da3c_D20220915-20220915" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3OTIx_ac44371a-4283-4d06-a34e-8088fb1cb1d0"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c951d2923244147b9f226b2ae6d9238_D20220801-20220831" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3OTIx_fea122b0-274a-47a2-ac18-e18a44e141a9">0.03</ix:nonFraction></ix:nonFraction> per share of common stock to be paid on September 15, 2022, to stockholders of record on September 2, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Quarterly cash dividend for the three months ended September&#160;30, 2022 totaled $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE4NzMw_fad8f883-b806-48e5-8526-d96ce2b8ff03">0.4</ix:nonFraction> million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE4NzM3_54732d03-62d9-45bf-84e6-5eb98eabf45e">0.03</ix:nonFraction> per share</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.</span></div></ix:continuation><div id="i45b6e518c14a4052bf67665f6ff68340_58"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5NA_2bfd7f4c-b8bb-4417-9488-4d1ea3b0c342" continuedAt="i64e713bdb2de42bcb75222b04932ed25" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i64e713bdb2de42bcb75222b04932ed25" continuedAt="ifdea9041a15b42d2a9f6a0c1c520f3ac"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="i7c717bd0b67741c8b344ee3df55eb9dc_I20061121" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMzA1_c23200aa-228b-4ac1-aba2-73275f1a9213">1.4</ix:nonFraction> million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of September&#160;30, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of <ix:nonFraction unitRef="shares" contextRef="i1f9cb90e49c84d6a98d875ed5d38d73b_I20100927" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfODI1_2a9510d0-910e-4267-8c86-f016f5ef221b">1.0</ix:nonFraction> million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i26ba0558720045eea67b29115b0a3986_D20100927-20100927" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE2NA_423e02a7-42b3-492c-9a3c-49f7355d6685">9.31</ix:nonFraction> per share, and vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE5OQ_d0bf6ea3-3477-49ad-9fc2-afc2a24fddbb">one</span> to <ix:nonNumeric contextRef="iaadfa48ed71d4f0fa49a9f9c6323fd8a_D20100927-20100927" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5MQ_7aadf0d6-cb1a-4427-836e-fd0c494641b3">four year</ix:nonNumeric> vesting periods. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally <ix:nonNumeric contextRef="i4f8f7854e7764dc285105b899092b475_D20100927-20100927" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTQ2OQ_6f4c5407-8a73-4a9d-ac9d-74062b4a77d1">ten years</ix:nonNumeric>. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of September&#160;30, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately <ix:nonFraction unitRef="shares" contextRef="ib9e2ea205a3d43158e970a0c0f8f359f_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTc0NQ_f0d0f965-b26a-4483-84a8-dcf5b2d1c83c">14,000</ix:nonFraction> shares of the Company's common stock.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifdea9041a15b42d2a9f6a0c1c520f3ac" continuedAt="i6da60c3a74a44ef3a89f133b0f99f226"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by <ix:nonFraction unitRef="shares" contextRef="if899b129124943fe800d819b6de66ec3_D20180202-20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjEyNA_8e015ce3-5ea9-4a30-914f-7ee3b19fe5e8">425,000</ix:nonFraction> shares, <ix:nonFraction unitRef="shares" contextRef="i1a45671ea82d4f1a932759250eb31f16_D20181115-20181115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjEzNQ_0d535551-1ee0-43b6-bba0-ad8184dfddc1">715,000</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="ifdc4810b41d540409fbcb3fe43b196b2_D20201112-20201112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjE0OQ_b644e0ab-e557-4682-b979-ee7cad14cbd8">650,000</ix:nonFraction> shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;September&#160;30, 2022, a maximum of <ix:nonFraction unitRef="shares" contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjMwMQ_1a6744a5-81b7-415f-baea-7f3b1a917f35">2.9</ix:nonFraction> million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) <ix:nonFraction unitRef="shares" contextRef="i44c9e56976144431bc767f09ba938466_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjQ1Mg_1760be0d-2148-4e48-b59a-6bf7059362fa">2,440,000</ix:nonFraction> shares and (ii) up to <ix:nonFraction unitRef="shares" contextRef="ifcad4b991602480e8c333048b37bc386_I20180202" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjQ3Nw_22068b22-62cf-4997-8270-3f71bc58f789">475,000</ix:nonFraction> shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjc0Ng_ba0a3060-c0a6-4e4b-8fff-72392305c945">4.44</ix:nonFraction> per share, and vest over a <ix:nonNumeric contextRef="i4218dd95179b44ee93fbc3f2fa44e6e1_D20220701-20220930" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5OA_b200a7bf-fa54-4a98-be0a-8d0ec4da7821">three year</ix:nonNumeric> vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of September&#160;30, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of <ix:nonFraction unitRef="shares" contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMzE4Ng_bba8270a-c329-4ca2-8a60-db2f3216f887">0.1</ix:nonFraction> million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved <ix:nonFraction unitRef="shares" contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930" decimals="-5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTA5NQ_b35e993f-69ca-4f26-8d16-5130b4a5fe03">0.4</ix:nonFraction> million shares of its common stock for issuance under the ESPP. As of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTE2NA_00fca1cd-91cd-47f0-93e8-48167156b5ad">0.2</ix:nonFraction> million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to <ix:nonFraction unitRef="number" contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTUxOA_9a506ffd-9e9d-46c5-8992-d1c166f53b8c">85</ix:nonFraction>% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to <ix:nonFraction unitRef="number" contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTY5NA_09900ab3-7cd1-4a7f-9a65-198ae7c88ca2">15</ix:nonFraction>% of their regular hourly or salary compensation, and up to a maximum of <ix:nonFraction unitRef="shares" contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTc2OA_fd120b13-bd2a-4bb4-aa0d-823d4f4fe0e7">3,000</ix:nonFraction> shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $<ix:nonFraction unitRef="usd" contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930" decimals="INF" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTk4NA_f42d1f01-049c-419b-973a-266604966560">25,000</ix:nonFraction> grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive <ix:nonNumeric contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930" name="lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5Mg_9046dd23-53d3-40c3-98c5-aa4a5b80a692">six-month</ix:nonNumeric> offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately <ix:nonFraction unitRef="shares" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxODg3_c71b232b-682d-4b58-87a3-b9cc4762bbdf">36,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxMzEw_9654f7ab-63a7-425a-b31f-8b09d0d55aaa">27,000</ix:nonFraction> shares of common stock were issued under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="i6da60c3a74a44ef3a89f133b0f99f226" continuedAt="i29eb00a4eafd490f8d938d20ac7431a8"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, compensation of $<ix:nonFraction unitRef="usd" contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNjk0OA_d250bc2d-d103-45ff-ad3b-36e108c4ed6f">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxNzI4_c4164777-063c-4cfb-9e67-7d97d5c3f4c7">0.6</ix:nonFraction> million, respectively. was reflected as an increase to additional</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i29eb00a4eafd490f8d938d20ac7431a8"> paid-in capital, all of which was employee related.</ix:continuation> </span></div><div id="i45b6e518c14a4052bf67665f6ff68340_61"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8 &#8212; <ix:nonNumeric contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfODQwMw_64577574-5ade-4503-801e-53c2dd5be724" continuedAt="iaab54f5984db4e4298b6ae1843dca15c" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="iaab54f5984db4e4298b6ae1843dca15c" continuedAt="ide8e4f8e28614240a4c043b904317a73"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  September&#160;30, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ide8e4f8e28614240a4c043b904317a73" continuedAt="i2d8763ebfcf247aabd25f32b09007118"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing <ix:nonFraction unitRef="claim" contextRef="i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfNTQyMw_bf0c8c52-f258-40e3-8ea3-e69fc21875b2">three</ix:nonFraction> of the Plaintiff's <ix:nonFraction unitRef="claim" contextRef="idccc1f3bca2347cc8ac18f61b4fb2b0d_I20191205" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfNTQ0NQ_0a3d56ed-d529-46af-8e34-729193300616">four</ix:nonFraction> claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. This case has been stayed by the Court until November 25, 2022. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</span></div></ix:continuation><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><ix:continuation id="i2d8763ebfcf247aabd25f32b09007118" continuedAt="idc4e72a2c2364a6295552aef8e4114e9"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idc4e72a2c2364a6295552aef8e4114e9">In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</ix:continuation> </span></div><div id="i45b6e518c14a4052bf67665f6ff68340_67"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. We are dedicated to helping people achieve their health, wellness and financial goals. We provide quality, scientifically-validated products to customers an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d independent distributors as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">well as a financially rewarding commission-based direct sales opportunity to our independent distributors. We engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. We currently sell our products to customers and independent distributors in two geographic regions that we have classified as the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.04pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success and growth of our business is primarily based on the effectiveness of our independent distributors to attract and retain customers in order to sell our products and our ability to attract and retain independent distributors. When we are successful in attracting and retaining independent distributors and customers, it is largely because of:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our products, including our flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> family of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, our line of Nrf2 enhanced TrueScience&#174; skin, hair, bath &amp; body, and targeted relief products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our smart weight management system;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our sales compensation plan and other sales initiatives and incentives; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Our delivery of superior customer service.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, it is vital to our success that we leverage our product development resources to develop and introduce compelling and innovative products and provide opportunities for our independent distributors to sell these products in a variety of markets. We sell our products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. In addition, we sell our products in a number of countries to customers for personal consumption only and in China through a China approved cross-border e-commerce business model. Entering a new market requires a considerable amount of time, resources and continued support. If we are unable to properly support an existing or new market, our revenue growth may be negatively impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19 on Our Business</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic caused by COVID-19 has continued to disrupt and adversely affect our business in fiscal year 2023. As of the date of this filing, we have experienced multiple disruptions at times at the corporate level as we have transitioned our corporate workforce from a remote working environment, to a hybrid work from home/work in the office schedule. We have continued to experience temporary closures of some of our overseas showrooms and will call locations in international markets and have experienced cancelled multiple planned large group events in order to comply with group meeting restrictions in certain markets. Our independent distributors have also experienced disruptions. Specifically, in Japan, independent distributors are required to provide a hard-copy introductory packet (gaiyoshomen) in person to each person they approach to sponsor as an independent distributor before presenting our products and business opportunity. This requirement inhibits independent distributors from connecting with potential new independent distributors virtually or through social media. Accordingly, quarantines, avoidance of public places and general concerns about physical distancing related to COVID-19 or otherwise negatively affected the ability for independent distributors to meet people in person and commence the enrollment process. To mitigate these effects and in an effort to sustain their sales volume, our independent distributors have adapted their approach for customer outreach and enrollment, including transitioning to a stronger social media presence. Our business may, in the future, experience additional disruptions and be negatively impacted by the COVID-19 pandemic, including as a result of limitations on the ability of our suppliers to manufacture, or procure from manufacturers, the products we sell or any of the raw materials or components required in the production process, or to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic or local, state, or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; limitations on the ability of our independent distributors to conduct their businesses and purchase our products; and limitations on the ability of our independent distributors or customers to continue to purchase our products due to decreased disposable income.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made modifications and are evaluating additional potential modifications that may be needed, to protect our supply chain and preserve adequate liquidity to ensure that our business can continue to operate during  uncertain times. Near the end of fiscal year 2020 we transitioned all of our corporate employees to a work from home model and during July 2021 we began to implement a hybrid schedule with opportunities for employees to return back to the office. That hybrid schedule continues to be in effect today. To date, our employees are performing and adapting well with the evolving environment. With </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respect to liquidity, we are evaluating and taking actions to ensure that we continue to responsibly manage expenses across our organization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are unable to determine or predict the nature, duration or scope of the overall impact that the COVID-19 pandemic will have on our business, results of operations, liquidity or capital resources, we will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state or local authorities or that we determine are in the best interests of our employees, independent distributors, customers, and stockholders.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_73"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Products</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of scientifically-validated dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+ , ProBio and Daily Wellness dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our line of skin, bath &amp; body, target relief, and hair care products, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our nootropic energy drink mixes, and PhysIQ, our smart weight management system. The Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product line includes Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is formulated to increase cellular energy and performance by boosting mitochondria production to improve cellular repair and slow cellular aging. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contains a proprietary blend of ingredients and has been shown to combat oxidative stress and enhance energy production by increasing the body&#8217;s natural antioxidant protection at the genetic level, inducing the production of naturally occurring protective antioxidant enzymes, including superoxide dismutase, catalase, and glutathione synthase. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was specifically formulated to target cell signaling pathways involved in the synthesis and recycling of a specific molecule c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">alled NAD (nicotinamide adenine dinucleotide), and has been shown to double sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. Use of the three Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products together has been shown to produce synergistic benefits greater than using the single products on their own. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+ is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ProBio  is a dietary supplement designed to support optimal digestion and immune system function. LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Daily Wellness  is a dietary supplement designed to support and strengthen immune health. Our TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> line of anti-aging skin and hair care, and CBD Nrf2 enhanced, bath &amp; body, targeted relief products includes TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Facial Cleanser, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Perfecting Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Eye Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Anti-Aging Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beauty Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hand Cream, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Invigorating Shampoo, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nourishing Conditioner, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Scalp Serum, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Lotion, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Wash, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Butter, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Deodorant, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Soothing Balm, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Body Rub, and TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen. Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a supplement specially formulated to combat oxidative stress in dogs through Nrf2 activation. Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our line of our nootropic energy drink mixes formulated to promote alertness and support mental performance. PhysIQ is our smart weight management system, which includes PhysIQ Fat Burn, PhysIQ Prebiotic and PhysIQ Whey Protein, all formulated to aid in weight management. IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  helps support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and may help support normal sleep patterns. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our products both individually and in stacks. A stack consists of multiple products bundled together that are designed to achieve a specific result. By studying the effects of nutrients and natural compounds, we have developed scientifically-backed nutrigenomics products that promote healthy aging on the cellular level. By stacking these products together, we have created a foundation for synergy from nutrigenomic products to promote a healthier life. The Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes four of our nutrigenomics products &#8212; Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ProBio. This product stack was designed to provide a foundation for wellness, supporting healthy organs, including the brain, heart, eyes, and other vitals. With the Ultimate Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we added Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and PhysIQ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Prebiotic to our Vitality Stack</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to support gut health and increase sirtuin activity, supporting increased health, focus, energy, mental clarity and mood. The Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Tri-Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> consists of our Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NRF1 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nrf2 Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Protandim</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NAD Synergizer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and was designed to effectively and synergistically reduce oxidative stress, support mitochondria function, increase sirtuin activity, and target cell signaling pathways to fight the effects of aging. We also offer stacks that directly support the following consumer needs: immune support, heart health, energy, well-being, eye health, cognition and memory, metabolism, gut health, skin care, and hair care.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have additional products in development. Any delays or difficulties in intr</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oducing compelling products or attractive initiatives or tools into our markets may have a negative impact on our revenue and our ability to attract new independent distributors and customers. </span></div><div id="i45b6e518c14a4052bf67665f6ff68340_76"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we utilize a direct selling model for the distribution of a majority of our products, the success and growth of our business is primarily based on the effectiveness of our independent distributors to attract customers and sell our products and our ability to attract new and retain existing independent distributors. Changes in our product sales typically are the result of variations in product sales volume relating to fluctuations in the number of active independent distributors and customers </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchasing our products. The number of active independent distributors and customers is, therefore, used by management as a key non-financial measure.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in our active accounts base by geographic region. These numbers have been rounded to the nearest thousand as of the dates indicated. For purposes of this report, we define &#8220;Active Accounts&#8221; as only those independent distributors and customers who have purchased from us at any time during the most recent three-month period, either for personal use or for resale.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:30.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change from Prior Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Independent Distributors</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Independent Distributors</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Customers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total Active Accounts</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i45b6e518c14a4052bf67665f6ff68340_79"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended September&#160;30, 2022 and 2021</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We generated net revenue of $51.8 million and $53.2 million during the three months ended September 30, 2022 and 2021, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Foreign currency fluctuations negatively impacted our revenue $2.7 million or 5.0% during the three months ended September&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Americas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three months ended September&#160;30, 2022 and 2021 for the Americas region (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,369&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,449&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Re</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue in the Americas region for the three months ended September&#160;30, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased $0.1 million or 0.2% from the prior year period. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Active Accounts decreased by 7.8% in the region compared to the prior year period which drove the decrease in revenue.  The decrease in total Active Accounts was offset by an increase in average revenue per account due to changes in our product sales mix, driven primarily by our new TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquid Collagen product announced during our Activate 2022 event held in June 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia/Pacific &amp; Europe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The following table sets forth revenue for the three months ended September&#160;30, 2022 and 2021 for the Asia/Pacific &amp; Europe region and its principal markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,168&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,844&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia &amp; New Zealand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater China</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in the Asia/Pacific &amp; Europe region decreased $1.4 million or 8.2% for the three months ended September&#160;30, 2022 as com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pared to the prior year period. Active Accounts in the region decreased 4.1% compared to the prior year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> period.  We continue to be encouraged by the results we are seeing from our launch of Philippines due to continued distributor leadership development and advancement. Decreases in total Active Accounts along with negative impacts from foreign currency exchange rate fluctuations have contributed to the overall decrease in revenue within the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, revenue in the Asia/Pacific &amp; Europe region was negatively impacted by foreign currency exchange rate fluctuations in the amount of approximately $2.6 million or 15.7% during the three months ended September&#160;30, 2022 as compared to the prior year period, mainly due to currency fluctuations in Japan. Revenue in Japan was negatively impacted by foreign exchange rate fluctuations in the amount of approximately $2.1 million or 21.3%, during the three months ended September&#160;30, 2022 as compared to the prior year period. On a constant currency basis, revenue in Japan increased 3.2% for the three months ended September&#160;30, 2022 as compared to the prior year period. </span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Globally, our sales and marketing efforts continue to be directed toward strengthening our core business through our fiscal year initiatives and building our worldwide revenue. During fiscal year 2022, we held our first major events with both in person and virtual attendance options since the start of the COVID-19 global pandemic. During these events, we launched our new LifeVantage</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> eye health product in October 2021 and TrueScience</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Liquid Collagen in June 2022.  We have plans for continued product expansion during the remaining fiscal 2023. We expect these product launches will help drive revenue growth globally through increased average order size and increased ability to attract and retain new independent distributors and customers with a compelling product lineup.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gross Margin. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit percentage for the three months ended September 30, 2022 and 2021 was 80.8% and 82.3%, respectively. The decrease in gross margins, as compared to the prior year period, is primarily due to increased shipping to customer expenses during the current year period as well as shifts in geographic and product sales mix. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commissions and Incentives.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Commissions and incentives expenses during the three months ended September 30, 2022 were $23.8 million or 46.0% of revenue as compared to $24.1 million or 45.3% of revenue for the three months ended September 30, 2021. The increase in commissions and incentives expenses as a percentage of revenue as compared to the prior period is due mainly to the timing and magnitude of our various promotional and incentive programs. Commissions and incentives expenses, as a percentage of revenue, may fluctuate in future periods based on ability to hold incentive trips and events and the timing and magnitude of compensation, incentive and promotional programs.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling, general and administrative expenses during the three months ended September 30, 2022 were $16.7 million or 32.3% of revenue as compared to $15.1 million or 28.3% of revenue for the three months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The increase in selling, general and administrative expenses as a percentage of revenue during the three months ended September&#160;30, 2022 compared to the prior year period is primarily due to increased event and travel expenses as restrictions related to the COVID-19 pandemic have begun to ease outside of our US market.  We have also experienced increased expenses related to legal fees, endorsement agreements, product testing, and salaries and wages. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Total Other Expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we recognized total net other expense of $0.4 million as compared to $0.2 million for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net other expense for the three months ended September&#160;30, 2022 and 2021 consisted primarily of foreign currency losses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Tax Expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We recognized income tax expense of $0.2 million for the three months ended September&#160;30, 2022, as compared to income tax expense of $1.1 million for the three months ended September&#160;30, 2021.</span></div><div style="text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate was 28.4% of pre-tax income during the three months ended September 30, 2022, compared to 25.2% for the prior year period. The change in the tax rate for the three months ended September 30, 2022 was mainly due to a unfavorable discrete tax adjustments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our effective tax rate will fluctuate slightly during the remainder of fiscal 2023 as the impact of discrete items and other permanent differences are recognized during the year; however, our tax rate can be impacted by various book to tax differences and fluctuations in our stock price that occur during the year which are difficult to forecast.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_82"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Liquidity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary liquidity and capital resource requirements are to finance the cost of our planned operating expenses and working capital (principally inventory purchases), fund capital expenditures, and service our debt, which includes any outstanding balances under the 2016 Credit Facility. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generally relied on cash flow from operations to fund operating activities and we have, at times, incurred long-term debt in order to fund stock repurchases and strategic transactions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, our available liquidity was $17.6 million, which consisted of available cash and cash equivalents. This represents a decrease of $2.6 million from the $20.2 million in cash and cash equivalents as of June&#160;30, 2022. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, our net cash used in operating activities was $1.3 million as compared to our net cash provided by operating activities of $0.5 million during the three months ended September&#160;30, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022, our net cash used in investing activities was $0.7 million, as a result of the purchase of fixed assets. During the three months ended September&#160;30, 2021, our net cash used in investing activities was $0.4 million, as a result of the purchase of fixed assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in financing activities during the three months ended September&#160;30, 2022 was $0.3 million as a result of our payment of a cash dividend and shares purchased as payment of tax withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan. Cash used in financing activities during the three months ended September&#160;30, 2021 was $3.3 million as a result of our repurchas</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e of common stock, and shares purchased as payment of tax </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withholding upon vesting of equity awards, partially offset by proceeds from stock issued under our employee stock purchase plan and stock option exercises.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022 and June&#160;30, 2022, the total amount of our foreign subsidiary cash </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $6.0 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $7.0 million, respectively. The federal tax reform legislation that was passed into law during December 2017 enacted a 100% dividend deduction for greater than 10% owned foreign corporations. Therefore, in the future, if needed, we expect to be able to repatriate cash from foreign subsidiaries without paying additional U.S. taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, we had working capital (current assets minus current liabilities) of $20.2 million, compared to working capital of $21.2 million at June&#160;30, 2022. We believe that our cash and cash equivalents balances and our ongoing cash flow from operations will be sufficient to satisfy our cash requirements for at least the next 12 months. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow needs. In the event that our current cash balances and future cash flow from operations are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds, which may not be available on terms that are acceptable to us, or at all. Our credit facility, however, contains covenants that restrict our ability to raise additional funds in the debt markets and repurchase our equity securities without prior approval from the lender. Additionally, our credit facility, as amended, provides for a revolving loan facility in an aggregate principal amount up to $5.0 million. We would also consider realigning our strategic plans including a reduction in capital spending and expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Capital Resources</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shelf Registration Statement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 24, 2020, we filed a shelf registration statement (the "Shelf Registration") on Form S-3 with the SEC that was declared effective April 3, 2020, which permits us to offer up to $75 million of common stock, preferred stock, debt securities and warrants in one or more offerings and in any combination, including in units from time to time. Our Shelf Registration is intended to provide us with additional flexibility to access capital markets for general corporate purposes, which may include, among other purposes, working capital, capital expenditures, other corporate expenses and acquisitions of assets, licenses, products, technologies or businesses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2016 Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;30, 2016, we entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance our outstanding debt. In connection with the 2016 Loan Agreement and on the same date, we entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of $10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan was payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If we borrow under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, we entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, we entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, we made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, we entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that we maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  There were no other changes to the covenants or revolving loan facility amount as set forth in Amendment No. 2.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows us to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict our ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of our equity interests, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of our assets. As of September&#160;30, 2022, we were in compliance with all applicable non-financial and restrictive covenants under the 2016 Credit Facility, as amended. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, also contains various financial covenants that require us to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Specifically, we must:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a minimum fixed charge coverage ratio (as defined in the 2016 Loan Agreement, as amended) of at least 1.10 to 1.00 at the end of each fiscal quarter, measured on a trailing twelve month basis;</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain minimum consolidated working capital (as defined in the 2016 Loan Agreement, as amended) at the end of each fiscal quarter of at least $6.0&#160;million; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">Maintain a ratio of debt (total liabilities) to tangible net worth (as defined in the 2016 Loan Agreement, as amended) of not greater than 2.00 to 1.00 at the end of each quarter, measured on a trailing twelve month basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we were in compliance with all applicable financial covenants under the 2016 Credit Facility, as amended. Additionally, management anticipates that in the normal course of operations we will be in compliance with the financial covenants during the ensuing year.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended June 30, 2020, we repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments and Obligations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our contractual payment obligations and commitments as of&#160;September&#160;30, 2022&#160;(in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payments due by period</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than<br/>1 year</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1-3&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3-5&#160;years</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,625&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating obligations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,757&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,382&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,924&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,408&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Other operating obligations represent contractual obligations primarily related to marketing and sponsorship commitments and purchases of inventory.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_85"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we did not have any off-balance sheet arrangements.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_88"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our financial statements in conformity with accounting principles generally accepted in the United States of America. As such, we are required to make certain estimates, judgments, and assumptions that we believe are reasonable based upon the information available. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could differ from these estimates. Our significant accounting policies are described in Note 2 to our unaudited condensed consolidated financial statements. Certain of these significant accounting policies require us to make difficult, subjective, or complex judgments or estimates. We consider an accounting estimate to be critical if (1)&#160;the accounting estimate requires us to make assumptions about matters that were highly uncertain at the time the accounting estimate was made, and (2)&#160;changes in the estimate that are reasonably likely to occur from period to period, or use of different estimates that we reasonably could have used in the current period, would have a material impact on our financial condition or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are other items within our financial statements that require estimation, but are not deemed critical as defined above. Changes in estimates used in these and other items could have a material impact on our financial statements. Management has discussed the development and selection of these critical accounting estimates with our board of directors, and the audit committee has reviewed the disclosures noted below.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Allowances for Product Returns</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record allowances for product returns at the time we ship the product based on estimated return rates. Subject to some exceptions based on local regulations, our return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. As of September&#160;30, 2022, our shipments of products sold totaling approxi</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mately $18.5 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were subject to the return policy. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor our product returns estimate on an ongoing basis and revise the allowances to reflect our experience. Our allowance for product returns was $0.2 million at September&#160;30, 2022, compared with $0.1 million at June&#160;30, 2022. To date, product expiration dates have not played any role in product returns, and we do not expect that they will in the future as it is unlikely that we will ship product with an expiration date earlier than the latest allowable product return date. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inventory Valuation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value our inventory at the lower of cost or net realizable value on a first-in first-out basis. Accordingly, we reduce our inventories for the diminution of value resulting from product obsolescence, damage or other issues affecting marketability equal to the difference between the cost of the inventory and its net realizable value. Factors utilized in the determination of net realizable value include: (i)&#160;current sales data and historical return rates, (ii)&#160;estimates of future demand, (iii)&#160;competitive pricing pressures, (iv)&#160;new production introductions, (v)&#160;product expiration dates, and (vi)&#160;component and packaging obsolescence.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2022 and 2021, we recognized expenses of approximately $0.1 million and $0.3 million, respectively, related to obsolete and slow-moving inventory. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revenue Recognition</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes that we collect concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the fair value approach to account for stock-based compensation in accordance with current accounting guidance. We recognize compensation costs for awards with performance conditions when we conclude it is probable that the performance conditions will be achieved. We reassess the probability of vesting at each balance sheet date and adjust compensation costs based on our probability assessment. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by the employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Research and Development Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all of our costs related to research and development activities as incurred.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are occasionally involved in lawsuits and disputes arising in the normal course of business. Management regularly reviews all pending litigation matters in which we are involved and establishes accruals as we deem appropriate for these litigation matters when a probable loss estimate can be made. Estimated accruals require management judgment about future events. The results of lawsuits are inherently unpredictable and unfavorable resolutions could occur. As such, the amount of loss may differ from management estimates.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_91"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks during the quarter ended September 30, 2022 when compared to the disclosures in &#8220;Item 7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Annual Report on Form 10-K for the year ended June 30, 2022.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_94"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act of 1934, as amended) that are designed to ensure that the information required to be disclosed in the reports we file or submit under the Exchange Act of 1934, as amended, is (a)&#160;recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and (b)&#160;accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. As of the end of the period covered by this quarterly report on Form 10-Q, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness and design and operation of such disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act of 1934, as amended. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were designed and operating effectively as of September&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting during the quarter ended September&#160;30, 2022 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation required by paragraph (d)&#160;of Rules 13a-15 and 15d-15 of the Exchange Act of 1934, as amended, was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter. That evaluation did not identify any changes in our internal control over financial reporting during the three months ended September&#160;30, 2022&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_97"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. Other Information</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_100"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 to our unaudited condensed consolidated financial statements contained within this quarterly report on Form 10-Q for a discussion of our legal proceedings.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_103"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the other information set forth in this report, you should carefully consider the risk factors discussed in &#8220;Part I. Item 1A &#8212; Risk Factors&#8221; in our annual report on Form 10-K for the fiscal year ended June 30, 2022, filed on August 23, 2022. The risks and uncertainties described in such risk factors and elsewhere in this report have the potential to materially affect our business, financial condition, results of operations, cash flows, projected results and future prospects. We do not believe that there have been any material changes to the risk factors previously disclosed in our recent SEC filings, including our most recently filed Form 10-K, as referenced above.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_106"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, our Board of Directors approved a stock repurchase plan, as amended on February 1, 2019, August 27, 2020, and February 17, 2022. Under the plan, we are authorized to repurchase up to $60.0 million of our outstanding shares through November 30, 2023. The repurchase program permits us to purchase shares from time to time through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by our management, in accordance with applicable securities laws. As part of the repurchase program, we have entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. During the three months ended September 30, 2022, we repurchased no shares of our common stock under this repurchase program.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;September&#160;30, 2022, there is $27.7 million remaining under this repurchase program.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_109"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Defaults Upon Senior Securities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_112"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Mine Safety Disclosures</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i45b6e518c14a4052bf67665f6ff68340_115"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:8.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.594%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Document Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith or Incorporate by Reference From</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914618000046/ex31-certificateofincorpor.htm">Certificate of Incorporation, as filed with the Delaware Secretary of State on March 9, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on March 13, 2018.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/849146/000084914619000066/lifevantage-amendedandrest.htm">Amended and Restated Bylaws, August 9, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibit 3.1 to the Current Report on Form 8-K filed on August 15, 2019</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220930-zionsrlocadden.htm">C</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220930-zionsrlocadden.htm">hange in Term</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220930-zionsrlocadden.htm">s Agreement dated September </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a20220930-zionsrlocadden.htm">30, 2022 by and between Zions Bank and the Company.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_093022xex311.htm">Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_093022xex312.htm">Certification of principal financial officer pursuant to Rule 13a-14(a)/15d-14(a)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_093022xex321.htm">Certification of principal executive officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="lfvn_093022xex322.htm">Certification of principal financial officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following financial information from the Company&#8217;s quarterly report on Form 10-Q for the quarter ended September 30, 2022 formatted in Inline XBRL (extensible Business Reporting Language): (i) Unaudited Condensed Consolidated Balance Sheets at September 30, 2022 and June&#160;30, 2022; (ii) Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income for the three months ended September 30, 2022 and 2021; (iii) Unaudited Condensed Consolidated Statement of Stockholders&#8217; Equity for the three months ended September 30, 2022 and 2021; (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2022 and 2021; and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:7.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This certification is being furnished solely to accompany this report pursuant to 18 U.S.C. 1350, and is not being filed for purposes of Section&#160;18 of the Exchange Act and is not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i45b6e518c14a4052bf67665f6ff68340_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIFEVANTAGE CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Steven R. Fife</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Carl A. Aure</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure<br/>Chief Financial Officer<br/>(Principal Financial Officer and Principal Accounting Officer)</span></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a20220930-zionsrlocadden.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>a20220930-zionsrlocadden</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- a20220930-zionsrlocadden001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a20220930-zionsrlocadden001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a20220930-zionsrlocadden002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a20220930-zionsrlocadden002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- a20220930-zionsrlocadden003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="a20220930-zionsrlocadden003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>lfvn_093022xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic5e020baa7e84ddeb80a478defd47d03_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Steven R. Fife, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;2, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>lfvn_093022xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i10e2ff01148640ae872636d49482702f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Carl A. Aure, certify that&#58;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">I have reviewed this quarterly report on Form 10-Q of LifeVantage Corporation&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:8pt;padding-left:22.5pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.57pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;2, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt;text-align:right"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>lfvn_093022xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id1b3a4c3dc494c47ab5b06de90c331b1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended September&#160;30, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Steven R. Fife, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;2, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Steven R. Fife</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven R. Fife</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>lfvn_093022xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i26d729bb1e9e41c9b570e7dc5d791148_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the filing of this quarterly report on Form 10-Q of LifeVantage Corporation (the &#8220;Company&#8221;) for the period ended September&#160;30, 2022, with the Securities and Exchange Commission on the date hereof (the &#8220;report&#8221;), I, Carl A. Aure, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:8pt;padding-left:45pt;text-indent:-22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.17pt">The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification is being furnished solely pursuant to 18 U.S.C. &#167; 1350 and is not being filed as part of the report or as a separate disclosure document.</font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;2, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Carl A. Aure</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carl A. Aure</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lfvn-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lfvn="http://www.lifevantage.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.lifevantage.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lfvn-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.lifevantage.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandBasisofPresentation" roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation">
        <link:definition>0000007 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestment" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment">
        <link:definition>0000009 - Disclosure - Gig Economy Group Investment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.lifevantage.com/role/Leases">
        <link:definition>0000010 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.lifevantage.com/role/LongTermDebt">
        <link:definition>0000011 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.lifevantage.com/role/StockholdersEquity">
        <link:definition>0000012 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.lifevantage.com/role/StockBasedCompensation">
        <link:definition>0000013 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.lifevantage.com/role/LeasesTables">
        <link:definition>0000017 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails">
        <link:definition>0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesSegmentInformationDetails" roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
        <link:definition>0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GigEconomyGroupInvestmentDetails" roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails">
        <link:definition>0000022 - Disclosure - Gig Economy Group Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails">
        <link:definition>0000023 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofLeaseCostDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails">
        <link:definition>0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails">
        <link:definition>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000026 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails">
        <link:definition>0000027 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationDetails" roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails">
        <link:definition>0000028 - Disclosure - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails">
        <link:definition>0000029 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" abstract="true" name="CashAccountsHeldPrimarilyAtFinancialInstitutionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_IncreaseDecreaseInLeaseLiabilities" abstract="false" name="IncreaseDecreaseInLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ReturnLiabilityReserve" abstract="false" name="ReturnLiabilityReserve" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantMaximumAllowedDividends" abstract="false" name="DebtInstrumentCovenantMaximumAllowedDividends" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_MoneyBackGuaranteePeriod" abstract="false" name="MoneyBackGuaranteePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" abstract="false" name="DebtInstrumentCovenantFixedChargeCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" abstract="false" name="DebtInstrumentCovenantRequiredMinimumWorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_AsiaPacificAndEuropeMember" abstract="true" name="AsiaPacificAndEuropeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_InventoryPercentOfTotalInventory" abstract="false" name="InventoryPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_HandlingAndRestockingFeePercentage" abstract="false" name="HandlingAndRestockingFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_NotesReceivableRelatedPartyMaximumCommitment" abstract="false" name="NotesReceivableRelatedPartyMaximumCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_March2016RevolvingLoanMember" abstract="true" name="March2016RevolvingLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_InventoryFinishedGoodsPercentOfTotalInventory" abstract="false" name="InventoryFinishedGoodsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" abstract="false" name="DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" abstract="false" name="ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_NumberOfGeographicSegments" abstract="false" name="NumberOfGeographicSegments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_TwoThousandAndTenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndTenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_DebtInstrumentFloorInterestRate" abstract="false" name="DebtInstrumentFloorInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_DebtInstrumentTrailingPeriod" abstract="false" name="DebtInstrumentTrailingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lfvn_March2016TermLoanMember" abstract="true" name="March2016TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" abstract="true" name="CashAccountsHeldatOtherFinancialInstitutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_CommissionAndIncentives" abstract="false" name="CommissionAndIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" abstract="false" name="ContractsWithCustomersRefundPercentForResalableAndRestockableItems" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" abstract="true" name="TwoThousandAndSevenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lfvn_RawMaterialsPercentOfTotalInventory" abstract="false" name="RawMaterialsPercentOfTotalInventory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" abstract="false" name="ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" abstract="true" name="TwoThousandSeventeenLongTermIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>lfvn-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_576c9a17-fdb3-4605-857f-34c349662f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7e86cc76-7213-46f5-899d-b8940dca2c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_576c9a17-fdb3-4605-857f-34c349662f2d" xlink:to="loc_us-gaap_Liabilities_7e86cc76-7213-46f5-899d-b8940dca2c7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2618f603-cfba-484a-8e03-aa72b184dec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_576c9a17-fdb3-4605-857f-34c349662f2d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2618f603-cfba-484a-8e03-aa72b184dec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b70e4696-9d7c-4a4e-91ce-d0cd08fe75f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_576c9a17-fdb3-4605-857f-34c349662f2d" xlink:to="loc_us-gaap_StockholdersEquity_b70e4696-9d7c-4a4e-91ce-d0cd08fe75f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6facc75a-23c3-457c-8862-77efc60e0004" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:to="loc_us-gaap_PreferredStockValue_6facc75a-23c3-457c-8862-77efc60e0004" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5787f4a0-6b96-4d77-8008-fc4f3dcd7e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:to="loc_us-gaap_CommonStockValue_5787f4a0-6b96-4d77-8008-fc4f3dcd7e5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_68375eb2-9c84-4357-880e-87f5125f9754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_68375eb2-9c84-4357-880e-87f5125f9754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1a3d2faf-450c-4c17-8031-0492596208df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1a3d2faf-450c-4c17-8031-0492596208df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe11f178-713f-4c82-ada2-1e0c2250f26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_31893025-8cbf-4842-8c92-005a7996add0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fe11f178-713f-4c82-ada2-1e0c2250f26a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_350ed7c9-8886-4c9d-931a-da8fca9b8fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:to="loc_us-gaap_AccountsPayableCurrent_350ed7c9-8886-4c9d-931a-da8fca9b8fb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_d780ca5e-2ccc-4741-a6f0-57b2e2600eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_d780ca5e-2ccc-4741-a6f0-57b2e2600eaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_4ec8051a-ab5c-41c9-b1bc-c8d3818c4c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_4ec8051a-ab5c-41c9-b1bc-c8d3818c4c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d478eec-aaa8-476f-a2fb-d935b7801c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1d478eec-aaa8-476f-a2fb-d935b7801c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8c6e9344-5b76-407f-994b-a3da3c54f50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_24e74dc6-4429-473c-97b9-82c4111b8e9e" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8c6e9344-5b76-407f-994b-a3da3c54f50d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e92cfbe2-01b0-433c-8536-d192cc3df79a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_AssetsCurrent_e92cfbe2-01b0-433c-8536-d192cc3df79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f7e2276-4aab-4675-8bb8-40b5c5b557bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1f7e2276-4aab-4675-8bb8-40b5c5b557bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0df8bedf-96de-494b-b242-54e95f5efe57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0df8bedf-96de-494b-b242-54e95f5efe57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b1feba0-3a2d-4ac4-a035-f8da4c375b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1b1feba0-3a2d-4ac4-a035-f8da4c375b0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_cb1ced58-150e-42c4-8cd0-34e5485d26f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_cb1ced58-150e-42c4-8cd0-34e5485d26f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_03d2aff0-66cf-497e-a770-9b7bbf58b829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d2e3fa93-4715-42b9-9118-bd2f8f1fd6b5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_03d2aff0-66cf-497e-a770-9b7bbf58b829" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea1d400b-6fa2-4ed5-a862-b507f1627ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ea1d400b-6fa2-4ed5-a862-b507f1627ea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_54bd3280-c9b1-4469-a4f5-c4749d28b197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_54bd3280-c9b1-4469-a4f5-c4749d28b197" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_717f9197-9e73-4d8f-bc16-4560073307e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:to="loc_us-gaap_IncomeTaxesReceivable_717f9197-9e73-4d8f-bc16-4560073307e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2a3bc74a-1bf5-4a7f-866f-f8559eecf337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:to="loc_us-gaap_InventoryNet_2a3bc74a-1bf5-4a7f-866f-f8559eecf337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_809c8e33-e33c-465d-b966-98d3b78ed875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_61862009-d32f-409c-843f-3c74372fa83e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_809c8e33-e33c-465d-b966-98d3b78ed875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9a2adff6-b826-43f9-a926-c5dab1ff74ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_df3e51a0-b61a-4d2f-abcd-c9a544ea0d74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9a2adff6-b826-43f9-a926-c5dab1ff74ba" xlink:to="loc_us-gaap_LiabilitiesCurrent_df3e51a0-b61a-4d2f-abcd-c9a544ea0d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_521d0b66-d723-4ed5-9951-8dcbc39bd142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9a2adff6-b826-43f9-a926-c5dab1ff74ba" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_521d0b66-d723-4ed5-9951-8dcbc39bd142" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_490cc705-05e1-4f0d-8249-18b8f9945485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_9a2adff6-b826-43f9-a926-c5dab1ff74ba" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_490cc705-05e1-4f0d-8249-18b8f9945485" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_83fcd66f-9200-4cf1-befd-c9fd0c3926f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e8894a4-1575-46c7-a37f-c0f96df470cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_83fcd66f-9200-4cf1-befd-c9fd0c3926f8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e8894a4-1575-46c7-a37f-c0f96df470cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e08f2638-8ea2-4b49-af43-bc6f0c7ae1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_83fcd66f-9200-4cf1-befd-c9fd0c3926f8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e08f2638-8ea2-4b49-af43-bc6f0c7ae1e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a99c4400-76cb-4767-9077-8c59fdf9eca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_77558e93-6fc1-4be5-a13f-3203f5def3ff" xlink:href="lfvn-20220930.xsd#lfvn_CommissionAndIncentives"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a99c4400-76cb-4767-9077-8c59fdf9eca5" xlink:to="loc_lfvn_CommissionAndIncentives_77558e93-6fc1-4be5-a13f-3203f5def3ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7aca4e39-32b0-4455-a0cb-bb4d1cb9ccdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a99c4400-76cb-4767-9077-8c59fdf9eca5" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7aca4e39-32b0-4455-a0cb-bb4d1cb9ccdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ee18aa30-c4b0-44e5-99ea-5410958f6ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4f000e4d-3460-4571-b29d-095458edcfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ee18aa30-c4b0-44e5-99ea-5410958f6ddb" xlink:to="loc_us-gaap_GrossProfit_4f000e4d-3460-4571-b29d-095458edcfcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_0a337d86-4821-45b1-b8de-cab9a982d158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_ee18aa30-c4b0-44e5-99ea-5410958f6ddb" xlink:to="loc_us-gaap_OperatingExpenses_0a337d86-4821-45b1-b8de-cab9a982d158" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6dca4a9-9343-4842-9e50-6776f14ea759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d7111ab7-0274-4a03-94ee-06e590e0128a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c6dca4a9-9343-4842-9e50-6776f14ea759" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d7111ab7-0274-4a03-94ee-06e590e0128a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e85b5f1b-d703-4b25-85d3-2a5b3587fe3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c6dca4a9-9343-4842-9e50-6776f14ea759" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e85b5f1b-d703-4b25-85d3-2a5b3587fe3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1197458d-e733-4f9f-bf44-a3383ba1398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_859edf7a-4c0e-45c1-92a4-989537c2fb62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1197458d-e733-4f9f-bf44-a3383ba1398a" xlink:to="loc_us-gaap_NetIncomeLoss_859edf7a-4c0e-45c1-92a4-989537c2fb62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_12f77291-1c19-46ee-a035-3a34f4e0e588" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_1197458d-e733-4f9f-bf44-a3383ba1398a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_12f77291-1c19-46ee-a035-3a34f4e0e588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c51e6969-80cd-4149-9766-09d26ef77ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_46cda4bd-2478-4746-b8e2-c0aa20ebdb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c51e6969-80cd-4149-9766-09d26ef77ce4" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_46cda4bd-2478-4746-b8e2-c0aa20ebdb51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_81eb3774-eed1-4404-bc73-b11d3fc56440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c51e6969-80cd-4149-9766-09d26ef77ce4" xlink:to="loc_us-gaap_OperatingIncomeLoss_81eb3774-eed1-4404-bc73-b11d3fc56440" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a7d88cbb-83f1-4570-acef-bd1a7ad9c911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0556afb-f3a2-4473-a91c-59bbfc935b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a7d88cbb-83f1-4570-acef-bd1a7ad9c911" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b0556afb-f3a2-4473-a91c-59bbfc935b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_167e8240-9e2c-48c1-bd13-e32699169ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_0d5d58db-7721-4aa5-9cee-1b170f7c611d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_167e8240-9e2c-48c1-bd13-e32699169ddb" xlink:to="loc_us-gaap_InterestExpense_0d5d58db-7721-4aa5-9cee-1b170f7c611d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fc36447b-88b5-4332-80ab-b4c4d679275c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_167e8240-9e2c-48c1-bd13-e32699169ddb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fc36447b-88b5-4332-80ab-b4c4d679275c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67e7a44c-7621-4aef-bb43-b66556f80d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0aa103f1-cfee-4716-b3fa-f0277fd1a690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_67e7a44c-7621-4aef-bb43-b66556f80d6d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0aa103f1-cfee-4716-b3fa-f0277fd1a690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82545b8-8ce5-45ba-84d2-70a0fb514f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c82545b8-8ce5-45ba-84d2-70a0fb514f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8709a532-73ff-4747-ad56-349666379def" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8709a532-73ff-4747-ad56-349666379def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9c3d9df9-bb2d-4394-a140-b2a7029b306d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9c3d9df9-bb2d-4394-a140-b2a7029b306d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_b957c490-1267-41b2-8880-61fa901e86f9" xlink:href="lfvn-20220930.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_b957c490-1267-41b2-8880-61fa901e86f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_820c97f0-65ad-46fd-be74-5a72cb2e623d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3115ffc1-76ef-46d5-a0f4-dba514871187" xlink:to="loc_us-gaap_PaymentsOfDividends_820c97f0-65ad-46fd-be74-5a72cb2e623d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1279e903-5f4f-4de6-bd70-be5f0b0d1e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4b76f7a7-d453-40bd-9201-89b7b88f9bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1279e903-5f4f-4de6-bd70-be5f0b0d1e83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4b76f7a7-d453-40bd-9201-89b7b88f9bd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d4e254-14ee-4b95-a6e0-cfc5b8839350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1279e903-5f4f-4de6-bd70-be5f0b0d1e83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_36d4e254-14ee-4b95-a6e0-cfc5b8839350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f39ce04a-a5f3-47a5-a99b-43471e22402f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1279e903-5f4f-4de6-bd70-be5f0b0d1e83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f39ce04a-a5f3-47a5-a99b-43471e22402f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f137359-85e2-4fd5-9665-285084d0f565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1279e903-5f4f-4de6-bd70-be5f0b0d1e83" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f137359-85e2-4fd5-9665-285084d0f565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2dbadfc-8640-4610-a880-fe80a301b274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_NetIncomeLoss_c2dbadfc-8640-4610-a880-fe80a301b274" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_87d854ec-f2a4-4bf9-9114-dac2310e6218" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_87d854ec-f2a4-4bf9-9114-dac2310e6218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d56f962e-dc55-422e-bce8-8584e1f832c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_ShareBasedCompensation_d56f962e-dc55-422e-bce8-8584e1f832c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a98c30bd-7fa0-48a7-9ed1-491f70ef9e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_a98c30bd-7fa0-48a7-9ed1-491f70ef9e29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4dba72d9-42f7-4482-923e-08ffbea3b466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4dba72d9-42f7-4482-923e-08ffbea3b466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_078862bf-e034-454a-aa92-0e0938914b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_078862bf-e034-454a-aa92-0e0938914b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_5cc8ee41-97ca-40b6-a186-a4c444f4d07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_5cc8ee41-97ca-40b6-a186-a4c444f4d07a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_d3fb8988-2e4b-4f8e-a10d-d78cbb591c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_d3fb8988-2e4b-4f8e-a10d-d78cbb591c1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_817ab486-e568-4fd6-8f04-32a5a205cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_817ab486-e568-4fd6-8f04-32a5a205cf27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f7290fb9-3eac-4038-bc0d-46a57ac4335e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_f7290fb9-3eac-4038-bc0d-46a57ac4335e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_03f2c4e7-5717-4d3d-9dae-a0fa3e4d3b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_03f2c4e7-5717-4d3d-9dae-a0fa3e4d3b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_493b7fda-5787-4368-a17b-ac41d9cba3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_493b7fda-5787-4368-a17b-ac41d9cba3f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_236b7060-1124-4bad-874b-806378671f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_236b7060-1124-4bad-874b-806378671f2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_bc52b50b-531d-4f64-a4ef-9c4ed33b1370" xlink:href="lfvn-20220930.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_bc52b50b-531d-4f64-a4ef-9c4ed33b1370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e0bfe3b8-dc52-4ee3-99b9-898be0144865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8767833-49d8-4b23-87c0-53764849ad3d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_e0bfe3b8-dc52-4ee3-99b9-898be0144865" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_12195b72-f0a9-4874-a8d3-1183e2076458" xlink:href="lfvn-20220930.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_f9c3915d-e970-4eec-bbb9-33ab6e6f507c" xlink:href="lfvn-20220930.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_12195b72-f0a9-4874-a8d3-1183e2076458" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_f9c3915d-e970-4eec-bbb9-33ab6e6f507c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_c3e01a37-69a7-49f2-846f-7ca477bdf229" xlink:href="lfvn-20220930.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory_12195b72-f0a9-4874-a8d3-1183e2076458" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_c3e01a37-69a7-49f2-846f-7ca477bdf229" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_368a63a6-760f-4019-860c-2b9fee515369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66a667f5-8eec-4954-92d9-09012321205a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_368a63a6-760f-4019-860c-2b9fee515369" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_66a667f5-8eec-4954-92d9-09012321205a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_75ea6674-5384-4057-ab11-90de3afcbfde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_368a63a6-760f-4019-860c-2b9fee515369" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_75ea6674-5384-4057-ab11-90de3afcbfde" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_236e3129-a3bb-4c5c-86c1-30df691bd142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0c4cfcd-0024-4aad-b4a8-952fc10caf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_236e3129-a3bb-4c5c-86c1-30df691bd142" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c0c4cfcd-0024-4aad-b4a8-952fc10caf96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e8676e1-0389-44fc-a38e-066634180639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_236e3129-a3bb-4c5c-86c1-30df691bd142" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3e8676e1-0389-44fc-a38e-066634180639" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4274a94c-2013-40c3-a767-b9e0bb0dc2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_30ecf54b-0b1f-4b09-b1a2-df71390f12eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4274a94c-2013-40c3-a767-b9e0bb0dc2f7" xlink:to="loc_us-gaap_OperatingLeaseLiability_30ecf54b-0b1f-4b09-b1a2-df71390f12eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0fa6a225-86b1-4c9e-87a7-2eb10e96148b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4274a94c-2013-40c3-a767-b9e0bb0dc2f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0fa6a225-86b1-4c9e-87a7-2eb10e96148b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_25a1038d-a199-4c4a-8de3-ba21a1cad148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_25a1038d-a199-4c4a-8de3-ba21a1cad148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_654c5baa-a4ef-4547-9094-0a784f0ed17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_654c5baa-a4ef-4547-9094-0a784f0ed17e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6d9b6fbe-4f5e-46d1-9889-633b76b38eda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6d9b6fbe-4f5e-46d1-9889-633b76b38eda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aff4f19c-30f1-44b9-a619-d0b79bdcdc65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_aff4f19c-30f1-44b9-a619-d0b79bdcdc65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_eb9a2afc-5aa6-43fb-be7e-0ecb03e5ee41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_eb9a2afc-5aa6-43fb-be7e-0ecb03e5ee41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_162ac87e-eba8-4aa3-9ab8-ac8d5d3b1d5f" xlink:href="lfvn-20220930.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8c9a678-753e-4849-b4d0-a055bacae5dd" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_162ac87e-eba8-4aa3-9ab8-ac8d5d3b1d5f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>lfvn-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended" id="iea5d048db28f48bfb2c05d3cc458220e_CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_126c143d-af6d-4927-a081-afb3acef8169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_126c143d-af6d-4927-a081-afb3acef8169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82e68022-228f-4291-982d-85baf7e3fdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockholdersEquity_82e68022-228f-4291-982d-85baf7e3fdec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c81bfef-7fb7-463d-b982-0fa6f757f322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c81bfef-7fb7-463d-b982-0fa6f757f322" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e000d56a-a91d-4a0f-876a-5313065deb04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e000d56a-a91d-4a0f-876a-5313065deb04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4f5f7a3a-404d-4ab0-9010-5e0c63df3a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4f5f7a3a-404d-4ab0-9010-5e0c63df3a66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a0ae16b6-6b3f-481b-b8a9-cab135a29c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a0ae16b6-6b3f-481b-b8a9-cab135a29c44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_31e39616-fdad-4f89-b5a9-c61337b32aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_31e39616-fdad-4f89-b5a9-c61337b32aeb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c64cb61e-bc12-4c48-a631-3217659ede67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c64cb61e-bc12-4c48-a631-3217659ede67" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2ee262f6-6049-44e5-946d-5d8b30f3a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2ee262f6-6049-44e5-946d-5d8b30f3a225" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_01b1324c-9bef-4466-8098-64897d0114af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_01b1324c-9bef-4466-8098-64897d0114af" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dff32d8a-a826-4e83-a76e-e519ac7e894c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dff32d8a-a826-4e83-a76e-e519ac7e894c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e366c33d-bc77-4cd7-82bd-095353fa7df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e366c33d-bc77-4cd7-82bd-095353fa7df2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59925bd2-f5e8-41c3-afb2-5b0c8d9ec05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59925bd2-f5e8-41c3-afb2-5b0c8d9ec05d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_9524f560-ed86-43a9-a03d-6cacf867f9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_DividendsCash_9524f560-ed86-43a9-a03d-6cacf867f9da" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b151abf-c3ce-4a9f-8149-6a6ec1722e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b151abf-c3ce-4a9f-8149-6a6ec1722e5c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_574cf58f-7daf-486d-b23c-62e112fbf108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_NetIncomeLoss_574cf58f-7daf-486d-b23c-62e112fbf108" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e7cd8af-0326-4c54-a9ba-e8778d2a4161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_22caae3b-5275-4706-ae18-1f087585b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:to="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fb841549-a634-49fb-b4b0-93effbdbe27b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:to="loc_us-gaap_EquityComponentDomain_fb841549-a634-49fb-b4b0-93effbdbe27b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:to="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_51b4c286-fc05-4e27-b649-6e067e485770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_CommonStockMember_51b4c286-fc05-4e27-b649-6e067e485770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4c15f8ec-4255-4e9c-87c6-4d24988abfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4c15f8ec-4255-4e9c-87c6-4d24988abfaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f671a672-1bf7-4c39-825b-274c5ad06036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_RetainedEarningsMember_f671a672-1bf7-4c39-825b-274c5ad06036" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_117e2035-2cc9-4507-89d0-4415105d65e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_117e2035-2cc9-4507-89d0-4415105d65e0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ib5d5358fa027441089f445f865927781_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_faef400a-1038-458c-9328-39d9df908937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_faef400a-1038-458c-9328-39d9df908937" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_188c1d58-9d2c-48c7-a9e6-c1b6c71bafc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_188c1d58-9d2c-48c7-a9e6-c1b6c71bafc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_4923575d-3a40-4de6-a07b-8af81366ca0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_4923575d-3a40-4de6-a07b-8af81366ca0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e2d91e03-4898-435c-a017-84937d97af0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e2d91e03-4898-435c-a017-84937d97af0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_d36edee2-5006-4c40-8730-27ce2f8a4270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_InventoryValuationReserves_d36edee2-5006-4c40-8730-27ce2f8a4270" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_0096834b-ce2e-4a50-92b5-deeae58ae07d" xlink:href="lfvn-20220930.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_0096834b-ce2e-4a50-92b5-deeae58ae07d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_e1f45538-3c16-4c52-acea-5b83a7a7ba4f" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_e1f45538-3c16-4c52-acea-5b83a7a7ba4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_b1a4099e-9ff0-45d3-9965-25b4df5ba2bd" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_b1a4099e-9ff0-45d3-9965-25b4df5ba2bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_d2d7ecae-f8fb-4278-8512-85c3a29ec8e2" xlink:href="lfvn-20220930.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_d2d7ecae-f8fb-4278-8512-85c3a29ec8e2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_cd5c87b7-4754-4f58-b473-89405065676b" xlink:href="lfvn-20220930.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ReturnLiabilityReserve_cd5c87b7-4754-4f58-b473-89405065676b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ad16207f-fc8a-4f10-8f09-f46460077bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ad16207f-fc8a-4f10-8f09-f46460077bf7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_297dcfee-74a6-41c5-b5e0-53962599897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_297dcfee-74a6-41c5-b5e0-53962599897a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bc1919ee-148d-473d-ab66-8a597ba6b4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bc1919ee-148d-473d-ab66-8a597ba6b4ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_f6d94d4e-07c0-4551-a6bf-74b1b72c8de6" xlink:href="lfvn-20220930.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_NumberOfGeographicSegments_f6d94d4e-07c0-4551-a6bf-74b1b72c8de6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c9a2b112-7d19-4bf0-8c3e-d448784b7f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c9a2b112-7d19-4bf0-8c3e-d448784b7f82" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_a73076bc-7018-443b-8bfb-74acf4ebf2bf" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_a73076bc-7018-443b-8bfb-74acf4ebf2bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_fe030e48-f1b8-4a15-9959-f8a30c0b066a" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_fe030e48-f1b8-4a15-9959-f8a30c0b066a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended" id="id0555b0f60954b6cac9447ef315f6820_SummaryofSignificantAccountingPoliciesSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da6fa6-d085-467a-8f96-0b06ce64d9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da6fa6-d085-467a-8f96-0b06ce64d9f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_0f82ac3c-21a6-4ce1-afa4-f7e5f0ba3b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:to="loc_us-gaap_NoncurrentAssets_0f82ac3c-21a6-4ce1-afa4-f7e5f0ba3b36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:to="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f419c95f-d05b-4538-86c1-76486bbea3f9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:to="loc_srt_SegmentGeographicalDomain_f419c95f-d05b-4538-86c1-76486bbea3f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:to="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2055f17c-79c0-4813-930d-c17b991275f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_srt_AmericasMember_2055f17c-79c0-4813-930d-c17b991275f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_2ca8de91-b726-4fd2-9451-a4bfcb8caa6a" xlink:href="lfvn-20220930.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_2ca8de91-b726-4fd2-9451-a4bfcb8caa6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_53a7563b-d2e6-4fca-bf38-d73183240254" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_country_US_53a7563b-d2e6-4fca-bf38-d73183240254" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_0f47252a-eafb-4d3d-a8b7-c22c9ff666c6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_country_JP_0f47252a-eafb-4d3d-a8b7-c22c9ff666c6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended" id="i4b8b558c0c3b4a3189d9e59d1faea9aa_GigEconomyGroupInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_3e42f5e0-62f0-4546-ab9f-be1d5feb73a7" xlink:href="lfvn-20220930.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_3e42f5e0-62f0-4546-ab9f-be1d5feb73a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_5efb2db2-a1df-4797-926a-62bce32dfd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_5efb2db2-a1df-4797-926a-62bce32dfd97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_36ba21c5-8257-4753-afcb-a7ed7eb8a8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_36ba21c5-8257-4753-afcb-a7ed7eb8a8e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f36a3540-d7c2-4b0e-8bd4-395a9378c016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f36a3540-d7c2-4b0e-8bd4-395a9378c016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c2cf9bff-5fad-4a0b-9460-84e2d404e8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c2cf9bff-5fad-4a0b-9460-84e2d404e8ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cd417918-3caf-4aef-a0e9-2393e349a614_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:to="loc_us-gaap_RelatedPartyDomain_cd417918-3caf-4aef-a0e9-2393e349a614_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:to="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_839db5a8-b310-443f-96ba-91c16537a64a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:to="loc_srt_AffiliatedEntityMember_839db5a8-b310-443f-96ba-91c16537a64a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_02fb4d23-7522-4e36-ad8a-32231f2da89a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_02fb4d23-7522-4e36-ad8a-32231f2da89a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_20168b18-336e-41e5-849d-efec31c222cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:to="loc_us-gaap_CommonStockMember_20168b18-336e-41e5-849d-efec31c222cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i6a9abfbfcd2f48669cb37d1d6e9389e0_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_bd98ef13-10a8-4ce3-af4f-017499e137e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_bd98ef13-10a8-4ce3-af4f-017499e137e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b48d65e7-f0d5-4b02-b624-17458b158159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b48d65e7-f0d5-4b02-b624-17458b158159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_af60d29a-1294-4209-a5dd-145b4697da62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_af60d29a-1294-4209-a5dd-145b4697da62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4eff5bde-7acf-43bd-bf96-632f1dfcaedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseExpense_4eff5bde-7acf-43bd-bf96-632f1dfcaedc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:to="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d2c275a4-bd04-4400-a9bd-7ddd086306ea_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:to="loc_srt_RangeMember_d2c275a4-bd04-4400-a9bd-7ddd086306ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:to="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ae6d15f-e8bb-4089-9c3c-0b8f1ccfa9a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:to="loc_srt_MinimumMember_8ae6d15f-e8bb-4089-9c3c-0b8f1ccfa9a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db97f380-25bc-465c-91f6-4d5db23d9adf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:to="loc_srt_MaximumMember_db97f380-25bc-465c-91f6-4d5db23d9adf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i8b1ca510405f439fb262d75f9bf5d012_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e44578ce-eec4-483a-8ad0-4199dad65762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e44578ce-eec4-483a-8ad0-4199dad65762" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5ace146d-8645-46e3-880e-aa7064913403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5ace146d-8645-46e3-880e-aa7064913403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_fec68940-fda5-4ae3-ab88-c4778e0e8c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_fec68940-fda5-4ae3-ab88-c4778e0e8c1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_1cef9e3e-1cba-4081-a829-2ef3c1ab2cdd" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_1cef9e3e-1cba-4081-a829-2ef3c1ab2cdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_156e0f80-0a40-43e6-907d-2aa3fed26a17" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_156e0f80-0a40-43e6-907d-2aa3fed26a17" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_eb81a1e0-86df-4e2d-aea5-6a481744b7e2" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_eb81a1e0-86df-4e2d-aea5-6a481744b7e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_3090570b-8d0b-4458-99d1-e678ed6a11c6" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_3090570b-8d0b-4458-99d1-e678ed6a11c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a0b06f45-dd88-4514-8a9a-d3cd30f4f172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a0b06f45-dd88-4514-8a9a-d3cd30f4f172" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bf6ce975-9622-4309-830f-3c1be253eeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bf6ce975-9622-4309-830f-3c1be253eeb0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_e22e554e-f4ad-4992-a380-7f5e348038ea" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_e22e554e-f4ad-4992-a380-7f5e348038ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_1dbe6c41-1a44-44d1-941d-e89c2d9a4c7b" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_1dbe6c41-1a44-44d1-941d-e89c2d9a4c7b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b8d87cf1-682f-420f-a329-ba5a8e1919c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b8d87cf1-682f-420f-a329-ba5a8e1919c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_c6ebbe20-f06a-49e5-b578-4da02e41e7c2" xlink:href="lfvn-20220930.xsd#lfvn_March2016TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:to="loc_lfvn_March2016TermLoanMember_c6ebbe20-f06a-49e5-b578-4da02e41e7c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_06da3996-b348-4062-8529-98bfed9f26a8" xlink:href="lfvn-20220930.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:to="loc_lfvn_March2016RevolvingLoanMember_06da3996-b348-4062-8529-98bfed9f26a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5c813886-10c8-45d1-ac10-575f3bbc9476_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:to="loc_us-gaap_CreditFacilityDomain_5c813886-10c8-45d1-ac10-575f3bbc9476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:to="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1115b149-3884-4d32-ad26-621420d9ee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:to="loc_us-gaap_SecuredDebtMember_1115b149-3884-4d32-ad26-621420d9ee8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34688dea-e915-414d-a153-441d13c3c856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34688dea-e915-414d-a153-441d13c3c856" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0990bce5-d349-4200-a8e3-afb902f71c23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:to="loc_us-gaap_VariableRateDomain_0990bce5-d349-4200-a8e3-afb902f71c23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:to="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_f8734532-e3e5-4b82-bf2f-f2536aa318f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_f8734532-e3e5-4b82-bf2f-f2536aa318f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9a6454b2-bcee-4808-a940-87896a8e838d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9a6454b2-bcee-4808-a940-87896a8e838d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_869a0e68-24d2-4a66-b8ba-c242fc0fe017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:to="loc_us-gaap_LineOfCreditMember_869a0e68-24d2-4a66-b8ba-c242fc0fe017" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended" id="i03b77b6d9ba84d0eae45b62793d8ad4c_StockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_24b4feba-1b4c-48cd-8589-7018bdd1cc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_24b4feba-1b4c-48cd-8589-7018bdd1cc2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18cd5c4b-3800-47f4-886d-ede38ce4d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18cd5c4b-3800-47f4-886d-ede38ce4d8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1f3b2c6e-8427-43f5-9a6a-fa55f282c400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1f3b2c6e-8427-43f5-9a6a-fa55f282c400" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1d673db-8ff2-4741-90ea-4243b64e595e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1d673db-8ff2-4741-90ea-4243b64e595e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4355c156-fad7-4df4-a082-cacb0138d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4355c156-fad7-4df4-a082-cacb0138d33a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b360927c-d537-4223-aeb0-74eb25caf22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b360927c-d537-4223-aeb0-74eb25caf22f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_7a40250a-a465-4afd-aa45-75afb4d4d394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_7a40250a-a465-4afd-aa45-75afb4d4d394" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_12899051-0253-49d0-8735-4cbab243fe6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_12899051-0253-49d0-8735-4cbab243fe6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_bcc7bfb7-528b-4f17-a8c6-122193621a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_DividendsCommonStockCash_bcc7bfb7-528b-4f17-a8c6-122193621a10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7238a765-2017-4c3d-88d2-c2aa65db3b0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:to="loc_us-gaap_ClassOfStockDomain_7238a765-2017-4c3d-88d2-c2aa65db3b0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:to="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_caf320a4-2724-4842-a82c-175fb533f4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:to="loc_us-gaap_CommonStockMember_caf320a4-2724-4842-a82c-175fb533f4b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended" id="i3c494da1e5b84d75b3db640a7972b127_StockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14fa1b65-e572-4845-8931-b0e41801227a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14fa1b65-e572-4845-8931-b0e41801227a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_94bb46dc-e689-4cf8-9b3e-fa0aaf0606a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_94bb46dc-e689-4cf8-9b3e-fa0aaf0606a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_776383c5-d6b4-4533-8e78-bf0afee9d827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_776383c5-d6b4-4533-8e78-bf0afee9d827" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_d021c6f3-ff78-45b7-8af4-316624f1cc89" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_d021c6f3-ff78-45b7-8af4-316624f1cc89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9941f3-1d6e-420c-9320-b34e89e29e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9941f3-1d6e-420c-9320-b34e89e29e21" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_21d6b84a-8bec-43d6-b257-1a15dad7990e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_21d6b84a-8bec-43d6-b257-1a15dad7990e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6a7caeb3-3a35-4fe5-a194-ab94977817b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6a7caeb3-3a35-4fe5-a194-ab94977817b7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0a254d78-259f-4795-b55b-351617043d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0a254d78-259f-4795-b55b-351617043d04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_079bb0a0-647e-41bf-8621-e5dc2936e646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_079bb0a0-647e-41bf-8621-e5dc2936e646" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8bc7a3d1-cc4b-462d-8d28-296a93646cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8bc7a3d1-cc4b-462d-8d28-296a93646cb8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_547cb283-6c4e-4af4-8ae3-55b7ff49798e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_547cb283-6c4e-4af4-8ae3-55b7ff49798e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_476b3389-49eb-4975-a00f-55b2f71a9082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_476b3389-49eb-4975-a00f-55b2f71a9082" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_4b4a96ce-0036-4e03-8466-c655114a83af" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_4b4a96ce-0036-4e03-8466-c655114a83af" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cc320fc2-e7bb-480d-a8e3-0b929a188625" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cc320fc2-e7bb-480d-a8e3-0b929a188625" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2d167a65-72c1-475f-b019-ae41375dacad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2d167a65-72c1-475f-b019-ae41375dacad" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_11696397-163d-4e9f-bf33-2d1e591772a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_11696397-163d-4e9f-bf33-2d1e591772a6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:to="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b8a8d9a2-0f78-4730-a16f-f7017394f981_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:to="loc_us-gaap_PlanNameDomain_b8a8d9a2-0f78-4730-a16f-f7017394f981_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:to="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f9f5c984-9e99-483f-8354-44b0fdfce731" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f9f5c984-9e99-483f-8354-44b0fdfce731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_ce10176a-7eb2-425f-bf54-5874f6674deb" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_ce10176a-7eb2-425f-bf54-5874f6674deb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_87bc2763-c745-488b-8a66-3f282fb38af9" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_87bc2763-c745-488b-8a66-3f282fb38af9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_0d5a0e6d-a5cc-4fac-baa7-c5fe62b83936" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_0d5a0e6d-a5cc-4fac-baa7-c5fe62b83936" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_b6faf090-d323-4578-85de-6a8e7471c57c" xlink:href="lfvn-20220930.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_b6faf090-d323-4578-85de-6a8e7471c57c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:to="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_63a7aeb1-7875-4983-9f6d-add052bf08cb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:to="loc_srt_RangeMember_63a7aeb1-7875-4983-9f6d-add052bf08cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:to="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_acb29808-9a1b-4918-a3ae-9ab490b9ee16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:to="loc_srt_MinimumMember_acb29808-9a1b-4918-a3ae-9ab490b9ee16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a09c5f55-f135-4732-af5d-f63c65d75e1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:to="loc_srt_MaximumMember_a09c5f55-f135-4732-af5d-f63c65d75e1e" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>lfvn-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b114b753-e7c5-4ed1-90b3-382838c18507_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6c0ccbd1-a161-46e1-afc5-b8e323b1fa08_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_656ae865-9f9e-4113-beeb-97ac08855f24_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cb3b9f5-e003-4fde-ae8c-3bbbc179a798_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_f4b27bbc-f0fa-469b-9947-628cdb1c9c53_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_1910d97e-ceb9-48ad-89cb-789662b551aa_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a1adc274-8497-47a0-b1bb-bd746b977e32_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expenses</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2088f336-e293-4526-9920-9121314da5b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_c3c196ec-3ef1-4104-8766-c0af2891cfb6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d7dcbd03-0f6a-4c69-a8d0-e4787db0447c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_8350f0fe-7e2d-491c-8401-328b61d7126b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_c7614525-d551-4d93-bf4a-e7c630006fcf_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_b870f9b9-e438-4dae-b9a5-8e422171f06d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_78316ba1-d649-40cc-9c58-2a91af93aca6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5ac432db-f0ab-4960-838e-a734e666d587_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7463161f-76d5-43b0-a6da-42c1d9b9651e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_dedc1673-cf00-48e5-adfe-d79982c979c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1bb00714-16b0-4acb-98bc-3d5ccaae6b0c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_77c7851d-5ad7-4cc1-ba52-a37c296f5201_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_292d08f2-cacc-4a56-b343-167d910696a0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_37edd652-e9e6-4ff1-8d53-198e2245517b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_188afa00-3779-418b-b7b2-3f5f33d3e890_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_cd5a1dc1-21c1-4407-b7db-fa64dcba1be6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_ebe01ce6-8fb8-4d2f-a2db-3c1fb6d38972_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_296bcb8f-ebc8-4422-b1a1-794778ea5094_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_876b8be3-954a-4f6c-a8af-d23b132db41b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_783c73ea-1a98-4946-8c3e-cc0df8d6b6d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares per employee (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6358b03b-d214-4795-bcbc-f1328dc91d23_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum capacity on draw</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_72821aca-adf0-4a15-a9b3-c101533cabf5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_34c50c88-855d-4b2c-95bd-6c06a8bf6e46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6d8ce2b9-769f-4fb9-8a2a-10be8e51f886_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,560 and 12,493 issued and outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_9533a1c0-3057-4c4f-b325-7820612e6f79_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gig Economy Group Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_26edcbb5-16e0-4e52-8ba7-cba3143668c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4aebaced-2e81-45a1-a5a5-09cdaf91c4ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_53401b6f-aab9-42b4-b7db-15727dc140ae_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_26323a30-7000-4e8f-a41c-bc0b92b0db7d_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_6f7b8e6b-ed46-49b6-abcb-4f1388dfa45f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f38d9efd-0fab-4ca3-92ca-0702e76141c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1035bc0-82d8-4ce4-a6a7-01afe8ddaef6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_75016962-01d8-488f-a937-093adf7bf2a9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cc19d442-6100-4fed-9e08-34aa5985dacd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_08871622-5df7-4c00-bfc4-5eade16aa4f9_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, maximum allowed dividends</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Allowed Dividends</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Maximum Allowed Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:to="lab_lfvn_DebtInstrumentCovenantMaximumAllowedDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_c1a0369d-114c-4942-a9cc-f2fc61ce93ad_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_993ac1bc-3a73-48c7-ae5c-6c2fe71d27a5_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa77b797-5003-4bcf-a17d-9790ee31efeb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee4e10f8-f5c7-4d73-ab75-bc8ba7df4ec7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents &#8212; end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1269bdf0-fcee-4279-832d-f38c912521d1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_398f6ec7-28d5-411c-8465-8be6db40856c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_972df3d0-0ca7-4c86-aed8-3a3610827a0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e235674d-99d2-4ec3-8835-4663baf25469_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_1ce2bebe-a3dd-4ef5-8472-367c0cce51aa_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, fixed charge coverage ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Fixed Charge Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:to="lab_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1551edfb-94a4-4091-ae69-a6cad82ed8b5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_7dd25128-0b51-4ff1-b158-6b7a0fc67fd8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_17c89c74-0f6c-44e4-9018-da972dbcc442_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a355ecef-bafb-4782-b2f8-6fa52787710c_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_34e8ac2f-295f-45fa-b29d-a0464047fb77_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_665c0bde-0e17-437f-b701-079434d5f018_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_457fc186-a18d-4d50-a82c-895a9b6115e7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from EPS calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_16773ec7-35a7-43c6-abab-56964237a5f6_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_TaxesPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_b9d08e1c-b8cd-49f7-848f-75fb46f8c727_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, required minimum working capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_label_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:label id="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Minimum Working Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:to="lab_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_8342abf0-e035-4fb9-8308-5283a0a0e43e_terseLabel_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:href="lfvn-20220930.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:to="lab_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_86f2d6e8-ee54-42e0-aeed-b78c05de899d_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2007 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seven Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and seven long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_6632a911-259b-452f-a7f4-f70ffc7915aa_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7f9fd5bb-4523-4551-a717-8836071b1ff6_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3af62950-b7c1-41b2-ad9c-84bb2272d1fd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_8adeac72-16fe-4bb8-a73a-bfc99568434b_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_61e3efe3-e968-4132-9803-c0dd72067be1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c92811ad-7301-4bd0-ab8c-e658325fadc5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_54aa9a63-f107-414c-9bc6-db746841c060_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CommissionAndIncentives_b1f9df01-c2e1-4845-91ed-cf094d69466d_terseLabel_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions and incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_label_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission And Incentives</link:label>
    <link:label id="lab_lfvn_CommissionAndIncentives_documentation_en-US" xlink:label="lab_lfvn_CommissionAndIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives" xlink:href="lfvn-20220930.xsd#lfvn_CommissionAndIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CommissionAndIncentives" xlink:to="lab_lfvn_CommissionAndIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_26a507ad-e949-4a48-813a-6a2fa072235a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_96798162-7ec4-4574-858c-13e209241572_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_ed52d4e9-62ab-4f80-a9ed-8788e9e1d388_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2d6144aa-8fa4-4a42-8599-2a4d3b86d337_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_ab5a843e-d439-41fd-a284-f66e4a22e454_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_4eed9fd9-673a-4fae-9b10-bfcc82ddeed1_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_11e04dfb-9ee5-4e45-aaab-239f0a66c32f_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_160a18ba-aa91-43ea-908f-c22882c6289f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_51706beb-d775-493b-9529-694f45ba835b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_05ca3f9f-3be6-4608-947f-7a56cfd0209d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f640c616-982a-444b-92e2-2a2fa36318bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (remaining nine months ending June 30, 2023)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_country_JP_2aba3751-fa0b-41e3-83fe-4eed251b9ba4_terseLabel_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan</link:label>
    <link:label id="lab_country_JP_label_en-US" xlink:label="lab_country_JP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JAPAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_JP" xlink:to="lab_country_JP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b180623a-d2d5-480f-b23c-232205ae5c93_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9ab4e5bd-276a-4be5-ac7d-a3c08d395c06_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_4282eb81-4657-45b4-a7d6-4c9f705d2b57_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floor interest rate (as a percent)</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_label_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:label id="lab_lfvn_DebtInstrumentFloorInterestRate_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Floor Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentFloorInterestRate" xlink:to="lab_lfvn_DebtInstrumentFloorInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_817d1989-28f2-4b01-a74b-db3745c80c25_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_68db89b4-aaa6-4742-aab1-27c5e29d4535_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_6bac333f-62b4-4467-ac39-56687ff5fbc5_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount in excess of fair market value of stock for option not to be granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_33d16e2f-990b-4ea4-8930-11b66a9ad013_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_89f1e011-4626-41ed-9a1a-f1e86933cc71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, net of awards expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_262d3b22-10cd-4217-8ab9-0783b942c2bb_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash accounts held primarily at One Financial Institution</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held Primarily At Financial Institution [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:to="lab_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_4e39bb48-c573-4fd6-b117-6716e1e6f866_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_18308fba-2d2b-4f68-98cb-b95cb2b9b16f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_ee826e19-e54d-4ee3-af82-d108a4b871bd_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_3d934bda-2d14-4e31-abaa-734bf6287698_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash (Used in) Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d2ff5e2a-7d78-4012-a9ec-16394d9472f5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_36e9cd95-1146-412e-9c08-2bd8c368c1b4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e35096c1-9a7c-4019-84e6-eb75191cfc82_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Effect on Cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fa6c0b83-b682-48b5-9168-4a047bd66995_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_dfb37591-cccb-44f5-b463-4d197f63818a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_20f86339-0469-482b-8668-36320b1f227c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_b8ca29ae-d7a2-4e9f-b43e-064c0e62304c_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of cash dividends</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e66815b5-9945-4a2d-8a64-5cb7a27e2b73_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_64cb75ea-215c-45a3-bc5a-719ff4574686_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_26fc7f99-482a-4994-b401-29cfb3d5b7dc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c237520f-c534-43e7-aaa4-8020a1e6eb81_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_1284bfb7-77a9-49ba-ab3b-04b02a6abf42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_233dce41-f268-4c17-819f-07f9f92c6629_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_b7fa6207-e561-4fda-ac1d-0aa6b19d82bb_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments, realized loss</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a151656a-f983-4101-8695-0018c455e20b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_a2e66c66-ccfd-43fc-9230-9f7e06bed25c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d7f8479-8d46-45e2-bcd2-6d2d7433c6d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_82816451-0e3b-42c4-8a44-3f0b42debd6b_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_bbdab0d0-34cd-447c-959b-3bc100cf391d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ff4a7dc7-8743-4557-9a77-b706aaf77167_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_70540054-eea6-46e3-a906-045de1fb6caa_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_21943961-39c3-4a7f-bbf4-ac81ca00b3ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_c7ab246a-7543-4b69-a722-7735a1735b47_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_402a792b-45c6-44d4-a5cd-89db61da6c7a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_be99b5cf-f55d-4f1d-9eab-2b8dc28ed3df_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_11995848-3bf6-4dbc-a5b7-e4ad1ef33d0e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition And Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4e3ef394-36bd-4d78-aa42-36e4b34475ee_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_72749643-699d-4298-a571-065bef55275d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_013163bb-b0f0-476c-a6af-100de53890f6_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6085dd37-2c38-4d27-afcc-814a972485e1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2e536b74-9795-4a33-9561-381cca7abe44_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_162c42fc-483f-4441-8085-501e006714eb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend, common stock declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_c9035ce7-28ee-4535-b8cf-d4fa341f6d65_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8505e739-fa65-4150-95d4-4d62ab5d99ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_621f8873-73f7-423f-a048-fc70e8dc7a49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_679a6dd6-c9b6-4892-90b9-9e6e396f2b9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction loss, realized</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_311bfe79-7ef2-419b-8b90-24d34a23dd13_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_bfc00a2c-5010-45bb-905a-5c303b44583e_terseLabel_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_label_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Geographic Segments</link:label>
    <link:label id="lab_lfvn_NumberOfGeographicSegments_documentation_en-US" xlink:label="lab_lfvn_NumberOfGeographicSegments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of geographic segments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments" xlink:href="lfvn-20220930.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NumberOfGeographicSegments" xlink:to="lab_lfvn_NumberOfGeographicSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ca4b5768-541e-4af5-a1f6-42d4702f9430_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f98fae0b-016b-4114-bb7a-01a7ec6f4bd7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_79b9918a-0206-40be-9075-75ba6a371dc8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_df6d67e5-fe9d-4370-983f-43381c0ec2ea_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_3c7e1d51-f81c-485c-b687-33f6067a776a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7b73123f-655f-48d6-a982-2303f013395a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_df7f9938-2e8c-425c-92c4-b0d9d52761a6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_fcc4b992-32cf-4dfa-b535-748dd73114e5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_05b9c69c-f319-451c-ad37-b3604b915f58_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEG</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_f165462b-fca0-4298-8fe1-c20a1cb21789_terseLabel_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and restocking fee, percentage (as a percent)</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_label_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:label id="lab_lfvn_HandlingAndRestockingFeePercentage_documentation_en-US" xlink:label="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Handling and Restocking Fee, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:href="lfvn-20220930.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_HandlingAndRestockingFeePercentage" xlink:to="lab_lfvn_HandlingAndRestockingFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8f34bcb8-5f94-456c-b3db-689187b8b5b4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_45dd1ce9-9858-4682-85c6-f7f143986e14_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_5d1b7d49-941a-4cc3-af6f-000dd12a6632_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_faea5573-ca38-48b6-adf9-6fcc478c2e27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_537430ff-f5fc-4b85-9ab2-c468b120f457_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_c4476f6c-d6ee-4199-a6c8-14fb698c55ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_c3de233e-c474-4446-af6e-8a4d0c92b96e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_517e14f8-21f9-4b11-aef4-e038575df6b7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c6fb16f0-c622-42d5-9265-39a598eff3f2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_cb2de4d1-d317-453e-ab97-0ecb8c0dc1ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_77ae5c8b-9c5c-4076-bad2-f6d03d0d75a4_terseLabel_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_RawMaterialsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw Materials, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:href="lfvn-20220930.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_RawMaterialsPercentOfTotalInventory" xlink:to="lab_lfvn_RawMaterialsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_c53f5a55-e237-4bc1-8ff7-20e378c96d77_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9594416d-be43-47de-9bab-3adcf2338cb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Used in Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2a09f4f6-96b8-4fa3-8161-63496a4f3f23_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5eeaa2d-9721-4574-a02f-1829208b399b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase common stock amount authorized (up to)</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_17a4576b-7c02-4b4e-92b0-38c44e1bb488_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9b32ceeb-d811-4a0e-bb0b-ed36c88dc45b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_6310fcad-7642-4d88-857e-095d2cad7021_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_993e4a2a-691a-4ef8-9d74-aef2ace2538c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6e193ff7-65c9-41d7-9a0a-1763ae259187_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c67b2c51-aff7-4271-b570-db91dd2b89f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_55494863-47d9-4e2d-9433-ea1525f40288_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_275c8ebf-7a5d-4639-a70c-d3d025f9feec_terseLabel_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods, percent of inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:href="lfvn-20220930.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryFinishedGoodsPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_d8c9212e-07ad-4e66-88e8-09922e5b3e0e_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions payable</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b6041c69-f8ad-4dbf-855b-5896cef9ba2c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0b429203-7139-4448-b083-575968cb9383_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_7a52e451-88fd-4071-807a-78ca840441cf_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3819aac6-efd8-4c5e-8e45-40688d809b2f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0c5c5b3-5dea-4251-8e0a-6eee9a163171_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_88468444-efb0-4fb9-a27a-fb14694f872c_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_a690b752-8c6b-4ab3-9d94-a5a61f0f0734_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_8db5be81-6795-4b33-a2a4-05a70e164765_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_d9194c7f-3c38-43f3-804c-30635b717a21_terseLabel_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_label_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Back Guarantee Period</link:label>
    <link:label id="lab_lfvn_MoneyBackGuaranteePeriod_documentation_en-US" xlink:label="lab_lfvn_MoneyBackGuaranteePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money back guarantee period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod" xlink:href="lfvn-20220930.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_MoneyBackGuaranteePeriod" xlink:to="lab_lfvn_MoneyBackGuaranteePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9612906c-53d4-4b70-80e4-cd8b459db591_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fdb2472c-2bc9-4c71-92b5-693129cca5cd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies - Note 8</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d66d7304-1ffa-43ca-87ee-befedbb2c4ec_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_58071349-c8bc-4fe6-9f21-1972792072cb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_f137b80b-be2f-436e-8d8b-37e549785c2d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_3ce773f0-e519-4168-81ab-37127457c752_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Long Term Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6327fb26-594f-468f-b3d3-80276643bb48_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_866599b6-8f9f-42e9-9dff-4eeabc55648a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_51bd48cc-77bd-4503-9b54-4f497e3a63a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_63c03545-d899-4af7-bdea-ddb8f69832b8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_e881b30d-1faa-43ff-a527-b94f4dafb411_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_9d2ddaf5-4977-4aee-a7a4-18c73d16b320_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term of stock options granted</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_d2cee47d-ab96-4f8b-bae7-592441d539a4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a681b2cb-2a55-47e9-979f-24ba9eaf847f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under equity award plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_b2c22740-91ff-469f-8e90-3630c41a4511_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_83b5d6e2-97ec-4ae6-9c57-3e8e75f8eb29_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e24b5f7f-5d9f-41e9-9396-d18d2996769f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_cad1b018-7978-4172-b1e8-6a4eabc91976_terseLabel_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, related party, maximum commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_label_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:label id="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment_documentation_en-US" xlink:label="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Related Party, Maximum Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:href="lfvn-20220930.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:to="lab_lfvn_NotesReceivableRelatedPartyMaximumCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_84696b24-d799-4dfe-b34f-5b10490d5b64_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f1b024b6-ccd9-4f66-9601-ddf4a7e48de1_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_66f08331-e905-4b88-9ef1-1ea2507e0bed_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_f8d0df21-e4c3-4cf3-8a9a-160ece997439_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4d0a30e8-9d71-4c17-9fee-ad54821480ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c1d513e9-b42f-45b7-991f-b4d2147c9b8b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_af20c594-d974-4ff1-a498-8f038a128c8e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f3fe2ed9-4239-4b85-91c0-3a14a68f3b07_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_6722ea05-8dd8-4fdd-b8f5-b9d9368d7e3b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_67e4f455-5be3-4c1c-8f45-de51509564a6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_10687882-bdbd-4014-b484-e5c92f1e2e5b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f02701d-5bc9-46d3-9dd7-d530667be9aa_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_4cf43c06-eb06-48a5-9eda-561ac3140087_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1e640093-a25b-4fa5-804f-cb8f5711dc6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock awards and options (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_95f7a801-7636-45ba-8303-77e4c64bb6f0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_37516194-b008-4a1b-9498-2b06a8490033_terseLabel_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_label_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:label id="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_documentation_en-US" xlink:label="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:to="lab_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_972df6fa-43f7-4828-8b29-5650e767d7cb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly installments</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e015eef-adc9-415f-a0d3-730e72aa3844_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_e7999aac-6eb3-468b-a7f5-d2d687a9d841_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed rate interest on debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_0d197a90-6ea9-4771-a398-8a0a6d35c4fb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_1c2d42be-126c-4434-9b64-65df867763f2_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_01af9176-7763-47e5-8576-8bd2fe839d54_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_936c27ff-4b95-4719-bfca-1587c0e9eb03_terseLabel_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_label_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016RevolvingLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016RevolvingLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Revolving Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember" xlink:href="lfvn-20220930.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016RevolvingLoanMember" xlink:to="lab_lfvn_March2016RevolvingLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_c50d490a-fad4-4938-915c-d3132ccbe41d_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_737cfa96-bd55-4790-9940-a68607ade381_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c76efdf-4a4f-4f85-a3b3-abae13ecb492_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_1218db89-6506-4939-acaa-839cae49a0c3_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9f7bbaee-82df-4540-9c38-a68e956277c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based payment award, vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_89c95fa4-175a-4e1a-be2d-4914a4ecc5e9_terseLabel_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash held primarily at Other Financial Institutions</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_label_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held at Other Financial Institutions [Member]</link:label>
    <link:label id="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_documentation_en-US" xlink:label="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Accounts Held At Other Financial Institutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:to="lab_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d0d4dc0a-6f1e-4bce-bfb4-2801e5374ef9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_186bd6a8-23dd-49d5-9cb7-2a477377d9ac_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_515a749c-ba11-4654-aaf1-48298ad4ff5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_71649e5d-469d-47f8-b3ec-c8678a43476b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a25d5acf-a793-45be-9365-1a9ba41d3797_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_71abeef7-5c50-4960-abd9-0fb354797ca2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_601c8ead-e0ef-42ab-81d2-a3d9659c4a82_terseLabel_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_lfvn_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:href="lfvn-20220930.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_EmployeeStockPurchasePlanMember" xlink:to="lab_lfvn_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_57038f75-3879-4470-b461-3e63b7c3edae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_80c9bbf9-a843-49ba-aee5-c438483780c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_5a9281cd-49df-47bc-81e9-a067fef71d71_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_0d10dd56-76eb-48cf-8f45-c7e3b6f28cd9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_11ab4ce0-a995-4d73-86da-a8eb32aaef02_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_835d2bc9-0bf5-4e69-9ff8-730336018b90_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c12b5a90-6544-4f0a-87db-1d930b819682_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share, basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_6f79605a-c11e-490d-8dd9-c237c5da3785_terseLabel_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return liability reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_label_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:label id="lab_lfvn_ReturnLiabilityReserve_documentation_en-US" xlink:label="lab_lfvn_ReturnLiabilityReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return Liability Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve" xlink:href="lfvn-20220930.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ReturnLiabilityReserve" xlink:to="lab_lfvn_ReturnLiabilityReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_70ad4630-74e4-4283-9ef0-b2f278e070ed_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_abe09c55-ee54-4dca-a98b-d006d035c793_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_561e4710-35ac-4cf4-b0e6-92a829b7aecd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_050d58c4-37c5-417a-9ca6-981711563909_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f0a7f1d1-b5cd-49c2-9b4c-5af505474f43_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_b200a367-df98-4d54-9e30-f02800b889ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c9e8df78-6bac-453f-ba72-d2d571b8223d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right to purchase common stock, minimum price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_41708218-b4d4-450c-88d9-8b851e4417c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_a385f2e3-7232-479f-a9b7-87c705adf0e8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_c0ef4578-84e9-4ac4-a782-26cbe1296271_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_557005d5-10c7-4ff4-8962-ee43f2d85f7f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5edfbb37-80d6-40a9-8c10-0bd29db850ed_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_b8def8c8-cd52-4196-80e7-651c0859b311_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_f05037d5-fe25-4f52-9f25-fd5c279654a0_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8d7bde5f-3adc-4bd2-937b-36721d41e090_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_73dafd5b-2298-4853-a8bf-525d82381894_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_7d98985a-45a4-4c9a-931d-ff0dc620cac8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Issued or Issuable, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7e49028e-2972-4d45-954a-7e84b53b8e30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e96fb4ed-814c-45d8-a7d5-4a4d60d4a302_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_96cc7cf7-041c-4e7d-b2c0-4920a0490dae_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f87e5af-299d-42c2-9533-c67a19767370_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_7a950782-1cda-4f0d-bcd0-f14ab4c946b6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_f477a3d8-a5a8-491c-9edc-eb534d2c520b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_3a7e8263-89cc-4132-9389-4e8948bb9940_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of cash dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_a2940b41-e29c-4c58-aeb7-aac808e4f110_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_3c658c18-2888-4a1c-a5ff-fcf6f28c4dda_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, common stock, cash</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_f4df564e-ddcb-499d-8c37-71d9c5055a10_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_a7513ab7-527a-4e97-b57e-d373afd0f738_terseLabel_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return period for resalable and restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_label_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Return Period For Resalable And Restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_documentation_en-US" xlink:label="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Return Period For Resalable And Restockable Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:to="lab_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_35ddac5b-cf0c-4dcb-b487-fd6530c03517_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c0dd347a-ed4d-4f4b-b411-e05af369dab2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_f828ff6c-f3f5-41c6-a294-299ef0c63729_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_ccda73ba-97dd-4674-9c2c-b79224fb0c34_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_127f4797-19ac-4405-ab59-40d856847d25_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_cc1f58aa-049d-4723-b2f8-6ea80f049a46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_82cd30da-7a0d-4689-a0ff-cd6c72aa65e8_terseLabel_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:label id="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments Due, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="lfvn-20220930.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_93554ce2-e4c4-4838-9e23-2df5e9d34882_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_67a4432a-1918-4359-9d36-10f3b323dda4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_83a97ad7-bfa4-4ced-8201-6ecc5a025b8f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_edf915f4-9165-4f18-8b9a-5bb132b8b8ec_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_023d07d9-a9ef-4e37-a087-014303e5d1e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the ESPP (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_73f38902-efdb-4b0a-8f94-c0d409279cf4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_cbaeff9b-937b-458a-b60b-87ce28a26b32_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ef469c5f-3e14-4f94-9015-e5320f46ac1d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_8a0ba7a1-8506-4b89-9ced-e76db941aaf3_terseLabel_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund percent for resalable and restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_label_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Refund Percent For Resalable And Restockable Items</link:label>
    <link:label id="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_documentation_en-US" xlink:label="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts With Customers, Refund Percent For Resalable And Restockable Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:to="lab_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_0906f7b1-531b-4183-880c-aa14bc4fd712_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation reflected in additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_91b70d6f-18a0-4db3-9a64-4608b8ac3e4a_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_c3a290d7-81a2-4021-8833-1ddd9e50ae64_terseLabel_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_label_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:label id="lab_lfvn_IncreaseDecreaseInLeaseLiabilities_documentation_en-US" xlink:label="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:href="lfvn-20220930.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:to="lab_lfvn_IncreaseDecreaseInLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_241a6c1c-adba-4534-a42f-4ffd1aaa0c25_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d97e374e-9dd2-4fbc-9b48-59d9a5a9a237_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9e5e5613-0ee4-440b-951b-df08c34b6677_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_5a6971eb-8e68-484f-b8cb-8521ffd42132_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_f8bcda04-cc95-4cdd-a71a-2429fd74c486_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1b621bee-7568-4484-aae3-9ae458ea9b56_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Cash and Cash Equivalents:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_95ba5f3e-0e4f-445a-9a00-da6082a8703c_terseLabel_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Long-Term Incentive Plan</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_label_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Long Term Incentive Plan [Member]</link:label>
    <link:label id="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_documentation_en-US" xlink:label="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two thousand and ten long term incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:to="lab_lfvn_TwoThousandAndTenLongTermIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_be360b16-1868-41a9-bc9e-560269336801_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue Disaggregated by Geographic Regions</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_dbb8a6e1-4a23-46bb-879e-e06b32094850_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_beaea619-2cb8-46f9-aff9-096134f08753_totalLabel_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of total inventory (in percentage)</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_label_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:label id="lab_lfvn_InventoryPercentOfTotalInventory_documentation_en-US" xlink:label="lab_lfvn_InventoryPercentOfTotalInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Percent Of Total Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory" xlink:href="lfvn-20220930.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_InventoryPercentOfTotalInventory" xlink:to="lab_lfvn_InventoryPercentOfTotalInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_f00afafb-2a77-469c-b7ca-db4076e0e1d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_label_en-US" xlink:label="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Interest Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:to="lab_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e91795dc-81d5-4aaa-94cb-92aebb0355af_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4b5e36d3-95d7-4e10-9197-e0291f3ed0b3_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_065db15f-f51e-4139-8b4d-ac24e6480106_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_ad4123f7-17d4-4331-8a78-d2b00f47b9bd_terseLabel_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia/Pacific &amp; Europe</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_label_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:label id="lab_lfvn_AsiaPacificAndEuropeMember_documentation_en-US" xlink:label="lab_lfvn_AsiaPacificAndEuropeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember" xlink:href="lfvn-20220930.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_AsiaPacificAndEuropeMember" xlink:to="lab_lfvn_AsiaPacificAndEuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_030ee464-88ce-4a44-b49a-18c72e13a595_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_March2016TermLoanMember_1f149e14-4d20-42a4-be7b-518f6b4499c8_terseLabel_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_label_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:label id="lab_lfvn_March2016TermLoanMember_documentation_en-US" xlink:label="lab_lfvn_March2016TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">March 2016 Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember" xlink:href="lfvn-20220930.xsd#lfvn_March2016TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_March2016TermLoanMember" xlink:to="lab_lfvn_March2016TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7f3cb3e0-d5d1-4f0c-9563-140ccf300348_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares canceled or surrendered as payment of tax withholding and other</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e0bea2c6-94de-4da4-b4ae-83932b9b491f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_9515a44f-b4cb-497d-826c-64472a9a5d33_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_0e8e1000-4dca-4b28-999c-4545abbc3c07_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_4aee60b5-92d2-491d-9c8c-76a32552dce3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1284a01d-1d82-4cf7-b3dc-d3c574234020_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0a95324b-4184-4f5c-b01a-288505c43a96_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b8cf7089-3244-4b8b-804a-3f4b61e225a0_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4a13e46d-d923-4d83-ae00-19477d4c5618_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b1da3ea7-80a7-4d63-bc8e-2d61189cb8ac_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_802e83b1-438b-4688-b8d2-ede40f4638e7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_22a8aec8-36f1-4a4c-adfc-10f96c6addc9_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_adf299ef-ac36-461a-b9d8-d5c53495513f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_94cf3f7a-6b91-43d8-81f1-0ad5be9d4216_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_0880c752-5afb-4855-917b-2409c00affc4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, original debt, interest rate of debt (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Interest Rate of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:to="lab_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_48f41b4d-a8a3-48cb-93a1-d3fd27f80590_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_ea334667-6397-4115-9105-de2a1e83e4d8_terseLabel_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trailing period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_label_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:label id="lab_lfvn_DebtInstrumentTrailingPeriod_documentation_en-US" xlink:label="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Trailing Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lfvn_DebtInstrumentTrailingPeriod" xlink:to="lab_lfvn_DebtInstrumentTrailingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_72be1cc0-30f7-48c2-831b-64136c62946c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_7f68b304-ecfa-4546-904a-3a02ae52d78f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_10ef8f33-7d04-4506-81de-64046bd91c80_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of company stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a0b906ff-dc51-4923-9097-3799c08c2cbb_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_0f890b72-1b75-4a7a-8356-8d7c1b8d8690_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_5c63c1b4-4365-430e-b8ba-19122f2c1470_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_23d640df-3d78-422e-b2a6-9165b693ce1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_2630d46b-bd41-44c5-8529-f4df4e13c11b_terseLabel_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate</link:label>
    <link:label id="lab_us-gaap_UsTreasuryUstInterestRateMember_label_en-US" xlink:label="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury (UST) Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UsTreasuryUstInterestRateMember" xlink:to="lab_us-gaap_UsTreasuryUstInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_b1ae6353-dbde-4bdc-a612-8683ef41feba_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_aef1e016-241e-48a0-b99c-aff77b4df9c5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_0078c07a-e37f-4536-b7ab-7ceeb8c7a090_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_29db2367-aa24-4c6c-a021-1952b506bcc2_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b01de28f-87fc-4cd0-bf7c-2d060b5dc068_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d219281-27b0-4be7-8e51-dcc12bb115ca_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_d2d12cf3-4265-48db-8149-11e393b5bfa6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_38f676c4-0eaf-46bd-ad07-a125307eb9bf_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7d28f2e0-702c-47f8-a54f-7ffd6433d91a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_56ac498d-d1ad-4be9-adea-392e50f7bd26_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3bdb689e-93db-42fd-b117-5af42569b099_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_81c2d708-01d8-4b1f-a8e8-514bfade34a2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities held without readily determinable value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_b0b75fa4-f794-48d2-8533-d4fd6767515f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e00ceb31-2410-4402-8b3b-8b900914f0b8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_228adb6b-e340-4b8a-a94c-b1370baf8665_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6ba74b07-7086-4f16-a613-9105a29d2d85_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>lfvn-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:eaa71907-2c84-4145-8419-6cbb06b9a097,g:07770393-5d68-4d0c-981d-48c8a64bf381-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.lifevantage.com/role/CoverPage" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_89cc1415-7d40-4895-83d3-f192471ef224" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentType_89cc1415-7d40-4895-83d3-f192471ef224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_5949bd1a-b2df-46f1-8b67-7f020082c829" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentQuarterlyReport_5949bd1a-b2df-46f1-8b67-7f020082c829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_67304bba-ca20-410d-b7d5-13a893c75b14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentPeriodEndDate_67304bba-ca20-410d-b7d5-13a893c75b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_11fb997f-ddf5-4fc7-884a-1b4ed6e6f49b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentTransitionReport_11fb997f-ddf5-4fc7-884a-1b4ed6e6f49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_49cfe2b4-052c-42d2-a2d4-014f2cda70ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityFileNumber_49cfe2b4-052c-42d2-a2d4-014f2cda70ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f03d9ca8-5869-466d-b7b3-1a98f6df06ab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityRegistrantName_f03d9ca8-5869-466d-b7b3-1a98f6df06ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_b6d09945-419f-409a-9ec8-84f46a90414c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityIncorporationStateCountryCode_b6d09945-419f-409a-9ec8-84f46a90414c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7b9b402f-3015-4807-8f69-ee3675555a3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityTaxIdentificationNumber_7b9b402f-3015-4807-8f69-ee3675555a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ad672cb-4501-46a5-b7fd-92c90374b998" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityAddressAddressLine1_7ad672cb-4501-46a5-b7fd-92c90374b998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_6ad5c789-d47f-4727-bace-6fbddd4f1e96" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityAddressAddressLine2_6ad5c789-d47f-4727-bace-6fbddd4f1e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_89a22ce7-1ad6-482e-aad4-9603c04a4761" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityAddressCityOrTown_89a22ce7-1ad6-482e-aad4-9603c04a4761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b75bf902-24b0-4ca2-866f-e81301b98f75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityAddressStateOrProvince_b75bf902-24b0-4ca2-866f-e81301b98f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2d71cc91-a620-4dc0-ae44-4e9930ba420d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityAddressPostalZipCode_2d71cc91-a620-4dc0-ae44-4e9930ba420d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_00de08f7-0f13-4fd1-a7b0-8014ff243ca0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_CityAreaCode_00de08f7-0f13-4fd1-a7b0-8014ff243ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d4ddc98f-eecd-4547-a9f8-e0c1a9abac75" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_LocalPhoneNumber_d4ddc98f-eecd-4547-a9f8-e0c1a9abac75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_409af17f-8ff3-4a75-bbc4-a57470ba2971" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_Security12bTitle_409af17f-8ff3-4a75-bbc4-a57470ba2971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_bbbc58bd-0e10-48fd-b75f-104320e62e77" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_TradingSymbol_bbbc58bd-0e10-48fd-b75f-104320e62e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_ec8e34af-1fab-415d-b866-79bc65e5b335" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_SecurityExchangeName_ec8e34af-1fab-415d-b866-79bc65e5b335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5b4ca14e-eb03-40ad-8d27-04f74b9b3adb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityCurrentReportingStatus_5b4ca14e-eb03-40ad-8d27-04f74b9b3adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b2b056f3-6e27-4164-ac00-0d4645b068b9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityInteractiveDataCurrent_b2b056f3-6e27-4164-ac00-0d4645b068b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_178f1b0a-af86-4b3e-85fe-b7e9cadfaa13" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityFilerCategory_178f1b0a-af86-4b3e-85fe-b7e9cadfaa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_682cab14-e6af-4b79-bfc8-73696af9e958" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntitySmallBusiness_682cab14-e6af-4b79-bfc8-73696af9e958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_193a6de0-c6aa-47a6-9f93-861ac8880cf4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityEmergingGrowthCompany_193a6de0-c6aa-47a6-9f93-861ac8880cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c0858a9a-0747-47c0-8d17-56c46c301ce4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityShellCompany_c0858a9a-0747-47c0-8d17-56c46c301ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_eecec472-053d-4bec-acf5-0d670f491c66" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_eecec472-053d-4bec-acf5-0d670f491c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8591f8af-976f-46ce-a338-6b9f6b994407" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_AmendmentFlag_8591f8af-976f-46ce-a338-6b9f6b994407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_95cb5af8-e035-4352-b4f9-b1dbbe9a94b0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentFiscalYearFocus_95cb5af8-e035-4352-b4f9-b1dbbe9a94b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_10741d44-fb61-4dba-a74a-f3d2fe1f1ad7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_DocumentFiscalPeriodFocus_10741d44-fb61-4dba-a74a-f3d2fe1f1ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2fce3cb2-2466-419f-a1e8-348dcc6a6893" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_EntityCentralIndexKey_2fce3cb2-2466-419f-a1e8-348dcc6a6893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6555217a-9738-4eea-bbad-501b1b697641" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_155536b5-4f29-4660-91d1-2ace7acc49ba" xlink:to="loc_dei_CurrentFiscalYearEndDate_6555217a-9738-4eea-bbad-501b1b697641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5431d6e7-b8fd-4f92-a288-872b0fa8d3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ddc5b9ed-d0d1-4000-a176-8070ace92468" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5431d6e7-b8fd-4f92-a288-872b0fa8d3b6" xlink:to="loc_us-gaap_AssetsAbstract_ddc5b9ed-d0d1-4000-a176-8070ace92468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddc5b9ed-d0d1-4000-a176-8070ace92468" xlink:to="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4eb07e11-7628-4ec7-8434-f9f107dba629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4eb07e11-7628-4ec7-8434-f9f107dba629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e7c0e067-1787-4512-aea2-f6a20da46e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e7c0e067-1787-4512-aea2-f6a20da46e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_dba2db9a-4b55-4cb2-99ce-34821dcac374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_IncomeTaxesReceivable_dba2db9a-4b55-4cb2-99ce-34821dcac374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_044a33ba-ca1a-4fef-9f4c-e3090b3a67f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_InventoryNet_044a33ba-ca1a-4fef-9f4c-e3090b3a67f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b41a64d1-a758-4971-924d-602b729aed7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b41a64d1-a758-4971-924d-602b729aed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_306e2204-1a6e-4fd0-8071-5d9ad67ed06f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_108af3d2-5beb-4db8-bb03-aab15c1762b8" xlink:to="loc_us-gaap_AssetsCurrent_306e2204-1a6e-4fd0-8071-5d9ad67ed06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddc5b9ed-d0d1-4000-a176-8070ace92468" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a6f62073-e8e0-452e-99b0-83fbcbccfa56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a6f62073-e8e0-452e-99b0-83fbcbccfa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a98277a5-4948-44d2-9830-a49790340e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a98277a5-4948-44d2-9830-a49790340e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9d3ae114-f38d-4be3-bda1-d923ca24e0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9d3ae114-f38d-4be3-bda1-d923ca24e0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_10d4faf2-0985-45ad-b39d-ccd2e965563e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_10d4faf2-0985-45ad-b39d-ccd2e965563e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_074f6ebf-2183-4e8b-9231-e637da8506a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29fb8b83-3ddd-4a33-8fd8-daf7c2c80a2f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_074f6ebf-2183-4e8b-9231-e637da8506a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4850473a-55b3-4982-9046-131d1192eb23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddc5b9ed-d0d1-4000-a176-8070ace92468" xlink:to="loc_us-gaap_Assets_4850473a-55b3-4982-9046-131d1192eb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5431d6e7-b8fd-4f92-a288-872b0fa8d3b6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8d9f1cf8-a807-4a90-8bef-db687d5c8e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_AccountsPayableCurrent_8d9f1cf8-a807-4a90-8bef-db687d5c8e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_351aa404-7f0b-4f5d-8ec8-d913ae0824c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_351aa404-7f0b-4f5d-8ec8-d913ae0824c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_9e61c9a4-0ec7-4ccf-b801-f616df9d8356" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_TaxesPayableCurrentAndNoncurrent_9e61c9a4-0ec7-4ccf-b801-f616df9d8356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_80ff6330-9ea7-47eb-b6dd-c6f29550dd43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_80ff6330-9ea7-47eb-b6dd-c6f29550dd43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d5087036-0d3b-4f0f-bca4-8409de849699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d5087036-0d3b-4f0f-bca4-8409de849699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1ed3dc58-1dbb-406b-a1c4-1e9434379e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1710b111-0f13-4484-ad25-b2d7d2805771" xlink:to="loc_us-gaap_LiabilitiesCurrent_1ed3dc58-1dbb-406b-a1c4-1e9434379e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_48a8ff37-3165-4f3f-a362-c730c59c43d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_48a8ff37-3165-4f3f-a362-c730c59c43d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_91dd0b24-a8f9-4058-b04c-789095636595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_91dd0b24-a8f9-4058-b04c-789095636595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_54ef6118-0632-4007-9d53-b1e1c88e752a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_Liabilities_54ef6118-0632-4007-9d53-b1e1c88e752a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6fdbc082-d50b-4c57-bf39-da53ce8d7a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6fdbc082-d50b-4c57-bf39-da53ce8d7a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7b3c083d-205b-47c1-8df0-131080dfa5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_PreferredStockValue_7b3c083d-205b-47c1-8df0-131080dfa5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e0a25a64-7540-4689-aec8-c71abcfeaa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_CommonStockValue_e0a25a64-7540-4689-aec8-c71abcfeaa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e5a83f93-d3b7-4695-b8df-e61943e6224a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e5a83f93-d3b7-4695-b8df-e61943e6224a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63bcfec7-dcd6-4b6d-b630-f06836aaa280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_63bcfec7-dcd6-4b6d-b630-f06836aaa280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0a31574f-e89c-40dd-b5c6-86057d620e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0a31574f-e89c-40dd-b5c6-86057d620e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9e78f845-99ac-412e-aa5f-9eefec9197df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38fe78bb-f4ad-4fa0-8d9f-f3d90e2c77c4" xlink:to="loc_us-gaap_StockholdersEquity_9e78f845-99ac-412e-aa5f-9eefec9197df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_79e33971-74ab-4f36-b077-f31dd54b01f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e971c960-83fc-42b2-9cdf-8301a0a508a5" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_79e33971-74ab-4f36-b077-f31dd54b01f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a37285ac-29c2-43b9-8686-46560bedcdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a37285ac-29c2-43b9-8686-46560bedcdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3245b052-be95-4664-8481-2b7dec32bc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3245b052-be95-4664-8481-2b7dec32bc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_bd4c1717-b0e6-4695-81c9-484005d84d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_PreferredStockSharesIssued_bd4c1717-b0e6-4695-81c9-484005d84d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ffd1fe0b-daf2-469f-8d8a-5f061a284bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ffd1fe0b-daf2-469f-8d8a-5f061a284bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4ad13a1-9320-43a3-90ca-b9a89abdc7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_b4ad13a1-9320-43a3-90ca-b9a89abdc7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b12068d9-2751-4566-af5b-d0d79d3ea3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b12068d9-2751-4566-af5b-d0d79d3ea3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f2451cb1-c694-40fb-8ca0-2511ef155930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_CommonStockSharesIssued_f2451cb1-c694-40fb-8ca0-2511ef155930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_83ddcad8-861a-4d11-87e1-11efff3e726c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d60c3c7e-8637-4038-a755-bc84f21aa781" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_83ddcad8-861a-4d11-87e1-11efff3e726c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23f17966-89e6-4b8d-a0ec-52f656a01ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23f17966-89e6-4b8d-a0ec-52f656a01ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_35859367-2f4e-48e5-a898-223f1dff3513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_35859367-2f4e-48e5-a898-223f1dff3513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cb5858b6-75cd-4ce2-b39f-02fa2f062541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_GrossProfit_cb5858b6-75cd-4ce2-b39f-02fa2f062541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_5aa5b4c2-3c58-4bb4-91d9-45b102afc0de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_5aa5b4c2-3c58-4bb4-91d9-45b102afc0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CommissionAndIncentives_76dd3e67-6ac2-4a8b-9656-1d8ee7742e4e" xlink:href="lfvn-20220930.xsd#lfvn_CommissionAndIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5aa5b4c2-3c58-4bb4-91d9-45b102afc0de" xlink:to="loc_lfvn_CommissionAndIncentives_76dd3e67-6ac2-4a8b-9656-1d8ee7742e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ea746703-722e-4269-8807-3c6ba2093ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5aa5b4c2-3c58-4bb4-91d9-45b102afc0de" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ea746703-722e-4269-8807-3c6ba2093ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ae258b2d-9754-4141-a143-a30bb9bd269f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_5aa5b4c2-3c58-4bb4-91d9-45b102afc0de" xlink:to="loc_us-gaap_OperatingExpenses_ae258b2d-9754-4141-a143-a30bb9bd269f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_bd107e5c-61f2-4f20-9c8d-8a777aba0297" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_OperatingIncomeLoss_bd107e5c-61f2-4f20-9c8d-8a777aba0297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9a0abaed-bcc7-4f25-96e4-0a48e6318dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9a0abaed-bcc7-4f25-96e4-0a48e6318dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9ceb4432-f52a-4f06-bd1f-88f487292d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9a0abaed-bcc7-4f25-96e4-0a48e6318dc2" xlink:to="loc_us-gaap_InterestExpense_9ceb4432-f52a-4f06-bd1f-88f487292d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_560378ab-277e-4caa-9e7a-d37711178738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9a0abaed-bcc7-4f25-96e4-0a48e6318dc2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_560378ab-277e-4caa-9e7a-d37711178738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_67a7c65a-74da-45d9-a074-be8cc6bc85ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_9a0abaed-bcc7-4f25-96e4-0a48e6318dc2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_67a7c65a-74da-45d9-a074-be8cc6bc85ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0ce81121-eb20-4bfc-8f91-fd8e24a3e59b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0ce81121-eb20-4bfc-8f91-fd8e24a3e59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ed57ae0a-a7b5-4e24-8a57-fc466c29a2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ed57ae0a-a7b5-4e24-8a57-fc466c29a2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2393b080-5c35-461b-abe0-63b7218fa7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_NetIncomeLoss_2393b080-5c35-461b-abe0-63b7218fa7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_feb0d152-73c9-47a5-9165-ffc4667fecf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_EarningsPerShareAbstract_feb0d152-73c9-47a5-9165-ffc4667fecf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a54b9b35-04a9-4064-b227-df916a6908e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_feb0d152-73c9-47a5-9165-ffc4667fecf7" xlink:to="loc_us-gaap_EarningsPerShareBasic_a54b9b35-04a9-4064-b227-df916a6908e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_619d3b36-f4e5-4e7d-b5a3-b096fb496906" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_feb0d152-73c9-47a5-9165-ffc4667fecf7" xlink:to="loc_us-gaap_EarningsPerShareDiluted_619d3b36-f4e5-4e7d-b5a3-b096fb496906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_47dafd56-1beb-4068-95fa-fdb57ab0b1a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_47dafd56-1beb-4068-95fa-fdb57ab0b1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b3e7049c-a146-4f45-a6f1-2e7a1c85e627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_47dafd56-1beb-4068-95fa-fdb57ab0b1a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b3e7049c-a146-4f45-a6f1-2e7a1c85e627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe68b152-a758-4f15-8830-6245a61229c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_47dafd56-1beb-4068-95fa-fdb57ab0b1a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fe68b152-a758-4f15-8830-6245a61229c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3c898c50-a031-4351-a1c0-844c2c829830" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3c898c50-a031-4351-a1c0-844c2c829830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9e483816-bc7e-4fd9-8cde-d60309367841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3c898c50-a031-4351-a1c0-844c2c829830" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9e483816-bc7e-4fd9-8cde-d60309367841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a3598fe-740c-4dc9-a10f-4f81de944837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_3c898c50-a031-4351-a1c0-844c2c829830" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a3598fe-740c-4dc9-a10f-4f81de944837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fecfa5a1-e661-4f95-9eea-0c68048246eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3b43585a-3a47-49e3-ae62-08555f51879b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fecfa5a1-e661-4f95-9eea-0c68048246eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e736d75d-5dff-4593-91a9-bc7f06f5111e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e736d75d-5dff-4593-91a9-bc7f06f5111e" xlink:to="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fb841549-a634-49fb-b4b0-93effbdbe27b" xlink:to="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_51b4c286-fc05-4e27-b649-6e067e485770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_CommonStockMember_51b4c286-fc05-4e27-b649-6e067e485770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4c15f8ec-4255-4e9c-87c6-4d24988abfaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4c15f8ec-4255-4e9c-87c6-4d24988abfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f671a672-1bf7-4c39-825b-274c5ad06036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_RetainedEarningsMember_f671a672-1bf7-4c39-825b-274c5ad06036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_117e2035-2cc9-4507-89d0-4415105d65e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_78f6a7cb-1bcc-42d8-848d-09d309c81929" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_117e2035-2cc9-4507-89d0-4415105d65e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d5a82036-cdf0-45c3-82db-fb77789518c0" xlink:to="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b4ff1793-b145-4d50-863b-5397579000bb" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_126c143d-af6d-4927-a081-afb3acef8169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_126c143d-af6d-4927-a081-afb3acef8169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82e68022-228f-4291-982d-85baf7e3fdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockholdersEquity_82e68022-228f-4291-982d-85baf7e3fdec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c81bfef-7fb7-463d-b982-0fa6f757f322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7c81bfef-7fb7-463d-b982-0fa6f757f322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e000d56a-a91d-4a0f-876a-5313065deb04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e000d56a-a91d-4a0f-876a-5313065deb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4f5f7a3a-404d-4ab0-9010-5e0c63df3a66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4f5f7a3a-404d-4ab0-9010-5e0c63df3a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a0ae16b6-6b3f-481b-b8a9-cab135a29c44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a0ae16b6-6b3f-481b-b8a9-cab135a29c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_31e39616-fdad-4f89-b5a9-c61337b32aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_31e39616-fdad-4f89-b5a9-c61337b32aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c64cb61e-bc12-4c48-a631-3217659ede67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c64cb61e-bc12-4c48-a631-3217659ede67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2ee262f6-6049-44e5-946d-5d8b30f3a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2ee262f6-6049-44e5-946d-5d8b30f3a225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_01b1324c-9bef-4466-8098-64897d0114af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_01b1324c-9bef-4466-8098-64897d0114af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dff32d8a-a826-4e83-a76e-e519ac7e894c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dff32d8a-a826-4e83-a76e-e519ac7e894c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e366c33d-bc77-4cd7-82bd-095353fa7df2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e366c33d-bc77-4cd7-82bd-095353fa7df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59925bd2-f5e8-41c3-afb2-5b0c8d9ec05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_59925bd2-f5e8-41c3-afb2-5b0c8d9ec05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_9524f560-ed86-43a9-a03d-6cacf867f9da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_DividendsCash_9524f560-ed86-43a9-a03d-6cacf867f9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b151abf-c3ce-4a9f-8149-6a6ec1722e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b151abf-c3ce-4a9f-8149-6a6ec1722e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_574cf58f-7daf-486d-b23c-62e112fbf108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_NetIncomeLoss_574cf58f-7daf-486d-b23c-62e112fbf108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_4e7cd8af-0326-4c54-a9ba-e8778d2a4161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_4e7cd8af-0326-4c54-a9ba-e8778d2a4161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_22caae3b-5275-4706-ae18-1f087585b6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9e698246-193d-4afa-b97a-4712dd27738f" xlink:to="loc_us-gaap_StockholdersEquity_22caae3b-5275-4706-ae18-1f087585b6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98737584-e67f-40c5-a686-87e79dd60638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98737584-e67f-40c5-a686-87e79dd60638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e45b6afd-814e-42df-bd4d-5cff8af14d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98737584-e67f-40c5-a686-87e79dd60638" xlink:to="loc_us-gaap_NetIncomeLoss_e45b6afd-814e-42df-bd4d-5cff8af14d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98737584-e67f-40c5-a686-87e79dd60638" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8294d31e-8fc5-4f07-8f63-e57d9430efa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8294d31e-8fc5-4f07-8f63-e57d9430efa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a3e53103-a51a-49ed-b706-653a03496815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:to="loc_us-gaap_ShareBasedCompensation_a3e53103-a51a-49ed-b706-653a03496815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17353928-8736-408f-87e0-217e99aa53eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17353928-8736-408f-87e0-217e99aa53eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b1ed86e8-015f-434c-b006-a338f74b8531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b1ed86e8-015f-434c-b006-a338f74b8531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8f3d9fc1-3553-4754-8dfa-409c734a4ec2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9615434-af09-4bbd-b78b-7374f569a58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e9615434-af09-4bbd-b78b-7374f569a58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_096a1bb2-101d-416c-8cd0-4dfc44aea8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_096a1bb2-101d-416c-8cd0-4dfc44aea8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_158b484e-3756-40f0-a088-6ed2d95c05ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_158b484e-3756-40f0-a088-6ed2d95c05ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_2631618d-8491-44c5-a088-29547911fde2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_2631618d-8491-44c5-a088-29547911fde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b8dcfbb4-189b-4a06-a46b-e14b47b0e47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b8dcfbb4-189b-4a06-a46b-e14b47b0e47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8b5bd902-5efa-49e1-a241-b1da8a1154c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8b5bd902-5efa-49e1-a241-b1da8a1154c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4b454937-cd7c-4845-b848-1791eb617c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4b454937-cd7c-4845-b848-1791eb617c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee4beae-8ebf-4e50-be3b-87b420ed901b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_8ee4beae-8ebf-4e50-be3b-87b420ed901b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_82296169-7f72-4f27-814d-fdb2a769a769" xlink:href="lfvn-20220930.xsd#lfvn_IncreaseDecreaseInLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_lfvn_IncreaseDecreaseInLeaseLiabilities_82296169-7f72-4f27-814d-fdb2a769a769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2529d46e-9303-46c0-aa75-644ed9328244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7494966a-ee11-4270-8924-57217c77107f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2529d46e-9303-46c0-aa75-644ed9328244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6bb38a27-ec01-48c6-815e-040a31e8ff79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98737584-e67f-40c5-a686-87e79dd60638" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6bb38a27-ec01-48c6-815e-040a31e8ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d22ef47-c8ce-47ae-84ca-fb93a70bd930" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d22ef47-c8ce-47ae-84ca-fb93a70bd930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24a59fc5-b788-492e-a516-a8dbf6bc04cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d22ef47-c8ce-47ae-84ca-fb93a70bd930" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_24a59fc5-b788-492e-a516-a8dbf6bc04cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3838e22e-d96d-42ab-9a17-2e5ef71e301c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d22ef47-c8ce-47ae-84ca-fb93a70bd930" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3838e22e-d96d-42ab-9a17-2e5ef71e301c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7e8ef2fd-40f9-4ec2-9e4b-af41e6397c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7e8ef2fd-40f9-4ec2-9e4b-af41e6397c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_50ddcaa8-3635-4a56-8fd7-6b35f62a02c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_us-gaap_PaymentsOfDividends_50ddcaa8-3635-4a56-8fd7-6b35f62a02c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c8253045-0383-4d01-847b-fd93b8a2dffa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c8253045-0383-4d01-847b-fd93b8a2dffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_9666b69d-ed96-443c-9a60-f37d3cb5e90c" xlink:href="lfvn-20220930.xsd#lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan_9666b69d-ed96-443c-9a60-f37d3cb5e90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f8d72348-3a89-4654-a84d-736610dcc4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f8d72348-3a89-4654-a84d-736610dcc4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9d368ee5-f996-4c08-ab47-30f699b12456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3f00b9b5-8190-456d-a54e-aa0930844e4f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9d368ee5-f996-4c08-ab47-30f699b12456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5f49e00-4d79-4304-8564-728e4dbe5ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5f49e00-4d79-4304-8564-728e4dbe5ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b57183f-e75f-4687-a75f-ea539b242229" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9b57183f-e75f-4687-a75f-ea539b242229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8497685-813c-4850-9e8c-840d68111541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e8497685-813c-4850-9e8c-840d68111541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a579659-0730-446b-9608-e4a9f52e1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a579659-0730-446b-9608-e4a9f52e1782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_029e28fd-dcd9-4443-bbd5-cb9940f29edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_51e2e49a-38ff-4f3a-8d3a-9c58301724d7" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_029e28fd-dcd9-4443-bbd5-cb9940f29edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_1a235ba0-22d1-4924-9946-dd9b2077ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_029e28fd-dcd9-4443-bbd5-cb9940f29edc" xlink:to="loc_us-gaap_InterestPaidNet_1a235ba0-22d1-4924-9946-dd9b2077ee0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_84902c28-f3e2-40d7-b241-ba507bf11d07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_029e28fd-dcd9-4443-bbd5-cb9940f29edc" xlink:to="loc_us-gaap_IncomeTaxesPaid_84902c28-f3e2-40d7-b241-ba507bf11d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="lfvn-20220930.xsd#OrganizationandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/OrganizationandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5451ec7d-4c9b-42aa-9f60-7548545cebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6fd59c95-8bbd-45c2-b8e3-4a79beefb85a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5451ec7d-4c9b-42aa-9f60-7548545cebe5" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6fd59c95-8bbd-45c2-b8e3-4a79beefb85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_18c3be82-191d-4a0b-9eb9-8ac4e7f1965b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c7b5f09a-0eef-4890-a401-fa01930e7544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_18c3be82-191d-4a0b-9eb9-8ac4e7f1965b" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c7b5f09a-0eef-4890-a401-fa01930e7544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="simple" xlink:href="lfvn-20220930.xsd#GigEconomyGroupInvestment"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a82f36cd-492f-469e-bb78-903df375dc64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_e94b8aee-24f3-48d6-822a-da9dd40630c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_a82f36cd-492f-469e-bb78-903df375dc64" xlink:to="loc_us-gaap_InvestmentTextBlock_e94b8aee-24f3-48d6-822a-da9dd40630c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/Leases" xlink:type="simple" xlink:href="lfvn-20220930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b8ad8b29-7585-4b1a-895e-b45263c7e14b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_95a4222d-bc51-4105-b2de-c1d973267af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b8ad8b29-7585-4b1a-895e-b45263c7e14b" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_95a4222d-bc51-4105-b2de-c1d973267af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebt" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aaad7d71-6fde-41e9-8333-36788744ac86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_a84d336b-dc58-4009-a05d-7a689b202dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aaad7d71-6fde-41e9-8333-36788744ac86" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_a84d336b-dc58-4009-a05d-7a689b202dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2cb3b180-d7a9-4988-b13a-69b118aa0185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_33554438-f187-4557-b314-f601ee711555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2cb3b180-d7a9-4988-b13a-69b118aa0185" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_33554438-f187-4557-b314-f601ee711555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_984becb0-3b2b-4c4a-ac79-3f47ee802bad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c9d0f102-aae7-40ae-95da-cf50d23b324d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_984becb0-3b2b-4c4a-ac79-3f47ee802bad" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c9d0f102-aae7-40ae-95da-cf50d23b324d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_829f3171-6188-4d0d-879d-8eb4a0a09bc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_9f4afcba-ab5c-48db-ba39-0160009a1140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_829f3171-6188-4d0d-879d-8eb4a0a09bc4" xlink:to="loc_us-gaap_LossContingencyDisclosures_9f4afcba-ab5c-48db-ba39-0160009a1140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_93d73d35-f432-412e-b53c-577bb04bdf11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_93d73d35-f432-412e-b53c-577bb04bdf11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5c7c8595-8e6f-4d51-bf5c-faf8c01ea9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_UseOfEstimates_5c7c8595-8e6f-4d51-bf5c-faf8c01ea9d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_dd1267d2-7ac9-4346-ac15-0c6d6cd0c458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_dd1267d2-7ac9-4346-ac15-0c6d6cd0c458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_d5c4d410-09e4-4bdd-affb-e2376dd3f220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_d5c4d410-09e4-4bdd-affb-e2376dd3f220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_80a74460-f15c-4507-89f5-cb59143e407d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_80a74460-f15c-4507-89f5-cb59143e407d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_ebbfaa9a-3e6f-476d-8a62-377d9f1859a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_ebbfaa9a-3e6f-476d-8a62-377d9f1859a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_89fe2627-ceb7-4231-bf7e-11a52b3d4e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_89fe2627-ceb7-4231-bf7e-11a52b3d4e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_29b43b6b-12ed-4214-8816-43c1e54c9b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_29b43b6b-12ed-4214-8816-43c1e54c9b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5e1cb884-a8a7-450e-871e-25178f743d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_5e1cb884-a8a7-450e-871e-25178f743d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_974ae08c-fc0b-49d0-b7fc-12d91748799c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_974ae08c-fc0b-49d0-b7fc-12d91748799c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_f185a9ca-9f93-4f32-b447-2f871e0cf934" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_f185a9ca-9f93-4f32-b447-2f871e0cf934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_5f8290c4-02ea-40c3-968b-56bd640d1214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_5f8290c4-02ea-40c3-968b-56bd640d1214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cb76cccc-9047-469d-b818-f0af0efe45a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cb76cccc-9047-469d-b818-f0af0efe45a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_b4ec8940-be30-4154-bd3d-d99f498383b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_b4ec8940-be30-4154-bd3d-d99f498383b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_d2f67e75-4640-422b-a5ed-8ac007d7dd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_d2f67e75-4640-422b-a5ed-8ac007d7dd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_0d0091a9-7aa5-4674-a1df-83b231dec3be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_857b360f-080d-41f6-ad2b-4d3f0f0c29f9" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_0d0091a9-7aa5-4674-a1df-83b231dec3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bea4bd9e-3003-4fa0-9663-f0d4a7e47796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3ccc50be-1cc2-4972-b97f-cab03402d124" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bea4bd9e-3003-4fa0-9663-f0d4a7e47796" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3ccc50be-1cc2-4972-b97f-cab03402d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_37993289-0df8-41ee-96d1-fa5a3f4ac55d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bea4bd9e-3003-4fa0-9663-f0d4a7e47796" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_37993289-0df8-41ee-96d1-fa5a3f4ac55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5c18a469-4c2c-451c-88da-d7f9c2d68e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bea4bd9e-3003-4fa0-9663-f0d4a7e47796" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_5c18a469-4c2c-451c-88da-d7f9c2d68e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_be6b4b30-3e1d-481a-ad54-e9376fd39c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bea4bd9e-3003-4fa0-9663-f0d4a7e47796" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_be6b4b30-3e1d-481a-ad54-e9376fd39c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesTables" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c54d8f29-a7fe-4b85-980d-1e6771accba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_2b712342-e0f7-4237-9055-216087ec1094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c54d8f29-a7fe-4b85-980d-1e6771accba5" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_2b712342-e0f7-4237-9055-216087ec1094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8e109193-4037-4ebf-9ef3-93bf0ce31d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c54d8f29-a7fe-4b85-980d-1e6771accba5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8e109193-4037-4ebf-9ef3-93bf0ce31d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf328c05-1234-4598-a014-c44330972057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf328c05-1234-4598-a014-c44330972057" xlink:to="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8aab1b4e-2a96-4d6b-b81b-32043e3cc69b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_a73076bc-7018-443b-8bfb-74acf4ebf2bf" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:to="loc_lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember_a73076bc-7018-443b-8bfb-74acf4ebf2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_fe030e48-f1b8-4a15-9959-f8a30c0b066a" xlink:href="lfvn-20220930.xsd#lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab8310d0-2f2e-4b8f-a7f6-0dddd2761453" xlink:to="loc_lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember_fe030e48-f1b8-4a15-9959-f8a30c0b066a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ab5caea0-6816-4f32-b18b-054273b39c09" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_faef400a-1038-458c-9328-39d9df908937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_faef400a-1038-458c-9328-39d9df908937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_188c1d58-9d2c-48c7-a9e6-c1b6c71bafc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_188c1d58-9d2c-48c7-a9e6-c1b6c71bafc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_4923575d-3a40-4de6-a07b-8af81366ca0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_4923575d-3a40-4de6-a07b-8af81366ca0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_e2d91e03-4898-435c-a017-84937d97af0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_e2d91e03-4898-435c-a017-84937d97af0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_d36edee2-5006-4c40-8730-27ce2f8a4270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_InventoryValuationReserves_d36edee2-5006-4c40-8730-27ce2f8a4270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_MoneyBackGuaranteePeriod_0096834b-ce2e-4a50-92b5-deeae58ae07d" xlink:href="lfvn-20220930.xsd#lfvn_MoneyBackGuaranteePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_MoneyBackGuaranteePeriod_0096834b-ce2e-4a50-92b5-deeae58ae07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_e1f45538-3c16-4c52-acea-5b83a7a7ba4f" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems_e1f45538-3c16-4c52-acea-5b83a7a7ba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_b1a4099e-9ff0-45d3-9965-25b4df5ba2bd" xlink:href="lfvn-20220930.xsd#lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems_b1a4099e-9ff0-45d3-9965-25b4df5ba2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_HandlingAndRestockingFeePercentage_d2d7ecae-f8fb-4278-8512-85c3a29ec8e2" xlink:href="lfvn-20220930.xsd#lfvn_HandlingAndRestockingFeePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_HandlingAndRestockingFeePercentage_d2d7ecae-f8fb-4278-8512-85c3a29ec8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ReturnLiabilityReserve_cd5c87b7-4754-4f58-b473-89405065676b" xlink:href="lfvn-20220930.xsd#lfvn_ReturnLiabilityReserve"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_ReturnLiabilityReserve_cd5c87b7-4754-4f58-b473-89405065676b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ad16207f-fc8a-4f10-8f09-f46460077bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ad16207f-fc8a-4f10-8f09-f46460077bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_297dcfee-74a6-41c5-b5e0-53962599897a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_297dcfee-74a6-41c5-b5e0-53962599897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bc1919ee-148d-473d-ab66-8a597ba6b4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bc1919ee-148d-473d-ab66-8a597ba6b4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NumberOfGeographicSegments_f6d94d4e-07c0-4551-a6bf-74b1b72c8de6" xlink:href="lfvn-20220930.xsd#lfvn_NumberOfGeographicSegments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_lfvn_NumberOfGeographicSegments_f6d94d4e-07c0-4551-a6bf-74b1b72c8de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_c9a2b112-7d19-4bf0-8c3e-d448784b7f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_d161318c-7885-46f8-8ddd-5fb27111ab19" xlink:to="loc_us-gaap_NumberOfOperatingSegments_c9a2b112-7d19-4bf0-8c3e-d448784b7f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d78ade99-0d4d-4156-b154-0a940dffad89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d78ade99-0d4d-4156-b154-0a940dffad89" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_348ff261-1bde-4c53-99fa-00d36c60a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_348ff261-1bde-4c53-99fa-00d36c60a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_644fab0d-91a6-4d69-8ca5-1409262bb27f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_644fab0d-91a6-4d69-8ca5-1409262bb27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_6bf678a0-a73d-49f7-a3b1-97a9fbb7f307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_us-gaap_InventoryNet_6bf678a0-a73d-49f7-a3b1-97a9fbb7f307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_385ee6a6-cc01-4b01-9f2a-09d10834c333" xlink:href="lfvn-20220930.xsd#lfvn_InventoryFinishedGoodsPercentOfTotalInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_lfvn_InventoryFinishedGoodsPercentOfTotalInventory_385ee6a6-cc01-4b01-9f2a-09d10834c333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_RawMaterialsPercentOfTotalInventory_97312c8c-e739-4bbd-8bf5-ddfe1897c28a" xlink:href="lfvn-20220930.xsd#lfvn_RawMaterialsPercentOfTotalInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_lfvn_RawMaterialsPercentOfTotalInventory_97312c8c-e739-4bbd-8bf5-ddfe1897c28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_InventoryPercentOfTotalInventory_c8f9543f-5242-45f8-be17-6b16d0862915" xlink:href="lfvn-20220930.xsd#lfvn_InventoryPercentOfTotalInventory"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5e1b0f81-f5b2-43f6-85a9-2fb9c2a27e7f" xlink:to="loc_lfvn_InventoryPercentOfTotalInventory_c8f9543f-5242-45f8-be17-6b16d0862915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_34f1e017-ad3a-4ca3-90c9-37f491255f35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_34f1e017-ad3a-4ca3-90c9-37f491255f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bdf3c671-ee13-4a7c-b305-844781f16e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_34f1e017-ad3a-4ca3-90c9-37f491255f35" xlink:to="loc_us-gaap_NetIncomeLoss_bdf3c671-ee13-4a7c-b305-844781f16e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_f1925688-a3d5-4bf0-b0cd-7da9d0fb1fca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_f1925688-a3d5-4bf0-b0cd-7da9d0fb1fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e7bfada-dad1-4907-ba59-183e44c7200a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_f1925688-a3d5-4bf0-b0cd-7da9d0fb1fca" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4e7bfada-dad1-4907-ba59-183e44c7200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_f521ebcb-08b4-4c23-b3a3-1ad2874ee5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_f521ebcb-08b4-4c23-b3a3-1ad2874ee5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b967625-479c-4d3e-bb18-143e0fa3613e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_f521ebcb-08b4-4c23-b3a3-1ad2874ee5e6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b967625-479c-4d3e-bb18-143e0fa3613e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_868b7431-ac2f-472f-9e7d-ce49da86d396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_868b7431-ac2f-472f-9e7d-ce49da86d396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_8b5c9ffc-28cf-47b8-b536-758ec96e079a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_EarningsPerShareBasic_8b5c9ffc-28cf-47b8-b536-758ec96e079a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bc87af6f-c028-4713-a04e-0fbc5ccd4eff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_563f6a82-2118-47d0-8388-308455f5f3fd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bc87af6f-c028-4713-a04e-0fbc5ccd4eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#SummaryofSignificantAccountingPoliciesSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6e972917-a31e-4d13-8d05-8be612c19018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e972917-a31e-4d13-8d05-8be612c19018" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:to="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f419c95f-d05b-4538-86c1-76486bbea3f9" xlink:to="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2055f17c-79c0-4813-930d-c17b991275f8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_srt_AmericasMember_2055f17c-79c0-4813-930d-c17b991275f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_AsiaPacificAndEuropeMember_2ca8de91-b726-4fd2-9451-a4bfcb8caa6a" xlink:href="lfvn-20220930.xsd#lfvn_AsiaPacificAndEuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_lfvn_AsiaPacificAndEuropeMember_2ca8de91-b726-4fd2-9451-a4bfcb8caa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_53a7563b-d2e6-4fca-bf38-d73183240254" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_country_US_53a7563b-d2e6-4fca-bf38-d73183240254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_JP_0f47252a-eafb-4d3d-a8b7-c22c9ff666c6" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_JP"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b9ba47e9-c177-4077-818a-5e17aa43db9b" xlink:to="loc_country_JP_0f47252a-eafb-4d3d-a8b7-c22c9ff666c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_41abbe24-c979-417e-9efc-7083ff4b2d5b" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da6fa6-d085-467a-8f96-0b06ce64d9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c4da6fa6-d085-467a-8f96-0b06ce64d9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_0f82ac3c-21a6-4ce1-afa4-f7e5f0ba3b36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_0b5fce6e-a93d-4194-9675-f3a786b769ee" xlink:to="loc_us-gaap_NoncurrentAssets_0f82ac3c-21a6-4ce1-afa4-f7e5f0ba3b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#GigEconomyGroupInvestmentDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_245940a4-777a-455d-8d0d-b8cb06823c30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_245940a4-777a-455d-8d0d-b8cb06823c30" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cd417918-3caf-4aef-a0e9-2393e349a614" xlink:to="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_839db5a8-b310-443f-96ba-91c16537a64a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_2f31ccb4-9fd6-4d01-a4a9-17af545a7e31" xlink:to="loc_srt_AffiliatedEntityMember_839db5a8-b310-443f-96ba-91c16537a64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityInterestIssuedOrIssuableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis_02fb4d23-7522-4e36-ad8a-32231f2da89a" xlink:to="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_20168b18-336e-41e5-849d-efec31c222cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityInterestIssuedOrIssuableTypeDomain_b5a088e0-0492-4bab-a0bf-205b3881deca" xlink:to="loc_us-gaap_CommonStockMember_20168b18-336e-41e5-849d-efec31c222cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_f0310cd8-07e4-4f80-884a-ebc04e9de3b5" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_3e42f5e0-62f0-4546-ab9f-be1d5feb73a7" xlink:href="lfvn-20220930.xsd#lfvn_NotesReceivableRelatedPartyMaximumCommitment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_lfvn_NotesReceivableRelatedPartyMaximumCommitment_3e42f5e0-62f0-4546-ab9f-be1d5feb73a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_5efb2db2-a1df-4797-926a-62bce32dfd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtInterestRateOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt_5efb2db2-a1df-4797-926a-62bce32dfd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_36ba21c5-8257-4753-afcb-a7ed7eb8a8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_36ba21c5-8257-4753-afcb-a7ed7eb8a8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f36a3540-d7c2-4b0e-8bd4-395a9378c016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f36a3540-d7c2-4b0e-8bd4-395a9378c016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c2cf9bff-5fad-4a0b-9460-84e2d404e8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce536c03-b6aa-441f-89fe-3bd9e5893b27" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c2cf9bff-5fad-4a0b-9460-84e2d404e8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_89aa0064-4159-4a42-a1ee-11e4fd3404f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_89aa0064-4159-4a42-a1ee-11e4fd3404f1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:to="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d2c275a4-bd04-4400-a9bd-7ddd086306ea" xlink:to="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8ae6d15f-e8bb-4089-9c3c-0b8f1ccfa9a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:to="loc_srt_MinimumMember_8ae6d15f-e8bb-4089-9c3c-0b8f1ccfa9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db97f380-25bc-465c-91f6-4d5db23d9adf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_de16e52c-4503-4fc6-98d1-c0ec1a6c8d99" xlink:to="loc_srt_MaximumMember_db97f380-25bc-465c-91f6-4d5db23d9adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_499b7098-7c18-4b26-bafb-8be40996f03b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_bd98ef13-10a8-4ce3-af4f-017499e137e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_bd98ef13-10a8-4ce3-af4f-017499e137e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b48d65e7-f0d5-4b02-b624-17458b158159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b48d65e7-f0d5-4b02-b624-17458b158159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_af60d29a-1294-4209-a5dd-145b4697da62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_af60d29a-1294-4209-a5dd-145b4697da62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_4eff5bde-7acf-43bd-bf96-632f1dfcaedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e92effaa-3b14-4f28-82d3-8fd2738460fb" xlink:to="loc_us-gaap_OperatingLeaseExpense_4eff5bde-7acf-43bd-bf96-632f1dfcaedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesScheduleofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2362f1d7-0083-467e-9d0a-3665744cc424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ff156354-650e-45a6-ac52-5805b0f60e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2362f1d7-0083-467e-9d0a-3665744cc424" xlink:to="loc_us-gaap_OperatingLeasePayments_ff156354-650e-45a6-ac52-5805b0f60e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_79a7088a-b96a-400c-b9b7-5d19d58982be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_79a7088a-b96a-400c-b9b7-5d19d58982be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_aeb194cb-d98f-419e-8208-1d593d679d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_aeb194cb-d98f-419e-8208-1d593d679d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7a6f796d-84df-45f6-ab7a-bc6d77cff01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7a6f796d-84df-45f6-ab7a-bc6d77cff01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9a651a3c-091f-4f35-a9c0-1b48b2eae4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_9a651a3c-091f-4f35-a9c0-1b48b2eae4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e59a4dc5-c4fd-4154-9d1c-34605955bda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e59a4dc5-c4fd-4154-9d1c-34605955bda8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2ab2ba77-0707-4abd-aad0-442e26cb14ea" xlink:href="lfvn-20220930.xsd#lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2ab2ba77-0707-4abd-aad0-442e26cb14ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c737348-f846-4cf6-a535-d57f2c9623eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6c737348-f846-4cf6-a535-d57f2c9623eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_64592b77-9c85-4dd7-8ae1-41ecd7b792ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_64592b77-9c85-4dd7-8ae1-41ecd7b792ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_338ca0b6-77a9-48b3-9f37-629e3f05f0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3b435b26-200c-42e1-b807-b98f1dea473d" xlink:to="loc_us-gaap_OperatingLeaseLiability_338ca0b6-77a9-48b3-9f37-629e3f05f0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bec0ff29-bc28-4484-a694-d05246963a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bec0ff29-bc28-4484-a694-d05246963a76" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b8d87cf1-682f-420f-a329-ba5a8e1919c3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016TermLoanMember_c6ebbe20-f06a-49e5-b578-4da02e41e7c2" xlink:href="lfvn-20220930.xsd#lfvn_March2016TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:to="loc_lfvn_March2016TermLoanMember_c6ebbe20-f06a-49e5-b578-4da02e41e7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_March2016RevolvingLoanMember_06da3996-b348-4062-8529-98bfed9f26a8" xlink:href="lfvn-20220930.xsd#lfvn_March2016RevolvingLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a304887-d1db-4001-af01-db8fb59b7944" xlink:to="loc_lfvn_March2016RevolvingLoanMember_06da3996-b348-4062-8529-98bfed9f26a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5c813886-10c8-45d1-ac10-575f3bbc9476" xlink:to="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_1115b149-3884-4d32-ad26-621420d9ee8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:to="loc_us-gaap_SecuredDebtMember_1115b149-3884-4d32-ad26-621420d9ee8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_34688dea-e915-414d-a153-441d13c3c856" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_11e1dfe4-e36b-447e-a999-986f99930ff2" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_34688dea-e915-414d-a153-441d13c3c856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_0990bce5-d349-4200-a8e3-afb902f71c23" xlink:to="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UsTreasuryUstInterestRateMember_f8734532-e3e5-4b82-bf2f-f2536aa318f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UsTreasuryUstInterestRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_dd4038a4-a980-4f36-a3a2-4475945be589" xlink:to="loc_us-gaap_UsTreasuryUstInterestRateMember_f8734532-e3e5-4b82-bf2f-f2536aa318f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_9a6454b2-bcee-4808-a940-87896a8e838d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_869a0e68-24d2-4a66-b8ba-c242fc0fe017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f8dd7fe-dfa7-44be-b291-49e5a5e6bab2" xlink:to="loc_us-gaap_LineOfCreditMember_869a0e68-24d2-4a66-b8ba-c242fc0fe017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_20e9cd36-03ef-40ed-8a69-f31e106f9ec2" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e44578ce-eec4-483a-8ad0-4199dad65762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e44578ce-eec4-483a-8ad0-4199dad65762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5ace146d-8645-46e3-880e-aa7064913403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5ace146d-8645-46e3-880e-aa7064913403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_fec68940-fda5-4ae3-ab88-c4778e0e8c1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_fec68940-fda5-4ae3-ab88-c4778e0e8c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_1cef9e3e-1cba-4081-a829-2ef3c1ab2cdd" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio_1cef9e3e-1cba-4081-a829-2ef3c1ab2cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentTrailingPeriod_156e0f80-0a40-43e6-907d-2aa3fed26a17" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentTrailingPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentTrailingPeriod_156e0f80-0a40-43e6-907d-2aa3fed26a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_eb81a1e0-86df-4e2d-aea5-6a481744b7e2" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital_eb81a1e0-86df-4e2d-aea5-6a481744b7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_3090570b-8d0b-4458-99d1-e678ed6a11c6" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio_3090570b-8d0b-4458-99d1-e678ed6a11c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a0b06f45-dd88-4514-8a9a-d3cd30f4f172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a0b06f45-dd88-4514-8a9a-d3cd30f4f172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bf6ce975-9622-4309-830f-3c1be253eeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_bf6ce975-9622-4309-830f-3c1be253eeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentFloorInterestRate_e22e554e-f4ad-4992-a380-7f5e348038ea" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentFloorInterestRate_e22e554e-f4ad-4992-a380-7f5e348038ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_1dbe6c41-1a44-44d1-941d-e89c2d9a4c7b" xlink:href="lfvn-20220930.xsd#lfvn_DebtInstrumentCovenantMaximumAllowedDividends"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_22e6211e-a4b5-424b-ae27-bfad09e811a4" xlink:to="loc_lfvn_DebtInstrumentCovenantMaximumAllowedDividends_1dbe6c41-1a44-44d1-941d-e89c2d9a4c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28434698-aa99-4dc4-bd05-08bffd8f94ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28434698-aa99-4dc4-bd05-08bffd8f94ac" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7238a765-2017-4c3d-88d2-c2aa65db3b0e" xlink:to="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_caf320a4-2724-4842-a82c-175fb533f4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4f3150b1-a587-476c-a85d-3050ff58f163" xlink:to="loc_us-gaap_CommonStockMember_caf320a4-2724-4842-a82c-175fb533f4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dd02a2e1-9c17-4598-b8e0-9ca64326ba4a" xlink:to="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_24b4feba-1b4c-48cd-8589-7018bdd1cc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_24b4feba-1b4c-48cd-8589-7018bdd1cc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18cd5c4b-3800-47f4-886d-ede38ce4d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_18cd5c4b-3800-47f4-886d-ede38ce4d8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1f3b2c6e-8427-43f5-9a6a-fa55f282c400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1f3b2c6e-8427-43f5-9a6a-fa55f282c400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1d673db-8ff2-4741-90ea-4243b64e595e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1d673db-8ff2-4741-90ea-4243b64e595e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4355c156-fad7-4df4-a082-cacb0138d33a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4355c156-fad7-4df4-a082-cacb0138d33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b360927c-d537-4223-aeb0-74eb25caf22f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_b360927c-d537-4223-aeb0-74eb25caf22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_7a40250a-a465-4afd-aa45-75afb4d4d394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_7a40250a-a465-4afd-aa45-75afb4d4d394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_12899051-0253-49d0-8735-4cbab243fe6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_12899051-0253-49d0-8735-4cbab243fe6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_bcc7bfb7-528b-4f17-a8c6-122193621a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e0851e3-df98-4ee1-ae94-61342478938e" xlink:to="loc_us-gaap_DividendsCommonStockCash_bcc7bfb7-528b-4f17-a8c6-122193621a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#StockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/StockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bf8e5a87-af85-4a47-bcd7-c0db921cf33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bf8e5a87-af85-4a47-bcd7-c0db921cf33d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:to="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b8a8d9a2-0f78-4730-a16f-f7017394f981" xlink:to="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f9f5c984-9e99-483f-8354-44b0fdfce731" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndSevenLongTermIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandAndSevenLongTermIncentivePlanMember_f9f5c984-9e99-483f-8354-44b0fdfce731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_ce10176a-7eb2-425f-bf54-5874f6674deb" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandAndTenLongTermIncentivePlanMember_ce10176a-7eb2-425f-bf54-5874f6674deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_87bc2763-c745-488b-8a66-3f282fb38af9" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanMember_87bc2763-c745-488b-8a66-3f282fb38af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_0d5a0e6d-a5cc-4fac-baa7-c5fe62b83936" xlink:href="lfvn-20220930.xsd#lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember_0d5a0e6d-a5cc-4fac-baa7-c5fe62b83936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_EmployeeStockPurchasePlanMember_b6faf090-d323-4578-85de-6a8e7471c57c" xlink:href="lfvn-20220930.xsd#lfvn_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e423289f-817b-4275-a752-e42d287669cb" xlink:to="loc_lfvn_EmployeeStockPurchasePlanMember_b6faf090-d323-4578-85de-6a8e7471c57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:to="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_63a7aeb1-7875-4983-9f6d-add052bf08cb" xlink:to="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_acb29808-9a1b-4918-a3ae-9ab490b9ee16" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:to="loc_srt_MinimumMember_acb29808-9a1b-4918-a3ae-9ab490b9ee16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a09c5f55-f135-4732-af5d-f63c65d75e1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61709387-038f-42d9-bb64-5495dd44ee7b" xlink:to="loc_srt_MaximumMember_a09c5f55-f135-4732-af5d-f63c65d75e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f7488d4-15aa-476d-9378-50795d0dce24" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14fa1b65-e572-4845-8931-b0e41801227a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_14fa1b65-e572-4845-8931-b0e41801227a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_94bb46dc-e689-4cf8-9b3e-fa0aaf0606a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_94bb46dc-e689-4cf8-9b3e-fa0aaf0606a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_776383c5-d6b4-4533-8e78-bf0afee9d827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_776383c5-d6b4-4533-8e78-bf0afee9d827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_d021c6f3-ff78-45b7-8af4-316624f1cc89" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm_d021c6f3-ff78-45b7-8af4-316624f1cc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9941f3-1d6e-420c-9320-b34e89e29e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dd9941f3-1d6e-420c-9320-b34e89e29e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_21d6b84a-8bec-43d6-b257-1a15dad7990e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_21d6b84a-8bec-43d6-b257-1a15dad7990e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6a7caeb3-3a35-4fe5-a194-ab94977817b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_6a7caeb3-3a35-4fe5-a194-ab94977817b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0a254d78-259f-4795-b55b-351617043d04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0a254d78-259f-4795-b55b-351617043d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_079bb0a0-647e-41bf-8621-e5dc2936e646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_079bb0a0-647e-41bf-8621-e5dc2936e646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8bc7a3d1-cc4b-462d-8d28-296a93646cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_8bc7a3d1-cc4b-462d-8d28-296a93646cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_547cb283-6c4e-4af4-8ae3-55b7ff49798e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_547cb283-6c4e-4af4-8ae3-55b7ff49798e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_476b3389-49eb-4975-a00f-55b2f71a9082" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_476b3389-49eb-4975-a00f-55b2f71a9082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_4b4a96ce-0036-4e03-8466-c655114a83af" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted_4b4a96ce-0036-4e03-8466-c655114a83af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cc320fc2-e7bb-480d-a8e3-0b929a188625" xlink:href="lfvn-20220930.xsd#lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod_cc320fc2-e7bb-480d-a8e3-0b929a188625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2d167a65-72c1-475f-b019-ae41375dacad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_2d167a65-72c1-475f-b019-ae41375dacad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_11696397-163d-4e9f-bf33-2d1e591772a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45f9ec-9eea-4479-b6dd-9d7353fe3d41" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_11696397-163d-4e9f-bf33-2d1e591772a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="lfvn-20220930.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.lifevantage.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3b67293-ec02-47e0-8a47-275e81c318d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_c09e64db-c00f-4c35-a566-6a109f18888d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3b67293-ec02-47e0-8a47-275e81c318d8" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_c09e64db-c00f-4c35-a566-6a109f18888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_3f80d0ac-d3cf-4a6d-8ca1-01b136eef4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3b67293-ec02-47e0-8a47-275e81c318d8" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_3f80d0ac-d3cf-4a6d-8ca1-01b136eef4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>a20220930-zionsrlocadden001.jpg
<TEXT>
begin 644 a20220930-zionsrlocadden001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BD'2EH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHS0 4449H **,T4 %%%% !11D49H **** "
MBBB@ HHHS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 444AZC@T +1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '/\ C;Q,GA'PI>:N4$DD8"0QD\/(QPH/MDY/
ML*\OTO0OB=XJT=/$9\4?8I+A!/:VJ,RJ5(RN0!@ CID-[UTWQTLI;OX;3R1H
MSK;7$<TBC^[RI/X;@:VO!'B+29?ASI-[]NMXX+:QBCG+2 ")E0!@W/'(H YK
M3_%/BJZ^$WB"[UJUNM.U>PMY/*N3 8O,PN0X![YR#CCIZUT/PJU.^UCX<:7?
M:E=/<W<OF[Y7.2P$K@?H!6%JGC>Q\<_";Q5=V%K<P+!:R1OYZC!.W/!!.>,?
MF*Y/X>_"JP\3^!]/U:;6-3MGG:7,4#JJ+MD9> 0?[N: .E^#GB'6-=U7Q4FJ
M:A-=1VMQ&L(D(.P%I00/^^1^58OQ;\;Z[!XJ71_#6H3V_P!@M&N+PP8X/!^;
M/95P?^!5#\#+B'1X?&UQ.Y\BS:)G=NNU/.R?R%<SX4US4YM6\0^(9/"&H:XN
ML^9 S0))MC1B=R95&!XVCVQ0!] ^%-=3Q)X0L-7C8%KBW!DQ_#(!AQ^# UX_
M\*?B;J4OBC^Q_$&I27,5[E;>28@[)1T&?1AG\<>M7O@1JTUK#K/A.\CD@N+9
MOM,<4J%74'"NI!P>#M/_  (UR/A+P>_B;X7:Y-9J/[4T_43<VKK]XXC4L@/N
M.GN!0!Z;!KNK'X_W.BF_E.F+9"06I(V!O+4Y'XFL?6O%/B[QOXZO_#'A"\CL
M+/3R5N;O."2#@G=@D?-D #DX)S6!\-?$,_BKXR0ZO<H$N)-+*2XZ,Z*JEAZ9
MQG%;'PKN8- ^)?C+1=1D6"\NKK?"9#M\W#NW&>I*NI ]* +=H?B+X'\5Z=;7
MEQ<^(](O&VS-%&TK0C.,Y/*D9!Y." :=X\UOQ3)\5].\,:!K!L4N[-)!N4%5
M;,I)/!/(0"L+X@:MXW\(:I&[>+XY8[R[<Q6L 7?%%NXW KTP<9J3XBZ-'K_Q
MUT;2Y;R6T2XL4!FB(#KCSCD'\,?C0!T]MX4^*,=Y!)<>,K5X4D5I$ ^\H(R/
M]6.V:]4[5Y=I7PCLM*UBRU%/%.HRM:SI,(WD7:^#G!]C7J/:@#R6P\3:S+^T
M'?:"^HRG2XXB5M<#8#Y*-Z9ZDFL#P_\ %/5++XHW^FZYJ+3:1)>36J!D4"W8
M2$(<@ XXP<^N:LZ7C_AJ34QW\@_^B(ZQ- \'Q^-+KXD6)PMY#J(FLY/[L@>?
M@^QZ'_ZU ';^-O%>MZ7\7/"^C6-\T6GWHB\^'RT(?,K \D9' QP:]4KY8TGQ
M#?:_\0_!2:E'(+_39HK&=I."Q65L$^X! /N*^IZ /%?&\_Q+\*66H:W)XDM/
M[,6Y(BBCC0R*COA!S'V!'>MKP/!\1+Z;2-:U;Q!9W&BW5OY[VZHHD(>,E.D8
MY#%<\]JL_'+/_"K[WG'[^#_T8*Z3P2?^+<^'B/\ H%6_3_KDM 'D?@W5OBAX
MXLKRZTSQ-:Q);3^4PN(D4DX!XQ&>,&O0/#.G>/M*EU&Y\4:]:7UJ+1O(6!0"
MD@YW?ZM>V:\B^%W@&7Q?I6HW2^(+O2_)N0FR'.U_E!W'##GFO7?#/@:7P9IV
MMO+X@NM4%S;\+,"/*VJW(RS=<_I0!P'@G5/BGXWTF74=/\26D<44QA99XD4D
MX!XQ$>.:Z?X>^._$%YXUU+P?XF$$UY:*[+<0J!DJ1D'& 00P(.![UYEX!\/>
M++_P#J6J>'->N;;[-.V;"$LIF8(I)!!ZX/3':N\^!5KH5Y'J&LI/=3^(F.R]
M-VP+("<Y7OAB.2><K0!@^&/BGXED^(UM8:KJ7FZ7+J$EH4,"*!DLJ<A0<YV]
MZT?BU\2O$&@>+FTO0K\6\5O:HTH$*.3(V3_$#_#M_.N!6SEF\)>*=2A'[_3-
M<@N%8?P@M(O\ROY4NOSR^(]$\6^,)(RHN=2M[>#=U50K$C\O+H ]:\=^.M=T
MFP\+:7I,L,6IZU&F^[F4;8R0@SZ#YG]#@#I6?=:E\4/!.H:?<:C<)XBTZ>3;
M-':6Y=D'4_=12#CH>1ZU<\7Q^$-=M?#'A?Q";R#4)[:(V5S$N%0LH&"QX.2
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M:CIGE13&%_.B1#N !Z;#QAA78-J'CW0/ OB34O$%Q8O>VT/FV+0(I"X!SN&
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MM\3-KDCPW\N[/^B7F?E;:<#'//3U'(R.:=+J7Q-B8@_\(SD*S?+;7;<+@'!
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M:F-[\3%!.?#!P,_ZB[Z8SZ?Y/'6@+GH5%>>_;OB85# >%\$$C,-WG'!]/?\
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MA^';6":\LO#;">Y2V01FX^\S #K@8Y'?Z9K3&I?$S _T3PQUP>;GUQZ>O^-
M'H-%>>C4_B:TA06?A@D =[D=<]\>QJ,:Y\1O.\G[-X5,Q&1'YMQGINZ;?2@+
MGHU%>=/KGQ&21XS9^%MZY^7SYR>,9XV^XJ0ZK\2_.$8TSPWNZD>=/ZXZ[?6@
M+GH-%>>G6/B6NW=IGAKD@?ZZX[D@?P^U.?5_B3&C,=+\.849/[^?IC/]WTH
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MMN/N_P!X8H/B;QV-V?"^E?* Q U0=""<_=]C^5.P<WD=_17G_P#PE/CGY/\
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M'@<9SMQ_;5MUW;?7^]Q]:1?'7B9L;?! ;(!&-:MCD$$@CGT4G\#Z4!<[^BN
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M2L',CT"BN!'Q!UDD#_A"K_).,?;(,YSMQ][U&/KQ3?\ A8>K[<_\(7?=,_\
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M<MGK4%K!=Q312,?WG'J,?-][V( KHM7\8ZZFE:+<6=WH6GM<6"74QU Y9I"
MP5$5<]26!Z98CM55?AWJ=SHEOI5]XUFGT>$ ):PV\<8:+.X'=OY7:"_.>%/>
MM+4?!DDGB$ZMI>LV^F0BT2U>-X(IA#$J\F,EOE(7#?1QUZ4:!J<OJ>K:WKTG
M@6[L8-/MA>32[+5P?+>>-M@#[1R@7"CJ:T-8^(-]'K6J+:1Z$;+2CY<T=\=D
MU[(.)/+P/55[?P#UQ5QOA]J">'=#M[+64@OM)N)I(IFBC;<TAP58>80&#?)Q
MQG\Z74/ M]+?7\^DZW;PKJ15YU-O"[-(>2\1+Y4,0YQGJC>U&@':Z'?KK>AV
M.IP!0+N/S=CJF?F!)!(7@DKO^J8[U92"/=,ZK"IW%O-"J2I!W[L;>2-WF_5R
M.U0:7&EKI-K9Q7"W$<,>/,WH/,'7=\K@#=CS!QP%([U-'.66:82Q[4?)E,@(
M7G=N/[WH,^9C^XX':D!Q_P 28UCT#38O)B"_VI:H;;"[3B3[F<#A<X]P_M7<
M>2#;2%?*.Z7&2J@/_#M/R\9_U?T&:X?XCREM!TZ()_S%+1/LYE4L2'/[O.\_
M,N<$\9WKSQ7<"Z;RP0T;_-CAU^;^''^LZG_5_P"\,TPZD)MA]J/F%)"5P6*J
M"Q*C/\/\6P'V,0'>O$O$1-C\9YM:218X[2^M!-, /NR(H\S&,<\D_6O;#=)+
M/(1(C*QR")1\V5!X_>\9V[AT_P!6_K7%:AX*.JZAXGG;4H%BUF")&!5&\J1,
M,'!\SIM'F8_NM[4AG%: 9M1^,]KK046]M>7=TMLPPXV11LG'M@ 5M:M\0=6T
MJ^>6]MO#[6R7GV<Z?%="6Z$0RI.5)4?)E><'VK:T?P,VE7?A:<:C'NT:&>.=
M3L&\OOWG_6<;2X4]>H_#$;X6WG]DW6C6^N6?V;[4;E2+>,S._*[)&\SLV4X_
MBIBL6;>YU]?BWKQ9[*:"&S(:-F;;Y.P%-@Z!B0F[Z&IKGQYJG_"MM,\4)!9"
M^NKS[.X*?)%AGQCG.0RA^_4BMH^&KI_'UQK\6K6_V6^L_LU[;C9F12@4%3YA
MQDKP?5&KFU^'>KR>'[;13XHM/[+L+CSH 8DSC<7)<B3^ZQ?C/RM^%%PL:MSK
M_B6?XAZAX?T/3-+9-/\ *E:2X)7;'\I]>H\QP,#^+VKCM5O+FV\'>,UTNVM[
M 0:RT=UY4[B3:6P&7YB,\[2!Q@GBO3+#13IOQ UK7?MT1COHHP(RR_N2@ 8L
M?,!('&1_TT6N?G\ 23:#XDT=M0CC_MJ^^VP9*[H3D'#GS/F ;]V>#\S T!8M
MZ9XCU*T\0Z7HOB"WL52\TQKD3P9Q(Z_?&6[%$4GN"OO5GP5J]YXHT4ZI=Q6\
M$;W,HA=$"ET!#;R"3\V\-)QQ\A'>N1^()N;K2-$\-SW)O/%/G#R);6$JIC?<
MC'<&(VE=H(&.4)/6O1]+L[31-&T_3;&XA^SVENJK()OE/ ?>1YHZG,O^X&'>
MD,N&WCC2>1 D/E]&W*?)Q\P)YY"[C)[B3':G+;*LR)^[1%!XW+P =N!S_"&\
MOWW@]J/.$2L?.$1!X#SY,>/FRW[[D+NW-ZJZCM3UGVS8\T!4X&9_0E<?Z[JN
M=A]693VH X_3E9?BSJSI"I<:9;J#N S\S#R^O7C;G_8]ZK_$N6X-MI.DP74E
MJNKZBMM<3Q/\RQ,06/WCPY._V'%7=)+-\6M7=0Y_XE=LI?S21U8;/]9][C&<
MGE6]:O>+-#C\2:7%";U[:\MKD7%K=(X;9(/FW!6E(P1F0#L@]J!%'3/A[8^'
M_$MCJ&A7\UA L>9X!*'2Z P<G+Y^48<\8PPQWK/^&&3H&L<;&;5IF5FE&& P
M#QO' W;?JX/.*LZ1X=UN3Q1;:UXE\2Q73:;$XMXXF58U)Y+.0XR I5R/[I7Z
M5F67A+QAHK7L6D^)[2T@NKE[GR652RL<@@\GD;E!]V7\&'4[JZLX[^SN[*XM
MWFAFB*20+.H:0%=I4'S."=OEY[-&3WS7E.F^!/#US\2[_1C&9-/@LHIH@L^#
M*65<LK;^.I;&3PIKUN)I#:,L\TDLH0+(89V4NQ4*0G[[@G;M'HZN>]8=EHEQ
M!\0]1\0"ZB>"]M4B94?HR["&!\SA3MW@9^Z&%(9D+XJUV\\7ZEH&E:7;+;:=
M<()+N:\8;(OOA\;QNP=[XSRORGBJ\?CW5+/Q!8VNH:99V]K=7BV<<,>HF2Y@
MY*H9%#D8^9AVSD'L*W-+T&73]=\4ZB]Z!'K,D;(5D^:(J&!)_>#@;EDQD_)^
M5<OIWPWU>S?3;<WFDB'3=0CO&E$6V:X"N21(VXX*Y P,\LO- K$U]X^UR(Z^
MUKH<3V&A3F*Z>6_=7\O)C  #'YMH SR,@MU-6=;^(6HQ7]O;V%O:1M+IT=\)
M-1O6@67S,-B,A\=0.I&,$=#5K_A$+MM+\7VBW<>[7IVFM^23%D<K)\W+9R@Z
M_,#536/!FJ7MA9V\5YI=Y!'I\=D8;^/<L3*%S+"ZG=@A2P![*WTH U-8\3:W
M9:9I-Q9V-HMQ> -*]YJ 2&V(&\*6$OS'+%N.JL!VK'A^)4\GA4WWV MJ!U :
M9:VL5V[1S2XX._?DKACG(Y++SQ39/AY?6UMX>6WU/3[UM%5U:'4$/D$,=Q8@
M.?N9![?*5I(?AW>CP[+8R:G E\-4&I6LT49 CE"A0&7=\H!&#C/+)S0"(_%G
MB;Q=#X-UB.YTM],O;=84EN8;QFC$;G:6C);DY54( .#N.<DU,FH2R^+?! U.
MU=;]M/DF<PW[-M0*Y#'Y@&!V[^HP/EP<5=OO#'B?6_#_ (@M]:UV*6ZU"*-8
M+> MY%N4920 6R2Q7'?!5JFM/">J3^(O#FJ:O=:?(-.LYK:6*V+ .&#A=I+<
MC:P;'' /&.*8&2/BAJ<ME/K\6C./#D<YA^U&^8R[]P*MY1D&1N(RO]T[<X%7
M]4\>:Q#KVJ:7I.C+=QZ;:K=/-+J+QXB\L$Y^8\X<C@G)P>U9C> /$"Z"_A6/
M7+9?#K3[O,,+><%\S=MVAMNWH^[.=ISTXKHX/"ES;>)O$=\LT0M[_3TM+5&9
MMZ%8]GSY/S#L>3R5HT TO#VN2Z]X;LM5W2Q_:HMQC\XYZ[2 3,#EMH"DX^96
M/\5>;IXFOO#_ ,6=9OY+II-&GNXK6[E5R(XV9<QOC=]W<I/7!7([UZ-X1T2?
M0?"6FZ1-,'D@C(<QN^"2Q8X.X8/(V\##!JR8?"+2WWBQM3N+:2SUTHNV'=E-
MH/S8SQ@D.#D_*#TH&<[X>\6#PKHOBW5IVEN?^)[(EO&LAVS.W**GS\ <D\'(
M(ZUT&E>--677K70O$&F_V;<WD1>V=+PS*VW(*,?,&'VY7D_>*D]*R-*^%UU#
MX'U'0;W4HTN);Q+N"YB!9(RHV@D'&.,DX[,IK5TOPQKUWXJL/$'B2^M'GL[?
MR+>WM@^,D$,[EB"&Y*\?Q%:!'83S2K.RB:0C: 8Q-AVR,?*?/&,X"CT:-S_%
MFN2L;F0_%NZD:XC?=HL18HX'F_O2VY#YG"_QXR?DXQ78R>9F5S+R.#L9]W3^
M#YN3@#'^T']:Y.Q$A^+UZI>$'^Q86(5F SYI.5^;[N><?W#BA/1@SIFNYMMQ
M(MQM57.UFDRJ#[P+_O\ D#F0^L;*.U2F:Y$L:I*T9V@[97W8 ]?WW.T$ACW+
MQGM0(I?+DP4&YN Q?!QTW#/W<YS_ -,]OI4A65959<@J!M\TOP.@R<\\9W>^
MRD,A%Q,;-<O(N7*X,O('0(3YWW\?NR<_ZPAO>@W$SW,Y29GC"YPDO)!]/WW<
M@8Z8\N3^]3DCE\B)3OVL<_QAFX/WN>&QUZ?O,4X+<+YV>_&Z/>#ZD*,_0C_M
MI0!")[IUAVW*AW.X,7)1N<Y'[[D9^?'_ #S.VK*W<<:*6F="-HQ)/S&!_?\
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M7K9/C;Y8^8;N&QCGYBO'%!)L6OQ0NKN*XETSPK>W4,$CHLJ$LH*G:I."1PK
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MK6Q=IY(G90%96"H#NX<@JO4?,<TP.]UOQ)IF@Z/<:K=74<\$42MF$+EV;!4
M;^2YPX] C>M8?A_QX-0UF'3=6TN;2+N>+[5:F5@RR)C=N)W#&"7;;Z''89Q_
MB/J5GXI^'^H3Z/=?;([*[ FV[QAEY?Y68Y'(9<#A5:H/[9LM>^)_@Z32;J.6
M*TLY)IY"V1 I5LAR6]3ZC 8"@#3OOB<EE=7SZ?HEU<Z9I;B&ZNU9?W1!"J N
M[Y\;F&<\[@>PK3UOQO::=;:-%I]G)J=SJZJ;.UCPID0@ DON./E.SZJ37FEG
MJ5MH7@#QKH>I3B+4OMC1?9F)\R1CM",/FY P^>#U4]JURC>&_$_P\U#5I%@M
MH],^SRRN_"-L?*_>^4_.%R<<J?2@#O?#7BVW\3V\Q:![;4+28PWMK)@$/C&T
M'>!\P48(Z>6?6CQ;XRA\/?8TCA>^OKZ0K:6T.!N/#;B0_ +%7''3CC)KCO!^
MIVS^+_'7B5[D?V4' >XBW!60%C\JAP=V "#ST;IFI/%^JPS>)_ WB07B-I;2
MR*MR4=5CD+ [F!?(0GY@./E&* .GT7QY::A::M+=))I=[I"EKVWF'F% ,D,N
M'^902W3KO4=JS=(^)$=_>:;;W6E75E9:F[IIMQ(VX3[3M"'YQM)4[,DGDANU
M<BT,NNS_ !,U#3Y/,LY(0JO&Y_?.A#$J=W*X4\<\,*BU/5+77_#WP[T:QN(I
M[Q9X_-AMWVO'MVC@[OE;&?3)&1BBP'N,LNY]C,&RH7:"H+Y'0?O.-V,#T*-Z
MU"ETDL4+&XCF+D#S$("RY4-\H\SC./,'^RI'>I)VF:0>9+D%2O[IRI8GJ%_>
M]6P-OH5?UJ%6F)7=<QNQ/S&*1MIR 3M'F\9(#CT0,.](9R>B2HOQ"\92"54!
M2Q?S6(VL?+9MX^<?*,;\9^Z"*GU_QJ='UJVTC3]+N-1U)K<SO;Q,!Y2 X&YO
M,/(4N,=]RGL*@T,R'XB>+RDJAW6P8L7.UV\MFW+^\'R9^8C)^3(K#FN8/#OQ
MQ>_U.X%K;W.F8MIII#M7:%#(YW_,WR..IY*G%,1NR?$+2O\ A$;77$2YG2\N
M/LD5JB'S6?H4_P!;P=H"[O4;L?-BIM!\;'6=8N-%U*QN--U:. S-;N01(IP6
M*/Y@'/RMCL%;GFO,],LK;_A4RW]_=S:?$=<-UIMPL)D,;[0N7PWW25(![%>O
M-;.B3ZAK'Q=DO3JMMJ,]K8N9[BSRD&2I541MV3R0>HZ-Z4= ZGI.M:[!H&A3
MZK<R%HH1O B4,9&)!7:!+W8B3']QL5AZ#X[74]=M=(U#2[K2[F[C\RS\YMRO
M& 3@GS!AB"XZ?Q*>U10:YXOT:TO-4\66EC'IL,'F@Z?+)*_F>8&7Y?-Y3YLG
M_9P.G%<S8W]FWQ:T._T;56UEM3#R.+IVD-A$X/R+AOE(!88.<<4 ;MW\3[2W
MN;YTTF^NM(L9!;WM[&<>6YRF /,R00%&<]1GO7<Q3+-;Q2"03"5 P96 \T,H
M.5_>\;\!AZ!3ZUX/#J=MIWPJ\2:'=3(FI#5/+6S9OWI8-&&)&[YA\A['!!YY
MKT66'QW8Z'HMIX?M+%[=-*B24WETXD\[:-P&)0,':"OI\W2@$+J'Q%\K6KS3
M])TNYU=[%3)=2P$(B_QEE_>'=\RAL<8 (]:FO/B-I5MX8T[7;037']H2^5:V
MRH0[2AON']YQM8L3V(=1VKE_&OCM[O4)/"^FWMO922GR]0U)Y&"1[L&0*=QW
M#/3T7Y1WJ'6X-*TF#X>W>C7L4VBV&H-"UY(<H',BLS. >N0YSQQB@+G:Z5XV
MT^YT?6KC4(;G3YM&.V]M)2S.B\@ 'S/F)4; ?[V&K/M/B7!/?Z?#JFD:C8V^
MJ!/LD[$@3%SC/^M^0$A".N,-_>K$\/ZC8GQWXVU]KCS-'M[>..2<2,P9>!@_
M-EG(4@-S\Q!K/TS6K;QSXGL-4\0:I:66G6=Q_P 2_2DD/F.^0%)&>.=IQGL1
MWHL%SL+[XC0PZG>V6G:9>ZHNG9-[<6V52,8+,5_>\_,NX>@!6NGT#6K3Q#H@
MUC3Y7^SS997D.!$0QR'7S?X6RQ''RLH[5YKXP\:?;M7NO#.DWUIIYDS%J&I2
MR%4P3EPOS'/)..X!P.]=[X.MK"Q\,P1:%>+/80JRQW&\[68,<LV' ^_N)X&4
M*CM0P3,;XENRZ-I28;!U:U'D&0&0@/PH/F'YES@GC.Y>>*O^)?&L>B:Q;Z/;
MV5UJ>I70\Q8+=B/D&58Y\PX.T%1_M*6[UG?$=9?[#TJ,^:T9U:T389&,H&_@
M ES\XY#'N2O-9U]=QZ/\=5O-3NHK:VN-)(2>20JK <$*V[AOE/?[U &ROQ$T
M>3PG)XG+71MED\EX@C>8LV!E,"7C)"L.P"L/XJG\.>,!K>L3Z-=6ESI>JPQB
MX,%QN(9#M8,")<8#-DC^Z=O:N+\ :]9^'O"&HZS?^?'I]YJ[JKQAB "H(+ ,
M,?,HYYX##O3O#TYL_BW/!I6IC7Y;^Q+O?2N6-LRY8#<K8\LLJ@C^Z0*0'I.L
M:M;:#I-SJ5S+)'!:)N8%C(PP<!2!-R1G:WJ74]JY[1?']GJNK6.GSV&I6)U"
M,O8F?=BX4 C ;S>"4X_WOFSFJL.O^,M(M[C4O%>DV]MIMO K.UM,TS;@=OS+
MYIR,,=Q]0I/2N8NM1M(?B;X:U33M7?7Q>LZ+;/(7>TC?A=G/RL%;G/.5-,+G
M:>)/'NEZ#J=KIK7#7=Y<3K%+';NQ\H-@%LB7 Y"X'48;^]FNM8F($F4(1D[F
MD^48^;)'G= ?G(_YYD+7E_Q)TFTTN71KB"TMH+FZUF.2:XCC(,DAY8Y))V]"
M!ZAJZGQ)<>.(-30>']+M;RT**S-<7#(0X<D@@RCCG/3[I Z"@'<K:IX]M-/U
MJ\L+.QU/49M.3S+L0!F$"CID^;@X#,#ZDK_=J:^\?Z-;>&-/UN":ZN8;V00V
MMO&)#*[ E2I!EZA203W;#<\5RGB_Q>YU+_A&M+GM;#4+A!%JEY<2%4@^4DKN
MR=Q^9@3ST7'(JGJ^G6&@:;X%N[&]2]T:UU+-U=Q.=NYG1MW7"G"D$<8(H!'=
M:5XUTR_M-4ENTO+"?28M][;W&]9%4C/RGS><[5QZ8;^_639_$>QG;3I;FRU2
MRM+V410WTJL(7D)SD@3?*N\9QS\F5Z5GZ3J-G<?$_P 7:RURLVD6VG*EY<QD
MNA($?"D'D_NSQWPU8]AK=KXX\1:=<ZIJ-GINB:?.'M=/>?YYI2WRDJ3PFXCC
MLHP* N>C>*?$=GX2TB74+W[5G<(X(?-9F>3DA6Q,<XY+9ZJR#M6EH]VNK:78
MW\#3""YMUE0-*2VTC@?Z[J =A/=RK=J\<\81ZWJ%_K>HZ]X?U$V]O&T%C(2?
M+@4./WA)^\3QSZ$>U>D?#Z[OK_P=I<DEK/:"W@2)=Q;$JA0 Z>Q4G/\ MA:0
M%?3E8_%;6R//+?V9;*624C/+?*/WGW^!SD\JWK76M$3O\QKC<"2"LI !W ]/
M-Z?Q ?\ //*UR&FQRGXJ:WQ<&3^S;9F*;L;<MR.X?I^.^NK87!220F;[Q!PK
MD9W#MC[N[_R&30!AZUK\VA7<,4>CZOJ D0N9+9&E1""< _O3ZDD=T*#M6-8_
M$/3M0FU.".PUB&73+=[BX$S'*I'P0W[W.X@D>[!"?NU5\?>+;K3I[?PWI=TL
M&IW>%>:XEV):Q'/S%FZ$_,/]P+[5%9VGA_0OAYK6GZ3JMK?7DMA+-=2QR[WE
M.QN6 R0H&<^AV>IIA<TK7Q]'?0I-;^&_$TMO,!MEAC8Y#?*2")/]D$'LVX]Z
MTU\5Z<WC:7PNTMRE^@#JX+"*3*J_R?O/?(''R;E'6N>\#Z/XF?POH]_!XHNX
MM+2,2-9Q6(9B@.XHK8).1T..N:P]7\-W/B/XC^*HK)_+U6PAM[FT="P"R!4^
M5/\ 9[#/0<T >AV^N6MWXGU7P_&ETM[IZI*6D8F-E.T@_P"L^[E^?^F8"]JE
M\0ZQ8>&=,&H:E+>I#E41/F:21SD!<;_F.-V[W$9[5YUX%UJ_\0^-?$NJBS/]
MH-IZ*ULPY,RE$V$8X0LN&SC"GKQFNF@\3ZUIT#W?CS3%TRRC:&.WD*^=OD.X
M'.T-C@$DG'(2D!?T?Q3IVL27]N1J=C<V49EN(;L/&Z1#J_W^NW!&/^6A)[U3
ML?B%HFJZA:VL2:E;K>-LLKF:!EBF?=T4AN%!P!Z*6'>L#0+B/3/B+JJ7&H_V
MVMQIQNI]22,[XHA\Q4J 06"[2,#[V*J^(]8M[K7_  SK^EZI#J=M<72QV>E&
M,QB!@5!(P,@;A_$.E.P'7:UXYTK0-9DTF>'4+B[B19)%MX#(JC&1GYQD<X/J
MNT=J74/&>F6&GZ?<E=2EEU!<6MH(W-P^/E.\;NO7/J0A[5RVJZ=8C7/%NK0>
M-+FQU"W)WP1@PF-@!L3E?WB94CC Q@UJZ5XI_MGPQH\6JZC%IVNZG;NUO>/;
MC!*,R;\E-H+*I)&1R$QC-%@N=1H.JV'BC39;S3I;O;&S1R*Z,LL;C!(*Y^]T
M(/\ >+GO571?$VF:[KMYI-F\K7-@?WSHO[LX.&\OG)"L<#C[A85YQI>J:II_
MA3Q%8:#9SWMTVI-;MJ5I$TC2A@Q,A&"00% &#P7-1>"K\>'/&-\++P]J\@^Q
M*A@,!>:%PH;+#:2 S<9QT:BP7/2=;\3:5H&MV.EW$D[7=[)Y<40&0N6"J9 2
M/D))7WCP.U,U_P 8:)X=U7^R[QM0N)XH/.N!!#YAA3  9S].3[JAKR#4+B^&
MH6>L:QHFI-K%QJ:3,)[<I%)&I79#&I&?;'IBNW6\@@\<>-[B^+0FZT=)8TN5
M"LZ& ?*XV\'ID<?,H%%@Z'HE@4O],AO[:4S0SIYB2Q*V&7@Y7C[W0@?WC)7/
MW_C'2K+QDGAJ59DO#+'"C[,1;W&Y1G.=F6"]/N,17/>%;[Q3IGPWT!=&T%]5
M21)V8M@&+$F4(RG/!RO)ZM^',>*;.XU/Q5X@U![86][IUE:WLMNP_P!00L09
M0,895S^0ZFD,]+U/Q=I&D^)K7P[=)<27EP8U8>6#&"QPH;)!P<X/'*A?2NF6
MSEVDE6)S@%U;)'/+''WL#)_Z:!*\(AD?6]<T_P 3219EU'Q L,,<HP@C79A<
MXP0/N_ATKWC%P%4>5N5WSDQ'+YRV2/)X)4%C_MJH[TP![)Q*<*^Q5R2J,&!Q
MGY1CZ$?[1DKE=/@9OBQ>(\<88:-#N" G;^];(CX^YVZ?<KJW,XE>9HR"JX9Q
M$2RC&>/W/.,AA_M/(.V*Y*QAF3XK7?\ HL2F'1X5VJI_='S6&U!Y?W,_)G ^
M3FA">YU;VDA$P2)<(V(Q(C;?0!OEX&<JW_3,+2O:NSQJ$+J5&?/1LD'U^3O@
M[O<1TTK.WVD?9D<R.00\9"RD_( W[GH2#&3VC5&[TK+++/"Q@\W:F%,L1!PW
M(S^YXW!26]#'&.](8"UD:(,R.6W$!BK;BO7).S[Y W$?\]0*=]ED$L@V'RU)
M9=D;<'J2!L]QC_>E]*9$)7M!^[;RV?S ?*^9LC?O(\G[Q7]Y_P!=!M]J<JS1
M33,+=8P%VL8XR<8YP/W/(!88_P"NDG]V@ :QD=5!AC+L<L&4[#VQG9R,_)_U
MRQ4D=K#(Y5EWN N!(G+ CJ^4X+$8;V5*C\N51 GV:/?&?DC*85?X< ^3P,YC
M_P"N>&KE-.B@E^+NJ.\:-')I$'SRQ@&;+?QJ4XSCG@?=% '4):)YTH"OPN\X
M0[^?F#$>7]XXW?\ 70"I!9QH[[H2A*G!CB)Z<\?N^P;(_P!II!VKS/Q-KEQH
M6N>*;S3+>TCG T\Q2R6H8R%SG=("HPV?FZ @@?2C4?%6MZ$VI:-/%87&HP:C
M;6D-S;Z>"-LJ-(/D Y9<M@>KMUJG$7,>E1V:H%5K=55#MPD1(7^$@?NN@/R#
MI^Z)-,-@7E=$M4<LO21" ^1M^8^5T)&T_P"RD9[UB^";N[U71K@:KIZP7EO.
M8-QLA$LR#"J=IC.."(B.RYKD;WQ5K,::MK_DZ2-*TS4S8W&G/9@RRIE4)W[>
MI 48XX1:5@N>C+;1&;:O^LSG)C/F$?>R1Y602/G/_34 =Z5;2*!@LBB)0=H
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M!=IG10P4![ACMP-H#GSN2,E3ZL4/:IE@B>:0;[C;LVD?:6W'( X/F_[.W/\
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MT#L<>WBKQ*[#=X$UQ0P&XK*GRY'.WYN,8&/JWK37\5>)V6)O^$!U<."-X65
M -N3CYNN[@?[)(KH-.^(&F27E_:ZA*MK)!J+V49\N0H>0%W/MVJ23T)%:=WX
MQT*RU"2RN+X)-$P25O*<QQ,<8#N%VJ>1P2.M(+'FNFWWBJP\3:[J_P#PA6K,
MFHK;E(]Z?(T:$8^]]TDX_P!WBM/4-:UC4BB7?PWU.Z13E5N'B< ] <%NNTG/
MN!7=>*M;/AWPU>:NJ))]F"L5<D#!8 ]/8U%#XST"6PNKP7X2&U"M-YL3QLH;
M[IVLH8ANV!SVIW"QQ7]OZX]D+*?X<ZHUKL\LP[XMA7D=,XZ!3]<U%9ZSJ^GV
MS0V/PVU.S#G+"W,:#)'/0^H&/8FN[C\9Z#):O<_;O+CCE2&3SHGC:-W^[N5E
M!4'L2 />GW'B[0[:*:22_7;#<_9&V1LY,V,[% !+-[#.*+A8XQO%GB(HP'@'
M6LXX7>FW@9 ^]TSD'_9Q5.QU2_TR0O9?#35+<E@7:)8D:09_BP>>"3]0IKO)
M/&>@16,-V;\-'-(T,:I$[2%UY9?+"ELCN,<5J6&H6FIV$=[9SK-;2#*R+T..
M#]""",=J06/+I]4OKJ^^V3_#+4WO!]VX98C(O8E6)X. "/?-7E\6^)2$W> ]
M;4XPP61 ,XYQ\W9@,>Q-=5#XVT.^9H;"]$TYCDDA!C=5FV#)V,5"M_P$FH/#
M'CO2O$6G6$GGI#>7-L)VA*NJ@[07"NP ?;SG!.,4!8XB2ZNY9&EE^%5T\SL7
M9VBA.6/S'//3=Q_NYJ<ZSJBV,EDOPSU(6;?\NP6+RSW&5!QR2P/L%KN+?QSX
M<NPYAU)2JPO.&:)U$D:#+,A*@. .?ES5JX\4:+:I$\^H0HDMJUXC'.#",9?.
M.!\PZ^M.X6/.XM6N(M+&E#X::REE]TQ+#$5<9QEAG!. #_O"JR7,:R1RCX4Z
MI'("'#QVD(:-NOR_0JN/JWM7J.D>(=+UPRC3[GS&BP9$:-HW4'."58 X.#@X
MP<57U/Q?H6C7C6E_J"13(H>1=C,(U/0N0"%!]3BD%CS8W<4LAED^$NI,[$LQ
M-I$<D_,?_'N/]TFM"S\2:CIUH;:R^'6NP0[V=8XX8U4D\X(!Q@DD'_9 KNIO
M%NA0:L^ERZE"MZB;WB.?D79ORQQ@#;SDFI=)\2Z1KDKQ:?>++(B!RA5D;:>
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MMK';YE6:, LC#/! .<YQCG-.3Q[I4UM9O;6U]/<7<LL*6D<'[Y6B_P!8&!(
MV]^>XH I> (-1M[C5UN; QV[/$8KN6R6UFN3M.[?&O'' W8&<URGBK19TLO%
MUI+X:N]2U'4[GS;*ZB@\T>7A=HW_ ,&S!X[]LYKJ?^%A1WVI:)%I=E<R6VH2
MW$,KR0E6C:(8(QD8P>N>U-\&_$&+6],TA=3M[B"]O]R)-]F9()9%W$JA)/93
M[<'F@#FM2T6XALO%5I=^';O4=3U24OI]RD <!3&H1?,_Y9;&!ZX_6K+Z;-IL
MVLQ:SX9NM>U"]> VTRQ;E91$B[?-'^JVN'.>.N177^)-=O-+\2^&;"W\KR-1
MFG2X+KDA4B+C'IR*SM-^(EC_ &=IR77VF_O[FQ^W'[#9O@Q;B"^TDE0,=":
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MPDHUB;5/.M)8M'DEG\KS%,92XW!50)@%>, $$5I:IX8AN;'5[^32I)+]O$B
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MLG@LWN_L]MYD8$:3LK; =W12IQ['':M8_#;P43G_ (1C3/\ OP*/^%:^"O\
MH6--_P"_ H X[Q)IMFVBVGA[3M2$MQ=:G+=B_BD14M4D=C)N.[^Y(ZCUKT5+
MW1H[!;*'4+..)8A$BK,ORJ!@ <^E9/\ PK/P5C'_  C.G?\ ?D4W_A6'@C_H
M6=/_ ._= &'9^#]+L[/2;8>)+5XK33I=+N0P7%S!(02!\_R-P.>:=8>&+.V=
M5N?%&G2VT,#P0+#;0PN=R%-TC@G>0#V"\UM_\*Q\$_\ 0LZ?_P!^Z3_A6'@C
M_H6=/_[]T 5K#2=*L)O#,@U^T<Z'9/9@%T'G!D1=WWOE^Y[]:O\ AZ/2=!T+
M^S%UJUF'FS2>9YJ*?WDC/ZGINQ^%1?\ "L?!/_0LZ=_WZI?^%9>"N?\ BF=.
MYX/[J@#F=)\&Z?I=SI97Q1IABTV1WB6.WCCDE#(R'S7#Y9L.>>/I4UAX0LDM
M=-T_5_%=I?Z9IMN\-O;A$B;+1F,LS!SNPK, ,#KSFM__ (5CX(_Z%G3_ /OW
M33\+_!!_YEJP_!,?UH H:9H44&HZ3/J7BJTO;?1T9+&)42(\ILW2-O.\A>.
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MZ ([SP3K-M'J5MH.H6$%KJEHEO<BXMSF-DB\K=&$( RH'!X!''I703>'%O/
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M57MT2UT\WL\]OYH;+/\ , 4!'&U:] C+^4GF[1)@;@O3/?%<2/A9HZ_=U7Q
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M =KFC-<5_P *Z/\ T.?BX?\ <2'_ ,12#X=2+]WQKXM_'4%/_LE ';45PX\
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MX/&1SZT :5%>(Z?XH\5_V#XAUZY\43RZ):.EO9WBZ;$'F?S4#.J9 *]5Y/\
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MRF\U9+*>.:$;@F,G9@X8D=""1P?2@#T*BN-^)FN:OH'A2.[T-E&H27D,$89
MV_<V-N#Z]*R=+^(,NK>*].$#G^S9M$EO+BV6/=)'/&X5EZ9R.1CO0!Z117F^
MK?%6.'P_J\UGI6H6^J6=HMREO>P 91FVAR WW03ST-2P>/EM=0U&\U6XN;:R
MMM+@NWLI;0*\;.Q'# DDDC&WZ<T >AT5Q)^)VD0Z;J5U?6.IV,NG1I--:W,
M64QNP5749P1D^M2VOQ$T^Y@U-SINK136$4<S6SVW[V5)"0C(H)SG'?&* .QH
MKS37?B--/HRRZ/%<V%]!JMK9W4%["N]5D/3J1R.^<UZ70 4444 %%%% !111
M0 4444 %%%(2 0/6@!:*** "BBB@ HHHH Y/Q1\/M)\6:I:ZC?7-_#<6T311
MM:S!/E/7L:/#WPZ\/>&VO9+2"6>:]C\J>6ZD,C,G=<GH*ZRB@#@+3X/>%[2]
M@FW:A/;V\GFP6,]T7MXV]D/]371VGA33[/Q9?^)(FG^WWL*PRAF&S:H4# QU
M^4=ZW** ,'3O".E:;;:O;QI)+#JT\D]W'*V0S2## >@Q63HGPO\ #VA:O!J4
M!O9Y;52MJEU<&1+8'C" ]/UKM** .5E^'N@3:EKE_)#(TVM0>1=#?QMP,[>.
M"< _44/\/=!D\(V?AIHI_L5FPDMW64K+&X).\,.^6/YUU5% '%Q?##08]!U3
M2GEOYQJI0WEU/<;YY=K97+$=L>E:^J^%-/UBWTJ"X>X5-,N([B#RWP2R#"AN
M.1ZBMVB@ HHHH *Y[Q3X0T[Q8+(7US>6[VDIE@DM)O*<,1CKC/3TKH:X+QU_
MR.W@,9_YB,O_ **- %ZR^'VEV5QITKZCJMU+87374#7=V92&9 I&2/NX'3UI
MG_"NM$DTBVTZWN[Z%K*YEN(+JWN L\3R$EP& Z'=TQZ55\9RR_\ "=>$K>UA
MM?MDR7WV>XN Y\EQ!D'"L 03UR#QTQ7G7A+7]6\,>&-'LM,AL%O=72:^EN?L
MD\Y94(4!E0DEB<Y;@ 8H ]3OOA[H&H>%K7PY=-<R6EK)YRN\^Z4MDY)8YSG<
MP/L:=KGP_P!)U[5/[0ENM0M96M?L<HL[CREFASG8PQTY[8KS35-9;5-5UO6+
MO33'++X,\R:SN Z ,)B"IP0V,CU!Q6]J?C?Q/97&M0Z5#I266A:=;7;B=)&=
MPT>XH"&]CR?0=: .OMO &DVT;(LUXP;2!HYW2+GR!G'\/WN3S^E59_AEH4WV
M023WXCM]-&EM&L^U9H " ),#DC.>W(%<Q>_%35WUN2/3M.1K:SBM9)[<6\LT
ML_G*KD(R#:FT-QNZXK>^,'[WX7:A@E=\EN 3QC,R4 5]0^&-I;Z3J(TZ:?4=
M0N; 6035;DO&\:L"H^4 J1C@C&#65X4^'%_)JFKW'B2V=+2]TX6)BFOS=3-\
MP8MOQP!@8 Z8K'TS7[__ (3BRM[\ :UH&C7L-QO!VR,FTI)[AEP?Q-=&/'.M
MZAIN@1QBSBN-8T6ZNW;8V(Y$0%2.<@<T =CX=\*VWAQ[J6+4-2OIKG:'EOKD
MRMA1A0. !U],U2\0_#_2_$6I?VA)=ZC8W30B":2PN3$9X\YVOP<CD^]<!X8\
M4>+H/#O@O2+"339KS6(+F19[P2'8L9# L0<D\M^E:R?$36H?'-OILS:9=:=/
M>R69-I#+F,JI()E/R%LCE1G% '27WPUT.ZMM/AM9;_3#80&VBEL+CRW,1ZHQ
MP<@GGZU9TKP'HFB:CI][I\<T3:?9O9PQ[\KL9MY)SR3N).<]ZYK0_''B6]TE
M?$M[;:4-#FMKFX2WCD9;F,1 D=3A\[>< 8S6;I/Q+\27%E>W-W8P/&VDRZA;
M2Q6<\<<#JI81NS@!\CNI[4 7_"?PN2W6.ZUZ6[-Q!J<M]':QW9:W+;\HY3^\
M!]/>MZ/X;Z'%KT>IBXO]L=T;R*Q-S_HR3$Y+JF.#GGKC-8&H>-=:N]*TN&$V
MD,^I^&IM1D8*V8Y1&K#;@Y ^8_E7.Z+KUQI%IX-U'4[:&]FAT.\NUF1Y/,"(
M@8*?FP21P20>>F* /0W^'>E'P_#H\=WJ$,<%Z;Z&>.51+'*6)R#MQCYCU%51
M\+M'BTV*UCU/5HGBU ZC'=+<+YRS,H5OFV]#CTZFJ-KXL\66_AN;6-5'A^."
M:P2\MG\YXQ$7(PD@.2PPPY7OQWKB/%?C+4_$7@3Q#I^IK#]HL+JS:.>VAD@#
MJ[C^"3YAT//?- 'IDWPUT:6TFA6YU"&5]1?4H[F&8++!,P .QMO"X'0@TZR^
M&^C6,>GA;B^DFL[\ZC]HEE#23S%=I,AQR,>F.E<_??$/6K#QR^EW4-C86 NU
M@B^VPS)]H0X^=)AE,\\*1^-:OQ8O;JT\'10V]Q);K>WT%I/-&=I2)VPQSV],
M^] '2:#X?LM &H_8Y97^WWLE[+YC XD?&0N ,#CIS]:UZ\TFTOP_\,9M1U32
M;QXO*TYII-&-R7\\@\2_.2PYX)'%59OB'XET:VN$UFTTM[J;2)-4LFM"Y10N
M/DD!Y[CD&@#U6BO,5\5^.FN]!L!#H N]:AFN8\B79#&J(RACG);YB" .PYIM
ME\0_$'B"+2;#1;#3DU:XBN)KIKIW\A!#)Y9VXY.YNGH/6@#U"BO*H/B1XAUV
MYT&QT.PTV*\U&&=Y_MCN4B:%RKX*]0=IQ]:6/XDZQ+XR@TA5TB>TNYY[:)K8
MRL8G125+2$!#DCD+R* /5,CUHKP[PGKM]_8_@W4-:5;N5[K4)([CSY#($1'8
MY&0"<@C!R,8Z&M[3?B1KVW2[S5-.L$L-<AFDT]8'8R1&-"P$N>#D#MTH ]3H
MKS+PM\0/$&HZIX:CU>QTU+3Q#;RRV_V5GWQ&-=QW;N,'L!TSUKTV@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_&?A6'QEX=ET>XNI
M+:.21',D8!/RG/>N@HH X.Q^'-W#,XU+Q=J^J64L,D,UG<OF.170J<\\8SD?
M2I- ^'DVB:G8SR>)M3O+33XFAL[-]J(BD8P^W[^!TSZ"NXHH \_/PJLSX"G\
M)_VI<^1+=_:O/V+N!W!L8Z8XJ?6OAM'JFNW>J6FN7^FG4(%@OXK;;MN%48[_
M '3CC-=S10!Y_'\+8;/3-&BTW6[RRU'2HG@BOHT4EXW8L59#P1DU9/PWMVLM
M MY-8OIGTB]^V^=<-YCS/G."3T'&!CH*[>B@#&N]#GN?$]AK":K=0PVL;H]D
MC'RI\@X+#/49].PK9HHH **** "BBB@#@+SX=ZF_C"_\1Z?XLN+*ZNU$87['
M'+Y<8Q\JECP,C/&*+KX9)J$^IW5YK,[WMX;.5;E(55HI[=2JR =#G.2*Y/Q?
MJ5X?B3KEJ;CQ6\5O90/;PZ&2PC<J<EP.@/'ZUJ0?$C4=$\$:#?7:6.I2SV+7
M%S<RW\<&XJ<;%7!+OVP!U!H UC\,?M"7-Q?ZW-=:I=7UM=S730JH/D'*(J#@
M#!(S5N]^'QN;S6KJ#6)8)-3N8;DH8$DC'EIMV,C9#J?3BLN\^*ETK3MIWAXW
M4%OI<.JRN]V(RL+KN(QM/S#Z\X-98^(<]G\09XH(Y[S^UK2P.GV,DVR-&D4E
MB6P0N 1G .: .\\&>$XO!^C2V$=R;@S7+W+OY8C4,V.%0<*HP.!7*R?">\DL
M-0TK_A+;J/1[^Z>XGM$M(\G>VX@.<GTKTM=VT;@ >^*6@#S75/A,E_JUU=0:
MMY$,T\-R$:T5W1X@H51(3NV87[OK5^7X<(]C>VZZFZFYUM=7#>4/E(8-LZ\]
M.M=W10!P=I\/[[3M;DDL?$=S;:/+?OJ$EBD0#-(WWE+]=A],56LOA<UK<6%H
M^MS2:#IUZ;ZTL/)4,DFXLH,G4J"3^=>BT4 >2^(O ^H:1\.]'T#3'GO9H=:C
MG,\4&6C4R,Q<KS]W</:M3_A5TERM_>W^NS2ZW<WL%['>QP*BQ/""(P(^01AC
MGUKT:B@#SA_A=)=0W5S?ZV]QJUY?6UY<7/D!5/D9VHJ \#!]:7Q;\+W\3ZSJ
M%Z-66".^@BC=)+196C,9R/+8G*@]P.M>C44 >=:K\-+G49=91=:$=IJ=Q!=-
M$;?<R31E.0V>A"].V:=J?PSFOKK4+>+79H-"U*[%Y>6*P*6:3()"OU )4'I7
MH=% 'G]Y\-C<6&OVL>I;!JNI17RGRL^5L*G9UY^[[5TOAY=:6;5_[7<M&;^3
M[#D*"+? VYV^^[KSC&:VZ* . F^&5O>Z5XGL;R\WC6;\WT3K'@V[\;<<\X(]
ML@FK&C>#]<T#0]'TNP\0)'!8P3Q3(;4$3,^XHW)R-I8'&><5V]% 'E<7P/T'
M_A%GLI\R:RZ,?[2W2#]X22&V;L<9 KL]!TG7=/NU;4M;%[;"TCB$(@"XE4 -
M)NZ_-C./4FNAHH X7Q/X$OM6UF^OM*UA=/&IV0LK]'M_,WH,X*G(P<$CZ5EO
M\,M7A);3_$4=L9-(ATJ8-:;PR(,,P^;@D=/2O3J* /)]7^#C7@EM[+5+=+1[
M"&T7[5:>=)#Y0P#&V1MW'EL#-=CXI\,WOB#P.^@6^HBSGEBCB>=4)! QN&,Y
MP<$=>]=/10!YD_P]\377A6?PY>^([%M.-O'%!'#I_E^64=&!R&R>%(_'-3:K
M\-+N^GU&SM]96WT'5+P7M[:^1NE:3*E@KYX4E0>G%>CT4 >?WGP[GN+#Q#;1
MW\:_VKJ45^A,1/E;2AVGGG[O6H+SX;7M]XUM]:EU*T$,%Z+M9$LPEU@?\LC(
MI 9.V2"<=Z]'HH P/%GA^7Q'IMI:Q7"P&"]@NB67<&$;AMOXXJ/Q3X<?7X=+
M2":.W-EJ,-Z<J2&"9RO'<YKHZ* .%A\"7=OX7UK2H[ZV,FH:E+?(9K82Q[78
M-Y;HW4<8)&#W%8]I\+M0L-#MH;34;.*]M]935(HUB?[-%A=NQ5)+8YSUKU*B
M@#GO%WAZ;Q'I=G;0W"0R6]]!=[G4D'RVW$?C7,7/PO9?&6K:YIFH_8H]2L98
M&1%.Z.:3&9%^N,GWS7I%% 'D=E\)=02#5$N+S3(S?:0=/Q9VS( X8,LC9)+$
MX^8]:T9OAMJ.K?VC)K&HVQN+S3H+8/;Q$".:)RRN >W3CZUZ710!Y?J7PWUS
M7[#7)=9UBTDU;4+2*RA>"%DABB20.>"22215_P 1^ =0UF?69;?4TMFOK"VM
M4P&X:)RQW8_A;..*]!HH \GC^%>IK:WL9NM+A-UJ%G>^7:V[11Q^3G<JKSUX
MY^N:]8'2BB@ HHHH **** "BBB@ HHHH **** "B@'-% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %87B7PGH_BF.V&KQ2.+1S)$T<S1%21@G
M*D=JW:Y/QSI.G:S;V5K>S[[@.\EIIK7@@2^D"_<;C+ =>.E $NF^ M TJ>RG
MMHI]]C)++;M+<R2;#(@1_O$\%0.*9/\ #SP[/I=AI_D3Q16"NEL\-RZ2(C_>
M7>#D@]P:X/PE9:=J_@J\\/:SJ4T<UMK,D9L?M0B0R*<K;(Y)+Q_3GFN:GO;W
M2/ ?BG1C++97*:Q!%/9Q2EX[2"4\+')G)!"G/3Z<T >QMX!\.2),JVA5)M._
MLQ@DK ?9\YVCGKGOUJ>3P7HLW]J[X9#_ &I;):W6)6^:-%VJ!Z'!ZBO(O$-Q
M<^$I?B#I/AUYK>PM[&TECC25B+=W**Y4DD@E6)/TKH?#-G#X8^+%AI&DR2_8
M+[0EGN(3(SCS0W$G)ZG&/QH [&Z^'7AV[N89I()U*1PQND=RZI.L6/+\Q0</
MC ZUM:WHEAXBTB72]00R6LC(757*G*L&'(]P*\X^*B:HWC?PI+H[G[=;0W=U
M%$.DQC57*'_> *_C5[X5:Q%K^K>+=4@W"&YNX)%1NJ$PKE?P.1^% '7S^%-%
MN/$3:]+;!K\VIM'?><-$<Y#+T/7K6=I/PY\-Z-=07-I;SF6")X8C+<R2!(W&
M"@#$@+UX]ZY'Q9X,T";XI^&HI-/W1ZHUW)>#S7_>LL>X$_-QSZ4_4]9UN6?Q
MCI%M'IB>'] L"ABECD:296MBRKN#]B.O!P?7F@#L-*\ :#HUQILUG%<!M-,W
MV0/<.XB$H 90">G' [5'#\.O#\&KIJ<:78FBNFNXD^U2>5'*Q)8JF=HSGGBN
M1T?QSJ5OHVH006]E%!IOABWU"V4*YQ(8\[22Q)7CZ^]5]1^(WBI+74+VT72E
M@TW2K+4)DD@=FD:9 60$.,#.??ZT =K8_#;PSI^IB^@LY"ZB01PR3N\40DSO
MV(3A<@D'%/TWX>>'-*:=HK::02VS6FVXN9)0D+=8U#$[5^E<7JGQ$\3:+8>(
M$N5TR6^L$LIX&2%UCVSMAD8;R>/7-9WC[Q%K1\/^*?#>M-937-O:VUY#<62-
M&N&F0%2"Q/![YY':@#T+3/AOX;TJ>.:WMKAY([=[53-=22 0L,&/#$@+CH.U
M.T[X?>'M,:S6&&:06<4L,*37#2!8Y1ADP3]WCIVJIX7U[7)/&.I^'=:-C*;6
MTANHI;2)H\!R05(9CG&.O%<GXZTN75?BND,?AT:Z$T5'\AKW[,(SYS#?NR,^
MF/>@#K8_A7X6CM[J!K>YF2X@%N!-=2.8HU8.%C).5 8 \>E/?X8>');6^@E6
M\F^W^4;F26[=WD:,Y5BQ).:\X\/7=Y+?^!H+:[:34;6/5H"D^76.54XC;GY@
MN0,YY%;T7Q7U*ZLY[ZULK9X-/T0WFH(0V5NMQ01 YX *L3G)Q0!UMY\.- OM
M3:\E%V%>Y6[DM4NG%O)*.CF/.,\5T.K:39:WI4^FZC L]I.NV2-NX_#H?>O,
M]%NM<N?BUHDNN2632S:$\R_8@RI@N#A@Q.2,]>]>D:\ZIX>U%C>"R'V:3_2B
M<"'Y3\_X=?PH Q=,^'GA[39+R3R9[R6[@-M+)?3M.WE'J@+'@5!:_#+PY:PW
ML6R[F^U6ILRT]T\C1P'_ )9H2?E' KS7PK9-X>U_PN^H:;+9273>5#K%AJ/V
MB#469>/-0Y.#UXQU_*UH/C+Q+I'A5F::*]O=0UZ:TAED@FG,6,ESL4EF'RC:
MJ].: .XU[P*VK>(?#;I+)%INEVLT#/#<-%.I955"K+_N\\U;?X;>'_[,L+&W
M6[M/L =8)[6Y:.4*YRX+@Y(8]<U8\#Z_JNO:7<OK&GO:75M<M"&-M) LZ#!6
M14D^8 @]#Z5P/B;P9I6I_$:QT+2GO8;F7?J6J7 O928XMW"J"V 68XZ<"@#T
M+3O!&AZ3>Z7=6-N\+Z;!);VZASC:YRV[/4DY.?>J-E\-=!L-3MKZ!KT/:W+W
M-O$URQCA9\[@J] #GFO-/$9FO[WXB:C/>7D5SH"V\>F%+ET$''4 '!+8'7UI
MU[-<^+M<U!M6N[J 6/A>*^MDBG>,+,R*QDPN.0210!Z;IOPZT/2VL_(-V\=G
M/+/;Q2SETC,B[74 _P )R3CU)]:;I_PU\/:=<I-%'=.(HWBMHIKEW2V5^&$8
M)^7.35KX>ZE=ZOX T2^OBS7,ML/,9NKX)&X_4 '\:Z6@#G++P1H]A+H,D*S;
MM#CDBL]TF<*Z[6W>O%='110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <5K'P_EU#Q/
M=Z[9>)-2TN>[BCBF2U"894&!U!JC-\)--6VM;>PU6_LHXK*2QEV[',T3N7;)
M8':2S$DCZ5@_$!-?'B^[N9)O$?\ 8D=J@@?0;@9MI,99I8ARP[]N*MZC\3+G
MP_X>TB>"73]7CEL3</>W-R+9[C:2"$AP6W<>F,YH W;;X9V5O:WL']HW+"[T
MB/27)5<A$7:&'OBHKGX5:9<QR%KZY6X-I:6\-PJKO@:W^[(A[$\9KCM:\8ZP
M]QXDU72KB>)&\.VE[#"TORP&0C<R@\;@I/;G%>C:7>ZC<_#.&\OLQ7SZ87+I
M+N)/EG#[N.2,-[$T =-$K)$BNY=@ "Y&-Q]:?7'^"=3NC\*],U.XD:[NAI_G
M,T\V#(P!/S.W3IU/2O/-<^*6H:YX-\26L:0V%]9VL-S'<Z;?>: &E52NX 8(
MSS@D<T >YT5YC)\6/*\,2:W'I\36DEXMC8237(3SGP=SR9'[M1@]>U=-X)\9
M0^,-.N9ECBCN+2<P3I#,)8\CD,KC[P(- '445Y)IUMK?CN_\2ZC_ ,)5J6D?
MV=J,MC906KA8D\L#YI%(^?.?45LZIXZUC2M2ET>PT>/6;K3;!+O4K@3B!0,<
M[%(.2<9Q[T >A45Y=??%VX#W$NDZ +VRM]-BU.69[H1%8FZC;M/S#Z]C3I/B
MS=VNGZM<WOA\0R6=C!J$$0NMWFPRN%&2%^5AN!QS0!Z?17E=S\5-=L_[46?P
M@JOID$=W<@7X.V%P"N/EY;V]C3]5^,MGIVM?9DLH7LX?LXN9'NU28&4 _)$1
MEPH(S@T >HT5YG-\4K^V&O7<OAT?V9I5R]D+A;H;IIPRA%"[<C=N!SSCWI/$
MGBG74T6+^U]'OM&N$U.UB62RO5995=N<-M.0.A4CTYH ]-HKSN7XFRV_CF#P
M]=:5!'%/=_9(Y$U"-YL]G:)<E5/N<U<^%>HWFJ>#FN+^ZEN9A?7$?F2L6.U9
M" ,GT% '<45\Z:=XKUV.UM-376?$1N3JOD.UU'G3?*\TJ09".N/?@UZ3J?Q,
M?2/&D&A76E1+#/=QVD<@OHVF)? #^2.0F3C)(H ]"HKS:Q^*5S=:A9)-H!@T
M^ZU.32ENA=!B)EZ';M!P<5C^$?'U]J7AR]TT+<WD]E:WD]]J#7&QX/GD\I5X
M.YMH7GH/PQ0![#17E-O\3-0L=+L[:VT2;5'@T*'5;FXFO55A$5^8M\OS-].O
M/%7]2^*4\,MT=)\/OJ%O9:=%J%Y(;E8C$LB[E&"#DXY- 'H]%4])OO[4T>RU
M 1F,75NDVPG.W<H;&>_6KE !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !112$X]: %HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K#\2:'H7B"&VL=;CB<F3=;9E,<@<#^!@0V<
M>E;E>?\ CZ2*'QGX$FGD2.)-0FW.[;0/W1ZDT ;7_"O_  P/#IT)=*C6Q,GG
M8#,'\S^_OSNW>^<U%:^"O"=CIMWX>2RA,5_^]N(99F>6;!^\2Q+'!Z'/!K"\
M=^+=0@UG0M-T*[D$-Z)WFN+%(II/W:@A5\P[.^3GG%<U;WNN^)/$WAN\%\FG
M:F^AW1EN(HXY0=L@&0,E1D@'OC)% 'HNE>#_  QHD%YH]M;Q$ZA&6N8YYC++
M,F-O)8EBHSCT%2>'_!'A[PE-/=Z;:&*61-CS2S-(RQC^$%B<*,=/:N'\'^)[
MC6_%/AS4M3-JCS>'9IYYS$JD%9MI.[J%P,D9Q7IVHLMUH=T\#+*DMLY0H<AP
M5.,$=<T 4KNTT.^O]-\0S30M)9!TM;D7&$'F?*PX.&STY[U3TBV\)^&;S4GL
M;NQM9KV<S72&['^LYS\I/R]3P,5Y5'>6LG[/_ANS2>(W37\""$.-^[[221CK
MTKI/%'AG03\7_"<)T>Q,5\E])=(8%(F<(""XQR<DGF@#T6YT?3M3U33M8DC$
MES8AS:RJYP ZX/0X((]:H7FB>';1]8DO&B@.N*(KPRW!02@)LP,GCY3VK>MX
M(K6WCMX(UCAB0(B*,!5 P /;%>-_$2S?6?B?]CM+;3KBX@T-VD75\_9T4OP\
M8'.\9//3\J .XOOASX4O;>W:XM&\FWLQ: K<NH:!1P'PWS8Z@FEE\)>$CI%X
MTHC%A>VD-G-*;HA'BB&(QNSCCU'6O*I?$[/\+/#N@6QU&.RN;&5KZ\2!I&VH
MS+Y2E00 S C/91[U'H=U9ZUIGPSTN\C+Z:D]U'=13IMBDD50R]>&'S?3J* /
M2_&'P_M?$>B:C_8Y@COM12VC>:65C&\<3@@<9[ \@5/;^ _!C:1JMO%$DMK>
MLJWDGVQG(V$$+O+$J%('&:\TTCQ->Z%X*U+2M*CN_(N==NK:UNX(6E%I;*4+
M,H4')PQV@=R?2IOAN_A:[\#ZYH6M331:<-5:0O<%X5=25"*S\?-E>5_.@#V+
M3M-T:36)]>L62:[GA6VDGCF+JR*<@8SC/ZU2U_P#X?\ $VI)J&J6TSW20^0K
MQ7,D7R9)Q\K#N37%?#2#^R?B/XGTN9+.*>2"&=8=,XM$0<< \A^1G\:];H Y
MRP\#:!I=QI4UE9>2VEB46VV1N/,&'+9/S$^IS4UCX/T/3TU:."Q3R]6D:6\1
MR6$A8<C!Z#D\>YK=HH XB/X7Z!8P7;:=',EY-9RV:33W$DH1'7&W!;[HXP!B
MNGL-)AM/#]MH\Q^TPQ6RV[F49\Q0NTY'N*T** ..TOX8>&-(U>#4K6TF\VV8
MM;I)<.\<)/=5)P*?_P *V\-_9[V 6\ZI=70O"%N'!BF&?GC.?D/S'I7744 9
M/A[PYIWAC338:9$Z0M(TKF20NSNW5F8\DT6_AS3[;Q+=^((HW%_=0K!*Y<D%
M%Z #MTK6HH Y/6_AQX<\0:K)J-]:R^;-L%PL4[(EP%^[YB@X;%/\0_#[0/$M
MQ%/>031RI!]F+6TS1;XLYV-MZKGM74T4 0V=I!864%I;1K'! @CC1>BJ!@#\
MJFHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#C==^'=IK&LW&JVVKZKI-S=1
MK%=?8)PBSJHP-P(/..,U4N/A/H[Q00V=]J%A%'8'3I%MY%_?0$EB&+*>2222
M,=:R;G1[?QO\4]=T[7)[K[%I=M;_ &6TBN&B5BZ[C(=I!)R<9K&T+QIX@L+*
MPT+3);:^DDUNZTRWNM0+/^ZC4,K$J03C<?K@4 =K%\,-)2UNK=[N\D2YTJ/2
MGW,H_=H,*PPOWN![>U=!I>A+IOAJ+1&O+BZBCA, FF(WE#D '  X!P..U>;7
M/Q3UN/3=-M1;V$>L7%_=6<TQAFD@40$;F5$RYSD?3G\/0/!NOW'B/PU#J%[9
MM976YHYHF1E 93C*AL':>",^M &!8?"RWL;'^SCXDUZXTPVSVQLIKA3%L92O
M0+VSD>X%0O\ "'3IK6[AN=:U:X-U9)8L\CQY6-'5TVX3C&W'ODUPNEP-H6N:
M7J>J_;B;G5"L7B+3[\3P78=R!')&3A5/0XZ8KJH_B3KA==:>PL!X;?5/[-6/
M<XNL[BOF?W<9'W<9H WKOX9:7<F]\J[N[9;BYBO8TAV!;>X08$D8V\$]QT-;
M_AW01H%B]N;^[OI))6EDGNG#,2>PP  /8"N)C^(NJOH]E=_9;/S9_$O]C,,-
M@1;B-P^;[W'T]JXFYU;Q9-H\<]W>12W \7K! %FD W@N&C/I%G;@#L3F@#T?
M6OA99:K>:C+;ZSJFG6VIOOOK2UE41SMW)!!P3W]:DU7X8:=>R![#4;_2<V2V
M$RV3J!- HP%;(/..,^E6_!7B74]:NM<T[5X+2.^TFZ$#O:%O+D!7<" W(KS/
M6_$=WX6^+NOZQ->R#3D M#"S,5#O:F2/Y>G+)C\30!Z&WPPT@1ZC#!/<007N
MEIIAC4@B.->C D9W?6F:C\+M,U*&[BDOKQ5N=-ATU]I7A(F5E8<=<J,]J\\\
M#Z]K'A3PSKGGWUK)?C48(0VISN43='N; 'S,>?NBM8>.+KQ&OAQ[VUB2ZC\2
M"Q=K>26)6P,[@I(.""/E;- ';:A\.]/U"37'DN[E3K%E%9S8*_((Q@,O'7ZU
M7G^&5F]^MQ;:OJ-FCI MU%;LJ_:#$NU26QE<C@X(S7.6GQ-\1NL&HW&FZ9_9
M!UK^R)/+=Q,6+8#@'Y0 .W?VKK/B7;WUWX,FMM.O([:YEEC55:Y$!G&X$Q*Y
MZ%@#B@![?#[3)-#UW2999W@U>]>]D;(#12-MY0X[% 1FL_\ X5A#/;RC4-?U
M2^N9+N"Z,T[J<&(G: N, '//K7G\>J7>B:+XML],.L:-J4.GBX_LW4IC,L2A
ML-+#+G.<'Z9QZ5U&G^+O%XO-"\/6MGI<]W+H\=]-/<32X" X))QDL1M_$GK0
M!K1?"RT@UQ-0BU>\$4>I?VDEMLCVB4G+9;;N(]!GBNC\+>&H/"ND-IUM/+-&
M9Y)]TN,@NVXCCZUP.B?%N]U3Q#;QOI]J=+N[Q[2,1>8;B+' =\C;M)]",4W1
M?BMJNMWT<<6GV*P7_GI9;6D,D#JI*&;C&UB,?+TH T5^#T!M&TZ;Q+JTFDM<
M&X:Q!18R2V['3/6K4WPJM9-9-\FKW4<7]IKJH@\N,_O@0>7QN*\<#/&:L?"7
M4M8U7P%:7FLS)/+*SM'-YA9W7<?OY'!!R..P%:7C?19-:TJ*..]OHA YG:UL
MI1%)=[0?W8;(QGZT 48OAQ90V5A;)?W&VRUAM60X7)<DG8>.GS&JUG\*]/L$
MB%M?W$;B&ZMYW5%!GCG);#<=5)R#[5R?ASQMXBT_PCH6GVXBU#6+O4;C3R+^
M1\V[(<A78<L0IY/IBF>-_&7B;4_"OBF&"UL[6WTHPVUU/%<.LPG)0N8^,%0>
M.<$CGVH [:V^&UG;1SH+^X;SM#716)5<B-1C>/\ :_2N+\6^!M9BN;JUT73]
M4ECN=+AL3<6E["D<YC7:OG(X!7&.JGD<=S77_$JXN+;X/:E/!/+%.MM"1(CE
M6!WIGGK7 :C;OIW@][NV@\4Z;,U]91DZI=,PD!?DIAOS^HH ]LT2S?3M!TZQ
ME(,EM;1PL1T)50#_ "J_0.E% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 44#I10 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !69K/AW1_$,<4>KZ=!>I"Q:-9ER%)ZD5IT4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+2A3EFP,A5 [=<UVG@KQ#J&OZ;=-J5FUO<VURT._R)(4G4<AU60;@"#T/3%
M&AI>@6&C:EJE];;Q/J<PFN-SY!8#' [5C:S\./#^NR:FU\EPS:C+%-/MEQ\T
M:E5*^G!.:XK1]'L_&]WXQU7Q'J-U%-I^HS6EM(ER\0LHH^0R@,![\^E,UO5)
M[?5G@TG44OKF/PE+-%K!F8M(%<@G"ML)P#AL9SWH [F\^&^A7K7$A^UPS37J
MWXEAG*/%,J[04....U,M/AEH-DT#QM>L\&H#4E>2X+L9\ %B3US@9KE-,\=Z
MOX9\/Z&^O-:2VEUHLMS!."_F/-&H8(S,3DE2/QS7HGA34-0U7PMINH:I%%#>
MW4"S21Q A5W<@<DGH1GWH RU^'F@II?]FA;CR!J7]J#][R)LYZXZ>U:_B#0-
M-\3Z2^F:G$TENS!QL<HRL#D,".017'>))95^-_@Z,3.D3VEUN4$A6PAQD=#6
M=I>DVOB3Q5\0+34C<2V]O>021*EPZ;6$3CC:1QSTZ4 =-9_#70K:+4EGEU"_
MFU&V-K/<7MTTLOE?W0QZ?_6%7-&\$:;HNHVM_#/>SW5M9FQ22XFWDQ%MV#QS
MCH/;BN8^"VD6O_"%V.O$W#ZA=)+'-))<.X8"4@?*3@<*.@KM/%MV+'PAK%R;
MMK3R[.4BX4$F,[3A@!W!H R;3X=Z/9:S%?V\^H)'%.]S'9"Y/V=)'^\P3'XX
MSCVIVE_#[2=(U6&\M;K4O+@,A@LWNV-O%O\ O!4].>A)KRSP/J\^@:WHU[JW
MVW2[.?2);B4SW;W(U(JNXR!<GRR!\V*G\*>,I=;^,%AJ=[J\2VU]:2I;V:R_
M+""V(XV'3S#C/XT >@6'P^71+[15TG4KQ-/L+F6=X9KEF!5TQY:J !MSAN>G
M/K6YXD\*V'B>.U^U27,%Q:2>9;75K*8Y8FQ@[6]Q7"^&UUFT^.%[::QK#7\D
MFB&?")Y<4>9D 55R>@'7KR:R=;LKKPGXQT2_BU?43976H+]JUF:\,R2[B?\
M1_)7@#C&['&?:@#O;#X<:%IJ:2MN;K=IET]Y&[R[FEE<89I"1SD?2H-9^%NA
M:W>:A///J,,>H$/=6]O<[(I7'1RN#\U<;X]L;O0-9M]?M=4U(QRZG&UWJ1O,
MQ64>0/(\E?O#GT^O6NZF\=Z5J&K7?AG1]11?$ 61(A- YC615)Y.,$#&>M &
MQKGAZR\0^&Y]!O3*+2:-8W,;;6PI!&#CU [5'KWAJQ\1:3#IMZTPAAECE4QN
M VY#QS@UP_PU75X];\=65UJKWM]!<QHMQ,#MW[&YV9P!G' [ 52\+3ZSI7Q
M\;1ZEJDFI75KIT<X8C9'N*[L*F2 !G% 'KX/%&:\"\-WNI:=#X#UR/5KZ>^U
M^\FAOTFN&>.52Q ^4G V\=*@_M#7?#]_HU]>MKR:])K7DZ@)C(;66)G(54S\
MA!&,;??VH ^A:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#A7EKC'VQ/_!99_P#QJC_A7=MVO8__  5V?_QJNTHH XO_ (5W;'K>Q_\
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M6\?>$I? FD3V!M06U1O*:,(GRY1R?O-C<,\YR* /8/&/B6'PCX6O-:EB,WD
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M;&U%S=27,I0 '!VC'?!7OWJ&;XN6_P#PKJR\1VU@9+Z]N!9Q61D_Y;<Y&?3
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M82R!@$W!2>V?YFH[WP]:Z5\%-'U>RBQ=:G-#%J-Q)*X!@+L0IP?E3(0' [4
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M05RDOQ"T9/ O_"6H)Y+'@>4% EWEMFS!.-V[WIP\;PW'A*Q\0Z9I6HZG!=D
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MXC^TM9S6+RYMS"NUC"""R@_P@\9QVK1TKPA+J=UX)L]3L+ZYTD3:BTD=Q:-
M(D*@QHRAV*KN'R@GD8%>Z44 <5\3$D'@U;>'2?M\+7$*2Q[)'6*,-RY2,AG
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MW#I'+@Y(:89R>X'0UUOA[P+IGAS4I-0@N=0N[IH!;+)>W)E*1 YV+GH,UTP
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M0[_OY4?-]?6E6)$9F5%5FQD@8)H ?1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444A7)
M!R1CTH 6BBB@ HHHH **** "BB@]* .!D^)%R=2UBVL_"NI7T6DSF&YFMY(S
MR!G(4D$\>E27GQ*@,&@2Z+I=QJQUM9&MTCD2,KY>-P;<< C)_*N<TR[\0^%_
M$7B_RO"&IZA_:6H--;2Q!5C(Q@9)/2L"\\ :EI&A^"[&_P!#N]:BLC=O?06,
MA4J9""H# @C'U[&@#T:]\=7^G65L;SPS=0ZA>W?V6TLVN8OWIV[MQ<':HX/7
MFAOB+#!X>?4+K1]0@OUO?[/33BH,DL_&%1NC*<YW=.#7)76D&?PE!96WP^O1
MI$5\7NM-N9V:Y8%.)87\S((/49_K5;3?#/B6VT"WU*+3;XII6M_;+#2;N8-/
M]FVA63<>_)(&?6@#K9_B6^GZ+K%WJWAV_L;S2UB>2U=E82+(P52D@^4\GFI(
MOB-)#>M9:OX=OM,N6LIKRW622.19EC7<P#*3@X]:PO%,OBSQCX'\2P-X=FL[
M>18$L+60#[3(PD!D8@' &!Q59O!5WX<\2WSVFG7NI6>I:/-!#/+*TTEG-M.4
MRQ^ZWKUR<=* -^/XG3WK:='IGAF]OIKW31J1CCGC4QQERN/F(R<@=/6F7OQ4
M,'ANU\0VOAR^N=+F4>9-YL:&&3S#&8V4G.=PZCCD5S7A_P !:EJ&I:#%JD>J
MZ=;P>&UMY9;:;R2)1,?W;$>QSBNF\<>$S9_"E_#WARQFE$4L)B@0EW($RNQR
M>IZDT :,7CR:+6='TS5="N=-GU,W!7SIHV\M84#ECM)&"#CVQ6:GQ63[''K$
MOAW4HO#LDHC74V*8P6VAS'G<%SWI_C3P]>ZUX_\ "\D5O*;&.VOX;F=!D1>9
M#M7/U-<Q>6OBR^\ 0_#[_A&+B*Y58[1]2++]E\I6'[P'.<D*.,9YH [J#Q_8
M2^+M9\.-"Z7>FP>>"6&)UV!B%]QN%:_A_7X=>\+VFNB,V\%S#YVV0@[![G\*
M\RU3P/J]SJOBV^L8)H;VVDMI]+G*C_2 L!22//<,.,>N*[;P;HUS%\+=/T:^
MBDM;@V!@D1Q\R$@CI^- &6GQ5B-O_:DF@:E'X=,WE+JQV;/O;0Y3.[9GO5R?
MQ[>MKNI:9I?A>^U(6#HDTT,\2KEE## 8@]#7&SV?BJX\ +\.D\-7*7"@6K:F
MY7[+Y2N#Y@.<Y('3&:V=(^'T-[XP\0W>JPW\<:7-N;.2.X>)956, G"D!L$=
MZ .Z\0ZY'X=\-7NLSP22QVD7FM$A&XCT':L?2O%NL:E- LG@_4K6"9"ZW$DT
M)0?*6&<-GG '3N*L?$&QNM1^'^MV5C"\]S-:LD<:#)8G' %<'X0LK+0]3M;J
M'P)XIMKR.!E:>64O%G8<C:9#U(P..I% '3V?Q/L=0;2[6VT^Z;4[V[>UDL"5
M$MJ4^^TG/"@8/OFHU^*-M-8QO:Z3=W%[/J,VGV]FKH#(\8RS;B0 N/6N9T/2
M/%6G>+(?'=UI;-)K%P]O?:<D7[VT@.T1M[D; 6]0:IQ^&M3M_#,MOJGA.35-
M/;7+NXN+>,,MTJMCRY(<,..N?:@#NX_'UU/HL][!X7U-[FTN'@N[1FC1H2JY
M+;BV&7W%9O\ PMD+X8'B&;PWJ$.G2-&L$K2QD2[F*\8)(QCN!3? FFZS!X4\
M0P3V>HV]C*7&EV>H2;[A$\O!!/8%N@[5@W_AO6I/@)HNCKI=TVHPSQ&2V"?.
MH$K$G'TH [6'XC:;+J?B33?(F6ZT.)YG5BN)U49;9SVX'/J*BF^)$!M]$73]
M'OM0U'5[47<-G"5!CB./F=B<*.<9]JXG6_ >L7MSXNU>RMIH=3COGDLCLS]K
M@DB"2(/4$9Q[BKMAI6M^%G\/:XNB7][$?#\>F7EO: ?:;=U.X,%)YZX]L4 >
MA^%O$\?B:UN7^PW=C<VLQ@N+:Z0!D<>A!((YZBL37/B99:%J&OVDUA<R-HUO
M#/*R%<2"0J !GN-P_*HOAG:^(HAJ]QK?]J):S3(;&+5+@2SH@!SNQP,DCCVK
MD/&GAK7;SQ%XYGM-*NIX[VSLDMV1,B4J\98#UP <_2@#T!?'VGS3^'UM8I9X
MM;@FFAD4@>6(DWL&'KV^M96E_%6"^BTNZN] U*QT[4Y1#;7TAC>(N3M ;:V5
MR01R*P!X,UC1?B?8&SMGE\.[;R> (GRVLDL)#H3V!8#';FLS3=/\2:G\/]!\
M$-X8U*S>&XC:YO[A56*-%E+DCG)..W% '<'XC74VHZE:Z=X2U;4$T^Z>UEF@
M,>TNO7&6![@_C2W_ ,26L]6U2RA\,ZO>KIFW[5-;K&0@9 _0L#T_E7!-H26W
MBCQ%<:KX0\4WK3:K+/;S:<S)&T9(QP'4'H3G'0T_7M%DN?%OB>:^\+>)[R.^
M:(VSZ>QCC($0!#X8 \^H/0T =MJOQ2M].TBTUF+0=4N])NHHW6[C"!5+L5"D
M%LYS^'-2W/Q%N+673[:3PIK!O[[SC'9CR_,"Q[<D_-C!W#\C7-ZUH?B*?X&Z
M;I=S822ZM')!OMX(P2J++D95>.%QG'O5KXGZ1+?^*O#EU+HNK:EI\$-RLXTS
M<)%9MFWD$8Z>O:@#:O/B++I]OIYNO#&KQW=_<M;06A$?F,54-G[V,<D?@:27
MXI:=!X=U74[G3-1MKC2I(TNK"=%29?,("D<X(.<YSVKC[F"Y@C\*7ND^%/$B
M6NE:I-)-;7,9DN""@^898_*2<#GL:BU_0]>\1Z=XNUXZ%>VS:@UC!:V$D>9F
M2)U+.RC/Y>QH ]&D\>:;]IT^.W26XBOM/EU"*6+:5V1@$@\]><?6J.@_$2;7
MVL7@\)ZW%9W>"EXZ1F)5/\1(;I7'IX,U70O'LUI9VMS/H*Z;>M8NL9*PM,,F
M+/\ O#@>A%5?A_IR:.=&27PMXNAU6,>6\THD^QJY!&67=@)SZ<4 =M9?%&RO
M+VT"Z-JJZ;>71M+?4C$IA>3<5['(!(/.*9=?%73[6_O8QH^K3:?8W1M+G4(H
M0T4<@.".N2 >^*X6STW6+77K%M'\,Z[HVM-J(^WF N=,>/?\[#<2""O/;GIV
MI?$.F:P-:U2XTKPSK>G^)GO#]GO=,9OL=RA;[\A8[<D9R..U 'NZL'4,#D$9
M!JKJ-U/963SV]E->RKC$$+*K-SV+$#]:J:3JES=WE[97.G7-NUGY:_:)$Q'<
M%ER3&>X!XK6H XNR\?2WJW\G_",ZI%!I[RQW4KR08C:-2S# D)/8<>M;MIXB
MLM0T/^TK-UF/V47)MUD3S%!3<%;G /U.*Y?2].OH_#_CF,VDZRW5[>O;HT9!
MD#( I7CD'MBL"?PM-::3X=33M%>*1O#MW!=".VP3*T"863C[Q;/![YH ]0AU
M:SD%LDL\<%Q<1B1+>611)@C.,9Y_#-72<#->+:GI6H0RP-;Z+>W%V\%CFVGT
MXRPS%%0<3+AH"I!R"<9&<<UZ1XSN=2@\)7,>DVTLVH76VVB$:%_+,AVESCH%
M!)S[4 )X7\9Z=XKDODLDGC:TDV_OE"^:F2!(G/*$JP!]C6VE]:22M$ES"TBG
M:R*X)!],5YM'X6UOPAJ>E7MO=I?0&W_LAUM;$QF&(@E)6PS9"OU/'#&L/3H[
M*"^\!6?]ASPZG#=.MQ?-#A)F\ERS++TE#-\V03^% 'LIO[0*[&ZAVQXWGS!A
M<],^E.>ZMXX//>:-8<9\QF 7'UKQR3PK/IWA/PG/;Z<ULL;&34U73C<N9"C;
M'DBZL%)8<]-P..*A&B:E_8FGR^5>#3$U>XG:.71BX0-& CBV#$^7NW$>A;.*
M /:C=0+$)3-&(R,ARPP1]:1;NV=HU6XB8R#* .#N'J/6O(=.\/37BZ)#=6-S
M<:8VORS>5+IQMT2/R&Y\O)VQE^1G')Z<U<B\)6]E%+>6VBM%>1>)T:%T@(9(
M/.7[O'$>TMTXY- 'J8N(3,81*AE R4W#(_"A;J!I/+6:,R8SM##./7%>,Z9H
M^I0Z[I\=PDXU1-8:>9X]&;<5\QBSM<E@IC9#CZ$#&16AI'AH6>B^'K^+27BU
M3^WI&N)?((E\MI)0=QQD)M(]NE 'I>CZU9:[:27-C(7B2:2!B1CYD8JWX9!J
MW]I@$_D^<GFXSLW#=CZ5QGPUM(M.TK4K$:?)9W$6HW!D#VYC#*97,94D ,-N
M,8SBN'N[.YF\5QW4>F-#=IX@221(M+F>98A-M\Q[DG;L*_PJ,8/M0![6;F!2
M0TT8(&X@L.!ZTIN(5B$K2H(S_&6&/SKR2+P=9SC1+JYT/==7'B"[-X[0MEH=
M\^T/_L8"<'@\>M9^I:)>">UAEMO)T.TU+455)]-DNX8\R QDQ*02I!<*>0,T
M >UO/%&NYY$5<9R6 %#S1H@9G4 ]"3UKR#P_X7.H:GX;M]9T^>[L(K:_>-+N
MS,2(#)'Y:E"S8&,[0QSC' Q5?2-,C@M](_X2;2KJXT>&VOH+>$VLDOE3_:GV
M?* 2"8P I]N* /6=&URTUO2+74K<LD-R"8UE 5N"1TS[5<NKJ*SLYKJ=ML,*
M-([8SA0,FO!WTIX_#&C&YTZ=KB'2_+2RO=.EF65O-<[$="&AEZ<^X]*]?U.T
MEU3P#=6LED5GN-.9?LKDN5<Q\*2>I!XS[4 /LO%>EZAJ-O9P2.3<6"ZA'(P
M0Q,P4=3D')Z8K:,B* 68#/3)ZUXYX9\,Z3K6LZ*EUH6^RM_#BH8Y[9D1;D2C
M>"I &[))_'(K%33]0FL]#;7 ([&+2#%"+[3);M5E$KAEVJRE7VA,$]NE 'OQ
M8!22>!5+3=7L=6TV/4+.</:R%@LA&T'#%3U]P:R?!]I<#P%IMIJ)N)I/LWEO
M]KA\N0KR '3<V#MP.IKR6'1\:-H%J;-+73[9[L:@ESILLT27&X;#)&I4G*<!
MN10![XTB*,LP ]31YB9QN&?3->+Z1X<;5K_PO9:M:7%WI/G:BRQSVC01K'A#
M&-A9B$R"5#'.,<<4-X1M9;"6\?2Y?MC^*C$TFU@_V8S[2 >T94GIQS0![.)4
M*;]PV^N>*<"",CD&O'M8T2""/5M/6WEL],@UR-[=19&>U4&T3/F1@@F,L6Y'
M1J[;X>EQX7"&Q%HB3RK&J"18Y%W9#HLGS*AR<*>G;B@#JO,3?LW#=Z9YH\Q=
MVW<-WIGFO"X87D\5:=?1Z>EK??VZ&N$CLIWN8XS*5)EG8[0A!& !C!&.F:V-
M-\.1V=GH.L0Z=,FK2>()%GN"K;Q"99EP<]$V[>.G>@#TW4];L]*EL8[@N6O;
MI;6((,_.P)&?084UH%@HR2 !W->)Z?I]C'<^%4DTZZ'B6'6=^I3-;R;C_K,L
MSD8*DE=O/3I7=?$*W$\>B&[BDFT9+\'48T1F!C\MPI<+R4#E<T =CO7;NW#;
MZTNX 9SQ7D,D&A&_TXS:=?IX02:[^2>-VMS+B/8P3J(_]8%!&,Y]J@TO1O[8
MU31+6\L;QM .IWYM()Q(H^S^4ICSGG;N!(!H ]D+J%SD8]:Q[;Q/8W;-Y,=R
MR)<S6LD@A.V-XAEBQ[#C@]Z\QM-/2WG@M-;AG?PQ9:O?Q&)U=XTZ&'<!D[ "
MV,\9Q3=%T^*=M/M;6RN5TZ;4=5"12HX)C:+Y0<\X/;- 'JVG^(+'5#9FR\^6
M"[MC<PSB%A&4! Y8C@\C@\XSZ5IA@>AKPG3K6^3PK80:'!<17B^&;J.58XV5
MA.)8=ZX/\>-V/TJQK$=DEE>)X+@NEM?[#N_[1,:2X,FQ?*#9_P"6N=WOUH ]
MN# YP>E (/0UXWJ.BQ:->26NG1ZA;VM]X:D>Z-J&E=Y0\?SX)^9\%L\@D9K<
M^&;QPZKJEG;06[0"&*0W5B95MG;+#;Y<F=LF "<$YXS0!Z02!UK(U'Q+8Z;K
M-GI,D=U-=W:ET2" R!$#!2S$?=7+#FN$\10:8_C;6I/%HN6LUM(?[)'[P)G:
MWF;-O'F;L>_2JWA#2+FY\7>'+S7;67^TAH3R2R2A@V]9E";O]K9C(- 'I]SJ
M]C::C:V$\X2ZNU=H(\'+A!EL=N :31]7L]=TFWU.P=GM;A=T;,A4D9QT/TKB
MO&-I9K\1_"%[=Q$1A;F+SB6"A]JF,$CN3G&>M<MX9TAM'\.>!]3TZ&:+4[N[
M:&Y=W<[D:.;Y6!. N0O;C% 'M>0:H:EK5EI,UA#=NRO?7 MH-JDYD() /IPI
MYKQGPH+^+5-"=KM%UN2\_P")C'%'.]P5RPD$P+;%3T.,#C%=]\1(YWN_"9MT
M+2+K*$$#(!\J3!/MG% ';YYHR*\9T>6WA_X1MK-[P^+9+Y1JR%W\PI\QF$BG
MY=N/N_ABL[1[M#X@T:]M-L%Q<RW/VN,7$TUP T4I"SDX13N"X7'4<4 >[YI:
M\J\'::-+N_!%W;FZ$VI6$QU!Y97?S6$:,-VXD#!SCI5WXG-<?VIH"331PZ06
MG:Y:X:1;<R!1Y8D9""!RV.<9% 'H^154:C VJ-IW[S[0L(F.8SM*DD<-C&<C
MIG->20:AJ6A^';/Q7%/-?V]G<W-LD4:R%7MW&(P-YRRK(!AC_":;?6FI:.XL
M);N]P-*L&U&2)VW!6NF-PPQTX)Y'(6@#UNWU6TN=4O-.B<FYM%C:9=I 4."5
MY[_=-7,UX;J!MXO^$B_X1:=FTM[G34N9A-(R"#Y]^'!+;,X!*G@%J:6N9;.6
MRLM1#:3)K6GQ(-.FF:.,.2)0DS<D$;<@'@_6@#W3(HR*\<U&WDTC5-6T6*6Y
MB\-0ZE8&Z0RNPBMWC8R?.26"EU3)SQDU6U:XLII;&WTJ[D/A9;NX$LNH7,BV
M?FA(RBK*AW>7DMC)QNR* /;<U1TG6++6].6_L)#);,SJ&*E>58J>#[@UY)IM
MRLS:./%%_,/#HCNC;S/)+%&T@E'E*7.&;";MI)YQGK79_"E5'PYL0GF;/-N-
MIDSN(\Y\$YYSB@#J=)U:SUS2X-2L)#):SJ6C<J5R,D=#SU%7:\'\)?8(M+\)
MQ:/>7+:Y/>>5J$"SNQ%L2_F;TSA% P5.!V(ZUU/AR34[SQ9:^&IKBZ\KPT\T
MEU*[G_25?_CV!/?Y"2<]UH ]&N=0M;.XM8+B98Y;J0QP*>KL%+$#\ 3^%1:3
MJ]EK>GI?6$IDMV9T#%2O*L5;@\]0:Y#Q_!9#Q'X/O+]S';1Z@R/*96C5<Q/M
MR01C+ #].]<?I.G+I?A/0==MI+J+49/$ @E83OM\I[IT9"F=NT@^G7F@#VS-
M5K;4;2\N;JWMYUDEM'$<ZCJC%0P!_ @UX=K.L(]W/JEO<_9=334PH6?4Y6O$
M190I!@4!$CVY/.>,<G-=UX'@L;3QWXT@5]MZUZL@C:5B3$8T.[:3TW$\_ATX
MH ]!HKR[Q-=:<?%^LIXJU&ZL+*VLHWTHQW+0;B5;S&CP1OD!  !SVXYKF=8U
M2^>^U6YOM3^RS11Q?V6UY?36]QL,2D.D,:E96+$[A@\Y&!0![I--';P233.J
M11J7=V. H R2:2">*YMXYX7#Q2*'1QT8$9!%>73:5+K]QXFFU6>\EN;73(#'
M##<2Q1B1K=BQV CJ>Q'X5AW.I:9)IFFVEG=DQ0:.DL+W&L20Q&0[L^4%R\L@
M8$;2<+P !0![1'J%O)J,U@K-]HAC65U*$ *Q('.,'[IJS7BMQJ^I7WAJ:?\
MM*Z2:;1]$8RQ2$,'DN'#L".A/>NTT"W&C?$'4M%M9[@V']FV]TL4\[R[9"\B
M,07)/(49YH Z76M=TWP]8?;=5NEMK;S%CWL"?F8\#BM $$ @Y!KSWQ8;SQ#X
MSAT6QLK>^@TVT>XNHI[@PKOF5HT&X*W(0N<8_B%96G3WFL/X:\.ZM>7$,]I)
M=V.I1VUPT?G-%&I3++@X*E6[=30!ZQ17D-A]KL(_#VIV]_?S7D^L76GL)KIW
M62%!.L:%2<<>6G.,^IJIX6U/4'U31I6U2 ZE=L_]H0?VE-/*_P"[8LKP;-L)
M5L8((QC&3F@#VFJMQJ-K:WMI9S2[;B[+"!,'YRHW-^0YYKRS2?M^GZ9X1U:T
MU#4+G4=6LYA.MQ<O(LK"U>1!M)P,,H QCCK56SNK9;[PS=:7K,VIZU)97<\T
M$MT93Y_V<]4).P[OEVC'3IQ0![/5674;2#4+:PEF5;JY5VAC/5PF-V/IN'YU
MXYH6NZY%96]S::E!=7]QI=Q/-"=3>Z>:58MP/D^6!$P< 8R!R1R:V-"EL)?'
M'A.2VUZ?5+B73KF6<2W/FE&98^<?P9(/''3VH ]5HHHH **** "BBB@ HHHH
M !1110 4444 %%%% !110>E &%=^-/#ECJ#V-SJ]M'<(P1U).$8] S=%/(X)
MHO?&?AS3K][&[U>VBNHR!)$6R8\@$%L?='(Y.!S7FGB;PKXMU.TUZS33[R1[
MJ\>2 07%O!:-'O!5F4?.TA YW=ZZJ^\-ZC<6/CY4LU,VK*!9DLN9/]'5 "<\
M88'K0!K^(?&^EZ)OMH[B&;45EAB^S;B.9'4 %L8!VL6QU(%=..E>9ZAH&OQI
MJ>G0:,EY#?:C;WRWAN$7RPIB+*5)SD>60,=C7I8Z4 <K/K^O3^(M3TS2=,TZ
M6/3UB+R75X\1<NI88"QMTQZT[3?'>F7'AVWU;4G33_-FDM_*+>9F2-F5MA4?
M./E)R!TK+N_ =IKOB7Q)<ZO8AH;N.!+2X#_.N(RK%<'((..M8[^&/$*VNAR2
M6$Z2:6EQ9O'I-S%;M*C%2DR _* P7YEX.30!W5QXO\/VMK;7,NJP>1<H9(70
MEPR#JWR@X49&2>!51?'.C'7[W37NH8XK6RBO#=,_R,K[CUZ8 "G.>=U<5)X3
MURST;3A#IE^EVL=R2]AJ2>;$TDF\))O^21#P3P<$''%7+K0O%7V:ZC^P6\]U
M>:%:6KRKY7EI-$\A=0C<<A_E.-H(]* .EU+X@:'::!J>J6MTEV;"(2R0+E&(
M)PO4=">,XQ5R;QGX?M/(%UJD$+31+,H;/"-T9N/E!YY.*X"7PEXCOSKA:UU
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M8M^ LBMC#H69!D8QDYZ5SNB^'M6\&W>FZD-/DU)I+&2WOH;1EWQ2-,9MR!B
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M=D8M&XM0<Q_[6X#D<\4 >PN(F*API/\ "#_2JEI>Q7KW.;:>$VLS0EIX]F[
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MV^W:9;VZ1F57*R*9=RDCC'SKS5[PKIE]I'@33-,N B7UO9K$PSN4.%QVZC-
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M520#@AAC.?F-+%HNKKJL?B Z#.++^V)+L:8IC\U4:W6,2;=VW=N!8C.?F]:
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MYATZ2#3X-/*W$5MIHN62Y9$^=XL<D@,-V"0?K0!ZS+?6D$0EFNH8XR-P=Y
M1ZY/UHEO[.&W6>6[@CA;&V1Y %.>F#TKRWP_X8DDU3PP-0TFXDL8DU"3R[Z!
M<0[V0H"@RJ9^8A3TK,70=0L%T>>>RO4TVQDU")(DL/M1A+7!\L^4>=I3(# '
M''K0![0+F!ND\9^3?PP^[Z_3WI/M=M\G^D1?.I=/G'S*.I'J/>O%;KPWKUMX
M9T^]T>SOFFNOM>GO!/"(Y((+A@5.Q<[45@6 /W0U1/X*U^72==T\6LXCT>'[
M#I@/+7%N]P)GVD\,?+54QWY% 'ML5]:3P-/%=0R0KG=(C@J,=<FL^P\26.I:
M_>:1:DR26L$<[3(5:-E<L!@@]?E->4R:+>:@FJ75A9:E+:9LS=6[Z<+-+F..
M7<ZK'P68)D$XP1QS75^"X8'\?:_J&GZ+<Z=IT]G;)&9;-K=974ON(4@>H'X4
M =Y/>6ML4%Q<PQ%SA1(X7<?;/6EDO+:)E62XB1F.%#. 2?:O*_B%:7%]XAU*
M%]*=UDTU8;6:/3'O'G8E\HK9V0X)') /.<\"J#^&9+[P[XAN;S1I9;\>';)+
M1IK<F02B!MP3(SO# 9QSG% 'J7B'Q'8^&]*N+^[;>(%#M#&5\P@L%R 2/6M;
M< N6X'?/:O#_ !'83/HGB&VU'0;V^UN^FBFL;F.R:7;"%CP/, ^3;M?*D@\]
M\UZ;X\L+[5/ NJV>F[OM4L/R*OWG (+*/<J"/QH W8[RUEC:2.YA=%."RN"
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M9:OX1\10:3X@T32;"RNK75MKK<2W10PGRT1E*D,6^YP<]^>E>FPJ4@C5NJJ
M?RH \ZL?%WB^;PW-XF^Q:3<:9"TS/:Q>8DYCC=E)#$E<X4G&.:Z*7QYH4"V[
M/-,1+;I=,8K=Y!#&XRK2%00@(]:YBPT+QI!X3G\*II^FVUO/Y\;:BUZ9&5)'
M8DB()][#<?-UJX_AO6]!;4++0]/M;ZSU"TAM_-N+GRC 8XA%R-IW+M /'?-
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M;( &..E6+_1-:7Q')-IVCWD?GWT$\BRM!/9S ;,R-N^>-U /W>Z@CK0!ZJ2
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ML +[3M!Z$UXMI6AZ_P#VUX=FETN\@^R74KW426<4,%MOC<81AEY!D\MDCUH
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MLV>VM[6.VF:&2255FWNX!)0,!PNX]?2@#2O?'6@Z5X,O=2\.?9+R'3WC1K6
M^4$\R0+TQ\OWB>G-=PO(SBO&]7\(>)M3B\0O'8W\GVVTM8X?M]S TKM'/O;.
MP[5&TG ]CZUZGIVJF]U'4K(V[QFQD2/S"<B3<@?CTQD<4 -UKQ%H_AZ*.75K
M^&T64E8_,/+D=< <FH+GQ=X?L],MM2N-6M$L[K_42^8")/IZUC^+[+6IM:TZ
MXT^WNY+6.&59'T_[.MPKDKM&^;[J$ YV\\"N>\,^'=?\-KI>HW.CRWLEM#>0
M26Z3Q-*ADG\Q74LP4Y P>0>>E ';W_C/PWID-K->:S9Q1W2[X&,@(=?[PQV]
M^E)=^-/#5A=?9KK6;**?R_,V-(,[=N_=]-O/TKEK'3=>T;5)M6/AB&=KW3TM
M_LEE)&%M7621MIWLHVL'4DKGD'BHQX.U:XTCQ=!)86MK<:GIMO!;K P\H.D!
M4HO<*&XYH [V76-.@N'@FO((Y4M_M3JS@;8LXWGVSWJII_BO0-5LKB\L=6M)
M[:V&Z:19!B,=<GT'O7 ZWX<\1>*[K4)VT>?30^BQVD?G7$1,DB3"0K\K, ".
M 3^--NO".N:S_:,IL]25OL<<48U6ZM]TQ69)#&!",!<(0&)_BZ8H [/1O&>F
M>(/$4^FZ7-!=P16B7!N890PR7*[".W0'\:U=7UW2M!@6?5;ZWM(W.U3,X7<?
M0>M<]H<&IW7CR\UBXT.;3;1M.CM4,[Q%W=7+'(1FXP>/I1XRM-8DU;2;G3K6
MXDMX5E$LMC' ;E&(4*%:;A5/.2.>!0!K7GC#PY86T%S=:U8Q0W">9"[3+B1>
MF1ZBGZCXIT/3+6WGN]4LXDN5WVY>8 2C&<@^GO7#>"O"NL6&M:7<:IIS1I!I
M]["S22)(5=[D.HX/.4)Y ]>E5O#/AS6_#:6EW=>'YK]GTIK!K>&2(M"PFD89
MW,!L967H3TZ4 >@^$]:3Q'X9LM:6U%L;U/,,8;=@YQUP,]*MG6M,\EYC>V_E
MQW'V5VWC"RY"[#_M9(&/>LKP#IEYHW@72=.OX/(NK>'9)%N#;3N/&02#7(7N
MB:Z@O-'BT2YECG\1)J8O%EB\KR?.1SU<-N&#QCM0!W,/BSP_<ZHNF0ZO927S
M%E$"S OE201CU&#Q[4MKXKT"]U$:=:ZO9S79!(A24%CCJ/K[=:XN'PMJT&AV
M\::?_I*^*OM\@#("8/M!;?G//R'IUQQBLCPS::AK7AK3-/LM(FCCBUY[V346
M>,1[4N'9B/FW[CC;C;T[XH ],B\4:#<:L^DP:M9R:@F0;=9AOR.2,>M5X?%N
MFQ:5:7FJW5EI[W3.D:/=HRL58CY6'!Z?AG%>>VFA>)9;[0$N=,OHC8:J+BYC
MB2VBLXE)<%H@OSMG<"2>>3D9K0T30M6\/-:WMUH,VH*;&6T,$+1L\3&XD<$A
MF VLKC)!/3D4 =[X<UE?$'ARQU98?)%U$)/+W;MOX]ZIP^+=.BMKJ?5;FRL(
MX;N6W0O=HP<(>OL?5>HH\#Z?=:7X(TBPO8#!<P6X22(D'8?3(XKD](\+ZI'X
MBLKB[T\_9X=>U&Z)9E($<B'RWZ]S^(H Z;4_'N@Z;;:5=?;8)[;4KH6T4T4J
ME <'+$YZ# !^HK2;Q'HJ:P-(;4[,:B>EL95\SUZ5PESX=U:TF:ZBTJ6:.W\4
MG4!#"R;G@,6TLH) ZGIUZUGR>$]91;K27M=8F:YU-KP20/:I;$&;S%D,A4R*
MP&..N1@<4 >FGQ!HPO7LSJ=G]IC5F>+SEW*%^\2,\8[TEGXBT74;.>[L]4LY
M[:#_ %TL<RE8_P#>.>*X&X\&:E=^&_&D*V*I?7VKO<6[$ING@!B;:&.0 =KC
M#<9/-51X;U#57U>YETG6KB)M.%IY5[-;VSS$2*VU%C7'R@$AF.,\=#F@#M;_
M ,>^';/P[=:W#J-O>6ELRH_V>56.XD #K[_D*Z.">*Y@2>"1)(I%#(Z'(8'H
M0:\DN-&\1:MI&OPIIU[-#):1+#)J4$$5Y)(DH8IN0@,FW.">YKT31_$,6IZC
M<:<MC=VLUO;PSNMPBK@2;L+@$X8;#D4 5M8U.SC\7Z#I%U8),]PL]U#<LW^H
M:)1D@8[AR,YITNN^%]39Y?[0T^[?2R;DA9E8PE01NZ\<$C/O6'XYTC5;[Q)I
M5WIM@EV(=.U&(B49C+O&@16YZ,016!I.C:S/XGT:XDL-26VALKBVF:YM8+>.
M%FC&$58QDKE<9.1TH [ZS\8Z%<Z#8ZQ+J%K;6UXBM'Y\Z+AB/NGG&1T(K=5E
M= Z$,I&01R"*\8MM&UB'^Q=0DTW6;>.#1TTUX;:T@ED29&^8E) PV/\ WAZ<
M]:]*\%:;/I'@[3+"XCFBEAAP8YI%=TR20I90 < XX':@"EIGCFSU+5]9AQ:P
MZ=I;^7)>O>)RXQGY.R\D;B>2#6\FLZ8^F_VBM_:FQQG[0)5\O_OK.*\UU;PS
MJDAU"YBL[A8XO$?VYD@BC>2:'R0H9%<%7PQS@^AQSBJ1\+ZO-:?VC';ZLD U
M87<L4L-OYTBB'R_-6#9L!!Q\IY.">N* /57US24TU=2?4;1;%R MP9E$9)]&
MSBKD$T-S DT$D<L3C*O&P92/8CK7DD>A74>DO?-I^NIOU8W4;B&!IX\Q;/,^
MS!-NUN05ZC[U=M\/XKV+PM&M]IZ6,GGRE(Q (2R%R0S1@D*QZD"@#?GU"RM9
MHX;B[MX993B-)) I<^@!ZTY[ZSBN5MGN85G<X6,N Q^@ZUYUK]@EKXA\2RZA
MX=NM5;4X(DL)8;3SPN(]IC)_Y9_-\V3@<YSQ5KP1X9N;+Q%?7.M68EO([#3X
MH[N5 Q+K$PDV.>^<9(]J /0Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M1-Y;F##6_P Q !^=B<>@YKL_%VD7FM^');&PE@BN_.@FC><$H#'*DG('/\-
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M.QSMPH(R <'!Y-4W\#>(+Z;7)GMO(6_T5[*(76I/=2B7<"-S,, 'G&W@8]Z
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M$TR-&>N>0"?YT >@4444 %%%% !1110 4444 %%%% !1110 4444 %!Z444
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M;C8#M7[V>^*W+/P8;"ZA6VUJ_BTJ"<W$6G(55%8DL07 WE-Q)VDX[=.*AM?
MD=O/ LFL7TVG07;7L=BX0()BYD!+!=Q 8Y )QF@"2R\:+>2Z1:+9XO[VXG@G
M@$F?LWDY$C$XY (4#@9W"NI8_(Q]JXWPQH<O_"5Z[XCNM.DL7N76*WAE=68
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MGA4"9!()0E1@XJ9O 5B--U^PAN)8H-8A2%@ #Y*K$(AM]> .M $WCO5;[2_
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MRAG$>1G<23R*S-1TN/0_A=8^.[/5+]_$!6WNGN6NW83M(R[HBF=NWYB, =J
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M]PX1W&Y=@PIV'D$GVK%TGX@ZO8>$M&N-6CL#<7[SD7=Y>&&+:K\*6\O <Y(
MZ87.>U 'JM%4]+O)+_2K:\F@\B2:,.T7F+)L)'3<O!^HKC1\1F3Q5;Z1<6M@
MBW-XUHB1Z@LES&?FP[Q 8525_O9&1F@#OJ*\YE^)EU;Z1'J5WI-K:P7ER;:Q
M>?4 JR,I<,TC%?D4!">Y.0,5T?A'Q7!XJM+IT$ GM)O(F^SSB:(G:&!1P!N!
M!]!R#0!T=%<AK_B[4M,\03:5IVCQ7I@T[^T99)+OR@$#,I4#8V6^7BJ4/Q#F
MCMOMNIZ1]ELI]-?4K1DN!(\D:E!M9< *Q\Q,<GK0!WE&:XB[\>W.A1RGQ'I
MLG-I)=VZP7/G>:$V[D/RKM<;U]1SUXK&UCQ'XACUTKJ=I)IL"Z%>77EVE[OW
ME3'@Y*#:ZY/8CYN] 'J&:*\?UC6M:75]2NI;F_AT[3[&S,2VU^$9FE; =E,9
M#$Y.>PV^_&]??%.RLM7NK?R[,V=I<BVF=M0C2XW9 9E@(W,H)]<G!P* /0J*
M\Y\3>,=8FTS4)-(TUULK:_CLS?K<@/O$R*Y$>.5SE<Y[YQBO0Y9/*A=]K-M4
MG:O4X["@!]%>=V_Q0/GW4-[I<,4L.G3:@L<%^D[;8P"4D"CY&P?<<&IV^(TE
MBMR=9T62R=;);VW1)UE,RLX15. -K%F48YZT =[17$:%K.MWOQ#OK+5+4V,4
M6F12K;+.)4W&1AO# #G Q^%;/B;Q!<:%';&WT];HS,RL\MRMO%$ ,Y=VSC/0
M<4 ;U%<#;_$E]0@T<:;HK75WJ;7*+$+M D;0'#'S,8*]P1UXJ32OB*;\V$]S
MHLUEIUZ\L*7,DZ-B6)79U*CG'[M\-WQTYH [JBO/M.^*=G>O;M)9I%!>)(UH
MRW<<CN54L Z+S&2H)&<^AP:EL?B1YD-C=ZGH\VGV.H6<EW:SF99-R1IYC;E
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MSXR\1Q?VCJ20Z8=*L-6&GO$4?SI$,B(7#;MH(WCC!Z&K$7C'5D\7_P!FWO\
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MH);<BTTWR6F#IM+NV\DMP#Z=?6NI\0:X=%AM!%:/=W=Y<"WMX$8+N8@L22>
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M61CC:3GDJ2 <<U9_X6/:36VGFULG:\O$E<VT\\</DB)]C[F8XSNX&,YI\/Q
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MIY98-B!R<_,,\ @>AY[4 3O\/-'E^47%^+7[4+Q+9;DB))M^_<!WRW.#D<\
M59E\$:7))<R>;=HTUU]M0I,5\B?!!>/T)!.1R#Z5P_@S5=8T/POX<N&N8)M-
MOM0FM/LH@(= 7F(8/NY.5Z8Q@_C5W0/''B+5$TC46LY'M=1G"20"R9$@C)(#
M++N^8C R".YQC% '4GP-I9LWB,UX;E[A;HWQG)G$JC 8-VXR, 8P2,5=T#PS
M9^'GO9;>>ZGFO9!+<2W,N]G8#&?RKA=.\4^+K_3_  W=?;M-3^W;B6WVFR;_
M $?:'(8?O/F.(SP>.:[#P;J]]JMEJ,>HM%)<V&H3632Q)L$H0C#;<G!P>F:
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M;' @BC2./>KC:JJ #E?QS[5-XRN-5B\9>$HM)>,33/=!EFD81$"+.7"_>QU
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MZ=,]:Y:3XFZG;Z5<:M=:1906#7S:=:.]XV7E$C*6?Y/E0!6)/)XZ<T ;FI^
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MIB!\H1E#&6(*[1Z@]*;#X\UB6/2=2&B6O]C:K?I:6\OVL^<JLQ42,FS&#@D
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MC_J]V[;C..O.>M5K_P -Z5J6K0ZG=6OF74430!O,8!HVSE&4':Z\]&!K6HH
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M[CN7%QYC\.QDSN)(X.>H ]!5C3_"&DZ9<65Q:Q2++9B8([2,Q8RD%V<GEF)
M.36]10!AV_A32[:UTRV2-S%ILCR6X9R<%E93GU&';K5*R\ :-8S*\<E^\44;
MQV\$MY(\5N&!!\M2<#@D>W:NHW+NV[AGKC-+0!@?\(?I)M]+@:.1H]-M7LX
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MK<W!CTR[^U1,2N7;Y^&XZ?.>F.U=%10!Y3!X3UZ34])M/LU_::?8:H+W8]W
M]JB*S-B,*/-.<C ?A<GVKO?$7A]/$$%FIO)[2:SNDNH)H0I*NH('# @C#'M6
MQD>M+0!Q]QX @N8+BP?5KX:-<SM<3:</+"%F?>0&V[@I;DKFMW7M%@\0:%=:
M3/))%#<1["\6 R\@@C((Z@5IT9H YL^$8Y;'6[>YOYYGUB!8;F4JJGB+R]P
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MKJY=H6"A2\S*=V/]HJ#GUQ0!PEQXD\2!;'1X[R[N+@W][;R75K%;K/*D# *
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M\KQ207,D4B&1BSX=6#8).<9Q0!)X3U:]UCP]%=W\!AN@TD;@QF,,58KN"GD
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MQ)O=V8DDD_4]N!0!Q]A\0;F?7VLKJUL[=!-,C6\D[1W4:(&(DVNH#@A<X0G
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M$O,O)X<8(!ZD9YXK1U[4K\^,I4L=::W1!8G1C+=W.)(F5=Q6-$83;CD,6Z4
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M%>6ZW/K#6GB;5(=>U&":QUF*TM8XY!Y:(QA!RI&&_P!8>OM4M[J.HZ5X@O\
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M\U8BRQR.@\Z(J0RL5) 8>HX/>O+8]-%G'JEU#/>B33O$UO;6@:ZD810,\&Y
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M:>'6Z2Q>:+<OS*=N<X]1UQ7G^J:B-)M+Q/#WB:_U%)-#N;F>66],YA==GER
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MS@6"VBCAA3[J1J%4=^ *\>OM7N-*T]&T7Q+>ZF;S0KJZN6ENO-,+I&K)*O\
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M(S44U[:0VT]PTL9C@4O(5(.T 9->4P>'XK3PWXPU@^'9KO5Y=4NT3ATE>%I
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MZ7#;1Z3&;*RU,^.#;W(N90KAA*8WYE9OE*%@NWGKMQ0!Z\D-NB[4BB"CC"J
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MW%/F;&>21@GBN_\ AY=7=WX=E>YOXKY%NY5MYHY'D_= \+YCJI?'(W8Y '-
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MN/;L<U:O?#37</C>ZU#3WNM1BTVW%K/)!\YE6WR63KAMX&=I/(QF@#UPNBL
M2H)Z GK060 DD #J<UY%-#:K?ZJ_B;2-0U"[NH+8:68H'=R/)7*QN!B)Q)N)
M)*^M69M,G;Q</")AD&FZE<)KD^Y\F-%'[R,_658_^^FH ]58JJEFP .I- *D
M @C!Z5Q7Q*M;FXTW3&1-UC%?*]X#;-<+LV, 6B4@NH8KD#ZX.*X]-.NY_#R0
M:/'=#49M6:32IEL6LXK0!1YCA26*Q'YOE.-Q)P* /7K>"TLDD$$<<2R2-(^W
M W.QY)]R:G9E5<L0!ZDUXW"N@6^H>%X]7TF\^S6^FW:S6T]L]PRW'FQAF<!3
MNR2Q#8P=P/'%59[&\ACT2XU>'R](%O<_9X;[3I;U8MTY:-7C1@5;RB@&<XP1
MP: /;G9$&6( ]2<4A9 0"0">F3UKRC0/#*ZAJ^GQZW9S7UO%H)\K[;;%=I,S
M;05+, P0@#)) K$U. IHFE3W=I+/?#0X(D@O].EG64@-D121G=%+D\D^WI0!
M[H2H(!(!/2D+(&"D@,>@KQ3Q':W,VM:LVIQ-#=W$</\ 9X.F2W<R+Y2\02K(
MJHRR;LYQSR214NJP/:^)O.>VEO=5:XM"8KVQ<3,0(QNM[B-BJ)G)*GC(;/!H
M ]HP*3('%4M.U6UU,W:VKLQM)VMIMRE<.H!(YZ\$<BO*=?T&*YLO%VI-93G4
M$UV%+>= PD6/$ ;81R!AGSC^E 'K-]>I8PI*T,\P:58\01ER"QQD@=AW/:K6
M!7D6K:2-*U[5;+3+1X+$7NCSQQ1*=F[SB'(_!1D_G4Z:-$EH^L+:2+JB>*"J
MW&&\P1&[VD?[A4GCIS0!ZM@>E+7DL&J*L.F:&5NSJ4/B:269!!)A(S<R,&+8
MQM*LN.>_M5?PQY5IXYL8K>'[5.\\XF=K::WNX 0Y)G.3'(N< 'CJ"* /5KK4
M+*QN[2WGD"37DAB@7:3O8*6(X''"D\^E48IM.\8^&;A8C(;*\26V8XVMC+1M
MC/3H:Y_Q[;V(\0^$;Z_@WP0W[H\GELP3=$VW.!Q\X7\:Y;2M$6QT3PYJT%O-
M'JC^(&CFERP;RFGE!4C^[C''3O0!ZY:6D5G:Q6\0.R)%0$]2 ,#-2B- " HP
M>O%>(Z.EW_;^FK<W4<7B'^TRUTJV4YN63S&W*[[]ABV=#C &,#-=Y\25B;0+
M83SM!$+M"[/ \L! !^6948'8?4=\4 =GM&<X&>E((T5=H10OH!Q7C>A:I]AC
MT#5+F-[/2;74[R*26-I7@97A^1D##<L9;( (P"*DTN(>(=3T^.X2Z;3[G7M1
MD,<F]-\?EY0,.#M.<X- 'K%SIUI=) DT"LL$JS1KR KJ<J<#T/-6J\AT;35T
MZZ\,WT/VD7,FN7=I+(TKL?(7SU2,Y/W0%3 ]A71_$$JNJ^'VU-IAX;$LO]H[
M-VS=L_=>9MYV;L^V<9H ZC7-6T_0; ZCJ"MY898AY<1D=F<A54 #))) JU;/
M%>6\-V+=HV= P$T>UTR.A!Y!]J\8U*VL]2TZ_P#L"33^'TUO3Q9&0N5&YE$P
MCR<[.1[=<5Z'\04DM? -Y]C$J^1Y+#RLEE19%)Z<\*#0!N:9HMII3730!F:Y
MN9+EV?!(9\9 XX'%.U?4['0M)N-1OCY=K NZ0JA8\G' ')))%>3^(-:@\0ZE
MXDETF]N);,VNG0I- 74;OM)#[#QSAADBE\5Z+:6,?BS2[>"3[!';:=<1PM([
M*)#,ZN1D]2 ,T >IZ1J-IJ4,@M[.YM@A&^.XM6A.2,]".?PK06&)%"K&BJ.0
M ,8KR._LC/KUSI1>ZCL_^$BM(0D<SK^Z^R\KD'...:CUDPZ,NK:6NY--77($
MC6>Z>.WB5K8.1(P!;RRW\(QR1R* /7UMX4)*PQ@D[LA1U]:588D;<L: \G('
MKUKQ32<ZC#9Z>T[&Q/B<1[+62:.,PFU+;5W'=L+9]CSCK5Z95L&:PNIKJ+PU
M:>(IHKK]XY6.'[,KQJQSGR_,;Z=* /7%MX4W[88QO^]A1\WU]:<(XP5(1<J,
M+QT^E>*ZO=P!]-.F7DR^&/M5T#)JDLJVS283:JLGS>5R^W=QNS[5)I]RS0Z(
MWB*_D;PT9KS;*&E6'=E?)5G;#% /,VD\' H ];TW5;/5X[A[.0R+;W$EM)E2
MN)$.&'/7GO5C[- &=O)CW/PQVC+?7UKBOA7]G/AO4#:/(]LVJW31-*26*%_E
M)SSTQUKC-'O+)X].:PU"\F\4-KC+)'YTC$0?:&#AE)P(Q'GVR!WH ]:UO0K7
M7=+DL+@M&DA3YXL!AM<, "0>ZBI+VYTW1;)Y[HPVULSJC';@%F8*!@=<D@?C
M7E5C=P'^RVCO[P^-#JJK=VYED)"&8B163.T1B,D@].A%4]4TFTG\!ZQK=]+>
M37"ZXR,\MS*5CA6] P%S@ *#VXH ]@LI-.N'N;6V@5?LLH65/(* /@,",@ \
M$'(S5M[:"4.)(8W#@!MR@[L>OK7D]_>*VHW"W%]<IX<_MN-;F9)W 6'[&AC!
M8'(C+XR<XY&>M5&E_M"_@L-.U"\D\./XB@AMI8[F3+J;=FEC#YW%-PQU[F@#
MV%K.U>W^SM;0F#_GF4&W\NE2QQI$BI&BHBC 51@ 5Q_@A7M-5\3Z6)9GM;+4
M%6V261I#&C0HQ4%B3C)/'O7+:W>Z<FO>*SXHUBZLKJWVG2DCNGBVQ>6-KQ*I
MPS%]P/!Z>E 'H5YJ^C2ZY#H-RAN+YT$XA^RM(J+SAF8*57E2!DBM1;>!&W+#
M&K9)R% //7^0KS?P=:R3?$ WNIK,NJ'0+*68&5P!(V\/E<X].,8!]Z=XKN-/
M'C>]C\2:G=6.FQZ6CV/E7+PJTF]_,*E2-T@PF!SP>E 'H<EA9RQ"*2U@>,-N
M"-&" >N<>M31QI$@2-%1!T51@"O!_%NM,R:O<0:A<PW%I:0B!K_5)(9RWE*P
M:*"-0"23R2>N>@K1U/5;%]5\7SWFOWD.H06UN^F6\=XZCS&@5@8XP<,2^,C!
MZ^] 'J%[J6@SRSVNH-;.UK-%&ZW,7"O)]P L,$G/:M)+.UA*M';0H5)*E4 P
M3U(^M>*:O-=:C;ZLVO3SI]EU#1Y)5\]E2#<B>9C!PHR3^/-5?%'B!DN-3OM/
MU&2&:VU"."$W&L2>=A60'R[=1M,9&3N8G(R30![3I]SI.IB=+)89!8W312*(
ML".8<MC(Z_-U'KUJW'86<5R]S':0)/)]^58P&;ZGJ:Y3X? "3Q4 <_\ $^N/
M_04KSW7=3U@Z]K\IUB"SOK:_\JR2;4IT=4R/+V6R(1(K \]<Y/3% 'MKV%G)
M:&T>T@:V/6$Q@IZ_=Z5%)HVER_ZS3;1^2WS0*>3U/3KP/RKRS4-4N3XV:W.J
MWJ>&A?0KJ$\<K 0WA4XA5\Y$1.S< , G'&:I6>J*KW%U;Z]>S^(5\2M;1637
MCN/(\_:4\K.-GE[CNQQCKQ0![ =&TLB('3;,B$YC'D+\AZ\<<?A3FTO3W6)6
ML;9EBSY8,*D)GKCCC->,:+JVM/K6G7,^KVZ:E-JS0W$#ZC,\K1[V!C-L$*(-
MO(;..ASS5C1FO+;P_P"%/$"ZKJDU_?:S]EG$UY(\;QEY5V;"=N/E'.* /4]4
M70K4V":E;6GSS+;V@D@#8<_=5>/EZ>W2DL]2T+4Y EN]M+)>1.=A3#2QHVQL
M@C) )QSZUY1;W-E=2^$[F^U>ZD\0S:T/M=E)=.1&P9\J8B<(%^4 X'XYJ*"6
M2ZDTB]DOKO\ M&30=46W;[4X9YEE(51SR<$\?[(/84 >Y(BQH$10JJ,!0, "
MJ]WIEAJ!0WMC;7)C.4,T2OM/MD<5Y+JOBLW4%A'INM/*\?A:ZFG\BX)(F"1[
M2V#]\$-UY&:9JT%_I<WA^Q35)VT^\M'NYIM1UF:W66XPG!E4,0,9(08!R: /
M7VL+-UF#6L!$X E!C!\P 8&[UX]:R]+\*Z;IEY=W8@BFN9[I[E99(EW1;@!M
M4XR!Q^IKRM]2U&\T'2/M/B&WF53=E$_M.XM!<(K@*1<[%WNG(P1ANO->E^#=
M=L]1\/Z3']LE>[GLQ.L5VZFX9 =I=L8R,_Q <T ;7]EZ?]O^W?8;;[9T^T>4
MOF>GWL9J%/[(^UKIB):?:(@+H6P5<IECB3;VYSSZYKS_ .(EU<1>)4*:L(XH
MK R&Q.HR6#$[C^\CD V.W;:>G'K6#>7[_P!M7>N:?<7Z:A-X3CN+07$Q$DC9
M<,=@.&8*-V ,9YQS0!['!I&FVMU)=6^GVL-Q)G?+'"JNV>N2!DU6FAT/PY;7
M>JM:V=C&JF2XN(X0I('4L5&37FUYJ1T>=$\'Z[=ZS)-I-W/.LUXUT%*(#')R
M3M8MQCC.>G%4==GTF/P3>+9^)]0U"[O-%EEN+:6Y:Y1B%4EFSD1$$XP,9Z8X
MH ]DNH4U#3YH-Y$<\3)N'7##&1^=4-&\-:7HNG0VL%G;%TMTMY)O(4/,JJ!\
MY YSBN<\!W5[-J.IPZY=2#68RI^RB0^0EN1^[:)>X/(+'G(/2L_6EU"Z\>:^
M]O?ZANTO28KNSLH;AEBDF/FXW*/O9V@8[T =W+H>DSF$S:792&!=D1>W4^6O
MHN1P/I1-HFDW$D$DVF64CVX"PL\"DQ@= N1Q^%>/:'JNKQR6$D.M02FZL)WN
M4.KS74DA$1;?Y90"%E8#N.I'-2:=J4L.F>'9=(\07^I:AJ.F3OJ,;WCS;"+8
ML'VDGRRLFU1C&<XYH ]LJ!K.U=YG:VA9IU"2DH,R*,X#>HY/!]37E$GBI[BP
M\'06>M/+=/I%S+>+'<98NMKD&3GJ'!//<&BRA:"W\(P:KXBU1+#5K-[R[N9M
M0="\XCC*QA\@HOS.< \E10!Z+=6?AVYU"VTNZL;":YB@,L$,ENK;(U(7*Y&
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MEIJS0W6JK>JZ7D"6RH75\NI!D#KC&!G.!@@5=N_"6J/X1N(8;1X[T:]+J#)
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M]K;&01C.#Q[&NP^'FJ)I_A+P]I6HF=+ZZ^T) DJ-DB-V."3TPH&,]A0!W1(
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M(8TT-4BD<(@CY$)7.U_,)SR#T[4 >DZYH-GK\,,%])<?9XY [PQRE4FP<[7
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M*#TH YJ\\>^'+&^FM9[]@T$GES2K;R-%$WH\@4HI^IXK.F\9WD_Q'B\,V$4
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M?)?:I&\KR[9VMU4' VD)N.3QR..]=[J.IVFCZ>][?S"&!,!FP3R3@  <DDD
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M<+AR1VV$R$?]=/:L_0_"^LPW&AVEYIU^4TN-E,MQ?Q&VR(FC'EJ@WD-GHP&
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M(.6(&<#W-8FO:%=ZAH&G6-O*LDUK>6<SR3,076*5&8Y&>2%/XT:T=1U&]N=
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M>\M+%+V![,,B3JS^6$(8DJ=^!G)X-32>*]8\/74D/B:+3W5K">]ADL=Z@>2
M7C(?.3AAAN.AXJEJG@K5O%CZM>ZL+;3[J>P2RM889C,$*2^;O9MHZL%X Z#U
MJW=^&=9\4WS3:_#9V4$>GW%E%%;3M,S-, KN257  ' Z\\T /TWQ3K<=_H0U
MJTL4M==!%N+8OOMW\OS%5RW#94$9 &".E=5JFJV6C6#WM_,(8$(!;!)))P
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ME)'%Y^DWOFW6)!@+ME&1Z_?% &EHWQ$TG4?#MMJUT7M#<2R0QP>7)([LI/W
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MN)'0PRI#Y19<*=RD <''- &E:>,X81<3:I<Q+'%:6DIBAMY"XDF!X[[LD8
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M#3Y+=61U=CAA,/NG=U'IS0!U6H^)]"T;R!J.JV=L9P#%YDH&X'N/;WZ4Z_\
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M(S,IVR?:,A>.N5&01QB@#TFBBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC4=5\B+3I;;4KHSM/<RS>9$&"[U\M?D?D<9(Z\YI;SX>WCZK=F*'3IK6[O\
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MK7#ZCHOB+7KG6KZ30Y+/[5)IA@ADGC9RL,^^0G:Q ('.,U3NM \53WQ5M.U
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M2#W++G&>M.\':+KNGZ_IRG3KVUTRVMI(Y8M0D@G6W)V[4MI%_>;<CG=V [T
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M'=6VHRVVR DJ@7'&2!G&>N.:Z@]*Y6#2=4\/Z-XBDTWR;F_NKJ>]M8RIV[G
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M"/&N%9@ORMP>QJ2?P)X@98KK[3;2RSWT][J%BMW-;P2,ZJJ ,@W$+M'4<\T
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MJVW8.7:,IL^G.<U'<>!8I+JZO;?49[>_DU W\%PJ*3"YB6)EVGAE*KSGU]J
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MSDF\I)6F1G\QB=W1MQ8Y]^E7/#W@FW\/364D5Y+-]DTXV"AU W+YF_<<=^U
M&=HWBW4-?\2:(]K:B/2[[2Y+EXWE&Y6$B*3]WDJ<CKSNSVK=U[Q#)I6H:=IE
MG8F\U#4#)Y,9D\M%5!EF=L' Y'0')-4-(\$_V++HCVFJ2#^S;>2U=6B4^?&[
M!\'^Z00.15_7_#IUBZL;^VOY+#4;$O\ 9[A$5P XPZLK<," /RH XWQ)XNU?
M4;&UL;*UET^]&LQ:?>HMV%=<KN 1PI^5@?O8!&.E=9XGAUF+P7/%HLDK:DD2
M*K;@TC $;\$\%RN[!/>J,/@)!%$]SJDUS>_VI'J<]RT:@RNB[0NT<*N,8]*W
MM>T=-=T>:P>XFMR^UDFA;#1NI#*P]<$#@\&@#S[P1=W%T=7M+#7-0AOV6Z\J
MPU:)F,;"9@DH9NNT85@"1GT-:>FSZE:^-]/TNRUF\U:*.%SK+3;6BA?:-FTA
M1M<M_#Z5)I?P_P!0MVOKJ]\0RR7\L=U#:S10JGV=9I2[. .KDX/H.U7/#/@S
M4O#)AAA\1--8(2SVWV&)#*Q&-S./F+9P23R<4 7O$T%X\MO<-KO]DZ-;QN]Y
M)&561CQLP[ A5'.>YXKC].UOQ%J=IHNER7MU;#4]2N5AOGA59WLHE+J<%<!F
MX&<=.>]:VH>"=:\16&D'5=?V7-EN>6/[*DL4LA)VLRD $J,8XQGFM.X\*:E>
M65H;GQ"[ZI97)GM;Y;1%V IM*%!PP()SWY]J .8U/7?$&F6WBG0[*74-1O+%
MK0V=Q%$LEP$F^]D!0"5PQ!(],UN>#=2,FKWFGW=YKXODA67[)K"0@^63C>AB
M&",\'GCTJ:/P/(+2_D?7+O\ MF]GCN)-1A41G=&,(H0<; .-ISG)S3&\+ZQ:
MKJFKC6&OO$,MB;6TF\A(DA )8 +R.6P23GI0!'<2ZIK_ (WU;2K?5[K3;72[
M: C[,L9:264,V6WJWR@ <<=ZQ]"\0:OXROM(L6U"?3E_L?[==26BH'EE,AC
M!93A?E8X [BNCO?"NIS7PU+3]=.G7\]K';WKK:K*)MN<, 2-K#<W/H>G%1'P
M)]@;3IM U-]-N;*S^P^8T(F$L.=V&!(^;=SGW- '/:/XCUGQ)=:-H<FHRVLP
M^W?;;JV5 \OV>41+MR"%R2"<#MQBNK\%ZA>7=KJEE?W)NI],U"6S^T,H5I5
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M:SQ'*5@5>$W<K@LOWL\=<T =)=^+U@FU."#3+R[GL;N*T*0@?,TB*X8DG"J
MW)/2LUOB3;)9RLVE7;WD=]'8&UA>.0M+(I9,.&VE3ZYX]*JW7PYO[^UN3?ZY
M;W5U<:C'?R"2P_<2;(Q&(VCW\K@ ]>W>EL/AM+979N#J=L"VIV^H&.VL1#&O
ME(R%%4,< @CGV[YH ;:^/[VWU'Q"VL:7/;6UA]E6& -&TGF2J,(2&P2Q;@]
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MZE,(;E+66[BA5HHY& (!^;<!\PRVW ]:UM#MM0M-/6#4/L(>,[8ULHFCC5
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MLC[MSE")"#_N#Y?U-5$^&5Q-!?)(FD:<TMF((GL868^8)%?>Q?D#*+\HX]Z
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M)8[);E9 Y()\R(HN,#L>M4K#PK?6MOX)C:2#.AQ[+G#'YC]G,7R\<_,>^.*
M-S7_ !%8^&[2&XOO/(GF$$*00M*\DA5F"A5YR=IK/;QUI"72PNM\J[D26<VC
MB*!W (21\85OF&0>F1G%6]?TF?4[S0Y83&%L-1%U+O/51%(F!QURXKCM3\ :
MA<:EJ216]G/:W]Y]I,\U]<(8E8J74PI\KG@X.1VSTH Z6[\>:)9:DUE(;MMM
MPMJUQ':NT(F8A1&9 ,;LGGTIX\<:.=673Q]K.ZX^R"Y%L_V?SLXV>9C;G/'U
MXK@]2NKN*YF\-64MG*DNOQW'E-Y@N@#=+*_R;<%0=S;]V-H]:TKCP3XAN]4M
MY[EH+AK?5TOA=2ZE.=T2S;PBP;=B$+QGGI[T =)_PL+02;HJUXR6\GDEULY"
MLDN[9Y:''SOD?=&3CFIO#'B<^(]0UJ-(REO93QQ1;XFCDYC5B'5N0021T%9$
M7A/5;3P_9QVYM'O['6)M1BC=R(Y4>24[2V"5.V3K@X(K5\+:;JMKJ.N7^K0V
ML,NHW"2I%;RF0(JQ*F"Q5<GY?2@"+_A-K6/Q=J^BW<3V]OIMI'<O=NC!/FR3
MDXP!@#'/)SCI5W1/$VCZK<&SL1/!*%,J13VKVYD3/+H& W#)&2/4>M<_K_A'
M5M2US7GMS;+::M8P1+,TA#0RPLS+E<?,I)&>>/0U?MM*US5?%6F:QK%O9V*:
M9%,D<5M<-,9FD"@DDHNU0%X')Y]J .OHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *0]#BEHH \9NM9\3'1Q*]TLD_P#PEXM852=T! D8>4QQ_J^ .GKQ
M737_ (_O]!;6+35[*T:\LH[=X&MG?RY3,Q10<@E<,IR>>*U?^$!T[SW<WE^8
MVU1=56$R+L2<$L<?+G:2>1G\JM:CX-TS5+W4+NY:<R7T$,+[7V[/*8LC(0,A
M@6SG/84 4O"/BZ?7]0OK&XCA=K>..5+BVCD2.0-D%<2 $$$?CFEN_#6H_P#"
M4MK2:O=-:B=)_L*NVTA870H!G'+%6Z=JT]$\.1Z-<7%R=0O[^YN JO->S!V"
MKG     Y/0<UKS1+/"\3YVNI4X..#0!YWI/C_4M8FEL]FFP7C6DLOV9FDCGM
MI%&0K(X!?ODKP,>]/\->)=?NM+T#28$M+C49='BOYKJY=]OED!5SCDNQR3V&
M.];.G^ [*ROK6ZFU+4[XV<3Q6L=Y,KK"KC:V"%!/'&233(/A_9VEI9Q6FK:K
M;SV<1MX;J.9/-$/&(B2F"HP,9&1ZT 5+3QGJVJ36>F6>GVD6K.UTMUY\C-##
MY#JC$$ %LLRXZ<9]*RM:\8WWAW7[.]UBT>.Y.F3I]CAF+0O)]HC57+]$4KSN
M;[H;!KI?^$#T^.RLH;2\U"SN+0R%+R"8><WF'=)O+ AMQ )R.H%367@K2K)D
M.V6X'V::VD%R_F"82N'<OD<DL/ISTH V=/>[>PA:^$ NF7,@@)* ^Q/)%>?_
M /"PM:AT"UU6[L]-BCU"Z-M9@-*VS:7W/)@$XPF0!SS7=Z-I4>B:7!IT$TTL
M$"[(S,VYE7LN<#@#@>PK+;P9I_\ 8%GI,=Q>0K92F:VN8I0LT3DL20V,?Q,,
M8P0: .=A^(6I7EK'#8V5I/?OJ<=B)&$D<#J\;.)!N&[C:05]NO(JXOC:_M]8
MCT>]M+8WJZG#93/$S;&CEB:174'D'Y<8/I2:OX&EDM=,@L[Z_FD&JI>7=Y-<
M#SP!&RY4XQQE< #'M6@? 6G-8R1/=W[7<ETEXVH&8&X\U1M5MVW PO&,8P>E
M %/4/&6I17U[96-C:R3Q:M#IT1ED95/F0B0LV >A/04^/Q#XFO)KY-/TW3[@
MZ;(EO<Q^<R--+M5G$9/  ##&[K[5;L? VGV+F3[7?SRM?IJ#R3RAF>54V#/'
M3'8?ABEU/P18ZG>7,QOM0MHKQE:[MK:8+%<%<#+#:3R  <$9 H Y?3O$^NZ1
M;:O?2P07.EQ>(9;4F6=S,%>X$8VC& J[A@>QZ5:UKXCSZ3J5W$1I;);7:0&U
M6=GN&0LJ[_E!5#\Q.UN>*Z.7P9ITVCW>F-+<^1=7YOW8.-PD\T2X''W=P''I
MWJC=_#RQNX[N ZKJL5G=7+73VL4R+&)"V\G[FXC<,X)(H JMXZO(_&!T>:"Q
MMU^UBW2&YD>.:5"!^]C)&QQS]T'/X\53TKXFMJ6K6D:16C6MW=FV2.,R&>-<
ML%D;Y=N"0,@'C/6MZ7P1:SZH+N34M2:$7BWPLC*IA\U3D'!7=C(!QNQFEM/!
M%I9WL4L>HZD;2&9IX; S@01NV3P H8@%B0"2!0!A:9XOO_$]W<Z'+]CL+FXM
MIE,(DDCNK1L84E6 W=<Y7@?K74>&M%O-%@NH[S49;TRRJZ/*S,5 B1".2>K*
MS?\  JIZ=X'M-/U2SOCJ6I77V'?]D@N95=(=P*G!VACP2!DFNHH \_O_ !WJ
MMC_;MZVG67]F:;=?8D8S.))924"Y 4A5R_/4\5AZWXWU+6O"^K6=O):QW$1M
M2;JSEE1"DDH1E!*A@P/!]FR*[R7PAI\VGZK9O)<;-2NOM<C!P&CDRI!0XXP4
M!'6JI\"VDUG=P7VJ:I?-=&$O-<3J6 C<.JJ H4#(YXR<]: .5F^)?]AO=6,-
MM;-#I,JVLL#S3//,1C>8R5.0,\;CDX[5JW_CW4=/37=0DT^T_LG2Y_LJL9F$
MLTK!-O&W"KF0 GFM6]\"6EY>W<R:GJ=K;WDJS7-I;3*D4KC&2?EW#.T9P1FK
MDWA+3KC3]6L9O.>'4Y_M$V6P4?"@%"!QC8I'7D4 <DOQ.NEM-5(M;*\GM+5+
MF)[9I%B?,@0HQ=00PW#GG.:TKKQEK&CR:C:ZGIMD][%#;RVJ6TS;)#-*8E1B
MPXPP'..AJ\W@.UGM[R.^U75;V2ZC6(RW$ZDHBL' 4!0HY YQFKFJ^$K#6;J\
MN+IY]]U;1VS>6^W8(W,B,IQD,&.<^PH Q=8\8:UX<M575]/T^.>>XC@M;A)V
M\AMRLSEAC<-H0]N<C'>JUA\1+O4X$MK.RM)M3DOQ91LLS_9V'EF0R;BN<;0P
MQC.16K_P@5LZ2/-J^JS7S31S)?23+YL3(&5=N%"@8=P1@YW'-/'@>!K(QS:M
MJ<MY]K^V)?O*OFQR;=OR_+M"[<C;MQR: (?!EWJEUK/BA=5PLL-]'&L23-)'
M&OD1GY,@8!SNQCJ36;XM^(TWAK4KZ$1:88K)$D\J6\_TBX4@%MJ*#MQ_M8S]
M*Z?P_P"&H?#[7\B7MY>37TPGGENG5F+!0O&  !@#BLG5_A[::M-JN=6U*VMM
M5(:\MX'0+(P4+G)0L!@#C..* ,-_$VOZ-J_C*^CM8[[2M-N4DD$UTP=$$$;,
ML2X(& 2W49)_&M"\\=ZG';ZMJMII,$VBZ5<&"=WG*S.% WNBX(PN>A/.#5R\
M^'MK?76HO)K&J"VU-T>]M$D01S;55<'Y-P!"C.#S3]0^']C?RWB#4+^WL+Z8
M3W=C"ZB*9^,YRI8 [1D C- $3^-[A=UJ-/C;4CJR6$< D.&C8"02YQT\K+'W
M!%8^F_%B&_U6RC$5E]CO;O[+&BW#&Y3+%5=DVXP2.@.0"*ZYO"FGMXMB\28<
M7D5M]F5 1Y>/[V,?>P2,^AJE:>!X;*[@,&K:DNGV]PUS#IZR*L2.23C(7<5R
M2=I.* .J!S7DUGKNKV7B?Q!?W$37D_\ :J:786W]H2K$K,J$ IC8!M+,6QG.
M1[UZ/HEG?65G+'J%T;F5KF9T8MNVQER47.!T7 _QK*N/ ]A<)J8-S=1R7U\F
MH"6-P'@F5552AQ_LCKGJ: ,;5OB!J>A+?6E]HUNVJ6_V>2**&Y)CGCEE\H$,
M5RI#9X(_&NQTV;4GTM9=5MK>"\ 8O';RF1!@G&&(!Z8[5SLGP\M+H74NH:E?
M7EY<R0,]U(4#!87#HB@* %R.>.<UU\@)B<#J5(H X'2/'VJW5EH^IZEHUM::
M=JTIA@:.Z+R(VUBI8%0,-M(XZ9%7K7QQ)<:=X8NC8H#K0D+*)?\ 5;8V?CCG
M[N.W6J'@WP%<6FB:$-<O;R673MTD=@[QF*&0[AG*C+8#<9)QFM"S^'UM9W6G
MR?VMJ,MOIK2&SMG9-D2NK*1PN3@-P2>,4 9EAXX\3:C;:&T>A:<DFMHTMMNO
M6PD2QARSX3KST%6+?QWJ6HW,&DV&DVYUKS;B.YCFN"(81"RJS!@N6R77 P.O
MM3[WP==17?A&STR[NK>UTB":$W<;1^8H\M53(8$-G!SQ^56HO %K:);2V.IW
MUMJ,+S2-? HTDQE(,F\,I4@D XP,8&* ,B]^)=S:V5H\NG6MG.T\]M=/>7++
M!#+$0-GF*AR6SD$XX!IVJ?$TV#:?;BWTR&ZN;);R3[7J*I$H8D*J.JL')(/(
MXQ6LO@.&VLXH;#6-1MIE,K2S%DE^T&0@N9%=2I.0,' QT%,B^'T%C;VJ:7K%
M_82PVIM'FB$9:5"S/R&4@$,S$$8QF@#)N?BD3_9[V=C:;+RSCN8UO+WR#*S$
M@QQL5V,RD<Y8=17::[K<'A_0+S5[I6:*UB,A1>K'L![DX%86I> 8]0L38C6M
M12TDMDMIXI&2;S57.&S(I*N<G++C/'I6_J6BV>JZ!/HUTC&TFA\E@#R%QC@^
MHH YQ_%>O6EU!9ZKH=K:3WT4ALO+OC(#*B[O+D.P;>,G(R.*C^%C:C<^"X-2
MU.>>>YOOWV^6[:;<#TP" (_3:..*T+3P<ZZA:WNIZW>ZG)9QO';+,L:B/<,%
MCM4;FQQD^IK5\/Z+%X>T"STB"5Y8K6,1J\F-Q'OB@#S>W\1^*Y?[+D,22W$F
MOW=LD(NRJ2HHE&QSLX52HQP<XSUXK?7Q;<7\VGPW=K+97D.N?8+B*VNMR,1"
MSY)*_,A&., YQSQ6A:^!H;74H;H:C<O'!J,NH0PLJX1Y%<.N<9()<GFI3X*M
M?[0:\^U3[FU3^TRO'W_*\K;TZ8.?6@#)\,_$67Q'K$=HNGVD<3LZLJ7ZM<0;
M<\R0E00#CL3C(KH/$?B"71CI]K960O=1U"<PV\#2^6O"EV9FP< *I[&LRU\!
M+'J6G75YK%W?+ILADMA,B>8#@@!Y0-[@!NA/89S6OKWA\:U]BFCNY+.]L9C-
M;7,:JQ1BI4@@C!!#$$4 8Q\6ZXTUKIL7AL?VS(LLDL$MV$BCC1E7>)-I+!BP
MQ\N>N<8HT_X@VMQ/"E[;?84>UN)7>23/ERP.5FC/'\.,@]QVIR>![F&X@OX?
M$-ZNK(9?,NW57$BR$$KL/RA057 '3'>FW_PXTO4/#=MH\MQ<8BN&N'N00))6
M<DR@D#HX9@0.QH RKGXI^3]DB^PV,%S):)>2Q7VI);[$<G8JDK\S%1DC@#(Y
MJROQ&N-1DB70-$%^CZ8NI,\ET(=J%F4I]TY;*D>E:VJ^#S>:I)J.GZD^GSS6
MZVTP6!)595SM(##Y6&X\BGV/@Z"PO'N$O;B5GTQ-.)E.YB%+'>3W8EC0!BZK
M\2C9:19ZG;Z;;FUN+)+S=>7Z6^X,N?+C!!+N/PZBI9O'U_/,Z:-X?-ZD>G0:
MC)))=K"%CE5F"XP<MA3_ /6J)?AA%!:_9[;5Y8Q)I\5A,[6Z.^R-2H*$CY"0
M3G&:V-)\'1:4MP!>22^=IMOIYW(!A8E90WU.X_E0!EZ/XIU36/'UM#!$@T:Y
MT2*^56D 92[<-C&2?X<9]ZU/%7BJ?PZ\"Q65O*LB,[S7=ZEK$H&/E#-G+'/3
M':F:3X,&C:IIE[;:C)_H>FIILD;1@B:-.5.?X3GGBEU[P<=8UR/5H;_[-<+:
MFT.^W68!2V[<H;[KY[_I0!DK\1KN^CMFTCP^]XTNF+J;A[I8Q&A)!7.#DY''
MK3-1\?W>H:+=2^'M*DN1'I:WL\WGB-K?S(V9 JD'>P SCCMZUJ:)X$@T6(1I
M?2S ::-.RZ@'8&9@V1W^;'X557X=M;:?]CT_6Y[1)M.BT^[*0JQF6-2JL,_<
M;#$9YXQZ4 ;FAZA,? VG:E<,T\YTZ*>0L<%V\L,>?<USEG\0-:OFT](O"3>9
MJ5J;NT5K] &C&W)<X^7[RXZ]>U=;:Z0MKX:AT9)6*16BVHD(Y(";<XJC8^%X
M[&XT2473O_95@UBH*@>8"$&X^A_=C\Z .<E^*MJUM8-:6<#3W-H+N2.ZOH[<
M1J6*A0S??8E6&!Z<XS5B]^)"1Z79:E8:?'+9W-J+HS7=ZEJH'/R*6SN<8.0.
M.G/-)!\-DL8;7[#JGEW$-K]DDDFM4E$B;V<$*?NL"S8(/>G/\-T6<R6VJ,&>
MRCLY'N;=)Y,)GYT8_<8[CG@C..* ([GXEKYNGI8:6)VO+".^5)[M('97SA(P
MW^L<8Y ([>M;,_B^."W\0S-92 :-"LKAF ,F8_,Q['M61/\ #B270X-(&M%K
M5+)+-X[BU69<*" Z!C^[<@]1GH#VI]_\.Y)[:^LK'7)[2RU"UBMKI#"LCN$3
M8"')X)4 '@Y]J ))_'[6]WJ)?1YO[.TVV2YN[SSEP@:+S%4+U8G[OMD&JD?Q
M/A6UU%[G3X1<6EH;M8;6_CN/,0,%8;E^ZP++P?7C-;)\&6TMEK5G<7,CP:K#
M'#(% 4QA(Q'D'UX!K/?P#/<VU]%>:PKFYM?LR>19)"J#<&+$ _,QVCGCZ4 0
MW?Q!U:Q.H)/X1N!+I]NMY<!;R,A8#NPP/=OD?Y0/X>M/U7XF6=C=3);6B7,-
MM#'-<NUW'"RAUW!41SEVVX.!Z^M:^I>%5U&?79&O&3^UM.2P8!,^6%\SYASS
M_K3Q[5D7OPZ,C2M8:E#;-<P10W#2V23-E$"!XR3\C$ >HX% #KWXA/"VH36&
MB3WVGZ?!'<W%TDZ(!$\8D!56Y)VG./:JDWCZ]TW5_$CWMB7TVR:U2U82(@W2
MJ,;V)^4'=G<>% K:D\&1M8:]9I>,J:M;);YV#,06+RL^_'/:H)O!5T;W4)[;
M63"EZEONC:V#C?$ HSD_,C*""OOU% &SX?UJ76K-YIK%[1T?;CS%D1QC(9'7
MA@?6N$\6^,/$-A/XPA@A:W@TVUMI+:=&0E69R"<'D[AQ[;?>NO\ "GA1?#/V
M]_M$<DE],)I$@@$$*$*%PD8)VYQD\G)K/\0>!9=:O-8EBU46T.JVT4,\9M]Y
M#1ME6!W#L2"/UH BO_B+_9%IJ3:IHES;7=E'#,+43([2QRR>6I!!QG=U!J;_
M (374VN&LXO"UW)J$$(GO+=;J+_1T8L$^;.&9@I.!^-.\2^!1XBU"[NCJ!@^
MT6UO!M$6[;Y4_FYZCKT_6K&I>%]0?7+O5=&UA;"6]MT@NEEMO.#!-VUE^9=K
M#<?4>U #=,\=Z=K#W7V&*66&#3H]063IO1]^%QU!&PU4B^(0O;>*72]#O;\B
MQBOKE8WC4VZ2*64'<PW,0#P*KQ?#>32U\O0M9^QQ2:<FG3B>V$S,BEB&4[EP
MWSMU!'M6'?:%JOA826>CC4F>72X+-YX+!;A+EHT91@!QY3 'JV1S[4 :,'CO
M4[OQ#%)IVDW=_976C07ZVJO$A@W.^69F(Y("C&3TKMM.UB+5_#UOK%C&\D5Q
M;B>)#A6.1D#G@'M7/>$/"-QI%K875U,%N1HEMI\L 7.QDW$G=GGER/PK<\-Z
M(?#_ (8L-&-Q]H^R0"'S=NW=COC)Q^= 'GNC>._$M_'X5N'TZ6XFU"&\,EK"
MT2"8HR;'W$_* ">^<CITKI#\1K5K*Q,&FW,FHWCS1K8LZ1M&86VR;W9@H /O
MSVH\/>!)M$FT9I-42X325N8H0+?86CF*G#'<>00><<YZ"JT_PV#M!/'>6<ES
M#<7<JB]L1/"R7$F\JR%ARIQA@1W]<4 =/X=\0VOB33WN;97C>&5K>XA?!:*5
M?O*2,@]0<@X((KB_#?C+4O\ A/?$>GZQ<!M,2:<63E%41^1M+KD#GY9 >?[I
MKL/"_A\>'-,DMC-%+++,\\C0VZP)ENRHO0  #DD^]<WJ/PS&H6NHPC5GA:\U
M62_\Q(N521/+DB^]R&7(S[].* *?A'QEKDNC:K>:I976H71U/R[:VMD0>5$\
M22HK-P% #\LQK1?XEVZ:>)?[(O'O?[1&F&SB>-F\XJ67#!MI! ZYXHU3X=F_
MEN'CO;?;)J0OQ;7%KYL!Q"L6QT##<!MW Y&#VJ&P^&LMI=13OJEN2FJQ:GY<
M%D(D!2(QE%4-\H.00><8[]: +W_"=RO//'#X=U*9+/RUU!HMCFV=E#;-H;,A
M4,,[ <5FZ#XXOUN+Y-4L;J:T76YM.COU\L(A,NR--N0Q'(&['>M2Y\(:HE_J
MKZ3KPL+759EFN +<M+&X4*3$^X!<A1U!Q1'X(>/29[$:AGS=;&K!S%TQ.LNP
M\\_=QGWZ4 ;FOIJ\NDR1Z)/!;WK,H$TR[A&NX;B!CD[<X!XS7*>#_$NHW^JZ
M[8+>G6(;&*-X)9X5MIGD8$E"N!\O PVT#D]:ZO7M,N]5TWR+'4I=.NED22.>
M,;N5.=K+D;E/0C(K+T?PQ?0>*9_$6KZC!=7TEH+-$MK<PQI&&W'@LQ8D]\T
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M(QP23@X%2>'?!<VA:Q8WGGVK1P:=):R)! (07>82;E5> .H]?7-9>C^"-?\
M#,5K<Z1=:;+?K:-9SI=>8(F42O(CJ5&<C>01CG\.0#;E\>Z5);P/I\=W?M-:
MF[VVT!8Q19(W.#@CD$8Z\'CBKW@W5;G6_!VDZG=[/M%U;K+)L7:,GT':N:L/
M VL^'Q!-HU]8R74ME]EO6NU;:6\QY/,0+_M2/\I[8YK:\,Z=JOA^UT?0I1#-
M9VVGE)KA%(_>JRA0,GH06/3MUH Z>BBB@ HHHH **** "BBB@ HHHH ****
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MINO]H&!1<-$  ),?-C\:XE?AI=37\EU?:K;.XM;BVCFM[$0RR^:A3=.P.)"
M<\ <\T 7M!\<3R66F1ZOI=]#<76G&[AEVHYN=B*7PB$D$[@0N.<_A534OB#.
M^E:I;I83Z9J2Z7-?6K2212D! /O*K':P++PP]?2K^I>!&U*PTBT;4FA%CIDV
MGM)$F&;S(E3<.>,;<XYZUC0?"Z[!D,NH:9"&TR?3@ECIODJ1(%'F,=Y+-E1F
M@#H/!^L7^IW^H17DYD6&VLG0;%&&DAW/T'<\U1U'Q=J&D^,]8MC875_IUGI\
M%TRVXC'D F3>Q+$%B0HPHST-;7A[PX^AW=W.UT)OM$%M%@)MP8H]A/7OUK,U
MKPCK%]KNI7VG:S;VD&I6<=E<126ID8(N_P"9&WC#?.<9!% "7GQ(TVVDN6AM
M9[JSLXXY;JZC>-1&KJ'&%9@SX4@G:#U'?BNKN+^VM=,EU"24"VBA,S..1L S
MG\JX.]^&)6:==*N--BM[E(DD-[IRW,L6Q%3,3$@#*H.&!&>:[>\TNWO=%GTJ
M4$6TT!@8+A<*5V\=AQ0!@P>-RT+S7'A[6+>,VOVNW/E+)YZ\84;&.USN'RMC
M]#61KGCRX;1=7BM;6XTS5K$6TFV9HI04DF"9!1F7LP(/(J:Z\&>)-2TB;3+_
M ,1P&V%H+>!;>U:/>0R$-+\YW9";2%QPQJB/AA<LFI[KO3+87UO#"(;&Q,4<
M?ES"3.-Q+$\Y)]O2@#I/^$Q1M1F@@TC49[."[%G-?1HAC27(!&W=O(!(!8+@
M<^AJ>'Q;9SZ;IE\L,XBU&\-G$,#*OEQD\]/D/3U%9Z>&-=M-1FCT_6H(-(N;
M\WLL?V<FX4LV]T5]VW:S9ZKD!C52V\%ZY;W&FVQU>S.D:=J#7D,0M6\YP2YV
ML^['&\\@<\4 1>&O&VH3>%].FNM/O-4U"<7$DC6RQQHJ),R#+.RKG  P#DXJ
M>'X@)=:UIKP6TO\ 8MSI4U_)<.J@Q[&4$GYLX7D$ 'DC&>:R8_A??P1:<JWF
MF78M89HO*O[5I8E+S/()%0,!NP^TY]*LV?PXOK73-+L#J%M)%#I]UIMV?**E
MXIG#!D /RL,#KD4 ;5KX_P!.E3S+NTO=/A>VDNX9;I% EB0!F("L2" 0<, <
M57L/%E]J?C'2;(:;>V%G=6$]RRW<:9DP8MA!5CC 9L@X/(R*RM.^&4JK+;ZA
M_8T=N;*6TWZ?8"*67>NW>[$G! SPN!D_A6UI?A_Q$OB2PU/6-3L+B*QM);:-
M+:W9&?>4)=B6//R#@<4 =?1110 4444 %%%% !1110 4444 %%%% !1110 4
M'I10>E 'D]SXZUR'4+:[@O!=V,VIK:%(=-=;<1M+Y?%PQ&YQ[ C.1[UHP^*=
M=3Q6D.H7"VEG)?FVBC:R+02H20NVX4D>8>/E8#G(K;?P%X5,L<;6T@"3?:(K
M?[9*$CDW;MR1[L+SD\#N:M?\(CX>M]06^,#(XN/M"1M<.(1-UWB/=LW9.<XZ
M\]: *?Q&6[?PQ&MG>?97-_:*7V;N#.@'&1W(/OC'>N1COM=T%?%6L6VH6QM;
M36P)K9K;)N"PA5SNW?+PW&!UKTS6;#3=5TU['5 K6TI7*F0H200PP00000#P
M:IR>&M"72[RQE@ M+V433AYF_>.-N#N)S_ O?M0!Q%[XX\0_VCJ-W9P3O9V-
M^;06JV!9)55@K%IMWRL<D@8QTZYKNO%9SX,UL_\ 3A/_ .BVJ"X\%^'[V]>\
MELV9I9!-+&)G$4KC&':,'8QX')'85M75K#>V<UI<)O@FC:.1<D;E(P1Q[&@#
MRJ;QAK\'G0:7#/Y&DVEN#$E@9EN&,*R$/)N'EC!P./?VK4;Q7K:^*E^U3-8:
M6]S#%$KV1EA=65<JTZD^7+N8C# #@>M=->>"/#]]*'GLG.8TB=5N)$65$&%#
MJ& ? _O T^7P?H,NJ"^:S(F,JSE%F=8WD7&US&#M+# Y(["@#E;7Q;K,'B5U
MU29X;-YITA@:Q_=3*H<IY5PK$%\("0V.X XJKI'C/Q'.+2\N4G>WO[26<(]A
MY4=N1$9%*R;OW@X"GCG.>*[6W\':':ZD+^*S83+(TJ*9G:-';.YEC)VJ3D\@
M=S3(/!GAZRF-Q'9%2L;QJ&GD9(D<88(I;:@(X^4#B@!/!LFLW6@6^H:U?P7,
MM[%'.B0V_E+"K*#MZG=UZUDW>IZ_JOB36K'2M2M=.AT=(LB6W\TSNZ;_ )B2
M-JCIQSUKL+*WM[2PM[>T %M%&J1 '("@8'/?BLK4_".B:O=O=W=J_GR((Y7A
MG>+S5'17V$;QUX.>M '!:4;CQCX\\.:Q>-;>5_9'VQ+:2V#B)_,4-L8G@EAD
M-C(&!78^.WD;1;73T<HNHW\%G*PX_=LWSC\5!7\:U[;0],M+RWN[:T2*6WMO
MLD13("19!V@=,<"H/$^CR:WHDEM;R+%=HZ3VTK=$E1@ZD^V1@^Q- '%>*/%N
MKZ->WTFG70>TT^6*,VL.G/)&%.S<LDYPJ-\W 7.!M]:Z2US8?$>ZMXF/D:CI
MXNY(\\"6-Q&6^K*RC_@ J2\\&:#JD\[W]JYENR)9X$NY!&[@ ;]@8*2,#YL9
MX%6;#1IX_%.I:S=R*QEBCM;1%)/EPK\QS_M,Y.?95H SO&&L7UC>:?9:=??9
MYIUDD98K)[N9@N,;47@+D\LQ&.*P]'\5:_XD71].MKF"PO)K6YN+FYDMMV?*
MF\H 1EL D\GGCI79ZKX<TW6;F"YNTF$\"-&DL%Q)"VQL;E)1@2#@<'TJI_PA
M'A\6=O:QV;PQVYD,+07$D;Q[SN<!U8-@GJ,XH X6[U?7K3Q#JVJG4K*2:T\,
M>?LMT,D+.KRC*G/]Y<GC_9[9KJ=8\3W6G:M'#Y]K%;_V+<7S-.#M61&C"DD9
M(7YCG K27P3X?C,/EZ>$6*T:R"+(P5H#G*,,X899CSDY.>M1P^ _#L/FG[%)
M*9;9K5VGN9)286()3+,<#Y1CT[4 >>:_XCUBZ\.:_IFHW#W,4^AW%RDDFFO9
ME64JI"ASEE^?J0.GO7K5B2FC6Y4 E;=<9./X16*? 'AY_/,UO<W#SV[6LCW%
M[-(QB;!*99C@<"NBCBA^RK"@#0A0@'4%<8Q[T >9Z9XG\17OFV>HW\=G>7-E
M-)';S:>\91U7(,,@8I,H&>X/0T[PUJ'B.ZL?#^@VNK6\,O\ 8D.H27DMKYC,
MK858PI;DC'S-GGC@9KKM/\$:%IEW'<V]O,6AC:.%);F21(588(168A01QP.E
M,'@704M+:VCAN8EM59()(KR59(T/5 X;=LX'RYQ[4 <]8>*=>U^YL-(M;BTL
MKW;=M=7@A\V-_L\PB_=J2/O%@W)X%9.L>)-2T7Q%;W4WV2YU!M+:VDNX,FU@
M/VD+YLF.54<$CL<C/>N]E\&:%)86EDEHUO%9AA;FVF>)X]WWL.I#<]\GGO3X
M/".A6T)ACL$\HVSVC(S,P:)VW,#D\Y8DDGGGK0!IV8F6RA%Q.DTP0;Y47:KM
MCD@9.!7F7_":>)XM%;57FM9$O-4?3+2WALGD:(K*Z^8VULO\J'Y0!DXKTRQL
M8--L(+*V#B"! D8=RY"CH,DDG\:S7\(Z+)H[:4UJWV1KAKD 2L&64N7+JP.5
M.XD\&@#BI/&?B:*TDLT1#>?;[2V@O;S3Y+='6=BIS$QSE2.H/.15M_%FN:;K
M2Z'>2VMS<1:E902720E!)#.LA(V9.U@8SW/!%7=;^'MI<V,,&G*WF2:C;7-Y
M/<W4CRRQQMR/,)+9 SCD8]JUE\$:$+*>V:"=VGE2:2XDN9&G,B?<;S2VX%>V
M#Q0!SVI>*=>?5;[3-.FM(9%UF'3X9I82X1'M_,8D!AD@_P"%3V6M>);Z:\G2
M^TJ.UTN\6QN(YXBGVAE">8^_<?+Y;Y1@]!D\UN6G@O0[$AH;>7>+M;TO)<2.
MS3*NT.2Q))P2*+OP7H=_J,E[/;RLTLBRRPK<.L,KKC:SQ@[6(P.2.PH X7PM
MJ>MZ)ING7'VBU?2KO7I['[+Y!$@WW$HW^9N[-VQTJY;>.=6.OZ=FYMKNPO[Y
MK0)!8S+$@P^UEN&PLA^3D 8ZXZ5VJ^%M(6RM[06Q\BWO#?1+YC?+,7+[NO\
M>8G'2LZV\!^&XI[=H4N'6RE\RW@-Y*T4#9).U"VT9R>,=* .9M/'NLV#7<^M
MF",QVL]Q_9\EG)!)F-2P$4OS),,#D@CUHT_QMXH:,LUB]Y)<V4MQ"ITV>T2"
M55#*ADD^613G&1CD>]=9:^!-!M;B.5;>>5(4=(8)[F22*%7!5@B,2J@@D<#I
M38/ 'AZ$%9+:>Y3R&MD2ZN9)EBB;&50,QVC@=/2@"EX*\1:CJMY=VFIW<,D\
M<:RB%K*2TGCSD$-&^05R.&5C69\0K";4?%?AFVGEMGT\M/,UO-;F0,T:;B3A
MQDXX'H>>>E=9I'A;3=%O)+RW^U2W4D8A,UU<O,XC!R$!<G SSBKMWI5G>W]G
M>SQ%I[/?Y+;CA=Z[6XZ'(]: .&M/%?B$:-I?B>X>P;2=1GAC%@L3++"DL@1"
M)-V&89!(VCO6QX2U3Q!KES>WUY+8IID=S<VL,$43>:3'*R!RQ;'\)XQ[U9B\
M"Z!!>6\R0W'EV\OG6]JUU(;>)\YW+$6VC!R1QQ6QIFE6FD6\D%FA2.2:2=@6
M+?.[%F//J2>* .2\9^)-<TC5XH++;:V MC*UXUA)=(9,D!'\LYC7'.X@_I4J
M>++V6R\17"FU=+#3(;RW>++*[/"SGDXRN5&.G!K9U;PIIFL7OVRX-W%<&'R'
M>VNI(3)'G.UMA&1DGKZFJ]WX$T&\ 5X+B*+[,EH\,%U)$DD2 A5=58!@ 3C-
M &-#XB\1ZU=7D6E2:;;#3K6WEF^U1LPGDDC\PJ"&'EJ!@9PW7VKGTUK7=&E\
M9ZY:2V/V*SOHYI[5U:1I288=RK(& 48/!P<FNZO/ ^B7K9>.YBW0+;S""ZDC
M$\:C"K(%(#@#(Y]:E?P?HK:9J>G_ &8I:ZD0;A$<@'"*@V_W0 B]/2@#3O[Y
M;#2;F_9&=((&F*CJP5<X_2N+MO$?B:&XT62]_LV2UU6"6X"PHX:#;"9%7);#
M=LGCZ5W9AC> PLH:,KM*GD$8Q@UQ\?@6+3_$.B75A)</96?G(\5S=/((HVC*
MJD:DX R?KCZ4 -M?&%Y+IWA"XDCMPVLQE[CJ F(3)\O/ R.^>*Q]-\?ZK-KF
MG0S265S;:AYH"VUM,JPE8VD7$S?+*"%QP!ZBNCL_AYH=G<6T@:^F2T#+;0SW
M;O'"K*5*JI.,$&BV^'^C6MQ8R";4)!8!EM(I;MV2!2A0JJ],;3CUX'- ',0Z
MSXMU6;P;J,]W86T&I7/F"WMTDY0P,V'.X;NGIP<=<5+I/Q$U34+VRN/LGF6%
MY<B%;>*QN/,B1FVK(92NPXX) X SSQ772^$--?3-)L$>ZA32F1K22*8JZ[5V
MX)[@J2#Z@U!;^"-)M=0BN4FOC##,9X;)KIC;Q29)W*GU)('0=A0!#X*UK7/$
M-L^IWZ6$5A(\L<$< ?S 4D9,L2<<[3P*DU?6-6D\2IH6BK9QSK:&\FFNU9EQ
MNVJ@"D<D@Y/;'2MG1M(M-"TN/3[(.+>-W<;VR<NY<\_5C5/6?#%IK-S'=_:;
MVRO$C,0N;*;RI#&3DH3@@C(STX[4 <[IWB[7-=U'3+.QM;*!I()9KQIF9@AB
MG\EPF,9R0<$UN>-M2NM*\':A=63[+LJL,+X^X\CK&K?@6!_"I]+\+:9H]Q:S
M622(UM:M:H"^[*,X=B<]6+#.?<U+XET8>(/#E]I?F>4UQ$0DF,[''*M^# '\
M* ./2+7-*\87VG:"UJUM::1:$B^DD8$AIA@8/!;'+>PZU;L];%WK?A?7K<R)
M;Z]:-!+;L20K!#*C?48=<]\BKDW@Y=;>/5+^ZU'3M3GM([>\CL;O:C!<DH>#
MD99N>O/:K*>'W'B?3&2WCAT?1[,I:(IY,K?+T[!47'OO/I0!#X^LK[4-%MH;
M(K(HND>XLS/Y1NXADM$&[$\'MG&*X'P]-(_PRU33?#L>I6^M/8V^+.><(J^8
M-OG0L6P%;YCP>HZ UZGK_A^S\0VD,-TTT<D$HFMYX'VR12#(#*?H2.>.:P-)
M^&ND66@3Z=?S7-_+<10QS7,LF& B^X$Q]P*>0/YT <G?:C)X-M]8B_LV[L-8
M;2I;BTG.KS7L3*&4-Q(<*X)!^[T[UH:R)_!,]E+I5Y>2FZTJ]>=)[AYA)+%$
MKK+AB<-G(..#NKJ;/P+IL4]U<7]S?:M-<VS6C/?S!RL+?>10   >YZ\4[3/!
M&GZ?=?:)[N^U%UMVMHA?3"011-C<BC ZX ).3@=: .8M(YM NO!5W;ZA>7,N
ML-Y6H&:Y>59]T)DWA6)"X9<C:!P<5L^+6EU#Q=X9T%[B>*PNQ<S7*PRM&9?+
M5=J[E((&6S@'G%6])\#:=I-]:W*WE_=BQC,=C#=3;TM5(V_(,#G;QDDG%-_X
M0TWNE64>I:A=_P!I6<\TUO?P3?O8M[L=H9@<C:0I!&,"@#CUO+W^T)O"@U*[
M^P_\)"MIY_VA_-6 V_G>5YF=WWAC.<XXS1K=]?:'J.J>&[#4+M+2:YTY8I9+
MAY)+=9Y"DBJ[$L,A,CGC=Q7:+X%TI=$;3Q)=B5KD7C7OG?Z0;@?\M-^/O<8Z
M8QQBB+P+I7]G7MK>2W=[+>NDD]W<2YF+)C80R@;=N,C XH HZ+&=%^(=WH5M
M<W,FG2Z8EXL5Q</,8I!(4.&<EL$8XSVK0U_6-7MM?TS2-(MK.26]BGE>6Z=@
ML2QE.<+R<[\8XJQH?A>WT2[N;YKR\O[ZX54>YO'#.$7.U!@  9)/3DU0\2>&
M[S6_$^CW<%W=6<%K;W*/<6LJI(K.8MHP0000K=O3VH Q9_B/= V=DMK;6^H,
MUPMT\IDDBB,,GEG;L7<VXXQTP.M26OCK6=6NM(LM-TRU2ZO$NC,;N21$3R65
M<K\N65MV1D#K6R_@6P2RLXK&\O[*YM/,*7D,P,S^8VZ3>6!#;FY.1UZ8JQIW
MA&QTV^TV[CGNY)K"&:%&FEWF3S65G9B1URO; YZ4 7?$&L+H'AZ\U22(R_9H
MB_EJ<;F[#/;)Q7*W_B_Q!H;7T6J:=8-)!I<FH(]M,Y5BKJNP@C(QNZ]Z[/4]
M/M=5TVYT^\3?;7$9CD7.,@CU[5QT7@27_A(;G[=J&H:EIUWI,EE++=3J74EU
M(50H&. 3GUZT :FL>*)],O9[=+2*7R]+>_!><1 L'"[2S<*.<Y-<W#\3;E)+
M^*>'3KMX--EOXWL9G*9C(!C8LHY^8<C-;!^'%E<)>#4-6U6_>ZL_L1>XE3*1
M[@PV[5&"" <\Y[YI)?AU;W=Q-<:AK6JWL\UC+8%I6C 6)\9 54 !R,Y_.@#-
M?Q#XF3Q+HD^H1V-K8RV5S=2V\-P[YC4(<ME!\P!X'3KS3-'^*$E_-9-/:VHA
MOHW:..WE=Y("$+@290#! QD=#ZUUFH>%K>_N-+G^TW$+Z>K1KY97$L; !D<$
M'((4=,&J%AX#BL7A1M;U:XL[>)XK>TEF7RXE9=O\*@M@<#<3B@"SX-UO5O$.
MC0ZKJ-C:6EO=Q1S6RPSM(VUAGY\J #TZ9ZT[QY<SV?@+7KFUF>&>*QE>.2-M
MK*0IP01T-26OAE;'1M&TRTU&^AATLQA2CJ#.J#&R3CE3WQBKVMZ5#KNA7NDW
M#ND-Y"T+M'C< PP2,Y&: /,]%UB?3/$NE,R>(K&QFM)VN%UB=I4N76,.!%EF
MPPPQ[< ]:T].^*B3JD]W:VHMYK66Z5+:Y:26$)&9-L@*  E0>A.#Q6W8^ X8
M;VVN=2UG4]6%JK+;PWC1^7'N4H3M15R=I(YSU-1Q^!_L=J\8U34-0MX;22WM
M-/NY@L"JR[=K%5#,,8 +$X[4 9NI^,-;MK%X]3TJWMX[K2+J]B>UO7WIY:*=
MA.P;6^8<C-,D\>:M:VFJ26VD0RV6B6UO-<RSWC>;(KQ+(0HV'+ $\D\_C5+2
MO!NL:IJN-7CU:VL5TJ>Q/VR[@F*^;M&V+RQT !^9^3QQ75-X&L&T[7+(W%SL
MUBWCMYCE<H$B$8*\=<#/UH Q]1^(.IVO]NW=OHUO)INC&-IY)+LK)(KQJ_R*
M$(R W<TZ?Q9=V&KW=I86+7=S<ZTEC&MQ>,(TS;+)N'RG:HQRHSW/>M63P'82
MZ3KVGM<W/E:R%$S97*;8U0;>/10><U*/!=I_:R:C]JN#(FH"_"Y&-X@\G'3I
MMY^M &;%XVU*XDBTR#2K8ZTU[/:-&UT1 HB569]^S<1AUXVYR:VO"VNW6NV5
M[)>626EQ:7DMH\:3>8I*'!(; X/TKG_$/A2YM9TOM(@OY[F34)+QYK2XB2>W
M+QJA""0;'4[1D,?3'2M3P#HE]H>@W":EYOVJZO9KIA-(LD@#MQO*_*6P 3CC
M)XH J:UX[FT:XURU?2FEO++[.;*%)>;T3':NWC@A@P/7I63KOQ!6[T1Y+2UN
M/LXT^TO9IK>Z,3Q--,BK%G:><;B?88[UU.K^#[#6?%&DZ]/),MQIN=D:D;).
MXW#'\)Y'O63!\,=)MM!U?28;BZ6+4[I;EWR"T>UU947C[H*\ ^IH YS7?$?B
M>*V\1,)$"VFO6MM;+#<%7VDPGR_N#Y6#\G)Y8C! S7:Z+XCO[CQ-=Z!JUA;V
MUW#:I=(]M<&5'1F*]U4@@CTJM?> H+Z^OIFU*[2"\O(+Y[=0FU9HBF&!QGD1
M@$9K83084\5R:^)I//DLQ:&+C9M#[@?7.30!C^*=4U>R\7>$[2P,8M;NYF6X
M5I"OF 1,<?=/09/N0![UC>$O%NL0Z1HAU:T26TO[F6U2\-V7F+ R,"R%<;<(
M1]XG@5UVN^'EUF[TN[6\GM;G3KCSHI(@ISE2K*0P(P5)%4[?P9:P:5HVGBZG
M:/2[LW4;-C,A._AN.G[P]/2@#!T3XHP:KJ&G(\5BMMJ,WE0+#?"2XC)!*F2/
M:-H.,<$X)&>M=;XGUZ/PUH%QJDD#SF,HB0H0#([L$5<GIEF'-8^E>!CI5]9-
M%KFH/I]BQ:WL3L5%!! 5F50S*,\ D]!6]KFCVNOZ/<:9>;Q#,!\R'#(P(96!
M]00"/I0!RE_X[U31IM0M]4T.!);2R2\4P7I=)%:41[<E 01GT[5J:YXMDTC4
MK^SCL!.;73DO03<+$&+2,FTEN% QG.?PK"/@2_O/$FI+J^I7FH6-]I(MC=OY
M<;1N)-P554#!'WLXY/Y5;N_AP-2^W/J>O7]Y<7<$<!E>.)?+$<GF+M4+CKU!
MSG- %+_A:!CL=9?['8WEQIRV\BC3[_S8IEED"8#[!A@>V/2FS>+]?TGQ7=R:
MW:VT&GV>B&]FMK>Y,F")& 8$H,L<!<$X'7/:K\OPW2Z-[)>ZU=SRWD4,4A\J
M-%412B10JJH &01WZUJ:SX-MM;UI]0FNYUCGL&L+FV4*4FB)8CDC*D%LY'H*
M ,"W^*4/DWAN;?3WFBT^:^CCLM26XSY8RT;D*-C8/N.#Z5U_A[4=1U73%O-0
MTZ.Q,N'AC2?S28R 06^48//3GZU@#P%+-;7T.H>(+Z\6YL9;% 8XXQ&KC!8A
M0-[^Y]_6NNL[<6EC!;*Q<0Q+&&/4X&,_I0!P6L?%6STK5[^W\JT:VT^=8+C?
M?*EPS';N,<6,L%W<\C.#CI5@^/KX7%S.VAQC2K751IDMQ]LS(6,@0.$V?=RP
MSSGKZ5;OO @N=4NKBUUF\LK:]F6>ZMH%0%W  )63&Y,A1G!_G5B7P5;R:5>V
M!NYMMUJ@U(O@$JPD63:/;*X_&@#GM9\7ZQJ-I:W6F61M]+.M068O%NL2.!.$
M?*;?N$@K][/M4\/Q4LY=66$167V-[[["I%^IN2V_9YGD8SLW>^<<XQ5Z;X?!
M[B-(=;O8-+COEOTT]$38)0^\C<1NVELG&>":EC\">1J@F@UF\AT\7;7GV*-$
M4;RQ<KY@&_86).W/?'2@#+NO%NKZF='N[2P:VTFYUB.W2Y2YS(Z"0J=Z;>%8
M@X^8]LUV7B Z@/#]_P#V2\::CY#?9FDQM$F/ESGCK7/IX#>*^M?+UR\72[6]
M^VPZ>(X]BOO+E=V-Q7); [9]JZ75]*M=;TFYTR\5FM[E"C[3@CW![$'!'TH
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M]R-N&UB@ SST!K6L--O-,U2TM+0A-"MM/$"0X7*R*P"X/7[H.>W2@#;HHHH
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M6[E>7*'*8<MN7!Y&"*B_X0GPM96-Y!)&P2>2.>>6:\D,GF+PC[V;<K#H""*
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MRWI7S/N%(A)MZ<YSC-8LGQ%OK;3]-DOK#3;"YU-&GMEO-1V1K %4Y=]O#$N
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MI-6=)\)7=EK=EJ5]KMQ?M96TEK!&\*( C;,DD<EOD&3W]!0!U5%%% !1110
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5B<<G.X9QV]:]>U"31M.M88;Z.WCM[FX6&.-HLJ\KGY1@#J3WJZ+.V AQ;Q
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MV>E7]LDPNRPAB>W\R/*#)SP0O'3./:F6NI:'-_9CVLML3=(XL2J8+(!E@G'
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M[K4S)86>I/97;S"+?Y3HICDD\LD*RN0I QPV2*[ :)H&KZ6=MG;7%E>2"\W
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MX?OIFO1:G>+I0,%O) D=C:M&)-^,L^YB!P/NJ !DUT&C^&O#NGW OM+L+9)
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M!?"\NGP6+Z):&VMRQA39_J]QRVT]1FMJTL[:PM([6T@C@MXE"I'&H55'H *
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MZRFDFDEM('>>,12LT8)D09PK>HY/!]33--TG3-'A:+3;"VLXV.66WB6,$^I
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MMU=:1"BS+]E61H$VDJH^4]E.%'Y5KZ;;:5);1WNFP6PBG@C5)84 WQ ?(/H
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M_+F1XP=VWIN_O8]\U9BT:VBU^;6%R+B2V2V(   56+?GS^E &C1110 4444
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MPWD=#)C')YKG]5BNY'BN-:-N4?1+0VQOK":X);R_W@C*.H67?^/3G%>[48H
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M-9RP,692!M>.0E6C;&0>O7(%=Z=-U"Z\ -I<QAM]1ETW[.QA&(XY3'M^7'0
M^E %BW\5^'KM;AK?6K"46REYBDZG8HZL>>GOTI^LZU#I=JS+);-<[0Z0RSK'
MN7>JELGL-P_$@=ZX?P_X>OKV_LX-3T_6(K:VT^:UD-[/;^4 ZJA2,1KE@0,Y
M)&,"H8/"_B&3PWK!U2,W&H!;>PLP&&7@A=3YGL7.6/T% '7Z_P"-=(T-'B^V
M6DVH))%']C%PHD^=U7IUX#9QCH*TG\0:/'JBZ7)JEFM^W2V,RB0_\!SFO/\
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M)D-Y97?]E3V.BFPDCM+6YTJ2_,+>:Y*E <QEE*$9Z#CC% 'MN ?QJ-9[?S3
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M]?HTOB"V41VEM+!!M,3B39N<ML/R@]!G..M 'LUS]DM(Y=0G6-!%&7>8KR%
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ME>'9*Z&=RN2>=N I':N:\3:)./%/B]K/2YA=W]A:FTN(+<YD"EO/190,*S*
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MDO8?G3]X#\H;ID%=OL:F@:XM++[''+<"&V77(8E+L2J*1L&>^!TH ]A 7)(
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M1>P^UF.2&5(R0@+[6*_,H)YVY-/\4:1JUYK<%SI]O%-"^FW=E,7EV&,R;"K
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M5\)>)K_5VD:*65$U:*[5Q?B.W\E)58!85',F!R6[@G/2O3+F-I;66-%0LR$
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MH^9VR#UR#P.!6BFB^(M)&L1V6D6=^=6$3J]S*OEP,(EC995/+*-N1MSG)Z4
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M1_G1E"G[GH"*]0_A_"@#@[;XG:!/)IMW$;>*UOY+B*>ZEE53"81E0V,YW C
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M$[EM;\/S7FF7$M@MWJ%PR7L49\KS%782B@*FX@D+C@FO59$5H'0J"I4C&.*
M,/2O&.B:MX<AUU+R&WL925W7$BIM()&#S@'C./>MJ">"ZA6>WECEB<95XV#*
M1[$5Y%X<TR\TO3/#D^H^';^6+2ENK:YMEM@S"5V4K,J?QKM!7<,]:[7P)87=
MI#K%S-9O8VE[J#W%G9R *T4951RHX4LP+;>V: .BO-2L-/*_;+RWMRWW?.E5
M,\XXS[D4@U2P-Z;(7ML;H+N,/FKO ]<=:YC6]#_M/XE:)=7.GBYL;>PN0SR1
MAT20M'MSGC.-V/QKC-*\-ZM;ZA9Z?<V^J&[AU8W4DT=K"L)3S2WF?:"NY@5.
M"N=QR1C% 'I.F^+]%U+1GU5;V&"T2:2!GGE50&1BIYSCG&1[$59EUJ%;G3U@
M6.>VO/,/VE)TVH%7=GDY8'&/ESCO7F,=AJ-AIUG:G0[F);74KXS7":9]I<;W
M+1M&O0JRMC=@XQCBC2="U=;;3%DTJ\C\J[U4E98E4HLL3&,D)\HSG'R\9)%
M'H=M#X>O_$QU&WNX+K5(8M@"W7F>4AZE4SA<\9('-;DLD<,322NJ1J,LS'
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M@L#5G1M7BUJUFN(HGC$5S+;D/C),;E2>.QQ7DJZ;J$LFJO!87SP7,FERQO\
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M#^F7;VMWJ*)+&JO( C,(U;D,Q (53ZGBDC\:^'I(+N==2C$-I&)97964",G
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M"QW(03SP>"..*?J7A_Q"-*U[PY;:.EQ%JU]+<)J33H$B61PV64G=N7M@'H*
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MV2S"5%$<JF5@""<\[P 161K?A+7/[0UI8K35+J'58XP/LEY#%$,0K&4E#@G
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M-8TGA7Q MS%8P3Z=_8L>K+J(9]_GX\[SBF -OWB<'TQ2VGA77H_L&DS3Z?\
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MA8!L'&W:.F<Y-0W?@[7=:N+O4M5FT^*^E%K#%%;%VB2**82DEF4$L3GL!TH
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M#E3Q@]2*S;KP=XIOQJUU<W>GQW-]=VL[6]O-,D;QQ(5:)G # '@Y [=*BM?
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MTD<%G;O*Q2&5D+;5R< !<GU-<O:_#;4+6_MX/LUG+:PZC]K^UR7]P28_-,@
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ML,"E\86WGWL.G]SIZU?\0^'M2U+Q#>O!'$;'4=%?3993)AH')<AMN/F'SXH
MZ!]?TV.>QA>YVO?0O/;Y4@.B@,QSCC 8=:J:3XPT37+L6MA=.\K(9(Q)!)&)
M4'5D+* XY'(SUKDY?#/B+6Y])CU&SM;&VL],NK"1X[CS'+2Q*F\#:/E^7IUI
MWA;PAJ=AK>DSWMB8DT^!U:6359KD.Y4(/*C8X1<9SD>@'2@#M]7UK3]!LOM>
MHW'DQ%@BX4NSL>BJJ@EB?0"N7U[XCZ?;>%KG4M'<SW4<T=N(IK:9?+D=@!YB
M;=RC!ST&>@Y-:?BS1K_4;C1M0TY89;C2[S[3]GF?:LJE&0@'!PP#9!]JP+GP
MOKNJ2:SJ5S;VUO<7]QI_EVJR[MD=O+O)9L %B">GH!0!UB:M):^$_P"U[_:[
MI;>?)Y$3@'C/"D;Q]",BN6L_BA9RW.D-=120VU_IANR$MII)!*&4% H7)49;
MYL8.,YKN;V%KFPN($P&DB9!GIDC%<7X6\/ZS9ZOHMUJ-I# EAHC::^R829</
M'AAQT(0GVH V/^$OT][BUN(KZU.E2V$UZ9COW;49!N'&,#<<@\YQQUJ?1?$&
M@^(-0F?3V#WT$85_.MGAE6-CD??4-M)';CBN0L?!6L0:3;VLEM92,FFW]JT<
MSDQLTMPKHIV\X*@\CI6MX.T36M+UJ[EN%N+?2VMU2*VNKW[6ZR;CDJY&0F.Q
M)_"@#?\ $VM'0-!N+](A-.-L=O"3CS9G(5$_%B!5/2/%EM<>%GU?57BLGM&>
M&_7)*PRHVUE]3ST]015;Q5X<N_$^LZ1 \TUOI-HS74LEO-LE:88$8!ZC&6.?
MI7*^(?"]QX<MM7ECOF?2IY+6^,^HS-)MNHY5!5\ G8ZA,MVV\\4 =+/XP\$Z
MU:3M>S03PV 2ZD6\LW_<Y.U7VNF0<G@X[U;D^('AF&VMYGU%E2X0N@^SR;@@
M)4LR[<JN0>6 '%<.XO\ QKXDUQK>VL\C3[*(>1=+,GRW#2$,X&-V 3CTQZUM
M>)O">IS>*;S5K*&ZN8[RTCA"6^HM:&-TW??Q@,A#>Y'/'- '3ZGXRT#2/(^V
M:@J^?&)D*1M(/+/1SM!PON<"F:CXW\-Z3)%'>:I&CS0K<1A59]T39P_R@_+P
M>>E<0W@/5]-='@@N;D2:;;VICLM4>W6)XPPPV3EXSNXZD8/'-;.C>#[[2Q+&
MT,&W_A'XM/39(642AI25!;YMOSKR: .AT_QEX>U2[FM;+4XI988C.^ 0OECJ
MP8C# =R":@M_&?A;6;.^$>HP3V\%NTMRLD; >3@[FPP^9>O(R*YR^\%:G?Z7
MI5DBK;F+P[-ITLFX?NY66( <=1E&SBLUO!NNWEK?A[*]CD&CW-I";W5/M&Z6
M10NU,' 0X'+8Z"@#K(_'?AF/1;Z32;N*:/3;0S"")&0>6HP-O'*]!D9 K;\/
MZQ%K^@6.JPC:EU"LA7GY21RO(&<'(S[5SFJ^'+^[GMQ;PJD:Z!=V#$L!MDD\
MK8/I\C<BM+PW)J]KIFCZ==Z,T"Q68CGE-PC>6Z *  ,Y# 9SV[T ='7":W\1
M%T6\\5Q3VJE-%MX)(3N.9WE1F"GCCE<9]Z[NO-=?\)ZU>W?Q DMK9676+&UB
MLR9%&]T1@P//')'6@#J-+2#Q/X?L-0URST^XD1_M$>P%XXV!.UEWJ"#CVZT^
MP\:^'-3N9+>SU6&61(VEP 0&1?O,I(PP'MFM>]6>33KA;81_:&B81B0?+OQQ
MGVS7E5GX3\327VBSW-G>!K.VN(9_M%U#Y2L\!4>3''@*F[ YP<$>E '=VOCO
MPQ>M*MMK%O*8HFG;;D_(HRS#CG'?&<5JKJ]@]S:6ZW49EO(C-;J#S(@ )8>W
M(_.N-L/#=_:P^!!=6T:Q:3820ZAN=<(3 J>O(W ]*J_#33)7O[[49[B.YM].
M#:/ILL;;E:W1RV[/<G*KG_IG0!VFL^(](\/"$ZK?1VOGDB(,"2Y&,@ #D\BH
M9_%WA^VTF#5)=4@%G<'$,@).\]P .21W&.*Q/&$]Q;>,?"DUM8&^D5KH^2KJ
MK8\L9*EB!GZD5@3>$-<^TV>LO;7:R_:KV:2ST^[2.:$3LA7:S84D;,,,_P 1
MP30!VUWXV\-6%C:7MSK%M';7:EK>0L2) " <8ZX)&:?:^+_#][JYTJVU.&6^
M!8>4N>2O+ 'H2.X!XKD/#W@[4[#7M"OI[,K%#+J$TPDN1*\9FV;=Q[L<'.W(
M!)J&W\+ZZFL-#;V5Q96TMQ</<;KE)K3;(LF)(5.9$D)92<8'+=J .TLO&7AW
M49;B*TU6WE>W1I) ">%7[S#U ]1FGZ5XLT#7+M[73-4M[J=4\PI&V<KG&1ZC
M)[5QAT+7M1L='T^31!8_V3I\\+S>=&5G=H#$JQ[3D*2=Q+ 8P*V=/\/WUK?^
M#)?LJI'INFR6]UAA\C&., >_*GI0!O-!H=GXDCG:&VCUF]B94D*_O943&X ^
M@R/TJ&[\5:7'HIU&UNX+A'$HMPK\32(K,4!]?D;\JS/B!H^J:AI4%[H,2OK-
MB[-; L%!$BF-QD\?=;=]5%<SIOP^U'3+^^M(X@=(M;*8Z<N\9:XFB5'R,\8V
MOSQ_K#0!V/AOQMHGB2"!;6_MS>M;K/+;*^3'D L,X&<$X)%6=-\7>'M7OVL-
M/U:UN+E<_NT?DXZX]<>U<M=>$]2N;/PG;1P" VFE7%I<R!A^Y:2W5!T//S#M
MGI38M'UK4?\ A%+)]$;31HD\<L]TTL91@D90K$%8L0V>X''6@#N]1U*RTFQD
MO=0N([>VC +R2' '.!^M94?BFQOGTM]+N+6ZMKRX>W9_.VLA5&8@*1DM\O3C
M@YH\9:=-JGAUK>"TDNG$T4GEQ3>5*-KAMT;< .,9&>#C!KBX?#GB&Z2)[V.:
M""/4)I5GN?)%RD36C1^9*8OE9@YP",G &: .VM?&GAN]NFM;;6;22=0Y,:OS
MA02Q'J  >1Z5)IOBWP_K-V]IIVK6MS.B>8R1OGY>.?<<CI7G%O<3ZC=^$M*A
MT^V5K?3;E$EBN(Y!+_H^P%-IR$)(Y;')%;]WX4U&XT3P[8P0K;O;Z3/:3NK
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MS0OIUM9HP0??-YY:Q/)T[H#SZL:ZKQ58ZGJ7AJ]M-'NA;7TB@1R%BN/F!(R
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M% L* MCA47H!CC))]ZS+WP8UYHWB;3Q?!/[;N3<!_*SY.8XTQC/S?ZO/;K0
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MH=)6!HUY)<1;2!Z\US^C^$=8U31-&_MG5%1+*PVVL<-J8I8Y'AV;G)8_,H)
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MI9HVN47;*C="K*S#/J#@C(XJCK'BBZT[QQH^B)8O):WEO--+,H'R["H!R6&
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M<SLH;R#EE8@'&<<'FMGQ5INJZOX<:TTVY6UNV>-GQ*R!U# N@=1E<C(W 9H
MKV_CK1IH-0DF-W9M81I)/%=VKQ2!7)"D*1ELD$#&>:S]1^(UG!:H]M8WYN%O
M+>":VFLY%E1)6P'V8R<@-CU(Q6)#\.=3:YU2Y46EE]I@M?L\7VR6Y*2P3>:/
M,=QE@2,''3T[UN:EI7BS5[=YITTN&2"YM9[6S29F4F*3>^^78#\W0 *0,>]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUX;YM1737L8W1G25EW+AL[2",<Y[^U(_Q1ACT^%VT._.I/?MI[Z>I4R),$+
M9S@@C'(]: ._HK@_^%G6RZHMI-I-Y%#'+#;75R639;SR!2(V&<G!8 D# -6M
M-^(,&K>*;G1[/2[J6&VN7M);M60A)%SG<@.\+D8W$8H [*BN)TKXE:?JNJ+;
M)8W<5M.TRV=XX7R[DQ9+@#.1]TXR!G%5=/\ BE!JD$$L.AZC$EY9S7-B\H3%
MPT0RR##<'W.,T >@45YEI7Q5E;PSHMU?Z1/+J>I)(Z0PF.-9%3&63>_/W@ .
MIP>*]$T^\&H:?;W8AF@\Y _E3IL=,]F'8T 6:*\L\0^/M:M];\7Z9;6LMM'I
M6E_:+>Y$2MMDVEMS9)!#= ,=C6WX>\?QWOEV%]I^H17RZ8M^I>$$W2  ,R*I
M)SNZ+@&@#N**\XO_ (HLFDZV(M%OK35+"R^UI!=*IS&3@.=K< 'D@\UV'A;4
MY]8\+:;J-U#)#/<6ZNZR*%)./O8'0'J/8B@#7HKA]=^)EGH>HZO9G2=1NO[)
M$3WDL"ILC2100W+ GKTQ3]4^)6EZ9J+VYM;R>U@6(W=[%&#%;>;C9NR<\@@\
M XS0!VM%>5ZWX^U71;K4!:+-J0&O0V C-NJ^2C(K%%(;YF;. 6[FI+7XDW&F
M>(/$46KVM[-IUIJ$4"SQPH$M$=5 #G()RQ]\4 >H45Q=U\2=+M=:GLFM+UK2
MWN4L[C45C'D13-C"DYSW )Q@5<T3QM!K_B&^TJSTV_"6,LL$]X\8$(D1@"H.
M3DG.: .HHKC/&_B^]\-:KX=M+2PDN4U&\\J8HFXA0.B\CYCG/T!K&T?XDM:W
MNJ0:U;WLL,>NRZ?'>1P*(85W!8U8@@D]><&@#TRBN0'Q%THZVVGK;7S0+>"P
M>_6'_1UN#_RS+9SG)QG&,UU-U<I:6<URX)2)&D;'7 &30!-17*+X_P!*:+3Y
M!%=8O]-DU.+Y!_JD4,0>?O8/3]:K:9\3-'U&<QR6NH6*&Q;4(Y+R#8LL"_>9
M<$]* .THKS6'XDB]\2Z?*(;VPT5M,N;Z;[7;!3*B;"CH1DD8+<#U'%:?_"S]
M(CTN_OKNRU*T%G%%</#/ !(\4C;4D49Y&??(H [>BN'/Q,M1-!;?V#K;7<D/
MVA[5;8>;%%O*ABF[)S@G R<4RY\;P:/X@\0_;[N>6ULH[0Q6J6H#!Y00%5LY
M8L>Q Q0!W=%</_PM#28[?4I+K3]4M9-->WCN89;<"16F.%P W/X?AFI8_B3I
M1L]1EFL]0M[FQGBMWLIH,3/)+_JPJYYW?7ZT =G17'?\+%TPZ=',EEJ+WCW;
M67]G+ /M F5=S*5SC 7G.<8I_P /?$-[XET:_O;TG='J5Q!$ICV,L:M\H8>H
M'6@#KJ*YSQ#XQM/#VHVNGO8ZA>7=U#)-%%9P^82$QN[C'6L^3XE:1_9NEW=G
M::C?R:E"T\-K:6^^58U.&9AG  /'7KTH [.BN.?XD:.S:0EE;W]^^JQF6W6V
M@W$*&VL6R1MVG.?3!KJ[FX2UM);F7=LB0NVQ2QP!DX Y- $U%<7;?$O2I_MH
MGL-4LGM;!M1V75OL:6 =749Y^AQ34^)^BLEZ[VVI1"UM%OCYMMM\RW9@OF+D
M\J">^#0!VU%95CX@LM0UN]TJV9Y)[***69POR 2 E1GUP,_0T:]KUOX?M8IY
M[>[N&FE$,4-I"9)'<Y. /P/)H U:*\O\2_$N>;2](;PY%>1S7U^UI*[V!E>$
MH#N39D OD#C/3/I5.P^(&M7VHW$\T\EC9#6X=-BAFTP@D$D$%BV0YQSQ\N1Z
MT >N45YQ8^--3GU!(+FY@B#>);C3$46Y8R1)G:N<_*>/O5KP_$72IM2%B+/4
MUDDCF>V=[1E6Y\H$N(^Y/'' S0!V%%>?:%\4+>]\*Z9J6HV%ZM_?O(L5G:VK
MNT@3DL@[J 1EO7-=GH^KV6NZ5;ZEI\WFVLZ[D;!'0X((/0@@C\* +U%<KJ_Q
M"T+1=5EL+IKIF@,8NIHK=GBMM_W?,<<+G.:L6GC+3;[Q-<:!;17DMW;-MG=;
M=O*B.W<-S]!D=/6@#HJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BB@]
M* .5TSP'I>E>--2\40/*;N_0J\3;=BYV[B.,Y)4=^YK.L?A9I&G>'-5T2VN[
MM+;4YQ+.P*AMH(_=CC[O;UY-<_9_$WQ*=+M-?O-,TL:*^H_8)1%(_GYWE?,
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M^7QN^;((ST!YH M)\(])@\.S:+:ZA?6\#ZD-2C>,KOB<#"A3CH,#WXK8\/\
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MTKBYB4 D9 ^1N1P0>M=1X5UN^\0Z,NHWFDOIJRD/;QO,LC21%0RN<=,YZ>U
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MZEJ%C%_85[#97=[)8)>NZ;/.7=QM!S@[3S0!G:9\-M<A-DM_K%C+'8Z5<:7
ML-NRG8ZA59B2<GCD<=*T)/AR]T=(CNKV-K>TT%](G"*0S[D5=R^W!I;+XG)>
MW^GHN@WR:?J-\;.TOV9/+E(W9.,[@/E.,CD5=^*.M7_A_P !W>I:;.\-S%-
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M_:X6GLY)9(V\]%QGA22IP<X/:M[6?$46C:KHMA);R2MJEPUNC*1A"%+9/Y4
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M..CLNT;3SG ^E '2Z!H=GX<T:WTJP#BUMP1&';<0"2>OXUF?\(-I!M#;?O\
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MRR:A%%/;QV\7EB-60':<D[CWJM\0-;UK2$T.WT.6VBNM2U)+,O<1EU565CG
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ML.V.9TA15)=I N68GY<!?7D\4 >B>'/#X\/6]Q&VI7VH2W$IE>:\D#-G &
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M-<[>HI\7W?;_ (KFS'_D,T >J-X \+M8VEG_ &4BV]I.UQ;HDCKY4C')*X/
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M'A_2[;6;W5XK1%O[U%CN)LDEU48 QT' '3TK-LO 'A?3I[B:TTI(WN(GA?\
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M58$$'W!JAX'UJ37O"UM>378NIPSQRRBW,!W*Q!!0D[6'?MGI7#:UXT\2Q_\
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MKHUC>I/%*;FW2;=&"%;< <@'D#ZT 8>J?#OPMJNJ37U]9NUU=NKS8N9%$VP
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M[?JN*Y:\^+,UOXHN+2.TM7T^WU!;"1=[_:#T#2 !=NT$],Y.*W_#7B?7M?\
M$NIV[:=9Q:1I]Y/9M/YK&5V0_+A>G<9H W]7\/V.L^')]"N$9;*:$0D1M@JH
MQC!]L"N;3X96!BU%;K5=3NY-0L?L$\DTBD^6#E=N%X(Z?G5OQ-XGU6Q\0:=H
M&A6%O=:A=PR7#-=2E(XXTP.P))).*Y^U^).M:U<Z+::+HUL;J^AF>=+FX($#
M12;' ('S#KCIVH ZJ?P983ZK-J+37 EETHZ4P##'E$YST^]5(?#G2A9I;&XN
MBBZ,=&SN7/DDYW=/O<?3VJYXX\2W/A70(]0M+1+N9[J*W6)WV [VQUP<5S;?
M$?5;"+7+34M)M3JUA=6MK!#;SMY<SW'W,L1D8YR<=J +MY\+-+N@ZC4M3MXI
M[**RNHX95 N$C7:A;*G!QZ8!JW<?#G2;N[>:>XO'CETY=.G@\P!)D485FP/O
M#J",<UR'B_QSXHM?"WB+3Y[6WT[6["&";S[2<LIAD?:63(R&!X_'(/%>F6EU
M>Q>&DN[Z*-;R.U\R6.-RR[@N2 3R10!BQ> XUT^[M9M?UR>2X\O;<->$/#L^
M[L"@ >_'/>J@\ 2:=973:7JEV=4O;NWFNKV641LR1L,KA% QMW#&!G/)K!L/
MB5XKU%; 0^'=.5M1T^2^M]]XP"K&<-N^7OD8 ]>M/U3XK7MMX;TC5K:STV,W
MMBUV\5U=D,2O6.-5!8G@_,1CUH ]$UO1K+Q!HUUI6H(SVMRFR15;:>N00>Q!
M /X5S*_#6QDLM2CO=2U&^NKZT-B;NXD#2109SM7C'7G.,FN?C\;>(+GQ,-0A
MMH/[)_X1L:F+9YSP2"V[[O+;@%^G/M6I<?$6YALM-N!I\1-YX?FU@CS#\K)&
MK[.G0[L9H VY/!5E)J,MX;BX#R:.=((XQY><[NGWOTK-O/AM:S161L]7U+3Y
M[?3TTV2:V90T\"C #9&,^XQ6'>?%+5[#3=)>\TO3;2[U93<6PGO2(D@"*V7;
M;G<2V  *O67Q)O\ 7WT:VT+1XIKN]LI+V=+BY*+$B2&,J&"G)+J0#CT- &I<
M?#JR:XCET_5=4T[,$5M<BUN,&XCC^YN8@D,.FX$&M&#PC:07^O7:W-VKZRD2
M3%)2K1^7'L!1AR#CG.>M9?PEO+N_^'.GW-]<33W+O-O>:0NW$K  D]< 8JA+
M\1M1CU*>Y.CQ#P[!JG]ER79N/WWF;@A?9C&T,<=<T 2GX=36%MJM[9ZQ?7>N
M7-B;.WNYI5B:-<@CYD7).0"6.2:Z^ZTF'4M ETG4"T\,]OY$QS@N"N"<^M<_
MX0\4ZSXFU+46FTNWMM*M9YK:.=9]SR21OM^[C@8S^(IGB+Q;K%MXG'A_P]I,
M%]?)8_;YOM$_E+LW;0J\'YB1WX% %>V^&5O"9&GUO4[N1],ETL-.RG9"^ ,
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M1C@(IVG+9!YQCI69=?&*9-'TB>'3[&.[O;)[Z6.ZNS&B(KE BG:=S,0<=.E
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M5L;/3[::R!:2"2&9B,-C=M8-]T[1QG'%=1;V]I:6T=A;)%%#%&%2%  %0<#
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MP7X;U;49;^_TBVGNI5"O(Z\L!T/U'8]:E;PMH;W#3MIT)E:[6]+\Y,ZC"O\
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MQ<*",$OC/6M'X=^)=9O/$/\ 9^O7MX]S<6/VI8I(X'@;# %X98C]WG[I'XT
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MI"Z/AF7'D@Y#?=^_[]/:O-O$OCC5?$G@76+?RH81;:0LFHF/(:&Z^T;/+'/
MPC'!YY%=-%XT\0:5?ZOINL_V.LMII":C!,ID2)<MMV.3DGGN!S^- &;XE\ :
MG82:5%X=L+RZ@M-/-D9[?4EM;AESD+(2,,G?C!ZUK:5\+T_X1C1(+O4K^PU2
MRLFM99].F"ET9MQ0DJ<@$\$8YYKE[[X@>)]2\.>*K+S[1+BST]+J*\@M9K8F
M-CA\+)\V?[K=*TM<\=^*/#%KI,$Z6$<9L4EDOY;:>6&1R3\I9>4^4 DD')-
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M2Z+I[HLD[LPF??$'7 Z=3SGL: .UHHHH **** "BBB@ HHHH **** "BBB@
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MK9V$D]F+S3]/(\^<H)?LX.78]PA;)/:N#G\>:K':64UAJ*WDZ>$VO98EVO\
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M DXR2,C'/:K<OBC7+/2-3TR?7[N2^A\0?V?;W$-K"9YD\L-M^8JBGD_,>F*
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M2JB7"VURT:7"H?E$BC[V.E<]J7CG5;/60T-S93V:ZDED]O!8S.%1I1'EKCA
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MG>Z[;6%]")H[N)W$L&GW$"V[* =C-(,,""<,,<CIS0!W-%%% !1110 4444
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MVUB<#/'/?-5SQ\7 >/\ D!?^UZS/%.OZV/$\VDZ4+N*.VLTN6DMK6.8N[%@
MV]AA!LYQR<GD4 =K?Z;::IILVGWD"RVDR>6\9X!7\.GX5B+X*T6%?-F^TSR+
M)%+Y]S=/(Z^4Q9!N8\*"2<>_-<RVO>)M5MY)8;Z'3&M]"AU&5%A6;,S&7(W9
M(V?N^W/O46IZMK7B7P]K4D%]!8PVNDQR20M '$S2P%VRQ.0N#@8[@YSTH Z=
MO 6A3Y.;PP-<_;%@6\D\E9=^_>%#8^]SZ<UI6WAO3[2]BNX4<2Q23RJ2Y(W3
M$%^/J!7 'Q)X@6W6TTA9TCTW3;9AY5HDJRNT(?\ >,SJ57&!P/4Y[5T^A:GK
M6L^)KQGN8+?3K18,V@@W2.TD"N<R;N "W8<T :<7A/28K73K;R7:+3WD>!6<
MGF165L^N0[5#I7@S3=)OK>[BFO9FM8VBM4N;EI%MT; (0'IP ._ I_BK5+S3
MX-/@L#''<W][':K-*FY8@026QD9.%( SU(KF-5\1>)-(^W:6MY:7-]%/8B&[
M>WVJ4GD*$.@;&1M)X(SD4 =O=:/:7FJ6^H3*6FMXI(4&?EVR;=V1W^Z*Q].\
M$:1875M+%+>31639M;:>Z:2*V;&,JI/! .!G.,\8K>T^*Z@L(8KVY6YN5&))
MEC\L.?7;DX_.N?\ !O$OB7_L-3_^@I0!N:1I5MHFE0:=9AA;P A QR<$D]?Q
MK,N_!^F7D6JI(9U.IW$=S*Z2E622,*$9"/ND;%/U%<HGC'Q!<:C+<V]O,]G'
MJ9LQ;BQ/EM&LWE%O.W<-P6QC';WJU;^(/$3>5J<MW9FQ;6VTT6JVQW&/SS$&
M+[OO CTQQ0!K'P#I1L=3MKBZU"X?4TB2XN)[DM(QC)*$'H"">PQP.*;?> -/
MU#[2LVHZJ([N!8;M$N=HN=J[ [\9W8 Z8![@USMS>:WKD?A_5[B\M%T^;7$"
M6B0D.BJ[JIW[N6^7D8QS[4[2/'6N:C>6-XMI(]C>7OV<VXTZ0+%%O91()\[6
M/ )&.Y]* .U&@:;$^IB4&1=658[B.5OE<"/R]H'NHYJ'2?"=EI-['=)<W]S)
M#$88!=7+2B%#C(4'Z#DY/'6L3PS'J/BO2M/U[6KFW=8IS<VEO;P^6(V3S(\L
MQ)W9!SVP14'A7Q/K-WKUM9:U*(9;F&1Q;/9E%++@_N95++(H!.<D'H?6@#T"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H/2BD8[5)]!F@#'T#PSI_A_
M3X+:WC$LD(8"XD1?,(9BQ&X <98U4O\ Q!X9LM6N1=F+[;91>;-+]G+&)<#
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M<XZD^I_,T )'H.CPZBVHQZ79)?-DM<+ HD)/7YL9J;36L6L(VTT0_9"6*>2
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MQCGUK?\ &.H2Z7X7NKF"Z>VGRD<4D<(E?>SJH"J>"Q)P,\9- %G_ (1G1!I
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M.U&358K"**X&]]Y=MD>[[S*I.U2><D =Z=-X6T*_T:RT][-6LK4*;41RLIC
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MCAC5HV=?*96\QB, $,"2,GBIO"UUK.BZ3X3>[UJ.;3[W3SNMWMU1( D&]2&
MW' 7!R?RH [+7/"&@:]=)?:K9^;-#$8UE$\D>$SG'RL.,\\U2N/#7@^YM=.M
MIH[<IM*6G^EL&E0G<5#!LNI)SC)%<?9>)=?DO;"*]N[VYLM4@N%)N+&*WA)$
M1<&+!\S''\74&F^!M*>ZU3PC/)>!HH/#D4T<#P1MM.5!PQ&0<X.1SQCI0!Z6
M-!TQ5F5+1$6:U6S=4RH\E=VU !T WMT]:SM1\%>'+Y(C>V"M'!;BW_UKJIB4
M8"O@@,!VW9Q4GB[4KO3M*@6QF2"YN[N"T2=U#"+S'"EL'@D#. >^*X/QM=:U
M::)XG\/WFLO>@:,;^.Y-O'&ZJ'*-$P4 ?-Q@@ ]: .TD\*^%M>CM[A8(KF.&
M(6ZO!<MM>-> C[6PX'HV>];-E9V%M=WDMHB+-,R>?L;/*H%4$=OE XJIX4TP
M:1X9L;0/&Y$08O' L(8GG[J\9[9[XS6=X8/_ !4_C$?]1&+_ -)8: -W5=)L
MM:T][&_A$L#D$C<5((.001@@@]"*S;7P;HEI9FUCM&9&GCN7>29WD>1""I9V
M)8X('!.*XBY\8^)GUF^N[2&]:QM-1-H+9+.,PNB2!&+2EMP<\D<8Z#!S5F;7
M_$T<=[K?]J0_8;37/L L/LJ_O(C.L62_7<-V>/2@#TMY$B4%W502%&3C)/05
MS-Q\/_#]SJ,]^\%TL\\OG2&.]F16?CG:K =AVKDM2O=8UVVT[5Y+^)=/_P"$
MBB@6P\@918[GRPV_.=Q*Y(Z8/M3M,\9^(]0U.PO8[:[-A=WYMGMVLE6&.+S&
M3<LV[<6& 2,8ZC'% '9/X*T*36?[4:UD\\S"X9!<2")I1T<QYV%N^<=>:N#P
M[IJVB6H@(A2\^VJN]N)O,,F[K_>)..E97@NYUK4K*74]5U"*:&>21(+:. )Y
M(21UR6SEB0!754 <R_@GP_%J:ZF8)8Y([C[4JBZD6))<Y+B/=M!))SQSFFP>
M%/#D>K+?P@ETE-PD'VIF@20Y)D6+=M#<DY [DUO:CIMGJUC)9:A;17-K+C?%
M*NY6P01D?4 UY?;^%M!LO#7CB]M=)LX;JVDOX894B :-/)'R@]A@G\Z /3=,
MTNTTC38]/LHMEK&"$0L6QDDGD^Y-9VE^#M$T;4!>V5JZ2JK+&&G=TA5B"PC5
MB0@.!]T"N1F\0>(O#%K.M]=V^H$Z*U[;I%;>7Y,BLB!>I++^\!YYX-:_A'5]
M=N-<GL=42]DMS;^='-=V:6[*P;!4!6.5.00>V.] ':T444 %%%% !1110 44
M44 %%%% !1110 4444 %!Z44'I0!G#0M'#R2#2K$/(?G;[.F6YSR<<\\U9-G
M:MYFZWB/F,'DR@^=AC!/J1@?D*\?MO$\3^$_#.D'4Y6UF'7(8KN'>QE4"X8$
M/[8P.>#Q5V*T)TVXUO[7>M?Q^)A#&YN7VK']J5#&%SC:03D8[T >CW\VDZ?<
M6;7<,2RW5V(H6\K),S*<'..#M4C/IQ4[Z1IDOD>9I]J_D<0[H5/E_P"[QQ^%
M>2BXT^;5]",]Q*_BE==?[7;O,YV@>;M!4G:$ *;2.Q^M1^%+N^G\2Z07U&U7
M5&FF.H0)/.\[#:^Y94/R* W0\#@8ZT >PC3[$/ PL[?=!GR3Y8S'GKMXXS[5
M4MHM'M=7GM+6RAAO)(1/*8[;;O4L1RP&"<@\9S7E$MK;:=X+\+73ZDL<E_")
M[E=3NIQ!<OY:\-*I)0C.5'0\\<4L>JZA/I<4MLVHQ1_V) 909VDD6$7A6616
M !)\H$AL9QCO0!Z[#I&EV\<T4.G6D4<XQ*J0*HD'HP Y_&KB*D:!$4*JC 4#
M  KQI[C3+F\URV\/ZC=/IKMI"(8KF3"%[O;((V)R 5ZX[YJ37UN=&_M_3M-N
M)(-+AU&S\[S)YBL43PY;+*2ZH6"YQZF@#V!U21"KJ&5A@@C((JI9W=C=/>:?
M JD63+!-%LPJY16 '8C:PKR:QN@NFWAEOH7\.#5+<71LI)GABCV-N =N=I?R
MMV.!D^IKK_AX=,-SXD;1YFET\Z@GDN79@1Y$>=I;DKGIV]* .M_LVP$T<WV.
MW\V(;8W\I=R =@<<5:R*\L^(-[:OXM6QO# D:V(9&OI93&S,S#]S''C?*,#G
M=W&*S=,O[&XTK0W\97<WV"31(Q;/(\F&N-Q$F2.L@ 3&>>N* /4K=M)EUF]M
MH;>$7MN(Y9V\D _/NVG=CD_*:MPV-E!/)/#:P1S2?ZR1(P&;ZD<FO(+MKE;V
MZN]U\WA^WM=.?4HILK=RP[9,,S ]N&=1R1GZ5:UJTBETGQEKT<]R;JROD-C(
MD[A8@(X3E #C!W'/J* /5(-/LK221[>T@A>4YD:.,*7^I'6DM]-T^TD,MM8V
MT+G/S1Q*I.>O('? _*O+/$-W8H?$@U&[N(O%*W#C28TE<.1M7R!$H."I/WO<
MMFD\02ZY'JE_H<$\Z36Y/B)761L-&J<PY_NF8'CTH ].O;_3DU.PTVZPUS=;
MY+=&CW F/!)ST!&1BK0M;8(B"",+&Y=!L&%;G)'H>3S[FO))+F]O+S3O$%@T
M\EWJ4.K7=DCY^11$B0@#ME41L>K&LS3+[5/+EDT/4H)K[^QYVFAM9YYI&D"K
MM:0.,)*&S[G)&* /:)-5LTUB+26D/VR:![A(]IYC4JK'/3JPI]OI]C:%3;6<
M$)4,%\N,+@,<G&!W(!->0-/IW]NS3>#;V:[NE\-79!$[RE9=T6"-Q.'/<=<@
M9%327^GC4I/^$*U&\N9AH5Z^PSRR+YP$>TX8D>9R<]^F: /6DL;-""EK"I4,
M!B,# 8Y;\SR?6FV>FV&G[_L5E;VV\Y;R8E3=]<#FO'='O'=+S[#K<"0G1YVN
MWL)KFZD0X7;(X?&V0'=QD$\^G'2_#2^274M4M8I+:=%BAD\^QO))K<DEQ]V3
MF-SC)&3VH ZW7[/3M0N='M[^<*RWAD@A*AA.PBD!4@CIM9C^%/TX:%KFB0M9
MVMM-II9A'&UN @*L5.%(XP0>U<_XWBT]/$GA*\U%O+B2_>/S&D95#&)]HX.,
ME@/Y5RFCZ?%8^%/#^LV\UTE[-X@$3-Y[[?+>[=&3;G&TCMCKS0!ZREA91%3'
M:0)M;<NV,#:V-N1QP<<?3BJ<,.A:G>WQCM;2>YAD^S73& %MVU6VDD<\,I_&
MO(M3U>.349KJ&YB@OEUA5"RWLKWJJ+D*P,:@)''MSP<C:1U)S7<>"8K"U\5^
M,;>,[;[^TA*T9=B?*:*,AL$]"V[F@ U+PO8R^+;:&_UFYD%],UU'920(^[RB
MKE1+MW*@.T[<^PXXKLGL+-[>2W>T@:&5BTD9C!5R>22.A)KC_%^K:?HGCOPM
M>ZG>16ELL-XIEE.%R5CP,U@^,/$,&KZMI4UIJE@_A^2";$T]Y+#;R7"L!M9H
M^I"Y(!XZ^E '<ZKX4TS4=(?38K>&SC=HR6MX54X219-O3H2O3W-:$.E:9:6S
MPPV%K%"S"1HXX552P.0V .H(!_"O-?#MI/KS>'+35-1NKJV:ROY<Q3S1B95G
MC$>XG#, &X)Z\&JFF:A:S66CKXFU:Z@T]-/G-M.;IXR\RSLIRP.6=4";0<]3
MUH ]*6'1O%6C1W<2K/9WRQ2B0*4,JJVY,Y .,]CZFMC(%>"P7=Q%H?AVWNKZ
MUM+!= BD@^TWTUJ#(2V]E,8.YP F >F>,Y-=SX6MKC5?$4=SJE]=S7%GI5A*
MJ+-)'$9'64.YCXR3@?>% '672Z)H9BNY;:VMVGNE19$@&YII2$!X&<G(!/YU
M;FTS3[BWD@FL;:6&1S))&\2LK-ZD$<GWKFOB- +G0-/@9Y$$FK62%HW*L,S*
M,@CD'WKD]9NET&XUK28[B\^QMJ5E'"DFH/%'&9(BS!Y2&98R5YQSD]LT >K6
MUM;V<"06L$<$*#"QQ(%4?0#BEDMH)Y8I988WDA):-V4$H2,$@]N.*\3L]3>3
M1]5MCK%M#;0ZQ&L2F[G:T8& $Q&?[ZH6R0>FX8Y!KT7X=WWV[PH"!+B*XFB#
M27!N%;:YY20@%D[*3S@=Z -JT.E7#:A8VT,/[J;;=1"+ +LH<YXPV0P)/-/@
MT;2K:U:U@TZTBMV8.8DA54)!R#@#&<@5YCX@N=,MM:\6R#5)X->2Y@.G6\=R
MR%Y/)B"80$!]S?*V0>/2JNH:AJ!\7WI?4[6WU!-8CAMXGOIQ+Y>Y-JB!5*E&
M4\GW))&* /6K_2=-U/RQJ%A:W?EG*>?$K[3[9'%6+>""U@2"WB2*)!A(XU"J
MH] !TKQN/4M2;Q,'DU.VBU/^VS$86U"<S>5YQ C^SA2NPQX.>G1LUMZ9;20_
MV1K/]H7[W<^O7%LX>Z=HS$99U";"=N %&..U 'HNH7=M8:=<7=XVVVAC+RD(
M6PHZ\ $FJMKH&B6JM]ETFQA$BLK>7;JNX-]X' Z'C-4O',TMOX$UR:&5XI4L
MY"KHQ5E..H(Z5Q.MP2-9>+]:%_J"W6G7D(M EW(J1XA@8X4'!!+-G(YH ]&U
M"33-+L_[0O4BB@LD)$GEY\I> <8&0.G2DM]!T:UNS>6^E64-R6+&:.W57)(P
M3D#/0G\Z\L\97&G2V/BE=8UBY@U:.X\NSM!=N@,15-@$8.&5N<G![\\5<\2>
M)!IVG^/+*75VM]0^TQFRB,Y60*T,6/+&<XSNZ>] 'H]OH6CV=W-=6VEV<-Q-
MGS98X%5WSUR0,FG76BZ5?6$=A=:=:3V<8 2WEA5HU &!A2,# K@FO+.37=3D
MU76K^UU6WU9(K.V@N&R83LV!8<X=6!.XX/?D8KG=%U;6YM7TVZEU2W&HRZF8
MKBW;4YWD*[V#1FU";5 7HV<# .: /4[RWT/1[2T@,4%@K/\ 8[-H8@IC>7C"
M8'RDG\..:P]*\"0Z1J4.J7]];3K9QR%2EE';EBR[6>5E^^=N1V').*XKS[2\
MB\+W=YK5S)X@EUZ(7=D]VS!6$K J8B<(% &" /QS7JWBB#[3X4U>$EP&LY1\
MC%3]P]"* )[2VTNYM+"YM(+9X(HPUFZ(,1HRX&ST!4XX[5':>'=%L+U[VSTF
MQM[I\[IHK=5<YZY(&:\RT*;2YK+P]IM]X@N;32ET2.:%H]1:)9;C)$JM(&SE
M/EPN>,GCBNX^'][=W_A5)KN>6X47$R6]Q+]^:!9&$;GURH'/?KWH TH_"^@1
M7_V^/1=/2\W^9YZVR!]WKNQG/)YK6KR3QCJ&HR^--4M)=02SM;2SBEMEDUB2
MQX(8M( B-YA!&,'ICIS2HFI:V=1FU#6M1CFL_#UK<J+*YD@C,S)*3)MX/51P
M0/<4 >C:C8:)K<_V'4;6SO98%$ODSQJY0,2 V#TSM(_ TRY\+>'[RTM[6YT6
MPEM[?/DQO;J5CSUVC'&:\PN]0N;/^U-<BOIEU>?PWI\X!N& ^=I!*X7D?*/F
MZ':23CDY8U_K%EI6NP6VKE$%K;NK1:L][)$[3A=XD9!MW+G*Y[=!0!ZI?>&M
M#U*&"*^TBRN([==D*RP*PC7IA>.!P.!5:31O#&MW)BETVPNY=-98,/ K&#Y0
MP09'3#*<=.:T-)TQ=)TY+-;N[N@I)\V[F,LAR<\L:\]UFXOKK6+VQCU2\MDE
M\36UJ6MYBC+$;1&95/8$Y/U.: /29[JVLUB\^5(A(ZQ1[CC<QX"CW-0_V1IO
MV4VOV&W^SF7S_*\L;?,W[]V/7=\V?7FO*=6M5$T^G7NKZA]ATWQ):I%-->N'
MC1XE8@R$YX)."3D9I^J:LPT/7M9/B2]@U^ROIHK:Q6Z(5=LFV*/R>CAUVG.#
MG=UXH ]+G\,Z%=:DNHSZ1927JD$3O I?(Z'..HJS%I6GP:E/J,5G"E[.H66=
M4 >0#H">^,"G32SKICS)'_I A+!/]K&<?G7F.E:F\:>'+^R\17FH7VJ(YO[:
M2YWJ@\EG9A'TCV. !@#K@YH ].NM,L;YP]U:Q3,(WA!D4'Y' #K]#@9^E(VE
MV#/ [6<):WB:&(E!\B, "H] =HX]A7._#JUN%\(:?J5WJ=_?7.H6L-Q*;N;>
M$8H#A!V'-4/$,J7WBZZT_4==N](LK734N8&M[KR/,=FD#N3_ !; B<=/FYH
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M1V:0(VY<L22<'FN!N]?UZ]TW3M26_O1 FBVUU<_V;+")()64LSR12#YT.!@
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M.QFB2*28)O0&,,5)4 $Y/I3->N+Z^\86/A^#4Y],MI+*6[>>VV>;*RNJA%+
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M +G?O(#LDHPT>!C"X.17I?AW4DU7P_IMX+G[0UQ;))YAC\LR<#+;,G;SV[4
M3ZKIUAJNGR6>IPQS6LF-RN<#.1@@]0<XP1SFLBT\+>&)+/4]/@@2=+@?9[[=
M<O+(>,A&<L6& V<9[^]5OB- ]QX654NY;;%]:9>+;G!G0?Q CC.?J!VXKC;H
MZII-OX\UNQUNYA?3+T2+#Y<92=EMX2?,RN3D8'RE<4 >NQQK%&L:#"( JCT
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M"7= V",E6*MU]P10!:HI,BESQ0 45036+.34[O3UD)FM(DEG./EC#9P">F<
MG'I52T\6:)?:9?ZG;W\;V-C(\4]P/N*4 +8/<8(Y'6@#:HK#LO%>FW_VI85N
MUGMX?/:WFM7BE:/G#*K %@<$<=ZU;.\@O[.&[M9!+!/&LD;KT92,@T 3T53O
MM4M=.>T2Y<J;N=;>+"DY<@D#VX4U;S0 M%)D4N: "BBLW4M=LM*N;.VN//>>
M[8K#'! \K'&,L0H.%&1DG@9H TJ*,T4 %%%% !1110 445!/>V]M-;PS2JDE
MPYCA4]78*6('X*3^% $]%5+O4K2QFLX;F79)>3>1 -I.]]K-CCIPK'GTJW0
M4455L=2M-2%P;282_9YVMY< C;(OWEY],T 6J*** "BJUY?VM@(#=2B,3S+!
M'P3N=N ./6K- !1110 4444 %%%!.* "BJ>EZK9:SI\=]I\XGMI"P60 C."5
M/7GJ#5R@ HHJC/K&GVUY+:3W*1S16QNI V0%B!P6)Z8R#WH O454BU2RFO\
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M9'M$CG>$_:<+DJQ7<.>AQD>U 'G'AOPX+O6-"74[6:[CMM)FDMGO;;9Y;?:
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M#"S!1W^52,"NZGAL])UDZFL-RT^HM%:R"%"RY&[:[#M@$@MZ8]JUP5SC(R:
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MWSD=!ZXVGV;SFX>T@:8XS(8P6.#D<XSU I386AN_M?V6'[3C;YWEC?CTSUH
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MU<8?/0[N@/I7L&.<T8% 'D.B>%[*4^"4G6\9=2TR234 ;J4>>RI&R[_F[$G
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MZY%G/HKWEZ]S<O*I=&3]Y\Q.WAFSC Z<5W:P1*NU8U5?0 8I3&AZJ#QCD=J
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MX/M_$,=LT*3PM,(6;)&,\9_"N29-;\8^)],U&X\/W>DVFD0W#?Z45WSS21[
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M[Q1?RS:K-/;S6#LD9C+94X#@'ZXH [S6/B2=-U&^M[;P_?W\.FA/[1F@9/\
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M^] '6[QSSTI=PQG/%>16EG%XBUVS^U6=Q)IUQXAO962>-T$D8MOD+ X^4D#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-HDD/55)!('U*C\JGHH *3:!CCI2T4 5[^SBU'3[FRGW>3<1-$^TX.UA@X_
MTME9Q6%C;VD.?+@C6)-QR<*,#/Y5/10 W8HSP.>M+M7(XZ4M% ";1Z4;1Z4M
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
(% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>a20220930-zionsrlocadden002.jpg
<TEXT>
begin 644 a20220930-zionsrlocadden002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  =**13E12T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 B_=%+2+]T4M !1110
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MSY&SGG(?'\)KT;1)M2N-'MI=8MH[;4&4^=%&V54Y/0Y/;'>@"_1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 B_=%+34.5%.H
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M- 'FGB?_ )+=X0X_Y=YO_07J+XQK*[>%DMY/*F?4U6.3&=C'&&QWP>:[*_\
M"MEJ'BO3?$,LTXNM/1DBC4C8P8$'/&>Y[TSQ7X/L?%\-I%>SW,/V67S8V@8
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M9$GAK39?%$7B)HW_ +1BA\A7WG;LYXQT_B-:] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 B_=%+34^X*=0 4444 %%%% !
M1110 5P]_P#$9()KYM.T2_U*QT]V2[O(,!$*C+;<_>QWKMSTKR?P)XBTSP?X
M/U/2];GB@U'3KF=I+:1@LD^3D%0?O;N@Q0!V3>-]/:\\.0V\<L\6O"0V\HP
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MY6B93 8PHPQ(XSM/YBNVNK#QBFI7US=:S9R:'MG(M%A DV%'V#=MZ@E<\]J
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M25"DBJZ$8*L,@UB_\)GX7_Z&/2?_  -C_P :/^$R\+G_ )F/2?\ P-C_ ,:
M-GRD\L1[%V 8"XXQ3E544*H  & !VK$_X3+PP>GB'2S]+M#_ %H_X3/PQ_T,
M&E_^!:?XT ;$D$,S*TD2.5.5+*#@^U.>-)%VNH93V(R*Q?\ A,O#!X'B+2L^
MGVR/_&C_ (3+PSVU_3#]+I/\: -L*%7:!@>E(B(F0BA0?08K$_X3/PS_ -!V
MP_[_ *TO_"9^&\X_MNQ_[_"@#:V+NW;1N]:4@$8(R*Q/^$R\.?\ 09M/^_E'
M_"9>',$_VS:<?]-* -L *, 8% 4 D@8SUK$_X3+PYC/]L6N!QP]'_"8^'?\
MH+6_YF@#;"@$D 9/6EZC%8?_  F'A_\ Z"</Y'_"C_A,- _Z"47_ 'RW^% &
MUL4 #:./:E  Z#K6+_PF'A__ *"</Y'_  H_X2_02,C44(]E8_TH VZ*Q/\
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M?_XB@#9HQ61_PDVF^EZ/K83_ /Q%'_"2:?\ W-0_\%UQ_P#$4 :^*3'%9/\
MPDNGXSY>H8_[!MQ_\11_PDEAQ^[U'_P6W'_Q% &M@48K)_X26P[1:C_X+;C_
M .(H_P"$CL?^>.H_^"VX_P#B* -?%)@5DGQ+8 G,.I?^"VX_^(H_X26PSCRM
M1_\ !;<?_$4 :^**R/\ A)+#_GEJ/_@MN/\ XBE_X2.Q_P">.H_^"VX_^(H
MU<5@Z1X833?$>L:Y-<FYN]19 "4V^3$HPJ#DY]2>,U8_X22P_P">.I?^"VX_
M^(H_X22Q_P">.I?^"VX_^(H UZ*R/^$DL?\ GCJ/_@MN/_B*/^$DL?\ GAJ7
M_@MN/_B* ->BLC_A)++_ )]]3_\ !;<?_$4?\)'99_X]]3_\%MQ_\10!KT5D
M?\)'9_\ /MJG_@LN/_B*/^$CL_\ GVU3_P %MQ_\10!KT5D_\)%:?\^VI_\
M@MN/_B*3_A([3C_1-4_\%L__ ,10!KT5D?\ "16O_/GJG_@NG_\ B:#XBM_^
M?+5#_P!P^;_XF@#7HK(_X2&#'%CJA_[<9!_,4?\ "01=M.U0_P#;DX_F* ->
MBL?_ (2!#TTS5,_]>C"E.O>FDZH?^W?_ .O0!KT5D?VZV?\ D#ZI_P!^E_\
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MJ7_A*.<?V1>_]_[7_P"/4 ;]%8!\48_YA%[_ -_[4?\ M:@>*,Y_XE%YD?\
M3>U_^/4 ;]%8/_"3_P#4(OO^_P!;?_':/^$G_P"H1??]_;;_ ..T ;U%8/\
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MN/\ MY'^%)_PC8_Z#&K_ /@3_P#6K<HH P_^$:7J=7U<G_KZ(_I1_P (TO\
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MD?\ ",:1_P ^A_[^O_C1_P (OHW_ #Y+_P!]M_C6O10!D?\ "+Z+_P ^*?\
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M.D>9(DQN*[7(R,C@D'FJTGAK6-3A,EWJ<4,R:=)9VKV\3*4,FW=(WS9S\BC
MQCGGTHM\/YI&O)%;3+1KK2[FP9;6V8<R[<.S%B6QMZ'UH VX?&=@_G-<VM[9
M1QVC7JR7,042PKC<R@$GC<." >1Q3'\:V\$!FO-)U2SC!B.Z>) "CN$#Y#$
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MD$T\A\M)1AXK=/EAC/N$ S[DT :VIZY]AOK>PM[*>]O)T:410E5VHI +,6(
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ML5!VLJH\C.B*PPP5&)501U  HA\)Z'!#<1)8*4N(?L\@=V;]U_<!).U?88%
M%+1[S5(?%=]H^H7T=XB6<-U&ZP"(J6>12N 3D?(,9YJEXMU*XTS5;BXM?*6:
M#0;VXC=HP6#HT>.3SCU'0\5U:V-LNH/?B%1=/$L+2]R@)('YL?SJMJ%CI5W<
M*E_'"TUQ!):JLC8,D; %T SSPH)^E &)H^H:O'K]E9ZC?1727VG-=X2$1^4Z
ML@(7G)4[^_/%=955=.M$N8;E8%$T,1AC?NJ'&5'_ 'ROY5:H **** "BBB@
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M!IEE96\L1MOM4\TTY3RT#A6P IR<'(''3K6GIFD0:4U\T#R-]LNFNI-Y!PS
M @8'3Y13GTN!]8_M)F<R_9C;%,C:5+;NF.M '&Z1\28]1O;%7@A^RWP=E,+N
MSP *64R H!R!V)P<#GK5NV\5:W+_ &%=3:3:1Z?K$RK&ZW3-)$K(SH67: 20
M.QX]ZTK+PC;V$]JT>H7\EM9AA:V<DB^3$"",8"AF !P Q.*P-,\+:G_:.BK<
M6]Q;VFF3F4(UXLD*C8ZA8E W8RPQOZ 8% &Q:>*;BZTWP[=&VC5M5NVMW7<3
MY8$<K9'K_JA^=<YH7BV^L?">D^=<6LDTZ3N9[ZY8O(RS, BHH+-QWZ#'>NHM
M/!=C9W-I(EY?-%97+W-M;O(OEQ,X<,!A<D?.W!)QVJ&R\"66G) +/4=1MVBA
M:!G1TW2QM(TFULH<8+M@K@^] &$?$NK:O)IU_$(X+&[T&YNY+;S7W!@8^A '
M(S@'C@FK^F^(]6O+$0Z196\IL=.MI9?M4[ R2/&'$:M@_P ./F.>3TZFM6+P
M5IT%I8VT,]Y''9VLMFF)%)>&3&5;*G/W5P>#QUZTC^#+$H$MKV_M ;6.SF^S
MRJIFC0$+N)4\@$C<N#SUZ4 9$7C+5]4GO3I%C:-;6^G6]^'N)6#-YJ,P3 '7
MY>O;T-=CIMX-0TNTO0A07$*2A2>1N ./UJC;>&M.LY[V6W1XQ>6T5JZ*1M6.
M-650HQQPQHT[19=.U-7CO)6L(K"&TBMV8D!D+9<CID@J,^U %+4];U.#Q3#I
M5G!:FW%I]LN)IF8,J!PK!0.IP>,XZ5@Z=\1;BX2UNYK,O:7-O).RQ6TRM;!8
MS(NYV78X(&,C&"1UKM6TFV;6?[4.\W'V8VV,_+L+;NGKFLJV\&V-B5-O-<R)
M!&Z6EK<2EX(-PQ@+U(QQR3@<#% &?!XCUV*]T/[=#IPMM4@EF(C+!H2L>\*6
M)(;MEN.AXJC;^.[YA(Q^QW"MIMQ=H\,$R(DD04[-[<2*=WWEQTZ<T:3X(O/[
M4T^74(8XK2RMYH3"M]+.K>8FPJBL!L0#/&2>@[5N1^!]+7!DFOYRMM):(9KE
MFV1.H4J!TZ <]>.M %2WUKQ%=7<%BL>FI=FS^VRY#E C'"1CD?,2'RW08''-
M<KH'B.XTKP_9:G)YLY30?,$+2,P:4W&U<XSGD@9 SBO0K[PU97TEM)YMU;RV
M\1@62WF*,T9QE&(ZC@>X[8JM;>"]%M;)+)89&M4LC8B)Y"1Y1;=UZYSWS0!C
MIXMUE[74%@LOM4\$,4L<JV,\*?,^UP4?YF*#YOE.6'& :%\8:A)I#W$#6L[1
MWH@FGAM)V\F,INW/!_K V<+C/<'I6M'X/TQ[2ZBDNK^Z-PJ(9IKIFDC"-E0C
M?PX;G/7/7-*O@S3EMW07&H?:'G%P;PW3>?O"[ =WIMXQTP>E %SPYJK:SH<5
MZ\EM(S,ZEK8L4.UB.C $'CD'H<BN?'BK5WT67Q$D=G_9<=VT9MF5O.,*RF,O
MOW8W<$[=O3C.:ZG2M*M='L1:6@DV;VD9I'+N[L<LQ8\DDFLQO!VE-=F;_2A"
M9_M)M!<,(#+G=N,?3[W..F><9H S/"EK<R>*_%%[=S0S21WHMT*QL&5/)B8*
M"6("\] .N3WQ47B/Q9J^D?VI;6MK;W%_#+&]G&0P$D)C9VSS][$,P&.X6NLL
MM-MK">]F@#![V?SYLMG+[%3CTX05!<:)IL^OVVL31YOX(6AC;=QM;KQT/?Z9
M/K0!R5_K=[K>I:;)ICP"WBUI8+>5U8AC]DE9RP!&0"V ..5ZU-<>+=6LXY;*
M6.WEOUU;[ LL-O(R;/)$V_RE)8G:2-H/7OBMZP\-Z+IEIIVGVD0CCL)6N;:,
M2$D,0RECW/\ K&_,5)=>&-+O!=>;%)NN+E;MI$E976545 RL#E2%4#CW]: .
M1U'6]<U"RCAW/9R0:Q9QK</92Q+<1NZX^1F!&#D,,D$#MGAEKJ^KZ):ZYJ22
M6KV$.O-%)"\;&1U>1$)#;L+C=P,'I74KX.T>/3KBT87+^?,D\MQ)<N9FD0@J
MWF9W C QSQ4K>'='GLKS32I:*>Y%U.GFG=YFX.#UR.5!Q0!S,OC36)9KZ:PL
M7FAM+YK46ZV,SF54?8[></E4_>(&#T&3SQO:-J&L:EKFJB22S33K*\:V5!$W
MFOB-&R6W8'+8Z=JDNO!VCWE\]U-'/B2432VZW#K#+(,89HP=I/ ZCG'-:MGI
M]O8/=/;J5-S,9Y<L3ER N?;A10!A^*=8U72[BT%E$!:NDC3W'V5[GRV&W:"B
M,& .3EN<8]Z31/$-QJ=XR&2VDA_LNWO%D@W;6=VD#8)YV_(,9 /K6CK'ARPU
MN:":Y-S'- &5);:X>%PK8W*2A!(.T<>U5)_!6BS):H(KB%+> 6ZK!=21AXAT
M5]K#>.3USU/J: ,;2/$>NZ_%:I9R6%M*-(M[^=YHF=7DE#84 ,-JC8<GGJ*J
M2ZGK5A)XLU>REL EKY-Q)"Z-()"+:-F57## QT.#G-=+-X*T6:UM;<17$4=M
M;K:)Y%S)&6A7HC%2-R_7/4^M6W\.:6]GJ%I]GVP7Z".=$8@%0@C &.GR@#B@
M!=?U&73?"^IZE;A3-;6<L\8<9&Y4+#/MQ63J>NZI!=?9[""&>9M)DO(XVZM*
M&0 =1Q\QX_6NDFM8;BSDM)HQ)!(AC=&Y#*1@@_A7/+X7\-:5'LN6.+B$V8-[
M>.Y=&(/E@NWJ!@#IVH QW\8ZC!9W:[XY[Q9K:*.-M/FAEC\URI9HB?F'!(VM
MS@CBM[PWJFI7US?07\+A(?+:&9K1K<N&!R"K$\@KUSSD5)#X/T:*UN;=H9YQ
M<A1+)<7,DLA"DE,.S%AM))&",'FK>E:)8Z(DQM1,7F(:66>9Y7?'3+.2<#L.
MU &/?ZKK$M[K?]GS6<,.E(HV3Q%C,_EB0Y(8;5PP&<'G)[8J'1=;UC7?$-RL
M,MO;:;!#:S>6\!:5_-C+%=VX!<<<X-:^H^&-(UBY-U=12L\B!)/*N'C69!T#
MA2 XY/7/6KUMIEI:7MS=P1;)KG8)2"<'8,+QT&!Z4 96KZCJ'_"0:?HUA-#;
MFX@FN)9Y4+D*A0!57(R27ZGH![UA:=XHUC5]1MM(5[:VN5FO([BY$997%NZ)
ME%)X+;P3DG&#76ZIHECK B^UQR;XB3%+%*T4B9Z[74@C/?GFJ\GA;1Y--M[#
M[*R0VY)B,4KI(A/4AU(;)R<G/.><T 85KJ^NZCJSZ4FHZ=%+:V?GRW,,9D25
MS+(@ !;Y0!'\PY.3C/%0R>*M13P]XJO#<6;7&FVBS0-#\T>XVX?()^\I;./:
MMN_\,>'%LK=;JVBM[>W40HRS-#\K,/D+ C<"Q'!SDGUHN?"OAO6)I)9;*"8K
M']EE6.0A-JC 1E4X. >,C(SQB@#GK[Q#KJ'Q1=0W]LD.BP13Q0-"#YN8!(RN
M<Y )R!CGGVJ'Q'XOU6TL]9O].G=QIR*WE): Q(?+5V65W(R?FZ)R 1U/%;D?
M@[3&\0W][J"13&[EB>WB+,,+'&BX89PX!7/(.,U;U'PWX:N;\R:A:6[3WI*F
M.1R%G(7NF<,P4=<9 'M0!@:KKNNPGQ1>6U_$D&CR1-';M #YBF&*1E+9S_$V
M,>OX5>74]2NKC4;UM7BL;:SU%;18)(E*,OR9W'[VYMW&"!RO!K=BTW1[ZQN7
MBA@GM=256F93N6<;0H.>_P H _"EFT#2)M174);"![M2")63G(Z$^I'8]10!
MS>BZUJMYJ=AHD]V#>V,MP=3<(,R(A"Q<=MXD1^/[IJ[XHNI;;Q#X<$1@7?+<
MY:5 0,6[D'<1E>1R1CC-3:%:VEMJUW?37UI<ZGJH$H>W7:K01X5=HR<@;ADY
MY+>F -R>RM;F>">:%))8"3$S#)0D%3CZ@D4 <CX5U?5'U"VM-9N;DW-U:&=4
MDCA:*0J5W/#)$?N?,.&&<$>]=M6;8:!I&ESO/8:=;6\K\,\<8!QG./89[=*T
MJ "BBB@ HHHH **** $7[HI:1/NBEH **** "BBB@ HHHH 0]*XGP_XLOW\(
MZ1>7D#7=U=12/+<,R0Q+M<@;F. "1C  YP:[8]*X:V^'TEI::.D>HV[S:=#)
M"&N+$2H=[[]RJ6^5ATSD\4 7[3QW87-O;7+PR0V]Q:W-PLC,I ,#;9$R"03U
M((." :CM/'*ZA:Z6;/39C>7WVC-M(X5H/)X??Z<[1_P(5%+\/H9O#EII,FH2
M,UM>2W'V@Q#<ZR,YD0@<899&4G\<5I:;X3M].\1ZIJZ3LQO0 D)7"P9 #[?]
MXJI/TH R?!&OWMS%IMEJ1GFO+_3SJ;322*P S&NU0JC ._(':K-OXEN-4UK0
M?L^^"UN9K^&:(X.\P,4!SCCE2>/6G)X.N+2/1GTW5C:W>FV/V RM;"031_)U
M4D8.4!'/?O4ND>$/[*.DDZA)<'3Y+N0L\8!E,[ECG!XP3^/M0!L7>J+:ZQI^
MG&(LUXLI#@\+L /ZYK$;QFSW=K:6VES3W%S<W=O&HD50# V"6)Z ]>]:.N:+
M/J=S87=EJ!L;RS9]DGE"565UPRE21Z ]>U4=+\'_ -GW>GW,FHR7,MI-=S,S
MQA3*TYR<XZ8]J &P>,C>_8[>TTZ1]1N'N%>V>4*(?(?9(6;!_B*@<<[ATK)T
MKQT8-)M!?%?M]Y=7I1+NX2 11QSNN&8\9 VK@9S^M:O_  AS6\RW5AJCVU\M
MS=2K,80X*3OO9"I/(!"D'/\ #4<'@A[*TM39ZLZZA;M<'[7+ LGF+-(9&5DX
M'WL'(QT_"@!;+QO_ &K_ &8NF::]R]ZL[,#.BB+R75'R1D$9;@CKQZUNZSJ;
M:58?:4MS.=ZIMWA%7)QN9CP%'4FJMAX>^QW=A=2WT]S-:V\T+/*!F0RNC%CC
MIC9@ =C[4[Q)X?3Q%8P0-/Y+V]PEQ$QC$B[USC<IX8<GB@#%A\>K/#/Y-@MQ
M<17\5ELMKI)$=I%W!E?@$<\YQC!JW%XN99C#>Z>UK)%J"6,Y,H98R\89'!QR
M"2J]N6IMKX-\FZ>YGU.6>:2[@NV)B51NC4J% '12,?E47B;0Y&TK6DM+:>\N
M=7ECV+'M7[/(J*J2$DCY59%8XR?8T ;NCZLNKPW,\<3+#%=26\;DY\W8VUF'
MMN##\*S4\37=S/>-9:/+<65I<FVDE$H#NRL%<HF.0ISU(Z' K6T?38](T>UT
M^(Y6",)N/5CW8^Y.2?K6._A2=+JY%IK-S:Z?=7!N9[6-%SO)R^V3[RACR?J<
M8S0!$_C"8137ZZ6S:1#=FU>Z\X!_E?RVD"8Y0,".N< G%1W7C6>UCO[HZ/(U
MA87GV2>83C<3N5=RICD#<,Y([]:GD\'EGEMTU2=-)FN3<R6 C7!8OO9=_P!X
M*7R2/<C.*GNO"D-SHVIZ:;F14O[HW+.%&4)96P/^^: .3U#5-=36[ZZ-Q)#%
M%KMIIZ(ESN01MY)(V; ,L')+9R,X[9K?L_$DP9;*UM9KN\GOKN-%GN %1(GP
MS%@O"C*@#!/(^M7+[PG#>>=_I4B>=JD&I'Y0<-&(P%^A\L<^],;PB(U22RU*
M>UO([F>>.X$:M@3-N="I&",X]_E% %*?7M:;7;&![#[) ]G>/<1-.-V8WC4,
MI"'(PV1TSOYQBC3?$U_-:Z?:V&ER7DK:3;7S23W84XD##:S;>6^7KC!R>E7Q
MX4(DLICJUV\\"3I+)(%8SK,5+@@CY1E%QMQC&*LZ1X<@T>2%XIY',6GP6 W
M<K%NPWU.\T 9UOXOGU,6PTC2FN6DL([^7S9A$(TDSL0<'+G:W' XZUK:-JQU
MKPS::L(3 ;JV$PC+9*9&<9KE+[0;_0I-/ATBWU258M/2R>XLY(,RA,[5D67
M7J2'4Y&XC'2NH\-Z9+I?A+3-+G8&:WLXX9"#GY@H!^O- '-:)XNNX?!_AZ>[
M:TDGN[!9I;J_O5MD+8'&=I)8Y],>]7K3QY;36=O=W-O]GMYK6ZG$GFAANMW*
MNH('/ + ]P#Q3;/P'_9T>EFQU>>">RL5L3+Y*/YD:G((# [3GN/Z"II/ EA/
MH]GIL]U<RI:WDETLC$;W#NS.C'NK!V4^U #]$\7G6'TR$V#P75T+@W$+2 FU
M\E@K \<G<R@=.M=.WW3]*Q+3PU!I^K:MJEK+)]HU #Y6/RQ$#DKZ;C@GW%:.
MG0W,.DVD%[-YUVD")/*!C>X4!F_$Y- ''Z-XLU">RTVUL=,-S+)I,=^SW5[@
M@$E=K-L)9N.N.>>E7+3QE=:SY(T32A<$Z?#?RBXN/*VB7.R,$*V7.UO0# YY
MJ_H_A.TT=[=H;B9S#IR:>-V.44DAOKS52+P/#9VEK%I^JWMD\5E'8RRQ;"T\
M29VYR" PRV&&#\QH HP^)KVW\3723P2^7<SV$"6TK@?9C*CENF02".?I6G?>
M*9K?4+JPM[$37274-K K2[5D9XS(2QP=H50QX!Z4V;P19OYYAN[F!V^S&"12
M&:!H 0C L#N."<[LYIR^#8=MQ))J=Z][-/%<B[)3>DB+M!4;=H!&01C&": ,
M5M7U&/5[Q-025&_MJS@CCANB44-&O(.T94G)*X&35RR\:WTT-C>7&E116%WJ
M#6"R+=%I V]D#;-@&TE?[V>:OQ>#X=QEN=1N[FX:]AO7ED" L\8 48  "X X
M%2#PC9KI=C8">?R[._\ MR'(RS^8TF#QTRQ_(4 4H/%>HSQV5ZNEPC3;R]%K
M%)]I/F*I<J'9=N,'' ![CWQK>)-9?0-,74/($L"3Q)<?-@I&SA2X]<9!^F:Y
M:#P_JS:Q:V_V*ZM["VU W?S7<;6ZC<S?NU WDDG[K<+DXZ"NXU&P@U33KFPN
MEW07$;1./8C% '(O\0!YVK6\5EF:VN([>S4R?\?1:4PYZ< 2*P/7@9JA+K6J
M?VEI<5@?+CE\0W-M.)[AF\P*DAP/E.%^7..Q '>N@M? ^EVMQHLZM.\NE(R1
MLS9\TMG+2<?,=Q+9]234K^$+-O+9;FYCEBU!]1CD4KE9'#!AR"-N&(Q0!B:=
MX@U>PTVYNY;.*XL(]8GMVE>Y;S=K71C!5=N,+N QNZ"K5YXSO8+36M3M],CE
MTS2)GBG9IRLLGE@&1D7;C R>IYP>E;+>&K1M'FTPR3>3+=-=,V1NWF;SL=.F
M[CZ53O/!EC=2WJ_:[J*QOW,E[9(R^7.QQDDD;AD 9"D _G0 MQXFDBTSQ->)
M CC2$+Q L1YH%NDW/I][%5-'U/5;SQW?PRO%]@73K69(@YRA??D@8ZDC!YZ
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MX<T@VTUNUC$\4Z1I(KY;<$^YG)[=CUH Y75]<UW2VO\ 3XM0CFGBN-/$-U)
MN0MQ/Y;(ZC )&"<C'##ZUL:+?ZG%XJU31=1O4O([>U@NHIO*$;#S&D4J<<'!
MCR/K6E'X;TB*U:V2R3RVF2X;<Q8M(A!5BQ.2057&3VINJ^';#5K?44EC"2W]
MK]DFF7[VP;L#TX+,1]: )M>NIK+PYJ=Y;L%F@M)98V(SAE0D''?D5REC<>)[
MC4M-L9-=C OM,^V22"T3=$ZE 50=,'S!][)X[9KM9;2">Q>SE0/;O&8G0_Q*
M1@@_A5:2UTW3S'?2B&#[+#Y"3.VT1QDK\N3VRJ_E0!QD/B;5[ZRTE4N;@W<E
MD9KB.PM$9BVXJ'+2'8B?*W'4]NE.TK6=>\0W.DQQ:HEDMQH:7TQB@1R92V.-
MV0!ZCFNGD\*:%,L(?3HB(4,:8)'R$YVG!^9<DG!R*M66B:;IS(UG9Q0&.'R$
MV#&V/=NVCVR<T <OX4\47^LWFD?:YHU2ZT<W4B*H ,JRA2P[@8/3IS6'IUS<
MZWJ'AC6-1U,LRV5_.288C'^[EC&?NY&5QD@YXXQDY[J7PEH$UO:6\NEV[16:
ME;=2O^K4]0/8]Q5N#1=,ME@6"R@C6!)(XE5  BN07 'H2!F@#AM*\4:R=5T
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M6/32L<7E6T;HSF)9,R%G!"_,!A0. 3GTZ.;P_H-W<&.2WB>8V8MF02D%K?D
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M5J)I5I]NM+X*QFM8&MXFW<!&VDCW^XM &;J&KW\GB=-"TW[-%(+0W<L]PC.
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M_-/:I"V',4D8.,MP3QC(..>N>.M;PEI+$,L<\4@DED\R&YDC;,K;G!*L"5)
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MA7.<LJYP"<G) YS6 ;[X>66K&Y:]T>*\BE9L&X4>7)GYF"YP&ZY.,]: )HO
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MMUV\1'!&1Z<$C\: .4\/Z_J>K:O8:6TI\W3XYAJ[[%^>16\N,=/EWD-(,8X
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MU/$FFZFL,5H(HC&T?[HE6)4M_&>A%=+XTE,?A>XCW%5N)(;:1A_"DDJ1N?\
MOEC6JVF6#Q3Q-9P&.X?S)E,8Q(W'S-ZGY1S["DU/3X=5TRYL9\^7/&4)'5<]
MQ[CJ/<4 9[^%]+_M6/51"RW,3*Z;6PHVQM&./3:YXKSKPWJVK-I/A_2;(W,4
M']EM<_Z/)#&TC>:RD;I0>% !( _B&>.OK-I%-#8P17,WGS)&JR2[=N]@.6QV
MSZ53E\.Z+/8PV,VDV4MK!Q%#) K*GT!'% '"MK.OW6G:9(VI!I/LDSSQZ?<6
MXE<J^U9OG!1EP#E00,FDU3Q!J3QC4[75;I[%-,AN2MJ8$EA)#$RR0R?># <
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M_EO>QM%*T;((\ L&4@@_/T[\T <?IZJVIQ?8(KD6B:[,%5U?Y4^Q#'#<A<]
M?45#HVCW%AI/@BYL8IX=0N('CNY'+Y.;5V DSV#JN >G:NO\.7^EBS@.FQ3+
M97=M_:!NIY@Q8L1]\LQ;=TZ\#&,]JWA+;S^9$KQOMX=00<>Q% 'F>AK;Q^(_
M!\:6U[%J @N!J#3)(N^41#<6+<.=Q.",\'T(KU.L'2M&T.RO4ELI#+-&K1PJ
M]VTHA7C<J*S$*/NY ]JWJ "BBB@ HHHH **** $7A12TB\*,4M !1110 444
M4 %%%% ",=JDGM7%6/B76)-/T36+D69L]5N$B^S1QL)(5DSY9W;CN(XW# ZG
MTKMNM8=IX7T>UNXI($EQ;2&6&W:=FBA=LY94)P#R?IDXQ0!6\&W^M:OI,>I:
MI+9F.X7,44$+*5PS#+$L<Y !Z#%9%SXA\18\5WMO-IZVNBS,L4,D+%I@L22,
M&;=\OWB <5V6G:?;:58165HA2"(8122<<YZGZUS%OX(MGU/7[K57:2WU&\$P
MBBN)$1XQ&B[9%! /*GUX/X4 9E[XWU2:YU3^S;:;%B$6.,:=-.)G,2R$,Z<(
M,. /3DGBK,_B'79;CQ!<0/;V]EI=HMPD4L!,K,UN7VD[AC#8[>U=!J/A/2-4
MGFFN(I@;A%2X6&XDB691T#A2 W''/;CI4[:%I82_C,(5=1C$,Z[R ZA-@ YX
M^7CB@#G8-0\4R:K8:?)?Z<K7FGO>-(MHW[IE* J!O^8'S!R?0^M8>J:Q>ZKX
M6FO9/(@O9?#%[*\T*?,K(R A23D \_3CTKT5-+LUO8+M8SYUO UM&VX\1L5)
M&._*+S[54C\+Z/';+;BTS"+62TV,[$&*0@NIR><D#GK0!Q,RWMK'>R/>K.D'
MA>-S#+ I1_\ 6\$?@,^M:=QJVND:S]BN[2WMM,L(KB)&M]Q9S$6*GYAA?E^O
M-;[>$=%=(D:VE(CMFM!FYEYA;.4;YOF')QG..V*MC0]."WBBWXO(5@G&]OG1
M5*@=>."1Q0!S3:UK&IKJEU8WEO9Q6-G%*D;Q;_,D:+S27)/"8( QW#5N6^K2
MIX*CUF=3),-.%TZ@8W-Y>XC'UK"U[P5-J-Q*MK%I_D/:+:Q/*TJO"H!'(4XE
M'.0&Q@YYYKKK*S2STVWLA\\<,*Q#(Z@#% '*0ZEK:C06N+^"1=91D=8X@/L[
MF%I%:/GYE&T@[L]0>.E8'ANWU*6\\(+%J1263PY*[3M"K,J[K;Y0.G7')SWK
MN;/PWHFD74=W!!Y4B QQ&2=V6,-_"BLQ"YX&% ]*=I7A[1M->&?3H-IACD@B
M(F9PB,REE&2<#*+QVQVH X^T\8ZQJ0TRT59EG>R>>XEL[42EG64Q#"L<!<J2
M>_(Z5>T[6?$.KWFAP--%I[SV$UQ>)Y(<EXY$3Y>> =Q/4\>];\GA'1);6WMO
MLC)';[Q$8IY(V4.<L-RL&P3SC.*MV>AZ;I[VS6EHD/V6 V\(3("1D@E<=.J@
M^M '+Z1K^J_V_:6FJ3R1-=2S((I+4>3(!N*^3*F03M&2'.3SP.E7O%<%Q-K7
MA<07LEN#J+@A$5L_Z/,<G(]B/Q]0*T;/PKHMAJ OK:SV3J[.F9798V;.XJA.
MU<Y/0#K5S4M)LM7BBCO83(L4@EC(=D*. 0""I!'!(_&@#BY?$NLKX;F\3K=1
M>5'?F$6'EC:T(G\G&[[WF'KUQG Q73^*M5N-'\.SW=I'ON2T<40*Y 9W" D<
M9P6S2GPIHIO_ +:;(&7S?/V^8_E^9_?\O.W=WSC.:T+R&TN[=[&[6.2.X0JT
M3G[X[\4 <1)KOB&!;B#=*F;BRCMY[RV17'FS;) RJ<$ 8(/'7VJ9M:UB'4;G
M1FOT>8:G#:QWC0*"D;P>:<@?*6X*CCN.#6];>'-"L\Q16X\R62.?,D[O([1,
M&0[F8DA3CC.!GWIFN^'(]0M+G[+#;>?<S1RSBXW%9M@  R#E" !AEZ8[T 84
MFOZI:_;;2XU-7EBU46D<EO:&25X_LZR85%!&_)Y)&T#/M2:5K^L:O+::<;O[
M+,US>I).8%\PI RJJ[<E0QW@G_=.,=KNF^#-.L],N(M5$&7NS>YMY'A$#;!'
MP^X-]T<DGG)S2ZOX1LX["%-.M[&*UBF:YFCN6=5+%<%Q(#N4X'/8Y.>N: ,B
MS\3ZY>?9+-I))9BUZTT^GP1L6$5QY2! YQMQR3R>GKFNO\-7E[?Z##/J,?EW
M>Z1'& ,[790< D D '&>"<50L/!6F)H%IIU]$DS0/)*)("T&UY&+-LVD%5^;
M&,] *WK&QMM-LHK.SA6&WB7:B+T H X?2=1U.YGT73K.Y@LXKI=1EF:.W7_E
MG<*JE1T!^8YX.<D]:Z3PMJEQJ7ABWOK]H_/!D25E&U24=D+8[9VYJW;:'IMG
M-;RP6P1[=95B(8G:)&#OW[L :L6>GVMA9BTM81' "S;,DC+,6;KZDD_C0!P>
MF^)M6EN=)D:ZN)[?4$FW226J10DB)I%,(.),?*/O @@U/I5_XAN+70C-JXDE
MUC39'/[A%$$HC5E9>,GJ<@Y'TKH+7P?X>TZ6.>#3TC>'=Y;&1SY8*E2%R?E&
M">!Q5I-.L5BACL(X!-IT9AMLDL("4  (!STV\=<4 8WAK7;[7KVV+L(EMK$?
M;X0 ?]*9RI7/4;3&_P#WT*J^(4>3XA::(])AU-O[*N?W,S*H7][#\V6!'M^-
M;WAS0SHMK=-,T3WM[<O=W4D2E4:1O[H))   'X9[UHM96S:@E^8E-TD30K)W
M",02/Q*J?PH X,66LZ(8$MS:Z5)K6LX:&V42)!%]G8'&0!N)C#=,9/?G,LVK
M:TNE^(-475B/[&F:*.V:&/;.(T4L9/ESER3C:5 R*[BXLK:[DMY)X@[V\GFQ
M$_P/@KD?@Q'XU1NO#6C7FI#4+C3XGN@5)D.?F*_=)'0X[9H XA;C4-._X2W6
M;2^>!+?6(V-MY:%9 8K<.')!;H<#!&*BN9;F\\3Z9&ERMLZ>)+N))4B0%5^R
M-[8+')&2#U[UW]SIFDQ65_\ :H84M;A_M%V9#A6( RS$],!%_*HKCPUH>H1G
MS]/MYD>8W.2,YD9=I<'UQWH YJ&_OY]9M].N+WSF@U.XM1=B*/>R_9?,4_=P
M&!?!P!G;R.HK&\-7NIP:#X;TNTDU.6.336NG:U^S>83O50H,N!M&2>A/(YKT
M:VT73;*.VCM[..-;9F:' ^XS AC]2"<GWJD?"OAVZT^.V&F6CVBNTD:H/E#-
M]XC'3/?% '/Z5JNM:Q>Z?876H&QD6PDN99+<0L9G$IC7GYEP ,L%[L!FMKP*
M-O@K2P75R(B"Z]&^8\BK=YX>T*ZMK.RNK"V,,'RVT97&P8Z+CM@=*M:?#IPT
MR.#3U@^PA2L:P$%,9((&..N: /+[C5;U[JZ\8PZ/J$I@OA)!<HJ&)K! 8V'W
MMV""\G3KMKK);V]U74=::WUTZ=;6,,9@*)&R-NCW^:^Y22G.."/NFNIAL;6W
ML$L8H$2U2,1+$!\H0#&W'IBLZ?PGH%S';1SZ3:R+;(L<(9,[$7[J_0>G2@#B
MKQYX#XJU%+]IF9['"[$:([A%R 5SW(&3T/KS6I<:UJ<.J7'AMKIAJ%QJ$9M)
M@J[OLC R,V,8^4)*F<?W?6NHN/#^DW5U)=3Z? \\B"-Y"GS,H(8 GN 5!_"I
M)X=,35K6YG6W74&1H;=W($C+]YE7N>F3CTH \]@-SJ6JV1DOIH!%XIO85\A8
MUPHAFQGY3D\8R>NX]\8-/UW69Y;;3X1<%9K[4F=K3R4=A%.55 9,+T;)[G;]
M:[^30-)E@D@DT^W:*2<W+H4!!E)R7_WO>HKO0]#DLOL=U8VAMI)C((W48,K$
MDD?[1)/3GF@#DX]2\03V5G$;J221;V>-XX+BV%U-&H^4?\\]RDX8#!X'2NH\
M,ZB+[1(9)+J667S)8BUPBQR%D=E*D*=I(QC(X.,T)H_AW4]*2QCLK&XL+>1E
M6)$4I&ZD@@8Z$'.:NKI&G(+0)90*+,DVP5 /*)!!V^G!(_&@"[7(ZY%&/B)X
M5'EKAH;[/R]?ECKKJADM+>6YAN9(4:>$,(I"OS(&QNP>V<#\J .!U$7MG+XR
MU2RU&>V:RGCE2&,)L<K;1$[LJ201Q@$4MYJ^N27^I7$$LZ+::@MO&#/!' $!
M3Y7#?,2VX\^XQ7<OIUG(ERCVT3+=<S@J,2\!?F]> !^%0RZ'I4^I)J,NG6KW
MJ8VSM$"XQTY]J *GBB\EL=/M)HIS#G4+2-V!Q\C3(K ^Q!(KF=8UF^DUC6[6
MQU1XQ#=:7"AC(;R?-EQ( "",E2.M=U=VEM?6LEM=P1SP2##QR*&5A[@USL>H
M>!M,EDL$N]#M9(Y%5X?,C0J\9R,CU4\^QH R+^_U'3[^[T@ZO<?9S=V:F\EV
M^9$DN_<-V !DH #CC?\ 2LVXO+S2+[6+>QOIKAKC6K6VDG+H)%0VZG;O(V@Y
M 7)_O>M>CR6%A>1S&2V@GCN459"R!A*HZ9]1R<?6H#I.C6.F7$!L;.&Q*$S)
MY2A"H')8=.E '"2WVN//;Z:=2N+:-]:BME=;B.6=(VMW=T=@",Y (SSR/2IK
MB_OM*U2::YU.^N+."^AMDGM[B.0(#Y:^7-"<$LQ))9<GY@1C&*[&WM="LM'A
MN+>"SATZ$?:HG1%$:#:3Y@].">?0TD%KH.H:I)>PV]E/?P[0\RHID3*AER>H
M^4@CV- '%Z=J5W?ZE9:;=ZI/:6<MSJ;-+'((VE>*YVI&'[ *6..^WV-.TFZU
M#5[K3+3^WKQH'N-362>%E#3)'*JH,XP,9ZC'?'6NAUG3;&[4Q6VI6ED+:?$\
M,L$<L322D,-RMCYR6!!!!RW?-:>BZ#:Z/910K^^E1Y9#.Z@,6D8NY&.@)/0=
M@* .)75M8D&GZ6UU<S*;O4(FF6=(99A#+MC3>1UVDDXP3L^M6-.O]3U&\TK3
MK[5I+>%EO&\Z"9"\YBE544N!C*J3N ZD>E=CJ5EHZZ;*FHVUI]B+[Y%FC4H7
M9NI![DGKZFI)]&TRZLH[.?3[:6UBQY<+Q*43'3 Q@4 9'@3_ )$^VQ-YX\ZX
M_?<?O/W[_-QQSUXKF++4+E+MUO+^XN_MIO(TE@NQ+;R!0Y"F,X,14+C(&,C!
M)S7>VUYID5ZVCVTUNES%'YQM8R RH3][:.V3^M21Z5I\-Q+<16-LD\W$DBQ*
M&?ZG&30!P.F2S^']/T"Y?5+V6&XT:62X5VWJOEQ(ZLB< $#(P.N>:HK?W:2+
M;O=W;PWNBW<DBW=ZLS2E40B38N5CZGA3CGIQ7HSW.DP^2K/;#9*+2,  ['(_
MU8QT)&.*DAT?3+92(-.M(@220D*C)(P>@[B@#E?!>/[6_P"Y?TS_ -KU+J.L
M+8:YXF2ZU'R(X],@E@1Y=NT_O@64>N0O3VKH;2\TDM ;66V5IU,<(7"EUC)!
M4#J0O/';-.BCTO68;?4%AM[I67=#,T8) /H2,B@#SVPN3J&K2Q:GX@O;2*/P
M_97*!+MH\2,)-\O7DC R#P<\@TMMJM]J^G7%SK6IW.F7-OHUO=0)%,809&C+
M/(5'W_F &TY QC'-=NOAG3SK5UJ,T*3>?#!$(9(U9(_*+[2H(X/[P_E6E-96
MMR\;SVT,K1'=&9$#%#ZC/2@#R^6?5+[1?%&K7.HZC;7MA807$4,5PT:13?95
MD;*C@_-U!XZ\5Z)>W=TGABXO+9-]V+-I8UQU?9D#\ZO-;0-YH:&,^:,294?/
MQCGUXJ0* N , =J /*9)EL+D7NCZO<:A>_\ "-74^99S,0^Z$AP#G;DY^4<<
M=*+J[O;73M8%EJRA&T>67]UJ\EY(K@KLE!91LZMWYXP.#7J$-C:6[,T%M#$S
M9)*(%SGKT^@_*D2QM(DD2.UA19/OJL8 ;Z^M ' ZEI4UK?:W:QZSJXA@TA+U
M!]MD)$^91NW9SCY!\OW?:L;Q'KD\VB7U[%?W"7UII<,JNVH-;JDK1>8#'$O^
MM))&=W';L:];:*)BQ:-267:V1U'H?;DU&UG:,ZNUM"65=BDH,A?0>WM0!P&L
M)<S6GC#51JE_')IP66T2&Y9(T9;6*3[H.""3R#D=?4U1\5SV]Y9^('O]4GAO
MH+R".VM!<LJF/$3*/*SA@Q+'=@]^?EKU'R(=CIY2;9/OKM&&XQSZ\<4U[6W>
M02/#&S@8#%02!Z9H P?'L[VW@C4YH[B6V9(U/G1,59/G7)!'M7)ZE-'#'K-M
MHFLW4UD;6U9Y5O7F,,S3[?E<DD%EY(SV'K7H6K:=#J^FRV,SND<N,LAP1@@C
M&?I2WDUCI6F7-Y<JD5K C33$)D  9)P.O2@#BKJUTRR\0W.FZQJMW::?;V*/
M9&7498]Y9W,K[]V68'8.2<#'K5&2^UJTT^Q6:6<W/B'3H;5"<AH[K(4OC^$^
M6Y<^\1KTL"*>-'*JZD!EW+3RJD@D#CIF@#S2>5$U:XM;Z^N(-)77#%,_VAD&
M!:1E$9\@A2W/4 G'K61'=/#;RQ:9>>9I,FORI/<W-W(J,H@'EAYAE@A; SWP
M!GGGV%HXRK!E4ANH(ZT>7'M*[%VGJ,<&@#EO 4T\NFWXDNXKF!+UUMVBEDF1
M$VKE%D< N V[!&1SC/%4O"OB'1M/.K6-WJME!=MK5YB&2=5<[IFQP3GG-=NH
M5  H  X %-\J(G.Q2<YSB@#R?0+O5)M7TR2XOK:/5'U&07<)NIFG9,ON1H=N
MU4"XVGH,*<\U9TZ*>PT_PEJ-G<73WU_)/%-YEP[K(#!*ZJ03@ ,BX^E>H;(]
MY?:-V,9QS4#W,,=[!9E'WR(\B$1DJ N <GH#\PQZ\T >36TR+>>&KG2KF2ZU
MW^R[R2YC>8R'[3Y*G#J20K;\C''IVJN\]Q_85Z]KJ=NS'0+IKE+:[FFD9_+&
M'D##$<@;/H>2.W'M 1 <A1GKG% 5 3A0">O'6@#.T32K;3M&2WB,KK*OF2-+
M*SL[,!DDL3UKS(7>J61@:22Y,?@Z0)<$9/GQO*5R?[Y%N%;ZM7K%U>QVC6ZR
M)*QGE$2^7&6P2"<MCH..IXZ5/A<Y[T >:0V-U(^DQ7ZN\^H:5J-S<Q;CCS)&
MA?;_ ,!W;1]*H>%M)T[4K[PA 4+6\7A^7SHT=E!E#P!E?!Z@YX/<>U>M[128
M - ',> ))6\-R0RR22"WO[N",R,6;RTG<*"3R<# ^F*X6[U)FUVVN+9UBG&O
M(D@EN7>\\OSMC!E  2$CH#D8([FO81M!XI=JYSB@# \8PM_PCYOH]WF:=-'?
M#;G)$;!G&!URF\8]ZX;3&NKG5+?3I#<M#XCFBU<ELXCC5G=T_P!D;5@7'^T:
M]8XQ2<$T >62Z7&OAK6]6/VAKYM;>%7:5SMB^W+\JKG '&>GK5/6])TQ+;Q9
M&]E&;A=;MKD@QY;R"T!9_=<F3/XU[!@ 8I/EH \DU[G5];-W<6$4;)&-.,\,
MKOY7E+M-L48#=OW?=YSC/&*U=/T9=6UZ].MQ274B:)9DF52@,I$NYMO0-^HS
M7HWRYHW+QR.>10!SW@.:XG\ :'+=M(UPUE'YADSN)V]\\YKB?#]M;'7X+%;6
M"]$JW*7#FWDAN(P021<@Y1\G !/<Y QFO5PRGH:HSZK;6^L66FN',]XLCQD#
MY0$ +9/;[PH \LM/L$>F>&['^SK2-8],Q(]];2/")LJ'01*!F;()R2#CIG-6
M=#LV%CX5O)[0G4!I][;PS7$!W).)%\I6)R5(PV,GUKTS4]3L](@BFO)"B2SQ
MP)@9R[L%4?F:+#4K?46NEBW@VUPUN^\8RR@$X]1R* /,O"L$RZMH(#JE['#(
M+Y(=/E21OW9#"YD9\$[\$'!R>G!J?2?#-D&\"&33,F>SD%\6C/[S]RI E]<,
M!@-TQ7J19 P4D GH*4@8H \A6TN[:+31=) FCV[ZA"BWME)<Q1N+D[,HI&/W
M8(5CQC([BMC1=&COIO#D.H6TEU:):WY5;FV9%"F6+8I1BQQC.T,<X K7M?B#
M9W%G:WTFDZM;:?<LBI>30KY7SL%4DAR0"2.<5UGFQ9(\Q<CDC/2@#S;0;-+;
M4_#LMYISE(6U*UA=K9F\D_:5\D9P=HVJ<$X&*U_'5O$]YI-U,''D><$,M@UY
M;;F"C$B*=P. =I'OZBNR\Z'8'\Q-A. VX8- FA:+S!(IC'\0;C\Z /)_)OO)
MT*YU'3DLM-CLYXEAFT^6[CCD\W@F/<&7=&!MW9QDKQFM#3-'$#>'FO+"XGWZ
M7>6JR7-E\ZEGC,:.!NV?(' R>G'4XKT?[3 8Q()4*-T;<,'\?PJG::W87M[=
MVL-PADM95B<%ARQ17&.>>&'Z^E 'E2Z9=R^%C#!I5VCCP>;1X_LKH?/# ,F"
M =Q.3[]:Z77_  \T5S<IH]DEJ9] NH3)$OEJ9-T>P,PX!Y;!/O7?)+&[NB.K
M,APX!R5.,\^E5[V2P=#97LD&VX4QF&5A^\!X(P>M '"Z+_9[>/\ 138:1-IZ
MQZ/<1N);8PGAX,+@@;L<_-T.>":]%K$TO2-!T.Z:.R"17,BA-LEPSOM'(4;F
M) '7 XK;H **** "BBB@ HHHH :@P@^E.IJ?<%.H **** "BBB@ HHHH ;(&
M,;!&"N1PQ&<'UQ7EW@UK^VLX?LTEE_:>LW]YY]Z]M\P6&60'/S9<]-H)  SU
MQ7J?6N>ET?PU!!;Z3(T,)$SSV\8NBDJR,Q9F1@P8$EFZ'OB@#G[SQ9KD%U_9
M,9M&OXM7AL'N3$?+>.6(R!]F[(8<9&><=LUD^(DU=$\<I?:I'<I%H,99$@,:
MDE9L;?G.WH<^N1Z5W\?AC1XT@5;4DPW0NU=I'9S, 0'9B<L<'')-1:EI&@7M
MU=M?&/S9X%M;E?M+)OC8D*K*& Y+, 2,\G% %*RU+6+3Q=::1J-Q;7$5Y8RW
M*>3 8S"T;1J5^\=P/F=>.GO5CQ1(8[WP^JK$6EU((&=-Q3]S*<CWX_4UKOIM
MH^IP:DT(-W!$\,<F3\J,5+#'3DJOY4MS8VE_+;R3QB1[6;S8CD_(^TKGCV8]
M?6@#SC1M0\1VGA>T\B[>Z>?4[M9YH[=9)D199.50N-V6 Z9P#P#7=>&]3.J:
M0)9+E+B:.5XI76%H2&5B,,C<JV,9'KTXJ-O".B,A46C)^_:X4QSR(8Y&SN9"
M&RF<G(7 .:T-/TVSTJU%M90"*+<7(!)+,3DDD\DGU/- '.WVI:Q>:WJ]M8:A
M:Z?!I<,;%KB'>LK."Q+$D;4  &1[^E9\WB'6KBPUW6[6\MHK72)706GE;_/$
M:*S$OD$;LG;@=,'G-=)=Z/H6MWLQG2*XN(=L5PJ2D''W@DBJ?F'.0&SU]Z?<
M>&=(NKMKF:S5I&*EP&8)(5QM+(#M8C QD'I0!R^HZSXACFU*\MM0MX[>TU6&
MRCMI+;=N601 EF!SP921CTJ*^USQ!927NF#4X)+J+4K*V2Z>V"C9,!G*@XR.
M<?A762VNAR7%U8RFV,SNE]/"9/FR"-LA&<@9C'/3Y:S+W1]%\6V@N=/N+2X@
MEO89KF6-O,681'&W(.,XXH Q-9N[_P R32K^\2]-IJVF2QSB,(V))A\C <9&
MW/T84EIK-Y]AM+.QN#;S237LC06-FKRNJW!4, <(J\\EN23]:ZJWTGP]&$L(
M8[=FE=;Q4,I=Y&C*XDR22VT[>>W%22>%M%E\O=8H#&7*LC,K#>VYAD')!;DC
MI0!RVCZ]KWB*/1HH;^*S>ZL+B:>06ZN=\4R1@@9P,Y.1DCT]:DTCQ!K'B0:5
M;17B:?+)IWVNXF6$/YCA]FU W  ()/?YE'%=98Z#I>F&$V5G'!Y*/'$$& BN
MV]@!V!8 U#)X8T:6SM[0V*"&W#+"$9E*!OO $'.#W'>@#C;CQ1K]Q>SV=A))
M.UC9Q2O<V,,+Q3R,&^8^8X(C^7'R\YW<\5WFE74U_HUE=S1K%-/ DCHK!@K%
M02 1P>>]5;KPMHE['#'-I\12&(0HJ90>7_<.W&5]CQ6@9;6R%O;EXH?,/E01
MY"[B%)VJ/HI.!V% 'G9\:ZM ;**9T+Z;<.FM'8!F/SA"K?[.0WF?135F+5+[
M5[W1KIG2,7_]H/:N84+PQ!0(RI([@!O?.#TKL9-!TJ8Z@9+&%CJ*A+LE?]<
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M3NZ^AX->DW%Q#:6LMQ/(L<,2%W=C@*H&23^%03:9IUS<"XGLK:6<#:)7B5F
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MZG!'-<#XA$)U;Q%_:IO%N/)0:,82^[_5_P#++;_'YF[/?&,\5W]O%;PA_("
M2,9&V_Q$GDU5NM8MK;5[#3F#-+>&0(5P0A1=QW>G% ' ZEIES<:3XLU"[^UC
M5+:")X#'*XV3+:QL2@!QG>.H^E>FJ28E)Z[:3S(SNPZ_+][GI]:0SQ*,F1 ,
MXR3WH \TTO)@TG>]Y_PEGVY#>@^9G;YA\T/_  ^7LW;>WW<<UTO@72H;/0TO
M"DHO+DOYSRNQ8@2/M&">  >,5T/VH?;S;>4^/*\SS>-O7&.N<]^E2B>$C(E0
MCCG<.YP/UH X7QDT,_B2&TNK=/+%GNCEN%FEC9BQ!6.-, R#:#G.0",=ZS=
MTVYU6ZL+F]AN)+JW\/6LD)G+@"Z#2<MGJX..O/)]:]-$L; LKJ0.I!Z4BW$+
MQ&594:,=7# C\Z /--'M8?,\/KH]K=Q:GM;^V&EC=6=?*;<)F889O,*XZGTX
MJ+2I7GM/!EDMK>>?I^FS0W@>W=1%(+<+M8D8R2#_ )(KT'3]:@U'4]0LH5)-
MD8PTF05?>NX;<5=:[MDN%MWN(EF;[L9<!C]!0!YCI.B76GV'A6?3;66#4KG2
M)DNI2&!:3R%*"0GT;IGIVJ?PW96*>(_#$EGIUU#=PV4R:C(]NZ8E*IGS&(PS
ME@W.3GUQBNXT[7K74)KJ$D0R073VH61@#(5QDJ.XYJ^]Y;)<);O<1+,_W8RX
M#-]!U- '+?$73X]0T*Q\VQ-Y%!J5K-*@A,I$8D&\[0"2-I.>.F:Q+GP_"VE^
M(]533G;4H]2,UG+Y;>8H CP8^X'!SCKSFNGM?%T%WK":<MK*KM?3V6\D8W1(
M'+?0@XKHSTH \DUG2[Z35M8>X\Y=2>]WV,D6E//-L^7RS%-O"H!R"#@<-G.>
M?6AG8,]<<UG6NM6TEBMS=2P6F=Y*R3H<*K;2<@XQT^F<'FM".1)8UDC=71AE
M64Y!'J* //\ PEX0GN_!VCQ:QJ.IF!(HV;39%2-%*D$*P"AB 0."?K4%SX;'
M]G:A?'2C)-+K3O=XBS+-9B?+*.[*0 VT=0#US7?1:II\]Y+9PWUM)=1#,D"2
MJ70>Z@Y%,BUK2YX[B2'4K.1+8$SLDZL(@.N[!X_&@#S;5K*R0W<T&D2QZ%/J
M.G*MK]F:,2R!SYC+$0#@@H#Q\VT]:FO])ENH-1DTO3I[719+^UD,'V(D2!5(
MD<6YP2N[R\C'.PG![]K?ZKX9NHC]MU333':7",Q>Z0"*4'*9YX.1P#Z5:NO$
M.BV$@BO-7L;=R%(66X1"0WW>I[X.* . L- :Y7RVMKBXT^;5X)&C?3_LL1 B
M8.PB/(4\ Y !(/7-6[_0XK-?$\EMIPM;BWN(=1L94@V(PAACPH<#'574C/0G
MUKI;KQ/]GUN?31;(?*%H?-><(&$\C)QGN-N0.K9P*FOKOP[K4S:'=WUE<3YR
M]G]H&\X[%0<GW'YT 1>#XI'T5M3GB:*XU29KUT?[RAO]6I]Q&$'X5S^K:>J:
MGXE.I:-<:B^H1HMB\=N904$0'E[@"(R'#-DX'S9SQ76V?B#1+ZZ6RLM5L9[C
M9N$$4ZL^WUV@YQ3[?7M(NM0DL+?4[.6\CSO@292ZXZ_+G/'?TH YWPMX?DMM
M;N+S5;19;^*SLX5NY$W$NL1#E6/N><5V54++6]*U*XEM['4;6YFA_P!8D,JN
MR\XY /KQ5^@ HHHH **** "BBB@!J#" 4ZFI]P?2G4 %%%% !1110 4444 (
M>E>>^&[#1K[X?7%[KT%NT\OGMJ5Q(H\Q9 [!OFZ@KC ],#%>AUC7'A30+K4O
M[1GTFTDN]P8R-&/F(Z$CH3[F@#GXM5O]0GU:/3]4:RM-,LX'@\V$,\NZ+?OE
MWC=CH.,'ALFN;NKZ35+AM1FC$<MTGAZ=U'0,UR21S]:]$U/1] U+4(!J-M:3
M7>PF-9,;V08SQU902.#D<T^6ST.XNT61+-[BY6.1%)!:186W(0.X4D$$=,T
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MTL+;2,XB,2_(C ?NG#[\Y((R#5:]TU(+_7D72Y([NXU/3;A76V+%X@]OO/F
M8.&5B1GL3[UZBTL:9W.JX&3DXK-O=?L[/4'L#ODNQ:/=B) ,LBD @9/4D\"@
M#E;?2)V\3#0&MI5TFTOCJT<FS]VP;YEB!]1,TC8[!5]:I6&GQ0ZGX:N[W2Y'
M"76HQF0VC.8V:X+1$X!*CJ0QXYZ\UZ-'=1/&C%U0OCY6(!!(SCZT\S1 2$R(
M!']\EA\O&>?3B@#R&"QN8+#09-3B*:?'I\D:K<:9)=I',923NC4@J2NW!(]1
MQGFU=:6+?3=":_-U*8[:9(C?Z0US"%9P51HD<NCA0 IR> 0>>*]4::)616D0
M,_W06&6^GK3Z .=\,ZCY>EZ/IMY:2V5]+9&5;=MS!%0JI!9LG/S+P3GGVH\>
M02W/@76(;>)Y97MR%2-2S,>.@%;(:RDD^V*T#/&IC\X$$J"1D9[<@<>PJ;S8
MMY3S$WJNXKN&0/7Z<4 <IXATB+5O%_AH7=D+FTBBNS('CW1@E8P W;UP#Z>U
M<DVG75LUF+J!TT>UN=1AC273GNTCS/\ NCY2\XV!@K8( /O7I5[K-M9_8SGS
M4NK@6ZM&00K$$Y//3Y35Z*6.9 \4B.IZ,IR* ,7PA:RV?ABU@E\_Y=Y19X_+
M=4+$JNW)V@#  )R!C/-<9I3SBT\+Z.VFZ@MSI^K.UT6M'$<:XFPV\C:0=RX(
M)ZUZ5-=6]MM\^>*+<<+O<+D^V:)KJWM]OGSQ1;SA=[A=Q]!GK0!YCH_A^2PT
M3P=<6>FO;:D;J1+J;R") C0S\2'&=N[9UXX7VINDZ:WVGP[#:Z3=6VKV5M<0
MWUW);.B^>T)&YI" )-S@D,">O7FN[N?%%E#?:C81@SWEA;I<21*R@E6+  $D
M<_+SGID>M:C7=O'"\SSQ+'&<.Y< *>F">U 'E6G:8YM62"TNTNX-*N([A!I1
MMP6,>-CR$_O6+<@KNS@G/-:>K:#IVF:;H?E:9);JD+%VCTO[9$9&1 ?.B7YB
MQV\-VP03S76IXIL1=VUK<_N)[F[EM859U.XQ[OFX/ .W@=<D#%6[/5X+C3$O
MKDI9HS,N)I4XPQ7J#CG&>M 'GHT_4I]%02Z2UKC2A$]N@959!<@F,;CP6C!P
MI.1NQ1?:?9ZC=ZY;:;HLUM#-;:9N@%N8BX%T^X[!R,*#S@=,].:]$U)M+GTY
MXM2EMOL=PNP^=( K@]LDTS2-'TS28G.G1!1/AGD,C2,^!QEF))'IS0!Q/B#P
MY/'=:U;Z/IS16<MM8.\5M" DNR>0RJJ\*S; N1W&!WJDVBW%Q:WMU;VM_/9_
M;+22XM7L1:K<)&^7V0\$G&,Y'S;0!FO5:YK7O%-WH5U$C:#<W$$]Q';0SQSQ
M /(_ &"P(YXR: *G@^V1-=\0WEOI<UA974D#0B6 P^81'AF"G!'/J!Z]ZQM>
ML+F/Q3?366E75Q<W$\$JI/9K-;S% @#"48,6,=">HR <UT\'BN&/4C8:M;KI
M4PMEN#]HN(]H#2.@7(.,_)G\:U[G5=.LDB>ZO[6!9?\ 5F695#_3)YH X2Z\
M..VD>(KA=+W:A+K2W%O)Y8,C*KQ$,IZX&#^1JAX@L-6NI]66+298[@ZA%-$+
M:S4^;&DB8E:9B>=JGY5P1C&.]>J @C(((J 7]F8UD%U"4:3RE82#!?.-H]\@
MC'K0!PVF:3J$7BJ*YDLY5A76KV<N1QY;0!5;Z$Y%=KI6I0ZOI5MJ$"2)%<('
M59!A@#ZBDBU?3+BZ%I#J%I)<%2PA292Y ZG&<U0N/$NFVNIV&F6TUO/+<7!M
MFCAF4F B-WRRCD?<Q^- '.:-X>F;5-!DU#3MR6L&H[O-0$(TDZ%/Q*Y(KH_"
M=E+I_AJ"SFB,+1/*!&?X5\QBOX;<5?AUC3+B[DM(=1M)+F+.^))E+KCKD Y&
M*KCQ/H#0-,NM:>8E959Q<H0"1D#.>I&30!QEGH>HGPM!H"Z*8-1@M+B)]2E9
M0JR.C+O1@26+LP)Z8&<\@4[4M*N]5TYDL-!FT]K?1;JT*.$7S'=%"1+M)W %
M2<].GJ:[-=:MGOUB2:U:U:T-T+@7"G*AL9V_W>^[.*(_$>B30231ZM8O%& S
MNLZD*"< DYXY(% '/77AP?VA<O!IL9B&A?9(OE7[^6^7\B/SK%T^*ZL]3O;6
M309=0N&T&QMI%4Q_*^V4%'W,/E)ZD9Z?2N]@U[1[JUN+FWU2RE@M_P#72I.I
M6/\ WCGBHHM6T(PW6JQ7UCY:[4N+E9%P,?=#-_P+@'^][T <7_PB^L075JAA
M,WD1:-&TP888P3,TIY.> <_C38M)\0RW^CM<:=<1BUU8W$T47V>.U1"9!O3'
M[QB=X)W?[7%=II'B"UUJ_P!0@M&CEAM&C431R!@Y9=W;H1TQ4][KVE:==+:W
MFH6T$[*&"22 ':3@$^@)!% '(VGAS4+?1O"L*6?E7%GJ4DUR59<QHRS MG/.
M2R\#-16^B:LWAFS\-?V/'#-:VTL#:G*R%0QB=!)%@EMS%@3D#@MWKI+?Q?IA
MU&]L;RZMK6>"\^RHCRC,F50J?;)? 'M5V;Q%H]O?_8I=1MDN0ZQF-G&0S8VJ
M?0G(P#US0!RGAC0]0@U;2Y+NUU*,:?9O"7N9X/*4D(-L:QC++\N<MC&!QG-=
M]7,6_BQY_$']E_8@H_M&6R\SS.R6ZS;L8[YQC\:Z>@ HHHH **** "BBB@!%
MY44M(OW12T %%%% !1110 4444 -=2R%02I(QD=17F$7C'6(_P"S3<W "Z0X
MBUXE%&XM*T*L?[OW3)]"*]1/%9-K:Z+JUA/<6]M:3VNH_-,PB!%QCC+9'S=,
M<^E '&+>ZGJ,VD_:)I(GU'2=1NL>6F^)2\1C4$KD;5< ^IZUF:!97$T_P^AA
MU.YB+Z',[RH(RZKL@^1<K@ ''4$\?C7JALK4W$5P8(C-$C1QOL&45L94'L#M
M''L*KVNB:78R))::?:P/'OV&*%5V[L;L8Z9VC/T% &7X.U"\O+/4X;ZX:YDL
M=2GM%F955G12"I(4 9P<=.U<WXK\0ZE:RZ]<6%Y=JNF[0&)@C@C?RU;80V7D
M+;AT '( .1FO0K>UM[7S?(ACB\V0RR;% WN>K'U)]:RKK3?#M[KSPW6GV,VI
MR6_F-YENK.T6=N22.1SB@#F-4U._C7Q5>1Z[)%+IDR_9;10F,^3&X5@1E@[,
M0/TYJOJ6LZG%#XNO8M8ECN=+ND%G9#81S#$P0C&6#LS*/TKKK?PKIL>JWFH3
MVUO<SSW N(VE@4M"1&B84GG^ '\:2T\*Z=;ZQ?ZG-##<W%U="Y1Y85+0D1HF
M%/7^ '\: .8BNY[;Q;>"'/[W7<21@#YP--+!?S4?E2VVLM:^';36+CQ/,]S/
MI\MS+ (DD!81[B40 ;=A&,$X.,'DUVEVFG6$4VHW$4,:PYN9)O+!((0J7X&<
M[<C/7'%-M=)TA6EN[;3[-'NUS)(D"J95//S<9.?>@#S?5-4OVMM>TVYN)A#+
MX=N;DQW%S',Z,NU0Q"#"Y#'@$@XJYXCNFCTO6K&WU:34[.709IY2SJ_EN" I
M!4<!P6XZ?+Q7>6V@Z/9Q&&VTNQAC964I';JH*MC<" .AP,_053F?P_I-VFE?
M8H4EU'):""S+"09 +2;5( RP&6XYH XS4-:ULW&LO#=QVK6-Q'%;++=B-%79
M&PW1["7#DL,YSS@8(KT+5_\ D!7^>/\ 1I/_ $$T3Z5IMQ=17L]A:RW,/^KF
M>%6=,>A(R*@L=>TK6#%#:SK-]HM%NE4HP#0L<!N1WYXZT >?QZQ<#1K6UM;N
MZC^QZ':RMBXCMXH6:,D,6.6<G XV[>/4U,?$&J_9=-8ZC(7\1Z1;BT< ?NKH
ME%D91TSMEWX_Z9FO0)-$TJ::":73;-Y8%"0NT"DQJ.@4XX ]JG%A9JMNJVD
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M3&4']Q'G#DDL,C&<FNLVIS\J\]>.M"A%&%"@8Z"@#SKQ!Y.G>.]9OW%T)&T
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M-_\ V9-<#20NG>:]N[DK;;G\PJPYZ8R1SC->@:1JMMK.DVNHVZLL5S$)45P
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MF&6[:6X:8)*'01D9)V%@9,J,#Y>G%.U+5].TCXF12ZE?6]I&^CLJO/($!/G
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M\5)"?F$(_P!9_M;@>#SP:Q-"T^XU*TTZUL[B2WN_^$5MF@D1BI619=RYQV)
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MOIIEN9]!F2.9I'9VF#1X &>6QN..^/:K?@O4!'KNG64=V=1\RV<2W,-U,2"
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M'^@37'V=)-0\_:&,9TNY! )(!.8^!D'GVKIZYB$$?$Z\.#M.CP@'MGSI/\:
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M?<77]^1/M'7>%W^^:->:%+365\,SW+Z7_9),S0RNZ+<>:NS:23ARN_./09H
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MVYD'J5SCO3Y_&>A00V\IO&D6X@-Q$(;>25FC!P6VJI. 3SQQWJMIN@75I?\
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M.O$NCW^K1:E/IVB3V<<>B2V7DE%#3R,Z%54*3D*$;G_:X[U>U;39)_&L6C1
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M)$F4H0N,<]]V3C']TUSUAH6J:7<:5JATRZN5MY;QWM'N(GG0S%2''W4S\K9
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MY4D#'&<<4 8W]J>(]1\3:WI^FW&EP0::\**+BUDD:3?$KG++( .3_=-6=/\
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M@@NK=VA(!&V79N^_@8.>/3% &NGCBQN!IHL[&_NY=0AEFABBC4,!$RJX;<P
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M6+2&W\^:6SE6*+ )9]IVXSWSBN;T_0K;4_$FNWMUHI^S3:;:PVPN;;;VEWJ
M1P>5S^% '9?VB@U*6T>/8D=NLYG9UV8)88ZY&-N<XQSUJQ!<074?F6\T<L>?
MO1L&'YBO,X=#OIM'$-[IU\ZGPW802+& '\Q)'+*-W!9>"5/7IWKHO!,=XEQJ
M;SP'R)/*:.ZDL39R3-@A@T?^R OS8&<^U '4W%U;VB![F>*%"<;I'"C/XTDU
MW:V\:237$,:.0%9W"AC[$]:Y+Q;'=R>(;!DLY/(2VE NXK(W3AV91Y87[J9
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MHSF6%1/%9^2LBEEWP22/\XXRIW@<'/6I?#?AR?3=3N+^YL]+M6>(0I'8HQ.
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M& ?:@#I:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK%_92F*YM[5Y(W"ABI ]#Q0!O45RK>-8[-KB/4=,N[66*U2YC1BC-,&?8J@
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M6V%TB65X)E==X0J6VC# L.V#GK0!H)X/G;39[.?4(52ZN$>Y6TLUA1X5'^J
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M=0 !U-84GC+5I+JVTVSTNU;5'NYK.>.6X(BC>.(2A@P4DJ593TSSB@#=\1:
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MO(#8!XY;L%(?,QN"#9P<G!ZYSGC&* .WT/2(="T>#38'9XX=V&8 9+,6/ P
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M'6[^[%Q&L0+B-?+4,&X"J 22!DD'\*@T#QHFL:W_ &7(MF96M_/1[2X,JC!
M9&RJX(R#[\^E:>O:U+I;6%M:6R7%[J%QY$$;R;%&%9V9C@\!5/;TH ;J_A^3
M4[GSHM6O+,/"8)8HPCQR)G/W74@-R>16/?>#K?3M/)TNWN9GC%JL2),JR1"
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MJUM;)!:27%]YUR;>>Z6-DN&500IW+N^8Y)P,8%=GHU__ &IHUG?;H&,\2N3
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M?)/R*6P.IX]\4K>$]$*/ (Y4/GM=KLNI%>)VSN9"&R@.3D# Y/%86D^)-?\
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M #I10** "BBB@ HHHH ****  \BN$TWPEK5HNC6,]S8MI^D7K7$3('\R52)
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M@4 =1&GEPHA8MM &X]3[UR.C>$M3L[71;*_U*VGM-(&8/*MRCN_EM&-Q+$8
M=N@YXZ8YJ:?XBU*XN;4:B)(3)KD]G$(9$*LB"3"O\N<#9VY)QSVK5MO%_G#3
MKB739X=.U&416MTSJ=Q8$H67.5#8XZ]1D#- %:?P69-"T&TW6-Q<:3;B "\M
M?-AF&P(<KG(/R@@YX]\U'+X(F:PL84DTPF&>6::V-CLM92_3]VK#E0  6)SW
M]K&F>-'OSILLFD7%O9ZA.]O#.TB-^\7>>5!R ?+;!^G%;6LZJVDVT4J6K3M)
M((_OA$CX)W.QX51CKSR1Q0!SUEX,O-,AMY;*_M([RVNIYTQ:;82DH^:/8&R
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MPV2I=VLIM;BYF\J\M/.A?SI"_*;A\RYP#GUXYJ72?!ATP6P-^)?)O;B[X@"
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MJNLR:HK'[3) ML?FXVJS,!CURQKEE\1ZI=ZW-I,$T,3-JTMLD[1[MD,<$<A
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M&+2+.X,$<AC221WF!=E'J%''^%=W0 4444 %%%% !1110 #BB@=** "BBB@
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M;R7\XD L2,C;M;/'./>LR7Q-J6AZCK;W\<#W33VEM B22-#ET8[\!2P& 20
M3Q^- '1:'X2BT.2S>.]N)S:QW,8,P7+^?*)6+$ <@C]:Q-8\'F72M#\.6\-S
M)#;W)D>_WHHCB.[S$/.XEU=DP!CYLD\4J^.-2EL]MO9V\MV=0AM$=EEBBD61
M3AQN7<,$'(P>GO5_4IM2\,Z7/J87[3=WMS$;@ 22PVHV*K,JJ"Q0%<\#JW..
M: .M"A5VJ  . !5#1-*CT32(-.BD>1(=V'?&3EBW;ZU7\-:LVLZ0+IY+21A(
MR%K5RR'!XX(RIQC*GD5R4&L#3M46>Z,LD:7VJNS&5OE6/G 7.#QP,].V* .G
ME\*VD^G:C9R2S;;V[-YO4@-%)E2I4_[)4$9K'U_PC>7&CZC*EY<7^JW*PPI*
MVR,Q1K*K$(  H/5B>Y ] *J6?CR_GCDDDLXF5K"6Z0QP3J(71-P1V=0&!'<$
M<CI6QI&MZS+JUA;:I:V4<5_9O<Q&W=F:,H8\JV1@Y$G4>E $A\().MY)>:G>
M7%Y<"$+=$(K0^4Q=-@"[>&))R#GZ<4]?"[R1O]MU:[NY6N8+@,X553RG#JJJ
MH  )')ZG/7I4^M:G?0:C8:9ID<!NKL2R&2XSLCCCVY.!@L<NH R.I/:L!O%F
MN7-Y9Z996E@-1:YN;6Y,S/Y2M$JN&7')#!AQVS[4 ;FHZ8;:^O=7BCN;MKBU
M6WFL(_+Q,%+;3EL8(#M_%C%'@W1)- \+VEE<.7N]OF7#LVXESR1GO@84'T45
M-XCU&^TGP]->65I]JND*#RU1F !8!FVK\Q"@EL#DXKFG\=7,>C1SI]CN;F6_
M%HKP1S$(/++EGBV^8& !^7OP<@'@ V[_ ,)K>7%\8M4O;2VU#!N[:'9ME.T*
M2"5+*2H .".G8\U?TS1+;2KV^N+<L!=F+,?&U!'&$4+[845RL/C?4;B&&TBL
ME_M&XU!;.":6"6&%U,9D,FUP&X56!7U'7!K1.N:U9Z_I6EW\-D1>74L1F@+?
M.BPF0,%)RAR,$'/KWH U=;T&/6&M9TNI[*]M'+V]U;[=Z;AAAA@05(Z@CL/2
MLY/!5L]O<_;-0O;R_G>-S?RL@EC,9W1[ JA5"L2<8QR<YJE-XHUF:=K2PM[(
MW+ZS+IT;3;@@1(#)N.#G/RXX_2J3W>JG5K>.VF@@;_A(##<_ZQA*?L>\]7X&
M<\=.%..N0#<?P7;3QR-=WUU<W<MS;W$ET^P.WD.'C3"J%"@@\ ?Q&HU\$PV\
MD,EEJM_:2QM/F2/RV+K-)YC+\R$#YNA&#]:2Q\1WUU<:?I[Q0+J+7D\-ZH!*
MQQQ#)9>?XMT.,_\ /2I?%4XAU'PTAB63S=55 2S#9^ZD.1M(STZ'(YZ4 %KX
M*L+6'3X8[F[,5E#-;A'96$T,IRR/E<D<#D8/'6G6?A+[-E)M:U.Z@6V:VAAF
M=-L2,,$_*H+L , MFLK2O$VNW,.D7UW%8"SO[Q[1HXU?S%P9 KY+8Y*=,=^M
M9FE>)-7TK0[=+JX6ZN;W5;R))5LYYS$B22%B40LS?= 4#  (]* .KN_"D<PT
MQ[;4;RRGT^ VT4T/EL3&0H((=6&?D7D#/%&E>$++2);!X+F[?[$;DQB60-N\
MY@S;CC)Y'']:Q$\6ZY<V=K%;6<27DVJ&R$MU:301R1^4T@E5'PPQC!'/((SR
M#4%SXVUB&748XK832Z<XA:*#2[J87,@16<+(@*QC+8&=WJ<4 =)XFTJ:[;3=
M3LHS)?:9<B>*/<%\Q6!21,G@95B1[@43^$]-G\0SZU+YK3SVAM'C+#R]K8RV
M,?>( &<] !6-?>+=3M-8*3Q16-@SP"%KNSF*RJX4ONF4[8F!) 5AU ]:AL+*
M_P!8M_&5K>7X=5OV6V**RM"ZQQLA!+' !VG  Y!/?  -[3O"5CIFFZ58P2W#
M)IMPUS&\C@O)(RN"7..<^8Q[=J;:>#[.SN;>9+N\=;:[ENX(G=2L;R!PP'RY
MP2['!/7O6CH-^=5\/:;J# !KJUCF8#L64$_SK1H S=.T:WTW4=3O(GD:349E
MGF#D$!E14&WC@84>M4-3\(VNI75U*+V^M([T!;V"VD54N<#;\V5)!VX4E2I(
M ]*X*Z\2V\?BB;Q-]IO#]GO1:K&MK,8#9#Y)&W[=GWB9,YZ*!73ZSXIU/3-:
MF64P6NF*T/DSS6DLD4JMC>6F0D1$9( 88X!S@T =38Z5;Z?<WD\&X&[='=21
MM7:BH H[#"BJVO>';'Q%%:1WOF@6MPEPAC;&2O\ ">.5/0CO3/%FJW&B>&KO
M4;41F:'9M$@R.753^AK,UO7]7M=3U6STVWBG>VL;>XB4H6;<\KJ_ (W85<A1
M@DC'>@"V_@S3'.O-F=6UN/R[DAQ\J[2N$XX^\3WY.:;?^"[#4&N]]Q=QK>6*
MV-PD;J%D1=VTG*GYAN;D>O2L-_&M\FGQK$5N+N74!:9&G3H\2>49"7@/S;L*
M< '!R#GK4MMXKUJ[GM--^RBVNKB^D@6ZN+22)6B6+S-XB8@[OX<9Z@GI0!T]
MWH5CJ&H0W=RAE:&VEM=C$%&23;N!'?[@_6J6F^%+.PO(9S>7UW]F1H[:.ZFW
MK ",':,#G'&3DX[U4\"K<K'KRWCQ/.-8GWM$"%/"8P"3CC'&3BJ4^J:A;ZO?
MP::EG%-/KD=HTDD9.5-HKEB 1EACCIP />@#1T_P)ING7%A(EUJ$J:>Y>SAF
MN-R095EVJ,=,,>N3P.:UM)TJVT2WEM[:27R'E:18Y'W",L<D+Z#))Q[U5\.Z
MA?74VK6>H/#+-87?D"6*,H'4QI("5).#\^.O:N'UP7YO/%G^EI(%U32UACDC
M.U29(".AZ<\@8SUH [.Z\(:9/?2W3/<QPS3+<7%HDN()Y!C#.OK\J]" <#.:
M1/!NG+=B42W9MA<&Z%BTV8!+NW;MN,_>^;&<9YQ7.>)]5U.SL=9T[4&L;_R8
MK*XB8VQ5<27!0AEW'."F0<U:OO$NLZ=J\OVUH[6Q%ZL,3M:-)"\1*CYI48E'
M))^\  <#WH Z%/"]A';00#S2D%^^H)E^?-9V<YXZ9=N*S-2\'"YU:QGMIIH8
MENY[J>5)RDB.\>P%,#V'!X^M;7B"YO[30KJ?3(TDO%4>4KD8)) [D G&<#(R
M<#-<=+XSU*"T>",F:_:^@M%26Q>*6%9%+$NA(#'"-M*M@G% '2-X/TPV4,"-
M<QS0RO,EXDQ$XD?[[;^Y/0@\8QQP*EM?"^GV;:?(IG>6QFDGCEEF+L\DBE69
MR?O$AC7._P#"3:_%%<VLL CE>[M;>TNKFWV<2MABZ!CDK@XP0#D>]'B$:UMM
M[236K4E-2L]K0Q 289P/WB9P!D9&.O/I0!N2^%-.N!.8;B\MYI+M[LS6UP4=
M9&4*P!'8@#@YIB^"-*A6V%H]Y9R0*Z^=;W++)(KMO<.W5LM\V>N>A%86EZO?
M-J=UIEG]EM9;C6KJ-[@0#[D<:L3@$ N21R>P/I3IO$>O?VC::3'/:+<_VN]A
M-<F$E7C^S^<&"[N& (!&<9!H Z&#PAI=LEFL"W"?8_.$)6X?(65MSJ>?F4D#
M@YZ"HW\&Z9Y-ND,M[:^1;):%K:Z>,R1(,*KD'G&3SUY/-3^'+V\NH]0@OI8Y
MIK.\>W$J)LWJ%5@2.QPV/PK+^*/FCX:ZZT,S1,MODE>I&1D?CTH W+/1["SN
M)FM8Q&7MXK9D5N%CCW; !V^^U6M/L8=-TVVL+<$06T2PQ@G)"J !S]!7&+;Z
MQ%K7B.2SU2.%X+>W8LUL&,L@B/49P%X' ]^:@'BO7-5N3'803QK'IMM='[/%
M$^9)5+?-YCKA!C''/7D8H Z(>#-(2V6");F%8YFG@:.Y<-;NV=WEG.5!R<J.
M.>E:>EZ3::1;R16B,/,<R2R2.7>1SU9F/)/ 'T %5],O+[5?"MO=LB6E_<6H
M8JK+(L<A7L02&&:XFV^(%]%)IMU?F)=/AM3'JI5>8[H+(2!Z8,)&/]M: .LN
M_!VF7FH75\TFH13W)!E^SW\T*L0H4':C 9P!3KGPAI-W=>?+'<$,Z22Q"YD$
M4SKC:SIG#'Y5Y(YP,YK(TN]\0:M=)8S:BEC-!I\%S/L@5G>64O\ +AN J[,<
M<D]Q531]>USQ#JFG)%?1VD)T\W-PL<(?S9$G,9VENBL%)^A% '4W&C:4+>:W
MG0+'=W:W+!I2-\P*D8Y]47@>E5KWPMH<MPUS=)(HDN$G,?VN1(C,&!5MF[;N
MW =N:XR[N=2U?2_!VLWFHQNMWK%O*;41*%CR6PJG[V1T.2>_2O1=6TJWUFR6
MUN=PC6:*<%3R&C=77]5'X9H SO\ A&-$O;O[>B.ZO,+AHX[E_(DE!&',8;86
M! YQU'K4]WX>MI='NM/M'DM5N)S<.Z.V[>9 [$'.>3GVYZ8XK.TF$:!KEKX=
MM)"-.BT^2<*X&=_G#G/_  (UC:3KFMZS?:#:)J@A2]TN:[GE2%&8LLB*I7(P
M.']#_6@#O+NT@OK.:TNHEE@F0QR1MT92,$'\*P[?PEH$@E=4ENF:"2R>26]E
MF(C8@/'EF..5'TQ6%I&OZSK7]BV+WHM99TO7N+F*)2TA@F$0"A@5&<[CQVXQ
M69I.HZO:)%I5D\LTMSJ6I2SSVB1!WV3=$$K! 27R>OW3@=P >A7FB:=J$DSW
M=JLQFM_LTFXG#1YSC&?7G/6HM-\.Z;I-V]W:Q3?:7C$32S7$DS% <A<NQX!K
MDH=4\2:A?:+ISWS:>\SWRSRJD$KNL3($/REE5OFPP'?/'2GIKFL6VJM)?7LW
MV :C]F2:WC@FMBI?8J-M/FI)D@$] >V* .NFL-+U>YM+V2.*YEL96:"0-GRW
MY5NAZ]1@]QZBHXO#>CP6DEK%8HD$ET+QT4D S!@^_K_>4''3BN2T34M0O[^+
M3([T:?&\^HS-+!!&&D\NY**HRI7HV2<9..O6ETG5=;UA="@76RGVDZB9[F&"
M,F00SA$*@@@<'TH [*YT33;R2ZDN;1)6NX5@GW$D.BDE1C/&"Q.1SS56+PKH
ML5O>0FS,JWD?E3F>9Y6=.<+N=B0.3P#@9KD3XB\023:7ID4LTTLES?Q37%NL
M*RR+;R[%"B0A Q!!/'8X'I8L=8UZ]O=.TFZO#9-+<7:M<H8))9$BV[4.W<BO
M\YR,?\LSP,T ="L/ANQ2\+3VR"YC^SW+2W1)=8E(*DLV<JI.>_K3[CPIH=Y'
M$)+/Y8X5@'ES.FZ)?NHVUAO4<\-GJ?6N7\->';+7]'U&/4I3<O'J>HPF9,+O
M$A:-CP.N#V[UTWBS4+C1?"MU=V;!)HPB+(RY$89PI<CN%!W?A0!<M;32K75)
M?LJ0QWOV>*-T1L$0J6V#;G@ E\<>OI4FHZ38ZJD:WD'F>6VZ-@Q1D.,95E((
MXXX-<!?W%[HGBS5/*U1[J>2RL(#<S)'NMUDN)%+$*H4X#$C(^O%6]5UG6M(N
MM2TZ#49;X*UD$N'2(26_G2,C G:J$X4$9'&[GB@#L8-"TRU-H8;-$-H7,!!.
M4+_>/N3W)JQ?6-MJ5E+9WD*S6\HVO&W1A7"/J.OK;:A:#4?+DCN;=8Q/<VXN
M,-DO'N4% Q RNX9Y/L:Z3PEJ$M]IUREQ+=23VUT\$GVH1[U( 8*3&2K8##D?
MCS0!I3Z1I]U<RW$]I%++-;_9I&<9W19)V$=,9)J"U\.:39+.L-DO[^/RI/,9
MG+)S\N6)^7D\=*Y#4M2UB&#Q3JB:S<(FE7P6"U6./85$<3%6)4L0=QZ$8S4E
M]J>HS)XIOAKDED^C.5MK9439@1*X,@926WDD<'ITYH [6SMK2RMUL+552*%0
M!$&SL4YQ[XZ_E4=G_9VGF'1K0Q0F& -';*>5B!V@@=<=JYSPU'+)XPU:\GN+
M@2S65I(UL[#:A8/D 8SP01U[FJ7C#4[ZPUC5C9W!A>'P[+/&P .V028!H [
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M,\$D-[JFIW@8JZ&>9<PNIRKH5488&GQ^%;0QRBXN[VZEEGAG>::0;B8F#(
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MZ%?16\=QIZLMO"((]KLI\L=$)!!9?8Y%;=% $<$$5M;QP01I'#&H5$08"@=
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MI9AM)(Y(]/I3([2WB39'!&BXQM5 !ZU-10 T(H??@;L8SWQ33!$RA6C0JIR
M5& :DHH C,,3;<QJ=IRO'0^U!AB.W,:G;]W(''TJ2B@!BQ(K;E10<8R!V]*5
MD5L;E!QTR*=10!2U/3(]3LVMWFG@)9666W?8ZLIR"#]>QR#W%,TO2(-+28I+
M-/-/)YLTT[!G=L!1T  P !@ "M"B@!-HHVCTI:* ,2S\+V-E>P7*S7<OV9G:
MVCFG+)#N!!VCZ$CG. >*VZ** "BBB@ HHHH **** "BD'2EH **** "BBB@
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MN\F/.W<<GDDG]360G@O2XY%4/=&R6;[0M@9LVZR;MV0O7&[G;G;GM6_YL?\
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MD(;<TIE89]"Q.1Z'%:(XIC2QIG<ZK@;CD]!Z_2D-Q"%1C(@#D!#N'S$],>M
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M4;6YO[JRBE#7-J$,R8/R[P2OYX- %JBBB@ HHHH **CN)X[6VEN)21'$A=R
M20 ,G@<FB"9+B".:,DI(H9200<$9'!Z4 24444 %%%9VGZW9ZI=7<%IYSFTD
M,4DAA98RX)!"L1AB""#C.* -&BBLW4-=T[2YFBO)_+=;66[(V$_NH\;VX';<
M..O- &E12*P=0R]",BEH **** "BBB@ HHHH ***IV.IVNHR7B6SEFLYS;S
MJ1M<*K8YZ\,O/O0!<HHJI<:G:6U]:V4LF+BZ#F%-I.X( 6^F,CKZT 6Z*@M+
ME;NSAN5CEB$J!@DR%'7/9@>A]JFR* %HHI"<4 +169?:Y!8ZI9:=]GN9[F[!
M91!'N$: J"[DD84%A[^U6-3U*UT?3+C4;V3R[6W0O(^TG 'L.: +=%4[;4[>
MZO[JSCW^;;*C/D8&'!(Q^56R0* %HHI-PSC/- "T4TNJ]2!^-&]2<9&?K0 Z
MBD#*1D$$>M-\U-H;<,'@'/6@!]%,$T; %74@],'K2>?$)1$9$$A&0FX9Q]*
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MNC\=CPIJ=^FJV%MJ=]=S37MJTBGSH9[>8C:2Z%0'08/ (Q@^M=E_96G?Z/\
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MHE$22E4=E((#@<, 0#@^E $/A>PN=/\ #UK%>L6O9 9KDDY_>N2[@>P+$#V
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M*G%Q S*JRH6<;E 898>HH \J\306\5EJRWNESRZO+JT;Q7JP,5\HSQB,"7&
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MD6]># )5V<L)"/4NI.?4&HK[0/#\B7$M[I]GMN)$>5Y$ WR=%8G^]\V >O-
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MO)=#OKE+LV^IM^]6X>T6%0R%@(@K^;E2.A!) ;."*72KCQ%>Q>'9)?$=PO\
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M6A_>Q["VTXR/53V/>@#S=M1U=-$T6075Q+)XATF&R5MQ)2Z./WGL?+>1B?\
MIF*[GQ.;VU\'ZC_97F_:X[5A"8_F<$#J/5L=/>ENK"W/B.QO9#>2LJM'#$N#
M!"VTYD(QD,5)7.>^,5L!E(Z@T >>VDFFWFNZ;:^']1N;ZRF@F35%%Y)*%39\
MC.2Q*2;\#LW)].-[X?6D5IX$T?RE9?,M8Y&#.S?,5&>I..G3I71$HJL1CCD@
M55TK5;75M*M=0M6(M[F,21;QM)!]J /((+B*7PUJ]A_PE,\<[7=Z?[&2V202
MCSY#L.U?,(<=<-T:NGU"ZM3?:@?$5U=6$YM(C801W$B!<QY;RMI&Z02;AW.
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M ,\XK*,,LHUR&S!^R365L5^PPS1Q%_/^8H6)W-@C+#%>M/<01%5>5$+'Y0S
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M<FU@,YQF4QC<<<CGK0!S_C>6*"UT:6:1(XDU>V+.[  #)ZDUD:]J\$NOM?\
MAQH+R^L=)NWG>W(<=%,2,1U)8$@=>#ZUW5Q;6]W%Y=Q#'-'G.V10PS]#2P6\
M%M'Y=O#'$G]V-0H_(4 >?/J-UIK0/H6KW.LR7&EW-Q(DLPE&]4#1R #[F6.W
M:, YZ<54O;];7PG)=6'B?4+N]FTIKJ4"4R=-I:3C_58R1M& >1CBO28+*UM6
M=K>WAB:0Y<QH%W'WQUHBL[2 RM%;PQF8YD*(!O/OCK0!YWXO\0RO?ZLNDZNP
M2+0&F!MYLB.0RJ _!^]C]*EU2SO;.^UVSCU[5O)M=(74(\W)W";,HSNZ[?D!
MV]/:N\CTRPBC,<=G;)&0056)0"#U&,>PJ8P0LS%HT+,NQB5&2OH?;D\>] 'E
MNMZQJL^H:H[:BEH;2WADM2^I/; !H@WF")4(FRY88.?NX ];6KMJ,EEXNU5M
M6OX;C3(4EMX;>X9(DD%LCGY?X@6['CKQDFO1I+2UF:-I((G:,YC+("5^GI3S
M#$0X9%(?[X('S<8Y]>* /,[\)'J'B>ZCU=K"\N([)P9+N14"MM!X4G8IQMW@
M?+D\BMWPEK%M#!?Q75ZP6">)2\NH_:X@T@ 54F;YCDX^5N<L/6NFOYK*PM9+
MR[V)#&F'<IG"DXQP.E$^F65S:):R0(($D258T^4!D8,O3T(!H S_ !A?KIWA
MBZN&EN(MVR(26[!74NX4'<W"CGECT&3VK@+/4KYKC7M.CU25(PVG>48-3DNS
M$9+C8^V5QG)&,KR/SKU.*YMKUKF%&63R'\F92.C;0<'/7AA^=/6V@10J11JH
MX 50 .] 'G>HR7.CWFK:8NK7_P#9RRZ>TL\UT[R6\<KNLA$A.Y0=@YS\N21B
MMGP;]B&M^(A87[WT E@ E><S$'R_N[R26QZDD^_%=)=WEE9S6\=RZ))>2>1$
M"N?,;!;;^08\U:CCCB4+&BH , *,4 <C;Z[I&D>,O$2:EJEE9O(UN56XG6,L
M/*'(!-<QK&IZG)K^I2+JEO;2Q7<*V2/JDT>Z,A"FVW1"LH<ELGGN.,5ZH\$+
ML6>)&)ZDJ#6=-JNEQW_V>1E,\,D<.1&3L>0$JN<<' S[ C/44 <=J$5Q';ZQ
MK0U/41/::O&D$8NW6)4WQ J4!VL#N;J#UXQ6?J,\-Q=E[[5;C^UT\201K9&Z
M8*(1<)Y8$.=NW9M;=C.3UKT2'5].N)+:)95S=F3R@R$;VC.&'(ZC'3N 3VJ^
M8T+;BJEO7'- 'E6GZCJ<NO6SR:I;1Z@VJO');-J,[2&,.P,?V;;L"A "&Z=&
MSS75^ +5SH8U*>]O+FXN7D#>?<.ZJ%E<*%4G"\ #CKWKJO+C\SS-J[\8W8YQ
M]:< %&!@"@#S;7+6>:7Q5?KJFIPSVE];1VRPWDB)$#' 3\@.TYW'.0:?JS?V
M!<:Y9"_U1[1H;!U\S49 8WDFD1CYS$F-"$7<1T&<8KT7:O/ YY/O055LY .1
M@^] 'E6FSZC<VWB(:?=^=-ITEK>VT<%[+<QG&XNBO)RP8*5('&:[+P==2:O8
MW>NN7\K4;EI+56S\L"@)&0#TW!2__ JT]:MK>;1KA)[R:RMQ&6EF@8(RH.3R
M0<#&:33[S3XITT>S8*;>UBE6,*0%B;*I@_\  #^5 'G.L26<T-Y_:%_=+KW]
MM1@6RW#_ .J$Z[ (\X,?E[6SC&<GK3+J[U$:]=&;4K>WU)=6VPQ-<3F<Q"0!
M%2%?E9&CQDXQR2>1QZWQG/%0/=VZ7T5HTB_:94:1$[E5*AC^!9?SH \U@N1:
M^,\?;?MDTNJ,IB6ZFBNH@Q(PT)RKPJ.A^48 (YJMI&F6LL.G:2DMS"LGB"^6
M\BAN9$<H!<,@8AL@$!#VS7K7&<\9HX]J /,K\P6RZG&U]=1>(8;M8M-M_M4A
M8H-HB"IGYD8??)!SELGCB^RWQ\7GPTKS"V-X-7,NX\V_4Q@_]=\<?W37?'!K
M$L(-/M?%&HA;BXEU*:&.63SB2$BW.%5., 9W<=: *_C)W33K3?)+%8&\C%])
M$Q5EAY[CD+NVAB/X2>U<C?+'=1:K:Z/>W3Z+)=Z:B2PW#D)*UP!*(GSD#9LS
M@X!)]Z]1SQ4%E>17UHEQ$LBH^<+(A1N"1T//:@#+U"*'P_X1OELX;IH[>VD9
M$BE9I3P3\K-DY]#S7FINYE_M(6ES \3^'KW/]GW$TR&154J6D;AI<;N@!]:]
MER*.* /-5L=.TLZ NL7%RFER6#S223W$A62Z(CYD;/7;NV@\9SCG%/TG1+#6
M-<NGG347M5T:U6'[5*ZR8+S_ #-@\L!C!/(SZUZ/D4N: /,],LM0U[2)T::=
M;XZ'I=Q!(S$8N%,S@GZL%#>H-1:E-J.KZ)-XA@2X@BO;V"*5)(W)CM(\AMR*
M0V#*6+8Y*^U>H\49% '#^  YO-8>*ZBFL&:/REMH)([=7P=_E;V.0?ESCC(^
MM8/C"PMUU7QH6MRMS>:1;FW<*<O@R!]I]1\GZ5Z3!JMM<:K>:;&6^T6B1O*"
M. 'SMP>_W35W(H \U\0Z;?:3J5];>&DN(Y;C0YF 1V;=*LB -DG_ %FUGYZF
MI?!9!\3NUG<Q-:_8<31VEE+#%OW+M+F1S^]QNSQG'7H*ZZ?Q%8V]]):.9/-C
MGAMVPG&^7[G/\ZLZMJMOHVFO?70?R49%.Q<G+,%''U84 <7XBDT6/XA3?V[$
M\L']CQ^6OEO(F[S9,\*#\_3:>O7%<_<"\-EIEGK%IBZ71HP)+V&:Y=Y"6&V-
M$( E "Y8G/(]*]673K0:LVJ!3]K>!;<ON."@8L!CIU8U;!!Z'- 'D=G+IC)9
MCQ'%=SS-X9LPJM%)(?-S-NZ XEST)YZX[TV_M[^*.!-?D03'1[:.,S6,UT_F
MA6\SRF1QMEW8YZGCG KU1;&VCU.740I%S+"D#-N."B,S*,=.KM^=6MP'<4 <
M+H&D-=^,;F[U2.:::VTVP,3S*5'FXEWOMR0'X&<$XSC-7_%8MAK&DRZM"\VC
M(LWFJ(FE03G;Y9=0#E=OF#D8!(]JZO<!U(HW+G&1F@#RVUT0:IK7AV*]LYY=
M)#ZD\$<RMCR2T9B#@]!U*J>@ ]*9%;2Q7<<NIV5Q-HD>N:DUQ"(&E!+-^Y9H
MP"70?-V(!(->J;U_O#\ZPM0ATK7M7.FW,<_VJPC2Y2:*1HB@DWK\KJ0>=C C
MZ4 <7H$"O=E[*UN8[1-9O=J2(P*+]EVC(/*C/0'IP*M:+HRZ39>$+JUT^5;M
MK)TNV52))?W&0LC=?O 8ST-=WIFFV.D60MK%!'"&9SERY9F.68L2223W)I+7
M5K>\U6^TZ,/YUFL;2,0-I#@D8.>>AH \O\/+)_;_ (8G@L/L^WS4O%@TV:(Q
M9@?"S3/S*=PZXZC/<9@^PA/#6D&:QEDN3HT<,<%QI<MQ&Y!<E4:,AH9.1D\?
MPGMQZAJ7B.PTR6[AF9VFM;)[Z2-%R?+7.<=L\'BM"WN8[FWCF0\.@< ]0",\
MT 4].U%972QEBEBO$MHY98RK%4W9&-YX8@@]R?SK2IJNK$A6!QP<'I0\B1C+
MNJCU8XH YOQQ!-<:18I!"\KKJMDY"*6(59T)/'8 $YJ+4=#M-6\<K)J&GI<V
MRZ6R S1;T#&3WXW8_&NH:6- "[JH/0DXI&GA0X:5%/'!8#KTH \H73[B"TT>
M35;6=K<:/%;QJ^E/>E) S;U*CE"08^2.<=>*] TJVEM/!EM;3F8R1601O/QY
MG"=&P2,^O)K866-RP6125X8 ]/K3%D@NXG5)$E0Y5MC _4<4 >5^%[:-]$\/
MMH^B7,=S:Z9+]L+P-")MT7RIYG <L^T@@G&.U5[.QN'NM/>TTR6(#3[J"X6#
M2)+58V:'*QLSY:0[A][)&1ZFO0[G5K+P[/I.A6EH\CS#RX88G4>5&FT;CN8<
M#(Z9)K;2XADD:-)HV=/O*&!(^HH \]L_#MII<7@BXCT-5:(*+MX[/=(LA@VJ
MSX&>'QECTZG%9*Z3=VT.CSZC:7)M%TA+=$&FF[,<NXEU,>"5+#9\V,<8)%>J
M_;;78[_:8=J %SO&%!Z$^E*]W;1P>>]Q$L/_ #T9P%_.@#RW4=%>TLK$26.H
M7%W_ &4EL@N=.%Y')@L1$^SF)ANP6# $8Y^6NS\36UW>_#K4+8VK&[FT]D-O
M%ESO*<J/7GBND5E=0RL&4C((.0:B:\MDN!;M<0B<](RXW'\.M '!^(/#4JG5
M+30M/^SI<:.(O]'C$8D82?=SP-Q4L!D]ZPKW1);[3-96PL]2:-]/2V>,Z:+1
M'82J0 F 791N^8 C!ZUZR+RV,HB%Q$9&SA-XR<=>/:J=]K=I8W-K;EA)-<7"
MP;$8$H2&(+#/ ^7]: .*U_0Q8>(#+#I\J:4]BL,,=CIJ7 63>Y=2F#LW I\V
M,';R>!4-QX<U%28(;2X,\WAD6$-Q( 669=WRNZ_=.T@;NA->EO(D2%Y'5$49
M+,< 5DZOXETS2-!N-8>XBFMH5)'E2*?,/]U23C)^M &'I-I'<>*K&]TW1YM,
MM;2RE@N?-M_(WEBFQ /XMNUCD<#/!YJ[J>8OB)H4L@_=2V-W C=A(3$^/J51
MO^^32:9XSAU/6DTN.U43+ )[EA=1.L()8*.&.X_)SCID9K9\S3-7"E)K:Z%O
M*) 8Y WEN.AR#P>M '(VMK-;V'@K3Y(6CNX[QY71N&1%BFW$^WS*/^!"M'QS
M;ZG':V>JZ+:M<ZC9NZ+&G5DD0H?R;8W_  &KNHZSH&G6UWXA>XMIFLX#'))%
M*K,%SG8.< D@<=SBMR&:.>%)HG5XW 964Y!'L10!YK8>$[W2KV;3X+ SZ?I-
MI+/I_F-\L]Q+$JE?J"LN3_TU%4H-)U674M.DATZ\C@CTN[M95^Q);QH[1KMC
M51\Q&5/+$CI@\FO4(]2L9KE[:*]MWG3[\2RJ67ZC.12VNH65]O\ L=Y;W&PX
M?R95?:??!XH \]?P]JZ6>D6EM;.D&J:7;V&J$8!@,84EC[E#*GUVTW7=!O3J
M.O1/:ZG/'J)46PLH+=D*>4J!"[J3'M96.> ,Y'.:[C4?$.GZ7J^FZ9=3*EQJ
M#.L(+ #Y1GG)[\ >YIFA^)=/URSMI8IX8[B>+S?LIE4R*/< YH DU"*[7PO=
M0VT*W5X+-ECBF;(E?9@!CQU/7I7GK:)J]Q([QZ?>E#H-Y9@26\,"K(RILC14
M^;'RG!8D>AKTN/5-/EO7LH[ZU>Z3[T"S*77ZKG(J6YN[>R@,]U<100@@&25P
MJ@DX')]20* .0/A>+^T=$B.G(EBND7%I=A% 7YA$ IQUZ/\ K2> 8;N<W=[?
MJ6EM -)AE)SYJ0,P:0'_ &F//^Z*Z1M1T74],N7-]8W-@%,=PPF1XP",$,<X
M'![TRPU+08-+3[!?:>MA!B)3#,GEIQPN0<#Z4 8-WH,MQXC\37S6(=I]-BAM
M)6"DE@LN0I[<LM8=C9SZ1/<&\TU;_?H-K;R1>;%NMBB.&616880YSD9S@^E>
M@IK6E/8M?)J5FUHK;6G$ZF,'TW9QFLW45\)ZE#;ZGJ3:1<1#*PW,[1LO&20&
M/!Q@G'L: ,#P/HS-;Z#>7-DK0IX=MX%=P#AR<LN/IBGZ!HNI:;J7AB::P?R[
M?2I;*<JR'R'+1E<\\C"$<9KN$EA%NLJR)Y&S<'!&W;C.<],8JE#K^CW$$\\&
MJV4L5NNZ9TG5A&/5B#P* *'B&UNGU30KVVLWN4M+MVF6-E#*C1.F[YB,@%AG
MO7,V^@ZJF@6?AY])<W$&I+<MJ1DC\O G\PR [MY<K\N-O4GM770>(K&ZU!HK
M>[LI;1+=IFN$NE.TJVU@0.P[MGCI3)?%.E26=Q+IVH6%Y+"GF&-;I1A<@9)Y
MP.>M $?BC3[J_&C_ &:+S/L^J03R\@;47.3SUZUD0>'[N/PWIUNMBJW,6LB[
MD *@A/M+.6SGGY#GU[5TDGB#1XKT64NJ6:76\1^2TZA]QQ@8SG/(_.B;Q!H]
MO??8IM4LX[K<$\IIE#!CT!&>"<C [T <CIND:Q::[ (+"ZMK5;Z6::.6:&:U
M"-OR\1/[U78MG' &YATK,MO#&N6.CZ7%%IMY'?1:8+9IK6ZAQO#.=DT<A*LG
M(.1D\M79VOBRR:75%OWALDLKXV2O+*/WK>6KY'OACQSTK:M;JWO;:.YM9XYX
M)!E)(V#*P]B* .>T2PU.S\37MS>0*T=U96JF:)AL$L88.-O4 [LCC&!VIMU:
M:AIOBB_U6VTUM2BOK6*$(DB(T31E^#O(&UM^>,G(Z5J:]K']CVMOY<8ENKNX
M2UMHR<!I&]3V  +'V!JN=??[=#;@67[R_>T_UYW?+$7X&W[_ !RO3'.>U &?
MX5\.W>CWL;W*1D)I<%MN5LA7$DKL@[[1O4#Z"NMKG[+Q&\]UI$<T4/E:G;L\
M4T$A=/,4;BN2!D%<D''\)KH* "BBB@ HHHH **** $'2EI!TI: "BBB@ HHH
MH ****  ]*\LM=8\1IX6T:_?5;BYGU:]\AAM@C$2+YIPA*@!F"*N6S[<UZF:
MHMH^FOIO]G/86K67_/N8E,?7/W>G7F@#A(=?UYY;;3+J[%K%/JWV4W8EADE2
M/R3)Y;%05#EAM!QG!'>I=/UG48[MH9=9:Z@B\1_8_.8(,P_9MP0E0!P^.>N:
M[0:%I"Z8=-&F68L<Y^S>2OEYSG.W&.M9VF^#M)L+74K-K6UGL;V[^T_97MU\
MN/Y44*%Z?P9SZF@# MM;NKO5X]MYYL(\2S6BX ($2V;MM!]F&:S[74M?3PYX
M;N)-5N;F;6&!E.Z&(*!$S!$8K@%L#).2<'&,UZ%!I&FVJ1I;V-M$L<GF($B5
M0K[=FX8'!V_+GTXITNDZ=/IZ6$MC;26: !8&B4Q@#IA<8XH RO"%W?W6FW8U
M"42O#=/%&WFI(VP $!BF!N!)'X#/-</KL!34?'12^F68FQV*[*P7.S#;<<[3
MTKT."[T72+=;6V-M;0)<K:"*! %25L$)A1P3N!_&K,^DZ;<W#7$]C:R3N@1I
M'A4L5!! )(SC(!Q[4 <9JNKW?AK5-5M9M9NW@&CF\6:6*.1XI!)LRJ@*#G<.
M#QQVYJC;:CJ<VN3:1<WEW'#<Z/<2F*>ZAEEWJR /\@PF0S< D<=.*] OX]-A
MAGOK^.V$:0,LTTR#B+J02?X>^*99:-I-BJO8Z;9V^,[3# J]<9Z#O@?E0!3\
M&+&O@W1UBG:=19Q?.S[C]T<9]NGX5F^#]6TZ#1Y;62_M5NCJ-Z! TRAR3<R8
M&,YYXK?T6;3)],272%B6R+N%$47EKN#$-Q@?Q TG]@Z-]I^T_P!E6/G[_,\W
M[.F[=G.[.,YSSF@#@_#^M:W>7^CW-Q?1J]U<R)<VSWBG( ?,8B"94H0.<]CD
MG-6-/O-8M+#P[J!U2[O9M1@E$D$VW:S"!Y$P H((* 9[YYKN4TO3HK][^.QM
M4NWX:=8E$C?5L9J)Y=,MM0L-.*1+<E))+6,1?=5 JL5(&%P' [=: /.I-1N+
M=])U.VU=]2OSH-Y=^4[*W[[9$<@ 949R-OMZYJ:75]5M;._>'5HI -&N;C U
M 7+EU4%)5P@V<D\9QR,#BO1+?2M.M9WFM["UAE<DL\<*JS9ZY('? IL&C:7;
M"<6^G6<0G!$PC@5?,!ZAL#G\: (M"M9K;28OM%Y<7<TH$KR3L"=Q R!@ !<]
M!VKAK35;D0?;8]<N+G4O[=DM5LC*"IB^TLACV>T>6W=1CKBO0[*[@O;42V^X
M1!FC&Y"G*L5/! [@U2TKP]8:63(D,4MR99I!</&OF#S)&<KNQG +$4 <19W.
MH#0[/4+K7;Y(K[5IK6YF>0!+>%990H7CY<E$3=U^;Z4R]UC4;;4KC3[;5)WT
M0:E:0M?F3<84=',D?F_[RQC=G(\S&:])^R6OV9K;[/#Y#9W1;!M.3DY'3DDF
MF1Z?8Q69LX[2W2U((,*QJ$QW^7I0!YM9W\>G:U?26^K-)9GQ'!'/<M,"-AM
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M40>1D_N@58IO*$J,<9/2K?D1-HMU*UZ?[.&I(Z?\2N3[&N(L$&(R%S$3CD8
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MC[-8QQP;8BL2JH54...!TYKSG1[.Q%[X32QTBZ@U2U9Q?S26CIM<V\@;S'(
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M@G S7K"NC,RJ02O4 ]*YAO&FZXND@\.:U<P6T\D#W$,<10LAPQ ,@8C(],T
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M5"<C"XR>N!GIS6OJ/AW[(_B%-'M%LE@BM+ZS\N/9$9XS(6QCC)"JK>QYKT+
MJIJ6EVFK6;6E[&TD#$%D#LN<=C@C(]NAH R/!HDNM)EUJ>(QS:M,;S8W58R
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M%6\W&&7847;GC'08KI/&8F6/1;F*UN;A;;5(YI5MX6D8($<$[5!/<5TU% '
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MM);2<%2-P=E8,ON"G0^M=+8B[%E&+]H6NL?O# I"$^P.35BB@ HHHH ****
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MQ<K;)=SA-V\$J"AQE2N[N#[&I$\/:D[2Z@-/U&<+J-M<M;W\T'FW"QJRE@J
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M2Q[) Q!V@KN^4'[QXK-U#POJRQZI9P0?:HKK1;:R28R*,R1%]P8$YY#CGZT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6VE/^@1#S1)O)4XZ<)C(]: .YHKC/#GC*6]M-,CO]/OPUY(\*7K1HL+R+N.
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MD9#O0$''$BN .P9:O:AXVU'28I&O]$BC(TNXU%!'>;\B((=C?(,'YQR,CZT
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MMKH6LF%YWEU3CVRPJ*X\4V5M=O"]O>&..X2VDN!"?*21RH49/)Y91D @9ZT
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MBVMTEO>R&*UNG">7*P!(P Q8 A3@E0#^(K;O+I+*RFNI$D=(D+E8U+,V!G
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MFY<!5=G4A!LRQPF1G'>BU\87%SH/A/4?LD:MKD\<4B;S^Z#1N^0>_P!P#\:
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M]4>Z&I64TBS>4B-#+'LSMVC&W#Y&<D;>IS0!T6KZ9!K.D7>FW0)@NHFB?!Y
M(QD>]<AJ'A3Q#K=JFG:JVAR0)M07ZV[&YV @\ \*QQU!QSTKH?"NK2ZOHBRW
M./M=O+):W) P#+&Q1B!V!(S^-8>H>,+FXN-(_LZUNH;.XU=;3[6PC*3*I<.
M,E@"5.#CG';(H ??^&-;N)+^SM[JQ33+J^CO=SJQF!#(S)_=P2AY]^G>JFJ>
M"M6O]3N9O,T^0->1W4-Q<^9)+&%=6$:J?E0?+C*]CTSS6R/&,0U2SLIM/NK<
MWLKPV[2E%+,JLWS)NW*"$."1Z9QFFGQK:K9:?<-:W&ZZCGEDB4 M (5)DW#U
M# +QW(H AG\+:@=%URUMKQ(KB_U$WB,K.HV90E&*_,,A"I([&J%OX(OT^U$_
MV;;+<7-E/Y-JC!4\B7>PR>6)'<XYKHM"\1#7"=ME+"AB65)?,CDC8'MN1B P
M[CW[TS4O$3V6OP:-;:;/=W4]L]RI1U5%56"G<6/'+#'6@#/U;PI>7U[J5W;W
M,"23W%E<P"120&MVW8;'8XQQ39O#&JR+<Z:MW:#2+J[-U+E&\X;G\QT!SMP6
MSR>0#CWJ6W\:#4+JPM]/TJ[G>[@>9@61/("2"-P^3U!],YQ4.B^*Y;O3K&"T
MMKK4;R2W:YD\QXT*)YC*NX\#)((  _A.<4 ;NAZ7)I4%Y')(KF>\FN05'0.Y
M8#ZC-4_%&B76M16RP)ITZ1L2]OJ%OYD;Y'# CE6'/3U-5[?QC]NO;&VL-*NI
MVN8#.Y+HGD!9/+</D]0<\#.<&IO%NK:CI5G8OIT*R/-?0PN&8+\K-@CD=^GM
MF@"OX=\*7.B7MK/-?_:O)T\VK,X.XL93)QDGY0#M ))P!6/%X OX;/3+9KC3
M[R*VL4M&CO8&DCB923YD:9P6.0.?[HYK9NO&1@BU*ZCTNXGL=,8I=SHZY5E
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M.TQ=)2SENHO[+B:"'$@^:-B"5?CD95?RJUXDT^75-"GM(88YI&*LJ22-'RK
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M_P N1V==N]SDXP,\+US^%;&I^,XM)N'^TZ5J LTN$MFO"(U3>Q !56<.R@L
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MI.TDQ0N%WL54JAYSM;\2*VM"N=3F\4>(HKF6)[2"XC2% 6RF8D;'/&.23[T
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MAL;0><=: +[^"=-="C37.#:6MI]\?<@<NAZ=<DY_I6UJ6G6^K:?-9708PR@
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M#3+"*RM@PBB7"[V+,?4DGDDGG-4M.\-Z?I<MI);"0-:QS11[GS\LKB1\_P#
ME%<[/XZN5T\7\%FKQ6^D&^NT(.5F8[8XACH=RR9X.-M0W7C+6['3M6GDM%E%
MKILEW'.VGW%M&LJ=8V\S[V<Y!!'0\4 =EI>EVVCZ>EE:!A"C.PW-DY9BQY^I
M-57\-:=)I9T\I)Y/VAKI6$A#I*TADW*PY!W,<?E7+^)=6UZWTS6M/N;BS25]
M'GO+>>UC=#'L(#*<N<GYAAACOQ73:KJ<^@>$;K4KC9<SV=JTK;5V+(P7TR<
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MALQ$=/W"V,;LI0,<L#@_,"0"<YR:\\UG6=6O/!WB"PO]0NX+Y=/$YAN;%8I
M V'VLI*,AX'!)'XUO2ZCXB35M<A35D^RZ/91RX-JA>=VB8\G^$;E!X'MTH Z
M_5-)LM:LFL]0@$T!96V[BI!!R"""""",Y%9]SX/T.\N#-/9EF8*)!YT@67:
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MPQ'XUA^!,#1=0_["]_\ ^E,E8NFZWJHTW0M<FU1YSJ=Z89[-D01Q(=Y(7 W
MQ[>22<X.: .I7PCX>229TTBS5YE99&6( L&!##CL03GZU<U'1M-U>!(=0LH+
MJ-#E%E0-M/MZ5P&B>(-6FU;1S)=7S6FHV\[K+=^2@N0$#J\<299 /<YP>:G\
M-:AK"#P7<W>L7-Y_;-LS7,4JIL!\GS%*X4$$8QUYR: .\ATRRMWMVAM8HVMX
MC#"50#RT.,J/0?*O'L*MTR*6.9 \4BNAZ,IR#3Z "BBB@ HHHH **** $7[H
MI:1>%'TI: "BBB@ HHHH ****  \UR>C^$[C2I;%&O(I;>RO+FXCQ&59A-O.
MUN2,@N>1V%=910!QFH^!Q?2FZ:6UEGCU&2]BCN;?S(F5XPA1U)YZ9!'0XK9\
M-Z+)HMM<++]B#SS&7R[*U6".,8 "@#ENG4\\]AQ6U10!Y_J/P[GO[F_D-U8%
M[F[%RMU-9F2X10X<1!RV HVXX X_.KUYX+N;[Q##J,MW9CR;M;E+A;/;=;0<
M^29 P!3MR"<>IYKLJ* .)B\"22:L+N]NK1P/-62:WM!#/=)(C+MF93M8#=GA
M>2 >*DT7P5+I5Y8$SZ<+>QC**8-.1)I_EV@R.<X(']W&3[<5V5% &7X>TN;1
M=!L],FN4N/LD2PI(L93**,+D9/.!R:R-#\(3:.=.C:_CF@T^6Y:(" JS)*2<
M,=QY!)Y &1V%=710!PMQ\/IIKN:47UFI>^6\^TFQW7)VR"01M(7^Z, # ' '
MX[%QX7,VBZAIWVO!N[TW?F&/.S,JR;<9YZ8S[UT5% '(7_@RXU'6DO)[^U>.
M.[2YBD-B!=1!6#>6LP8?)QCE2<$C)H;P/BU*I>0M<+JD^HQM-;"2/][NRC)N
MY&&/.1R :Z^B@#F[#PQ+;S6$]Q=V[36UV]TRV]J(8SNA:((J@D@#=G))/7\-
M37-+76M#O=,:4PBYA:/S N=N1UQWK0HH YEO#FJ17EU?6>K6\%W?0I'>,;,L
MC,@(5T7S!M.#CDL.!6C:Z'#9>&(]#@E;RH[7[,LCC+$;<;C[]ZU:* .13P7-
M=6ZVVLZH+V"*PDL85C@\HA74*SL=S9?"@9&!UXK0T?0KRPU W5U?6LRK%Y2)
M;60@SD@EG.YBS<=L#KQ6]10!D7>ABZU*\NS<%?M-A]CV[,[>6.[.?]KI[5DW
MG@=;S3K*T.HR1BVTF33-\:8+!Q&-_7C_ %?3WZUUM% '$+\/(Y7E-S<VB1R6
M$ECY-C9"W10S(P<#<WS H.N>W3'-N;P?<ZG<7DVL:JMPUQ9"S406WE"/#[PX
MRS9;.#Z<#BNLHH YZST'4K<W<SZM"+F6#RH3!9+''$?[Y7<2S9QWQQTK?0,L
M:AFW,  6QC)]:=10!G#2@/$3:OYQR;06WE;?1RV<_CBLK6O";:KK@U2.\BBD
M-I]D(EM1*47).Z,DC8WS8S@]!Q7344 <A'X$580C:D[-LT]-WE#G[+)O!Z_Q
M=/:I8?!TT5]9/_:\AL;*^DO8+7R1PS[\JS9R0#(V.GXUU5% './X45=/TN*W
MO3%=Z8Q:WN#$&!W JP9<\@@^HZ YK3TC3I=-LS%<7LEY,\C2/*ZA>2>BJ.BC
MH![5H44 <?!X&:-&M9M7EFTU]1;4FMC"H/F&7S0N[^X&P<8R<=1G%.TG2)9_
M'FI:[+9W%K (5@A29EQ))T>4 $XRJQJ">2 :ZZB@#"\0^&TUV?3[@7"Q36,K
M21B2$2QMN7:=R'KP>#GBJ6F^"H["[MKJ349KB6#4)M0RZ*-SR1&,KQP  Q(_
M 5U.12T <3XE\-SOHE_8:>ES-=:GJ"W4=Q'M46<@*8<DG.%V9X!)Z5UME906
M&G06-NNR"&)8D [*!@59HH Y&'P,&U"VNM1U:>^^RQ210EXD60JZE#YD@&Y^
M#[>IR:;!X#0M:1ZCJMQ?VEI92V,=O)&B*8G4*=Q49+;5 S7844 <E/X(>]L7
MM+_7+ZXC^S"VB!"J$4,K;B ,,_R 9/O@#)K;71XU\2/K7G/YC6BVGEX&W <M
MGZ\UI44 <YKWA:36Y)Q_:UQ#;7,/D3VQC25".?F0.#L;DC(]N.*BE\&F)YSI
M6L7FG+<Q1Q7'EJCEMBA ZE@2K[0!GV'&>:ZBB@#GY_"D$]Q.[7MT8KG3UT^>
M)BK>8B[L,6(W;OG;G/-5G\#VMPD_VN_NIYI;>"#SCL5D,+L\<BX& P+>F..E
M=310!S+^#H[I;M]0U.ZO+JYB2#SW5%\N-6W[550 ,D9)Y)_"NE90RE3T(P:,
MBESF@#EK?P4MG!8BUUB^BN+!&AMKC;&66!MO[H@KAE&T8)&>.M:^B:+!H=E)
M!#++,\TSSS33$%Y9&.68X 'X  #%:5% '$Z3X-N'ENWU*]NEMGU>6^6Q#(8W
M(E+1L3C<!PK;<]1]16Q-X4M)M,%GY\Z.E])?PW"$;X9FD9\KD$<;V&"#P>:W
MJ* .?7PG;/8:I;WEY=7DVIILN+F0JK[0N%"A0 NW)(P.I)I8?"5E#;:) )[@
MC293-&S$%I7*,K,_').]B<8Y-;]% '+VO@FWM;NQ?^U-0DM-/=FM+)RGE1!D
M9-O"[F #D#).*GTSPHNF7%L5UC4YK.T!%M9R2*(XAC !*J&< < ,3BNAHSSB
M@#+U?0XM7GT^X-S<6UQ83^?#) 5SDJ5((8$$%6(_K567PI9S:-!IC3W B@O5
MO5<$;MXF\X#IC&[CZ5O4=* ./NOA[9W=M>V3:MJ::?=S/<-:1M&JK(S;RP;9
MO/S<@%B/PK>M='CM-9O-2BN;C==A?-@)4QEE 4..,@X4#KCVK2HH R3X>M#J
MFIZAYDWG:C;);3#(VA4W8*\=?G/KVK//@JWB2%;'5-1L"MK':3-;-&#<1QC"
M[MR'# $_,N#S7344 <Y<^"]-G1(HI;FU@6P;3S# RA6A(( .0>1DD'UZYHN_
M!MG=,0M]J%O#+&D5S#!*%2Y51M&_*DCC@E2I(KHZ* .<N?!MI/=S2QZAJ-M;
MSRB:>SMY@D4KC')XW#.!D*1FM?5--CU73I+.66:%7((D@?8Z$$$$'V(%7**
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M5.^BQ1C5K:26S"W>XEUCWA7&P!00#@@GW%:ND^)O[8N]/BM[;Y)[#[9.S/S
M2=JH1CDY$@[8V&B'PQ;Z=9:(L#W$QT2)EMTRH,O[LIAN,9P?;FH?!NA3:7%J
M%[=0M!<ZA=//]G9P_P!GC))6/()'5F;C@%S0 _Q7=78FT;2[2Y>T.I7ODRW$
M>-Z1K&\C!2>C'8!GMDUEF]M/#NKS16^JZG*RVLS&ROA/(LLB*'#),X(& ""
M2.>G%=1K&CVVM6:P3O+$T<@EAF@?;)$XSAE/8\D>A!(/!K+M?"""[6ZU75M0
MU::.-XHOM1C58U<;6PL:J"2.,G/X4 2R>(9$GT^,6H8W6G37I'F ;2GE_+D\
M<^9U.,8K$@^(32/*C6UC(XT^>] M+WS@AB"DQN0@&?F'()Z&M"V\"VT:A+S5
M=1OD6REL(UG= $@DV@J-J@D_(/F.33%\!0MY?VK6M3N?+M);*,2&)0D,BA2
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MO?LA54E,A ?8T@(3;@-GC/09SVK>L?"UE97,%UY]U/=12O,T\S@M*[H$);
M^Z    !BHCX1L?MYG2[OXX#<?:391S[83+G=NQC/7DKG:3G(H RKOQK<VNJ>
M1LL9(A?QVC112/)*H:01AV95V*>0=I/MG/%4+;Q3J6EG4Q>/'/)/KDMI:Y61
MA$JIN.0H)("KP .2>W4;[^!]/D=@;S4!;&Z%XEJL^(XYO,\S<,#)RW.&)'/
M%3R>$-.>2ZD66ZB>>Y%VK1RX,,V,%TXX)!P1R".U $GAK6Y]:MKIKFV,,EO.
M8@P1U25=H(=0X!QSC'8@\FL_Q-XHN='O)+>V^QEH[;[1LD,DDDG+?*$C!*CY
M?OGCVXK=TK2HM)MGBCFN)WD<R237$A=W; &2>@X X  ]JH:EX8L-1OYKN6YN
MX&N(E@N$@G*+.@SA6[_Q-T(/- &+<>-+N*XM7:"VM;.>WMYD>[\Q5D\SE@)
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MBY)(E((+DDY9B&.2<]: .:N-9UY+/Q!=QW]LHT(;"CVX'VETA65V;GY V[
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M1MIPB4(J22!-JMC=O7.22<?*>!5:'5?$<T-I=KK047.MSZ<(FMD*I$))5#=
M=XV#'./4&NNBT/0+;6EFCL[./46W3K@ /Z,X'K\V"1ZU<72-/6..-;6$)'.;
ME%"C"RDDEQ[Y9CGW- &?X:NKV235[*^NC=/87OD),R*K,ABCD&0H R-Y' [5
MFWM_J6H>+-4TV'53I=MIMG#.K)$C&5I-^6;<#\B[,8&#UYKJH;:"WDFDBB1'
MG?S)648+M@+D^IPH'X54U'0=)U>2.34-/MKIXQA6EC#$#T^GMTH X@^(M:+>
M(-4AU5+FTTC3XKJ*""!1'=,UN7Y)RP7(##!SSUIJ^)/$6E@7$HN+J*73Y[G;
M=M;*2Z(&4PB)BQ0YP00<9'->@Q6%I!+/+%;Q)).%$K*H!<*,#/K@<54L?#NB
MZ;.\]CI=G;RNNUGBA525],^GMTH Y)HKV+Q-X5>ZULZ@9XKF7#QQKSY/5-H'
MR\]#GJ.:Y[2[_4++3HM?BO'\^/PM;3" 1QK#N.\9*A<A5)W8!'3TXKTVT\,Z
M'87"W%II-E!,N=LD<"J5R,$ @<#':I%T+24^S;=.M!]EB,,'[I?W<9&"@]%Q
MVZ4 <1XBU?6O#MKJ-O#K4M^S:)<7R7$D<8:WECVA6&U0"K;N 0?N]:L:B/$=
MG<:=;1:U>7QEBDN)X[8VT=S_  !=BR*%,:DMGG/S#DUTD>D>&[%+NP2RTV!)
MH=UQ"(T4/%R,L/[O7KQUJ:]LM"UJ=+.]M["\EAC$J12HKLB-P& /0'!&>^*
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MI-U//#+*KAB$7#\#Y<Y/'3T[U'IT-WI]AX<LSJM]<1:MHDJRQO(-J,D*,IC
M VXR1QZ^M=5HGANTBO1J!U 7[P++;KMBC15)($FX(!N?Y "3Z'@<ULVTFGW%
MQ)# L+2V#>20$QY)*@[1QQ\I7I0!Y9IDEY!X2\,166J3/$-)662WCU$6\JL0
M/F4L"KA<$;"1COUKU#0;U=0\.Z=>H\LBSVT<@>90KME0<L!P#].*?)HVES1I
M')IUFZ(Q=5:!2%8]2!CK[T?VI8122P&XB0V\B0NI.T*[XV+]3D8QZT >>VNJ
MWO\ 8^FZPNM74VM7.HI#-IQDR@#2[9(1'_#L7<=W7Y<DXKH/ FG1V9UN1+B[
MDSJ=PA6:=G'#=<'N<\GO73K86:W9NUM8!<D8,PC&\_\  NM3)''%NV(J;F+'
M:,9)ZGZT ><^*=3U9O%M_8K<+:VEO8I- S:D;/));?)D(V_:0HVG@=P<U1O]
M<U(V&ESKJ\N;K3HFUF6VW%+6$D8N4S@HQ^8=,XRV/DY]/N;*TO-GVJVAGV'<
MOFQAMI]1GI45S-86<L23K&CWL@@7Y,^8VUB%.!_=5NOI0!PVL7ER)]4BAU7R
M474K9(EFO'@65/LRL8Q,H)3)^;/<C'>J"7-OJ)\-27=_?1"UUF>W>5[_ '#<
M878*)5P''W5!//4'O7ISV=K)$T3VT+1OC<A0$'' R/P%*;2V,"P&WA,*_=CV
M#:/PH \^TX7FM:K964FK7\$+2ZNT@MYRC.([Q50$]0 #@8P<<5#9W[2G2;76
MM<N[:R1;Y%G^U&$W$D5P8U#R @Y5 #C/)SUQ7<'5=)@O9[<,BW%O+'%(%B.5
M:8@J,@?Q'!)_.F:EH0OI(9+?4;JQ:/=E;<1E'W')+(ZLN<\@XSR: *'@"ZDO
M/"$,TEY->$SSJMQ.<NZB5PI/X 5S%QJ4QLK^]?6;F+Q#'JC0P6(N&"D"7;'%
MY.<%63!+8S\Q.>*]!TK3+?1]-BL;<NT<>3ND.6=B269CZDDD_6K!M[<SB<PQ
M&8# D*C<!]>M ',>%;.6?4M6U*?4+Z5EU"X@C@>X8PH@;@!.F>.OO5;Q18PW
M/C[PH[O<!C]I&([AT'RQ[API Z]?4<'BNLDNK6UN(;=GCCEN6;RTZ%R!EL?A
MS1:7-MJ%O'=PC<AW!&="K#!(/!&1TH \ULO$@;0/"VGOJSMJ_P#:R0W<0G)E
M&)'#+)@YQT'/'2F:3<6NB75JPOWM[6+Q)>QWOFW;%55DG\O?N8X!.P\]3@]:
M]1$$"NSB*,.Q!+;1DFE:"&16#Q(P;[P*@Y^M 'F5O>2Z].8HM4O1:7'B>:$2
M03LA:$6A;:K#HI(R,?451UO4+ZTU/7;=]6AM);1DCL?M6J3I(B>4I1EB5")B
MS;LYR2<BO4-4U'3]$L6O;^2."!& W%<DL>   ,DGH .:IZ5XATC7;N2&!9%N
MX%#F*ZM7AD53P& =02/<4 :$LET-)>2)%:[\@LJC."^W@<]LUYO8W^GMX?A:
M#6]2GUM]+GDO(A<N^)/*.XRJ21&5?A<8.>.E>I9%((XP6(106ZG'6@#RW4Q<
MZ4VAPRW^W3)[-IYI]1OYD26Y(3AG!R/EW$+P.OI3M-OXVM-$_P"$AUJ0Z8T-
MT8KG[1+"LSB10@9SM9B$SM)^]R>:]"N]4L;::6UE.^:.V:Z,*1EV,:G!( '/
M/ '4U<0QS1(P4;6 8!EQC\* /(+-&NO" M8I;J>&71=:91(S!Y6%PFQF'=N3
M^9]:T;.[T/S;9=3U*6#1O[*A^PD7<B1O+N<3'<#DR*0HP3D=J]1PH["C:N.0
M,=: /,M M;W5-8T<ZS+?-)#HHG"^:Z%W$YV.Z@C<^T#(/<GBE\#7:#7X+6"Y
M6_'V-_.N8I)E=6#)_P ?$3Y D/."&S][C%>F''7C-9FAZW;:_9M>6<-PMN7*
MI)-$4\T#^)<]5]_:@#-\3%1K_A83C]P=0<>WF>1)L_K^.*X;4-0+:\\D>(;V
M/6HU9#YTMR(A.JDDC"QQ%>0,,,$=Z]3U+3;;5+98+D'"2)*C*<,CJP96![$$
M5;&,=: /.=/T[RI++4U%P;Q_$5U&SM(QVQ&68;<9P%P ?3O7H])D>U+0 444
M4 %%%% !1110 U/N >U.ID?^K'3\*?0 4444 %%%% !1110 A&17&-%<^!="
MU/5K_57O_+M42.-TVYD4O@#DY+%U'X?EVE9VJZ/::PUD+LN1:7*74:*V 73.
MW=Z@$YQZ@4 <3X'UI+35[C1&U<:FT]LMY%)N))F  G3YN@+88#L&/85I:%XP
MU"_U**UOH;*WFF61C9-YD5Q$5&0H#C$O?)7 '7D5T>J:'9ZM/8SW <2V4WG0
MNC;2"5*D'U!!((JA:^#]/MKBVE:>\N5M PMHKB<ND(92IVCO\I(Y)P* ,;2?
M&]VZROJRV<+I:273V@22&XBV#)3:X_><9RRX''3FC2/&.JW][8Q2VL9COU.T
MQ6=PHM6V%EWNZA74XQD;>2/7-;-GX.TRTN89GDN[K[/$\-NEU.9%A1@ RJ#Z
M@ 9.3BGV'A.PT^[MITN+V9;0$6L,URSQP KM^4?0D#.<"@"A\-KG4;WP-97.
MIW*W$\K2$2 ')7>W7).3G/X8KC8(+6[UCQ*9]#U[4+P:K-'#<64[(D8VKA=W
MF*%P23T[UZ5H^F:?X?M3IUG,4AWETADEW>7N.<+GD#/./>IM-TFUTMKQK8,#
M>7+74VYLYD8 $CT&%'% '+V6K>(K">WTNZ:SE_L_2[>ZU"XDW%W)\P.$Q@$G
MR\@G\N>);?Q!KW_$GEO(]/6#604@6)7+V\AB:1=Q)PXPI!QMYKIAIEJ-3N-0
M*$SSP);R9.5**6(&/^!M6?8^%--L+NVGB:Y<6@*VL4L[/';@C!V*3QQQ[#@4
M <5HGBO6+;PSX>LO.$U[<V)NY+DV,UR0@8* 40Y+$MRQ(''3FMNS\3ZYK#Z;
M8VMK!87\UO-<7+7D,FU%CD$8V(2K'<3D9(P/6M1/!>E06EM!;->6_P!E#K!)
M#=.KQHV,H&SG;P.#P,"GGP?I"VUI#"MQ;-:!Q%-!<.DH#G+Y?.6W'DYSSS0!
MS.HWNN-JE\]W-9&&+0)9+BVC#LCL#(#M8,,9*CMD#CKS5Q=?UHZ=>2Z7'IZ6
MVDVD3213JY:9O)61E5MWR *P )#<YK83PCHKV\(MUD2);9[4>3.P$D3YW!L'
MYN23DY.3FG77@_2;M61Q<)')"D$R17#HLZ*, . ?FXX]QQTH P;OQ;KCVVL:
ME81V"Z?IL$5R4GC<RRJT*R%>& 4X)YP?I7;75K!J%E+:W,?F03(4D0DC<I&"
M.*S[K0=+:RU2*9 EO?Q[+KYRHVA G']T;1VJTNJZ=\JK?VI)P /.7G]: .%T
MGP?H \?:W:C3D\FTMK.6!-[81V,N2.>^U?RJY;^)?$#:<VJ3'3UM#J0L8XUB
M??C[7Y)8MNQ]W/&.N#[5UT.EVMOJEUJ4:$75TD<<K[B=RINV\=!]XU4E\,Z7
M/HDND20L;.65IF42,&#F0R;@P.0=YR,'B@#'UGQ)K%MJ6MV>FVT-Q)9VEM+"
MA4EBTCNKG&1NP%R%&">F>:Q=0UW5]3\,WT2:G;1WEO=6N?\ 09;>58WD48>)
MVRN3GD,00".*ZD>#-$6.[6:*:9KL1K/+/<R-(Y1MR'<6R"">"".U2+X1TD6U
MY#(EQ/\ ;%19Y)[F1Y&"'*C>6R,$DC!'- $<'A*S^U37EX3//<Q21W  VQOY
MBQJ^%R< ^4,#)ZFCP7>2W7AF-)G,DMI--9-(>=_E2-&#GOD*#FM:6*>WTMH;
M$AYXX2L)N'8@L!\NYN2><9/)JOH&E+HNB6U@'\QXP3+)C_62,2SM^+$G\: .
M-A\>ZB+G2K:>*WS%.\&L/M(\H^:((RO/&YSNY_A!K/OM9U+4UN+]5M[:YGT"
M^N;:<1MO2$2KY8^\!DI@Y]2#TXKM;[PKX?D75FNK6-1K!C2\)D*^:1PF.>#D
M]L9-6V\.Z6\B.UL#LLVL NXX\AL93&?]D<]: .0TZ#7FU^TCM-0L4N1H<!FN
M)K9G##S&V@(''XDD]/>K=AXEUO6O[)LK5[&UO)[>:>[F>%I$'ER"+$:[@>6Y
MY/ KIM/T&QTR5);9)?,2 6X:29Y#Y88L%RQ/0D_RJ!O"FDM!;1+#+$;8R&"2
M&>2.1-[;G =2#@GJ,XH Q=(\6:A>7]C97*6ZRC4;JPNFC4[9#%&6#)D\9XR.
M<<BLS4-5U?5M0LDBO(;=;;Q.]FNV(L&18&8;OF&>_P"./2NGD\,:'Y%KIJQF
M%H)&NH/*N728.<AGWAMY)WD$DG.[FGQ>$-%ALA:1VKI$+K[8"L\@838QOW;M
MV2.O/.3GK0!1^([W,?@347M+@P2 )EPN3M+J".HZ@U@S7&O:7?>,=0LKRR_T
M%8IY1+;$FX=;9"PX<;!@#'7D^U=_>V=GJ^G2VETBSVLZ[77=PP^H_F*J)X>T
MU+6]MO)9HKZ,1W.^5V,JA G+$YSM &>OXT <?JOC36WO]432;24KIZ1[4%F9
M5E=HUD(=]PV## # ]3[5W'VR1]$-ZL?ER&W\T(W.T[<X/TJA?>$=$U%RUS:,
M=\:Q2*D\B+*B\!756 <#/\6:U)[<-826T05 8S&H P%XP* .*TS7_$":9H&H
M:A>65PNKP,3%! 5\IO(:56!W'(PA!]SQBJ$.K:Q]G\):UK3V5V]VKW21PVI1
MH1]CED(4ECDG &<#N.];OA7PWX?L[*WMK:6"ZO-/MQ:S>5=-(D3E0'VH6(C+
M8/0 \UO)H>GQQZ;&MN NF#;:#<3Y0V&/UY^4D<YH YFSUS7(O^$?O+R[M+BW
MUGAK>*':8"T32*4;/S !<'/UXZ5J>#+G6=0\.V>IZQ>6\[WMO%.D<$'EB+<N
M2"=QW=1Z5:L_"VCV%TES;VFV2,,L0,KLL0;J$4DJF?\ 9 K0MK>UTK38K>$+
M#:6L01 6X1%&!R?0#O0!PVM^*]<TTZA90>1+?VMZTRJ8_OV2Q>:>/[W!CSZU
M)>>)=8O98GT>[MDMKW5UL+662'S%\M86+OP1D[U8#G^&NFMK+0]7OAX@M!;7
M4TENUH+N*3>&BW9*Y!P><T^U\.:196-A9VUDD=OI\GFVJ*3B-\,,CGG[S=?6
M@#S_ %LW^S7K8WD274&I:2DMS#;A3,6,0)(SZGIZ#%2S:GJ_A_5?&5\MV;V:
M)K*")'A 7?(%4-@$<#<3C(SZUWEQX?TN[%\)[17^W,C7&6/SE,;#UX(P,8QT
MIK>&=(D>=Y+))#<0"WFWLS"6,# # G#$ =3S[T <5>^+?$.GV.N!X9U^S:8U
MW;SWEO'&XD5L%2BL<J<@@X&,$<UN6.I:U9^,+#2M1OK>\BOK&6Y_=V_E>4Z,
M@P.3E2'[\\5H#PIX>MH;F![1"+Y!!,9YG=Y5[)N9BV/8&M1M-LVU""_:!3=0
M1-#%)DY5&()'X[1^5 &3XAO[]-6T?2K"X2U:^>5I+AHPY5(UR54'C<<CKV!X
MK.AO]:O-5AT==9LU>*&:6:ZMX0QDVR;%4*<A2/X^O/ Q71:MI^G:C%##J*(P
M$F827*,'P?NL""#C/0],U0B\/^'M0TZVCM[>%[:W:187@E8%3N(D&]3GE@=W
M/)'- '-:9X@U[7=2TJQ2^BLS);7AN98X _F-#,D8=-V< Y)YS_6HE\1^(KO2
M]-N5ED8FWG^T#3X8I)3(DI02&-SGR_E).WG)Q7<VVB:=9RVTEM:1Q/:P&WA*
M#&R,D$J/Q4?E56?PGH5U!#!-IT+1P;_+'(VASEAD'.">2.AH Y"X\7:OJ%PR
MZ6]Q)%%I<%VLUK!#MD>0.=SB5P5C^7H.>O-+%K_B'5I-4DAOX[ 6FCVU\(DB
MCF4RNDC$;^<IE.WX$5UFJ^'/#US!&^HV%J(;>/RE+?(JQ_W#C'R^QXJZFC:=
M&]PZ6D*&XA6"7:N T:@A5QZ ,?SH Y;PW)<:AXTNM2>[E43Z/8S&WVIL^?S3
MC.,\')Z]S[8O:IJ.HW/C:TT"UO/L$!L7O))DC5I)"'"!%W@@8SD\'J.E;<6B
M:;!=V]U%9PI<6\(MXI OS+&.BY]!D\>]0:AIVC:[<_9;V&"XN+0"3:3\\0?(
M!R.0#M/UQ0!Q)-[K^J:%%?WXD>TU:ZM6DAAC,<QCAD(?#*<''RG' .<8KI_&
MH_XE6GY[:K9?^CTK7M]&TZTCM(K>SABCLR3;JBX$9(()'U#'\S3M3TJQUFQ:
MRU&UBN;9B&:*094D'(_(T 9'C'6;O2M,M3IZ2/-=7<5MNB",R!CR1O(7)Q@9
M.,D=>E<[)KOB.*PU&$RRP31W=C';RW:P&95FF5'#K$2O3)!P.OMFNIM?!_AZ
MRM;FUMM(M(X+H*)HQ'P^WD9'MFIK3PSHMC:-:VNFV\4+3+.RA?O2*058GJ2"
M >?2@#EKK6M9L=0O=&.IF5Q=V<27LL,8:))MV[@ *3\A )'5AG-9UQJ6I:!?
M:ZEO=->75SJ]I;?: D8=%:%>H.U-^!@9P,D<=J]!N=$TR\%W]ILH)A=JJW&]
M ?,"_=S],\57@\,:);6%Q8PZ7:K:W)S/%Y8(D/JWJ?<T <;+K?B0[K 7CVTO
M]JVUNDTXMY)UBD4EED2,E0>,@X&01[UZ#: QP)!)<FXGC51)(P4,QQ]X@8 S
M["J=IX=T>QMXX+;3[>*..83J%3I(.CY]?>KD=E;07<]W'!&MQ.%$LBK\SA<A
M<GOC)H DG_X]Y/\ =/\ *N3\/:E_9_PJTZY@"S7%OHZ2)"#R[+%D#'X5U-M=
M6]_:K/;R++!)G#+R#S@UE67@[PUIMY'=V.A:=;7,>=DL5NJLN1@X('H30!R-
MIKOB*.RCN);F21)]+N+@R2O:X+J@99(5C.XKGC!SU&?=][KVO:!IWVB34&U"
M6;0IKX++"@6.:/R^0$4';^\Z$G[O6NQMO#&A6<ES);:390O=(T<QCA53(IZ@
MX['TJQ/;:; UO)-%;HRI]EA+@#Y6Q\@^NT<>U 'F^M7^H:!XDDOTU)M3N8?#
MDTT9E2,;6,L8W?(%&SO@^AYJ?4-9\1V%IJ2K>R(1:12Q-<R6\DJ2&95W!8QC
M8P)ZCJ.#766MCX3T:8O:6FFV\LDOV)C#&N2[X/EG [X7@^U7;7PSH5E;SP6N
MD6,,,Y#2HD"@.0<C(QS@]* +%O;S6&DM%+>S7<J*Q\^8*&/4_P ( XZ=.U<#
MH,^OW]MX4:7Q)>$ZO8O/<_N8?E*JC#9\G!^;!)SFO2R RE2 0>"*K0Z;8VZV
MRPVD$8M4,< 5 /*4@ A?08 Z>E '!Q:YJDUK863:A?2W?FWZ,;9($:5(9S&K
MN[_*H QG:,DGVJ*S\6W^GZ)H_B'4KWS]/EANK>YP%P949C$X*@#)$;)QP2RX
M'-=AJVE>'3:PC5--L9(!<?NQ+;AP)97QP,'EF;D^_-9FJV&CWOV6T6]M(-*@
MOU2YL8H%(EN2RNBDC[IW$$C'.>: -S0([Z/0+(:G,9;YH@T[$ 8<\D#'8$X_
M"O/G\5ZKITMFEUJ&Y-$G>/6F95S*CR&.)CZ?+A^U>ICI5.32M.F%T);&V<7>
M/M&Z)3YV!@;N/FP/6@#R_7)]2O/!NKK?7,WFS>&WO73"@J6D=@AXZ!2%^@_&
MM/3M.FNO&WD0:O>0HOA^U+2Q&,NY\V7&25(P.>@%=_/:V(66:>"#'DF.1W08
M\L9)4Y_AZ\=*@TNTTE+:&[TNUM$AEA7RI+>-5#1'+* 0/N_,3^- ' :#+?>)
M=8T2\FU*XMIY?#V^:2W5 SMYH&>5('.3@5:T#6=1UR/18-0U:6U672S</-%L
MC:XE$FT\D?P@ D#'WQ7::2ND7%I#>Z7!;B$(T,3QQ!,(&(*C@8&X'BGSZ'I-
MU9QV=QIEG+:Q',<,D"LB'V!&!0!YE<:UJ3G1=4$GVR]MK76/LTP0?Z2(\"-\
M#@[@JGC@]JT[38_C7P=/_;<FHRS65S*X=E;ED3+J% V@GMTXX[UZ"+&T5X'6
MUA#6ZE82(QF,$8(7T& .GI6<MKH&DZI:QQ6-G;7MV\AA,5N%9V"Y<Y XX]>M
M &7XX@CDD\/O+=RVR+J: NDNS&8Y.<^O'ZFN9DEOM)T'5=:M-3N4>'7F5;<;
M?**-<JC C;DY#'G/TZ5Z;=6EM?0&&[MXKB(]4E0,I_ U3N/[*BG@TR:WAS=N
MTB1&'*NRX9F/&,YP>>] ' ^(/$5W!)JE]::C<QI:7JPJTMS'%&I!0,BQ $R
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M:O2%AA2+RTC18^FT* /RI5CC55544*O0 =* /,O"6I7L^JZ*9-2MGN[A'-_
M-0EGD8A"6W1%-L)5\#J!U7FNF\;W+00:2DEW)9Z?-?I'>SQN4VQ['(!<<J"P
M4$Y'7K73K%&KLZHH9NK <FH+F\M8;FVM)W'FW;,D2$9WE5+'] : /-+*>WCU
M?7FTS4);FW.KZ6B2^>9,@L@90^267EAU/I4FD:B]OXHAC2\-_<W%Q<JQ@U"0
MNN Y GMG!$8& H*D<X]:].6*-0%5% '0 4HC0,6"*&/4@<F@#RR._LE\+B>'
M6=0EUZ;2IY+R)+EGV2"$EO,3)\K:XP,!><"IM5MYM*DT:U>^9=-N;>2>YFU#
M4YH5DN,1@ R#)7C<P4$ \^E>F>5'ECL7+?>..M.**R[2H(]"* /++403W'A"
M[U2],\2W=W%#<_:)0I&3Y8WG:7Y  )'S#US4FGW-O,NE1^(M0FMM,-M.T;O<
MM"DDXG8$.X(.0F-H)]?2O3]HQC QZ4%5(P5&/3% 'F=A!<:Q?>';2^N=0:RD
MBU$@^>\;3PK,GDER""?DP<YR?Q-;_@O5D72TT^[N6,_VZ\M[592S.\<4K <G
M).%QR376X'H*,#T% '+^,'%I=:!JDRNUC97Y>YVJ6V!HG19"!V5F&?0'/:LK
MQ'XCTS6-(UQ=&Q=S0:/=,=1MQE83MX0./XB>< _PUWU(%4# 4 ?2@#S#7M/&
MD:AI]HUR(M)EMY)GEU"\GV/<$J#N<-D';RHR!G.!FJTMTTMKHUGJ4GF,+)Y$
MN;^6:*%P9"% 0#=)*% ZD'!SU->L8'I1@>E 'C-I%YMC::A>"=K]_"EQ%'-)
MO#&9-P*\_P 6W/!YXK3U<0$:VVI372ZDMK#_ &*J,X;/D@@Q <,_F[L_09XK
MU3 ]*,#TH \JO].N)8O%&IW@G_M2T-H\#1R.%2001%BB@X/S9[=J[_Q+_:)\
M*ZG_ &1G^T?LDGV;'7S-IVXSWS6M@>E% 'FVE6NC3:CH<.B1W+F2.2/5E?S,
M&(Q-D3;OX_,V=>>O;-;_ ,/-.BTSP+ID<=K]G=XA)*FW:2YX)(]< 5U6!Z44
M >-V/VB?Q'H=_%9FVG?56^U1K;S-<1HP?(GF8[<$[<+C'3' K2T?0(K'2_"V
MHQ6,T>H/J;+<R;6W>6WG AL]$^[QTZ5ZE@>E(0#0!P'AFTG?Q2^E2HXMO#9E
M6!CT<3X,6/\ <CW+^(KT"J.F:1::2DZVJ.#/*997DD:1W8@#)9B2>  /0 5>
MH **** "BBB@ HHHH ;'_JU^E.ID7^K%/H **** "BBB@ HHHH *\GO]=3_A
M)[GQ/']N9+*[2U0I9S-";-,K.V\+L^^S-U_Y9"O5V&Y2O//'%4+/1;"QT5=(
M@MU%BL1B$1);*G.02>3G)_.@#F=;\2ZMINK73/Y5MID(C:*<V<D\<BD N9'1
MLQ8Y RN._--OO$VJV&L7#79CM=,CN(TBE-F\L4D1"Y9I48[&R6 RH P,]:U#
MX%T)O+!MY@BQ)"Z"ZE"S*@PHD4-A\#CYL\5/<>#]%N;]KR6T)9W5Y(A,ZQ2,
MN,,T8.UB,#DCL* .9F\8:Z\E[=65B\T%M?-;+;BU)5T238Q,NX8;AB!C'0>]
M;7A9;T:[XG^U7@GC&H!47R]NW]Q$?4\8(&/4$]ZNW/A'1+N^:[GL]S-()9(_
M,<12.,89H\[6;@<D=A5VUT^QAU.\OK9<7$Y5;@K(2"R@ $KG ;&!G&< 4 >>
MW=FMW\1/$N[PC#KS(EIM:5H5\G,9_P">ASS[>E:>EQ^(=(DT'P^ES;0M+#=W
M$QD0S^4BRH4C4Y7.U9-F?:NP@L;&UU6ZNHU5;V]5#*=W+B,8!Q[;L<>M2R6%
MM+J,-^\0-S#&\<;Y/RJQ4L/QVC\J .-'B/64TJSU]YK9[2YOUM_L*PD,L;S>
M4"'W9+C@GC'!&!UK*TO5]7TRP^S17$EU<7^N7L(=;<.T2H\C':I8 D[1C)P!
MZXKM!X<T.'5TNQ;(MT7:9(_,;;O_ (G$>=N[GE@,\U))X7T>5+A&LE"W$WVA
M]K,,2_WUP?E;D\C'6@#FH?$.O7!M-,DV6=U<:A);BZFA&3$L7F9\L,0'/W<$
M]B<=J'.HW'C;0$EUF&8P_;4D^S1C:VTQ?*X).&P<''3MC-;\GA[P];Z;_9TM
MM"D 8W)WR$/N'67>3NW#(RV<\]:E.@Z':6UHS6L,4=DYEAD+$%&)Y;=G))/7
M)Y[T <QX<U#5-3M-/TZRN;;3TCTU+IV2V4[F>1U"JN0 HV'/'.X=*;I?B'7O
M$-U8PP7=O8B33&N9F%OYF9%E*93)^Z<9YSQCZUU4OA?19[:VA:Q14MT*1;&9
M&13U7*D'!],XJW;Z1I]I+'+;VD43QVXMD*#&V('(4>V: *>A70\1>$-/NK^"
M&07UG&\\13*-N4%A@YXYZ&N1\/\ AW0C\2O%<']BZ=Y=LEB\"_94Q$2C$E1C
M@Y /'I7H%G9P:?90V=K$(K>%!'&B]%4# %,ATVSM]0NK^&W1+JZ"">4=9 @P
MN?H": .%@UKQ VD-JTNHQF-M:%A' MLHVQB^$));N=H([>O7FKFKZYK(U/Q#
M9:;-&7M5L1 O[L,ID9O,V[B SE0-H8XSBNH?0],?3)=-:SB-G,[.\)'!9F+L
M?KN)/UJM'X4T**UN+9=,M_*N0@F!&?,VDE2Q/)().#UH XO5KN^U32[6V?5;
MN*YMM<M(W$EFD4J!F4KO'*M@G<"O!Z=C7I:] "<GUK*7PQHJZ?)8_P!G0FWD
MD$KJP+%G&,,2>21@<YSQ5FQTR*PNKZ>(G-Y*LKCT(14X_!10!QWB'Q'J=IJ-
M]+8WDS06-S!"\<=JGDKN*;A)(YR3A^-G3C-%QJ^O12:GJ"ZBGV:RUB.S2T-N
MN'C9HE.YNN1YA(QCISFNFO?#&@7EU)<WFFVTLTQ&\N.'8# )'0M@#!Z\5<;2
M-/>&:%K2,QS3">12.&D!4AC[Y5?RH X'4;O4=7L4U&XOU2WC\0PVJV(C7"K'
M=J@.[[V\D;NN,'IWKIO&.K7VFP:;;Z<K^??W@MR\80NB[&<[0Y"[CLP,\<]#
MTJY>>'] %R^IW=A:+(CB=YI  %9<$.>V1@?-UXJW)#IFOZ:F];>^LI<.C9#H
MV.0P(_0B@#C6UW618I9375U#?'4&MX_+@@ENIHQ%OQA6,2.,\EN,#IR*@TWQ
M!KNH26VD27LEK-)J5S;/=O%$9A'%&'"X7,>\YP< C"GC-=8?#_AUXDTK[#:$
M0G[0L/\ $I.07]<GD9[\U(WAS0H=/EM?[-M8[1G\YT"!5#@ ;_8X YH Y )J
M.H>-;"WCU^,W,-C?127EO A;"S0X4J05#C@-QCK@#MT^CWMSK/@:UO)I?+NK
MFR#/+$H&'*\L <CKS5G1[;098+>\T=+-X8D>"&:V(*A2P+*"./O*,^XK0MK2
MWL[6.UMHDB@C7:D:C 4>@H \T\(#5Y-(\(Z;:ZU/;P2Z0]W*WDQ,QVM"%097
M@?.1ZX[YYJ:'Q+JIU71+J.^NY[#4=0-L7EAABMW0A\>6O,N1M').#^(KL[.T
MT#3+LV]G#96UQ;Q%C%$%5HXY&'.!T#,@^I6G1>%]!AN!<1:19),LGFJXA7*M
MG.1Z'//% '*V-]KBP:9JLVLRRQW&J/:/:-#&(_+,LB#D+NW  <YQQTJ/2]4U
MEM5A_M'4[L07UU-;P2P"WFMGX<H(ROSHP"_Q!AD$'K7=#3;)88X1:PB.*3SD
M38,*^2VX>^23GWJM!X=T:VU%M0@TNSCO&)8SK"H?)ZG/J>YH \N\,3:KI_AO
M0+'39;R1]2>\GG>'[.LO[N3 56D 7G<6)(+<'''3>M;[Q)JDFD:=)JDEA*\]
MY'--$()9)$BV[<XW(K@G!QZ'@=NO;2- NX#H[6-E)%;8D^RF-2(MQ;#8[9.[
MGZU;MM*T^S6W6VLK>%;966 1QA1&&^\%QTSWH R?%E_>:?I5E%:W!@EN[V"T
M>[*J3"KM@M@C&3T&1C+"N4\4/?Q:5XIT*76+J[ABTC[8L[+&)(R=X,;$* 0P
M7(X!QGGI7HM[#:W%G+%?112VS*?,2904(]P>,5G6=CX>C2XTBSM;!5FB$L]M
M&BX>-LJ&8#J#@C)]* (SY?ASP;*YNV$=I:O)]HDB4E< G)5 H./0 9Q7'0ZS
MK]IJ%W:2ZA<Q>9HL]U$^JFW&R5"@63$7W%^8\-GI[&O0Y)["2X.DRO TKP%S
M;-@EHL[2=O=<G%5K7PWHEB&%KI%E"&1HVV0*,JV-RGCD' X]J .)75-<@T[4
M[&34+RWU3RH)(8]0:VR TFP^7*@VDMT 9>#CM4,FOZU!9G34FU(ZBVI1V\HG
M^SK-#&T3.%60?NVW%."1D;L8SBNTLM*\,P27VD65AIJ,45KNUCA095L[=ZXY
M!P<9JU%X>T6#3WT^+2;)+.0[G@6!0C'U(Q@F@#SUVU;4QIMOJ5_<PO::^L4<
MB30O*%,#-MD* KN!)'0<$=ZT=*U75D\1P/?ZA<RVEU?3V\,D$D$EK)C?M3:
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M1#*6:2,(-KEN6)'?/?UH \IUB;5I]$U^POKF1+>$6DJI]M2::)C, 0651\I
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MJ 3MW') %,TZR@CE\.3ZA!+)%9ZO?VZ2S*SF) \HA!/) R% )]J]3P*,#TH
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M3Q;P*I40Q@%0A 4<J.@^G)XILEE:2F,R6T+F,80L@.WZ>E '*^*8?M'PAU)
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M>WRT :M%4UU;36L#?+?VILQUN!,OE^GWLXIIUK2UL/MYU&T%GG'V@SKY>?\
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M=1<!R$F=BK!C][ ;GO7?444 %%%% !1110 4444 ,BQY:X)/'>GTR(YC!I]
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MG:-;R330DLKB2"38ZE3D$'Z]CD'O4.EZ-;:3-<W N)[BZNBOG7%PX+OM&%'
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MI_-VZG9MY2[Y,3J=B^IYX'O5/4/$UA9P6$\4B7<-Y>)9K)!(K*K-GDG.,#%
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M$Q802%!EPIVCU-><V#VT'A3P<+N\DM-)DM3)>3+.T(,YC#8D=2" 6,A/(RP
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M4;9 A=0-SA693C!X[<56U/2WN)]/NK'2Y].T*.YN7>%K W&9&5-DQM^JJ<2
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MK.C-(\/AFWMO]*AW%909 Z\_Q=/?GWKT5;RU:Z-JMQ";A1N,0<;P/7'6I^*
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MFVGOE2+'1C'$B.P_X$I7_@-<Q=Z7K]SJOEMI]X(X]:CN\1_9X[;REF#;P?\
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M+C4/#M]!9/=1V.H&6=8P"P0PR)D GD;F7BL+_A&KE/#)"Z8!J!\1?;,A1O\
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M<(K*Q5EW$;<Y'3/3GI4>K>)=-TBX-K<22FX\DSE(H))=B9QO?8#M7(ZG'0T
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MT56N;FUDBC5C@%BI R?2L:33)]2U"2^UVTATVPBTN6QD1IU8/YC*6.1P$ 3
MS@\]!6C+XUT6WNY;:26XW0W(M99!:RM''(< !G"[5SN'4]Q27_BW1;>:XM+I
M;B2.-Q!,ZVDDD(=L (7"[<\CC/>@"C\/K6Z;2IM5OIQ//=%8HI0<[H(1LC;_
M (%\TG_;2K/B[2;G49+":WLY9S;L_P"\M;LV]Q'N &4;(!![@^WI5_Q-K'_"
M-^%M0U2.V,OV.W:1(D4X) X''0>I["L2/QY##>RB^M[I8!I\%X%BLIGD3<9
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M[;=UR,C)R5(=2?8>M6;?QG8S6<]Y+9ZA:V\5HUZ)9X,*\0&25()YQ_"<'VH
MPKGPEJJZ?8Q1V-E<R0-<_,+Z6UEB\R4NI65 3C!&5QU'>K \&ZE=.5U&^27S
M?#_]F3SAB7:4MDMR.1[YR?2ME/%EHMC=W=W97]E';1+,1/#RZMD+LVDAB2,;
M<YR1QS6?K7C5K/0]8EM]-NH=3LK/[4EM=*@)0Y ?A\%01R <CTZ4 9L'@[5)
MHKE;FRTVV<:?-;0RQ7D\Q>1UV[L. (TQG(^8]/2NZLH3;6-O V-T<:H=O3(&
M.*2">2;3TG>)X9&CW&.3&Y3CH<$C\C7F>D^,]2F\.Z;J1\2V%YJ5RT0;21%'
MO;<X#*H4[@0ISG';F@#IM>\.ZO>ZOJ-[IUS' ;BQMK=#YK1LQCF=W7<H)0,K
M;=PR1GI5"P\$WDESJG]H0V=O::CIWV-XH+F6=U8,Q#&20 M]X]AC ZUL2>-;
M..6^4V&H&.SE\AYEB&QYMZHL:?-EF)=<=O4BJ.O^-9K+1-4>VTVY@U2R6)_L
M]R$Y21]H<$/M8?>'!X(YH S[;P!J#?V3/?7EN]T+B27563=MG4RK,JKD=GCC
M'/\ #NJ[<^$]5G\2B]B:PM(OM:W#WEL\D<\L8(/E/& $;.,;B3QVK1OO&=M8
M27*R:?>O]CC62\:/RR+?<N[!R^6(4Y(3=Q4LWBN);NYAM=-OKV*U,:W$]LJE
M4+@,  6!8A64G:#@$4 :6ES7L\,[7T*1,MQ(D07/S1AB$8^Y&#5#5M,U+^V8
M-7TAK5KE(&MI(;HLJ.A8,"&4$@@CT.<UBVWBJ^FN(5O(I[1&UN2R1D$;+*BB
M3Y6Y) &P$D8.<8[UH6OC2WN?[/F.G7D5AJ$WDVMXX38Y.=I(#;E#8X)'.1TS
M0 S1_"MSI^L6FI3SPR2B.[-P$! ,L\B.=O\ LC9CGGI755S6G^,$OY[,?V5>
MPV]W<26T5S(8]AD3?D8#%L'RVP<5TM !1110 4444 %%%% #(QB,=/PI]-C^
MX/I3J "BBB@ HHHH **** $/2O*;2R0VNEA+:4>+QJ:->S>6PDV>;^]+MCF(
MQYP,XQMQS7JQ. 3@G'I7,?\ ";VWV\6/]BZU]J,1F$7V49* X+?>Z9(% ''1
M>'],>33]-725CQXDN#=QI;E T6+@QEB!RNT@>F#BFWFF75O%K&FV<*V^BP:[
M&7A:U::)8&MT)_=J1NC\P@D XZ]@17JRRHR!C\N1G#<$4_<N[&1G&<9[4 >4
MV>C+=V+6@#7&F2ZU;D)!9-;0;=G[SRU+L=A[]!G..M3:SX98ZO<>%--L&MM*
MNU&HQO#'MBBD2)D"\=#YBP/COS7H>I:M8Z3IDVHW<P6VA&6=?F[XQQ[U=!5E
M##!!&<B@#S.TBN=3N-$\036%Q%<7^M^8\3QD/%#';31H&'\/()^KU1T&RGL]
M1MHM)M US)%<1F2;3WM[FS8HQ!GD!*2Y8*.>N<C->GV6J66H"Y-M,KBVE:&0
M],,O7\/>K:,DBAT8,IZ%3D&@#R?PCILEOK6@,#(M['&_VU(M(:!E_=G<L\Q?
M#Y?!!^8DC(XS74?$.*UFM="2]MFN;;^UX3+$J%]RA)"?E )(&,D=P#77R21Q
M)OD=47U8X%9NHO8S7NGK<PM)Y<K3QRAL+"Z(>6.1V8COUH \_N=&BU.\M4AT
MQSH4_B*.2. VY5#&+5A(Q0CA"_'(P>?6IM4TJSALM?L?[&D;69)<:9+%:,<
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MTQWMX[^6!665985ED"DNO0CGG%4+_P 56-I=7]E%MGOK*".=X!*B$AB0.6(
M(QDY]1ZT <II6F75G=Z'<W6G7!2+5=1WX@+%!+(_EL0!D*>#GH,@U9\-Z?)_
MPE,FFO&38^&C(EJYY#-/AD ]XXR5_P"!"NVFU+3XKI;.6\MTN7^["TJAVSZ+
MG-5--&AZ7*VE6$MK%.6,C6ZS R$GJ2"=QXQ0!<T^\_M"RCNOL]Q;[\_NKA-D
MB\XY':L?Q?YR6NFW$-I<W7V?4(IGCMHR[[1NR0/QKH20H)/ '4U4L]5T[4)'
M2SOK:Y=/OK#*KE?K@\4 <=X@N;K7TTR\@L-8M8+"]WSJUFOFX,;*LBHX8/M8
MC. 3W'(J#2M$>:YT>6:QO9+?^UKF[;[=$BLN8&4.455" MD@$9R<]37?7-U;
M6</G74\4,>0N^1PHR3@#)]350Z[HX6!CJ=D%N.83]H7$G./EYYY]* .*ATVZ
MTW5;&_FTVYFL;6_U("&&$NT?FR920(.2,!AQTW^E95EHVIV2:1?-9ZI96EN^
MH Q6D"2RV[23;HSY;*V04!&5&1D=B:]-N=8TRRN$M[K4+2"=\;8Y9E5FSTP"
M<T/J^F17RV,E_:I>-@"!IE$AST^7.: .(\->'I(]:T>:YT^Z%O%:WSK]L5"T
M;R3QLN0JA5)&XA0.!D=JZ/QE:FZT:$"TN[CRKJ*7-FP\V+:V?,52"'*]=N#F
MM7^UM-^W_8/M]K]L_P"??SE\S_OG.:;%K>E7%V+2'4;22Y)($*3J7.#@\9SP
M0?RH X33]*U2\U#1I+ZPDDMHM9DN!-+:K#(Z?9G DE1> V\X!P">.!23V&JV
M-_<-%8W,5J=;GG$]O:K-+&K0H%:-3D ,Q<%L''/'.:[R/6M*EOC91:C:/=@D
M&!9U+Y'4;<YXJAHGBG3M:M(GCN+=+MU9C:>>K2* 2.0.>WIWH XO2-%U98(/
M,T^\CVSZJV)PNX+*,H3M^7+9[<9S7H&CP26_AJPMY5*RQVD:,IZA@@!'YU5L
M_%&ERZ+INH7MW;6'V^W2>.*XG53AE!QSC.,]:VP0R@@@@\@B@#SW2]#O;'P[
MX/CATW;<VEM*D\3* %9K=OE?V+[<^]9^CZ-?ZAJ^AIJ&G:A]EBL;BUNTGMXH
M8(=Z*/+C5!G;\I&22.G-=;;^,K"^N98+)H9FAU$6$H:Y12/ESO SSR" .IP?
M2M'_ (2;01*\1UG3Q(@)93<IE0.N1GM0!PI\+:U?^&]6CN8'^W6\<&GVFYUW
M3P02!RP)X'F>_H,UT'A6RG?6[W5)K?5H]\"6XDU)HE>3:S' 2-<8&[AB><GC
M S6\->T@Z?\ V@-3LS9[MGV@3J4W>F[.,^U6;.]M=0MEN+*YBN(&) DB<,I(
MZ\B@#E/$VGZ@_B(W=M937$,^CW5EOBV_NY&*LNX$@X.TC(SS5/4?#-_<Z?HE
ME9P_9BFBW-E)(.!"[Q1JH/\ P)?TKK;_ %,VVI6&GPQ"6>Z9F8%L>7$@&Y_?
MDJ,>K4B>(=&ENWM(]4LVN4W!HA,I8%?O#&>W?TH Y#PYI5\^NZ3+<Z?J\1TZ
MV>-Y+R:$1QEE5=D809<'&<D@# [\5O>*-,GU'4/#31V_G16NJ">?IA%$,H#'
M_@17\Z7PKXG_ .$G^W31Q0):P3M%"\=QYC2!69=S+@;<[<@9/!K2O]>TG2IE
MAU#4K6UD="ZI-*$+*#@D9Z\F@#B]5L;JQUZXU)[421+KD5Q#;F1$:Y7[&(_W
M>Y@"RMD@$C[IJK8V-UK&JW5Y'I;0QCQ+!<21,R$HJ6R@LVTD9#$9P3S]*[/5
MM1\,76F1?VM<Z;-8W(\R+SW1DD YW#/! SU'2M+3K:PM;"*/3(;>&T(W1K;J
M A!YR,<<]: .,U'1]36_\075O82S(^HZ?=Q1QE09UB\HR;<D#.$(Y(Z5VKAK
MG3V'EM&\L1^1\94D=#CC-9%MXHM3=:Q'>M%:1:==I:B623B4M&CCMU^?&.>E
M7)/$.CQV,=ZVHVWV:5S&D@D!#,,Y4>I&#Q[&@#C-&L]8TI]"U*YT*\E-GI/]
MF36Z-$TD;J4/F+\^"C;2,YSP..M=+X+TFZTC0&BO(Q#+/=3W/V=6#"!9)&<)
MD<< \XXSG%7)?$VAP6T%Q)JMHL,X9HG\T$.%^\1[#N>U:4<J2Q++&P=' 964
MY!!Z$4 <+?Z;JC6.KZ#'I$\AU"\>:/4%:/RD5W#;FRV\,@X&%/W1CVH7VCZU
M<:1XD\/IH<V[5K^22&_\R+RD1BO[Q_FW9&W( 4]!^&[-X^L8Y+X!4"V.IQ6$
M[R2;0H<J#)TZ L1CVK;C\2:+-82WR:G:FUBD\J27S  K\84^AY''N* .5U33
M=>B;6XK+3WD$VI6]XDX\EB\02-7$8<X$H*'!8 <Y!K-_X1[7+J\U*X.GWPCN
M9]+DC^VW$;R$0W#-(6VL0I"X.!VQWXKN1XHT0V4MX=3MUMX95AED9]HC=B
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M3;5L.<;H)S))VZ;3QZUHZYX:O9?$5SJMI;"[%Q;1P[#J,MJ8V0M@_)]Y3O\
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M +"VIP"Y\[R#'DY63. I]"3TSU[5;&MZ<;?SQ=)Y?VG[)G!_UN_9LQZ[N/\
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M:K-;QPP.\CA?O':!D8[YQ@\5?TW4K35K&.\L9A+ ^<-@@@@X((/(((((/3%
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MT^*:9Y@+PRPSAMVTQQ-DQ')!."!UZYKH?%6DS:YX;O-/MV19I I3S/NEE8,
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MB/&,=3U[5;U+P_?3>(O[8TW48K662S%G,LMN904#%E9<,N&!9NN1STXKHZ*
M.(B\!SV^A:;I2WUG=0VEM]G9+_3UG1N2=ZC<"K<XZD<=*T-.\)RZ3+HSVNI,
M_P#9]J]I)Y\6\S(S*W7(VD%!CKQ73T4 5K"&Z@LTCO+H7,XSNE$8CW<G'R@G
M&!@?A5FBB@ HHHH **** "BBB@!D7^K%/ID7^K'TI] !1110 4444 %%%%
M:\R3PWJ<7A,ZA8VK1ZU ]\C0.NTW-N\TC>6?KE64^OL37IM% 'FFG:?-I,D%
MSJ^B7FH03:):VD$<<'FM R*1+&R_P[B5YZ?+R>*8NAZC8:?;13Z9--</X>GL
MP\2"3RI,$JC-U^[\H/<_6O3J* /.KCP]/;2:9]BTPHJ^'+JTF,<>/WA$.Q#[
MDAL?C0/#DLUAXC>;2]]S-H\,$#/$"S,(&!5??=C\:]%HH \MU2!K&+Q0]YI9
MU W6EQ8<-&?LX6 @I(&8%!N!8''.?45U%[97%W\*+BQMX6>YFT1H8XAU+F'
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M6G:#>Z9+<BWU-1;SW[WAC, +;7+,Z9SW8@@XXQWK>HH **** "BBB@ HHHH
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M+::*"%;H3/(\NT$D@   +^9H\=Z3K%[J_AK4M(T];YM,NWGDB,ZQ9!3 Y:@
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M+E[7[&$42JZ#<V<MM  P<[L<CUJ;PIJEQK&DS75SN#"]N8E5T"LJ)*RJ"/4
M 50D\+7L5])J-C>0)>"^EN8_.B+(4DC1&1@"#GY <CTZ5K>']+N-)TUX+JZ2
MYGDN)IWD2/8"9)&? &3C&['6@"GJ_BV#1A=RW&FZ@UI9E1<72QJ$7(!R-S!G
M R,E0?TJ.\\:6ME<7ROI]^]O8SI!<W*(ACC+*A!Y8,1\ZYP#BL77/AY<ZQ<Z
MP6O;$IJ#%DGN+(RW%M\H&Q&+@!>,\#/)^M;=WX8DN=+UVT^UJIU2X$P;R_\
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MLUD(-+)D0VV[=/)Y9C#$$ (,,QP,\XYH / FM:EX@T)]3U$%#-*WE1&#RPB
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MS>"[*67B]OH[7[:+_P"R(Z^7YP?S,\KNP6Y(SC)-/;P;9-*5^UW@L6N?M36
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M<R2&)8LQR*=H4A5!W8VX)Z$5U5[X9GNM-\26HGC5M68&,D'$>((X^?Q0G\:
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MJKZ3''H][<I!%,+G,H5WV1R,FS #,5XW9&:Z:QLUL-/@LUEFE6*,)YDSEW;
MQEF/4UA6W@R"W^S0?VE>/IMK<"X@L&V>6C!MRC.W<55L$ GC H I^"#J5U=Z
M[?:E)ND_M"6!%6ZDD1%1B-JH0%4#CD#)SS6-XJUG7+>3Q>J3A;>T@M&MQ#,R
MR*6;MQQNYSSZ=:[S2M)ATE+I89'<7-U)=-OQPSG) QVK+U7P=::K=:A-)>7<
M2W\444\497:?+;<K#*D@]1UQ@]* ,S6?$6I6VGZQ::EI\<$D>ER7L+6EXQ+
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M6YYV+@=N>353Q7X8NM>GB:---FC6)D"WD3;X7)_UB.F&!]LCH.10!;N?%UI
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M9G"JX^?:P/S <GGJ,9JRGC*ULK:;[1!J$T5@4AOKXQQ[(9"%)W[6Y(W#=L!
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MB@DV/(IE4%0<C&1QU%<_I=[#HNM:I=6MAJ.G6>E:=+->65Y>&5YB0KHR+O<
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M]7N9DN&*3LNR55VAUY^4[0 <=0.:8?".G&S6$R79E6X^U"Z-PWG"7;MW;O\
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M\)QGQ.+R\OM)/E7BW)*6H2Y<DGRU9MV!R.H4%MOUKNZ "BBB@ HHHH ****
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MH$C)1B,EV49=OE')XZ\5HWF@6^H:_;ZG=D3QP6[PQVTB!D#,P)?G^+"@?3-
M'/:/XT8^%+"0B/4-3:]_LLB*4!))@3\Y89PI5=^0#P>AJ6;QO>PSW%HVB*;V
M&_AL1&MUE7:2,N&#;>@&.V>M1^(?"0ADFU#2[>X:22XMYA;V;1QF&2/</.0.
M-I;:0"IX(%1^'_"U[<7-SJ.K2W:2/J45[&+@Q>:WEQ>6-XC^4 Y) '0 =\T
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M&R\V;RX;\WZG(R7,QFP>.FYB/7'>L^7P/:M)'+#J-]#+!>2WENRF-A"\N[>
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MYHNE7/VFPTVVMYMA3?'& 0I()4'L,@<=*6ZL]%\20M!=V]K?Q6TY5DE0.$D
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MY3="YW&5@OG$,FX+G )#L.G.?6G7/AS2+R.\CGM5<7DZSS'>03*JJJL"#E2
MJX(QTH Y9]?\2K$UJ?\ 1Y3J5M;PW%S%'O,<@.X.B,0",<'C.1Q71:^;BR\#
MZJ\TR74\-A,Q>2)=LA",>4Z8]NE36GA?1[* 0PVIP+A;HN\C.[2CH[,22Q^I
MK1N[6"^LIK2Y0203QM'(A_B4C!'Y&@#A[S5==!\1R6FH16\&DV45Q#%]G5M[
M&$N58G^'Y>W/)YK<\27KM\.]3OPD9<Z;)-L= Z9\LG!!X(]C6F=$T]EO5-LI
M%]&(KD9/[Q0NT \_W3BGWEG8/H\ME=K&+ PF*17;"^7C!!.>F* .&U77-?MU
M\4WMKJ*10:-Y#06QMU97S#&[*QZX^8XP0>>M7[_6M4T>YU>SN=55S';VLMO,
M;0,RO+*\90(N-V=H ST)Y)KI9=!TR:"_ADM4:._ ^U*2?WN%"C//]T ?A2WN
MA:9J+7#7=JDK7$:12EB?F5&++],%B01SF@#A)?%VN6,NMVCF8-;Q6;0/?11>
M9%Y\K1LS"(XVJ & //KQ5C4_$&MZ'J>K6*ZB=0,-O9F$O%&'C>:<QDMC:IP.
M1G ]?6N@F\':;!8WB:9;PV]W<P>2\\R&;S%SG$FXG>#TY.<'@U4T#P9!8OJ+
MZA#I[&]A2"2VMHB(Q&N[KN)9B2QY/8 #I0!FC7?$$37>GSR26[/<VD,%S=?9
MVFB$K$-N6)BO\/RD@9+=\5?\.I-;^.O$D5U>FZ:.VL@)9%56Q^].&V@#/)Z
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M;C3[F*5V<LSQH8BA8]\%C@G^^?6J'C:>\&L01VM\56*RDFDM4OVLWQD#S58
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MM1JMU<K';WLUVE@2A17,SLC;E&2,,&QGK0!I0^*VFTG1[[[& =1OOLA3S/\
M5\N-V<<_<Z>]4X/&.JW.GVEY'H<6R\O!:6ZM>8+'+AF;Y/E V9[Y!J>+P0L5
MW:,=8O6L[*[-W;6>V,)&Q+$@D+N8?,<9/%,U+PO<1Z/HNFZ;/.!::@)VG5E#
MQK^\);D8/+ 8P<B@!O\ PF=S]L&D_P!FQC63>FS$/V@^4<1"4R;]N=NPC^'.
M>/>H[KQO<VD<L4^G0PW=O>_9+EI)V\B(&+S%D+A"=I! &5')P:NCP5;>3YAO
M[K^T_M7VO^T1L$OF[/+SC;MV[!MVXQCWYJ1?"7E6K^1K&H17\EP;B6^4IOE?
M;L^92NPKM  &WC QSS0!GW'CKRH--&S3EGO$FDWO?;H%6-@ORNBG<26&.!WS
MTQ6_X?UA==T6'4!%Y1=G1DW;@&5BIP<#()&0<#((K,3P9!;VT'V'4[VTO(FF
M;[9'Y9=_-8-(&4J5P6 /08P,5N:;8C3K"*U^T3W!3),L[[G<DDDD_4]!P.V!
M0!S$WC._73-3UJ+2XGTG3YY8G)N")I%C;:[JNW& 0V 3SCM2Z,E]>^/=8NKI
ME,-JL<4"I<R8160,/DX4DYR2<D'I5JY\$V5P;J#[;>1Z;=S-/<V",OE2NQW-
MSC< 3R0" >?6MFTTN&SU"]O(V;S+LH7!/ V+M&/P% %/4=<_LK6(X;M42QDM
M)9A.3R'CP64_\ )8?[IK$/C#4%L=-DN(-.L[B\MA<^3<3MOY/"!%4L3C&3C
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MI,\>],YVN%(#+GL<CDT <5/XPUUM'TW5@ZV]M+I<5W-)%9F>-)#DOYH#;T3
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M9W,FF6-S%'"JV[>4"!%C( _V?;I5X0:?:ZF9@D$=[=($W<!Y53) ]P-Q^F:
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MC:1QP1I:PJEN<PJ(P!%P1\H[<$CCL:;%IMA!>27D5E;1W4O^LF2)0[_5L9-
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M;/['%-96ZPPRHK*HB\LXQQE< CCL:?/86=U(LEQ:03.HP&DC#$#\: /.&O\
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M15O_ +:+,^=O64@RN4,BXPY3.TMP/F(SQUJUI6DII7VTI*\AN[I[EMW\);'
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M_6N9\<ZXT&J:V(;XVUW9^281+?.LA^56)A@4 %>3N9B>0>PKUI$2-=J*%7T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $4!S"I_K4M0
MVQS%_P#7J:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (;
M;_4@U-4-L,0@^M34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!#:@^3SZU-4-J,0BIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH AMO]2*FJ&V_U7XU-0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% $%K_J<5/4-K_J1U_&IJ "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH AMO]5[5-4-J<Q?C4U !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 0VN?)_&IJBM\B(9J6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** (H/]4*EJ*WXA%2T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!%;_ .J&:EJ*WQY0P:EH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&VQY0QP*FJ"U_P!3^-3T
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!:_ZK!]:GJ"T
M/[G\:GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"&U_U7
MXU-5>SSY//K5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M *]I_J?QJQ5>S_U/6K% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 5K,8ASR*LU6LO]4>F,U9H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"M9',/6K-5K+_ %/%6: "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH K6?^ISCO5FJUD,0CC%6: "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH @M/]2*GI%4(H Z4M !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>a20220930-zionsrlocadden003.jpg
<TEXT>
begin 644 a20220930-zionsrlocadden003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDCZE& (/K^#'UK#U/X=^)CXXU'Q+H7B6VTZ6]C6,JUIYI"@+D<\=5':O3Z*
M.$LO"OBZ;1M:T_Q!XIAU);ZS>W@*VBQ>2S C<=N,]1Q[5B:5\/\ Q_HFEP:;
MIWCNV@M( 1&@TU6VY))Y.2>2:]6HH XUO!=U=^)-$UC4M1CNI++37LKM3#M^
MTLZX9N#A022<>]<SIGP9;3?!FN:&FK1M/J4T3"Y\@_(D;!E4C=R>OYUZQ10!
MY]XG^'VKZMXTMO$NC>(4TNZAM1;@FU$IZMD\G'1L=*TO#_A[Q;8:BTVM>+QJ
MEJ8F3[.+%(L,<8;(YXYX]ZZ^B@#@-(^&45E\.KWPE?7RW:7#NZ3B';Y;'&T@
M9/*D ]:V? GA1_!OA>/1WO1=LDKR>:(]GWCG&,FNFHH Y+P!X-D\%:9?6DM^
MMX;J\:YW"+9MRJC&,G^[76T44 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 45SGC7Q4?!^AIJ*V#7K
M/.D"PK)L)+9Q@X/I6;X:\?3ZOXCDT#5] N=%U 0?:(DFE$@E0'!(( [_ ,C0
M!VM%1I<0R.R)*C,O4*P)%*)8RQ4.I*G! /0T /HIOF)NV[AN/;/--N)XK6VE
MN)W"11(7=CT50,D_E0!)17G^C?%>PU;6+*S?2=0L[74':.QO9TQ'<%>..XKT
M"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\73W-MX
M.UJ>SW?:8[*9HBIP0P0X(]ZV:1E#J58 @C!![T >3^'-#\'7'P8TF;7XK-+(
MQ++-<R85A(7Y^<<YSQ^E:1,*_&K1A;,#"V@,(SG.5#G'/?M5O_A4'A(ZB+DV
M]R8!+YPL?M#?9@_KY?3\.E:'B;X=:!XLU""^U-+GSX8?)1H)VCPF2<<?6@#J
MP<UYC\6+. 7W@YT@B#/KT <[!\V3W]:[;PWX9T_PKIK6&FF<PM(93Y\ID;<0
M!U/;@4[7?#6F^(_L/]HQR/\ 8;E;J#9(5Q(O0G'6@#A_%L>MW_Q+TOPUI&N7
M&CV,^G//-]F5>H<\KQP3Q7,^+_$&K:1XA;4].U[6KJ"UU.*UFC6()9HHP'C)
M)^9R<Y('K7L,OA^PF\1V^O/&_P!O@@:W1PYQL8Y((Z'FL#4_A;X5U>_N[R[L
MYFDNG\UU2X=563CYU4' 8XY/N?6@#A]=O_$FHZ]X^2V\1WMA9Z'#%<P1P[1\
MWE;MI/7:<'(I-9UOQ/J.B>#[I+C5)+.YTT3WG]CRJETTNT?.5/+(.X''7/:O
M3/\ A#-&\W6I##(6UJ%8;TF5OWBJA08YX.">15*^^&_AK4=+TZPGM)!'IT?E
M6TL<S)*B8^[O!R1[&@#C+GQ!'JO@KPVEIXIUZ>6[FEC#6-LJ7EV4SE3SA-O&
M3WX-9T/BGQ#)X/T32&U2YM;F\UR33)M1F8&>.-6R,L,C?@XSSTKT6\^&WA>]
MT?3]*>P:.UT\LUL(9G1D+?>^8')SWS3O^%=>&!X>GT'^SA_9TTYN#$9&.R3C
MYD.<KT[>_K0!Y?\ $71+K3_ >J6<WBV]U7[#J,#".:3,B+(% 64]^?F7I717
ME_J7AGQPEK#J-YJ$5KX7FN!]I?>9I%D.&;&,GM]*ZZU^'7AJU\/7NA+9.]C>
MN)+A9)G9G88P=Q.>,#'-6=+\$:!H]U;7-E9%)K:U:TB9I7;$3,7*\DYY)/-
M'ENGW&N:=HGA/Q:WBZ^O+G6-0@AN;*:0- R2,051 ."H_D:CG&L:V_Q"NG\4
M:S;IH4\LEI!;W6Q05#D \9V_*!C->EV'PT\):9K2:M9Z1''=1L7C^=BD;'NJ
M$[0?H*T(?"&AP)K"1V0"ZR6-^-[?OMP(/?C[QZ8ZT '@R]N-1\$Z)>W4IEN)
M[&*220]68J"3^=>)6TNH>'/&OB7QA:F62RL]:FM=3MU/6W<_?QW*DD_E[U]
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M*&81J@..0H /7FN;?5KBU\;^&==UO3=6&J3WUQ/.CVARL94+'%%_>51D_P#
MB>]>Y:#X-\/>&))9-&TN"TDE^^Z EB,YQDY./:K=]H.FZEJ5AJ%W;"2ZL&9[
M:0L1Y988)P#@]!UH \#^)VIW6NOXBN=4T[58H++;::8C6S"!2)5WSLW3<>5'
MLU=+J^K6][X^^'&JW,,]MI[QS(GVM/+VR ;02#TR=I'MBO6]8T>PU[2YM-U*
MW$]G/@21DD;L$$<C!Z@5!J_AO1]>TM=-U2PBNK1,%8WS\I P"".0?I0!YMX
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MH@!V^Q+_ (UTVG69L-/@M3()#$NW<$"@_@.E %JBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK-KX7M;9[61[J]N)K>[>\$L\NYFD9&0YXP!M;@  # I 8UEXXOYI[876AK!
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MQ2?9$,J2X=L$F-T#8 R<KG=C YK7B\#:/&YW&[EB$#V\4,ERYCA1NH1<_+T
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MEMNY3_WPO/7BE8#E;[Q%KGA\ZG<:G]EGN/L]FEM%:1R% \DLJ9*Y)/..G)
MJK'XS\2O$]J+.(79NK>&&XN;.:WC<2E@<HQW94KU'!S74)X)T1;2]MI(KB>.
M\BCBF\^ZDD.V,DH 2V5P22",<\U):^#M%M&9U@FDD::.<R37$DCEH\[.68G
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M=P!@#MV]!Q77U473+%+EKE+.!9V<.T@C 8L 0"3W.&8?B:MTP"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$=L'N1;F[5UU A3%OV@G,?WNG%:MCXR%U)XE26T6)M%D*?Z[/G8CW^G'IWH
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M?7[:VEB2/ ^RS(A0I+GD#D'\#3KSP?<^(_'.DS>)[#[1#'H12YEMW>.(7/F
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M.1PA#!@" PR #GIFO4K3[0;2(W:QK<%!YJQ$E0V.<$\XS4V* /![C0[BZO\
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M'YW()&> 1CWKDI/ >O)J.M:5-?-?:?KFE"%KSR4B6WFB&V,%%/(*]P*]8HH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<9+*+1_[)^RN@(9-VXL3ZFF:7X"-@F@)<:O->#1))O(,D8R\;IM",<_PCO\
M2NSHH X>;X<02:1+IT.ISV\<=_\ ;].>% &L7R3M7L5R3Q[FK"^!3<6VN#5M
M7FU"ZU:U^R-.T2IY,0! "*.!RQ/N:["B@#@H_A7I:^'_  _I+W4LBZ/=_:EE
M*@&8EBS*P]"<?D*T;GPA?_\ "1:EK&F>(9M/?4!$)HUMHY!^[7:,%OQKK**
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MXR?3(K?^&VDZMI7BWQ3%J<,Y2-;6WM[J1"!<QQJZJ^X]6V[<X[F@#TRBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI6^<_P# =M=#:6D%A:QVUM&(X8QA5'^>3[U/13 **** "BBB@ HHHH ****
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MB;Q*EQXBT4Z/'9Q7KQ6NEO9QE;B)'VL6EQE2<$\4 >G_ -MZ3_T$[+_O^O\
MC1_;FD_]!2R_\"$_QKEKOQ'H&G^)X-#O- :&2>9((KEK6/RGD8 @*<Y([9QC
M/%8ESXKM=3GT1]*TAK2WEUR.PG>>UC"SKB4.%//0H.>* /1/[<TC_H*67_@0
MG^-)_;VC\_\ $VL>.O\ I"?XU@^.YX- \&ZA>V-E:"^VK%:YB3_6NP1>",'!
M.<>U8.@>)K6S\#ZI?^(+.VN-0T.=[:^\B!,R88!748 P00>W0T =W_;^C?\
M06L?_ A/\:/[?T;_ *"UC_X$)_C7,ZIXOT+2;S5K:;22QTVQ2_E9(D^9&.,#
M/>JESX_T6TAB,OA^Y68Q-<R6_DQAX;<''FL,XP>P')]* .O/B30UZZQIX^MR
MG^-)_P ))H7_ $&=/_\  I/\:ET]M,U+3K>^LXX)+:YC66-Q&!N5AD'IZ5Q7
MB :OKOC9_#>C:A'I$%I8K=SW"6R2.[LQ"*-W 'RDG'TH [#_ (270O\ H,Z?
M_P"!2?XTA\3Z".NM:</^WI/\:\X\0W&MVMUX4TS4M6_LZ>XBG-[/IEH)O,9
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MS;MQSC/.* -O_A)] SC^VM._\"4_QII\4^'U.#K>G#_MZ3_&O,/%?BC6K/\
MX2.TTHWTLHU6VLUD B7[,' .(\]=V< GH3FN@L/B'I=IJMEX>O8+AKA6ALY[
MJ9HB1<LF=C!2"3G +*-N30!UI\6^'!_S'=-_\"D_QH/B[PXO77=-_P# I/\
M&LC3/&=EJ;64":=(EY/=7%M-;$#? 802Y;U'W1Q_?%8UG\4].N;G4;>;1)[>
M6SL9;X(TD3,\<9P00I.QN>C8- '8)XM\.R$A-<T\D>ERG^-*WBOP^B[FUK3P
M/4W"_P"-<3K_ ,198-"UW[%H5S::G8V:74:W2QX\MS@2<,>G7'6K6H_$B'0A
M8+K&@7-L)TB,KO)"-C/Q@+NR^.^T'% '5?\ "7>',9_MS3__  (7_&C_ (2_
MPY_T'-/_ / A?\:YO6OB/9:1>WT<6B7=Y;6,\5M<7<6P1I*Y&$Y.3@,.0,9X
MJ:'XAZ1/XO.@QVV46Z-D;KS(POGA22FS._J-N[&,T ;_ /PEOATX_P")WIYS
M_P!/"_XTB^+O#CYQKFG<=<W*?XUC>/;_ %&W&C:3I%U'8W6JWHMS=% QB0*6
M8J#P6XXJNEW?^#-$N?\ A(;I=<9KI(-/,4(%Q<,_2-A]W.>_IUH Z3_A*/#W
M'_$[TW_P*3_&E/B?0 <'6].!_P"OI/\ &N7N?'.F6VF^?<>'K@7Z7Z:?+IXC
MC:5)77<@R#M((((P>]17/C_3;&6<7GAJ[@AL_(-],8XRMKYJ@KNYR2"V"!G&
M,T =6?%?AX'!US3LYQC[4G^--7Q?X<8'&NZ<<=?]*3_&L*?QKI\&JW,"Z)/)
MI]I=+9W6I*B>3#*V, C.X@%E!(&!FF_\)M$\VM+'X:O'M]*::.6X58]CNFWY
M5YZD-GT '-(#?_X2[P[C/]N:=@]_M*?XT'Q?X<'77-._\"4_QK@+[XFM>Z'9
MW>BZ'(TO]L1Z?<19B<@\,55@2I+@X!' YK5A\60Z7%=QFRN]2U"?6)K6UL@(
MP^556*J>@11W)I@=3_PF'AT]-9LC])@:>/%6A,,KJMH?^VHKG(OB#%.EK%9Z
M#=S:C-<36DECN1'BFB7<RL2=N,<YSBNB\,:[;^)] M]6AMW@64NK128W(RL5
M(...H- #_P#A)]# !_M6TP>A\T8I3XFT,'!U:R'?F=?\:T_+7&-HQ]*/+3^Z
M/RH RO\ A*O#^,_VWI^/^OE/\:0^*_#P_P"8WIW_ ($I_C6KY4?]Q?RH\J/^
MXOY4 90\5^'CTUO3_P#P)3_&E7Q3H#=-:T\_]O"_XUJ>4G]Q?RI?+3^Z/RH
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MP9LH /+,N<[,#@8XS5]? NW3M"M!?\:5J;:AN\K_ %I+2-MZ\?ZSKSTKL:*
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M]9O/ D*'4+1((I5N+FT)1[8F!0,G^'+#'Z5A0:)XCL/#_B;PT]C>W.KZE=)
MFLOO=+B!N/,=N=NQ,@CWH ]&\*>-=+\7:3<ZE9":""WD*2"Y4(RX4-NP"?E(
M.<UEZ;\3M+U'4K2V.G:K:VU])Y5G?7%MM@N&SP%;)//;(%<[8^&/$FD^);JQ
MG6"73]:TIK-IK*!ECMI(X]L;."3C*\?E6IHVN^)6DT30X/"5S:_92D5_=78
M@6-!M)B8'YB>HX_^L 7HOB1'=ZA>VMAX:UV]6SNWM)I[>&,HKJ<'DOG'?ITK
M3?QKIZVGB.X\FY*Z#N^TC:N7PF\[.>>..<<UYII%G=Z/KNOO?>'O%TIFUF>Y
M@;3G9(7C+?*2 Z@YQZ=,5H>(K77-/N?&VGVWAW4+]?$4:_9+BW"F-"8?+(DR
M?EP<_6@#I-2^)T&FP:=<-X=UN>VU!8?LTT44>UWE7*IRX^;M]:T8_'NF++>1
M7T%WI\EE8K?W"W**/+1LX4X)^;CI6+XFT'4'\*^#+"WLY)YK#4K!KA8^?+6,
M89B?0>M9/BOPOJFO^+O%D-M:RHEUHT"03LI$<DB2;O+W=.<8- '8>'?'-MX@
MU(V!TK4].G:W%U"+Z ()HL@;E()]1P<'FK.D>,=-UKQ'JVB6PE%SIK .S@;)
M.QV$'G:>#G'-8<'BGQ/?K=RP^$KNRAMM/>3%T )9;G'RQQ@$Y7/<UR&B>%?&
M/AB^\,:U.L5Z!*Z7T%O"PF5;@[I&DYPVUO0#I0!ZQHFNVNO6]W-:+*JVMU+:
M/YB@9>,X;')XS7.VWQ,TZ[U!(HM,U,V#W9LEU+R1]G,V[:!G=G!/&<8S6/X0
MU/5= N=5TVY\+ZU*MUK5Q/'<QQ+Y0CDDX8DL#C'/2N?ATG6;77@VD^'-8TC6
M7U(-<26\I.FS1>9EG(+$<KV SF@#UK7M>L_#FE/J%\7,8(18XEW/(Y.%11W8
MGM6-IWQ"TN\L-5N;VVO=*?2T$EW!?1;'12,J0 2#GM@]:3Q]I=_?:?I=[IUO
M]JGTK48KXVP.&F5,@JN>-V#D9]*Q-5/B#QYX7\0V@T233;<I%]@2_79+.Z,'
M8.N>%)4 ?6@#7T3XC:?J^J6^GS:9JFF2W:EK-K^W\M;D 9.P@GG'.#52T^*F
MG7)BDET76;>QEN?LJW\D"F /O\OE@QP-W'(K+DN=9\::_P"&(7\-:AI,6E7(
MO+R>[4(H95("1D'YP2>OI6'I_A+5=/T#3M2N+75+R"'59I+S0V=MKQF9MDBI
MW*G:^.AH [*Z^*6FVDVH[]'UF2TTZY:UN;R*W5XHW'4G#Y  (.<=ZL:O\1['
M3M4N-/L]*U35I;15>[?3X!(EN",_,21SCG KGM'\ R:S>>*$U:?5K.QN=8DE
M6VCE\J.YC(4Y(QE@>G7M4T=WK/@KQ'XBC7PQ?ZI9ZE<"ZM+BQ0-\Q0 QOD_*
M 1UH V;GXFZ2CZ8EA8:GJC:C;-=0"QA5SL4D'(+ @@@C%7+3QYI5WX8U#7C%
M=V\&GN\5S!/$%FCD7&4*YQGD#KWKSG2_ 6N?VMX7MKEK[3_+T^[:>ZL&V_9Y
M))&<1EAQQNQCH:(O#NOWGAZ+P<-.GM;MM7:?4-2GCDEAN0@WK*23SO*J",CD
M4 >E6OC*WU'PG%X@TW3;^]BD8K]FA1?.4ABK9!8#@CGFLVS^)EC=Z!=:Z=&U
M>#2X(1*)Y8D E^?9A,.<D'UQ57P1INN>'=9UO1=3C$]M<$ZA#>6\)2'>YP\8
M!)P<\XSZUDIHFJ+^SZVDMI]Q_:/E,/LNPF3_ (^"W3KTYH Z+5?B39:?J=S9
M6NCZQJALP/MDEA;B1+?(SAB2.<=A5E/B)H<FM:-IB/*6UBV%Q:S%0(R#G"GG
M(8X/&.O%<UI]QKG@?4]?M#X:O]7AU&\>^M+BS4,"7',<I)^3! &?2LA/AQ>W
MVH:587L+VYM] <1WD0^6TN_M D4*P[KD].H!H ]1T#Q#;>(4U!K:*6/[#>RV
M4@D Y>,C)&">.:UZX;X5V.KV/A_4O[<M6M[^XU2>XD!7 <M@EE]B<XKN: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ,4444 %%%% !7/>*O$H\/VL$5O;F[U2]D\F
MQM%.#+)CJ3V4=2>U;[NL<;.[!54$DGH!7$>#1;^)]8O_ !FRNZRNUIIID&-D
M"<%E';>P8Y] !0!5TV7Q!X>\::5:ZUJSZBFNQ3;TVA8[6:,;PL8Z[=I(YZX!
MKT/%<OK.G2:AX[\-S>3)Y-@ES<-+CY0S*J*N?4[F/X5TY( R30 M%(2 ,D\5
MR^B_$'P_XA\2W6A:9<23W-O&9&D"?NR 0#M;O@D=L4 =3136D1 Q9@H49))Z
M"L#0_&FB^(]7O].TFY-R]B%,TJ+^[RQ( #=^AZ<4 =#1110 4457OK^UTVSE
MO+VXCM[>)=SR2-A5'N: +%%<!X=^):^)O&PTBQTZ5-->S>XAO)@5:;:X7<J_
MW#G@GGBN_H **9+(D,3R2.J(@+,S'  '4FLIO$^DIX?EUU[R,:;&&;[1G*L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112'I0
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M)%6K;P=9?:!<ZI<W>KW(.0U])NC7_=B&(Q_WSGWKHJ* "BBB@ HHHH ****
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M7G'GR?\ @/)_\36-\0;V\M].TJSLK][!]1U."S>YC(#HC9)VYZ$[<?C5-B?
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]#-F)HET82_9T#Y#&08<OD9).2>W6IO$G@_3O$TEI/<2W=I>6C$P7=E+Y4J
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MI#/KVFQ2R(LB+)<HI96&589/0CD5XS!.;7Q;JAUK6M#T^\-EIXE.K6@G+OY
MR5RPP0>OU%'BV":\UKQ3=Z;%I=W8Q:98^?FS$I6!HVS)!R I4?,![#TH ]^1
MUD0.C!E(R"#D$4ZN3\*OI\<6C6UAKSW,*Z0GDVIV_O8P0/./&<_PXS@5UE !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4'FBB@#.BT#1X)EEATJRCD4Y#I;H"#ZYQ1!
MX?T>VE$L&E6,4JMN#I;H"#ZY K1HHN*R*[6-HT+0M;0F)FWLAC!4MG.2/7/-
M,.EZ>;C[0;*V,Y;=YOE+NSZYQG-6Z*!E6;3;&XD,D]G;RN>K/$K$_B14B6=M
M&&"01*&4(V$ RHX /M[5-10!7AL;2W*&&VAC,:%$*1@;5)S@8Z#/:K%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ"0*FY.1ADZ9!_K2>'_'^I:UJOA&U+&*>9;R'5;9HU!::*)64CT!W!ACU]J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *AO$GDLITM9%CN&C81.PR%;'!(],U-10!YIX/\ !OC+PQ*Y?4M$G-W=
M">_G:&5II\GGYL@ XR!QBGVGPYU*ST9!;ZI;PZQ:ZK-J%G<B,M&HD.&1U[@J
M2#^%>D44 >?IX%U?4)-9U'7M4MI]5O=/;3K<V\3)#;Q-DGY2<DECG/M3KCX<
ML?'NC^);:^6$6D06ZM]IQ,XC*!QSP<''X"N^HH \V'P\UZZU32#JNO6UW8Z5
M>B[@E-L?M<F&)"/)GIR!QUQ6[XS\+ZCX@GT>ZTR_MK2YTVX:=3<0&5'RI7!
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MBWF:"4IT5QC(_6KM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ*7%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML8V.O]M;MO\ P _^SI?L6NC_ )C5L?K8_P#V= &Q16-]AU\@_P#$[M?PL/\
M[92K9:[_ !:U;'Z6./\ V>@#8HK(-EKNXD:S;XQT^Q?_ &=(;'7>VMV__@#_
M /9T ;%%8_V'7<?\AJW_ / '_P"SI/[/US))UR/Z"R7_ .*H V:*QO[.UO\
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MN;F:ZG;?))[$]A[# K4HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3[UTP_[82?\ Q-%F*Z-BBL7_ (2O1L9^UL?I#)_\32?\)=HF,_:W(]K>0_\
MLM(9MT5BCQ9HQ_Y>9?\ P&E_^)H'BO1R,B>;_P !9?\ XF@#:HK'7Q1I+' F
MG/\ VZR__$T[_A)-,_YZ7'_@)+_\30!K45D'Q-IF,[[H_2SF_P#B:!XETXC(
M^V8_Z\9__B* ->BL@>)=./3[9_X S_\ Q%!\2Z<.UZ?I83G_ -DH UZ*R1XC
ML3_RSO\ /_8/G_\ B*/^$BLO^>6H?^"ZX_\ B* -:BLD>(K(G AU#_P73_\
MQ%-/B6Q4X,.H_P#@MN/_ (B@#8HK('B2Q/2#4O\ P6W'_P 12?\ "2V7_/OJ
M?_@LN/\ XB@#8HK'/B:Q'6#4O_!;<?\ Q%-_X2BPSCR-3_\ !9<?_$4 ;5%8
M1\6:<I ,&J DX .F7'_Q%(_B[34^]!J@_P"X7<__ !%%A71O45SP\9Z66QY.
MJCZZ5<__ !%!\9Z8!G[-JY'MI-S_ /$4[,=SH:*YS_A-=-R?]$UGCG_D$W/_
M ,149\=Z6/\ ERUOKC']CW/_ ,12 Z>BN9'CG3"N?L6M]<8_LBYS_P"@4?\
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MW$3RQ3QI&T+2-M&WS.>N>1(P_*G8"CJ,'A_3=#.L2)<O:C9ADNI 3N8*/O.
M!DCDD4VW7PU<&,,\D4L@^5&O68XVAOX7(Q@CG/<>HKH[K3K6]M?LUQ'OAW(^
MPDXRK!E_4"JTWA_2[B>:>6U5I)EV2$,1N'R\<'_87\J ,!I/"'V=YUNG95A>
M9@MS-G8A(8XW=B#Q[5:AA\+W<\5I!=>9+,I:-%NY#O SDCYN>A_*KW_"):%Y
M0B&G1*B[\!<C&\$,.O0Y/%/M_#&CVE];WD%C''<6\8CB<$Y50I4#KTP2/QH
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M /BZZ&B@#G/^$&T(C!BO,?\ 7_/_ /%T'P-H1QF*\X_Z?Y__ (NNCHH YU?
M^AH<K#=CG/%]/_\ %U97PQIR*%4W@ [?;IO_ (NMFB@#'_X1K3_[]]_X'S?_
M !=+_P (W8?W[W_P.F_^*K7HH R#X<L,8W7O_@=-_P#%4G_"-6']Z]_\#IO_
M (NMBB@#)'AVQ'\5[_X&S?\ Q57;*QAL(FCA,I5FW'S)6D.?JQ)_"K-% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M4R1V1<K&SG/0$?UJ+[1-_P ^DOYK_C0!8HJL;F8?\N<WYI_C2?:IO^?&?\T_
M^*H M456%S+_ ,^<_P":?_%4OVB7_GTF_-?\: +%%0B:3_GWD'XK_C1YS_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
;!1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120694560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIFEVANTAGE CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">90-0224471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300 Triumph Blvd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LFVN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,569,302<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000849146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121249904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 17,619<span></span>
</td>
<td class="nump">$ 20,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">3,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">18,636<span></span>
</td>
<td class="nump">16,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">4,752<span></span>
</td>
<td class="nump">5,205<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">42,923<span></span>
</td>
<td class="nump">46,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">9,403<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">10,410<span></span>
</td>
<td class="nump">11,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax asset</a></td>
<td class="nump">3,044<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="nump">1,333<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">67,600<span></span>
</td>
<td class="nump">70,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,846<span></span>
</td>
<td class="nump">7,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions payable</a></td>
<td class="nump">7,367<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrentAndNoncurrent', window );">Income tax payable</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">5,052<span></span>
</td>
<td class="nump">7,927<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">22,769<span></span>
</td>
<td class="nump">25,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities</a></td>
<td class="nump">12,642<span></span>
</td>
<td class="nump">13,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">299<span></span>
</td>
<td class="nump">308<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">35,710<span></span>
</td>
<td class="nump">39,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 8</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock &#8212; par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $0.0001 per share, 40,000 shares authorized and 12,560 and 12,493 issued and outstanding as of September&#160;30, 2022 and June&#160;30, 2022, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">131,726<span></span>
</td>
<td class="nump">131,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(98,204)<span></span>
</td>
<td class="num">(98,437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,633)<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">31,890<span></span>
</td>
<td class="nump">31,516<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</a></td>
<td class="nump">$ 67,600<span></span>
</td>
<td class="nump">$ 70,706<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120569264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">12,560,000<span></span>
</td>
<td class="nump">12,493,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">12,560,000<span></span>
</td>
<td class="nump">12,493,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121359888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 51,774<span></span>
</td>
<td class="nump">$ 53,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">9,942<span></span>
</td>
<td class="nump">9,431<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">41,832<span></span>
</td>
<td class="nump">43,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_CommissionAndIncentives', window );">Commissions and incentives</a></td>
<td class="nump">23,813<span></span>
</td>
<td class="nump">24,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">16,729<span></span>
</td>
<td class="nump">15,076<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">40,542<span></span>
</td>
<td class="nump">39,181<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">1,290<span></span>
</td>
<td class="nump">4,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(438)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense</a></td>
<td class="num">(438)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">852<span></span>
</td>
<td class="nump">4,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(242)<span></span>
</td>
<td class="num">(1,116)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">12,457<span></span>
</td>
<td class="nump">13,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">12,495<span></span>
</td>
<td class="nump">13,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">$ (510)<span></span>
</td>
<td class="num">$ (135)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(510)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 3,181<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_CommissionAndIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_CommissionAndIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193119574592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS&#8217; EQUITY (Unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">$ 36,807<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 129,048<span></span>
</td>
<td class="num">$ (92,346)<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of company stock (in shares)</a></td>
<td class="num">(500)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of company stock</a></td>
<td class="num">$ (3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,492)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">$ 37,310<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">129,862<span></span>
</td>
<td class="num">(92,522)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="nump">12,493<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">$ 31,516<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">131,075<span></span>
</td>
<td class="num">(98,437)<span></span>
</td>
<td class="num">(1,123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Common stock issued under equity award plans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">$ (72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under employee stock purchase plan</a></td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends</a></td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Currency translation adjustment</a></td>
<td class="num">(510)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(510)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">12,560<span></span>
</td>
<td class="nump">12,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 31,890<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 131,726<span></span>
</td>
<td class="num">$ (98,204)<span></span>
</td>
<td class="num">$ (1,633)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193116380944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">841<span></span>
</td>
<td class="nump">793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">602<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax</a></td>
<td class="num">(1,755)<span></span>
</td>
<td class="num">(1,082)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,326<span></span>
</td>
<td class="num">(366)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">1,751<span></span>
</td>
<td class="nump">1,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="num">(2,568)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other</a></td>
<td class="nump">415<span></span>
</td>
<td class="num">(877)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">429<span></span>
</td>
<td class="num">(1,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax payable</a></td>
<td class="num">(346)<span></span>
</td>
<td class="nump">640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other accrued expenses</a></td>
<td class="num">(2,248)<span></span>
</td>
<td class="num">(1,873)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_IncreaseDecreaseInLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(235)<span></span>
</td>
<td class="num">(384)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(311)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash (Used in) Provided by Operating Activities</a></td>
<td class="num">(1,345)<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(727)<span></span>
</td>
<td class="num">(378)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Used in Investing Activities</a></td>
<td class="num">(727)<span></span>
</td>
<td class="num">(378)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payment of cash dividends</a></td>
<td class="num">(377)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding and other</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan', window );">Proceeds from common stock issued under employee stock purchase plan</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Used in Financing Activities</a></td>
<td class="num">(328)<span></span>
</td>
<td class="num">(3,323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign Currency Effect on Cash</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in Cash and Cash Equivalents:</a></td>
<td class="num">(2,571)<span></span>
</td>
<td class="num">(3,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; beginning of period</a></td>
<td class="nump">20,190<span></span>
</td>
<td class="nump">23,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents &#8212; end of period</a></td>
<td class="nump">17,619<span></span>
</td>
<td class="nump">19,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 439<span></span>
</td>
<td class="nump">$ 468<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_IncreaseDecreaseInLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_IncreaseDecreaseInLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193122534832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text">Organization and Basis of Presentation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. </span></div><div style="text-indent:23.4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> family of products, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> dietary supplements. TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is the Company's line of skin, hair, bath &amp; body, and targeted relief products. The Company also markets and sells Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its companion pet supplement formulated to combat oxidative stress in dogs, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> its nootropic energy drink mixes, and PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, its smart weight management system.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein have been prepared by the Company&#8217;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#8217;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of September&#160;30, 2022, and the results of operations for the three months ended September&#160;30, 2022 and 2021, and the cash flows for the three months ended September&#160;30, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#8217;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120677952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of com</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended September 30, 2022 and 2021, net foreign currency losses of $0.4 million and $0.2 million, respectively, are recorded in other expense, net. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for three months ended September 30, 2022. For the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> realized losses of $30,000 related to forward contracts, are recorded in other expense, net.  The Company did not hold any derivative instruments at September&#160;30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such risk. Financial instruments with significant credit risk include cash and investments. At September&#160;30, 2022, the Company had $12.2 million in cash accounts at one financial institution and $5.4 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions.  At June&#160;30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company had $15.4&#160;million in cash accounts at one financial institution and $4.8 million in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounts at other financial institutions. As of September&#160;30, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#8217;s cash balances exceeded federally insured limits.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable as of September&#160;30, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of September&#160;30, 2022 and June&#160;30, 2022 is not necessary. No bad debt expense was recorded during the three months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of September&#160;30, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of $1.2 million </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $1.3 million at September 30, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;September&#160;30, 2022 and June&#160;30, 2022, the returns liability reserve, net was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.2 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0.1 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expenses all costs related to research and development activities, as incurred. Research and development expens</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">es for the three months ended September 30, 2022 and 2021 were $0.1 million and $0.2 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the Company recognized income tax expense of $0.2 million and $1.1 million, respectively, which is reflective of the Company&#8217;s current estimated federal, state and foreign effective tax rate. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, the effects of approximately 0.6 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193122762944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Gig Economy Group Investment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Gig Economy Group Investment</a></td>
<td class="text">Gig Economy Group Investment<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Note Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#8217;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $0.0&#160;million in aggregate consideration).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities under ASC 321</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $2.2&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at September&#160;30, 2022 and June&#160;30, 2022.  During the three months ended September&#160;30, 2022 and 2021, there were no impairments recognized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193124957952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ximately <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTU4_994c7e14-50db-4ced-ba65-b8b872893dc3">one</span> to nine years. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.46 years and 3.27%, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, operating lease expense was $0.7 million and $0.8 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at September&#160;30, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining nine months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193124943808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term DebtOn March&#160;30, 2016, the Company entered into a loan agreement (the &#8220;2016 Loan Agreement&#8221;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#8220;Security Agreement&#8221;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.0 million (the &#8220;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#8220;2016 Revolving Loan,&#8221; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#8220;2016 Credit Facility&#8221;). </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#8220;Amendment No. 1&#8221;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#8217;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#8217;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#8217;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of September&#160;30, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193125007248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> September&#160;30, 2022, the company issued no shares of common stock upon the exercise of stock options and 17,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.  During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> September&#160;30, 2021 the company issued 30,000 shares of common stock upon the exercise of stock options and approximately 19,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23 and, on February 17, 2022, the Board of Directors approved an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended September 30, 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased no shares of common stock under this repurchase program. During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company purchased 0.5 million shares of common stock at an aggregate price of $3.5 million under this repurchase program. At&#160;September&#160;30, 2022, there is $27.7 million remaining under this repurchase program.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Certificate of Incorporation authorizes the issuance of preferred stock. However</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as of September&#160;30, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#8217;s board of directors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividends</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the board of directors declared a quarterly cash dividend of $0.03 per share of common stock to be paid on September 15, 2022, to stockholders of record on September 2, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Quarterly cash dividend for the three months ended September&#160;30, 2022 totaled $0.4 million, or $0.03 per share</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193206213888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-Term Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity-Settled Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#8220;2007 Plan&#8221;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of September&#160;30, 2022, there were no stock option awards outstanding under the 2007 Plan.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#8220;2010 Plan&#8221;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices of $9.31 per share, and vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE5OQ_d0bf6ea3-3477-49ad-9fc2-afc2a24fddbb">one</span> to four year vesting periods. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally ten years. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of September&#160;30, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately 14,000 shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#8220;2017 Plan&#8221;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares and 650,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;September&#160;30, 2022, a maximum of 2.9 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 2,440,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of September&#160;30, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of September&#160;30, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Price.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Offering Periods.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duri</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ng the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;30, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately 36,000 and 27,000 shares of common stock were issued under the ESPP, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2022 and 2021, compensation of $0.6 million and $0.6 million, respectively. was reflected as an increase to additional</span> paid-in capital, all of which was employee related.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193122632960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#8217;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  September&#160;30, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Accruals</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class Action Lawsuit (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Smith v. LifeVantage Corp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.): </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#8217;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#8217; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#8217; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#8217; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#8217;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#8217; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#8217; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#8217;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#8217;s motion for class certification. This case has been stayed by the Court until November 25, 2022. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">    </span>In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120736336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#8217;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#8217; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded </span></div>as a separate component of stockholders&#8217; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Instruments and Hedging Activities</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative Instruments and Hedging Activities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.</span></div>To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableThe Company&#8217;s accounts receivable as of September&#160;30, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#8217;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of September&#160;30, 2022 and June&#160;30, 2022 is not necessary.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1&#8212;Quoted prices for identical instruments in active markets; </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2&#8212;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3&#8212;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition And Shipping and Handling</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates the majority of its revenue through product sales to customers. These products include the Protandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of dietary supplements, LifeVantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Omega+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, ProBio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, IC Bright</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Daily Wellness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> dietary supplements, TrueScience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> skin, hair, bath &amp; body and targeted relief, Petandim</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Axio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;nootropic energy drink mixes, and the PhysIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.</span></div>Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#8217;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping and Handling</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#8220;ROU&#8221;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments </span></div>made and excludes lease incentives and initial direct costs incurred. The Company&#8217;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#8217;s lease agreements do not contain any residual value guarantees.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income Per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Per Share</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#8217;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp; Europe region.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193119897200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Components of Inventory</a></td>
<td class="text">As of September&#160;30, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:31.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,636&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Net Income Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,316&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock awards and options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share, diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue Disaggregated by Geographic Regions</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia/Pacific &amp; Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,774&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,224&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information as to the Company&#8217;s revenue from operations in the most significant geographical areas is set forth below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,658&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,549&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193122626272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease, Cost</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases was as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturity of lease liabilities at September&#160;30, 2022 are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:82.501%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023 (remaining nine months ending June 30, 2023)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,539&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,039&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121230528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>region </div>
<div>segment </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction loss, realized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments, realized loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_MoneyBackGuaranteePeriod', window );">Money back guarantee period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems', window );">Return period for resalable and restockable Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems', window );">Refund percent for resalable and restockable Items</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_HandlingAndRestockingFeePercentage', window );">Handling and restocking fee, percentage (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ReturnLiabilityReserve', window );">Return liability reserve</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 242,000<span></span>
</td>
<td class="nump">$ 1,116,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from EPS calculation (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NumberOfGeographicSegments', window );">Number of geographic segments | region</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember', window );">Cash accounts held primarily at One Financial Institution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">12,200,000<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember', window );">Cash held primarily at Other Financial Institutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Concentration of credit risk</a></td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts With Customers, Refund Percent For Resalable And Restockable Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contracts With Customers, Return Period For Resalable And Restockable Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_HandlingAndRestockingFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Handling and Restocking Fee, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_HandlingAndRestockingFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_MoneyBackGuaranteePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Money back guarantee period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_MoneyBackGuaranteePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NumberOfGeographicSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of geographic segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NumberOfGeographicSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ReturnLiabilityReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return Liability Reserve</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ReturnLiabilityReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120650224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Components of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 14,571<span></span>
</td>
<td class="nump">$ 12,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials</a></td>
<td class="nump">4,065<span></span>
</td>
<td class="nump">3,798<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 18,636<span></span>
</td>
<td class="nump">$ 16,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory', window );">Finished goods, percent of inventory (in percentage)</a></td>
<td class="nump">78.20%<span></span>
</td>
<td class="nump">76.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_RawMaterialsPercentOfTotalInventory', window );">Raw materials, percent of inventory (in percentage)</a></td>
<td class="nump">21.80%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_InventoryPercentOfTotalInventory', window );">Percent of total inventory (in percentage)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryFinishedGoodsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Finished Goods, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryFinishedGoodsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_InventoryPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_InventoryPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_RawMaterialsPercentOfTotalInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Raw Materials, Percent Of Total Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_RawMaterialsPercentOfTotalInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121363920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 3,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,457<span></span>
</td>
<td class="nump">13,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock awards and options (in shares)</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">12,495<span></span>
</td>
<td class="nump">13,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share, basic (in USD per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share, diluted (in USD per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193119396304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Segment Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 51,774<span></span>
</td>
<td class="nump">$ 53,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">36,369<span></span>
</td>
<td class="nump">36,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember', window );">Asia/Pacific &amp; Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">15,405<span></span>
</td>
<td class="nump">16,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">34,658<span></span>
</td>
<td class="nump">34,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">21,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,790<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JP', window );">Japan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">8,168<span></span>
</td>
<td class="nump">$ 9,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 1,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,869<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=lfvn_AsiaPacificAndEuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121338048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Gig Economy Group Investment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 16, 2019</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities held without readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment', window );">Notes receivable, related party, maximum commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt', window );">Debt conversion, original debt, interest rate of debt (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">GEG | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted instrument, shares issued (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted instrument, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_NotesReceivableRelatedPartyMaximumCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Related Party, Maximum Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_NotesReceivableRelatedPartyMaximumCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtInterestRateOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtInterestRateOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193120894176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">8 years 5 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (as a percent)</a></td>
<td class="nump">3.27%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193121393248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease, Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193119413936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturity of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (remaining nine months ending June 30, 2023)</a></td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">8,123<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">17,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(2,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 15,039<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, Payments Due, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193115143264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th">
<div>Feb. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 04, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 03, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 30, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentFloorInterestRate', window );">Floor interest rate (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | US Treasury (UST) Interest Rate | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember', window );">March 2016 Term Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Quarterly installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Fixed rate interest on debt (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.68%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.93%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentTrailingPeriod', window );">Trailing period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio', window );">Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio', window );">Debt instrument, covenant, fixed charge coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital', window );">Debt instrument, covenant, required minimum working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payment of cash dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember', window );">March 2016 Revolving Loan | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum capacity on draw</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_DebtInstrumentCovenantMaximumAllowedDividends', window );">Debt instrument, covenant, maximum allowed dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Fixed Charge Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantMaximumAllowedDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Maximum Allowed Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantMaximumAllowedDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Required Minimum Working Capital</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Floor Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_DebtInstrumentTrailingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Trailing Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_DebtInstrumentTrailingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_UsTreasuryUstInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lfvn_March2016RevolvingLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193116320192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 15, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Feb. 17, 2022</div></th>
<th class="th"><div>Aug. 27, 2020</div></th>
<th class="th"><div>Feb. 01, 2019</div></th>
<th class="th"><div>Nov. 27, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Repurchase common stock amount authorized (up to)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000,000<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of company stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,492,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend, common stock declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividend paid (in dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends, common stock, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares canceled or surrendered as payment of tax withholding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193119003024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2020</div></th>
<th class="th"><div>Nov. 15, 2018</div></th>
<th class="th"><div>Feb. 02, 2018</div></th>
<th class="th"><div>Sep. 27, 2010</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 21, 2006</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock based compensation reflected in additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember', window );">2007 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm', window );">Contractual term of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, net of awards expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Right to purchase common stock, minimum price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember', window );">2010 Long-Term Incentive Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based payment award, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, net of awards expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">650,000<span></span>
</td>
<td class="nump">715,000<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember', window );">2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,440,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common Stock, capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for issuance under the ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Maximum number of shares per employee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted', window );">Amount in excess of fair market value of stock for option not to be granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod', window );">Offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lfvn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndSevenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lfvn_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140193122534832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Claims dismissed</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Pending claims</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>lfvn-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lfvn="http://www.lifevantage.com/20220930"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lfvn-20220930.xsd" xlink:type="simple"/>
    <context id="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6856ea53c1704440948a893bb1e74c15_I20221101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="i880f6ec9d0804b6fb4548530f81b7956_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id131ac0747904e089c449612a8c5c709_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i134c0b1b046448648f3d5b336aadf135_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i772c3990679040deb003807e322e476d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifd874c225db84fa692c8f0221e9780f7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i300ef21b8a32406f85a8fce070f62833_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i65ee8ebabf91481da59551eb50755285_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i30d47334a25b4d05bf35eb2fc4cac648_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i142357a5c6e948f8921ab76bcc4e3980_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8a4a8394481341fcb8c2b42fce932721_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic912ea6c452d4756ad15fcde7ddd86a5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib49d1d736bed499fbe9fe5f9d1dc89f7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3e24f72d093b44669e0b2c6422958fd3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6b9681a3c672475a84d9bba889cdf521_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3d4ba4946fe945eb89d86d3343e4c4c1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26d3269d23ed46ada597b50493898abc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i91ee4c90e2c44881aeb0c71eb0112c0e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7b7514593bd74a78a67f8118af0c54be_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i905940febcac4f6fb8131e1282d2be84_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0ecb61b96c094f12ae3c415be0611510_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idaa677e07c6d457c8eece153824244a4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i78d3fcefe8f444849b3d928b4112c0a6_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iff5c682417d44fc6afa71d4889a5fe31_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i21ed018d6d084503a906e48fc59af41e_D20220930-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-30</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8404347bcfbe4f78be26db732735d417_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldPrimarilyAtFinancialInstitutionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i03174868560f44ff80cf933d2f69ab68_D20220630-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">lfvn:CashAccountsHeldatOtherFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib732a4247f1c4b9f9cef9f2ced8879ce_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i402d171eca914ca896c2460efa80a95d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe7711d279984593aa89a86b806404b8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i939ab82e679a4c00953b5bcdb1aa7115_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">lfvn:AsiaPacificAndEuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i429b06262ff74cbc894e05c074db49f0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i46736b895fa9494fb40c592102713ba8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia36a6256f3744258b47971555a767ab1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5e7f9e3862de4c17a2b53bbc46589c1d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibfdce7f7d47e4eb1b5e54bb8f86005b4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic7afcea9cb8e4e9c88e904f1a007bcb5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6b8444b610764ffab7c655e6f33040ba_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1dca30b124b04669a1465dfa6dd2bbc0_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JP</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie2be38077dec479a8c4f830a7cc40030_I20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-31</instant>
        </period>
    </context>
    <context id="ie46dcc75834340edbbb0d6971d255894_D20190531-20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-05-31</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityInterestIssuedOrIssuableByTypeAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-16</startDate>
            <endDate>2019-12-16</endDate>
        </period>
    </context>
    <context id="i977658914054449698f6d6c732ed2032_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia6f19746429c4cdca994057d70e98d3a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ica5344233c204858b6afe60475269d38_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i6036eac111f84de4a9039a3e7d031527_I20160330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-03-30</instant>
        </period>
    </context>
    <context id="i14dbc7cf32884923b5dc54345b785092_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i75b346e2c97643deb010bf416bf02431_I20180503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-03</instant>
        </period>
    </context>
    <context id="icf1f3dc19a5f44f8b47022c121a77785_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="ie05a0f91cf5441fca02cab96f9dd1693_D20180504-20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-04</startDate>
            <endDate>2018-05-04</endDate>
        </period>
    </context>
    <context id="ic93efb3d8dea497aa299e88710676864_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="ie69d6cfdbf8c46398d7508667051f58b_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="i1887e1c461be424086a7149e6dcee766_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="ifc83d833f5664c16b3b8e21685061d73_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="iec815bc3224c4b2eb6f03e0428ec3199_I20180504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-04</instant>
        </period>
    </context>
    <context id="i454d5b7910c542ef883eed9a307e6da4_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:UsTreasuryUstInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="iac6026a96d5b4fe780ee9d2e9d5aafe2_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i7eae71368a024d6ba653f381ffe0db1c_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i11854662ecd64eb0ae73d899d84d814f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lfvn:March2016RevolvingLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i88116b05befd4416b9cb7a08d858f271_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7191113c25f247479215258c91e7ce5a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i071a21c613194e0ab1b99e7ce4356c02_I20171127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2017-11-27</instant>
        </period>
    </context>
    <context id="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="if01d6b23161a4099ae7e64005f8ac196_I20200827">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2020-08-27</instant>
        </period>
    </context>
    <context id="i0fbeb3758f03482b8e51a3ca187c8244_I20220217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2022-02-17</instant>
        </period>
    </context>
    <context id="iaa6a6dc1ee6443578385523d83f7da3c_D20220915-20220915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-09-15</startDate>
            <endDate>2022-09-15</endDate>
        </period>
    </context>
    <context id="i6c951d2923244147b9f226b2ae6d9238_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i7c717bd0b67741c8b344ee3df55eb9dc_I20061121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndSevenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2006-11-21</instant>
        </period>
    </context>
    <context id="i1f9cb90e49c84d6a98d875ed5d38d73b_I20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2010-09-27</instant>
        </period>
    </context>
    <context id="i26ba0558720045eea67b29115b0a3986_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="iaadfa48ed71d4f0fa49a9f9c6323fd8a_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="i4f8f7854e7764dc285105b899092b475_D20100927-20100927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-09-27</startDate>
            <endDate>2010-09-27</endDate>
        </period>
    </context>
    <context id="ib9e2ea205a3d43158e970a0c0f8f359f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if899b129124943fe800d819b6de66ec3_D20180202-20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-02</startDate>
            <endDate>2018-02-02</endDate>
        </period>
    </context>
    <context id="i1a45671ea82d4f1a932759250eb31f16_D20181115-20181115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-15</startDate>
            <endDate>2018-11-15</endDate>
        </period>
    </context>
    <context id="ifdc4810b41d540409fbcb3fe43b196b2_D20201112-20201112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-12</startDate>
            <endDate>2020-11-12</endDate>
        </period>
    </context>
    <context id="ie4cb4a2f4cdf4160909164d620456770_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i44c9e56976144431bc767f09ba938466_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="ifcad4b991602480e8c333048b37bc386_I20180202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandAndTenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-02</instant>
        </period>
    </context>
    <context id="i4218dd95179b44ee93fbc3f2fa44e6e1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:TwoThousandSeventeenLongTermIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lfvn:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <startDate>2019-12-05</startDate>
            <endDate>2019-12-05</endDate>
        </period>
    </context>
    <context id="idccc1f3bca2347cc8ac18f61b4fb2b0d_I20191205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000849146</identifier>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="region">
        <measure>lfvn:region</measure>
    </unit>
    <unit id="segment">
        <measure>lfvn:segment</measure>
    </unit>
    <unit id="claim">
        <measure>lfvn:claim</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV8yLTEtMS0xLTI3MTE2_48885d52-4bb0-402e-89a3-4e9078032041">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV8zLTEtMS0xLTI3MTE2_f40b3e46-a7e6-4149-9129-6693c69b2846">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV80LTEtMS0xLTI3MTE2_efa7011c-aa5a-473d-803b-ab9b743d9651">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV81LTEtMS0xLTI3MTE2_e4266568-bf8c-4500-9ef1-db1da86250e5">0000849146</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80L2ZyYWc6NDY1YWY4ZWY1ZjU1NGU3OWE1NjU2OGFjODdmOTUzODIvdGFibGU6YzYwYjZmOWNmMGNiNDVhYzlmODI2ODc0ZTc3ZDI3MTUvdGFibGVyYW5nZTpjNjBiNmY5Y2YwY2I0NWFjOWY4MjY4NzRlNzdkMjcxNV82LTEtMS0xLTI3MTE2_eb287945-3a08-44ee-bf84-73cde8759f39">--06-30</dei:CurrentFiscalYearEndDate>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80My9mcmFnOjQ3M2Y0YmFlZTk5OTRmYzRhOGU1YmQ3ZGE0ZTc5ODNhL3RhYmxlOmY5ODQ4NWNmZTBhZjRkYzliZDI4ZmUwNzBkODI0YmM0L3RhYmxlcmFuZ2U6Zjk4NDg1Y2ZlMGFmNGRjOWJkMjhmZTA3MGQ4MjRiYzRfMi0xLTEtMS0yNzExNg_642023d8-7dac-4854-801f-68152f06ac0d"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i977658914054449698f6d6c732ed2032_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTU4_994c7e14-50db-4ced-ba65-b8b872893dc3">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i26ba0558720045eea67b29115b0a3986_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE5OQ_d0bf6ea3-3477-49ad-9fc2-afc2a24fddbb">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xNjQ_fdd8889c-894e-4a59-9be1-cb9f23806af9">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MWJmNjU2OWIzMzVjNDlhNzgxOGFiOTc1MjVmM2YzOTQvdGFibGVyYW5nZToxYmY2NTY5YjMzNWM0OWE3ODE4YWI5NzUyNWYzZjM5NF8wLTAtMS0xLTI3MTE2_c2128c90-668d-45be-86ee-ef5d12d83ba9">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yODE_89a3aee6-0c40-48d1-970a-7087e2fd2d6d">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6ZTJhMDMxYjMwOTUzNGQ1ZWEzZDZlMTVmY2I1NDAyZmEvdGFibGVyYW5nZTplMmEwMzFiMzA5NTM0ZDVlYTNkNmUxNWZjYjU0MDJmYV8wLTAtMS0xLTI3MTE2_eab7ae1f-86aa-4fee-918b-85b8d1b97808">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18zNjY_9b92f888-c43c-4f31-ac45-f0cc035e168c">001-35647</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM180NTE_4a8b62c9-2ff1-40ca-b904-b3c82a7066f7">LIFEVANTAGE CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY2Y2YyMTljYjgwNGFkODk0OWE3YTU2MzNlMDIyM2MvdGFibGVyYW5nZToxNjZjZjIxOWNiODA0YWQ4OTQ5YTdhNTYzM2UwMjIzY18wLTAtMS0xLTI3MTE2_c5b3d712-6649-401f-b92d-c8750387b80f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY2Y2YyMTljYjgwNGFkODk0OWE3YTU2MzNlMDIyM2MvdGFibGVyYW5nZToxNjZjZjIxOWNiODA0YWQ4OTQ5YTdhNTYzM2UwMjIzY18wLTItMS0xLTI3MTE2_03bfb1f8-14de-4788-9a34-df42d284342b">90-0224471</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEy_d16cc90b-37a8-4231-9484-a4e3d70be5e0">3300 Triumph Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEz_f7234e84-eae9-48cf-9316-03847944215a">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDE0_f41d794e-451a-45c0-abd6-3a772c9be852">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182MzU_ca413316-5837-4c91-b57a-a84db50358ff">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182Mzg_f35cee5e-816d-486c-8ac0-639ece1c864d">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM183MDM_f2f9ce82-d8fe-42ac-ab93-d426b8f82734">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM183MDc_42d56037-19e9-4591-862e-158d93090b51">432-9000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTAtMS0xLTI3MTE2_317395b3-b0c3-42c8-beb4-65fa8c2072bf">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTItMS0xLTI3MTE2_93de9b6f-991b-4693-a8fe-6cc833a90a21">LFVN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6MTY3MzEwNmYxYjljNDVjOGJhOWQ3YmFiNzFhMjg0NjEvdGFibGVyYW5nZToxNjczMTA2ZjFiOWM0NWM4YmE5ZDdiYWI3MWEyODQ2MV8wLTQtMS0xLTI3MTE2_90023ad7-df75-43c5-8b8a-fe30c0d35e60">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xMjM0_bdbfc997-39ba-4081-9a45-d7119c348187">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18xNTU5_ee581d06-fae9-4057-96db-9c2067db1091">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8wLTItMS0xLTI3MTE2_6a4947d8-1170-456b-a4ef-e86d68a06572">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8xLTMtMS0xLTI3MTE2_c7240fcb-957a-4cd8-a1ad-aa9ec26ef7a2">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGFibGU6YjIwODA5ZTY4OWE5NDYxNGJmYjRlMjM2MzQzNDI5NWUvdGFibGVyYW5nZTpiMjA4MDllNjg5YTk0NjE0YmZiNGUyMzYzNDM0Mjk1ZV8yLTEtMS0xLTI3MTE2_32916bb4-dbf6-469b-b5ef-07ccb76b7fe2">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM182MDQ3MzEzOTU1MjA5_e52f81cd-3018-4b8f-b413-51073a795fd2">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6856ea53c1704440948a893bb1e74c15_I20221101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xL2ZyYWc6OTYxYzNkMjYzZGFjNDc4YjliNzdlNDg3ZWU5MDMyZjMvdGV4dHJlZ2lvbjo5NjFjM2QyNjNkYWM0NzhiOWI3N2U0ODdlZTkwMzJmM18yNDEw_d13b1e59-2018-4362-80b9-1b3808234a9d"
      unitRef="shares">12569302</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNC0xLTEtMS0yNzExNg_86769409-eae5-4611-8fea-d0ff265c9d02"
      unitRef="usd">17619000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNC0zLTEtMS0yNzExNg_9161877f-1851-4822-acda-5b3ca927aaa9"
      unitRef="usd">20190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNS0xLTEtMS0yNzExNg_b7b2fa86-6a65-44a0-ac40-e0a35cb060aa"
      unitRef="usd">1916000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNS0zLTEtMS0yNzExNg_062d2dbd-a487-476d-bcc3-7449108b0182"
      unitRef="usd">3338000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNi0xLTEtMS0yNzExNg_1fed2a51-5282-429f-b38f-92730b6b2230"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNi0zLTEtMS0yNzExNg_eccb1ff3-ee72-4c71-b847-1430d0fa8e1a"
      unitRef="usd">1752000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:InventoryNet
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNy0xLTEtMS0yNzExNg_d371181f-f5c5-490c-a79c-0e2a9bc7ebc2"
      unitRef="usd">18636000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNy0zLTEtMS0yNzExNg_79e77ea0-1f65-4e28-9423-1ad72d663d70"
      unitRef="usd">16472000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfOS0xLTEtMS0yNzExNg_547211c6-4a3f-436e-869c-59b2b5f78804"
      unitRef="usd">4752000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfOS0zLTEtMS0yNzExNg_d1e8c90c-a90a-4a4b-b925-c0418fc32730"
      unitRef="usd">5205000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTAtMS0xLTEtMjcxMTY_d74a4f37-83ac-4892-adea-823b1a90d7ab"
      unitRef="usd">42923000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTAtMy0xLTEtMjcxMTY_b4ad59d3-15aa-4d96-9088-bb5364df3550"
      unitRef="usd">46957000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTItMS0xLTEtMjcxMTY_372788b1-cc25-48b4-8de2-240b78f0e53f"
      unitRef="usd">9403000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTItMy0xLTEtMjcxMTY_558e89fb-bb63-4923-a7d9-c134a799e0e0"
      unitRef="usd">9500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTMtMS0xLTEtMjcxMTY_27b9568e-cbed-4216-bfe0-d78f2cee6496"
      unitRef="usd">10410000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTMtMy0xLTEtMjcxMTY_1d3f09f5-6a63-4947-8dd8-22be5f026d09"
      unitRef="usd">11040000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTQtMS0xLTEtMjcxMTY_f55c4578-ffe1-414d-8c2c-4be20d18ee08"
      unitRef="usd">554000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTQtMy0xLTEtMjcxMTY_2bbc41c4-8bf9-4d2f-858c-3a6969cd5f03"
      unitRef="usd">587000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTUtMS0xLTEtMjcxMTY_04208465-d98d-4a68-b56e-c2c43c9a878b"
      unitRef="usd">3044000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTUtMy0xLTEtMjcxMTY_1ec7a2e1-bc2a-471e-b419-1e7785176c67"
      unitRef="usd">1289000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTctMS0xLTEtMjcxMTY_e983cd8c-8c18-4041-af9b-f30bf8d78ae1"
      unitRef="usd">1266000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTctMy0xLTEtMjcxMTY_47fb04a4-f3db-44d6-81b2-c5f0d705c3f4"
      unitRef="usd">1333000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTgtMS0xLTEtMjcxMTY_fb79b02d-554f-403e-bb78-27ac4a83c41d"
      unitRef="usd">67600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMTgtMy0xLTEtMjcxMTY_853d9fb2-9bf0-447c-9235-0f8eaa48178c"
      unitRef="usd">70706000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjItMS0xLTEtMjcxMTY_7da4e8e3-1b92-48a7-ac2b-b37c2be10231"
      unitRef="usd">7846000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjItMy0xLTEtMjcxMTY_d7a3acf6-2d59-4b97-b882-35f40f22de5b"
      unitRef="usd">7462000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjMtMS0xLTEtMjcxMTY_277798ca-feca-4fc0-947c-09e2acb029f6"
      unitRef="usd">7367000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjMtMy0xLTEtMjcxMTY_f757f13f-96db-4b98-a419-6743d89122e7"
      unitRef="usd">7285000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjYtMS0xLTEtMjcxMTY_424df2ea-8340-40b2-afbf-a7e8ad7b9396"
      unitRef="usd">107000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:TaxesPayableCurrentAndNoncurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjYtMy0xLTEtMjcxMTY_cea0b0cc-c556-4564-9822-9d31de6c6470"
      unitRef="usd">453000</us-gaap:TaxesPayableCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjctMS0xLTEtMjcxMTY_7fdf40d9-4f60-4dff-9bc8-92cd09598691"
      unitRef="usd">2397000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjctMy0xLTEtMjcxMTY_3b00feb7-c686-44a3-9360-952e0ec674ca"
      unitRef="usd">2601000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjgtMS0xLTEtMjcxMTY_79c96a53-38d3-440f-bc8f-55333206d2ac"
      unitRef="usd">5052000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMjgtMy0xLTEtMjcxMTY_c80eb12a-7130-4d93-9fe0-436d04498bee"
      unitRef="usd">7927000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzAtMS0xLTEtMjcxMTY_34be9451-42d1-4f56-9075-64c0e2bd0157"
      unitRef="usd">22769000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzAtMy0xLTEtMjcxMTY_c434a2e2-04eb-44e7-ac96-be85225eee10"
      unitRef="usd">25728000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzYtMS0xLTEtMjcxMTY_df4cdd6d-a402-4902-bb5c-2814003110d5"
      unitRef="usd">12642000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzYtMy0xLTEtMjcxMTY_10f20c11-20a6-4d14-97ae-e6ea814b0ff8"
      unitRef="usd">13154000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzctMS0xLTEtMjcxMTY_0e556217-8a1f-4bc3-bee1-4c7be0156164"
      unitRef="usd">299000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzctMy0xLTEtMjcxMTY_fb60d476-7124-475e-b956-b3ee65114aa8"
      unitRef="usd">308000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzgtMS0xLTEtMjcxMTY_3ea1a446-5a5c-4104-bdd3-6c8f1fcfe024"
      unitRef="usd">35710000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzgtMy0xLTEtMjcxMTY_d9391a8c-6344-4d48-b411-d6e55be653be"
      unitRef="usd">39190000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzktMS0xLTEtMjcxMTY_ed123740-6c69-4862-80ac-ae8648c41819"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfMzktMy0xLTEtMjcxMTY_2ba03464-db45-43d2-9180-83655129cdf1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF8zMg_4120d28f-012a-44ee-a480-2d38a5717ffd"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF8zMg_dfbf9300-fd31-4586-8dbb-a62fb2e55168"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF80Ng_b38420c2-70fb-48a6-beb1-6b892c49c09f"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF80Ng_ce0b5d0b-e096-4b2b-8ca7-27f2fd461e43"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_2d16c40e-33f3-46c7-9429-a1756cea7d74"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_7b2caa0c-3e4b-4f3e-8361-aacfed7ae4c7"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_8bc151e7-a1e9-4b3a-953a-f3434574bec9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjo0NzM1ZTdiOTNhMTY0YWUxYWRkYmIwNDQ0OWFmMjRkOF82OA_8bca26c6-79e1-47ae-8c7f-63e3f636f536"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMS0xLTEtMjcxMTY_4e3bf21c-f670-4000-8cc1-9b325019fae8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDEtMy0xLTEtMjcxMTY_4c7e7397-ad45-449a-bec6-20c85a810a42"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl8zMA_d705b8cb-a752-458d-b365-99bc61ed09ed"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl8zMA_dcce3950-0ba7-46ce-b3db-71aa3ed0a45b"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl80NA_415fc9ec-f0fd-46b4-a221-3726dded9ea5"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl80NA_d319044b-0d40-432f-9541-624d7aa60448"
      unitRef="shares">40000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl82OQ_27fe81d9-c063-4d76-9e9e-e292333eecb1"
      unitRef="shares">12560000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl82OQ_fff3b630-a53b-4687-89e7-b2abe6a355c5"
      unitRef="shares">12560000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl83Ng_a101fbfb-a5cd-4d1b-aeb0-43b106736f19"
      unitRef="shares">12493000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMC0xLTEtMjcxMTYvdGV4dHJlZ2lvbjpkN2U5MWE3NTUxZmE0ZDM3ODIzNTczN2MxNWI2MzBiMl83Ng_aeca09cd-06a0-4c80-94bb-7c46f740b2d2"
      unitRef="shares">12493000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMS0xLTEtMjcxMTY_d1991dd8-79eb-4c66-8b93-850ed66240a0"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDItMy0xLTEtMjcxMTY_3382f7e9-1a68-40c5-8b22-71cc1a7dc733"
      unitRef="usd">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDMtMS0xLTEtMjcxMTY_12193280-87bc-4d39-8bf8-a0c4e110d11a"
      unitRef="usd">131726000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDMtMy0xLTEtMjcxMTY_88d4e8d9-0c33-4e3f-84e9-359b46f0c899"
      unitRef="usd">131075000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDQtMS0xLTEtMjcxMTY_37dec837-696a-4ad5-9850-e995bd2c5534"
      unitRef="usd">-98204000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDQtMy0xLTEtMjcxMTY_ef5ce950-cf2c-4093-876d-7cc258c88598"
      unitRef="usd">-98437000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDUtMS0xLTEtMjcxMTY_b87f78e2-bdfc-4af9-bad2-fd7913668629"
      unitRef="usd">-1633000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDUtMy0xLTEtMjcxMTY_e078f161-879e-493b-8b2b-621a81aa2ce2"
      unitRef="usd">-1123000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDYtMS0xLTEtMjcxMTY_b47e3b36-37e4-4ac1-a2c6-2e0851786803"
      unitRef="usd">31890000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDYtMy0xLTEtMjcxMTY_eb01c39a-de47-4e8e-8b96-d4b9f00c843f"
      unitRef="usd">31516000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDctMS0xLTEtMjcxMTY_b07f9e6c-e609-49f6-b45e-bc9aacd813a5"
      unitRef="usd">67600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8xOS9mcmFnOmRlMjY2ZTM1ZGUwNDRjYjZhNzMzMjllYzJmZDkyNTQ5L3RhYmxlOjVlMDAyMWUxMjczZDQ1MjZhNjc5ODBmZTRkOTNkMWFiL3RhYmxlcmFuZ2U6NWUwMDIxZTEyNzNkNDUyNmE2Nzk4MGZlNGQ5M2QxYWJfNDctMy0xLTEtMjcxMTY_25dec42d-7100-43e5-a62d-70487f327e7e"
      unitRef="usd">70706000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMy0xLTEtMS0yNzExNg_d7dbfcb5-5638-4283-b925-9d0221cad667"
      unitRef="usd">51774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMy0zLTEtMS0yNzExNg_e78d1e93-99c2-4940-9381-644147462087"
      unitRef="usd">53224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNC0xLTEtMS0yNzExNg_27b9414d-5478-434e-bdd2-cdb2dfdb0431"
      unitRef="usd">9942000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNC0zLTEtMS0yNzExNg_48e1fdfc-0301-4758-8719-adfc23904c30"
      unitRef="usd">9431000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNS0xLTEtMS0yNzExNg_bc946b85-9c8a-46a8-9f5e-a82b99ecb16b"
      unitRef="usd">41832000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNS0zLTEtMS0yNzExNg_a09fabbe-aa54-4bd4-b276-231b0f911af2"
      unitRef="usd">43793000</us-gaap:GrossProfit>
    <lfvn:CommissionAndIncentives
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNy0xLTEtMS0yNzExNg_a32568fd-44ef-488d-92e9-299a5e32ff00"
      unitRef="usd">23813000</lfvn:CommissionAndIncentives>
    <lfvn:CommissionAndIncentives
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfNy0zLTEtMS0yNzExNg_1a1fe274-bdbe-4eb1-b4bb-2a786137f801"
      unitRef="usd">24105000</lfvn:CommissionAndIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfOC0xLTEtMS0yNzExNg_31b8b5fa-0191-46c2-b3ba-d94b0232526d"
      unitRef="usd">16729000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfOC0zLTEtMS0yNzExNg_128201d2-b099-4682-8323-a5b3f30e9711"
      unitRef="usd">15076000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTEtMS0xLTEtMjcxMTY_1d3e8494-9fce-4531-adb7-032977971445"
      unitRef="usd">40542000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTEtMy0xLTEtMjcxMTY_ba3e61c8-1885-4076-86c5-bf868ee26e62"
      unitRef="usd">39181000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTItMS0xLTEtMjcxMTY_db911ec1-1815-4864-80a3-ee642cccf1b0"
      unitRef="usd">1290000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTItMy0xLTEtMjcxMTY_b4893db6-e7a5-42d8-bfc9-5aedb2d1d756"
      unitRef="usd">4612000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTQtMS0xLTEtMjcxMTY_dac20eb8-c2db-4e6a-b567-d1710657b201"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTQtMy0xLTEtMjcxMTY_7929363c-6369-4280-8051-9f41719ca5fe"
      unitRef="usd">3000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTUtMS0xLTEtMjcxMTY_b35b346a-cf8f-4b75-ad78-1983ccfaa59b"
      unitRef="usd">-438000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTUtMy0xLTEtMjcxMTY_53e2eea8-92ee-4c89-b243-5b288ea2270e"
      unitRef="usd">-177000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTctMS0xLTEtMjcxMTY_e56d60f1-2929-40af-9028-77b4c4386704"
      unitRef="usd">-438000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTctMy0xLTEtMjcxMTY_6fbf0689-a7c5-4a6b-822f-2ab74ea90f9c"
      unitRef="usd">-180000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTgtMS0xLTEtMjcxMTY_0f7a971e-c72f-4788-bdfc-49abd71c5cb0"
      unitRef="usd">852000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTgtMy0xLTEtMjcxMTY_c1a3b099-2d96-489b-99fa-437c1b8ab17c"
      unitRef="usd">4432000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTktMS0xLTEtMjcxMTY_fb3fe919-dddd-438c-9874-d6265e69ab88"
      unitRef="usd">242000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMTktMy0xLTEtMjcxMTY_8f8f6a88-8f63-4402-bc51-c06629cf96b1"
      unitRef="usd">1116000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjAtMS0xLTEtMjcxMTY_92d783d5-07e6-4f84-a7e0-7f01fd0510e6"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjAtMy0xLTEtMjcxMTY_a004ab79-9739-4527-862c-cb3d4fec9d64"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjItMS0xLTEtMjcxMTY_9ddc0000-b66c-44de-9286-f38f78e5028a"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjItMy0xLTEtMjcxMTY_03eec91e-d0ba-4a55-a4aa-c15a53d43701"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjMtMS0xLTEtMjcxMTY_fdac9da9-88ff-4f1f-808d-7ae033de475d"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjMtMy0xLTEtMjcxMTY_ea25990c-503e-40ff-888f-eed6300666cb"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjUtMS0xLTEtMjcxMTY_2a054f67-1bd3-4962-8aca-4d524fa0db87"
      unitRef="shares">12457000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjUtMy0xLTEtMjcxMTY_1dea4fdc-c577-4c5f-a5f5-7a091dbefb68"
      unitRef="shares">13394000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjYtMS0xLTEtMjcxMTY_51f9463c-2a1c-4a2d-b078-ee2e60042b04"
      unitRef="shares">12495000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjYtMy0xLTEtMjcxMTY_193cf361-6f50-478a-bd8d-62ee72d6ff11"
      unitRef="shares">13469000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjgtMS0xLTEtMjcxMTY_94ae3a48-180a-48c5-b648-8603574e0a47"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMjgtMy0xLTEtMjcxMTY_b6581aff-7623-424d-bae1-532c207c763b"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzAtMS0xLTEtMjcxMTY_268fc34d-394d-46c1-8431-f3363d0c9448"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzAtMy0xLTEtMjcxMTY_23ff2fbf-ed0d-4993-bf0a-0275d83d9a9b"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzEtMS0xLTEtMjcxMTY_903cb5c7-0419-435a-9a10-3f4e18ce01d9"
      unitRef="usd">100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yMi9mcmFnOmUwNjJiOWM1OWQ0MjQ0MWQ5ODljODI1MjNiODUxMTJmL3RhYmxlOmIxNzM1NjIwYTg3NjQ2NTNiN2E1YTRjMzZiMTgyYmUwL3RhYmxlcmFuZ2U6YjE3MzU2MjBhODc2NDY1M2I3YTVhNGMzNmIxODJiZTBfMzEtMy0xLTEtMjcxMTY_7b77caff-651a-4f24-81f1-42387677bf9f"
      unitRef="usd">3181000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i134c0b1b046448648f3d5b336aadf135_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0xLTEtMS0yNzExNg_0b1da986-78e4-4ce1-a7e9-3981e9f3f513"
      unitRef="shares">12493000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i134c0b1b046448648f3d5b336aadf135_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0zLTEtMS0yNzExNg_265aec8e-a561-4ff8-964f-f98fc6d8609a"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i772c3990679040deb003807e322e476d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy01LTEtMS0yNzExNg_c661e986-1051-4d4a-89cc-14ce8cd17ef8"
      unitRef="usd">131075000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd874c225db84fa692c8f0221e9780f7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy03LTEtMS0yNzExNg_b1da8713-66f9-4f43-bbfc-af1be07fe9e3"
      unitRef="usd">-98437000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i300ef21b8a32406f85a8fce070f62833_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy05LTEtMS0yNzExNg_01c00e2d-10b2-4f08-8ce3-6b4a7f198942"
      unitRef="usd">-1123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMy0xMS0xLTEtMjcxMTY_2d9064c7-0580-4d5a-a74c-dad91262e744"
      unitRef="usd">31516000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNS01LTEtMS0yNzExNg_5a4f27a0-2924-4915-8fc2-d1958068fe10"
      unitRef="usd">602000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNS0xMS0xLTEtMjcxMTY_3b478346-0ef5-42b6-a153-a0b8953743a0"
      unitRef="usd">602000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNy0xLTEtMS0yNzExNg_76df20fa-4910-476a-a5f6-3980f59e872e"
      unitRef="shares">48000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfNy0xMS0xLTEtMjcxMTY_24856160-d315-49dd-a4d0-7afd33e13ad6"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC0xLTEtMS0yNzExNg_3a1f0550-f985-411a-9276-e24fbf0b14c1"
      unitRef="shares">17000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC01LTEtMS0yNzExNg_5cd480ae-a3dc-4a57-9326-b8d9acd81668"
      unitRef="usd">72000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfOC0xMS0xLTEtMjcxMTY_f831abdf-28c5-4ec9-a353-78be90a053da"
      unitRef="usd">72000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i65ee8ebabf91481da59551eb50755285_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtMS0xLTEtMjcxMTY_db89dc26-dc81-4df0-8f53-a8d68f18589d"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2e8f61e841324a32bc4ddcd6e05683ba_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtNS0xLTEtMjcxMTY_bb7274cd-225f-4013-bcfa-3d136e778dcd"
      unitRef="usd">121000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTAtMTEtMS0xLTI3MTE2_8a34e639-0ec9-4466-85f5-115c9065e91f"
      unitRef="usd">121000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:DividendsCash
      contextRef="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtNy0xLTEtMjkzODY_f0ff1e9b-e67d-4984-9a53-d9c22c44e393"
      unitRef="usd">377000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtMTEtMS0xLTI5Mzg2_c8d6971f-8aad-4654-aab2-0110d1afee16"
      unitRef="usd">377000</us-gaap:DividendsCash>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i30d47334a25b4d05bf35eb2fc4cac648_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtOS0xLTEtMjcxMTY_0eebdb51-a8da-4b5d-bb99-45f7c62342e6"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTEtMTEtMS0xLTI3MTE2_848874c1-f122-48d0-a653-48f9b1bee9c0"
      unitRef="usd">-510000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i92077ec60c474ef49a4f908019b0e8a4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTItNy0xLTEtMjcxMTY_aabf17fc-0771-4226-bc64-bca94dcec609"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTItMTEtMS0xLTI3MTE2_4051e58a-d016-4919-957c-5dd126133e54"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i142357a5c6e948f8921ab76bcc4e3980_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMS0xLTEtMjcxMTY_b765f7e4-6bdb-4b7d-926c-d809ce89a38b"
      unitRef="shares">12560000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i142357a5c6e948f8921ab76bcc4e3980_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMy0xLTEtMjcxMTY_e8d4d45c-0543-4484-ba0e-f27fd09e633b"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8a4a8394481341fcb8c2b42fce932721_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtNS0xLTEtMjcxMTY_181af417-a5ae-4b90-9534-dcea07ca7d37"
      unitRef="usd">131726000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic912ea6c452d4756ad15fcde7ddd86a5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtNy0xLTEtMjcxMTY_09f28d5e-ebf7-4600-80b8-47399b71f3b7"
      unitRef="usd">-98204000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib49d1d736bed499fbe9fe5f9d1dc89f7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtOS0xLTEtMjcxMTY_4881c98f-04aa-483a-8653-ec58b08ce448"
      unitRef="usd">-1633000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yNS9mcmFnOjg1YjI2MTZhODE4MTQ3ZDU4ZmZmM2RkMTBhMzJhODY1L3RhYmxlOmYwZTllMDdjODE0MjRhM2Y4ZDgyNDEwNzc5MGExMjM1L3RhYmxlcmFuZ2U6ZjBlOWUwN2M4MTQyNGEzZjhkODI0MTA3NzkwYTEyMzVfMTMtMTEtMS0xLTI3MTE2_f1a681f5-4fb1-4df6-9044-2c19ab751712"
      unitRef="usd">31890000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3e24f72d093b44669e0b2c6422958fd3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0xLTEtMS0yNzExNg_d6c431da-d4e0-4676-856a-08443dce2f1e"
      unitRef="shares">13609000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3e24f72d093b44669e0b2c6422958fd3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0zLTEtMS0yNzExNg_80888c92-2fbe-482b-97c7-ca00a0a9cf58"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b9681a3c672475a84d9bba889cdf521_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy01LTEtMS0yNzExNg_22f13ea4-f9a3-4358-823f-318f83de9744"
      unitRef="usd">129048000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d4ba4946fe945eb89d86d3343e4c4c1_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy03LTEtMS0yNzExNg_cb6b1679-8622-4163-89bb-9553f62f42ad"
      unitRef="usd">-92346000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26d3269d23ed46ada597b50493898abc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy05LTEtMS0yNzExNg_a3f06e50-d492-4252-97d1-cd73c95777ad"
      unitRef="usd">104000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMy0xMS0xLTEtMjcxMTY_1c5968e7-0e1e-487e-9de0-8779c31a7dd4"
      unitRef="usd">36807000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNS01LTEtMS0yNzExNg_7e1243b7-7519-47be-b3fe-84e24aaef3fc"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNS0xMS0xLTEtMjcxMTY_17231ca4-0c1d-42b7-bc7f-e754164014ff"
      unitRef="usd">645000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi0xLTEtMS0yNzExNg_3b07f92c-4332-457b-b997-edadb5cd0b45"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi01LTEtMS0yNzExNg_ae1cd60a-9966-44ff-9ee7-be3d4ac2efdd"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNi0xMS0xLTEtMjcxMTY_d61cb496-c0f8-450e-97bb-2e8cebbb956f"
      unitRef="usd">133000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNy0xLTEtMS0yNzExNg_bc5c4fd3-b337-472f-8bd2-faad67fc27d7"
      unitRef="shares">49000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfNy0xMS0xLTEtMjcxMTY_693d3bfc-37fc-4e79-abe8-742f4d10bd8b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC0xLTEtMS0yNzExNg_eb239767-1b16-4746-8419-227a9757e74c"
      unitRef="shares">19000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC01LTEtMS0yNzExNg_f91a4c62-d442-450e-801f-a340b6eb3120"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOC0xMS0xLTEtMjcxMTY_b16124c7-52b9-4f78-ab25-bba20d4f2e1b"
      unitRef="usd">139000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS0xLTEtMS0yNzExNg_703f092c-4978-4181-a646-2b8f8f166ebf"
      unitRef="shares">460000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS03LTEtMS0yNzExNg_2b1e11f5-74c9-4fb2-87a8-d1adf197ae43"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfOS0xMS0xLTEtMjcxMTY_a2eafbf5-d471-4151-b59f-54027526ab8f"
      unitRef="usd">3492000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8ce279241d444d4496335df3e3c9f0b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtMS0xLTEtMjcxMTY_4a3d7b65-cba6-4c4f-a6a6-419672f7b0ba"
      unitRef="shares">27000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i2607f851fab14b9aab9902b33a758e0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtNS0xLTEtMjcxMTY_13486b52-983b-485e-a719-0df368605581"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTAtMTEtMS0xLTI3MTE2_5907e282-0232-49df-9438-739546120852"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i91ee4c90e2c44881aeb0c71eb0112c0e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTEtOS0xLTEtMjcxMTY_33ec03cd-5eb9-46cb-8812-1b58b9f7a151"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTEtMTEtMS0xLTI3MTE2_5c46676d-1da8-408e-b921-050806f6eca7"
      unitRef="usd">-135000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i229dd1c538154410adaf7bc1c455ba67_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTItNy0xLTEtMjcxMTY_f659f442-85b4-4b29-8e84-288a3dee533d"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTItMTEtMS0xLTI3MTE2_1a6554b1-2a21-4347-bce2-95f426b01914"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b7514593bd74a78a67f8118af0c54be_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMS0xLTEtMjcxMTY_0f2c9849-0916-46d7-8eae-546533685494"
      unitRef="shares">13236000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7b7514593bd74a78a67f8118af0c54be_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMy0xLTEtMjcxMTY_cb7b1e07-33ca-4372-91b0-f3bd523e6d93"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i905940febcac4f6fb8131e1282d2be84_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtNS0xLTEtMjcxMTY_182042e8-e856-4d7d-9f5b-da7f96f4b6be"
      unitRef="usd">129862000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ecb61b96c094f12ae3c415be0611510_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtNy0xLTEtMjcxMTY_b468bfe6-9d67-41f8-a8e7-e0681e2424ee"
      unitRef="usd">-92522000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idaa677e07c6d457c8eece153824244a4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtOS0xLTEtMjcxMTY_00614be3-d9be-4ff2-a032-cddf5a4064dc"
      unitRef="usd">-31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i78d3fcefe8f444849b3d928b4112c0a6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8yOC9mcmFnOjQwOWJlNmE1MzAzMTQ1YzU5YzlmMjdjMWE0ZGJiNGVmL3RhYmxlOmRkNWMzYjAyMjcwMTQwYmY5ODMyYzQ5YmRlN2FiNmJmL3RhYmxlcmFuZ2U6ZGQ1YzNiMDIyNzAxNDBiZjk4MzJjNDliZGU3YWI2YmZfMTMtMTEtMS0xLTI3MTE2_159028fb-60b6-45ce-a89e-c795c388bf4c"
      unitRef="usd">37310000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNC0xLTEtMS0yNzExNg_684886ec-cb02-4045-aea9-19d6a86205c4"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNC0zLTEtMS0yNzExNg_4092cfc5-62c5-4a76-8a72-c16de5d04002"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNi0xLTEtMS0yNzExNg_3dfcc5ff-9394-493e-9772-d087db3a701b"
      unitRef="usd">841000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNi0zLTEtMS0yNzExNg_f46db732-f257-4e5e-b787-82f24c4621ff"
      unitRef="usd">793000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOC0xLTEtMS0yNzExNg_98367160-1ba6-4818-968e-9652ac29b4ab"
      unitRef="usd">602000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOC0zLTEtMS0yNzExNg_369713c0-5c9b-40c7-8eca-ba6ae713b400"
      unitRef="usd">645000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOS0xLTEtMS0yNzExNg_e693478a-d4ef-4e80-a50c-322908f032b2"
      unitRef="usd">143000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfOS0zLTEtMS0yNzExNg_d19339cc-7e60-4251-b41f-14e1d51a49ee"
      unitRef="usd">558000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTQtMS0xLTEtMjcxMTY_583ecf67-29dd-49ca-9013-529b818662a4"
      unitRef="usd">-1755000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTQtMy0xLTEtMjcxMTY_dae187aa-5b8e-42fb-8e20-318698e405c8"
      unitRef="usd">-1082000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTYtMS0xLTEtMjcxMTY_35e0324b-f015-468e-9d52-69bd851e7281"
      unitRef="usd">-1326000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTYtMy0xLTEtMjcxMTY_db721b08-8fd1-4830-aff1-a25a1ed21f74"
      unitRef="usd">366000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTctMS0xLTEtMjcxMTY_96936c82-49f6-45e0-a62d-a87dddd44b9e"
      unitRef="usd">-1751000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTctMy0xLTEtMjcxMTY_2323ad2b-0e13-47b9-8ecf-314fee7958ac"
      unitRef="usd">-1039000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTgtMS0xLTEtMjcxMTY_0db25544-d386-4bc1-b79b-c06eaf0c2b23"
      unitRef="usd">2568000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTgtMy0xLTEtMjcxMTY_3425f8dd-36cb-46d9-a0fd-b8b94c8120d8"
      unitRef="usd">45000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTktMS0xLTEtMjcxMTY_287ba4c7-4255-4d8e-91b1-e38856ed24e2"
      unitRef="usd">-415000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMTktMy0xLTEtMjcxMTY_ec31e857-93ba-4e9f-b265-5ace9863881d"
      unitRef="usd">877000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjAtMS0xLTEtMjcxMTY_66792572-279f-4326-9855-4a8da5968939"
      unitRef="usd">-1000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjAtMy0xLTEtMjcxMTY_b3fb1eec-838e-4d99-ad23-bd55806dc93d"
      unitRef="usd">-13000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjEtMS0xLTEtMjcxMTY_9415d7fb-1301-4b3b-a2ea-5fca25956c9d"
      unitRef="usd">429000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjEtMy0xLTEtMjcxMTY_cbf89e93-cea8-4268-8544-cfec5b411ec8"
      unitRef="usd">-1891000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjItMS0xLTEtMjcxMTY_7a8cc2d6-a376-40fd-9b9e-82f7fefcb28e"
      unitRef="usd">-346000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjItMy0xLTEtMjcxMTY_eb4dc34e-6c6f-41ff-9f62-4cd6f05bc929"
      unitRef="usd">640000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjMtMS0xLTEtMjcxMTY_56de4c10-9a44-4947-a1b5-f81dc5db9026"
      unitRef="usd">-2248000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjMtMy0xLTEtMjcxMTY_9b117288-fe98-4fcd-a063-486f32f769e6"
      unitRef="usd">-1873000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjQtMS0xLTEtMjcxMTY_44df752a-3067-424a-906a-d4f26b006dbf"
      unitRef="usd">-235000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <lfvn:IncreaseDecreaseInLeaseLiabilities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjQtMy0xLTEtMjcxMTY_d39a6ce1-fe72-4624-80a3-d004ff9fc41a"
      unitRef="usd">-384000</lfvn:IncreaseDecreaseInLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjUtMS0xLTEtMjcxMTY_decd8fec-a65d-4b6c-b12c-a950970dfe3e"
      unitRef="usd">-311000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjUtMy0xLTEtMjcxMTY_3f11a48b-507f-4cb2-8759-bfdd81743ff8"
      unitRef="usd">-21000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjYtMS0xLTEtMjcxMTY_2b080ef5-07f7-4c76-bf0e-663d41dba7e9"
      unitRef="usd">-1345000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMjYtMy0xLTEtMjcxMTY_2650040f-055c-4083-b5f1-92d58388f0b1"
      unitRef="usd">465000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzEtMS0xLTEtMjcxMTY_45d13cce-bfc7-4ccf-8af8-ac951dd634cb"
      unitRef="usd">727000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzEtMy0xLTEtMjcxMTY_07977590-51e7-4a9a-be1b-3a1b31c6d012"
      unitRef="usd">378000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzItMS0xLTEtMjcxMTY_5927cb79-bd5e-4c50-871a-8be6c0589a55"
      unitRef="usd">-727000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzItMy0xLTEtMjcxMTY_ee7888d6-2c9c-4b49-b123-45f9eec3921e"
      unitRef="usd">-378000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzctMS0xLTEtMjcxMTY_7bd80ffe-8224-4e71-9de2-5bce3c40d978"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzctMy0xLTEtMjcxMTY_e34b850e-3a38-42e6-b921-c3bfb8795de1"
      unitRef="usd">3492000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzgtMS0xLTEtMjcxMTY_a7cd42af-c5ef-4b5b-a1c8-d1190111824e"
      unitRef="usd">377000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzgtMy0xLTEtMjcxMTY_67f876f3-572a-4628-b7bb-58979bab29b6"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzktMS0xLTEtMjcxMTY_e534abba-051d-4e91-8ca0-1cff98b74f49"
      unitRef="usd">72000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfMzktMy0xLTEtMjcxMTY_6ebf2ec0-ac5e-4c18-b99e-a6350155afa7"
      unitRef="usd">139000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDAtMS0xLTEtMjcxMTY_cb8e6dd3-5063-4e35-8111-c3b4dc548d4a"
      unitRef="usd">121000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDAtMy0xLTEtMjcxMTY_dc45e9af-1d23-42b0-9b01-0f9307bf95f8"
      unitRef="usd">175000</lfvn:ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDEtMS0xLTEtMjcxMTY_827f822b-ad12-46fe-b65b-27a42d18a474"
      unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDEtMy0xLTEtMjcxMTY_0d867dd4-f055-48bb-917a-dd531972079c"
      unitRef="usd">133000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDItMS0xLTEtMjcxMTY_e8ec8f7d-4bbb-4546-82fc-635b7e655676"
      unitRef="usd">-328000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDItMy0xLTEtMjcxMTY_dd7e425f-898e-4016-8085-efcfea699727"
      unitRef="usd">-3323000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDMtMS0xLTEtMjcxMTY_5e5254e9-7447-47d7-aab0-95ac2f3dd804"
      unitRef="usd">-171000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDMtMy0xLTEtMjcxMTY_725c6592-17a1-494e-9a6e-ce2cc1f32f61"
      unitRef="usd">-9000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDQtMS0xLTEtMjcxMTY_77ed841c-d495-441e-b69c-80eaafc78bf9"
      unitRef="usd">-2571000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDQtMy0xLTEtMjcxMTY_d5853080-6590-4b0a-a545-a6be22d67163"
      unitRef="usd">-3245000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDUtMS0xLTEtMjcxMTY_fad3ba77-e9a7-4727-97b6-7a7187930fbd"
      unitRef="usd">20190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i90da942ee6e8491ea70d3e37a9a9ccce_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDUtMy0xLTEtMjcxMTY_d2496131-bbee-4fa9-9470-1d68db7c621a"
      unitRef="usd">23174000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDYtMS0xLTEtMjcxMTY_eff411cf-7135-4599-a649-3225a3e0183d"
      unitRef="usd">17619000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i78d3fcefe8f444849b3d928b4112c0a6_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNDYtMy0xLTEtMjcxMTY_36379386-3e01-43f5-ad40-973f69cdd78a"
      unitRef="usd">19929000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTEtMS0xLTEtMjcxMTY_103917c7-7468-4db2-bb6b-c9c2060d87f0"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTEtMy0xLTEtMjcxMTY_87487573-a6df-4778-8337-f3f7c31fb765"
      unitRef="usd">3000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTItMS0xLTEtMjcxMTY_5d8510c2-b14b-472b-a1c1-3f57a23575d3"
      unitRef="usd">439000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zMS9mcmFnOjA5MDJiOWM3MWU0NDRhYTU4ZTVhM2Q0ZDljYmVkOGZiL3RhYmxlOjlmZjFiYjU4Mzg1YzQxZDRiYmEzNzc1MzJlOTRjYWQzL3RhYmxlcmFuZ2U6OWZmMWJiNTgzODVjNDFkNGJiYTM3NzUzMmU5NGNhZDNfNTItMy0xLTEtMjcxMTY_7b5ec53b-1912-4720-9d10-e9b32cc18cbe"
      unitRef="usd">468000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF8zNy9mcmFnOjA2NTkzNWYxYjY1MTRjMmI5ZWU3YjdmMDI0ZWFhZGQ4L3RleHRyZWdpb246MDY1OTM1ZjFiNjUxNGMyYjllZTdiN2YwMjRlYWFkZDhfMjgwNQ_498eeb34-9004-47a7-95db-e18348d2b314">Organization and Basis of Presentation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:23.4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LifeVantage Corporation is a company focused on nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company is dedicated to helping people achieve their health, wellness and financial goals. The Company provides quality, scientifically-validated products to customers and independent distributors as well as a financially rewarding commission-based direct sales opportunity to its independent distributors. LifeVantage sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The Company also sells its products in a number of countries to customers for personal consumption only. In addition, the Company sells its products in China through a China approved cross-border e-commerce business model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:23.4pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &amp;amp; body, and targeted relief products. The Company&#x2019;s line of scientifically-validated dietary supplements includes its flagship Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; family of products, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; dietary supplements. TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; is the Company's line of skin, hair, bath &amp;amp; body, and targeted relief products. The Company also markets and sells Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; its nootropic energy drink mixes, and PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, its smart weight management system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements included herein have been prepared by the Company&#x2019;s management, without audit, pursuant to the rules and regulations of the SEC. In the opinion of the Company&#x2019;s management, these interim financial statements include all adjustments that are considered necessary for a fair presentation of its financial position as of September&#160;30, 2022, and the results of operations for the three months ended September&#160;30, 2022 and 2021, and the cash flows for the three months ended September&#160;30, 2022 and 2021. Interim results are not necessarily indicative of results for a full year or for any future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and notes included herein are presented as required by Form 10-Q, and do not contain certain information included in the Company&#x2019;s audited financial statements and notes for the fiscal year ended June&#160;30, 2022, pursuant to the rules and regulations of the SEC. For further information, refer to the financial statements and notes thereto as of and for the year ended June&#160;30, 2022, and included in the annual report on Form 10-K on file with the SEC.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5Njc_5ce12bf6-1800-480c-8c0f-35adbe70d803">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of com&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income. For the three months ended September 30, 2022 and 2021, net foreign currency losses of $0.4 million and $0.2 million, respectively, are recorded in other expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting. There were no realized gains or losses for three months ended September 30, 2022. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended September 30, 2021&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; realized losses of $30,000 related to forward contracts, are recorded in other expense, net.  The Company did not hold any derivative instruments at September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;such risk. Financial instruments with significant credit risk include cash and investments. At September&#160;30, 2022, the Company had $12.2 million in cash accounts at one financial institution and $5.4 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions.  At June&#160;30, 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company had $15.4&#160;million in cash accounts at one financial institution and $4.8 million in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounts at other financial institutions. As of September&#160;30, 2022 and June&#160;30, 2022, and during the periods then ended, the Company&#x2019;s cash balances exceeded federally insured limits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable as of September&#160;30, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of September&#160;30, 2022 and June&#160;30, 2022 is not necessary. No bad debt expense was recorded during the three months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of September&#160;30, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method, which includes a reduction in inventory values &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of $1.2 million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $1.3 million at September 30, 2022 and June&#160;30, 2022, respectively, related to obsolete and slow-moving inventory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis. As of&#160;September&#160;30, 2022 and June&#160;30, 2022, the returns liability reserve, net was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Research and Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company expenses all costs related to research and development activities, as incurred. Research and development expens&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;es for the three months ended September 30, 2022 and 2021 were $0.1 million and $0.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2022 and 2021, the Company recognized income tax expense of $0.2 million and $1.1 million, respectively, which is reflective of the Company&#x2019;s current estimated federal, state and foreign effective tax rate. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realization of deferred tax assets is dependent upon future earnings in specific tax jurisdictions, the timing and amount of which are uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2022 and 2021, the effects of approximately 0.6 million and 0.2 million common shares, respectively, issuable upon exercise of options and non-vested shares of restricted stock are not included in computations as their effect was anti-dilutive. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzc_435c3417-dbc3-4676-95af-564c60a83cec">ConsolidationThe condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5OTg_c7b848b4-b924-4f9f-a77e-8f07546ce268">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including, but not limited to, those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of assets, share-based compensation, and loss contingencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5OTQ_0239da5d-6530-49e9-b11a-891df2318ce4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s business operations occurs outside the United States.&#160;The local currency of each of the Company&#x2019;s subsidiaries is generally its functional currency.&#160;All assets and liabilities are translated into U.S. dollars at exchange rates existing at the balance sheet dates, revenue and expenses are translated at weighted-average exchange rates and stockholders&#x2019; equity is recorded at historical exchange rates.&#160;The resulting foreign currency translation adjustments are recorded &lt;/span&gt;&lt;/div&gt;as a separate component of stockholders&#x2019; equity in the condensed consolidated balance sheets and as a component of comprehensive income. Transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations and comprehensive income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjA1Ng_e05fef9e-887f-4259-b957-c58db4c86f92"
      unitRef="usd">-400000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjA2Mw_e94a2b8a-00c6-4b06-9249-55b7d89ac7ee"
      unitRef="usd">-200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NjU_c40bb934-d774-4cce-b026-bd4d428257fd">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Derivative Instruments and Hedging Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's subsidiaries enter into transactions with each other which may not be denominated in the respective subsidiaries' functional currencies. The Company seeks to reduce its exposure to fluctuations in foreign exchange rates through the use of derivatives. The Company does not use such derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;To hedge risks associated with the foreign-currency-denominated intercompany transactions, the Company entered into forward foreign exchange contracts which were all settled by the end of December 2021 and were not designated for hedge accounting.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTY0OTI2NzQ2MTEwMQ_d3906bf7-95e1-44bd-bbd9-5897376e1ff1"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMjk2NQ_356464d4-0523-4c49-aef4-7a7497684127"
      unitRef="usd">-30000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDU_186606ec-e586-417b-801b-daa497c1e772">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers only its monetary liquid assets with original maturities of three months or less as cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDY_70c91c1d-dd7b-4770-9efd-1eee1d1b8f4a">Concentration of Credit RiskAccounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="iff5c682417d44fc6afa71d4889a5fe31_D20220930-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzY2NA_3225d68a-4aee-4a3d-9978-9e116c5db055"
      unitRef="usd">12200000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i21ed018d6d084503a906e48fc59af41e_D20220930-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzcxNw_764b742c-f9e5-4a65-b9e9-e6be5ad44b7e"
      unitRef="usd">5400000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i8404347bcfbe4f78be26db732735d417_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzc4OQ_0abc13ef-e34a-4da9-becb-36e5d6676ad2"
      unitRef="usd">15400000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i03174868560f44ff80cf933d2f69ab68_D20220630-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMzg0Mg_626ff802-ed96-4ff7-9484-0f0fcfee118e"
      unitRef="usd">4800000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzE_8f072ed6-24d3-433a-a74f-47b0cdd392fe">Accounts ReceivableThe Company&#x2019;s accounts receivable as of September&#160;30, 2022 and June&#160;30, 2022 consist primarily of credit card receivables. Based on the Company&#x2019;s verification process for customer credit cards and historical information available, management has determined that an allowance for doubtful accounts on credit card sales related to its customer sales as of September&#160;30, 2022 and June&#160;30, 2022 is not necessary.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDM4MA_d8c687bd-b3a0-45b9-9e89-5cfb219e6843"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDM4MA_eada0fa0-0550-4cdf-81f1-6491fd52e15d"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NTc_cc90147d-b3f2-435c-9e35-df7b7be7cd02">As of September&#160;30, 2022 and June&#160;30, 2022, inventory consisted of (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.778%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS0xLTEtMS0yNzExNg_ffee517f-c9de-4b56-ad0a-b5209f9b3a42"
      unitRef="usd">14571000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS0zLTEtMS0yNzExNg_f4315188-59a2-4c75-8e4c-1492c3de7246"
      unitRef="number">0.782</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS01LTEtMS0yNzExNg_542feb4e-a491-41f8-92b1-f520b4fd5fc5"
      unitRef="usd">12674000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <lfvn:InventoryFinishedGoodsPercentOfTotalInventory
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMS03LTEtMS0yNzExNg_f202fced-a356-489a-800c-15dfc9da32a9"
      unitRef="number">0.769</lfvn:InventoryFinishedGoodsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi0xLTEtMS0yNzExNg_47377617-45b9-4e75-b1d4-89c03e88e600"
      unitRef="usd">4065000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi0zLTEtMS0yNzExNg_e913cd21-a976-4dc2-ae4f-6a7001c873ea"
      unitRef="number">0.218</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi01LTEtMS0yNzExNg_c004a9a9-6e18-462b-b5e3-347f4bf81a6d"
      unitRef="usd">3798000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <lfvn:RawMaterialsPercentOfTotalInventory
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMi03LTEtMS0yNzExNg_ba0d3c52-00db-496e-b41a-90b2e386af19"
      unitRef="number">0.231</lfvn:RawMaterialsPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy0xLTEtMS0yNzExNg_2eb69dae-4981-4b11-b6f5-df2da39b6bea"
      unitRef="usd">18636000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy0zLTEtMS0yNzExNg_9a065fcc-ebf7-47e8-b1b6-62b27b1518a8"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryNet
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy01LTEtMS0yNzExNg_cfe58721-aaa7-4665-a1b2-84e466cc1c66"
      unitRef="usd">16472000</us-gaap:InventoryNet>
    <lfvn:InventoryPercentOfTotalInventory
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmU3NTdiMjI0YTJiMzQxNTk5YzI3ZGRhYTgyMjZhMTJlL3RhYmxlcmFuZ2U6ZTc1N2IyMjRhMmIzNDE1OTljMjdkZGFhODIyNmExMmVfMy03LTEtMS0yNzExNg_1458695f-b37c-4f44-b7ce-8b4479259a94"
      unitRef="number">1.000</lfvn:InventoryPercentOfTotalInventory>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzI_f03ce45e-4db4-4b0f-9e2d-83cb63f69426">Inventories are carried at the lower of cost or net realizable value, using the first-in, first-out method</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDY2NA_cad10847-d12e-4496-a4ad-1f2be6cfbd32"
      unitRef="usd">1200000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfNDY3MQ_ad706daf-0a76-4009-8437-b182b93c1c2a"
      unitRef="usd">1300000</us-gaap:InventoryValuationReserves>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NzM_d01fb7be-ff04-40b1-9692-3d9b62d8fc31">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for assets and liabilities using a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the fair-value hierarchy below. This hierarchy requires the Company to minimize the use of unobservable inputs and to use observable market data, if available, when determining fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1&#x2014;Quoted prices for identical instruments in active markets; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2&#x2014;Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3&#x2014;Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company are measured at fair value on a nonrecurring basis; that is, the assets are not measured at fair value on an ongoing basis, but are subject to fair value adjustments using fair value measurements with unobservable inputs (level 3), in certain circumstances (e.g., when there is evidence of impairment).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5ODg_c5ae4e61-33eb-4b7a-bbff-8e39ed9c253c">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services are transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates the majority of its revenue through product sales to customers. These products include the Protandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;line of dietary supplements, LifeVantage&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Omega+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, ProBio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, IC Bright&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and Daily Wellness&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; dietary supplements, TrueScience&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; skin, hair, bath &amp;amp; body and targeted relief, Petandim&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Axio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;nootropic energy drink mixes, and the PhysIQ&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;smart weight management system. The Company ships most of its product directly to the consumer and receives substantially all payment for product sales in the form of credit card receipts. Revenue from direct product sales to customers is recognized upon shipment, which is when passage of title and risk of loss occurs. For items sold in packs and bundles, the Company determines the standalone selling price at contract inception for each distinct good, and then allocates the transaction price on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Shipping and handling revenue is recognized upon shipment when the performance obligation is completed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also charges independent distributors to attend certain events that it holds. Tickets to events are sold as standalone items or included within packs. For event tickets sold in packs, the Company allocates a portion of the transaction price to the ticket on a relative standalone selling price basis. Any discounts are accounted for as a direct reduction to the transaction price. Fee revenue associated with ticket sales is recorded in the month that the event is held, which is when the Company has performed its obligations under the contract.&lt;/span&gt;&lt;/div&gt;Estimated returns are recorded when product is shipped. Subject to some exceptions based on local regulations, the Company&#x2019;s return policy is to provide a full refund for product returned within 30 days. After 30 days of purchase, only unopened product that is in a resalable and restockable condition may be returned within twelve months of purchase and shall receive a 100% refund, less a 10% handling and restocking fee and any shipping and handling costs. The Company establishes a refund liability reserve, and an asset reserve for its right to recover products, based on historical experience. The returns asset reserve and returns liability reserve are evaluated on a quarterly basis.&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shipping and Handling&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs associated with inbound freight and freight out to customers and independent distributors are included in cost of sales. Shipping and handling fees charged to customers and independent distributors are included in revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <lfvn:MoneyBackGuaranteePeriod
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODM3Nw_882bdfdf-e4be-42b8-9c68-db78a2239999">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:MoneyBackGuaranteePeriod
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTA5OTUxMTY0NzQzNw_882bdfdf-e4be-42b8-9c68-db78a2239999">P30D</lfvn:MoneyBackGuaranteePeriod>
    <lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTA5OTUxMTY0NzQ0OQ_5c64d98e-85d0-4b3c-8091-36d6cf0cd983">P12M</lfvn:ContractsWithCustomersReturnPeriodForResalableAndRestockableItems>
    <lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODU0OA_30bad79f-a425-4a59-82c7-aec46f247940"
      unitRef="number">1</lfvn:ContractsWithCustomersRefundPercentForResalableAndRestockableItems>
    <lfvn:HandlingAndRestockingFeePercentage
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODU2Ng_24dd4e28-28b6-47af-bf13-a50a5bcd8246"
      unitRef="number">0.10</lfvn:HandlingAndRestockingFeePercentage>
    <lfvn:ReturnLiabilityReserve
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODkyMg_e51d3303-d43d-47fb-90d8-20e8a5ae3528"
      unitRef="usd">200000</lfvn:ReturnLiabilityReserve>
    <lfvn:ReturnLiabilityReserve
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfODkyOQ_ea07b8a8-2bf8-41f0-a23a-f7ced58f75a7"
      unitRef="usd">100000</lfvn:ReturnLiabilityReserve>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzM_e13ab7a5-6024-497a-9bba-f1d1fff54524">Research and Development CostsThe Company expenses all costs related to research and development activities, as incurred.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfOTQwMA_308e5d18-9cd9-4310-a007-f26eb4e2b8cd"
      unitRef="usd">100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfOTQwNw_871a9d49-e315-493a-816e-41ba4850acb8"
      unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMjQ_0119196d-0d5c-48ce-80e3-7588c8f40466">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") 842. The Company reviews all contracts and determines if the arrangement is or contains a lease, at inception. Operating leases are included in right-of-use (&#x201c;ROU&#x201d;) assets, current lease liabilities and long-term lease liabilities on the condensed consolidated balance sheets. The Company does not have any finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of future payments. The operating lease ROU asset also includes any upfront lease payments &lt;/span&gt;&lt;/div&gt;made and excludes lease incentives and initial direct costs incurred. The Company&#x2019;s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with a term of 12 months or less are not recorded on the balance sheet. The Company&#x2019;s lease agreements do not contain any residual value guarantees.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDI_e5c51d20-6bf7-44b7-8c0c-9b307669d5a4">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation by measuring the cost of services to be rendered based on the grant date fair value of the equity award. The Company recognizes stock-based compensation, net of any estimated forfeitures, over the period an employee is required to provide service in exchange for the award, generally referred to as the requisite service period. For awards with market-based performance conditions, the cost of the awards is recognized as the requisite service is rendered by employees, regardless of when, if ever, the market-based performance conditions are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options and options under the Company's 2019 Employee Stock Purchase Plan. The determination of the fair value of options is affected by the Company's stock price and a number of assumptions, including expected volatility, expected life, risk-free interest rate and expected dividends. The Company uses historical data for estimating the expected volatility and expected life of stock options required in the Black-Scholes model. The risk-free interest rate assumption is based on observed interest rates appropriate for the expected terms of the stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock grants is based on the closing market price of the Company's stock on the date of grant less the Company's expected dividend yield. The Company recognizes compensation costs for awards with performance conditions when it concludes it is probable that the performance conditions will be achieved. The Company reassesses the probability of vesting at each balance sheet date and adjusts compensation costs accordingly.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5Nzg_74cd6124-2d7d-48d9-aa3e-b9cf0039b5f9">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry-forwards. Deferred tax assets and liabilities are measured using statutory tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled, updated as needed for changes in corporate tax rates. The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period that includes the effective date of the change. The Company recognizes tax liabilities or benefits from an uncertain position only if it is more likely than not that the position will be sust&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ained upon examination by taxing authorities based on the technical merits of the issue. The amount recognized would be the largest liability or benefit that the Company believes has greater than a 50% likelihood of being realized upon settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTU2MDE_1ad522ff-883f-48ed-9d3d-d536cb6fcb29"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTU2MDg_6e1ce81a-3f07-4da6-9473-243594f72f07"
      unitRef="usd">1100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzQ_28ca4736-ec4a-43bc-bc2b-36a9095f8375">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Income Per Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic income per common share is computed by dividing the net income by the weighted-average number of common shares outstanding during the period, less unvested restricted stock awards. Diluted income per common share is computed by dividing net income by the weighted-average common shares and potentially dilutive common share equivalents using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTYzMTQ_fb11036b-49ec-4784-a786-95df28a802dd"
      unitRef="shares">600000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTYzMjE_18e4c482-eee4-4980-af9d-f9a49a6808ca"
      unitRef="shares">200000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMDc_ec7433da-a427-47b6-98c2-641473c8cdd2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of net income per share and the weighted-average common shares outstanding for purposes of computing basic and diluted net income per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock awards and options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share, diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMy0xLTEtMS0yNzExNg_92d783d5-07e6-4f84-a7e0-7f01fd0510e6"
      unitRef="usd">610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMy0zLTEtMS0yNzExNg_c44635c7-3d91-4e61-8b0c-3a382493feb6"
      unitRef="usd">3316000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNS0xLTEtMS0yNzExNg_c7b7890e-a8af-4021-9960-d57c91e15f27"
      unitRef="shares">12457000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNS0zLTEtMS0yNzExNg_7c9945da-d082-4741-a441-4770304c7673"
      unitRef="shares">13394000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNy0xLTEtMS0yNzExNg_2b1435d7-824f-4a8a-96c2-6263edc85e65"
      unitRef="shares">38000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfNy0zLTEtMS0yNzExNg_eda8cb33-fa20-4c4c-8aab-866b9734924c"
      unitRef="shares">75000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfOS0xLTEtMS0yNzExNg_70312b35-461c-40c6-9413-4a1d835ac3d0"
      unitRef="shares">12495000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfOS0zLTEtMS0yNzExNg_68702e31-f698-4cc1-824f-9199311f8c5b"
      unitRef="shares">13469000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTAtMS0xLTEtMjcxMTY_9991a633-ce33-47c8-b962-75cd61c5fa2c"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTAtMy0xLTEtMjcxMTY_591bc499-94e0-4079-90d1-0933c4b41aec"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTEtMS0xLTEtMjcxMTY_da7a0841-da41-4df0-8e6f-ca9e11ff8543"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZhZTAyZWU3ZDZlNTQ1NTc4NTYyMWVmNDM4YWMxYzdiL3RhYmxlcmFuZ2U6ZmFlMDJlZTdkNmU1NDU1Nzg1NjIxZWY0MzhhYzFjN2JfMTEtMy0xLTEtMjcxMTY_783a8522-4b3e-48ba-ab64-342e8359e911"
      unitRef="usdPerShare">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NzY_d88f5dbc-9f57-4622-9e5b-a55a659952ce">&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment by selling products directly to customers and through an international network of independent distributors that operates in an integrated manner from market to market.&#160;Commissions and incentives expenses are the Company&#x2019;s largest expense comprised of the commissions paid to its independent distributors.&#160;The Company manages its business primarily by managing its international network of independent distributors.&#160;The Company disaggregates revenue in two&#160;geographic regions: the Americas region and the Asia/Pacific &amp;amp; Europe region.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc0Njg_33e2f189-e9df-4a02-967b-84b98b16b030"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMjA_43318fd4-9988-4d0f-9f62-455ac80e206b">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's revenue disaggregated by these two geographic regions (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia/Pacific &amp;amp; Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional information as to the Company&#x2019;s revenue from operations in the most significant geographical areas is set forth below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <lfvn:NumberOfGeographicSegments
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc2MjM_33e2f189-e9df-4a02-967b-84b98b16b030"
      unitRef="region">2</lfvn:NumberOfGeographicSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib732a4247f1c4b9f9cef9f2ced8879ce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMi0xLTEtMS0yNzExNg_39318671-5383-4bc7-bf52-ef91d2e33945"
      unitRef="usd">36369000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i402d171eca914ca896c2460efa80a95d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMi0zLTEtMS0yNzExNg_6fa07be3-5579-418b-adea-7cc23730f450"
      unitRef="usd">36449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe7711d279984593aa89a86b806404b8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMy0xLTEtMS0yNzExNg_4896aafa-ef42-4372-99a5-2f512d03b54a"
      unitRef="usd">15405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i939ab82e679a4c00953b5bcdb1aa7115_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfMy0zLTEtMS0yNzExNg_a4579139-2acf-4964-9213-c0e621af7940"
      unitRef="usd">16775000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfNC0xLTEtMS0yNzExNg_e56ee4c0-6aac-4874-9c35-6494fbccec22"
      unitRef="usd">51774000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmM2NTU3MzEzOTBlMDQyOTM5YzdiZDgxNmIyZWI2NWIxL3RhYmxlcmFuZ2U6YzY1NTczMTM5MGUwNDI5MzljN2JkODE2YjJlYjY1YjFfNC0zLTEtMS0yNzExNg_f8f89a88-be1e-46ba-ac69-91539c0f1268"
      unitRef="usd">53224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i429b06262ff74cbc894e05c074db49f0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMi0xLTEtMS0yNzExNg_9304cc46-800a-4e0c-b368-8973a1602681"
      unitRef="usd">34658000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46736b895fa9494fb40c592102713ba8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMi0zLTEtMS0yNzExNg_5f9c57ce-a332-475b-860b-981e33f7862b"
      unitRef="usd">34297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia36a6256f3744258b47971555a767ab1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMy0xLTEtMS0yNzExNg_a1b597fa-e5e0-474e-b9ec-0981d3ca81e0"
      unitRef="usd">8168000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e7f9e3862de4c17a2b53bbc46589c1d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOjc2MmIwOThlYTg3ZDRlZmE4ZjZlMjAzMjQ5MzExYmEyL3RhYmxlcmFuZ2U6NzYyYjA5OGVhODdkNGVmYThmNmUyMDMyNDkzMTFiYTJfMy0zLTEtMS0yNzExNg_8c2a3dc3-fcd3-4268-add5-40438b02efd5"
      unitRef="usd">9844000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTc5NDM_d8be7990-fd43-4e0c-b273-f48c2787d841">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RleHRyZWdpb246OTBiMDUxNTA3YTEwNDk1NTlhZGJlNDAzOTQ5ZWM3Y2ZfMTgwMzY_2b782ba5-e66c-479c-82c5-6e9b328876cf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company's long-lived assets for its most significant geographic markets (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Japan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ibfdce7f7d47e4eb1b5e54bb8f86005b4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMS0xLTEtMS0yNzExNg_95b4f5f7-873a-499f-bc66-b85b77c07021"
      unitRef="usd">21305000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic7afcea9cb8e4e9c88e904f1a007bcb5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMS0zLTEtMS0yNzExNg_51f70e2b-ec7e-4713-a8f6-e67c605f1cba"
      unitRef="usd">19790000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6b8444b610764ffab7c655e6f33040ba_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMi0xLTEtMS0yNzExNg_ddda3d93-283a-4330-9819-fb6c26d5e888"
      unitRef="usd">1549000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i1dca30b124b04669a1465dfa6dd2bbc0_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80MC9mcmFnOjkwYjA1MTUwN2ExMDQ5NTU5YWRiZTQwMzk0OWVjN2NmL3RhYmxlOmZlYTg2NDJiMjE1NjRjMjliZmUxM2IzODI1ZTU3ZWMzL3RhYmxlcmFuZ2U6ZmVhODY0MmIyMTU2NGMyOWJmZTEzYjM4MjVlNTdlYzNfMi0zLTEtMS0yNzExNg_a5515204-dea7-4d49-872c-1c758325e3fa"
      unitRef="usd">1869000</us-gaap:NoncurrentAssets>
    <us-gaap:InvestmentTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfMjk1OA_048b32b5-46cf-4a92-9486-28d73ef6d1bc">Gig Economy Group Investment&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Note Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a convertible promissory note agreement with Gig Economy Group, Inc. ("GEG") pursuant to which the Company agreed to loan to GEG up to an aggregate of $2.0&#160;million in a series of loan installments, evidenced by a convertible promissory note having a maturity date of May&#160;31, 2019 ("Convertible Note"). The Convertible Note accrued interest at a rate of 8% per annum, compounded annually. On May&#160;17, 2019, the Company and GEG entered into an amendment agreement to extend the maturity date of the Convertible Note to December&#160;31, 2019. In all other aspects, the Convertible Note remained unchanged from the original agreement. Pursuant to a Common Stock Purchase Agreement between the Company and GEG dated December 16, 2019, GEG issued to the Company 1,000,000 shares of GEG&#x2019;s common stock in consideration for conversion and cancellation of all principal, interest and other amounts due under the Convertible Note (representing $0.0&#160;million in aggregate consideration).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities under ASC 321&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon conversion of the convertible promissory note receivable with GEG, the Company held a minority interest (less than 20%) in GEG, accounted for under ASC 321, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("ASC 321"), which is included in equity securities in the condensed consolidated balance sheets. Dividends received are reported in earnings if and when received. The Company reviews securities individually for impairment by evaluating if events or circumstances have occurred that may indicate the fair value of the investment is less than its carrying value. If such events or circumstances have occurred, the Company estimates the fair value of the investment and recognizes an impairment loss in other expense, net on the condensed consolidated statements of operations and comprehensive income equal to the difference between the fair value of the investment and its carrying value. In such cases, the estimated fair value of the investment is determined using unobservable inputs including assumptions by GEG's management and quantitative information such as lower valuations in recently completed or proposed financings. These inputs are classified as Level 3. Because GEG is in the early startup stage, GEG is subject to potential changes in cash flows and valuation, and may be unable to raise additional capital necessary to support its ongoing operations, which may result in future impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities held by the Company lack readily determinable fair values and therefore the securities are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar equity securities of the same issuer. During the fourth quarter of the fiscal year ended June&#160;30, 2022, the Company determined its investment in GEG had declined significantly as a result of the business failing to achieve profitability due to weak market conditions for its products.  The Company determined the book value of its investment exceeded its fair value and concluded this decline in value was other than temporary.  The Company recorded a non-cash impairment charge of $2.2&#160;million related to these equity securities.  The was no carrying amount of equity securities held by the Company without readily determinable fair values at September&#160;30, 2022 and June&#160;30, 2022.  During the three months ended September&#160;30, 2022 and 2021, there were no impairments recognized.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <lfvn:NotesReceivableRelatedPartyMaximumCommitment
      contextRef="ie2be38077dec479a8c4f830a7cc40030_I20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfMjQ3_0498526a-d90b-4dac-b668-52ced3843942"
      unitRef="usd">2000000</lfvn:NotesReceivableRelatedPartyMaximumCommitment>
    <us-gaap:DebtConversionOriginalDebtInterestRateOfDebt
      contextRef="ie46dcc75834340edbbb0d6971d255894_D20190531-20190531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfNDI5_c2a521e8-b849-41e4-9ec7-a5eed72b088f"
      unitRef="number">0.08</us-gaap:DebtConversionOriginalDebtInterestRateOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfODAy_0effb2b4-6bb6-41ab-8b6b-52062d6452ba"
      unitRef="shares">1000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i18498a7047a04862bc7c85fea4d5715d_D20191216-20191216"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfOTcz_b373f9bc-a3b6-4f47-bc0e-b73644f244d2"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="id131ac0747904e089c449612a8c5c709_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80Ni9mcmFnOjEzYWVkMmU3NmQxYTRlNDliZDExOGJhNDBkNjJhZWJkL3RleHRyZWdpb246MTNhZWQyZTc2ZDFhNGU0OWJkMTE4YmE0MGQ2MmFlYmRfNTQ5NzU1ODE3MzE5_ebd0254c-6d43-493d-8542-af6f00706a25"
      unitRef="usd">2200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjEz_e2e5be27-e319-48ee-91b8-470e12daf6de">Leases&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for current corporate offices and certain equipment. These leases have remaining terms of appro&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ximately &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTU4_994c7e14-50db-4ced-ba65-b8b872893dc3"&gt;one&lt;/span&gt; to nine years. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the weighted average remaining lease term and weighted average discount rate for operating leases was 8.46 years and 3.27%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2022 and 2021, operating lease expense was $0.7 million and $0.8 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at September&#160;30, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining nine months ending June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ia6f19746429c4cdca994057d70e98d3a_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMTY0_4c7fc92b-f147-4158-8c8e-23258d07c9b5">P9Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMjgw_69c8a51c-fe2c-47ed-a944-0aa319744f16">P8Y5M15D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMjg3_c0a29d30-680d-426d-9952-fb44f63b8c26"
      unitRef="number">0.0327</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMzUz_37f1d3a2-ba9a-4842-acef-b98922a644be"
      unitRef="usd">700000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfMzYw_e9a9f3f5-331c-4770-945a-d2dcab9a2484"
      unitRef="usd">800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjE1_08030a3a-6fc9-4603-8a49-0abbc02031f8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to operating leases was as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmE4ODI1OTc3ZGJiZTQ1MmU4MmFhYzc4OGUxZTc3OGMyL3RhYmxlcmFuZ2U6YTg4MjU5NzdkYmJlNDUyZTgyYWFjNzg4ZTFlNzc4YzJfMi0xLTEtMS0yNzExNg_61a4d1c7-5308-4bec-9c1e-28a5646bf561"
      unitRef="usd">755000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmE4ODI1OTc3ZGJiZTQ1MmU4MmFhYzc4OGUxZTc3OGMyL3RhYmxlcmFuZ2U6YTg4MjU5NzdkYmJlNDUyZTgyYWFjNzg4ZTFlNzc4YzJfMi0zLTEtMS0yNzExNg_7ee56ccd-b7df-45e2-b8f8-a3ee06a6bdcb"
      unitRef="usd">768000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RleHRyZWdpb246Y2VjNjgwZDllNGVmNDY4OTk3NTUwNjlkYjJjYmU1ODBfNjEy_93310192-c7d6-4f24-a8cb-f1b0072e2294">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturity of lease liabilities at September&#160;30, 2022 are as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.567%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023 (remaining nine months ending June 30, 2023)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMS0yLTEtMS0yNzExNg_08cc70d4-1233-4c85-9f36-c3f4c02badc3"
      unitRef="usd">2366000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMi0yLTEtMS0yNzExNg_767d64d9-70e7-4f56-b669-fc92222893e0"
      unitRef="usd">2111000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfMy0yLTEtMS0yNzExNg_26839f2e-4744-4e8f-afba-424432842fc0"
      unitRef="usd">1606000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNC0yLTEtMS0yNzExNg_79430858-5cc6-48fe-b33d-ab26c3c006cc"
      unitRef="usd">1646000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNS0yLTEtMS0yNzExNg_157c370a-5ebe-4559-a7db-58c041581bb1"
      unitRef="usd">1687000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNi0yLTEtMS0yNzExNg_1098c7a5-4138-4410-a5fe-3a1e18bc76c5"
      unitRef="usd">8123000</lfvn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfNy0yLTEtMS0yNzExNg_b7afeeea-cd6f-42c1-9ddd-c8b5f71958db"
      unitRef="usd">17539000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfOC0yLTEtMS0yNzExNg_f394b656-3db1-4cf1-8b1f-314a2dcfb6ea"
      unitRef="usd">2500000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF80OS9mcmFnOmNlYzY4MGQ5ZTRlZjQ2ODk5NzU1MDY5ZGIyY2JlNTgwL3RhYmxlOmJmNzA2MjY4YzE4ODRkNjQ5OTRiMzg4OThlNjM4MWNmL3RhYmxlcmFuZ2U6YmY3MDYyNjhjMTg4NGQ2NDk5NGIzODg5OGU2MzgxY2ZfOS0yLTEtMS0yNzExNg_209d1152-e0bf-4db2-87b0-7af9ba521f4a"
      unitRef="usd">15039000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMwNw_5f797dee-f8e2-4def-88a7-42f8fe4fd32c">Long-Term DebtOn March&#160;30, 2016, the Company entered into a loan agreement (the &#x201c;2016 Loan Agreement&#x201d;) to refinance its outstanding debt. In connection with the 2016 Loan Agreement and on the same date, the Company entered into a security agreement (the &#x201c;Security Agreement&#x201d;). The 2016 Loan Agreement provides for a term loan in an aggregate principal amount of &lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$10.0 million (the &#x201c;2016 Term Loan") and a revolving loan facility in an aggregate principal amount not to exceed $2.0 million (the &#x201c;2016 Revolving Loan,&#x201d; and collectively with the 2016 Term Loan, the 2016 Loan Agreement and the Security Agreement, the &#x201c;2016 Credit Facility&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal amount of the 2016 Term Loan is payable in consecutive quarterly installments in the amount of $0.5 million plus accrued interest beginning with the fiscal quarter ended June&#160;30, 2016. If the Company borrows under the 2016 Revolving Loan, interest will be payable quarterly in arrears on the last day of each fiscal quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May&#160;4, 2018, the Company entered into a loan modification agreement, which amended the 2016 Credit Facility (&#x201c;Amendment No. 1&#x201d;). Amendment No. 1 revised the maturity date from March&#160;30, 2019 to March&#160;31, 2021 and increased the fixed interest rate for the term loan from 4.93% to 5.68%. Amendment No. 1 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 1) was revised from a minimum of 1.50 to 1.00 to 1.25 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was increased from $5.0 million to $8.0 million. The funded debt to EBITDA ratio was replaced with the total liabilities to tangible net worth ratio (as defined in Amendment No. 1) of not greater than 3.00 to 1.00 at the end of each quarter. The minimum tangible net worth measure was removed from the financial covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the 2016 Credit Facility, as amended, are secured by a security interest in substantially all of the Company&#x2019;s assets. Loans outstanding under the 2016 Credit Facility, as amended, may be prepaid in whole or in part at any time without premium or penalty. In addition, if, at any time, the aggregate principal amount outstanding under the 2016 Revolving Loan exceeds $2.0 million, the Company must prepay an amount equal to such excess. Any principal amount of the 2016 Term Loan which is prepaid or repaid may not be re-borrowed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;1, 2019, the Company entered into a loan modification agreement, which further amended the 2016 Credit Facility ("Amendment No. 2"). Under Amendment No. 2, the Company made a principal payment of $2.0 million and increased the revolving loan facility from $2.0 million to $5.0 million. Amendment No. 2 also revised certain financial covenants. The minimum fixed charge coverage ratio (as defined in Amendment No. 2) was revised from a minimum of 1.25 to 1.00 to 1.10 to 1.00, measured on a trailing twelve-month basis, at the end of each fiscal quarter. The minimum working capital was decreased from $8.0 million to $6.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;1, 2021, the Company entered into a loan modification agreement ("Amendment No. 3"), which amended the 2016 Credit Facility, as previously amended. Amendment No. 3 revised the maturity date from March&#160;31, 2021 to March&#160;31, 2024 and modified the variable interest rate based on the one-month United States Treasury Rate, plus a margin of 3.00%, with an interest rate floor of 4.00%. Amendment No. 3 also revised the debt (total liabilities) to tangible net worth ratio (as defined in Amendment No. 3) covenant to require that the Company maintain this ratio not in excess of 2.00 to 1.00, measured as of the end of each fiscal quarter, and revised the definition and calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 3).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into a loan modification agreement ("Amendment No. 4"), effective September 30, 2022, which amended the 2016 Credit Facility, as previously amended. Amendment No. 4 revised the calculation of the minimum fixed charge coverage ratio (as defined in Amendment No. 4) and allows the Company to declare and pay dividends, up to $500,000 per quarter, through September 30, 2023.  There were no other changes to the covenants or revolving loan facility as set forth in Amendment No. 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2016 Credit Facility, as amended, contains customary covenants, including affirmative and negative covenants that, among other things, restrict the Company&#x2019;s ability to create certain types of liens, incur additional indebtedness, declare or pay dividends on or redeem capital stock, make other payments to holders of equity interests in the Company, make certain investments, purchase or otherwise acquire all or substantially all the assets or equity interests of other companies, sell assets or enter into consolidations, mergers or transfers of all or any substantial part of the Company&#x2019;s assets. The 2016 Credit Facility, as amended, also contains various financial covenants that require the Company to maintain certain consolidated working capital amounts, total liabilities to tangible net worth ratios and fixed charge coverage ratios. Additionally, the 2016 Credit Facility, as amended, contains cross-default provisions, whereby a default under the terms of certain indebtedness or an uncured default of a payment or other material obligation of the Company under a material contract of the Company will cause a default on the remaining indebtedness under the 2016 Credit Facility, as amended. As of September&#160;30, 2022, the Company was in compliance with all applicable covenants under the 2016 Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s book value for the 2016 Credit Facility, as amended, approximates the fair value. During the fiscal year ended June 30, 2020, the Company repaid, in full, the remaining balance of the 2016 Term Loan in accordance with the terms of the 2016 Credit Facility, as amended.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ica5344233c204858b6afe60475269d38_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzY1_453fea04-422a-4f81-b29c-a9de7e31aa1a"
      unitRef="usd">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNDY4_4ae496d9-e92f-4fb6-9d2c-6c0ff6a1c43e"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i14dbc7cf32884923b5dc54345b785092_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNzI1_f8796b66-663b-4b58-9d01-1e9bee50d040"
      unitRef="usd">500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i75b346e2c97643deb010bf416bf02431_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTE3NA_eff93a7b-418a-4afb-8bf1-fd149bd15501"
      unitRef="number">0.0493</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTE4MA_9c6346a5-4a90-4bff-a485-48646601bab7"
      unitRef="number">0.0568</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i75b346e2c97643deb010bf416bf02431_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTM0NA_f5e455e1-5091-40cf-9b07-66ef2e590b78"
      unitRef="number">1.50</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTM1Ng_695c0833-d892-4952-910c-663070864009"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="ie05a0f91cf5441fca02cab96f9dd1693_D20180504-20180504"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMxNA_502589fc-8560-4a43-8732-87c4641463cf">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i75b346e2c97643deb010bf416bf02431_I20180503"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTQ4Nw_71ed97b3-873f-4e12-a955-63d91736380a"
      unitRef="usd">5000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTQ5Mw_641ffa4a-ca9b-4046-b8a0-49b34c1757f1"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMTY0OQ_1296a5e5-c3e1-4809-ac83-990c2671569e"
      unitRef="number">3.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjE2Ng_65f5f6d7-2c99-4c58-9ae0-865495473d66"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic93efb3d8dea497aa299e88710676864_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjUxNA_a824aead-10e8-4c59-8e64-c2bc1523fb65"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6036eac111f84de4a9039a3e7d031527_I20160330"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjU2NA_65f5f6d7-2c99-4c58-9ae0-865495473d66"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie69d6cfdbf8c46398d7508667051f58b_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjU3MA_87f9ab3d-9831-4141-97b0-fe9f15834065"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="icf1f3dc19a5f44f8b47022c121a77785_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjczNA_695c0833-d892-4952-910c-663070864009"
      unitRef="number">1.25</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio
      contextRef="i1887e1c461be424086a7149e6dcee766_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjc0Ng_f694be9c-95e1-47fe-b528-3a3e512b7df2"
      unitRef="number">1.10</lfvn:DebtInstrumentCovenantFixedChargeCoverageRatio>
    <lfvn:DebtInstrumentTrailingPeriod
      contextRef="ifc83d833f5664c16b3b8e21685061d73_D20190201-20190201"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTMxNQ_ce12b7f0-7636-436f-bfa5-76826eb52d8f">P12M</lfvn:DebtInstrumentTrailingPeriod>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="iec815bc3224c4b2eb6f03e0428ec3199_I20180504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjg3Nw_2df67bfd-fae6-4f99-b169-05177ccca6b1"
      unitRef="usd">8000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital
      contextRef="i1887e1c461be424086a7149e6dcee766_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMjg4Mw_d9b4925d-2840-453c-a222-3c1131d6576d"
      unitRef="usd">6000000</lfvn:DebtInstrumentCovenantRequiredMinimumWorkingCapital>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i454d5b7910c542ef883eed9a307e6da4_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzE5OA_1fc84a49-d10d-4609-a846-0d3746cd8613"
      unitRef="number">0.0300</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <lfvn:DebtInstrumentFloorInterestRate
      contextRef="iac6026a96d5b4fe780ee9d2e9d5aafe2_D20210401-20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzIzMw_86e0171b-3f50-43f0-8c4e-197c7e8cd614"
      unitRef="number">0.0400</lfvn:DebtInstrumentFloorInterestRate>
    <lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio
      contextRef="i7eae71368a024d6ba653f381ffe0db1c_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfMzQyOQ_df25003e-d133-4544-874f-3d63158e71f5"
      unitRef="number">2.00</lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio>
    <lfvn:DebtInstrumentCovenantMaximumAllowedDividends
      contextRef="i11854662ecd64eb0ae73d899d84d814f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81Mi9mcmFnOjA3Y2NkMWViY2MxYjQ0NWM4YmE4NGRlZTFiODY0YjcxL3RleHRyZWdpb246MDdjY2QxZWJjYzFiNDQ1YzhiYTg0ZGVlMWI4NjRiNzFfNTQ5NzU1ODE0NTQ3Mg_02e0a1a7-37dc-4eba-9026-dc275bf68ab2"
      unitRef="usd">500000</lfvn:DebtInstrumentCovenantMaximumAllowedDividends>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjYzOA_a70b2a67-58c7-46b1-a354-4e15b0a22735">Stockholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; September&#160;30, 2022, the company issued no shares of common stock upon the exercise of stock options and 17,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.  During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; September&#160;30, 2021 the company issued 30,000 shares of common stock upon the exercise of stock options and approximately 19,000 shares of restricted stock were canceled or surrendered as payment of tax withholding upon vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 27, 2017, the Company announced a share repurchase program authorizing it to repurchase up to $5 million in shares of the Company's common stock. The repurchase program permits the Company to purchase shares through a variety of methods, including in the open market, through privately negotiated transactions or other means as determined by the Company's management. As part of the repurchase program, the Company has entered into a pre-arranged stock repurchase plan which operates in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Accordingly, any transactions under such stock repurchase plan will be completed in accordance with the terms of the plan, including specified price, volume and timing conditions. The authorization may be suspended or discontinued at any time. On February 1, 2019, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $5 million to $15 million. On August 27, 2020, the Board of Directors approved an amendment to the share repurchase program to increase the authorized share repurchase amount from $15 million to $35 million and to extend the duration of the program through November 30, 20&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23 and, on February 17, 2022, the Board of Directors approved an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendment to the share repurchase program to increase the authorized share repurchase amount from $35 million to $60 million. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended September 30, 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company purchased no shares of common stock under this repurchase program. During the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company purchased 0.5 million shares of common stock at an aggregate price of $3.5 million under this repurchase program. At&#160;September&#160;30, 2022, there is $27.7 million remaining under this repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Certificate of Incorporation authorizes the issuance of preferred stock. However&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as of September&#160;30, 2022, none have been issued nor have any rights or preferences been assigned to the preferred stock by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the board of directors declared a quarterly cash dividend of $0.03 per share of common stock to be paid on September 15, 2022, to stockholders of record on September 2, 2022. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Quarterly cash dividend for the three months ended September&#160;30, 2022 totaled $0.4 million, or $0.03 per share&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of dividends is subject to the discretion of the Company's board of directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by the Company's board of directors.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i88116b05befd4416b9cb7a08d858f271_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3NTU4_f6d244fc-30f1-4921-9c96-bcdde7b133e0"
      unitRef="shares">17000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i7191113c25f247479215258c91e7ce5a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTkw_ab71dfb4-babc-4c2f-a8f9-421591cc507b"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i7191113c25f247479215258c91e7ce5a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNDgy_e39f56f6-c11d-49b7-82a3-c93f52712fb4"
      unitRef="shares">19000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i071a21c613194e0ab1b99e7ce4356c02_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNzA2_114a1837-0e91-46d5-bae0-7e9bdfc51a84"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i071a21c613194e0ab1b99e7ce4356c02_I20171127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTU5Ng_b489dfd2-0774-40a6-9703-bcb7d75e8c0c"
      unitRef="usd">5000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTYwMg_7c5937f3-4057-409e-aab6-f556314f42df"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ia8145b81e6f04ee59ed741afa35fd2a8_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTc1OQ_e164aeaa-cde0-4659-b526-8d113ec00859"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if01d6b23161a4099ae7e64005f8ac196_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTc2NQ_38f69f2e-c098-468d-b0c8-db680d550674"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="if01d6b23161a4099ae7e64005f8ac196_I20200827"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMTk5Ng_38f69f2e-c098-468d-b0c8-db680d550674"
      unitRef="usd">35000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i0fbeb3758f03482b8e51a3ca187c8244_I20220217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjAwMg_c568341e-b8dc-4d5d-a963-50800abbefd9"
      unitRef="usd">60000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3MzI2_295f9283-8a54-418e-9ab0-2ae6607556b0"
      unitRef="shares">500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3NDAx_e82b23d2-effc-43ea-a3f3-bb11cd5333c9"
      unitRef="usd">3500000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i880f6ec9d0804b6fb4548530f81b7956_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfMjM1NQ_1c7ccd13-32ed-475c-8cbe-057849a4f3d7"
      unitRef="usd">27700000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iaa6a6dc1ee6443578385523d83f7da3c_D20220915-20220915"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3OTIx_ac44371a-4283-4d06-a34e-8088fb1cb1d0"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6c951d2923244147b9f226b2ae6d9238_D20220801-20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE3OTIx_fea122b0-274a-47a2-ac18-e18a44e141a9"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE4NzMw_fad8f883-b806-48e5-8526-d96ce2b8ff03"
      unitRef="usd">400000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81NS9mcmFnOjg3YmMzOWM1OTgwOTRmNGU4OTA1YTUxZGJlNDJhOGEzL3RleHRyZWdpb246ODdiYzM5YzU5ODA5NGY0ZTg5MDVhNTFkYmU0MmE4YTNfNTQ5NzU1ODE4NzM3_54732d03-62d9-45bf-84e6-5eb98eabf45e"
      unitRef="usdPerShare">0.03</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5NA_2bfd7f4c-b8bb-4417-9488-4d1ea3b0c342">Stock-Based Compensation&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-Term Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity-Settled Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2007 Long-Term Incentive Plan (the &#x201c;2007 Plan&#x201d;), effective November&#160;21, 2006, to provide incentives to eligible employees, directors and consultants. A maximum of 1.4 million shares of the Company's common stock can be issued under the 2007 Plan in connection with the grant of awards. Effective November 21, 2016, no new awards can be granted under the 2007 Plan. As of September&#160;30, 2022, there were no stock option awards outstanding under the 2007 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2010 Long-Term Incentive Plan (the &#x201c;2010 Plan&#x201d;), effective September 27, 2010, as amended on August&#160;21, 2014, to provide incentives to certain employees, directors and consultants. A maximum of 1.0 million shares of the Company's common stock can be issued under the 2010 Plan in connection with the grant of awards. Awards to purchase common stock have been granted pursuant to the 2010 Plan and are outstanding to various employees, officers and directors. Outstanding stock options awarded under the 2010 Plan have exercise prices of $9.31 per share, and vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE5OQ_d0bf6ea3-3477-49ad-9fc2-afc2a24fddbb"&gt;one&lt;/span&gt; to four year vesting periods. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award will be added to the 2017 Plan pool as described below. The contractual term of stock options granted is generally ten years. No new awards will be granted under the 2010 Plan and forfeited or terminated shares may be added to the 2017 Plan pool as described below. As of September&#160;30, 2022, under the 2010 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of approximately 14,000 shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted, and the stockholders approved, the 2017 Long-Term Incentive Plan (the &#x201c;2017 Plan&#x201d;), effective February 16, 2017, to provide incentives to eligible employees, directors and consultants. On February 2, 2018, November 15, 2018, and November 12, 2020, the stockholders approved amendments to the 2017 Plan to increase by 425,000 shares, 715,000 shares and 650,000 shares, respectively, the number of shares of the Company's common stock that are available for issuance under the 2017 Plan. As of&#160;September&#160;30, 2022, a maximum of 2.9 million&#160;shares of the Company's common stock can be issued under the 2017 Plan in connection with the grant of awards which is calculated as the sum of (i) 2,440,000 shares and (ii) up to 475,000 shares previously reserved for issuance under the 2010 Plan, including shares returned upon cancellation, termination or forfeiture of awards that were previously granted under that plan. O&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;utstanding stock options awarded under the 2017 Plan have exercise prices of $4.44 per share, and vest over a three year vesting period. Awards expire in accordance with the terms of each award and, upon expiration of the award, the shares subject to the award are added back to the 2017 Plan. The contractual term of stock options granted are substantially the same as described above for the 2010 Plan. As of September&#160;30, 2022, under the 2017 Plan, there were stock option awards outstanding, net of awards expired, for an aggregate of 0.1 million shares of the Company's common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;General.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company's 2019 Employee Stock Purchase Plan ("ESPP") was adopted by the board of directors in September 2018 and the Company's stockholders approved it in November 2018. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Reserve.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The Company has reserved 0.4 million shares of its common stock for issuance under the ESPP. As of September&#160;30, 2022, 0.2 million shares were available for issuance. The number of shares reserved under the ESPP will automatically be adjusted in the event of a stock split, stock dividend or a reverse stock split (including an adjustment to the per-purchase period share limit).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Purchase Price.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Employees may purchase each share of common stock under the ESPP at a price equal to 85% of the lower of the fair market values of the stock as of the beginning or the end of the six-month offering periods. An employee's contributions to the ESPP are limited to 15% of their regular hourly or salary compensation, and up to a maximum of 3,000 shares may be purchased during any offering period. A participant shall not be granted an option under the ESPP if such option would permit the participant's rights to purchase stock to accrue at a rate exceeding $25,000 grant date fair market value of stock for each calendar year in which such option is outstanding at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Offering Periods.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  Unless otherwise determined by the compensation committee, the ESPP will be operated through a series of successive six-month offering periods, which will begin each year on March 1 and September 1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Duri&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ng the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;September&#160;30, 2022 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; approximately 36,000 and 27,000 shares of common stock were issued under the ESPP, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with accounting guidance for stock-based compensation, payments in equity instruments for goods or services are accounted for by the fair value method. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September 30, 2022 and 2021, compensation of $0.6 million and $0.6 million, respectively. was reflected as an increase to additional&lt;/span&gt; paid-in capital, all of which was employee related.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7c717bd0b67741c8b344ee3df55eb9dc_I20061121"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMzA1_c23200aa-228b-4ac1-aba2-73275f1a9213"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1f9cb90e49c84d6a98d875ed5d38d73b_I20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfODI1_2a9510d0-910e-4267-8c86-f016f5ef221b"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i26ba0558720045eea67b29115b0a3986_D20100927-20100927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTE2NA_423e02a7-42b3-492c-9a3c-49f7355d6685"
      unitRef="usdPerShare">9.31</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iaadfa48ed71d4f0fa49a9f9c6323fd8a_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5MQ_7aadf0d6-cb1a-4427-836e-fd0c494641b3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm
      contextRef="i4f8f7854e7764dc285105b899092b475_D20100927-20100927"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTQ2OQ_6f4c5407-8a73-4a9d-ac9d-74062b4a77d1">P10Y</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib9e2ea205a3d43158e970a0c0f8f359f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMTc0NQ_f0d0f965-b26a-4483-84a8-dcf5b2d1c83c"
      unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="if899b129124943fe800d819b6de66ec3_D20180202-20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjEyNA_8e015ce3-5ea9-4a30-914f-7ee3b19fe5e8"
      unitRef="shares">425000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i1a45671ea82d4f1a932759250eb31f16_D20181115-20181115"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjEzNQ_0d535551-1ee0-43b6-bba0-ad8184dfddc1"
      unitRef="shares">715000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ifdc4810b41d540409fbcb3fe43b196b2_D20201112-20201112"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjE0OQ_b644e0ab-e557-4682-b979-ee7cad14cbd8"
      unitRef="shares">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjMwMQ_1a6744a5-81b7-415f-baea-7f3b1a917f35"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i44c9e56976144431bc767f09ba938466_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjQ1Mg_1760be0d-2148-4e48-b59a-6bf7059362fa"
      unitRef="shares">2440000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ifcad4b991602480e8c333048b37bc386_I20180202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjQ3Nw_22068b22-62cf-4997-8270-3f71bc58f789"
      unitRef="shares">475000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMjc0Ng_ba0a3060-c0a6-4e4b-8fff-72392305c945"
      unitRef="usdPerShare">4.44</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4218dd95179b44ee93fbc3f2fa44e6e1_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5OA_b200a7bf-fa54-4a98-be0a-8d0ec4da7821">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie4cb4a2f4cdf4160909164d620456770_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfMzE4Ng_bba8270a-c329-4ca2-8a60-db2f3216f887"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTA5NQ_b35e993f-69ca-4f26-8d16-5130b4a5fe03"
      unitRef="shares">400000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTE2NA_00fca1cd-91cd-47f0-93e8-48167156b5ad"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTUxOA_9a506ffd-9e9d-46c5-8992-d1c166f53b8c"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTY5NA_09900ab3-7cd1-4a7f-9a65-198ae7c88ca2"
      unitRef="number">0.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
      contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTc2OA_fd120b13-bd2a-4bb4-aa0d-823d4f4fe0e7"
      unitRef="shares">3000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted
      contextRef="ib3b8e8ff21b64134a1f677ebccbcf1f9_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTk4NA_f42d1f01-049c-419b-973a-266604966560"
      unitRef="usd">25000</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted>
    <lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod
      contextRef="ia549ff78a50d44d986b3cfb82bc3ca75_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNzI5Mg_9046dd23-53d3-40c3-98c5-aa4a5b80a692">P6M</lfvn:ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxODg3_c71b232b-682d-4b58-87a3-b9cc4762bbdf"
      unitRef="shares">36000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxMzEw_9654f7ab-63a7-425a-b31f-8b09d0d55aaa"
      unitRef="shares">27000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNjk0OA_d250bc2d-d103-45ff-ad3b-36e108c4ed6f"
      unitRef="usd">600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="id47c18af0c574efe8bb103a1becc5c6b_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF81OC9mcmFnOjJhNTFhOThmMWU5MDQ2YmViNWM5OWFmM2EyMjA5ZWVlL3RleHRyZWdpb246MmE1MWE5OGYxZTkwNDZiZWI1Yzk5YWYzYTIyMDllZWVfNTQ5NzU1ODIxNzI4_c4164777-063c-4cfb-9e67-7d97d5c3f4c7"
      unitRef="usd">600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:LossContingencyDisclosures
      contextRef="i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfODQwMw_64577574-5ade-4503-801e-53c2dd5be724">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company accounts for contingent liabilities in accordance with ASC 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#x2019;s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of  September&#160;30, 2022, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Legal Accruals&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable publicity or resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding or publicity related to such could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact of any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class Action Lawsuit (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Smith v. LifeVantage Corp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled Smith v. LifeVantage Corp., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, Plaintiffs alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, Plaintiffs' amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the former Chief Executive Officer remains a defendant in the case). The Plaintiffs' amended complaint added an antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. The Company filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to the Company&#x2019;s Motion to Dismiss on December 17, 2018, and the Company filed a reply brief on January 10, 2019. The Court ruled on the motion on December 5, 2019, dismissing three of the Plaintiff's four claims, including the antitrust claim, unjust enrichment claim, and the securities claim for the sale of unregistered securities. On December 19, 2019, Plaintiffs filed a second amended complaint which included three causes of action, including a 10(b)(5) securities fraud claim, and renewed claims relating to the sale of unregistered securities and unjust enrichment. LifeVantage filed a Motion to Dismiss the Second Amended Complaint on January 28, 2020, and with the Motion fully briefed by the parties as of March 17, 2020, the Court decided the matter on the parties&#x2019; briefs only on November 25, 2020. In its decision, the Court dismissed with prejudice the Plaintiffs&#x2019; Section 12(1) claim (sale of an unregistered security), because the Court concluded the claim is time barred. The Court also dismissed the Plaintiffs&#x2019; claim for unjust enrichment against LifeVantage without prejudice, and the Plaintiffs did not amend their complaint following the Court&#x2019;s order to re-plead unjust enrichment. The court found that the Plaintiffs had sufficiently pled their claim under Section 12(2) (offer to sell a security that misstates or omits a material fact by means of a prospectus or oral communication). LifeVantage filed its Answer to the Second Amended Complaint on December 23, 2020, responding to the Plaintiffs&#x2019; remaining securities claims. On February 2, 2021, the Court issued an amended scheduling order that reflects the parties&#x2019; agreement on a schedule for discovery and other litigation matters. On June 15, 2021, the plaintiffs filed their motion for class certification, and on July 13, 2021, the defendants, including LifeVantage Corporation, filed their opposition brief that opposed class certification. On July 27, 2021, the Plaintiffs filed their reply to LifeVantage&#x2019;s opposition brief. The court held a hearing for the motion for class certification on March 28, 2022. On April 19, 2022, the court issued an order denying the Plaintiff&#x2019;s motion for class certification. This case has been stayed by the Court until November 25, 2022. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Matters.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;    &lt;/span&gt;In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfNTQyMw_bf0c8c52-f258-40e3-8ea3-e69fc21875b2"
      unitRef="claim">3</us-gaap:LossContingencyClaimsDismissedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="idccc1f3bca2347cc8ac18f61b4fb2b0d_I20191205"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ1YjZlNTE4YzE0YTQwNTJiZjY3NjY1ZjZmZjY4MzQwL3NlYzo0NWI2ZTUxOGMxNGE0MDUyYmY2NzY2NWY2ZmY2ODM0MF82MS9mcmFnOjk0YzY2MGE4NDBkMjRhN2ViODI1YTM3M2FmNDhkODNiL3RleHRyZWdpb246OTRjNjYwYTg0MGQyNGE3ZWI4MjVhMzczYWY0OGQ4M2JfNTQ0NQ_0a3d56ed-d529-46af-8e34-729193300616"
      unitRef="claim">4</us-gaap:LossContingencyPendingClaimsNumber>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>45
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,. 8E4'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " ##@&)5@(3R]^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)\U2#Z&;B^))07!!\1:2V=U@TX1DI-VW-ZV[740?P&-F_GSS
M#4QGHC0AX7,*$1,YS#>3[X<L3=RR(U&4 -D<T>M<E\10FON0O*;R3 >(VGSH
M X+@_!8\DK::-,S *JY$ICIKI$FH*:0SWIH5'S]3O\"L >S1XT 9FKH!IN:)
M\33U'5P!,XPP^?Q=0+L2E^J?V*4#[)R<LEM3XSC6XV;)E1T:>'MZ?%G6K=R0
M20\&RZ_L))TB;MEE\NOF[G[WP)3@0E1-4W&Q$USR5K;M^^SZP^\J[(-U>_>/
MC2^"JH-?=Z&^ %!+ P04    " ##@&)5F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M ,. 8E7L'ZVWW04  *(?   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MM9EK<^(V%(;_BH9V.NU,B&V9D&1+F"$$MIEFLVQ@M[/M](.P!?:L;7EE&9)_
MWR,#-LF(@^M9OB2^G1<].KJ\DGIK(;]E >>*/,=1DMVT J72=Y:5>0&/678N
M4I[ FX60,5-P*Y=6EDK._"(HCBQJVUTK9F'2ZO>*9Q/9[XE<16'")Y)D>1PS
M^7++([&^:3FMW8.G<!DH_<#J]U*VY%.N/J<3"7=6J>*',4^R4"1$\L5-:^"\
M&[JN#BB^^!+R=;9W333*7(AO^N;>OVG9ND0\XI[2$@S^K?B01Y%6@G)\WXJV
MRM_4@?O7._5Q 0\P<Y;QH8C^"GT5W+2N6L3G"Y9'ZDFL_^!;H NMYXDH*_Z2
M]>;;3J=%O#Q3(MX&0PGB,-G\9\_;BM@+<.F! +H-H&\"G$._X&X#BIJS-B4K
ML.Z88OV>%&LB]=>@IB^*NBFB@29,=!JG2L+;$.)4?RA67)()9(RT218PR;.>
MI4!8O[:\K<CM1H0>$'')!Y&H(".CQ.?^ZW@+"E26BNY*=4M1P2E/SXEKGQ%J
M4VHHSQ /?Q2K<V([IO!7Q7'+2G(+/1>MI'\&\TQ):'?_FFIHH] Q*^C.^"Y+
MF<=O6M#;,BY7O-7_Y2>G:_]NPOM!8J]@.R5L!U/OWPDOAWZJR.PEY292/-RQ
MVY],2&A40Z2+$NFB'M*GG$G%9?1"GG@JI#+AX5)*YJ9*&:)1#?&Z)5ZW'MZ$
MRU#XNA<2& R,R<.5RGYWL..A\0TY+TO.RYHM4S*81XIIX' ><:T%BS)C(M&P
MAH!7)> 56JA1HD+U0L9AQ,EC'L^Y-('A&K;MM-V+;N?2!(>&-H2[+N&NZ\ ]
M\66HAU%(XR.+C6T4UWFX'X^^#!YG@_<C,OSX-#%QH@H-.1V[FE+M.J3WB2<D
MM$ZF&^H9F2KHDD1(,A1YHN0+_/>-^$?4[T8F8CRH*?*>BW#J(,_8,[GWH8N&
MB] KN)%V?$3RVF[#&-3I7#I&7C2X*2^M>&D=WH'O@WIVMKL@#_ =^9B8\XI+
MNJYMP\@6YG$:D-MHY1NQ48VFV)4/<E#G@6//UL*(C4M.\Q"ZQ:5M&W%/882<
MR@DYN)=YBSO4=]"#9V*=&%%QN0<>A$;*4W@CIS)'#FYIWE*6 ]5$BE68>.;&
MC&M^GAE!3^&2G,HF.;B[>0LZ$9EB$?D[3 ^/Q;CB5<?NN$;24_@DIS)*#NYN
MBH8Z@&7]83!<X,HVC[JG<$=.98\<W-L\" _R-0E$@OFC(R(=E[:O[0/CS2D,
MDE,Y) >W-K-0@?,3"^+07^>_D2GW<@F9-$+B2D,1QS#Y3I7POIV1E$FR8E'.
MR<_V.:";<WL*TT0KTT1Q6P.>W@^3)9F^Q',1F9"/"#R,OSP:MPI.X8QHY8PH
M;F-V222C9R]@R9(?M+U'A!X'T[N!<6F-!S8EK+P0K>6%AKF4>G&V69$5J82)
M)#=N)QU1_&K<A!KB44TY*_-#:YF?^T1QN=E]U*MLM@,W<N**ASA/X7IHY7IH
M+=>C5Z&P6 $OL!32. 8=T1EX'@<)$/ W8D;64W@?6GD?6LO[3&,61>0VS^!U
M9FZQS;:%\+"F>)7CH;4<SRCF<JE[Y'M04 &8@CAEB3FGN.#!;1,\KBEH97@H
M[E=V>0PXY!'#:[@KA,<UQ:N,#ZVU,?1Z5I\6N_7D8Z[ QB9Z\C02_R!+LZV'
MC=I%H::/B%9]AUYTKUV;]JR5B;$R/Q2W+(.8)WZQO3>.F!D%%SB<O%,X&[=R
M-NZ1#9O=MN4XS+1__<K!CHWAH7&@.2)&;6I<<.!A31DKE^/BYN0MXW8G^C E
M+O?)Z%#QH*:,E<]QZ_D<P)2 >)_X_)G\R8WCS!$I\.#V5>?:Z72-G*?P.>[>
M81?N2G9&;K^Y8D<*1^3:;;O;=HW++3SR_X):>Z>@>L(K#H<SXNGMULV!:/FT
M/( >%,>N5O7YYO3Z ]/S948BOH!0^_P2!CRY.1#>W"B1%F>J<Z&4B(O+@#.?
M2_T!O%\(H78W^@?*8_G^?U!+ P04    " ##@&)592&#TY &  ")&P  &
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MK36N%LX^+_CWVVT$T"H#:+TI "IENA^^]0KJ)?8NBPW@=@G<?A.P?F](15A
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M+'84VX<=TND,Q*TS]#JP)=8#6W/7CXD_TS7:T\Q"=W%['\:"R@-0:"I5G3Q
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MA<[=0UULFA<0/Q5U7:R;CRO.Q I)&HC?;XNB_OH@WVG<OU9[\0]02P,$%
M  @ PX!B5<HIGGTU!P  XAX  !@   !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6RM66UOVCH4_BL6FZ9.&@/;0*!KD2AMM4I=0:6]^^PF!GR7Q)D3VG)__;4=
MFD!RXFX27]J\'!^>X_/RG!.?O4CU*UUSGJ'7*(S3\]8ZRY+33B?UUSQBZ5>9
M\%B_64H5L4S?JE4G311G@5T4A1W2[0XZ$1-Q:WQFG\W5^$QNLE#$?*Y0NHDB
MIK87/)0OYRW<>GMP+U;KS#SHC,\2MN(+GCTF<Z7O.H660$0\3H6,D>++\]8$
MGT[IT"RP$O\(_I+N72-CRI.4O\S-37#>ZAI$/.1^9E0P_>^93WD8&DT:Q^^=
MTE;QFV;A_O6;]FMKO#;FB:5\*L.?(LC6YZUA"P5\R39A=B]?OO.=07VCSY=A
M:O^BEYULMX7\39K):+=8(XA$G/]GK[N-V%N@]< +R&X!J2[H-2R@NP74&IHC
MLV9=LHR-SY1\0<I(:VWFPNZ-7:VM$;%QXR)3^JW0Z[+Q='9W>76WN+I$^FHQ
MN[VYG#SHF\6#_O?CZNYA@6;7:#I9?$?7M[.?"W3R&+--(#(>?$9M]+BX1"<?
M/Z./2,3H82TW*8N#]*R3:61&?\??H;C(49 &%!3]D'&V3M%5'/#@<'U'6U28
M1=[,NB!.A0N>?$6T^P61+B$ GNF?+\<..+3896KUT:9=9ND:7>N42=%2R0C-
M$JY8)N(5FI@P%IG@Z2FT;;G:'JS6I/AIFC"?G[=T#J=</?/6^-,'/.A^@VP^
MDK*#'>@5.]!S:1_?Z8HD8E]&'#(S7SNP:TWA>1X/</>L\[R/OBY#*1X40@>H
M^@6JOM,OD^!?G6*Z*F4IRJ0N2[Z,?1%R%!=PS7-SYQL7GFQ2'N@7GU&BY+/0
ML8J>MD@6WF1N;_:/Z<TC*3O8MT&Q;P.G-R^Y5NH+EE?B.$ LDBH3_]D'D.6Y
MNOZ>\X8]7'%P7<8;4=B_7H'3<^)<9-+_U39E/D#:F9K[TD:(7NWG!UU2@0C(
M]/HPQ&$!<>B$.-G;.2272!G>:<ME6X<:8FG*,[">#FM(<(]6T-9E^OTAC'94
MH!V]X_@E5\KF0)X<[!5"-ZK]<AM[_7X%'R35'1(8(>Z6C-9U%]LUBU<\-92T
MEYEV)VVLAH(]B; Y2W?JCY2FQ])VN!E[]([=X>7[<F/*F\Y7+I[94P@6X)V6
M@WBB9%!Q&"#5IH.&&HQ)B9$X,=X4L?0>2E)'Z?6K=022ZM)1 \J2PK&3'S7*
M9\T34FV_&#X X='Z]I#^8%C%!X@U51%<\BMV$^Q<\82) /%74^5X'NHR6W,%
M0NW5,/1P-3\!H?;0\QJ0EIR+G=0TGAE0*)3QJIUQ%3F*W$[1@2>K& &1!M+
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M^%F"C[$XZ;ARC)9C\=P!W@O\01U**Q6&WM52&T0\WK3T F$HU^2Q5X2_GN?
M]D\$@;;@])W4B\$ZV[YL<3"-Q;FG; ['4*4[V'B% ^,W[&(:O81E"0)HG&AF
M^Q>U-KI%!M G&XF==?=$+9&GS9P\9VV!9 0$^F07<8PBHWQP%FE20'6ZILT2
M8\UR6YS#B%(ZBU+<\'JWP[,:6XUYWG55#??Y7;:<;""L\"Z$K;GS"IAHBS.
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M<73W(?2,!6]^#F'EA@PYBPK/T"W2)HUI8X>(^VVL#^]AQVZC3X<^CQI6B62
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MCH85Z+S0VIT7[*#_N[#Y#U!+ P04    " ##@&)5E]UT*"4)   \'   &0
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M"3R0 -[/K0W;!SJ@N:F__A]02P,$%     @ PX!B55,)**4(#0  VR,  !D
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M'THN$GO9A1M1Y&MIE9E(6B%*"*'_NDC\NX&7FDM+]GE0".X'L_22KBSUK$P
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M)/(PN)Y_OK%TP^!:_A.P!QQI 3Y?.3>D!SH@_Y[GS?\ 4$L#!!0    ( ,.
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M&%PQ'KJOX3X*?2*==QU/\^A\!3A/5:/3K-EFT,'IVK62><;^" H+1K!ZQR!
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M%'3+R;("+SM:%+:(?1":2F+;G-!7"THS@9Z/A-"KCEF@^@Z*_@!02P,$%
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MP@[OI:Y9BC./IE.CVJ"7O'TSF@;OA_3])[)G:L>]VO$A]N1+C8H9+M:0,ET
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M?;0CVYNE[6A1VVH^%QKO!MLL\#8&:1;@_%((_=8Q%T1WOV?_ %!+ P04
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M-_&X/*A!"J7Y4%H I8506H2BF>*I#5+/ZJ$!;VKLB8Z6D]MT1^":TXH/S1E
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M2\[UBN3SXD/"!RXE3XO%&:,3)O0!:O\CYW*SHA-4W],._P-02P,$%     @
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MOA"M &M\(,"N ^Q3 YPZP#DU8%P'C$\-F-0!D_<!DP,!TSI@>FH)LSI@=FK
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M:Y;'S\O')N*<S#AK^-US_ 502P,$%     @ PX!B558,451_ 0  PQ(  !,
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M2P$"% ,4    " ##@&)5!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,. 8E6 A/+W[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M ,. 8E697)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ PX!B5>P?K;?=!0  HA\  !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M ,. 8E5E(8/3D 8  (D;   8              " @2 .  !X;"]W;W)K<VAE
M971S+W-H965T,BYX;6Q02P$"% ,4    " ##@&)5QRKYJ0<#  !E"@  &
M            @('F%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#
M%     @ PX!B58_3,"UZ!0  (A<  !@              ("!(Q@  'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( ,. 8E6L^<XWZ <  &([
M   8              " @=,=  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q0
M2P$"% ,4    " ##@&)5RBF>?34'  #B'@  &               @('Q)0
M>&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ PX!B50\:A,K.
M!@  G1   !@              ("!7"T  'AL+W=O<FMS:&5E=',O<VAE970W
M+GAM;%!+ 0(4 Q0    ( ,. 8E5F[<VN;Q@  -Q(   8              "
M@6 T  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " ##@&)5
M[__0!YL'  "!$@  &               @($%30  >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&UL4$L! A0#%     @ PX!B59I8F(R; P  .@@  !D
M     ("!UE0  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ,. 8E4U^HM@1A,  .8[   9              "
M@5=^  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ PX!B
M559'F&#]!   [@P  !D              ("!U)$  'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"% ,4    " ##@&)5?\JUWQ<#  !-!P  &0
M        @($(EP  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0
M   ( ,. 8E5]J8'P# 8  /$B   9              " @5::  !X;"]W;W)K
M<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ PX!B56IEN-'E @  GP@
M !D              ("!F:   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q0
M2P$"% ,4    " ##@&)5S3-L,'X#  "@"P  &0              @(&UHP
M>&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( ,. 8E6T)%#&
M+@0  "P7   9              " @6JG  !X;"]W;W)K<VAE971S+W-H965T
M,C$N>&UL4$L! A0#%     @ PX!B57NN+H>@ P  71   !D
M ("!SZL  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " ##
M@&)5(=INESL#   3#0  &0              @(&FKP  >&PO=V]R:W-H965T
M<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( ,. 8E64 -&68@(  +H%   9
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M970R."YX;6Q02P$"% ,4    " ##@&)5>%)6P0\"  "4!   &0
M    @(' S@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (
M ,. 8E6_!XRH20,  ,P4   -              "  0;1  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ PX!B59>*NQS     $P(   L              ( !
M>M0  %]R96QS+RYR96QS4$L! A0#%     @ PX!B54J"N5D< P  !A0   \
M             ( !8]4  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( ,.
M8E7:L 5M4@$  /X1   :              "  :S8  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,. 8E56#%%4?P$  ,,2   3
M          "  3;:  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     E "4
*^@D  .;;      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>92</ContextCount>
  <ElementCount>230</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>26</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/OrganizationandBasisofPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Gig Economy Group Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestment</Role>
      <ShortName>Gig Economy Group Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/Leases</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Components of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Gig Economy Group Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails</Role>
      <ShortName>Gig Economy Group Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/GigEconomyGroupInvestment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/StockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.lifevantage.com/role/StockBasedCompensation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="lfvn-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.lifevantage.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:LesseeOperatingLeaseTermOfContract, us-gaap:NumberOfOperatingSegments, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 -  lfvn-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="lfvn-20220930.htm">lfvn-20220930.htm</File>
    <File>a20220930-zionsrlocadden.htm</File>
    <File>lfvn-20220930.xsd</File>
    <File>lfvn-20220930_cal.xml</File>
    <File>lfvn-20220930_def.xml</File>
    <File>lfvn-20220930_lab.xml</File>
    <File>lfvn-20220930_pre.xml</File>
    <File>lfvn_093022xex311.htm</File>
    <File>lfvn_093022xex312.htm</File>
    <File>lfvn_093022xex321.htm</File>
    <File>lfvn_093022xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="383">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>51
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lfvn-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 12,
   "contextCount": 92,
   "dts": {
    "calculationLink": {
     "local": [
      "lfvn-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lfvn-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lfvn-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lfvn-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lfvn-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lfvn-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 328,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 23,
   "keyStandard": 207,
   "memberCustom": 10,
   "memberStandard": 14,
   "nsprefix": "lfvn",
   "nsuri": "http://www.lifevantage.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "role": "http://www.lifevantage.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Leases",
     "role": "http://www.lifevantage.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Long-Term Debt",
     "role": "http://www.lifevantage.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Stockholders' Equity",
     "role": "http://www.lifevantage.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stock-Based Compensation",
     "role": "http://www.lifevantage.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "role": "http://www.lifevantage.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Leases (Tables)",
     "role": "http://www.lifevantage.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails",
     "shortName": "Summary of Significant Accounting Policies - Components of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Summary of Computation of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Summary of Significant Accounting Policies - Segment Information (Details)",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "ib732a4247f1c4b9f9cef9f2ced8879ce_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "id131ac0747904e089c449612a8c5c709_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Gig Economy Group Investment (Details)",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
     "shortName": "Gig Economy Group Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "id131ac0747904e089c449612a8c5c709_I20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Leases - Schedule of Lease, Cost (Details)",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails",
     "shortName": "Leases - Schedule of Lease, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "role": "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails",
     "shortName": "Leases - Schedule of Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i7eae71368a024d6ba653f381ffe0db1c_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Long-Term Debt - Narrative (Details)",
     "role": "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i7eae71368a024d6ba653f381ffe0db1c_I20210401",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lfvn:DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i0fbeb3758f03482b8e51a3ca187c8244_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stockholders' Equity (Details)",
     "role": "http://www.lifevantage.com/role/StockholdersEquityDetails",
     "shortName": "Stockholders' Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i0fbeb3758f03482b8e51a3ca187c8244_I20220217",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Stock-Based Compensation (Details)",
     "role": "http://www.lifevantage.com/role/StockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://www.lifevantage.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i0a7746acb60c4e52a38181c84a1cbc6b_D20191205-20191205",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyClaimsDismissedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i880f6ec9d0804b6fb4548530f81b7956_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i3e24f72d093b44669e0b2c6422958fd3_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS\u2019 EQUITY (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i3e24f72d093b44669e0b2c6422958fd3_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "role": "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Organization and Basis of Presentation",
     "role": "http://www.lifevantage.com/role/OrganizationandBasisofPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Gig Economy Group Investment",
     "role": "http://www.lifevantage.com/role/GigEconomyGroupInvestment",
     "shortName": "Gig Economy Group Investment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lfvn-20220930.htm",
      "contextRef": "i6ea0024d4384433faf08e2c9f681957b_D20220701-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 26,
   "tag": {
    "country_JP": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "JAPAN",
        "terseLabel": "Japan"
       }
      }
     },
     "localname": "JP",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lfvn_AsiaPacificAndEuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific And Europe [Member]",
        "label": "Asia Pacific And Europe [Member]",
        "terseLabel": "Asia/Pacific &amp; Europe"
       }
      }
     },
     "localname": "AsiaPacificAndEuropeMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldPrimarilyAtFinancialInstitutionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "label": "Cash Accounts Held Primarily At Financial Institution [Member]",
        "terseLabel": "Cash accounts held primarily at One Financial Institution"
       }
      }
     },
     "localname": "CashAccountsHeldPrimarilyAtFinancialInstitutionMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CashAccountsHeldatOtherFinancialInstitutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Accounts Held At Other Financial Institutions [Member]",
        "label": "Cash Accounts Held at Other Financial Institutions [Member]",
        "terseLabel": "Cash held primarily at Other Financial Institutions"
       }
      }
     },
     "localname": "CashAccountsHeldatOtherFinancialInstitutionsMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_CommissionAndIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses related to commissions and other incentives earned by independent distributors. Commission and incentive expenses include sales commissions paid to our independent distributors, special incentives, costs for incentive trip and other rewards",
        "label": "Commission And Incentives",
        "terseLabel": "Commissions and incentives"
       }
      }
     },
     "localname": "CommissionAndIncentives",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ContractsWithCustomersRefundPercentForResalableAndRestockableItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts With Customers, Refund Percent For Resalable And Restockable Items",
        "label": "Contracts With Customers, Refund Percent For Resalable And Restockable Items",
        "terseLabel": "Refund percent for resalable and restockable Items"
       }
      }
     },
     "localname": "ContractsWithCustomersRefundPercentForResalableAndRestockableItems",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_ContractsWithCustomersReturnPeriodForResalableAndRestockableItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts With Customers, Return Period For Resalable And Restockable Items",
        "label": "Contracts With Customers, Return Period For Resalable And Restockable Items",
        "terseLabel": "Return period for resalable and restockable Items"
       }
      }
     },
     "localname": "ContractsWithCustomersReturnPeriodForResalableAndRestockableItems",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_DebtInstrumentCovenantFixedChargeCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "label": "Debt Instrument, Covenant, Fixed Charge Coverage Ratio",
        "terseLabel": "Debt instrument, covenant, fixed charge coverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantFixedChargeCoverageRatio",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentCovenantMaximumAllowedDividends": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Maximum Allowed Dividends",
        "label": "Debt Instrument, Covenant, Maximum Allowed Dividends",
        "terseLabel": "Debt instrument, covenant, maximum allowed dividends"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMaximumAllowedDividends",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantRequiredMinimumWorkingCapital": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "label": "Debt Instrument, Covenant, Required Minimum Working Capital",
        "terseLabel": "Debt instrument, covenant, required minimum working capital"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRequiredMinimumWorkingCapital",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "label": "Debt Instrument, Covenant, Total Liabilities To Tangible Net Worth Ratio",
        "terseLabel": "Debt instrument, covenant, total liabilities to tangible net worth ratio (not greater than)"
       }
      }
     },
     "localname": "DebtInstrumentCovenantTotalLiabilitiesToTangibleNetWorthRatio",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "lfvn_DebtInstrumentFloorInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Floor Interest Rate",
        "label": "Debt Instrument, Floor Interest Rate",
        "terseLabel": "Floor interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentFloorInterestRate",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_DebtInstrumentTrailingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Trailing Period",
        "label": "Debt Instrument, Trailing Period",
        "terseLabel": "Trailing period"
       }
      }
     },
     "localname": "DebtInstrumentTrailingPeriod",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_HandlingAndRestockingFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Handling and Restocking Fee, Percentage",
        "label": "Handling and Restocking Fee, Percentage",
        "terseLabel": "Handling and restocking fee, percentage (as a percent)"
       }
      }
     },
     "localname": "HandlingAndRestockingFeePercentage",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_IncreaseDecreaseInLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Lease Liabilities",
        "label": "Increase (Decrease) In Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLeaseLiabilities",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_InventoryFinishedGoodsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Finished Goods, Percent Of Total Inventory",
        "label": "Inventory, Finished Goods, Percent Of Total Inventory",
        "terseLabel": "Finished goods, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryFinishedGoodsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_InventoryPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Percent Of Total Inventory",
        "label": "Inventory, Percent Of Total Inventory",
        "totalLabel": "Percent of total inventory (in percentage)"
       }
      }
     },
     "localname": "InventoryPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "label": "Lessee, Operating Lease, Liability, Payments Due, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_March2016RevolvingLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Revolving Loan [Member]",
        "label": "March 2016 Revolving Loan [Member]",
        "terseLabel": "March 2016 Revolving Loan"
       }
      }
     },
     "localname": "March2016RevolvingLoanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_March2016TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "March 2016 Term Loan [Member]",
        "label": "March 2016 Term Loan [Member]",
        "terseLabel": "March 2016 Term Loan"
       }
      }
     },
     "localname": "March2016TermLoanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_MoneyBackGuaranteePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money back guarantee period.",
        "label": "Money Back Guarantee Period",
        "terseLabel": "Money back guarantee period"
       }
      }
     },
     "localname": "MoneyBackGuaranteePeriod",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_NotesReceivableRelatedPartyMaximumCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Related Party, Maximum Commitment",
        "label": "Notes Receivable, Related Party, Maximum Commitment",
        "terseLabel": "Notes receivable, related party, maximum commitment"
       }
      }
     },
     "localname": "NotesReceivableRelatedPartyMaximumCommitment",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_NumberOfGeographicSegments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of geographic segments.",
        "label": "Number Of Geographic Segments",
        "terseLabel": "Number of geographic segments"
       }
      }
     },
     "localname": "NumberOfGeographicSegments",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lfvn_ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "label": "Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan",
        "terseLabel": "Proceeds from common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_RawMaterialsPercentOfTotalInventory": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "lfvn_InventoryPercentOfTotalInventory",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raw Materials, Percent Of Total Inventory",
        "label": "Raw Materials, Percent Of Total Inventory",
        "terseLabel": "Raw materials, percent of inventory (in percentage)"
       }
      }
     },
     "localname": "RawMaterialsPercentOfTotalInventory",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lfvn_ReturnLiabilityReserve": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Return Liability Reserve",
        "label": "Return Liability Reserve",
        "terseLabel": "Return liability reserve"
       }
      }
     },
     "localname": "ReturnLiabilityReserve",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Amount In Excess Of Fair Market Value Of Stock For Option Not To Be Granted",
        "terseLabel": "Amount in excess of fair market value of stock for option not to be granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAmountInExcessOfFairMarketValueOfStockForOptionNotToBeGranted",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Offering Period",
        "terseLabel": "Offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOfferingPeriod",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Contractual Term",
        "terseLabel": "Contractual term of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingContractualTerm",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lfvn_TwoThousandAndSevenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and seven long term incentive plan.",
        "label": "Two Thousand And Seven Long Term Incentive Plan [Member]",
        "terseLabel": "2007 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndSevenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and ten long term incentive plan.",
        "label": "Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan, Excluding Two Thousand And Ten Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan Excluding 2010 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanExcludingTwoThousandAndTenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lfvn_TwoThousandSeventeenLongTermIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "label": "Two Thousand Seventeen Long Term Incentive Plan [Member]",
        "terseLabel": "2017 Long-Term Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenLongTermIncentivePlanMember",
     "nsuri": "http://www.lifevantage.com/20220930",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r294",
      "r420",
      "r421",
      "r423",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "GEG"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r201",
      "r203",
      "r204",
      "r205",
      "r224",
      "r258",
      "r295",
      "r296",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r480",
      "r482",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r201",
      "r203",
      "r204",
      "r205",
      "r224",
      "r258",
      "r295",
      "r296",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r480",
      "r482",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r198",
      "r201",
      "r203",
      "r204",
      "r205",
      "r224",
      "r258",
      "r293",
      "r295",
      "r296",
      "r327",
      "r328",
      "r329",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r480",
      "r482",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r198",
      "r201",
      "r203",
      "r204",
      "r205",
      "r224",
      "r258",
      "r293",
      "r295",
      "r296",
      "r327",
      "r328",
      "r329",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r480",
      "r482",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r290",
      "r291",
      "r481",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r290",
      "r291",
      "r481",
      "r490",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r29",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r175",
      "r176"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r6",
      "r32"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions payable"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r42",
      "r43",
      "r44",
      "r469",
      "r487",
      "r488"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r41",
      "r44",
      "r52",
      "r53",
      "r54",
      "r99",
      "r100",
      "r101",
      "r369",
      "r419",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r337",
      "r338",
      "r339",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Stock based compensation reflected in additional paid in capital"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r298",
      "r341",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from EPS calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r9",
      "r93",
      "r151",
      "r160",
      "r166",
      "r185",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r365",
      "r370",
      "r391",
      "r424",
      "r426",
      "r450",
      "r467"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r28",
      "r93",
      "r185",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r365",
      "r370",
      "r391",
      "r424",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r72",
      "r79",
      "r84"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents \u2014 end of period",
        "periodStartLabel": "Cash and Cash Equivalents \u2014 beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r72",
      "r394"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in Cash and Cash Equivalents:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r90",
      "r93",
      "r114",
      "r118",
      "r119",
      "r121",
      "r123",
      "r130",
      "r131",
      "r132",
      "r185",
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220",
      "r256",
      "r257",
      "r261",
      "r265",
      "r272",
      "r391",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r37",
      "r456",
      "r473"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies - Note 8"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common Stock, capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividend paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividend, common stock declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r99",
      "r100",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock \u2014 par value $0.0001 per share, 40,000 shares authorized and 12,560 and 12,493 issued and outstanding as of September\u00a030, 2022 and June\u00a030, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r47",
      "r49",
      "r50",
      "r59",
      "r459",
      "r476"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r139",
      "r140",
      "r174",
      "r387",
      "r388",
      "r489",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r135",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Concentration of credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141",
      "r387",
      "r390",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r139",
      "r140",
      "r174",
      "r387",
      "r388",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r86",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r63",
      "r436"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt conversion, converted instrument, amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt conversion, converted instrument, shares issued (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": {
     "auth_ref": [
      "r82",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Interest Rate of Debt",
        "terseLabel": "Debt conversion, original debt, interest rate of debt (as a percent)"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtInterestRateOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r89",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r238",
      "r245",
      "r246",
      "r247",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r92",
      "r97",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r248",
      "r249",
      "r250",
      "r251",
      "r404",
      "r451",
      "r453",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r35",
      "r92",
      "r97",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r228",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r248",
      "r249",
      "r250",
      "r251",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r35"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Quarterly installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r347",
      "r348"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r77",
      "r94",
      "r353",
      "r358",
      "r359",
      "r360"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r77",
      "r149"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r377",
      "r378"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "negatedLabel": "Derivative instruments, realized loss"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r373",
      "r374",
      "r375",
      "r376",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Instruments and Hedging Activities"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r301",
      "r302",
      "r332",
      "r333",
      "r334",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r279",
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Cash dividends"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "terseLabel": "Dividends, common stock, cash"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r60",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r112",
      "r114",
      "r121",
      "r122",
      "r123",
      "r126",
      "r127",
      "r383",
      "r384",
      "r460",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net income per share, basic (in USD per share)",
        "verboseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r60",
      "r104",
      "r105",
      "r106",
      "r107",
      "r108",
      "r114",
      "r121",
      "r122",
      "r123",
      "r126",
      "r127",
      "r383",
      "r384",
      "r460",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net income per share, diluted (in USD per share)",
        "verboseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Foreign Currency Effect on Cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r52",
      "r53",
      "r54",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r129",
      "r188",
      "r272",
      "r279",
      "r337",
      "r338",
      "r339",
      "r355",
      "r356",
      "r382",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of equity interests that are issued or issuable in a business combination.",
        "label": "Equity Interest Type [Axis]",
        "terseLabel": "Equity Interest Type [Axis]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.",
        "label": "Equity Interest Issued or Issuable, Type [Domain]",
        "terseLabel": "Equity Interest Issued or Issuable, Type [Domain]"
       }
      }
     },
     "localname": "EquityInterestIssuedOrIssuableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities held without readily determinable value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Realized",
        "negatedTerseLabel": "Foreign currency transaction loss, realized"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r62",
      "r93",
      "r151",
      "r159",
      "r162",
      "r165",
      "r167",
      "r185",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r391"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r57",
      "r151",
      "r159",
      "r162",
      "r165",
      "r167",
      "r449",
      "r457",
      "r462",
      "r478"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r110",
      "r111",
      "r150",
      "r349",
      "r357",
      "r361",
      "r479"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r345",
      "r346",
      "r350",
      "r351",
      "r352",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r74",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r16",
      "r455",
      "r474"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r115",
      "r116",
      "r117",
      "r123",
      "r300"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock awards and options (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r195",
      "r196"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r55",
      "r148",
      "r402",
      "r403",
      "r461"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r71",
      "r73",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r23",
      "r193"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r27",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r7",
      "r25",
      "r87",
      "r128",
      "r190",
      "r191",
      "r194",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r27",
      "r193"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesComponentsofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r27",
      "r192"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r182",
      "r184",
      "r186",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Gig Economy Group Investment"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (remaining nine months ending June 30, 2023)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r416"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r93",
      "r161",
      "r185",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r366",
      "r370",
      "r371",
      "r391",
      "r424",
      "r425"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r93",
      "r185",
      "r391",
      "r426",
      "r454",
      "r471"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r33",
      "r93",
      "r185",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r366",
      "r370",
      "r371",
      "r391",
      "r424",
      "r425",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum capacity on draw"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r30",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-Lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Fixed rate interest on debt (as a percent)"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r35",
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r200",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r199",
      "r200",
      "r202",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r200",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Pending claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash Used in Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Used in Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r72",
      "r75",
      "r78"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash (Used in) Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r45",
      "r48",
      "r54",
      "r58",
      "r78",
      "r93",
      "r102",
      "r104",
      "r105",
      "r106",
      "r107",
      "r110",
      "r111",
      "r120",
      "r151",
      "r159",
      "r162",
      "r165",
      "r167",
      "r185",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r384",
      "r391",
      "r458",
      "r475"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r151",
      "r159",
      "r162",
      "r165",
      "r167"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r408",
      "r412"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesScheduleofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r405"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r414",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (as a percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r413",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/OrganizationandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r363",
      "r364",
      "r368"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r46",
      "r49",
      "r363",
      "r364",
      "r368"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of company stock",
        "terseLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Payment of cash dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Shares canceled or surrendered as payment of tax withholding and other"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r14",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock \u2014 par value $0.0001 per share, 5,000 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r68",
      "r336"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r197",
      "r426",
      "r463",
      "r472"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r61",
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expenses"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r179",
      "r180",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r294",
      "r420",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r294",
      "r420",
      "r423",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "terseLabel": "Payment of cash dividends"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r344",
      "r435",
      "r504"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r279",
      "r426",
      "r470",
      "r486",
      "r488"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r188",
      "r337",
      "r338",
      "r339",
      "r355",
      "r356",
      "r382",
      "r483",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r146",
      "r147",
      "r158",
      "r163",
      "r164",
      "r168",
      "r169",
      "r174",
      "r289",
      "r290",
      "r436"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition And Shipping and Handling"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue Disaggregated by Geographic Regions"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r7",
      "r24",
      "r25",
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Components of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/GigEconomyGroupInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r56",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r297",
      "r299",
      "r302",
      "r303",
      "r304",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r90",
      "r130",
      "r131",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r261",
      "r265",
      "r270",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Share based payment award, vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest quantity of shares an employee can purchase under the plan per period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee",
        "terseLabel": "Maximum number of shares per employee (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Number of shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for issuance under the ESPP (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Options outstanding, net of awards expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r305",
      "r324",
      "r325",
      "r326",
      "r327",
      "r330",
      "r340",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Right to purchase common stock, minimum price (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "terseLabel": "Right to purchase common stock, non-vested and outstanding, exercise price (in USD per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock (as a percent)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares canceled or surrendered as payment of tax withholding and other (in shares)",
        "terseLabel": "Shares canceled or surrendered as payment of tax withholding (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r85",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r90",
      "r93",
      "r114",
      "r118",
      "r119",
      "r121",
      "r123",
      "r130",
      "r131",
      "r132",
      "r185",
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220",
      "r256",
      "r257",
      "r261",
      "r265",
      "r272",
      "r391",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r39",
      "r52",
      "r53",
      "r54",
      "r99",
      "r100",
      "r101",
      "r103",
      "r109",
      "r111",
      "r129",
      "r188",
      "r272",
      "r279",
      "r337",
      "r338",
      "r339",
      "r355",
      "r356",
      "r382",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r419",
      "r483",
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r129",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockBasedCompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r272",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Common stock issued under equity award plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r272",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Repurchase common stock amount authorized (up to)"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of company stock (in shares)",
        "terseLabel": "Stock repurchase program shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.lifevantage.com/role/StockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r14",
      "r15",
      "r272",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedLabel": "Repurchase of company stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r20",
      "r21",
      "r93",
      "r178",
      "r185",
      "r391",
      "r426"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r257",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r279",
      "r280",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r11",
      "r452",
      "r468"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.",
        "label": "Taxes Payable",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "TaxesPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UsTreasuryUstInterestRateMember": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate on direct treasury obligation of U.S. government (UST).",
        "label": "US Treasury (UST) Interest Rate [Member]",
        "terseLabel": "US Treasury (UST) Interest Rate"
       }
      }
     },
     "localname": "UsTreasuryUstInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r133",
      "r134",
      "r136",
      "r137",
      "r142",
      "r143",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r113",
      "r123"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r112",
      "r123"
     ],
     "calculation": {
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average shares outstanding:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.lifevantage.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.lifevantage.com/role/SummaryofSignificantAccountingPoliciesSummaryofComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r505": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r506": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r507": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r508": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r509": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r510": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r511": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>52
<FILENAME>0000849146-22-000076-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000849146-22-000076-xbrl.zip
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MOK@>]TI;=P__M>2[:&]W"1C>:[?Z9\</="7<BOR_A^GIOY;6>]T!B#%J7IS
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M"1-2AU- 13C EB5,DB3QV!DR;K]9LLZBL<[-GAY\1FX5D1$7@GKK!/<& V^
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MBC)@$\)CHQ)*09BT%PX^''>YD&/+1C[_KH)?6#?Y<"-"SJ9</[8QB8W#1L2
MME8:Q@%\F4NBR!OE<I<Q-!:E"^LR?F[K;EUW)GM"-<]ZS:/>,--=M]9UN_[4
M=X-C&6+N6WD_J?34A]N>TVK'(M>,,W'D$C#3%?9<67#=A%9@K\>1=Y%CTL6L
M2)EBK)Y?+SP;C9HO0"&" _K,1&\!TF@<13(&NO/(>RUB0\$ZC\#K9DJ*/'65
M4PB]5U+]= #SW!IQ(VDUQ08_2EI-7?J4<*]VB>82;%SB>(+A9Z5#?S3!*$N<
MU"7'_!K'/->.CI?G&)[())81]W$LN+-41@2#OZ04\(;A<51RS.NDJU&>>DUQ
MI)GCC$32JQAK;#'0FT7J%81I%XB<SQ(U34#(# %]3KGB+/$28R>),L)Y(;P=
MU\G".]'XA]=)JMQ2'OB7$3Z9QU'H0X1OZM*G[%;6/!(Q\5I2%SJAA".((T4C
M[ TC"2D,-TE([FX7/Y2D_072@BOTH(C ]*5/(&WB+)<$&TY<Q#''*C'6@/1R
M9H@2IDBH8Z!HD-KBAY*TCPY:X)Q>#Y':Z4N?4O'%K>&:)MRZL&4)@PE$P"82
M% =ICE_!Z>Z+1=%GT9J<6^4CH6)!. ?#QMA8Q E6!D!6\E%5[YM5EM5SVQZZ
M%+YY<4MH6ET^J417.VX42!NF7&(O+0M]JZ1AL;%,OGJ:OGX*<4JD<RHBL3(A
MDJL8J#V6T$3#;\*_I@S_8F'DR^?[\WIXF224&,$)XYHDX: I8ZT)>SG5J]1Z
MU<Y)NW?A?9[8_SSLVR.=O28MIR.NDB26.L*.<Z>D,,PF1E*0.JN+J,SKE;<Y
M4N?EY0OK..9"6R.PY3ZBFDGP^*P$00,)$V;<N0I':/S#@J40BQ9+^$&.UM2E
MOW@"B6WKM'-W([_\J_']#V[CYZRU)&'&:LIX;&VH?)")((8GAAKLBBJ0!5G[
M&U4@-Y;SH8CR,3U?Z?NL!Z+EL^+7(Z]=_GZ7GJ[^"7^-MS<8X2,B+>&:XX@:
M '\AHD0DB9",XV\A07M]3S:X:,/4.VD7'?GT\&BPPNF'.#H9_'&6NL'1"L'X
M_U_*+UW],SO1W=4_3?\C/*#XN7C.[:?I_B$\<- [66'PI# %I-OI(1 [Z.)P
M$DVX?WRY[;5[_97_P/E_?R0P9Y3H3MJ^6/GO)L!/5JG[L\I.KZ.[_[T,*CU#
M&:Q24ER8I9=^A0AX2_[K63&'&)[33KM^/"?@ YA%9:^^U:QN5':;:\WJ[LTY
M3(Q^48:[6UW?V]EJ;E5W*VOUC4KU?]?_7JM_JE;6&[7:UN[N5J/^@E,@#YK"
MOLZ.P+<9]+K+E8T/ZQ\J((]<O=RP'[;PWV;\W[WS75 YV>SU.Y4_ 6*ZO6Y]
MF!]Y4QDAT8Y/0A&-USCL'.#@H'/&$IU@&5K$ ,(0%<7F+F.FTM4!8YU/5S9Z
M-J^6#H7[2R,X9U\OS$;O=)ONG+98;>B.JZ<'G]1QX_@+:1T?M.O-*F]=5G&K
M^>6LWOPG/3ANL?IQBQP<'W3@9UZ[_'*VS>KMUF4/U_>WZ$%S[[SQJ78.\H)K
M&WL7K4Z+UB_ASWZ+'L#/C8T:KFW*\VUZ<-':MZ+1;)VW+NO?:\>MRX-/F\?U
M#<M;Q^VT?NG:]8U#=K"_%]4V:A<'Q[53]^DK=W__TSZ@[5-SW(OJQYO'-?KE
MHGY<_][:K^'ZY5':V-]B=;J'&QNN?=#\?E:[_*=3(_*\?OSE6^*<E%)9%,[P
M0%Q'"BGC";*A%HE)+'2BEE8)1E]RG+\FPFHI.#^8[R#L2QM?8'I]4(X(YMW6
M)YE?&?_PATNSD[:^ ,6;#S^_Z8^1')K>8-#KK 3E=^K[@] O>?22_'W%UR.]
MJ-0'&;&@&@>@@P=N_.*1UOR0:\V/ W?[.P[J5=S[+?Y [OWN1T]5[ /F_$&/
M_9B/N!@UK$M8XG\ML:7Q#2?:A7C4"CTYKY";J-3VR>VEZ9T\G-GVX<'AX=E#
MU0J?YK/"''E^;/HR!)/8]]L7._ZDUQ\L51( 13V %\!J@'6X8GJ]MM'M=F]@
M>N>O$L4V4_-I3]3V_^G4C_<H(-9E[?(KW-,^JE\>PGLWTT;3DMKQUTZ-MBX;
MS2^C>[["NZ+N0;-WGH^GV8I:Q[7+.B!?8[_*&ALPQ_VMJ'ZY=P'CO(1W1?5-
M>;;=7!O4=O'Y=G.+U9I5^LU20J55& DA'0*SU2,IO$<^B1RA3C*C 0;_ZS]"
M%]$_[D7"$;,_G8\[J7-M/W\[*6?H+WMK.\WJSG:KLE/]W-AI@J6Z4=VI@ 78
M!#.O0EBEL5,A4>4W]_M__0<1^(_&9J7Y=[4R82)>F8=KZ\T*?$T4XS=6*1?[
MCSG@W6^*C" PP/V$<2+F8IS@AQDGL!)AZM=+]KFZL]4 ^QB6;&,>9LOGW$>K
M%H[P#6!8<? )ZL [C\)MR.D+=.%U'_GNJT2(7[9S+@ %ODFEF?9>(&PY1EPZ
M@D+%"HJQC#U-''7"!2_G<[-:^PNXG>'E2ECW^V2]5/"E@I^A\Q$:M:?Y<<%O
M7,,?-/\Y@L_.04N?-9I[E_5/7\C!?O7R8..@76M^A;=LD?K&VL5!ISJEX4_:
MM4X59'HSK5VN1?5F#1]L?&VWFO7O]<[>>7T?9G2\!^/^I]/Z>H>&]]K$VI,$
M]+K6B">@W!61!LG( !@8%4LL1QJ>OW4-W]Q9J^]NY=I\I.(_[^WL[JW5FY5F
MHU3T/U#T$RLWTO2;.XU:93SE^0^M6"'G;:\X;GQEV 55%*X*S!R(-O^_7VXU
MEE8# Y?4N(L:/PKXJ042M;!G.LU"EJ^2I&!C%>?%/Z<M7<VS)9OPLGIQ-OUK
M5*^_;!Y?PIB_*:-H(J5$EC,+VI$1I"V/4(*MQ2SR1$@;<D\$L4CPN(P%/G*^
M=V6JYKE,E#YHG9Y=R';\89H-P-H=A*3]^Q(T#//XQK4T E8-T20AB&.KD5&8
M(\.LI#K&0B3QTNKVUF;U*YAC:WF&;>?SM+PU=M::/TJYW;2KYI+.40]BL-^J
MY]H.<K:H])+*-3M4=%;)3GPX.]V[2MJMI(.L8H_RN.?O);R\A52#_! Q]DNA
MB!]]1S]$\M?N_.%@Q0<N'Q8W^?4 1T'"Z34OEGO^QM=SQSH*!;#5!=OX9&0>
MYQUTUHOS/]=[SM\.>V3ABI-^[S0\YY4&+D>IC6:+PO\N:LWV<>OX\*S^:?-[
M8^-[GJ9H-?=H[;+>KFUL7=1H[59JHWX,(S_>.F_LU]/&QAIN[7_AC>:7J-5T
M1_5FZ[)&]\YJQUN7+7)7:B,RS,6$(B&X HU#$M XU"$KXP@S&1N)DZ75#=_6
M9[KOGS_R\3S\+1\4RIORB'YI3G=+[:,"DZ]+9)OZ?&M48F9SL7W%7M*\97'K
MIBQB9A)#$HD(=Q[Q&!PNI1E'+N'44<D9IV9I56$$Q. \)C^4QM>A>!XFF+_E
MJJ#2ZU=Z@R/P]H^'_31S:7YT:3 4TTFUD5_6/]3=]#+__?<2I%X!A;=V=BNC
MTNQ^Y2:@5.J]#[\_/FR\:)&K9T?B->?Z/LM&_X3&LN15HO"OIW+K&]6+;XX(
M:Q4VB,5:(DX908I+CC3W8.E@XR./EU89P[C2[*?#SLE1Y:_VJ9L&T^7GCRG>
M)AA]?P2[_);$E'$/%/+:@PDJ;8(4R\^3E#Q6G%,2Z:75W6$**@!$Z^4(M0X_
M-OK-WMGK]#2>1";\+>'$Q7D9:$0T_&4QTL8)Q'0<PX(:+R.ZM+KMC]*7HU!N
M)S3ZG\$E!)O@G440P3#=^V8U)RQ(3R19C+A5!)DHUDA+[@QX=)%,P)_;:T[3
M:&XD^MP#K[U]D)X4+OT[(]#AMX1%UH,.0I((!V@G+)(:9$DPY:TG5@KNEE8E
MQYPM3A[EIT9<$;X=D3B8Y"=]$,#T1+<K_MS;8=C$"A^#2>>SY6"O%SO)*Y?I
M";":\_<'<1?4FOOM&>4EZ)FUOM?O3T(8/.-;0A-EO:3(R02T#=46%(UBR'$J
MC$PDC1D'"<&W_-_?GQ/$MGO@*7T^ZG7?91H8"&._<>HB@4&M$!4,M0ATBQ34
M(Q))!ZL%-G=$EE8YHTCAVW;:PJ/7=;KIO_Y#4A+_D54&ONU/ LU'=0:/SS6]
M=&KW@7"6'\F5#E)X8C]?!M_WKG(R[&?#D'X;]"IP1>Z,$_J;^3T@_.#(5];L
M8.6UU;PR\D%R.O-,$_[ 9#3S3-/K&VR9%INEUAG)Y06AIID.VJ_3'+@*J[/:
M9?6LWH%[C]MPS]?CQJ=_CAK[7UBKLPGW;A[5C@]Q_7BZMC>$U>UEK;E&#XXW
M04.!IMJO\5:G&AULN+0%&JNV7[UH;'RAM;MJ>QF)F8H,0P9;!O:$E<AXPY&(
M$BTMK#TU25%8!O"6MX58KISH?N54MX>^\I_X W#/CV/M/V9B'%AXZ37$:E^>
MWYM]'19B]Z)C>NV2V1_ [%,Y),6<5T8D2"EB$!=@-^M@1@MK)6-:81W:WF]O
M?JV7'#U7!*^>VZ/0V+FH;)NN9/#P[5LH8I@3TW^98GH@$-,N1BZ)(\29C9 T
M4J/$,VRQ8Y$7>&FU"09K76=._[M ^4I-][_[065[>_TIF=21J1L"%,#HE:S7
M3ETEL.P?"R(##\O Y>9%L.N]MD<5&PZMFBTBO)5U*C14I5!1OV6/22^_GU6J
MCTHX<V;R(^BK@'UU=I3")]<^YB/RNN^MG/-FY'/F%;D?H@>%1;:Z+N3A?<5<
M5.R1!]B$<7T'.OJ\%"-$ ?K7=;J_D=%FL".=Y1LT7$6WVW!%V+<88@O_'J8A
MLC#H58P?70 /'@47BEL)"R4<DSO+1M&&B2#%6)N&"$3@L["SK.+@6Y#,<.E)
MWUN?RRFAE7R7<U;Y#9X*>K>2#8$#LZ->*!ZN%%VLX!X]F)[+F;XYX'R_27[S
M:#J_+U=TUU5^HQ-S-J#"X2)S##,*-^77PYUA**.'A2V=63Z2?*0Z&U04KCA]
MD7VX=Y?.<R=GUH?]/@RKV%\:#/"!'@RS5VF+_'K'F]IQ#7\SSB16J1@Q933B
M6!*D-(^0BPE1EG%)9+RTVO+9M,UPDVIY*XC)C^J])VR"^]E>Y8<*<WBY?.B>
MK]>!.$'H0-XZZ6  8NK;('?]7C>HP?9%Q8-*O*CD1[QKF^>@-O1 5\)FKFDL
MNG[&9-1S9PA7<AR-MB,,VT5%TBYJ5GX+BQG_01G],+I@<)3FNQ).PJZ$YT:C
M8KQ7^.*SWU\./286.*SO"$S>&7K4FWO1-^\C21P6(!HA18*C&"GA#%*68A$[
M0[ B)7HL#GJ P.I*&P;N*]I:0(^^#A 0!*H?M/N=GU: ;NC.+[(.P Z\I3_6
MHR!L'5B%B^5@TL#C0/F'13JL'/9[9X.C\=<?P+;Q^=B<3])NWNLA3Z.'3!2%
M:=XSPOQK\L?XLI]><._XQM<%>V9T[3U#'5^9=@MP)-0@.LX'39IE'UXF,03^
M1PC8_M(>)/Y!1;^6;/G18^D'R>/9[T%ZOL&J%VC=\CS.Z@- (V>5[2!?!;9.
MR%#Q02Y(+U]#/@,0QW> ^(+7Q#]T5G/9_]]?!ZXX[/4O[HC?YA?EK&)'%[WJ
M4&[K>.NLL;$6'31;O+%?C>H;+7C?/YW6\4X;W"0*8[JL;VQ%]?V]Z48\:>UX
MC=<VVNWZ\6'4:GX/X5[<ZARD]4][%[5+&$D8W_%W<G!7_D)HKGCLPIE),48\
M$B84;B?(2^&$U%A$,5U:79M6=*]U8]JM_,1]0CMJ+3B3#3Z+)[[UNPRJEZ=A
MB;D_FM5N84P66O+*HBQ^'1F+KV7*#Q3#9]<R^9+^-<S@S5EVLU]CDIY[AP;]
MX6NN 9F36@%U4IO:YAQ3CA,+CG@HAN<6%(PFVB&ME;=4^"36]&$=7%^P8^%L
MQ;<Z]N\^%?[=>BFROR*RXV4L5G&TB'>);J+;62F[/Y7=B^UF=:I^BRHBC.'(
MF42$DA:#3 0F(8ZM-;$P<>+I+'HS/J*JY<:E=V<M7RK\E?P@S!1V7MP9'4N3
MN\+J>3 =K+%N+X^%#[,B1 7RX[LN1*&O^I*. ]<AH!W>U;X(+S]+X=7PVDH7
M)M<+4:?3-,NMNZ[NVE2W0T0K]/<(%X?#99SNNZP2&GJD[K[R8_:;_OW.<%/E
ML9W]RK#HC\.BV9%OM\>L4_D-&"(/3A8-F'X<^_L=J%&IM'QV*ZS-?Q36?G;S
M*LSH34+T$_:D;7P)15N7C>8> 9B.OOF()I)8AU@XQ)$;F2##"4,1P3'3L8H2
M]P!3Z5%28+3]#D@U[#HT$H@D_^^/N8E'J T;M9($=LZ.=!\>WAL.<E0*\#1B
M\C3+AL'E&>T/L471<'9/T7" Q>)ARZ&#&3RCWCO-SY,;53H47<3SW-Z(^3?S
M/!H\,QPGEK-^,9BE*7&0$4A$Q"R),><<*RZU5,P8XF-N250<G$@()DL@M38%
MOR+[U])6??..U'\^A[PB;C=_5>-ZVC>%!!8(N5[>P30\$+0B&'GP+/R^1"9L
MAS[[Y@B#Q8Y4?H@ZXDQ0)+%1B!@FL:2,:^665@E=CH1:9OBJ5?R8P*L?[I65
MJ=/-3GJ%DEWI^Y!^/O6WSCN[3J[D>1)\?8LV6:\]'-R^Y6='I#WVJ+9X:7S/
M4?_:6CKTR/2]_HYT,O#]%=T^TQ?9TL?G/\]MM!+R9L]HN4 ;2-?7]D*3QK6=
M5J7>:%8K.]5/:SL;6_5/E<W&SC[\B+8;C?\)O^=GP-6J]>;]Y\ ];-9@_,&,
M5R@-H#A_?VP$M&!;_'M\8LTH$1D* _.3O,))4L%(#5 *+N2P#8@Z2D=N#7RG
M0C]4:KH+;!5JJ*Y0>"/-[+#H"1SREVM=W;[(TAQO-Z],S?4>(-I@?,V.SX;M
M07Y)X\07C8.RY<DL:([VW0+^PEW7/8:*DK6^3WS?=ZVO@/WD8<@!GW7:S<8#
MAEO/P)Y%[5[O^\C '12U7^/7_):7KMBC"JQ%)]A<$_;5C8HX&J]5;M? 79>^
ML5R] *[G9GD8_<W;2?6.V^\JH9M\#MAPH!4S/S'PY5'Y9MH][;5/P6),L^]9
M_KXA+$0_3#\\>CDL3O =0(."/U!4@X#;< (?C58:'C$(.9/\YU %,P@+>SC:
M?PC+ENM<N!N0+$M#_C@9#H;]8*1>$:YW3;B@:'-2P3"*HCQMCU)_6@S[0V"N
M>V@QVHL.=P5O!31^I9UVTF*8*Y/770]K-!)P4]S0AJ'TQS\# 4]]NW<2[OCC
MAS=G8(C"K\N50]^%6;2+,3O PMP$STN5;"\;%*L+D_:Z;X_R7R;>$7JBYGKZ
MGI<%BH]'>[U ^=K!TG;]X*S7+QP!G_M@/DE"7>,]3POW3!)Q\JON82_\VP;6
M.LR_O><9@>S];GX%3+KP3@MY^]%J73N,-^A\#R]8?0($;.=C#3(_#+9<_HIA
M:$"0@M!>A'O&UUT=5IH7>8(1FL]T],2ILLVQ3-POW!4PH6!)G;_AO@9*9#H!
ML-!]4S ,^,+C*H_P[>=^>AK\LPD)W;Y:3<"K,.UK4551P3$GX9#BO+ZB#PY9
M=H>8A\NN1'VB>WKX?&2^MO79_<;(:U(M/Z%,1U^$2K^K$W%SH,V+]D9JZ'&X
M#[^ _+@1ANLKX >2IZ'UQ<!/E]\8WPZ@-/VQ[0W;;OI#GPW R+[]C$("IS_-
MX?36,T[:NGOKL[X/G?-N?]P[ON.YV5$8VZ1>S  >@UH..JO@+AA1Z/HQQO5Q
M:X^KA<KE2H/CU#DI<*,0]S'@WU8S=ZJ/?.V2XN8@8D:'4%).H&MBC2X&PT*?
M:AAF$(P\<O4!1 ?H& ;6OE@.1+[YQO#$B:KMD3(K%-SRM'8K1"</6\'\\H\*
MO9@3$G E1,K"V,'2'Q8 $W!J2DN%@K ))15>Z]($UJP2R-Y/\P+6I-_KP&A[
MF1\O<\ZU^=UI!X0_9\KE417IU7S>B#B#,+?;O;-<$\!:]OH%H32 UN%H5?)2
MV2#8Q:K?7/$?K&D@S_U0L?*(]1O%A%%(?:PP,;6$B,@76\%<;,6<#ERY:P@W
MUX;P@INVNMJD8"E<!/( [ISDGD GM^N7*YW>H%"$A>&3BV$@5EC/H,\#%KA@
M)*5FF'-$V$<!^#(8]//>\3!N< : .+Y?@,7]-P8E>&6Z )ZDV4^CN/?+3<D&
MCV2#(-_KC:];&X@H\/=@G3JIK8QVQ9R!DLX [W0PQ@9Y#"'8-B$07;2 3=OM
M;MYJ*D\X=(;=D1D$%/8Z\T6Y[?CBDZ$!,PD<-=T.R1! ]338B3E::W<*G.*#
MR@"@&"D=,TK!WV-CYGQU;93:L6M9LL_+H<@@T$X?!@]\4+$7(9*;C;9>3_BI
M<&TGZ'&=6WX^]T<.\VN P$X/=$G"%R)A@?]@Y0!$!SPNO-(0'0#PSF']IN\X
M^CX(.EA&^J;7!C):$G)^A SE>WG:-]4CQ^B'&KO("U^[KFWP]]LW=T>&'MYY
M]*<='/9"=D'(K7?!FY]T,SHZM]W &,XMB7#EQUZN'_*GVK9.@Y]B0F@G?^1$
MV,;K?C<D@(%M@O\74BX7)=^\!   ^@81OR).CM7>'G5A=(>AE@@HWNV=CM0O
MP$4 ^BM#+_>&[N:V\%4!%?GVF9-!X-"2QO.C<6/"G!IY_J'WQDD_M7X<D9FV
MP8*/FXPP),?\W,8:]'MM$%6X=,+VNM[)E&9YH8K/GQ"R9"617T:3%PU?_23:
M5MIZV+5'!80#'[AA'I<!%._[/(Z3AS9"J+=7>'O9$-1#J%31(=@Q&>+)+C)P
MT@M6ZESE@DIBOQ"Q08V#WNVGX+%?.?$CR3V%]>OU2X4Z1])LI%E_.(JR7L5-
MKF7G2J->C,6H),X\Y6;2?QGT0XZH: ( =W:ON^0 %(+U8J\2I6.,'&@82@(?
MC>\HHMWVXOK6I#T, =#2 7I)2.SK-$2B71$3"K;+*-$X+H[U@[#/.\L[.6@+
M7D]1K%-2[*4H5I0L%W[I9%@/-)C.:P0Z)[VL2/_E*:F00AN$E$3QA*NT8>=$
M%PE:Y\V@ J,]#49NS[1':=RK;'XAWZ>^N/#J124#S%%5CKQ%(-#P)*0"*LFD
M YH4]>J^.RP=B3E29?_*)QQVQ]G;B230571PTL,'4ME<DUZ% \PX S!*"DUB
M\61NZ./]<8-2%N=(];_A^U 4F*/I.%-;R."-D%W!&H#6/D_KA@+!/%W?,P6'
M%/5)W>P->O^$OCCY8 CWZ-*KV&MAM/XT )PG[4_37COD>=OZ+"MV!XW;:V6C
MU-R1[G=NI./N)^H\2J;'M\R_@OAN8:;WUVTO=@WVPX[&>)URNL@P.V'R]/+"
MM[XK"JV+$BUXYS"4V>1AN G8?6M0NM DF@C@C,I&\UV6(<@]*G$#3[_K03L.
MLZ(1X!6REE1[>:MUHH907P6_^SYTHRP),C^"['43?=KKYQY$4?R3)QF[-ZR)
MB<+][(]*29UYBLM4O6U1H),;:P6H?6KW#'AK]=X@[-T(VW5T.]]R<=C79=1Z
MWOE;E_8#H4:;5L9D&%GIH8]WV+H;R!82L*'"OEN9* ?)PVKC,NY>V'=R%C*]
MKG<2B'V7^0_WG^I^VAMFXS*?DN+SH_AV7CB3IVKSIL57&R>NG.LBX@GC"&GY
M;-@).Y!* LV-0+MY^+AR&$HANOD^L$GAF=)R)6'FBY7K8)YKD[JTUPXMPO-=
M-.M_;8RVT/P^4>)T4P4"X.5-4_+-)2&;E^]Z\"[L#EPNMB8$F&R'8T@+T)S<
M<W)G%7-9N[R@?+(S(:Z%%%]WBL^Y(SAZ5X5KH_83I7/W0L0"VS2L?RAHR?(-
MF;U^D?/SW3SUD"-P$?HLZ3(_NGRZ5G]Z.#CJC?:[!EOEW\- J9$B'.CSRCBX
M6^P6"@&5L"<LU"#F]NRXRCCDD(I""I#%M%_ ;!IR@YT0=.D7@>L"<<=U&45>
M:EQTF+^M/\+J?//)62@&>$0DNV2463/*ID[;(:8YE>@/VW21[?5'\;:<V"59
MYNAF]$(()BFVLMXH*2RRMLN5[_XB;)G->B'@69+F)>*91[Z=%ZR< '86;3@"
M1HYV1P/6%:"ILPPP;;23.NS$R7?=3=:]%'FX8.040>W\L)A1X?^/4H4EU>='
M]= 8#ZS-4=>#XC22U _ +RG*L4>&3MB)DPME7MF6-[LH0S0OX&BF=VV '.^9
M:(?^"<,BC /4RO= PB-+(LUU@_,XP7HQWH:6VX]G>8.1<#C8* \;3,T[B592
M:W[4^CS>J9*.Q6J\=7"TIWA8"L]<E5$(+/N0>\C T<JK]X(B&C6\ H_*I*%,
M,V\+$J2G5SABMM?MA3X"V=#:TL^:*\FJH[5?SAWJO /\\NW=#=?VX6A7?I;U
M;)KG_7*W[.8N[W(_]XM@82]OS@?K[WQ[5'$[,M0G.]Z.M_%U;V[_SLE8'+3^
MW]FH4=(P9/I&3YK<Z%U2=7Y4_1KJ+:^V6P?S?K0QNMB+>P>!\XY?)87FE]@;
MFM!Y.9>\4/"0332C#@YYUQ_FU:SMB_%>DX=0\2TT ]L_\GF'U2QU?GRL[@^;
M_2U7+GK#2M&^KO+=^Y/@TG;2T4X=JX=7%L5D*] [NP&ZGAU>]0J]NQ?@A]!B
MT9\,*I.'],(%;7VV'.S](WWJ 28G0B)%*\^B8F(("]P?Z.]%K[H3-PH?%\<E
MY&V,BE-^[^]LF.^2*'KFA3TK17<+F_9AX%G>\0#T;*C^+>:3/S^9G.O+]J)>
MM,)J-HN&V 0O2$?L15G5[:W-ZM>U>G/M4[6RWMCYW-A9"PVP'WABP OT[;[G
M((WZ1O5_;PUZUJ=Z/%"+31X&/=]C=I7Z("/V*Z?LJ@]413,_MS96'V+RL(-K
M'_78#T**QQR'.X6;I%"9SW/PT&//*%KPPR+ESY@>WV;Z13^E;'YS*D#Q969U
MZX2#?%:? >E_?G2>>-K1>3_"WB1Y'CT LRL&Y[SM%>&)E=R&"U?!F/3"C*5R
MU _'Q?S' \P5%@BVTZQL?9@X-&'KNGG(GQ_UM*5Q/Y^.U$_0W4#)"MA]J:N,
M&>Y7!?-NFR;/:]S/X"4//(X'HGOHO/#'7CYHF<!\ Y=I=/C2A]DKD1*39LJ/
M8FGU&HMV)[MS/P*+2KA98/(^$6X>80Z7$OP2)%9Y)L_Y;MBL&G)ZP1+(PV=_
MZ7:>+=@]\J&-[V_#KAZZ%+[YO5**]UNA?2G>;YK$E-XKWM?:^N89:WG<.U2:
M]?W1:#/95C?OZ#*! "4 O!7N$"4 O&D21S\'@"#_^>FR1[TVO"$;'=M8J?Y[
M&%+1I=B_09Z(2[%_RR1FY(%Z?UUG1Y7-=N^L-/#?)A>H4M#?-(EY.-QE4/0'
MNT?B[XK0E5K]+7("P>\F.4#+Y,"",Z2(EU9K5^=__/?L3H$O\>JML =YHG7R
MBO"*E7BUX RIP%K^$HZ#3P=YX6P.0%_RGM?%[P&_VKTL/ZU^+3^NKE84=H<&
M)"4HO14>H$^,C;PB4.(E*"TZ0_(\D%.<K!< Z?/5&9LEXKP5 O\,<5Y3R7)9
M+;H8;!6/JT6W/E0:^6[>7RT5+:%C@6E,Y;LQ5LIRT$5G2'C0N#GQY^OFQ"78
MO!G:OB>T62OA9N%9DHV:OV[F369*I'D[9'U'2%-FLA:?(T4XL:;O#]-LX$/G
MB-UQ[X]1C=RNM\-1>^,0I-G+\OX-(R.HQ*6WPP7O")?*C-7B<Z0*9P8F.L^1
M[X5#DG=]-^WU)_"HQ)XW0^EWA#UE8FKA.9+0I=4:W .V4.+!!)K(CI>8\V8H
M_(XP)RHQ9^$Y,EI:+9-9;Y>V[PAM1(DV"\^1<FFU>GZ4AC[F)<B\&9+2>18=
ME\(X(\I1LK2Z"^NJ![_L8<Q^+ULIN7.E/_OA]J:/>:O4\><_;,'[SMLG\YFT
M3V9+XYM>MGWRK1[IS[ZJM[IITJ*;Y@^;,T[SWP-762PM\)0GB[/NW&;ZR]-6
M/YCVHC6<OJ=O=F6MOE'9W?MK=VMC:VUGJ[I[+P8MRD36&_6-:GVWN@'3J.\V
MMK<VUIKPRU]KVVOU]6IE]^]JM7G_+&Z?5; H\_IM;V*O<S'ZU]*+6X@/DLV^
M&7<XST(\K&WVX[Z+&'V>P<:/Z?%==IQ>T([3N_X$-(/Q_0K#RQ6**7W$#)]F
MOR_>8OPS[/J[U^$UL+$*A\V,?@^/7$D'\#K[ -;^;2L<X](;PF-=MAP.'@L'
MLYP 4^0GZ83C3_3O#^"+9^EA_5QK-%MA?X HO.G5^8F &&V_'_9[X&BBT2BM
M]1Y\W$?.NY,ZU_8O->^UW=U)>^L'I/[9=!_"+G-_QJ-IF.3_O2X:K@_[_?Q0
MYBSS$^[08]9P:MJ_1(?G?L:,Y+&2_ZL6GJBA:5JH\[3AAW":V*ENWW!W;]JI
M#YH^KKP*AO[/)\WQC^GHZ&)-[L_T?*7;ZV[VM<U;T R[Z6 G1"B'F5O*#\J$
MX><?I%+B1'BK'):8&Y$8'G'P\7 BB8E5)+YM!:L.*X:7*L[;M*/;V;^6$,A$
M5W=\>"(ZU/ID)?!2^%.]YJ(=GPWZJ05W-7RQUG4W/YBX<JE2!)A@/.>#E>ZP
M@UPO#[6&UX'TP;KZ7 [SJ(MC7R_,1N]TF^Z<MEAMZ(ZKIP>?U''C^ MI'1^T
MZ\TJ;UU6<:OYY:S>_"<].&ZQ^G&+'!P?=.!G7KO\<K;-ZNW690_7][?H07/O
MO/&I=E[_5,6UC;V+5J=%ZY?P9[]%#^#GQD8-US;E>6-7=6QGL]OH[+1KQ_!=
MLT8./NV=U3=VCN&]1_7+VF7MN W/_:=SL/']HM[\$FVSG:-6Y[S=./[:KFVL
M7=3V]\YKQ_;R8.,+J85[CFW4V/BK<]#<^=YHUK_7]C?3\3WPKN$!W1/U_;VS
MVL;6^4&S>E&_K'^OPQCKG2J,\3NO?8+Y?OH2U>B7\];^/TE]'9]O-ZN#VBZ&
M:ZOG]<-O4L1"<:R0USY"7!""9.(U<CA)J(@"Z>G2*HF716AC<Y-S[K'H?@4.
M'R$SLU3O)72]6>ARA!%M<<QCA;G'4EG.E2!42QO9&*L1=(D2NEX+=%U.09<B
M@L@X3A"1$4%<4HJT=1I%AEFM:*RU#O7$>)DHO$#0-2./X)58D6O6PEP&X817
MZT$L3-O?ZQ_0QRW"G8#\ND%K5O;6>-5WKA:][@<C+ZW$I)EATNXM<\K$AB9:
M"B2T '.*:PR8Q#'R6+/(&BRPUF!.+0-V/162?@ +SV5-/=3!+@5Y5M9'*<AS
M$N1IXP(+ZJ@S#FDN8\1CX9"QEJ$8Z$BP-)A(\(O8,F-R@03Y?46H1B?V#/3Y
M4ZV+A[I[KQN49F5=%.O>U.=^ I=NHE&2GGN'+GV_5P+18X HO651D,0[JL'!
MB:BDB%.5(,-D@L#!8=@(0RF0:S4_S8;^L4!NSJP3,*7XSLJF>(#XEL;$DV1X
MVICPUAJ2) QY'X,,VY@@(WF,"&?88? 7/,F]@CBB"R3![RM0L=4]!9NZU[]8
MKG3]H(Q1S,&*&"TX>#0E^LP,?2YN61".Q81(DJ DLA'B"END8V41]E0K8V-O
M;$CQR&7!RJ#$6Y;<V1D0I>0^B^1.VPVQ\G'L-48D"=%$3R52G#)$M(NI$X*Y
M&&Q_(I9Y_&3#87Y1B'&].0SV)\(^KRO?5]CD<]^?Z-15_/E).$>M:.;6"PT'
MRMC)LUL]H\6O%FN_UG5YIX>UO'"NC.O.&%(;MQ,T$4 E(58@KEF".!,>20'&
M4*0,-5$2 YWYTBI?,%>L#*8LJBU4RO-\Y7G:1'+$2YN[- IK$&IND%$T0A9S
M(A/+0I1T:35:ICA:('F>96B%Q8MN<#1[ ]VNV(<5B3_ 37OPIH\WB%LSJQ I
M$>HY$*K67 OH5%@=Q_:\UFQ]<S' 4L)B))FVB$M%D79>(TF9(0!;+M8&3 ZZ
MK"B;D1?WF&U1KR4X\YZE?F;E)*74/YO47]R4>L.UBY1CB$0:#!.G!%)82F1,
MQ 1W"8LB,$RX6%91_%JD_IZ3VO@/3FI[G;OV%FCGWZL)*O5.8#P7>3 I;!8[
M":U1RES:O*)*Q>I_;NON )S0ZI@ 981^IC"_=<NX8S&-I30$60M>)Y>&(^D\
M191C$\L$^X@E2ZMJF>-9V7:OU'Q[XY(\NWA2*<ESDN0I@RV*I)<J,6"A"88X
M.&-(QTXA2QC7L5(>>QPD.<)/WDU45OS^HD#NA)]1+T'#S#\ED/0^8MRSLBX:
M@$AZ  NU[77F<QHTDKW,Y]YD"4JS Z7:+?."Q@8()3VRQCO$*1'()!XC![8%
M!286H&265@E>YF21]CB6^:I%M2]*69Z?+$\9&,2Q!*LD"GL#@X'!8W 5G$24
M&A\EF H7SC\B9!GS19+E]Q7'V.H.=/<P#7TS"_NB#&',JQQXO/!%D!K\G>JY
M;0_#VGWJ]=Q9VBXAZ'$0].66.9%$D>51+%&2>((XX0Y)2RWBQE/LB/2@6996
MHX@OD(=3QBH6U98H1?8Y1';*:J#&6$XL1](D"G%'$R0C:1'30@EE'5@.#$16
MSBJ)5 8E'BMY&S[Q_7!><GJ]'SFW'<K0Q+-;#>.UO]K3>(5$I2\S.U3:NV5(
M8$ZQY")"3DF'N!82F4AX!,8$9U9I&4L3VB-@_F13H@Q+++ <S\J4*.5X3G(\
M'9/P-M84? %CJ48\)AX93A0B/HYE1&)A11QV)E.Y2-T?W_X&HU<=0RD.+VWW
MNH=HX/N=&53\OG$4G5FBYGKO0;W7M669WZP!U-XRA+R2S#KPQZ0E$G',"=*)
M,BAAV"32Q5)[D@.H*/=6OV41GEE^IA3A9Q?A*1N(QXG!7'.066<0YTX@P%V*
M;)1@%^/(LH0'$69LD4JXWL7A(,U&<VV[<O<1(3^;Z-/V"RS>6CRZL??#%^#M
MP/!LMT>5N#L[W#V\G8P"BAA,'8HBGH#IQ,#W-+%$--:6:S"K.'%+JR)>%D^O
MN'NL2"SXN00EMKU#;)OM)K 2VV:*;5,V)>@<IQ(P(I5),-B4L46*L@B!(O):
M<TEB:9=68[P<XR?[A?/"MIGL_GJH1_F 9TQ,F,&47&\8JG:F9_S2)XG]PBC?
MA6F_O;7VU];V5G.KNEN<(=ULK/_/WXWMC>K.;M[--OZC4OVRM]5LE6<#OH6S
M =NI-FD[':2^/"#P;=0]7!WM<J(O[NJ\_N34Z.)-N3Q<ZWG.J?E<<%#9F&#6
MINGQ[1VKL=/<2\\0,8HB+G6,M*4&&1;#/YY@R@B8ILN2S\HR?46.=8E)BS6Y
M%SQRI\2D9\2DB^D629IIFPA$7:00-RI&1DJ*6)1PG%#J?&0")G&Q2%T9WU=5
MQWJOTTFS#);\7HNOS <_AX74'WJW"_"275.@!*69@])=>V_C6$FK4>+A+YY8
MC%0(Y&'EJ;8&4Y6( $I,+%+M?5G:L<"&12G*<Q+E*?LBB:,X(2Q!2H02#Z,D
MTJ',5<2<.:D(I3X.HDSED[O$SJ_$X]65N;ZZ ;^Q@-W$>8E/,>#>Q\Z&61EP
M^3EK-WW)M:Z;K.TKL?T1V-ZZ9:9QREU"0S]=QC'BV%"D$Y,@'7NI76P4*UJD
M/-E(6[QH5BFN,S?22G&=M;A.F6+6:VRPM<A&D4 \$API22E2CA'GA14\G&G$
MHR?7VI:!GE_-S(?.0 _*UY:^X?.T6-L>K?U%Z1S.')%N;^&)$Y=P[!3BB0 #
MPB7@)AHKD:+6814I*1196J7+3)5QGK<LR\_38JV4Y6>5Y2GK@AF,$V]B9(4$
MZX)KAA0#J581]=A;$7.K@RP+3!9(EM]7&*+8'JR+:.C5*81E*&).VX.+==^^
M-N]*8)HY,-W>[!(KJX2.&&+2,0 FG""P,1(418PQ4"J.:AO.*</EN8-O6I9G
MNT^XE.6YR/)T"$-B;X!D*"8L. P*C(S0E)DSX3"04QKO0S9)T46*.;[]Y,P/
M+++7=DCBC*(O[_G,M%E9326Z/B.Z7MX^+I%QXQ6/".+4P5])% Y.BR,DN,6>
M&H=)%(,+1Y=C\>2>5(\5DU<4K'G/HC\K(ZL4_6<6_6G#BC.NJ:<(J!8ZL?BP
M-4$)9+R,*(V\]P2#Z$?+,96O1?3+,Q-GMR/RU=FHY8#+ ;_)7;W;5\T=VV6V
M>%&RQ67#N.<P4VY7G+F$6^>$0YICBKB"OXR)+**2 (LP0K"+EE8)71;\R<'<
M,F.\P/+\S!GC4IZ?29ZGFV#CA&)+"*)8"\0=X4C%VB,OO :1-CA)),@S6R8+
M=3#.NV@3,]U+^JF&QOO(,LTT8SP1!2GK8'\1=&Y7G6$?18*2&$E-$L2-9<CX
M<"B7C8W')!)$\*55JA:I[WZ9#EY8"Z(4U)D)ZO3>02.PX[% ,:$<\3CR*)S)
MBPSS7D2$<*W!.F#XR1')!2U8?RVITS)ENC!FPP00E9[+[+#I=E49\YIHS@6*
M=&01)Y@CXQQ#PLJ$)#;QF((1P:+E^.G'@Y>YTC<I\\^0*RUE?J8R/]TK23%%
M@#I(, [VB.,R'-E%D!/@41@P29@!OF-JF:A7(_/O(I21]_P8='QHF:F[+A=#
M&+SO6I"9"JK4>P-?D4_I=OL@.HV!\GG,@O,L7>FF[7\M#?I#/XT1$RNPUG7K
MD_,OP> !8/#]]O%3CE 6<PP:7RC$I:!(8FV1]E)P:3F11 4AFX*!%\OZ/Q.'
M/D:)E1SZO!QZZ_QJC1D7'#F #<29HT@1B9%D(HH(5=8EY%X.?1>Y]-U!SWX_
MZK5!,+)QYW/_[V$ZN"@;9<](W[OT=/SLT2-0N'Z%R'Q,+T+VS_WQN>%98(!*
M3GKZ1^5$]RNGNCWTE?_\$0)^]OW=(]WW,S'GM^J;TTAX-;R</3_K?J._.] #
M[[Z&L5V_?63-XQ(>?PJ/]0V Q?4;\'CJ/GWE[N]_V@>T?6J.8<Z7,.ZF2^%]
M1_ ];L&86OL[WUN=+9C+%]S8W^S4CF$\F_*R=OB-$XH=E0G"83\*Y]XCS0%=
MJ6-21S&)D\3]6)/>PT>_%@HJ^>B5\I%+3 *TQ"AQC" >28&D,P9I01-#P;$D
M0BZMX@^ B;<W3M_ZH'+B^Y4LT'6Y<B_OY=]G\V&[G,>RM>'@J-<'C'9EA&)!
M>1'7#[\9)CG%EJ(8)R8TJ \%X(8@8:2BEBN+5?(#3+N3KYY)+99\]8KXRGIL
M(H<-\E@)Q TU2%H=(QHG-'%<$,]9O@7[CN,&;T-<P685?47[A8*ZQG"0#70W
M6+HW>3))S[U#E[[?*]GQY=B1-M:^44>$Y=@CQA*&N+ Q4IPJI$D<">MU[&*^
M4#!7\M3"\U1LJ-4:6\0\!]69,!_B+ 1I;1/O8NVYC1>*I[:R;#BM-DMV6A1V
MDL:2B(1=>,2'8SF81BJ"OQ+&&8]B;D!]/9:=GE7ME>RTX.RDJ; "Q2H4.H82
M:VGC! GF62*82"(FEE:[O9];7P^WS]*<(RJ]?J5WK;ZNXJHN/2W+$I^Q$.BF
MC.81GU(X9R6<TWVP/3,))18E(@Y]L#$&Z;($*<-HA(E*M)=+JZ,H\P+5*I9%
MQ8M:TE-*[S-*[U2:% QS'S,%II8+:5*N- +K2B"*K8RT)%ASNHC2.^\,[2)F
M\D+10*\[TS3>S*SD8FQE[F5VLKOU$[/XY'N=[D6U_2JKP[P/.E5\L%%CC8VM
MRWK37M8IK .L2>WRK[36EI>UM6\NQI&1UB =1S3D7APR3$1(*6,%\0XK_VLY
MO)EY[B43+3X3 :8S%6&$C8Y#--$#$SF#8J(U Q[2/)R@^?P)O.?@N3++\DH8
M$=?7OG$2)59Y<$-PXH 1#4>:4H)83(5SWBFOHQ>+&95,]3J9RC$"<,(-PBZ<
M\<1H@E3$"1*4NUAK =^!;\OQK^;N\GKL>?#D;2?K%DO>%<,LV7%AV)$VOGRC
M<>(E<0I94&0(6% @Y95'GBK*&//>&C(?C'L /]V;MBN9:J&8"KQB9L N0CIB
M!A2GC)%4/D:&:N.%9E%DBZY"D7@(QCT>T685-BHY\!5R(*L??M,$D\0DX(A&
MUH4^./"3-T'?&H)%S$1"'IWN>S:F*M7DXO.3MQHK8"4L-'"1E>$ =0,^J>4B
MB<-)G8[FB,;5[=/^;B/:*)47@&TBEU?16:675';]R<!WC.\7H5"&ERN!L?*K
M_QEV_<V/ERO 02<>'GSJVQ=/2 >^CSYGSV";C+()I8 ^3D"G.Q$2I8AS,F34
MP6:P0B!I%$,RPMX)\(ZPQB!A"]2TK&Q"N*C9OE(XGRJ<TV?1,4F3V"M$M)"(
M8QN!<%**8F(MT;&S,6.+)9SOZQRZ-1AT6'#=KISHU*&T6['Z)!WH=ME9\-E-
M@>O%_PQKO]5=+U9^ H1*TWYVX%2[93D02A2C81]V;"SX>DP!."42:6RY#QV,
M"=&AYRE9CJE8H'J#LEIH4>V'4J+G+-%3YH:4CGOI%,*6,<0]2Y#D8'VP2!GP
MM[&52A42C>-H@21ZEKT*7X'18>VP,VR'^@F0IB2UZ>"]'9CPVUS,C0PF"C]-
MH]2.'V@8D:OJ?A<6+IN@QT9!CA*E9H=27VYW+(QA)26+D5!"(ZY=A)2,,/)*
M1<91&T6,+ZTJN4SQ[5[KOY<1BS<AU;]N<I12O1A2/65[^"2R/E2?V82"-X%#
M"#(6#L76TDA:*2,E<ZGF[/:1N"\BU>\LU#%A=?3R$Q5LKW/2]T>^FZ6GOM+N
M9>_N.(47-4,F")*W;E^?),=6%ZCCMX$F=3]H)$U]7J+7[-!K[Y9-8F2<Q-)3
M9%P"Z*43A8QV%"4N5H0)(04-GM.R8+?3E \'KS((LL@2/G.3I)3PEY3P:?L$
MQS(A@H!5HCSBBIF0BC%(4*(ET9I:'RH1E@E=$ E_CP<X9(_O@UGV=I]+LF:R
M0VDUIT@)5[.#J]L'3!H>>V:80"SV' P22Q! E$ 4%%-$8BDD9DNKC"S+U]/B
MO3S6X55F=4K1?V;1G[94#":6*0T+RF/$O?2AHDL@QXU*,+:2LR07_8@\.2U;
MGNXP2QNFT5S;KFQOK?VUM;W5W*KN5M;J&Y7=9F/]?_YN;&]4=W;'-DWUR]Y6
ML_58JW)$)=,;#'J=%0:D<+VA:?LK2CT-[19O0?_S!5?H[>B!9SC2:ZWK2JWP
MG%KA]F&A!L>)\L(B+[ "_S41" CID;%*:^LD86%3K8B7Q1W['W\MM3\[:7KA
M*%<)K"6P+K"!70+K7(%U^G2:"%:24X=B8 #$F8]"RWOX%7,9)XS&/@9FC/%R
MC&=5!?GRP)K;XQ\'&EXZWO0TT5:IH_N':3=__51>TWK@__ZL99/@GXDFS>WK
M(U_1-J0M=?<B[/OJ]@9A#W\?/NY64AC983^OY.X/PGZPP9'/?)!8Y[N9SP];
MRQ<R3X$F:5=W;9K''.&#_+BG#S=W@4TLR&@8G'Z( XJ<]+*\SG&E[]LZ;"#[
MXRQU@Z,Q@DS<."(QOKY%&QC$<'#_+8NRVM'4GKB)OX_ZUPVX#L$$Z7O]'>D$
MQKJBVV?Z(EOZ>).?@)FFEG!Z]L4<5_\T?;CUCA<_GCOO>E9X2@Z2/#+"1T1:
MPC7'$36)B(6($I$D0C*.OU&Z=,>K%X4VVUN;U:]K]>;:IVIEO;'SN;&SUMQJ
MU M_<^^OW:V-K;4=<$#O9>A%F<AZH[Y1K>]6-V :]=W&]M;&6K,:?&;XIU:M
M-W<KC<U*XW.UF%_A4*\W:I]WJG_#;5M?JY6M.OQ>O7>B(V89R:%<(#3[;:^K
MARX%,+I*+^5X? T=N0Z X;3U2>97QC_\X=+LI*TO5M)N_M#\IC]NSC-(V!3^
MY],NOAX)GU(?P T,\C<*S(Q>/!+-#[EH3JFTXCLA/D@6W?LU_D#N_>Y'CR7\
M0R3$+SWVQ]]%C#[/8..'/O8.+V9,1C G?N+OS.O*GP3I'AF+*WAMUL(E'V3$
MWVV67<U)/61.!3B\S*SBN^.+1WWO*S6X[BBK5,&L<==[WBL,+S_@K,"201[$
M(!.QAD=8XHO-/<$7G=6$'W(:Y%M:./+LHO7NQ35_X$K8+I;:AQ1V;77!P>L-
MX:$N6Z[X<PM(>-VSL@)>GKY5MC-#-GVU@#8'$7ZU:_/J1'A6>5,@\?R]H)PV
M._[4=X=^N=+UMW;!/;D@=7Z,^,#9/CKN_KC(^8O.[1&!<^$UQI0[SB3GC"4Z
MP=)3JQ(AB8IB\VTC#YS'F*"'I29'7+39[W7"@>UA"/OIX&A]F,%Z^'[UW+:'
M81W7LLS#_]UKJ;:]J*7CH/K>6?WXG[2Q7R.-_2^X=@Q_]K]$C8WV<6-CB]2.
MZVEC8^^\UORG<Q54[VR=A^-YZL=;9ZWF(8SG"ZTWZVF=5DFKN7-<NSQ(:\U#
M>/?>V710O75<9;7+/5H[_NNHL6%I?:-%:G2+M9I?C^J?:I=U>'9C ^;9_"NY
M"JCOXHOZ9?6\?OC-Q<XDUD0H$DPB3B5#1M$(*0?D)%8[(>*EU8@LQ_'M+7[S
MW(=\)3'S3#>6N+5(<WM,PH_'EDA *QO%W"=>&D,PT\1X:R,K"MPB8]PB)6XM
M.FY=3N&6CZ4C7C&DE*6(*XZ18I(@P3GA,1<4RX!;;)G2Q<>M-V#-_MI),2]G
MS:[WLCSUF($0_MINRB=M_WXM.#IS^R^L>R/YU.NYO(+"]T]3Z[/=7OMU=(=]
M%7!97[]EYM'8* !&AR(>@YG'N$?&.8JL,]0ESF#.R-*J6E:<OFB+NU^S\EZ\
MF\-K$>>9FT6E.,]%G*>M'RX]2<+^9\QP.)PUDDC&1"$-GU&F,+= .!!GD.J%
M%^?_Q]Z[-K61+.O"?Z6#L\_9:\5+L>I^\:P@ AL\B]F#\( \#ON+HZ[0MI#8
MNMC&O_ZM:DE<)($1"-02-1&#=6EU5U56/O5D5E;F&I"?1Z:;6!X+^KW;Z?6*
M\VXG/#"SU<TPN44>WEH52%TX0ZID\JX22<;0A6'H\10E,E91;B0#RDH-*-<2
MJ, \T!(;I5)5&&XVMBG:E.31G&A>-5FR6RRK_G+85%;]IU']2?JDH0K:F*CK
MFE% C:/ 8,$!)LC H!#2 4?5)YMB1JV+E5+]-2!7J^99.CSW7=U/0>_^QWF*
M9^^]ND]TPX.-VOK=8PTFW<HR^I3!N>SU(E#UJG(Z93N%:97?'NCD?%1"J559
MQQ=&X5OA6_O5E01VVF[_<OCS@KZP!7UZ%UL3S+A,)6PC#P-42@<4]@I@I33S
M!(< X<8V)IL2+6I!7U&ZOMZ:O#!&GC7YF31YDIHCC8+'(A)R%_DY]08!D\K0
M82TD1T0$"5'49+J)X'+SXK]H]KT"1.C8M^*')YO%B6_[=-@TL2'MSLIVV>MW
MJ[.@>=OWV9R:(VG\/I1%A-.=&Y+8&UI*&5D7A:R'TUO !!EI6-  (H4 Y18#
M0XP&3E$#<210F+N-;<0W!5:UWS3*>\#+YTA9MY>FVU.L"4L,D8L:#95*Y<@Q
MD 03H)DA@4"O!(JL";%-*!:5B"ZSIAHW>%6NS -;%YY_ARUTGY34R^/YPW34
MG2FG^Y.$,ZPY-5@X[;_<"QF1@.P[65Q,_) !W*P3ZHB75%&@@O6 ,H* =D8
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M'B6'4]A85=0)_S;?$OUTZ^T<G'H%U6ZN@KZ+9LA3>I?U:S[]FB# 0F%%.+&
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MBA2?R^ 1W-CF$->^J%'6^@S.64Q93$M?0Q>>OS"OH?5:0Z?<8L10(0GE /K
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MX8UM@C:EROMMN4I!OO+IJA34K\'YRCP!\I5Y N0K\P3(5^8)D*_,$R!?F2=
MOC)/@'QEG@#YRCP!\I5Y N0K\P3(5^8)D*_,$R!?F2= OC)/@'QEG@#YRCP!
M\I5Y N0K\P3(5]X^ ?[5UZ;EX[^N_+;][_AG_(LSW3TIVU5 JKH90&]]N^^[
M&\\>>XM3[&WSU!?:VLY9?/9%V3XIVIU^O+ONQH_;11E;=M+5K>)<=_M%)Q3]
M4]_S<4#:SK=[/@U-NPJMU?WX)I1MW;9EO+S7CQ^D3.6]K<NPW@<.R/:_3?=?
MVT]\E]&04+PE6+S+>:=7IJCH5UV?4J]_\[]]+UW_=!Q+?^V'H^AC>/43;>*
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M#R[%PQ"2T7;%U#BC;193%M,Z>&/RHOC4%LBD>\5Q9$VT'8&%0483!'J@A#$
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M$0^4B"N5@U(X0W24EMG8EG0ZP?#*$^>LN4_&-+/F+EYS)SEFH-P903 (F E
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MT *"L8(R0((-WMA&M$[V5O:4U)U'9"U^6BV>9!@.*4*4M4#X:!)0S! P% 6
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M!Q)-":X\KYP:8GK#)#LUGE1%JRR9U_.89)_&,S*05OC6GH%/E5!NH%,&H#D
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M'P>V7<EU:WJ9+Z9@[@EU^WW/'X:]7K\\2]$ +TZ;+3MLGGRV<=)1:2@P"E-
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M<S^VY2]\$*\]^.NS(PIR$U(^"H] -%X=,,9%BB:5(()[% +:V&YWIAE:=\2
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M)1&5B<1&RHDI"U-:YU4:O4:7'?#8>IY2%2GI*F0)T'AL%LUM+)4=S+IVX.O
M=CCW)9>Y)K#9%'9@O4&JIENK;YQSR)K?YN11C,\G)Q)@5P3/W\(8J6+F6(.(
M#\%B[?53EBDF7_23-S^O90R_9VZ>WRY_LK"@G!>1TPSS_4WK?P': (X"79L-
MPL6LKU8:Z9[]7]>=ZSZ<6NB2_<'JXQ/S2$N![[,..+?:31OU=[--=4WFJB1S
MN4#X>KIUL!]*ZCDO. &PYD$@1$MTX4$^%$&9T@1>,K!9BPL*@!\TQ'3?!< K
M,OL!,@/("09!994!NK)1X2BZ@AC&#8F5"[Y4L2I-A62VV)^Y(;/98M[%ZMQ%
MU\WEKI@GD*8YX\!N ,XS<#<O=\PGI+#@]6QW;2\YH_HY;&2F?L9V&C-!%_SP
M7)<UJN^Q<QDSO>O84G*HGA<M ( SJ+WA_@;/6IY >6'IVR.ER3O/8A\$+#L%
M&+^)Z?F]%)!Y!>BM.P@_:2D\]K/9V@^4&UN9DDC88B)T98BV%J0H]12 72E*
MMN"0]I'1*$PL+0L"3\,:56 O8Z;+LF +J>O-[N?DHLG^ W0?#!?\ ,] $BU7
M'I=NVTS +&3B'*0@<Q9B4\TF^M-;ZJ>V=))PO89AHG9.T/;+3(CWY]TC/_I1
MXO^ZSB_%N0[[H?$EM5!:^O/:>, /M'6"93;7P74_)'8NZO!RH1!:0;VE4 _O
MA4XD%4I/T6_M-1&< M0KBHI$)G$8,;/*^8NAWO51O:@<57#FKJQ$B$%92PMN
MJ T.8+W,IT^;TZ>KT[^CT\?X146-]D*3P&D)*@HPOJ(R .2W!@SZPCA[B3TY
M!_1;"TC_#J''WV$P".'O8$"6_^S5<@ YOKS;+RC55$M/"E\Z(A2VO2P")Q48
M4$Y%40@I%V+@P'Y2\U):#KK3@>+DOL*S+R.8@25_@M5RF22> =HYM\%.)[UA
MKG3'5(24[Y3,KXU\&9I"'U(N3-\/X!X^54HGT?S+BXT/?[[XM:4$FW7S@LW3
M#B<-+*KC,S6$&6>EM7-6CNGWL?KMJ$Y9@27A-TP;/;1Y=6N8HS9.35MO[1RG
M&CM85[WX!9,+7YST(L'&,[^DTO;B]_<[']-/]/=?Z]KDM593&)?N,]-@*#4<
MZG4/""YWR>=U@1^&2U$W^)2*B-U8$_BSII/V<7 8PKP+W/?@ZU@1G1KSX&]B
M:NH4ZK=Y#DEE<R?4@KUOZL'[X1AQ<7>X/$.E<>V/4GPQIR!U3I-MGMSU#;#,
M]TV'DXYJX8 N?LY40A^V,S)?FSO6F:)(4^U<6XXYG^,GKD^_RO('-UD]=79A
MTS\T7>=Z1T<8B$C$CJ0R"5BDO*UQBE"S]F]-XZ^YU:6PQ^P^S%+9*#$U7#FY
M)W!(+HPWG9;M]?N]DY03N;"*=C?CG(3(FM9,.4UT?O7MV69-N;YV;N5Q-!SU
M)TO/R^R=1R Y!W'2"A5?Y1C.8,RDXRU8M1:Z7FLA]OA;"UW:*F@.<#A?V4"C
MXX9)H2A5BG%N)5>EH550XI%!C.OX(2[%4B^/C,]1R[I>>U S""K*[C EPF<_
M91L3X9M,U.RD&'L<IF7&6#A.9,H@90$U1<V].NT0$WJ_IP1@%,:)^U$83,11
MRF5L#W.FJAGTNB!!3L?9PN,TU496G8 ! '<,?=?&Y^+'O5K5)_S5N%F2\$^M
MYT9'\])@-J4[!6@' #L2$$BEQ"E(NUQN9I"708_).@7D%F6-WR*AI,&DE<DX
M9[,6F#/:_J(M-0?]4+<F\;UTJQKJM#)H&K3]"(XJB\Z#)G5N66CY/HVC#X?P
MXG^@AL"W@H-(2]A))P2&\MN&WOZ!7?B)6Y9NOMT/I2NI9P61:3B4L!51KG!$
M6UY44FI?FJ?8,N0#IGR01 &M:1)X!D!UUFBIY0<6)^ ;9U3DIMX8FR3E#D,-
MW!E'DIHF(KG%1Q]]G?UD"4PAJP-DZ(R<IEL@93LHY+9,Y@3LK'EKZM*%Y8P0
MN%.=9%-#/A"8,;01?X&Q,Y9]QRF5$N%U.#KN]$Y#71&3>GWZZ:3P^JV6="D)
M>:%K=2L-++3JATG?%#.H,UC@GH"4)G?*S\XU'>D.M=S-_=7J-YLNO1DGI-8Y
M[<V&CY<P+_O/?72ZK#F6T_&[#]#Q=  W2C(>[HS:*_4E#=^PZ4ON$'+IZG)Q
M"QS&(+:?3V70'QT#]/;!'?:P\B1KY52P@O2?>O#AMHX&^=0;PANWF9U0>"+<
M,8)(C6N.YZM,)AUN64%UZU5#G$G^M/YITDY1SV0&:6P/,UWE,_O<YBFP2A,C
M(* PW^GL?VJN:LKA,/.LE;,5$T--NNRNU4@(WSUW],'6@SVT&3 ?9&WRRTX[
MAK54QT<B!D#:"/QA=[*UE4%;?2F0!K84\X,E]MM4$EOJ)9R*\O(>-_)GR3IF
M[X]+63R ,;/7!42SYYP.MDZ6.^\=QMN"6SN6<KG56KKOU-6P]\<@4F"#D^BK
M!<AXB1EIUL<WL\[GPD:S-(G[ J>*KY[?-NF%P<Q&)E'7Z2471-TON:ZKC$N)
MM_Y*TBUP2=8T2:+-7KU =ZW3=NB<KW!FM%\V'N*<Z#Y''C9& /:?RO9)M@B
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MJIF.A-T^^^TT.:N>3S9U\V/33M/9<(#6>>]3KVEZS^$53)K.!E^SV(,?!PG
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MF@BJ+#$^&%(YQWC%BRC*(HE#(9ZX.'P&N'MY(=XCQMWGQ7!6C;S.Q9^AJB@
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MO]82TV].KC7.^23>KN,XN>ETV@4/RBP[O,K+>AK>D7OGA[./9_N\BA00$@,
MI@W82>@,<2$2JY5FS$@A;,#DAT5V:#7.$*2*:SG+;C@?<W7F-SGSO9/]H(V.
M/):$<XK*KBJ(%J4AG@%TMMHP( ,\\\6DR>;,[U@2WK6S!*CDS]Y@^*@Z\SV
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M:-4*H3TWB?:Z-UIYV6Y/H"UZV6A9.5X5AI3! DXK2TU,Y2TIE2NP\I]:2Y-
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MP#:$/4W)+=/OIT$>M0W1,? %;U)G#M [AW.+? XC79.E=YKW6*0M5I>;>4?
M1SA4-'&TF8C1/ @7>+#KZT&?RZ1IZY=:U&[@A4DV;_?66W0B9><^2 .T!_4=
MCYIN*3Z-U\&&FHNFJD: ,?UKFEH.T#RAN>OZZ&WU-=U]GZ;,\=">-!!C;+NE
MYUQOM$M56BXDNHPJ*3B8L@4M;!14VE@PP6D"*ZHH"WX96.EU#U FHSBKY[>
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MW<K'?GTK0I3"E[9"%%L*%J)2/ 2O#>!9$!M&U,-_13/\5UQJ\LZ*CS]0/WZ
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M8%'72^<9S=-R"S8'9$<G37&&*S#6#$??AK/T8-R/CJ]MB%%5"BE9 %$N@BU
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M^:8^8)9GG=7?M!(QZ:+IK-+>J-\*IM_-;6BF>XUTF]%;39%!2G9M'QWW!O7
M,:QYFNY:D;J2U%FF4_.WUK*BJMN5U(U?XFB(L]_ _L>\UF%>>$Y KE?9PF8T
M =NQ=<(W[ "XD(1\J8FWO$?!%0OQU8LG5A5?W5=5_*3^/7EKQP4_[[&[ ]8
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MCJRR/%:=.A*Z9#U3Q8P+*'?-:4MXL^KG^F$*6=),<_5ZVCKVT@G&!M%H&[B
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M;I9!51U_N)K?,5;'[[U\4@UP,A7JMY5W6>76;J-CEUL/J-QZAQ*S%,N:]UE
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MU*F8T_SP0W+8<,)+O/Q"VHB*Y<P >0*,SJ3<R,W\!A]F]H,^(ISGP<D/*'>
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M[1J=/)H Y*9)8P_E5U&Y]FVX'S_.,7-?G[D*1=X;@ Z;R-NM6GO0NI.#YAZ
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M$-[A;H^IPV5QM]V-7%_'=*MN=RV=KO=H/_7(PF!]9&$;&BBZ>>XW'@%P\.H
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M=[1C^BXM0K\V$7Q=^O;3_P%02P,$%     @ PX!B58$'3GQO%P  A=@  !4
M  !L9G9N+3(P,C(P.3,P7V-A;"YX;6SE75MS6S>2?I]?H?6^;L>X7U*33"FV
M/.,JQU+)SF3VB85+P^*&(C6\V-;^^FU0E"/)NE D#G7LK4IDD:*$K[N_TQ>@
M ?SU;Y]/1WL?<3H;3L8_/>,_L&=[.$Z3/!Q_^.G9;^]?@7OVMY__\I>__@?
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MI9P +R0"<Z5$##(JT_F-2H_?VKZKD\!W%LK:&:GEILP;M=375UH,F'7.B%@
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MJ2?C]=2$)"'4FVBC1Q8CRTF4UJU5ZV)KNY_CRP@#R3 5K2*PR"GYCLQ#Y$%
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MG67D6=_8GG!'&]5&PS_R)()OET<[LM":<R.K]^N72!A^_LO_ 5!+ P04
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M)A,<+0R/QB]G;0OC^/6PQ<71QTX3X]3]-.K<@DN/HCLA06=B( -3S(=,HHB
M G*96(8N@_8:(C.<@ZIM3O4SDOWFXC>@_26DWOK^ (%<CF.@C(Q9V4Q,\N7<
M&/W5P$4DF@-C/(?,J*W,Q6L ]IM"F\MZB>:W/J2_,SA)@HGH3F1"1?$GHI+$
MN^ )6&-LXEXRS1XM3*Q*L!/GT7LH$8#<*%0?U<0#LX1E:HVR*NC0BPUX1[#3
M%D&PASZ,T M4Z/Y1H4E,F1*IT#:R/ 62@T&U.<5LI'T%P'8(*L[?*[D0O0=X
M;B'&99%Y3^:1[3_'48/.^B]/I^T,+G_9C*?P9?IZU+WPEZ<3."K?5&/"G%AE
MHVK&Y>#R^9?A9)"#E4SAMN*UD$2Z'$B0Y:9:0,XA!>"FM\CH98 J\N2._)0[
M>+.!HE=Q9FN!]Q#<>0/3JVXO7 O4X$;&3"4V+ 54<[=?E?%S!P>V5US3E]1W
M1@ECL_8F!L)"C$3R9(F5MIS?)$%=M,SQVN'@.Z3"M62JQV?"0X3= P.N&%B_
M=5;Q0+$@(T=G.D>*>R:.B 1=G ^@VH"TRIC:]L(M$+LW^2LH9W6<_P:2[2$%
M9$74[@*<C$QE"V64JH!SD5@3T<Q/7#IKT1NM?O%W)Z!]H$ ]B?<P\S_"%,<'
MZ;5OQ^A-31:HLC;,:\-QO+D<W@N'YH\*A*-GJGRB&DVCRCQ8CF0?"%!!QGUD
M=\0X.YEUH0NK#K 60!DS@+:P(CQ&A[8P-<2ZA%8Q;H*,JJ05U-X+U@:W#_SH
M1Q,KTR/^_NR&K-!3_G.+E.I/LY,3WWYM\J?AT7B8AQ$_@$-J9N-IN;EI1L,X
MA,E[W[9^B@-Z56;#:'(=YGK9U!N^J4XB=8UAWLBA#BHIH6SV%.>\9-2Z+"7N
M!EHYCEXF&VSXSFV-P7%$8K?SO)WAY,_+DY3$-!/H^A)C+6Y6.B/+4TI$Y< -
M8\P'5C]%=!6:;1? U4?SO^*,+@>Q'\&/AO\#:9 ]9$FI)XP*B_,.)> $MT2X
MY%)VJ#A1.]QS?72[7P(K,>3F.MB30GHPHE]!.SSKIMS;\63:=O5Z)N^;Z2N8
MX #*0OY\\D](1SA)KWS@?!3O83I@UD:6E"4N\5B*[!CB'6@26=#1L.!S]?/8
MK4'O#=%VJ[Y>_/4;<GG9 CH9Y;LWP[$?QZ$?72+_S7\9GLQ.7G\Y;2:S%@;2
M<:&,2D1XB;9#0MR>FD"LSY:5J!U/:SMY6P'>&][M3FT]^ L?VN9L6 [/<)E^
MU<S"-,]&"UMD,@">' ,J<"HX7(^%BHB-H74J<2%.SOA,:]\BW(5G;QA33>@]
M)$N_'9_AB)OV:PG+6B1Y3Z ] QRRT)  .%&4ECMBY*LU@J)K&X%GZR6O?GJX
M&LW>D*&2P"OF,Q<7;? ;^L%?7_CXYZ\SCR;;%!;)_0-*G;9"!H(82@"+HL3Q
MH @"]:"L!VK2?2[?G6_X[C5;3WX5\X<[4#A0'&6<3DI&R\O99-J<0(OV]W36
MCN?P<$5"^OE1N2Y]/DXEU:^)?Y:?YO( EJ52:)V+R+HX$4Y\!$]4L,(;;X*7
M>2WM;PUE/VBR6XU43/V]$WV>C1.B+]*Z#WY@:/<X!\3E[DH^">*<5H2K(%-6
MP?.;83D/)-3Z6/:;43WII&+N;@?_GWZ<\ ]'E[A*UEVW>A;H_@@&B2<#T0/)
M-@>"FR"*1C&.7Z+PW$&TP->BS/WOV@]*5)9IQ03:#MY\M7LW]&$X*M&7<_-G
M$).*UI2"049)(C/ZY4$:0:R35%&MM-%A+34O?_Y^J+:"['I(1BTP\(''2+A7
M< :CYK2+NOA2LF5AX'&TG)I,<K0>P3$T:S-U)$LM-:7&A%S[W/5.0-\]$^J+
MO8]$T_F=UZ'_L@#T L8HZNF .Y-B!B!&>ET2?!0)"F@)Y-1<.6?1YZWN5BZ%
MLC=$J"'J/K)&GX^GPS0<S<HA[2>(LQ;%"Y/77^)HEB"]0?&46]+9M!/'03Z_
M6L=]JHL0?WY2CD@&(3+''(Z"E;M87-82\:&D37OET-S50<8E):FWN[FN 7QO
MZ+5[-=9,)>WVS?>S(KF#_"LT1ZT_/1[&3_.X[,D@Z^1DDD"HB<7Z58P@F(QS
M)K!@>+0)]%IVQ^IW?/=,J"G#/I(VSZ$=G$(9\OCH EETZ+TPM&Q-8H[(@ Z.
MC0)(DM(:*X/)MG8"^DHPWST-ZHJ[CQS.6P.>)P+XH-#9\91H6PY-LN D,!L(
M5>CZB"!<I+V'/.PT@697=U\/%^^WDE!S:R@OOA[B/^U"PZU'(01<SKAW)8A3
ME_)Z+!#!J10@8M2N]D78'7 >*YFFAK+OX\^&0M_%;7P!MH@+7 =:3XDU=\!Z
MG/2::BJ\=VG93OX[IH@/5C":*.&Y7/,$FXDW61.*2VOB1C.IQ/=.C7O2;1Z#
M&0\1>T5&S$_>_>3X_!K_GS!*']KAB6^'HZ_/I]<"08;364&^B/[U1E"C VZ_
ME%DBI0BD--XI+GK,$D+F8<T;M4U>_PV8H)MJK]FIZ"O&&RY%[*==E/@RM!>I
M!4 %!6E)9@'A>J:(<\J1;+V@D0:JM=^(*?>_>T]I4EGH*Q>4QPG.7SAA;\>Y
M:4\Z.?8>I;_ZE;L,UU]SX#?B]A-52@6:-75*AE)DR$EI( NFLK:<KAFWO_KE
MV]ZIG,%X!I-RO/8:D;=C/[JXWGT^3N^:\=&[X5F)<IW ='+IW]&@<@0-Q'<5
M3)B3Q&FC2!;>6!V,=E#[N'13K-O?.W7OG9] SJ_!K]Z"ST\HRT4HOA;_2Z4@
M3Y3)Z^PU2;1S?XTG-J--4J8VBDTFEVN7P-D YNX7X)WP[?8-5K\*["%KX#UN
M5%UNPW0NB '-EOLH(N&L7+)$*"V^O"39@,HT>'2):V=9WL3P@[!E*]'WT6(M
M'D.:C> @/U <\X,4R7P(P"6)SC@4A0'B(!?KU(J<9>!)52_:LA7B71U>/@JY
M=JC,QSX"G;33R]H8E[<Y?C2OBX%RBTYE7%]5(+*$&EH=&3%:H@P#>)'7.BO'
MMURA)/YT2<<[ 3Q:[: =$J"IK8B*JUL':DZPJY#.J]VL >HA1Z'WL605D-T>
M?E945-.7E'=&@>""1T?)D<A*36B*7RRSGBA@QGLI4ECO=N3;4OV*P\U=:_XA
MPJVL\>>XO"&2\Y,0COYQ9@97,%?N]"T3Q F:"K#@'.-&K><HW:/FZV_=G25;
M40U-%1G6/G%\/AGZ#SZ6@PO<LU[/VN;TO (%C]XF<(P$4ZI_YL2)DR5F0X8<
M@XW>KWFRN/H=W[,B:XJOXASM3I[:KX/?/PT4&K2J5+],' J"Z$G(N/@D(Y@5
M7%*N[NKI-X'XTU%S]FSQQ/GT7/QP.3LOW_<]*W-#J57,O3U'\.\?T&&5ABON
M"?@2=I]*#)P-AD3.H\M9:QWO.BMXF-[^_<,^Z.V!4MM9P9Q?AT>OT2]K3K[^
MVC:STY+6.2_]O<6A^[W/K'.J_C#H-X[-9;!!*1MI%$%ZG#@N.5 NL>S!.^\'
M]SY]VS/?KL;2!]].KQ87N3P$B*"$CE20H+TO194RL2X#$:$ M4X$7C_=X&Y,
MVX6N-M/2%33"\*PXFE??M2@N4,H3#CL1#P1(GDN(M^9=*I?4Q >720"65(9@
M< E<+YCU 6]]C./'BB2X'N3:E[1[*6 3IB\;G%]M<6$.VN'1<(QK+O[V[7@*
M+4Z[CPC^()??#!3DP%/@Q+.4B33.$,>U1^@A@N I)U=[6CP$WYYPJ'?5]'",
M?1WK_#L4S&4-DWFY_GDG'S80.GA>4DDL5UW"66G0$P/Q!I*!8+VM7DCP80CW
MFDI5U=-#@9E[T<ZS0=@@"^V%DA2M[\B)#!2(#4D2X91WPJ"!P6I?FZV+[4<C
MT"8JZ:$4S;PFYV6"4;D);F;3C^#3</05K4=H3W 5Q5WYC1^V71NQ16I1Y#&[
MD#-1N32?]C247JR46 D\22K!YMJUL#8&NV?DVHW2*E:[67;=LU0^DQ=?K_VE
MN^7)5# :DR740$FTMHC72O1,0T3$+H$(M;LW;P1T=U>U/7*K?Q4]]DWL/6*\
M,;[NRB$FR8QCI?Y+:2OE(1-/P1$NG  AG=?LKJ._BN[M$G3?PMUM3TRY%;G4
MB\9Z*0Y_B6=Q'K<.HI[R66ZC>9PTEK[T=P=-MA#^;FC!LV Q!DE<3B5)@Y8K
M#>\(,SXKJ="#$+6;PNV*#O>DKCP>&QXB\]KWO3D/1\,"Z/5XBD;<XG;+"I>"
M\I8$7!U+ED0F#GU*XEAD6@GCM5RK/L=]][Y+W_ZXUO$F.FFJ"K2'4\*YA7Y^
M[#0_)CAHR__+)G@E1XOR'&3B@AC%T?T#H8DO+><%YX)EGKQUM0NSK(OMQ[$K
M>M%6#^<\=^.\DKRS#LY>F]+=C_%Q+)!^-/T@.FVIIMZZV*V!%Q=4:BU00J4K
M9U4^X#8<,I) !6$M2Q!WNU@]<O+MM\6FAVBGET3MF_W:.&7:AF*U"0U$,E"E
MP'8BD"'B9L\YC[6[ 7\SG?!JZ^O>YG@/$?9*@Z=VO,:[TOV[2@.C%4^J$YNQ
M#LP;$1G:.Q]RR#'Q+*W6+@9A$DL:G+ .Z&#%,[>;8^]*0A:\F_=6G\1V>'K]
MX \<AYP]+BR!%2.(V])[5Q";$S?"2DUS[>R6>R!MNZK,'W]1\ZA[SR&T)P?Y
M/'=M$)*SD)D@C**]+R.4RS>9"65&.@=,&*A=9^A^5+M?=VIRX^9R4UD+/3A<
MU['] <.CX]*,Y@Q_>X1K5I'@5>!L$*0M3=\,R32I<N_&2=!<HK\I%:ZCRC)5
MFS4/Q;A?'.I50SW8,W?B?36<=+&2):!D4>%YX+.FB3M/&'<H'-R[B%<I$295
MD-J9Y'7MJG</Q?@#,6I;#?7@OE_'>UXR6.+X54A C(^92!$2"26U6@N>6<K1
M0XJ]TN;1*C3OCAN;R+J'8(OE UZD,CH7#'66F%CJY 2N22B1US9 Z1.@,Q6[
M,=UV>I7=O]&RO;0?^[ZZG')_]..C^5%"XI$;Y24)B:)$)*7$.^2Q22E1JP75
M4..FX.*%CW4*7$U[S;92K'P#U(%8..WKP*B8V'OEU;M/Y=U0^#?5MX7D^E0D
M, VJ-+14I:M<CIHXFQB)%"+S.MKD:N3O]Z[ .Q)R*^OO 0*KK+??4%(GLY/S
MBT(/.C&5"=@0B*36$5>JF]!@,XLQ>^=K9-Q>>^EN4\0V%GM30V85??T.R#P?
MY'PXP9DL+"U=DW!,6D7B6"[7QRH%+I+S::T8U/N4=_6EWZ'R-I;9SHKME>H>
MQ>LO8=-5CHOO>EZE0^.U(=\X.K:!1:\8E51E*5Q&\X4GHTI<KDJ4\<&=3][2
M T'+^B#/F^>^\;'K9W1I;7,.FC,&):E:H7\L _' #?I(/E$'EC%?.\SQ3D!;
M^UM+'KZ8#"^:MFT^HW_XTI_B7Z9?!R"E,C8" 8BXJUGAB<5AEXI&+OFDE:E^
M?/,0?(_@GE?CRBW/K"^]])3O=YFU,6\7.8P?_-?NQW8XCL-3/QHH'X%)G8C5
MLA3( _11+47I>$.U=$Q(6KL4]7K(]HDW/>BBAX/CJ\OW9?>_%^#;TA%P^*5D
M 5VF(PXR1%U:QI&<O"JQC8+X8"V)TA@+%"SN[;77G0<AW"<&]:B;B@?&75+T
M=;*_;,Y@C"9(A_'EL6^/H/RJNSLI!7 '+$)V(("P&'RQR1GQECO"(0M$&7A,
MZ_5X?=A[]X$<?8N[XDGR$JB'+=J%I3;RO/4U4QIHB7ZD'GDK!:"30$TBW'N1
M(7'MV7K%".YZRYYJ?0M15DR6NX..'^&_9T.4P<(=_Z-I_YR;2L,I[GL0+/,,
M*.Y[):4=>$(IX+JEO;3,2!G,FCU[-WCYGC*BON!O$V6[=O/+\1XVB.N\8^T0
M)H?-H1\?#<,(WL,4T4^/Y\N8H(XJ0P.Q";^@I6T)6M6,@,;]+2'!V<W:2 ^B
MS)HP]IP\?2CC-HTV[C)_F91Q.K>D)P?YJITT\*7*=T93.B6T?:1B$CTPYTD2
M,0F:96:FMF>\"LL^,*6JO&_S8./6\,N]K!=^,IQ\.FW!IX/QO]!.[BKTH'',
M!B'K",XHXG2):D;Z$HOX"!I  ;@2 *&/HB3K8-LGGO2BC]N\V:Z__'60;T9-
MTU[SI  EH)0$DF4I/. <)[X<0INL0$A+A;UY;;W61G/K1?N@^.H"O:WLC;O/
MW['-+4[PGH]&S6=(KX9GPP3C-!FP%$!'R0@.M5P7XH[F)$L$K(L\.2^C"5O8
M&"M>NZ=$J"GL)6=?6Q^7+A/"/&B#4W"X?VE"!:"13"'AKJ8=R8(!P_W.0=S%
M^?INPYMV>H3^<#D_=FC3\BVN"S((-ED3,R/:\EQB-3.N;]R1X)6W4+J:QWX/
MU!\U^*F.=N\T)!XLY9ZJX%TB>N]/+G*CUL#54P+K*DR/D["ZK<[NI,"6 M\E
M(9@75%IK2,(=#GE?R@-D_)*"S4&Y8)RL?36]6R+<DVJZ*QX\1,ZU>[O^AH\Z
M+GF,Q1-^U_CS%J)10^GR0DFFVJ.I"XH$9= S3IYRD S,3<MAA0&YX@6[-Q7K
MB+^I++O:S1 N,'V$LV9T5H+Q+X%1G;QP3I. W@J.5'-B%;+7V9 AN<SUS;B[
M^Y2ZY"U[I=EMI=A'SO<U"Z5;E52T3%BK":.Q'%ZA ^(CHT09E44(T4E3N\3H
M;13[9;=M*>4>,IFN(UHP?!U,/=ELR_ \CKVVK:[N5/T6@NY]\I\O<TCGE$$2
M$+K<89C2%]"5!0DY[G#ASKFVE[\[Y=]CH^U"]P^1;Q_=-TO-64AEEUOL0(PQ
M%9AT!(<I2Y\03GSBFFC.T"1-#L#63E^\!>(1.J=OK9N;95>W$FP/<8\7UL:-
M,,TY."&UM0D\ <<4D4PFXID2I=9L8B**:%7M7?Y.0'O @'H"[V'>7[UHFE<T
M<HZ&B-Y$$DA1)"0EZ'26F@_!49X-B[SV\=Q-#/MEY&TEX1YRE:_B.2]7M@:B
MG@R\VV@>Q[S;3DMWJ'P+$?<\W1?(4I)46"]Q0;.4R%Q*F G/RR*GG%2AU!7_
M3I5^CUG7M\X?(MD>=/W[Y+ %/YFU7W^?7&N4L]AYLC5"*K0^0$ IPV(Y"9EG
MDKD2VI=F9+EVE,<]D':_V6^KM:8_D?=@^I5@I.DB&.FBA*'S6BH9$$D$(-)2
MBR.7E%ACG4;Z6V%K%_-;AF._-OVM)=U#CXZ;F!9\7P=53YO_<D2/8P!LK[%[
M*+"%N'O*95J"CF:;DLDX<[(WN.3A' K<L>Y^P2O0P8?JL1P[),$]!L&N./ 0
M*?>A^RM+WGGBOW:>@K:$RX1;G=>:!!L\B5SR'&D&>C.YI&H,SV-M_S7T<T?\
MS@;"W5D%UZ[$['$SPG=,YI5MM\C*7_VP.BGY:X*]D8]/13 FZ.2"MS)1\(#F
MF^;&B61]DG&P^K%;'J"/_&1RD+O'O[N("J- K6+H3J3L+)$ C'APDF@F))>X
MF@@+E>?84B!;'Q5W'1(_^&%ZT[2'_DMI4E:$6!(MF[;[ZPL_@?2R.2G%V4H&
MQ'C 99 9D/0LR(BK:$1C"@UI8BBS(246(Z\]^$UP/L)QX]9<N77BW+=^>O!,
MNN'/2VJ_FK47F7KSH71_/.C*A$U>?T'3?HCH!PPQJB@#$1;]=&FR)-;J1""!
ML!%DLJ%VX-##4>X%G_K531^760741SB=M?$8F?ZA;8Y:?_)\-CUNVN'_0#IO
MT<FR"#QJ(%9RW.=%5@2M/4^R5RISRZ.DM4] UH2V-[RIK(4>0AYNP%S"\0&P
MI(U(@=B<T8 SDA&'YD2)[!9!2U!.5=^\[D6UAQ395O8]W)8L:I!,<.>\Q%FJ
MHU^T:1A(H51D2B-A$_(WX6+GJ>4D^A@H0^]0B-IU/NY'M0_LJ"S['H[4EB]Q
M%S7/+]>ZR\^<KWI!:.JXB20I@<@Y%RB80(F1$+B*/G->N\ORYFCW@4T[TE7%
M,@ 7LK@D_$4^&*Z1W0+Y"N((_Y<&QDO*%?7$2UTJVN1$O)>*&.5+BR*9A*MM
M#J^#:Q^84UW^/>3XWX7QI9\<%W=PP+AUCBI&$*D@TJ5RBBD0;2PG6FAY@:Y=
MBGP=7/O.D8WDWT?^_SFP*V +MD&(T80<#%'<!E+*$!!OHR:,<^:$YLRSZOG^
M*[#L Q>JR+EB'O_%#GC1?[.#].)K-_3Y96=*E'N.HW0144F%@PZEA9F+7DO!
M=?#K]:E]B#FR&LZNTGA[L#(JR?A;2>#]-/73[HE71=7=BQDNK#>XUW%:1A-%
M(M8F-+VY]UJE( *M[Q2O //X'6VWU/8M6[6&U/M(#;B"9W%9M@ZBOK)#;J%Y
MG-B!2NJZ:5+4D?5N6""S8(H&7"F5161&1]S:5"*"*IJSLIGIVF'#N]+^/4$#
M.U/^0T3<A])O=29%QU=PZB7AAI<"SI*74IF1,*-R4$)D&5A_[L2CY0=LJ9E[
M&[X^1*R[#1>X=6VX;<C R@=6#!M8#_2-T $1I9/),U#!RF14$"EH2;UQA@?&
MS>#N1U>X8+_U[.=M6UI&=*7"OEY^9'%(^ORS;].E"<NC5"5 D3@H9^72.!)T
M2L0E]#?1SQ1)UIZ:VZ.N$IBP"8+WLS+Q<$YW5PZ7)X$#)K-G 5=P4(:7J:@(
M6O^,X,(MF:7HMYGJ7E'M0>Q^A=PQ?Y?&/SP:#?H(CE@ZH)LH?\?EJ[UR'?]A
MY"^OY#^TPPA=RYEWS6=HY]\-3X;3@9,A2)TB 6T=&BG9$A<$D.RI]YEJJJNW
M!NES/'^Q_;'(T4<<QZ:B[;[\"R;3B]MD-C!&"RNB(DD'-*O0D"(6##KEF?H,
MX)+EM4-<:^+_B]B[4G[M?@\;#V015G4PFTZF?ESB]\Z;LL_\J)0#&B3*6=19
MD)Q+Z1\5#+$^2R*8UER6EFTW<_=6U-KI#^,/P]MO2=<]!,)4'-G<SAJDY)QD
M.""6-)1L2Q0W.KZEXA%8!QS_^V9\E%6#^&'8_6W0H(\0GFV]A><I=2KWHUM^
M \<A!2M]Z5\<B11)D\"5(<PSE7PRSM6_(NEO.']Q_9&HT4-(48<GW#^TL&(:
MOV_&9VAA0?H#AD?'^/_G\QY*O^(#IJ_\%-[X8?LO/YK!0'L3/01!A"^A#AD4
M\<Q)XH.3SAC+3.C%[M[)Z'[,.?'M$:??B*I%.Z#Y)/X($VC/H"37O)E-9RV4
MU @_CC"@GBN9T#CCRF6"8BTE.54@0C'-#,5)3GL,P5L/Y ]'V'[5V$.45JWC
MRS,_')5 !!Q@-[D&U+@0J*=$E_)5DH5,K.:,@$J1.Z%!R]JEO?H:RP_'XF^"
M%'V$I&VZG7RX".,>QNLY 8ONGP,;HO&B=%$OB6A2\T1LXCBKG?8X,*ECL-^*
MW7'O:'Y,PC\^,2HVV-E:L(O.,*]/3D?-5X!/LS")[; SJ[K&04J:&+@51$<)
M)0*]=!<#07#O,CFCR>2JYY?W-98?D^Z/38H^V@9M.[#K^Q=.X?.1#J3108AR
M+>4 IW%IC^8IS65DI52;=]36+E73VV#^XONCT&()X;=K=+'YG567:?9V_/I+
MA!)=5KS@WWS[)TP[7W@1;H96V]R-?M],#YL7<Z<9TD &Z9V.0"@5FDB@@EBI
M-8E:*<:DM\+?R"6L?0VT%?X?AOW?"T>6S(O'N@+-&2Y3P@<Q"DYSY 1,"*46
M5YH7Z*3!<>>91==%]7S?>0W07\SM6XM+J+C]5>9=!4TN+*G.93AW)DJXS( G
MIHW7BA@>&9%&91(H<\2#9,*HY*.O72ES0Z@_#"]WJ=(E5-SZ]O%Y^J_99-I5
M.3AL+J^+2K;HV_'5\\K;$5Y7"N]T3>PGPRE\@O8,W=[YX#]";([F>A\PIIT6
MSA"F1<+5W^$XLQ $QP_*,6.XKWWVMZ.A_7!4_Q8ILV1J;']%>9E;=Y_ )ZLD
M/L_$L]E(:Y,D3'E?TC-0T,)8HJAQ*M$4@5</<:T%?E>9L(^]?C^*LK^5)-NR
M%Y6.<HONC]XFYSFA79R7$91XIC/)AC(CG,S.U@Z+NOK^;R"5=I<,N%ER:%--
M]!#]?([EHI'K_6AZRK.]CN1Q<FPWU\P*%6\AUOZ5#9(+;G'++5$.1/)RBF44
M>DR2)VZ-UB[6KM2R"R7?DTK;EXX?(LW:O6\//S>'Q\ULXL?I^3A]@C,8EZK3
M):3W[;C<1PW/.E_DO$.$RRHZ*W$3=0Y]8X&@A9*E"#7-*4<PXL;JO^*$XV'O
MW;T5O8V*FMW(MW;;W.M0#^\&&H$AS[4G!@)'@13/-"-098W,6AN9(&Q A+O?
MNB\TJ"C;'M>#CJQ3N!NK-2%RHP6)1BHDK VE"XDFHI1&S4%8G]=+\7C@B_>"
M"M4E7#LW:&VLK[_$T:Q$S3^(Z#2ITGD@$:]B)#+[2(+WAD250?-@A1.Z+GDV
MPOD#<*U__57,^>F&MO+4=($MZ.PS=90DP061I?>\50E(Z8EBI&%1F;@6M^YY
MT?=+CIH2K)CY,FFG@R['MS.SM?#&0V#$6!R8=%80EPOC4J**ATSM>IX&/O6*
MEX$_77H8UU[X8YXO;"[SBCO.!8@%_]:!\9 3A74H4'].WW^$L(7P;ZIO"\E5
M-"1OP6$&EU1K"!4VXPJ5' E!HSTKD9!)2@!3;0[WJ< 5QP,]Z.\! JNLM]]0
M4B>SDP40'P-WI:68\ZQ$*S%;FDT"_ABDH\$!L+7NY>[1W+67[FY#W4KL30V9
M573A.R#SZ+-S(-2A(:84R:PD*)G2R#VK1+(64:MD%+"U F[O4][5EWZ'RMM8
M9BMGWHKB9HM?ER\E+/P??_O_4$L#!!0    ( ,. 8E6Q=:CO>I8  .X>!@ 5
M    ;&9V;BTR,#(R,#DS,%]L86(N>&ULU+UM<^,XDB[Z_?P*W-D3NST1QC1!
M@B0P^W+"5>7JJ3W599^R>^?L[;BAP*NM'5GRDG)5>7_]!?@B499$ 11)<R-V
MI\LVB<Q\0#Q( (G,?_I?/QX7X)O*\OEJ^<]_0'\*_@#44JSD?'G_SW_X[>XC
M)'_X7__R/_['/_T_$/[?=U\_@P\K\?RHEFOP/E-LK23X/E\_@+]*E?\-Z&SU
M"/ZZROXV_\8@_)?BI?>KIY=L?O^P!F$0AJ__FOU9,98B&J0P% 1#C' ,"484
M)H+S(.&4!32]N/]SD*9I$-$(QC(A$,M 0$J0A)@(PA+,=410T>ABOOS;G^W_
M<)8K8(Q;YL6/__R'A_7ZZ<\___S]^_<__>#9XD^K[/[G, BBG^NG_U ]_F/O
M^>]1\32BE/Y<_'7S:#X_]*!I%OW\?W_]?"L>U".#\V6^9DMA!>3S/^?%+S^O
M!%L7F)_4"QQ]POX$Z\>@_15$(8S0GW[D\@__\C\ *.'(5@OU56E@__O;UT]'
M1=*?[1,_+]6][=D;E<U7\G;-LO5GQM7":%^TMGYY4O_\AWS^^+10]>\>,J4/
M-[O(LIU6K9;4:HD2J^7?'1/V\QGJ]Z3O>E_7'I0KS/W2EXYMF'[I3=T[PP]J
M>(4;8LY6N?R@KI9RK&]W(^ILU8?7N*_/8K5FBQ$^BZV8ALH+^XO/YE^5&-M0
M"YD6<BKJ;JBJ?JS54JJ2+7>:!G/YSW\P_YH]Y_">L:?9[7HE_O95/3UGXL'0
MK?SPG)E)LB*N!Y:I?,81PCR-(ZA2$4.L)((TX!&,2$@B(A")@W2V]['/U!+^
M=EOK50CWE?P'%Q#<QK1I;64$;6?#Q\6A*<[,;G8^)#\OV:/*GUCU@E'?.@ZE
M1?^RU1FL-!"KQR>V? &Y-0?\-%^"O%#^C__T\];R7OHA$8$0W*#/4((@3I3Y
MES8]PHF*PH@CS0(R6X_> =57N!X!^4)CD&WQ?\I6]QE[K"!O_$4.VA.+-\!W
M,0:T#6U!J2XH];T I<9'H5R)'=46UA%<9:_168D.Z&RI-C>&%=!HEO/"MJJU
MGZT;_K-:K//Z-]#^IN!;#X$_[WT=EUEM%\O$B6ZJGOA9K(Q7_+2&.SUF5Q%=
M 5BONGY896<8Q?X 5IE4F5D+'3!R;PA\6@JS#LK5!U7^]].R$/FP6I@V\JO_
M?)ZO7[ZN%HN/J^P[R^0LB1.F2!)#JJDRRQT40:X4AS1E(B DCG6(?9C)4_[4
M:*I6'_Q4&_!'8-BH:<,_@-(*\+NU U2&_']^3.7;36ZT-2#X W/8 +A[TUI'
M]'KB.%_IHQ)>1VA>LU_79KI1X6>5YTI=/ZF,K0W)?K82/\\9GR^,F!OV8G>-
M\@_/:D8%CSC5,51VPP)KJ:#A1 $CSKE *64I-=[9QND_.0Q=!7N1WY&E39^#
ML%C7^/&8,\9N!#8$<@,S5ZGR!=@H#0JM+\!&[PNP7@&NP V;R_[8RA>JGFC*
M6>RH_.0+QFMB\GZ_&R,97E/S^^7[YRQ32_%RE[%ESH3==<TOE[+X<5%LPN8W
MJ\7</*!^K-\9._\VTYB'J6$CJ /-S *2&@^-XA0F(1&2(T%%'/FX:9TUF9K#
M5AD":DM 0W<_*NO>.6[<-@KD Y/=8;0K*P!;RB;\.2@- ;]7_[46@<*D'KVV
MLV'MB1B[ZS$J4YX-UVOJ/+_!CM[=*L_?KY:6KJW<&[6T1X3O%VS^F']Y?N0J
MFR&* DE3!87B%&+")"3&UX,IH4D2\CA&C/F0YFF14V/'2D4@"AT]7;O3 #LZ
M=;W"-K0[9Y0%#6TO0(UAJ? %*%7NT9%SAJ<O%^ZTP'&=-V< ]MPV]S>[D<Q-
MMOHVMY$(AN4^K)[Y6C\O+H58/1MW<,80DR),,228IA"G+( <<0ZY3''":9JJ
M*/2AES9A4R.6=TP"J?@:J!]/:IFW["[[X^K&*GVA-3"?U"J!KTJH^3?&%V9I
M^#Y3<KX&!==<E0""G[XJ&_7"%L?//+RIQ06CGDBE5=2H=.)B]&LB<7JGKPWY
MZ_6#RKX88PJ7:5VO,^<JGX4!(3J*$JA"&D$<AXE9YH4!I"A$$<*2Q3P^;S?^
MN/"I44RA*5BLEO?0B'L$BZVJY^ZUM_1 UXWV?G!]FUWV$NFM\N"S ]0];*^?
MQFRPO?46T6^\L7X:E-.[Z@YM]$5F-YEZ8G-9S6(S$0E$$R5@I#2"& 7&.TJ3
M!(J Z9!0)#1/9LV@GPY#;5=DATB3H1==I7X;UZC8%UG9+CF7MUZ!W96K.@#X
MIOQ4 UHI/"0E'89F,!IZ)>Z-J>>P\:?IYLA[G2EF]:CNV(^JN7=JJ?1\/9.I
M%%P&$0QTPB 6"86,R  JG))4\@#C5'@SRR%)TR.44E&P9C]J3O$FDH.0DB@.
M=* 53%4H(3;L;):R 8)12'B"9(K"A'MZFYT!'3?&8Q XG>GX7)"&9V&+CU%Q
MNSBMM.QQ;7H"A_XH]Z"4L9FVS=0#!-OZN!^OYMEZ=JON[0GF+\J&7#X]S 5;
M?%@]LOER)M($F65F#&4<&W]-FE4GUYC9>.$D"H(@T4*[4$"KE*D10%-#\'NI
MHV/\5CN:[0S0&T8#CW\_>)P'OI/Y;</>-- 8\N:G[7!O;WN4P>YD7CW4W1[N
MYD!]4%J999_<T,AEGJMU_D6M9YRD@::<&J<ILI?6F(*<LA@2A<,0I4@'B?29
M\(^+FMJ0KS4URXG-Y,^LLGY3?PNV;K-_/X@-3  ;L!J>0*GG!?C2 IFW#W :
MC9[<@!9!HWH"IPU^[0PXO-'U:*MJN0C!O&'9=7:[MHN9?V.+9W6CLB(<?9:2
M""6<(2@33"$.A(!4Q 2&C"*F:<0$2_P.N5S$3HT^-EJ7=X4NP!/+P#>K<7%9
MY;?;#^!)9>6E%<\[*X[]X'HHUC>Z U/-%MC;$EBCL_F,0:DU*-2V]UC*.RQ]
MGHSY -7;&9F3T)%/RWR V#\W\WI[V#CN?U<L^VB^S%G,!(Y"R:$.&(>8)@$D
M$5&0I1%629+(F*1><3^>"DR-O<R'F X3UKV!W(V>A@1R8*+R"_.^ -8$8&T8
M/^+[-7HC1WYOQ$\R OPU.%TCP??:.6>WN^!,V_(ES]<9$^M9BA/C=R$-4\-6
M$$<\@"R1#.)0(&E6<$F,E/_6[)Z<J3%5M>#8Z E^KS7UOU]W$%>?/=JST!IG
MC]8+J(Y;M$=AZ'6+=E_*&VS1'C7U\!;M\<?]R$"J^>QJN38$<RFE^4KRFU6^
M9HO_=_[T?B65^;,4*$DC*'000$Q4#)G4"LK4?"6AH"D5@0L7M(N9&A64FH)*
M5;,P*)0%1EM@U76C@Q/(MK-!?W@-3 9=H7(F!#<D#O!!KL2?[E???C8-E%1@
M_K%E@!/-CD( ;J;5X]_QZ6Z^@&ER;B]*L(5U(3\MW[.GN6G\5U5>9N \"%*$
M(4J,,X"9X) 2+F D8R$84^:WPL<C:)4V-3+8*ENXU_#3$E3Z^KD%[1"[.0>]
M 3<P*[S&;+[!#/Q>*MNCJ^ $2D\.0[NL4=T&)[-?.P]N+_F[$'4FQ(_S7)BV
MBYPB'\WO\EF:BI3$2,*8R11B(1#D+ XABU(1TD3'88!</8BC4J;&&9O$D*6F
M538<4.CJ[CT<!_6T\] +5$.?]71!R<MQ.(E")[_A>*NCN0TG#6MZ#:<?[N8T
MO#<.R+7^9;62]KKEK<J^S87*;U<+.0MI* .B0RB8$,9CB!/((QP9!R*5% 4)
M39C3NN&TJ*D-?:NI3?"6LX7O98$6/-W<@WY0&GC4UP 5:A;QR;6BP&K:GU]P
M&HV>G((60:-Z!*<-?NT..+S1C1K^JFR:8R4OOZF,W:OR0N2U_C!?/)O?EMG&
MKI_7-A6PO38YBU(E96+< D55 K'6"!(9&[Z@1(4ACF.4>H6#>LJ?&HE4>G;/
M1NB+/R*$:18$,$I3"C$B'/*4AS#2L8XB&2E" Y\T1$/B/T(VHAK_[Y49D)5V
MV+2=CZNZ3\!J:\%X7>4V%0S8 0//#[7FH%*]NO1NIXQ2;=#0^P)4%O4W;71$
MKJ>YQ%?ZJ!-,1VA>SSI=F^DCV&A_/ D9,R3-LC1$YG\P#E)#??8 GR58"LX0
M5V=$&4U^JMD++^J3VTYA[\9E/2(Z,'?MA13M,]90<41#$],I:6\8.>1,/*ZO
M^1'-0G];SCXHOOZTS-=9L=)^O_JFEFRY+K.U;Z_ WJWNS.<RYPOU1:W_NLK6
M#U]M?J*9XBI PGB^1',;'!UJR&P04220YHF,"$V=TGF<K\K4Z,D: ^8;:RZ,
M!U;:8T->['YRXVJ^#8)95T:!I5J#[]8L8*,I5N"GY6H-[HLZ+1E8/["E(Y7U
MT+OM+#=NGPV]I6>[ZU.CN]YONJLPIGF]W_P&U/;8V&Y06 0*DT;K&UGMC15I
MPB;21SLZ_3?N*^<9K3]XR\G.ME?,8 &-@F(6ZT'"*!-<?TC4<U^/+7;SOVW=
M)_F\4-?ZT]+(-5_ 2YFP;WUG,Q)M4UF&-.&"$PT5%V82Q&$(.6((IA2G*5$L
M#JA7.GA7P5.;\FJ][8KW_>KQ:;6T<7_VIXT=GJ4I7'O S1T? M>!IZ4FI!NE
M+ZI4HFOP>Z'X,#E"?='JJVR%J]AQBU=X@K%7PL+W_:[7&)MT>?ECGL](FG#"
M501IC!G$.A&0$::AM"5T;, _1EX;U/LBID9#K]P#\+M5TC,4]@"0;AQS'CSC
M.KFGD.EP-?&8\;U=2=P3,/)5Q&,&[E]!//ID1V_$+OK?V?(W=FI5R[QPLB^S
MS'1P$4_[[F7[2!5S?VD+0OS*?LP?GQ_KS<IR\^!&95>/3XO5BRIN*XHT4@PB
M1HW[0K%9S8M(02$"J8E,[#K>RWT92M.I$4VE+UAN]OFK+4A[K5%52I]1F&NP
M'G=TEZ;0CT/[5U8W6%@ FE:"AIF OX#F<Y6IH+#U M1?P=YIC[V!69O<HULV
M=*_TY<<-IN>XCM_0<.]YBH,+['BA=+XTWFN9A/<C$\75KDKDNU66K;[;)-+,
M##/S^UD2Q80'$3=>)L(0IS2&9H4LH#8>)Y&"(N-]>ETF]1 ^U5E"5/H!PRXR
M8]\]+Y?ZP._&[T.!.C!E6[6+'88R'W2M^9:(-\J#6OL>KY-VP*ROJZ0^HL>]
M1MH!E+TKI%W:Z!K]:4-ABI.T#_-O<ZF6,J]OW;]G^8,-,)^E(0D1$\S>&K,W
M1U ,&>41%"A <10)QK574FD7H5-C+JL7D)6VH,@F:IU9N5HL6)9W3M[AA+\;
MA?6-ZL#45:I;'[%O-+[8)NNX  7H_58]\T&IM\A2!Y$CQYBZ@[ ?;>KQ;L<J
M9VR>%?D_KO7'^9(MQ9PMMOL'51F@681%' A"((EC"3$/!:0QES 10<((UXG"
M7B$_3E*G1DM6Z2K)C7$#-GHW-K8\P]?=L'=CI-X1'9B2',"\&*<DF0]P?94?
M<Y(Y;JDQ'QCVRHIYO7RV]U2(FB62"!5R"M.$:HBU^1=A(8,HX(JH&&E"O#CI
MM8"IT4\UB1=!A^#O_\ZXB>$_-E*;_<_@3T$0H*UW= %P<&%^56\.LN?UPRJ;
M_Y>2Q1T2%%[$25#_$],(S//\N?IC,Y:1%2>IM^8;*NX\_OW?H23XQRBX /:S
M+I[^U^>EVOWU!3 2GY18S[^IA>?AZUY'>[MDWMTWJOM5:'<!/A5H#^)L[=C?
MOV-5-O]63M2.<2T.T^YS71/^?%/YVG+8]LB?FE480R* 41#;Z[E80QZ%,4Q)
M&"0H5(E.J5^RGST94V.>7^;WX,KTU.KQ!?R2K9Z?P%9IWTP_^X"Z#>\S81IX
MA&^U [\/XJ6TF-];9I]]"2-G]3EJXGY&G^./]A' \,5T=94E/$R4%)S'$"4J
M@%C%(22<I5!P%B$<)0D13K?Q3PF:VIC?BW6TJGKF7S\);I?0AFZ0C1O@X(K6
MF8$.^U ,$N[0$/.&00_[QK:'/AQXO@]J>,?R>7[[E"DFKY?_QK*Y#:/ZRM8*
MS3!3W'P>$H:*((ACAB"+60P#*B33%!E7P:D\@Z_@J5%'H2G("U7MH=.W2EE[
MKT"!G\QZ@ME5BC!&>>[@.G=%%V+I!^"QB:8$^W8#=JVXC33O\?3?%ZI!B*A%
M[!L2TVDPVHG*X7W_(C)?[:E]E2DKCG" >*(A8[:R>LAQ>5\3Q6F82H%PP)S2
MD[YJ=VJT4ZC6H4),$ZIVWC@#@(%IP2:WG.?KH@C,KXKESUF5:+37@C ';#^C
M!$RSM=&*OAPPH5GFY="?.X9-VCV(<H_GPW,V7]Z7683*Z)CBC]=/-L FO_IA
MIL)YKJ19:D1AQ*( IH%-':J(&;$8"<A%P&G( VE&[>R;ROC*.2+26PF?;[JI
MRG"?=JV:W81<E=J>$=KHWRMNKL2P2 _-'N<'(U;678#:OKRH!5J T&,,8F>4
M^PHN]%=@W*C!S@#MA0-V;VD PORJC+<T%^OJ(GKQT7U1ZVO]<95I-5^;^2Z?
M)3KE1"4<*HD3B"E/(.."0ZQ11(C4#,=>ZZ^S-9J:A[1S@E2=]CPOI0T:_\]G
M&R'(K!7@R;PT%,<Z=60/E-MW]PSNO]DN*8T!I345>=89,2[ UJ3R)*FF7GNY
MV!ZA;PT;B7!],!Z#?YWTF0X=^\#GQ<Y>#7<CZ]V2&Z_2$WV8YV+UO%S;->Q-
MN<\STQ&15&D) VVK_ @601H*!H,T")4M:XJ$5V"VKP)3H^)-SJXZ3YJL=#Y_
MD\R[;]SH=DC$!V;7O3) >QG3:OV+7;,B+%*TG6UZ\VA7\'JB36_QH[)D5W!>
MDV+G=CJ>"Y@6%RN[U7*MFZNFKVIABZK93*%Y0<B\<6,FWQ2W82B(8K.TAR24
MQ#"BPI E+(4!8EH1*9G27N%+YZDS-7[<6E,G==@L2BN#0&%1Y1Y!WER4YITK
M$9W9IX['#J/UU(C[!IO]@,:6P1!ECOH!KZ_CB?.4&??0HA?@]HXR^FFUOT25
MEYLHQUD:!RBA26@HU3(LL?NI-#(,2R,F=<IUR+PBM=K%38U!CZ6I;(2!]IJE
ML@&\&PWV!^? -'<L1^56V6%35.Z#,F"&RH:P-T]0N6^X2W[* V_U6N*I$6,Z
M$P)1B7$($V2/;+22D*J P @S%E,22R9D#W6>&B*G1C.-PD5/5>$BT6.QIR;8
M;K32+X0#4\NKLD]@6_;))A?<1HT/7OOI #S#%H!J"IQ"%:@# #B6@CKT9F_Y
M<*NKR)>+Q>J[DIM+@+. D!0E80ACX\F8U:-A'ZX%AK%B4J&$,:R=?!M_T5,C
MH)9\MX_5Q7Q6FK"Y4NQX3:]#M[13U+!@#TQ5+<E/ZP0(E?;;"\:#X7QV$MH>
M\'[[I+/^N/>18/8$=!T2RAYK\:T3R)ZPU"%A[*D6NCFF7XQ%91+'RSQ7ZWPF
M$ NBA$J($!8VDUIH5KI"0!UJD2"A[(+7QPU]+6!JG/]YM;R'B_DW>WY2*.CG
M:^[AY^99GH/*P.1< /*Y .2R'1!OA_&8U3VYAWO-C^H,'C/NM>MW]+F.=YE9
M_F#__^H_G^??V,)NB6T/;>T?+I=R]Q>-)V?4#&>!;#5AED80$Y%"IF(!$Q%J
ME2(9ILPO1<PYVDR-&HHT)O92LK#_4%M%/2\AG]5#C*4I3VD*8V,[Q%QHR% J
M(4UIH%2$E%9\]E0>V:]9MIY8/[W6;(3>*O[14'=SP9VK^_ER:<]N5QH\M<<3
M#M"32F&% DV@CLTPP](,.,93FU7.W@*4&BN15CUYM923[,=:K[?L19O'Z4WZ
MSVUF'ZU'!G8#K&87>[VP$SI6/F([Z]4OFV_TF)6@#V3[2F%PEB[CYCOH [:]
MY B]--HQ8&S]H#)[0)BI![7,C:?Z:2E6C^KS*L\_KC(UOU^6>>G%RUW&ECD3
M1?;1I2Q^6I2Y2.5_/)>WOHMHMCOV8X;"A'*;*$\+I2 .4PI)%$JH(R(H"N,0
M2>1W96(817TX8IQK%;418+W5&["-XIXA9\/TKAMYOWV/#<SJA8%@QT)0F@A^
MLD;^\0)4=H)-KS8L+<B^82O8&KL)'C8&]QCL-FB']!42-XR2XP;.#0KT7GC=
ML-*Z9H?>%&.JZIIL@K$B2G1BW',8$AE#C)" !"<Q)%PEDN. Q(GPRP5]3-3D
MUL!5E9Y&I3_?I,]'477CY'ZP&GK3;*MDH[+1 #%KI]'H+57S44$C)V8^9?!^
M&N:3;W1-X64YRA"-RHO\OC0-I8YD  /![,$I22!3DL"(10D*2)BRP(L57K4_
M.2JP*[LB@[)>96!>>@UKJZUOXJY=&-UHX QP!A[[E?]4J-9SUN,C1O>6IFNW
M]9%3=!TT;3\]U^''ND9YKLSB3N8?C3J'KVBK,(J3%$M(J0PA5B*"A$1FSD^2
MB#,=QCCQ#/0\(7%JH_S '7G?@,Y3&+L-^%Z1&Y@":EV!_<ZK*Y65NIM;[+U&
M=CI"TUMPYREY(\=W.IJ_'^+I^F)O05<?YS^4?/_ LGME?V6O#Y6UCY%-.*RX
M@BR2TA"--JL)G(8P2E(1"*%BQ-B945?'9$^-<EK"KK0U 8C"AN+7Q16[K)<J
MU4>[IIV?!@9\8*9J"0$JM >E^J#6OZ>*X$>Q/COZJ@_,WS[\J@OV?01@G4*O
M0P36T2;?.@3KE*T.,5@GFS@['WUY[Z"\CC]#<8R4U!Q2S##$ 45F@9E0R!+!
M) G-6I-W+>#3E#.U^:"96V1SUZC*,=+YGM$QC!U/=<]';NCSVIW$\'6BCP$S
MPQ_"H?\$\3M2WBI/_"%36]+%'WR\*S,L[?7RK+P(.<__]GF^5)_6ZC&?I5*&
M,0H)#'B,(-8:08YB A.>LD"+)-62^)'#,5'3XX>&IL"J"GZWRH)"6\]KVBT(
MNU)#'[@-S@[=(.M $*?0Z(TCC@H:F29.&;S/%"??Z!C+K=;;8[092@6A(L4P
MT(F &"L,:8 (E,SN6W,A, YGZ]6:+=SX8:=U+TK8R!CN^[9GS^6.M&?X]@YD
M+(IC)92&G!FG"Z<DA#S4AE(UB\.4I"D*A%\(2&?0QHG<Z >V""O"1*AA2&,-
M<:R9@8U*R *<X "GFJ>IUY6!SE_:")-//Y"Y32V=@1AX-K$8[$2-@,OU.IOS
MYW61+GR] C<LZS7IT4$D^KHVL-/VN'<&#IFU=V'@X$,=8QQ4GBM5)#7ZH'*1
MS8L-T#O;;;,DB47 I8*!0BG$46IX, T0#%**(RQC;68/KR"'X[*F-JA+52_J
MG%X-=<'OA<*>3F4;S&Y#OR?P!B:",W#SCWPXC4A?H0\MDL:-?3AM\E[P@\,K
M'5-8+-=S.5\\VSI\MTH\9T6$Q=4/L7B62MHC%1O0]5QNHE[K*Y;9JQ:;&K.7
MCS9EV@S'J1;(1DH@(J%AE0 R$@I(:,PH3Q"*E9>OT(M64Z.CIE$@WU@%5&56
M><QX=7,+!%N(YRH6L_/66#\]Z\9KH_?7P RXTU5;@\#53E<U;++GZK55S9K9
MI64])N?H$^B^\G?THM.X*3[ZA'$O"TBOC7>C]2JTYL7.$'6XW%)N+ZG.4)*F
MD8U]C6(;Y18)FPJ=<1@G-,%AE++8+[GD*8%3(^-/FT W\%1J[<>N)P%V(\X^
M81N8$^M(N':PO!G-%8&>R.JDN%%YR-7XUQ3C_%YO$2]?[47I3,E?YTN;K^*O
MJ^QOAK2J!$<S3F5 E*U$0X3Q_ZA.(<%$PS36'">:B#1T\O^Z*C U=FF)?<DJ
M.\!C:0CX7EKBEQ2M<T^UT](8^ ],4RWA&+4)H+(!5$;4&=4&AO[LH)C>NN#M
M(V,Z=T4?X3%..':(D6EO]ZT#99RL=HB6<6NGP\33C..TQ^S,6%KD#*Y/X'^S
ME6BN'I\6JQ>EBM_<F$_U@>7JQGQW,Q+AD'$=0!78T&[-[57?@, X)!$+6*!P
MY%3%L ]EIC8A[88RB^-E?BJ#JK\]5285%7\\Z/'<KG28I4;LH(%GK$W?6%-
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MRU[8P-V/B]7W3TN]RA[+2M9U062LE*1:&N_=AM1BS12D' 4VN%:04$KS9[^
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M[%\.W@,#4W@!?FT L!: C0G@<GT8^-/%E?OJ 9^B/D/WQ$B;=0/UB&?=G'/
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M9T2FFN"40B)MCA[C!T$N9 @3&<H41Y%()!FEKM!&I:GQ2UEHACL6I.'[!6G
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M<..IV$K C.'0_*@PCS!.8^5%;\=%38W*-IJ^2O4S+Q/V=4[STP*V&V?U ^'
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M;760.(A5&E&H66(6:R@.S&)-8HAE$C(>2TJU]J&((W(F1Q!N)6:]H'1C@QX
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M[*_S]</[9^-V/:K,K$H7S]9%LMF!S/_)._9CED1AJGF8P)ABXXXF1$,>27O
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M%;L.R)Y*#:_CL'A4]6III&.UD2IDICJUN5O=L1\VY^K#:F&]RX^K[/ EMYE
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M/$NL;AN?VM"K A>L@J#4T#>PHP&<:S1'-SC&">%P0:)#V,:^R6?$:C0:&SE
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M+_ ]09,+->K<MB-E$Z?MW2:)8>BV3_"8F T=.'2$JT,F8#L6/9(!;SQXY'S
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MJ;G/1N4J(_%(Z8HR,S@YZC[D?E%79" ']JTW,=PI/$XGE #,HJ4%W)<X<EZ
M-P27B0'^MW:(V_[DGIU"5+B4TE^6^_1G9!!F5=L4E4* 4VX]D"8"Y(B:0F#,
MF*3>0=L-(5-S.96:B=.SSCAWF@:$'[>@](C4(@ TL"NYADV7&.T62 $!6@2P
M1HK.NH$6%IK=0:,U+KMU[WA!V1WM3R*R>]?VIM;_K*M\JZ>E+QT7,9D4F89
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M4?>1&H0<JD7L*Q)#W0>CG13*X_Z>^YUU1J++!YUEU!2DD!A S0UPA6V *T@
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MT<'Y\X"$I"MH'=F 187Z]A1JPS1?:E\3SU D:U/KTJ$]W^H.87T/AZI&JN@
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MVDL1/6+J[)HO9#?R%#DDXQ6)IT1P*3 0FG,L7&LO!SRSGFQJ#18E.SR6=E!
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M^;1*I_)S)J\)!JN,91*L$'1U"N/!U=9;,ID8*@*P>87\=I2-:\"TQ=6 .ND
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M-EWX+^2S6&[^8KU>3N/)NL[M^[@X[9,U\:B<=-Q K+5_JF0/+F6$;)ADM6[
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M9^TN[KZ2\!=+NC<F7+NHG$*05E<+N=3!,,Z!P2RRUXGIT#KU[$&">NLC<S#
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M-YDXVP^3F)P-Q11(3%3!< F!U13G$I-.*2LLK9--[B%EW*>7 V%G%['_\%G
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MT ^-FUQA^O.GQ=>?SS[Q]%@X^^+R5+A<;YPGG_9 V%&"'>C\?[R;L**LT"(
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M[1R*<!=NI2LD\X!2IY\Y EL#;P"3LV7K@9)[ R48R/GY$-*0<(G^1<54;[=
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MS(L? U6_X=,D_Y'4^7\!4$L#!!0    ( ,. 8E4*FW")6@4  #X3   5
M;&9V;E\P.3,P,C)X97@S,C$N:'1MW5AM3]M($/Y^OV(:="U(\6O"2UY 2I.@
M(G&$(^YQ_71:>]?)JH[7W=TDI+_^9M<V!"A5.>E*6X0B>U]FYIF9?6:\_5>C
MR3#Z<#F&N5YD</G^[?G9$!J.YUVWAIXWBD;P+OKC'-JN'T D2:ZXYB(GF>>-
M+QK0F&M==#UOO5Z[ZY8KY,R+KCPCJNUE0BCF4DT;)WTS@K^,T)/?^J\<!T8B
M62Y8KB&1C&A&8:EX/H-KRM1'<)QJU5 4&\EG<PVA'X9P+>1'OB+EO.8Z8R>U
MG+Y7OO<]JZ0?"[HYZ5.^ DZ/&YP&<8NTDQ9-VIUVTCXD\7[L'U#6\9-6*XB#
M?P(TTL/EY1ZE-QD[;BQX[LR9T=]MA^[A?J%[:T[UO!OX_N\-N_2DGXI<HSZ)
M^\O'4LQC843.4%XLM!:+[A'*TNQ&.R3CL[QK039*8?6&1&1"=G=\^]<S,TY*
M%CS;=-]$?,$47+ U7(D%R=\T%0;&44SRM%RH^&>&5J(2^[HN01RBG(SGK 85
MA ;&^&;.8ZZA%;K!?0Q;UF_9FJ"[F?S?C6U_T=CA^"HZ.ST;#J*SR06FZ]7T
M_> B@F@"P1&\=Z?NT(7I>&AG@]:^WX3!% :CR64T'CT)[JNA>5&XVP!K6!W_
M ":G$+T;PW1P]79P,9XZD[_/QQ]@,(S,3.C[X7.Q\IPBSF[8MFG^0FC/<DA$
MGK/$4 RLN9Z#GC-(>6:X0:3XQA5\6A*)$<DV(%DAI 9<>RKD @+?^=.L.N<I
M^XODFLP8,HC$-<0*W#7"7N\<A:'?&XI%0?*-?0MZ>Y *:745:+F@P- =%*:L
MT&P1,_EZ)SCP>RW,)L-#S3O3IBQ92F1$] ')*8QODCG)K=K%@BMEM.*_64F1
MY6#.)$,#MPTI,=1V-.&L"5/-5BR'*Q=.$4D3+B7/$UZ0#.6C/LU7#"9IRA,F
M2Z=8?09.$W!,\Q0?BJ542W0":+%]-$K?EGC*\T'0="H*P\';>^ZM-"E7:9H2
M&9.<*6=RD[$-#!)M9DS*-7&>()+]H]XSLJ\@E&)TG8REF!;[#_+1"4/WY?(Q
MV*N!?'_M]QT3M-W@T/@APA!4:9\N,SP#"48^,_EWFY.2?5IRR4Q55"8VJCI/
M06N7[ 'F>;"_2_=NXWF7P;?96P4UZ+3:&,Y.S^3V+Q+2\,<,*<^1@!8E32$%
M:H);*8Y6 2WC3;@AO4(R94+;--,DRP"WH37(#CA18*Q5LV+-G"!MX#@*I+9K
MLQR%JY99F1D"V<[J5 ]XQ/TIRX=Q)+J1S80I%R43\J1T*M:-F)GA="ESKN;H
M724R9OSY1:(TO'?8LRV$]1KNSX6N9? ,]R-Q%D3JVG5U,9*64?'4X:3A?,I5
MD@FUE/A8-:O/<.\+N7*$EELFAPNQVBJ!85D!:_LUB3-6VQ8+29ETT,2,%(IU
MZX<>>J#(R*;+<ZO(;NK=1VI(8F4"EI"LZKML7I735=?=#MR#@P/3>&OLMC6M
M%5<]N6M[<D_3QW.=([?C/SWMN\'MG&=EE_(1@<+C<-QH->H-U1'NAL4-!/<;
M17.J'X(H[?_^0;1@7^^T#WO*_C[H*6[S[QL05V'5HN@B8'-J.(7:^&>Z X6\
MD"_^._Z?!N(E,CLW-&P):SCG+'W<,/Z2R'>_TB'O/4;L60;Z@=EW  H=BB5&
M2(X&(:SZVV>-K9K&/%8:"=K>GU3='H5X\[AGGQ-3]G!](<6*FT\:+');==YF
MRIIC$Q&; E:U'2CIX9J[JED)^)8/'PD<^PPT-4UA6>"(L96IKY2_!Y<MA2AO
MF[J29<0$]='URQU)V9#Y=UM(C$RUU$]O>>H3_\F[G.JWO%FR=UPG_P)02P,$
M%     @ PX!B58SXX&-0!0  *A,  !4   !L9G9N7S Y,S R,GAE>#,R,BYH
M=&W=6&UOVS80_KY?<76P-@&L5]MQ_-( GNV@ ;(XB]5U_310(F43E465I.-X
MOWY'2DJ<I"[: 6O:!H$AZ<B[>^Z.SYTT?#&9C:/W5U-8ZE4&5V]_NS@?0\/Q
MO'>ML>=-H@F\B7Z_@+;K!Q!)DBNNN<A)YGG3RP8TEEH7?<_;;#;NIN4*N?"B
M:\^H:GN9$(JY5-/&Z= \P5]&Z.DOPQ>. Q.1K%<LUY!(1C2CL%8\7\ [RM0'
M<)QJU5@46\D72PVA'X;P3L@/_(:4<LUUQDYK/4.OO!]ZUL@P%G1[.J3\!CA]
MW>#A,>V&O3@.6(^U@Z07=[H^Z]*D0[N](&B?_!V@DQXN+_<HO<W8Z\:*Y\Z2
M&?O]=NAV.X4>;#C5RW[@^[\V[-+382IRC?8D[B\O2S5/E1&Y0'VQT%JL^B>H
M2[-;[9",+_*^!=DHE=4;$I$)V3_P[=_ 2)R4K'BV[;^*^(HIN&0;N!8KDK]J
M*DR,HYCD:;E0\7\8>HE&[.VF!-%%/1G/60TJ" V,Z>V2QUQ#*W3#AQAVO-_Q
M-<%P,_F_.]O^I+/CZ75T?G8^'D7GLTLLU^OYV]%E!-$,@A-XZ\[=L0OSZ=A*
M@U;';\)H#J/)["J:3O:"^VQJGA7N+L :5L\_AMD91&^F,!]=_S:ZG,Z=V5\7
MT_<P&D=&$OK^_D3NP<ISBCC[8=N6^3.A/<\A$7G.$D,QL.%Z"7K)(.69X0:1
MXAU7\'%-)&8DVX)DA9 :<.V9D"L(?.</L^J"I^Q/DFNR8,@@$M<0J_#0*'MY
M<!*&_F L5@7)M_8N&!Q!*J2U5:#G@@+#<%"8LT*S5<SDRX/@V!^TL)H,#S7O
M79NS9"V1$3$&)*<PO4V6)+=F5RNNE+&*_V8E19:#)9,,'=QUI,10^]&$\R:,
MB<Q@Y,)H+5D3KB3/$UZ0#,YX3O 2KV9IRA,FRY!8:P9,$_"9YBE>%&NIUA@"
MT&+W8)21+=&4IX.@XU04AH%W]SQ8:0JNLC0G,B8Y4\[L-F-;&"7:2$S!-5%.
M$$?G9/ 5M5<02C&W3L92+(K.HVITPM!]OFH,CFH@W][ZP\ $;3?HFCA$F(*J
MZ--UAB<@P<QGIOKN*E*RCVLNF>F)RN1&5:<I:!V2(\ J#SJ'].@NG_?U>U>[
M55*#7JN-Z>P-3&7_)"D-O\^4\ASI9U62%!*@)KB5XM,JH66^"3>45TBF3&J;
M1DRR#' ;>H.<@(("<ZV:%6?67($*J9W9+$/AJG565H9 KK,VU2,><7_(YF$"
MB6%D"V&:1<F$/"F#BETC9N9QNI8Y5TN,KA(9,_'\)%$:WNL.[ !AHX;[<Z%K
M'3S#_4B<!9&Z#EW=BJ1E5#QU*#2,3[E*,J&0R8%6H^I7A/>90CE!SRV3PZ6X
MV6F 8=G_:O\UB3-6^Q8+29ETT,6,%(KUZXL!1J#(R+;/<VO(;AH\1&I(XL8D
M+"%9-779NBK%U<S=#MSCXV,S=FN<M36M#5<3N6LG<D_3I[+>B=OS]XM]-[B3
M>59WJ1\1*#P.KQNM1KVA.L+]L+B%X.&8:$[U8Q"E_]\^B1;LRX-V=Z#L[X.)
MXJ[ZO@!OE50MBC["-6>&4ZA=_\I@H))GBL1_1?_C %QRECX=#W]*K(>?F8>/
MGB+V+-]\QUP[ H4!Q88B)$>'$$S]GK/!P4RS'!U".K;?2JK9CD*\?3JA+XEI
M<KB^D.*&F]<7;&D[7=TVL@W'D2$V[:H:,E#3XS7W/;)2\"4O.1(X3A7H:IK"
MNL GQE>F/M/L'GU8*43Y9:DO689-^X8]^=1R3THV9?[]%A(C,ZWU_BW[7N?W
M?K>I?LNO2/9[UNF_4$L! A0#%     @ PX!B58[[X>-> 0  ;00  !P
M         ( !     &$R,#(R,#DS,"UZ:6]N<W)L;V-A9&1E;BYH=&U02P$"
M% ,4    " ##@&)5J)Q3U>M4 0 CV0T $0              @ &8 0  ;&9V
M;BTR,#(R,#DS,"YH=&U02P$"% ,4    " ##@&)5K N6LJ\*  !D8   $0
M            @ &R5@$ ;&9V;BTR,#(R,#DS,"YX<V102P$"% ,4    " ##
M@&)5@0=.?&\7  "%V   %0              @ &080$ ;&9V;BTR,#(R,#DS
M,%]C86PN>&UL4$L! A0#%     @ PX!B50*(U\ZR)0  :6X! !4
M     ( !,GD! &QF=FXM,C R,C Y,S!?9&5F+GAM;%!+ 0(4 Q0    ( ,.
M8E6Q=:CO>I8  .X>!@ 5              "  1>? 0!L9G9N+3(P,C(P.3,P
M7VQA8BYX;6Q02P$"% ,4    " ##@&)59H9+9GQ1  #O>@, %0
M    @ '$-0( ;&9V;BTR,#(R,#DS,%]P<F4N>&UL4$L! A0#%     @ PX!B
M5:3;(J[6!P  DR4  !4              ( !<X<" &QF=FY?,#DS,#(R>&5X
M,S$Q+FAT;5!+ 0(4 Q0    ( ,. 8E7"_#;ZQ@<  '\E   5
M  "  7R/ @!L9G9N7S Y,S R,GAE>#,Q,BYH=&U02P$"% ,4    " ##@&)5
M"IMPB5H%   ^$P  %0              @ %UEP( ;&9V;E\P.3,P,C)X97@S
M,C$N:'1M4$L! A0#%     @ PX!B58SXX&-0!0  *A,  !4
M ( ! IT" &QF=FY?,#DS,#(R>&5X,S(R+FAT;5!+!08     "P + . "  "%
%H@(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
